Citrus Sinensis ID: 024118
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 272 | 2.2.26 [Sep-21-2011] | |||||||
| P85193 | 242 | Putative serine/threonine | N/A | no | 0.860 | 0.966 | 0.591 | 1e-79 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.878 | 0.250 | 0.531 | 1e-70 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.856 | 0.228 | 0.531 | 2e-69 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.863 | 0.227 | 0.531 | 1e-68 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.860 | 0.226 | 0.529 | 1e-68 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.841 | 0.221 | 0.541 | 9e-68 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.841 | 0.220 | 0.541 | 2e-67 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.841 | 0.225 | 0.525 | 6e-66 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.779 | 0.208 | 0.550 | 1e-64 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.845 | 0.324 | 0.514 | 3e-64 |
| >sp|P85193|PK01_HELAN Putative serine/threonine-protein kinase (Fragment) OS=Helianthus annuus PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 296 bits (758), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 145/245 (59%), Positives = 183/245 (74%), Gaps = 11/245 (4%)
Query: 1 MKSIFSCF-SFPSR-----VSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGG 54
MK F C F S V ++N GGE K FSY++LK+A +GF NK+GEGG
Sbjct: 1 MKMCFPCLQCFCSTSDDKVVVSKNDKGGESG-KKFRLFSYHELKVACDGFSSKNKVGEGG 59
Query: 55 FGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112
G+VYKGRL DGT+VA+KVLSVE S +GE+EF+SE+A++++ HENLV LHG C++
Sbjct: 60 CGAVYKGRLTDGTMVAIKVLSVELESMRGEREFISEIAALSDAQ--HENLVNLHGCCVEE 117
Query: 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172
R LVYDYM NNSL+ LG E+ R F W R+ +++G+ + LAY+HEEI PH+VHRD
Sbjct: 118 ATRCLVYDYMENNSLAYQFLGREQNRNSFDWTKRKNVLLGVAKALAYLHEEINPHIVHRD 177
Query: 173 IKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVY 232
IK SN+LLD NFNPK++DFGL++LF E T+HISTRVAGTLGYL+PEYA+S RLTRKSDVY
Sbjct: 178 IKASNVLLDHNFNPKVADFGLARLFQEGTSHISTRVAGTLGYLSPEYAVSERLTRKSDVY 237
Query: 233 SFGVL 237
SFGVL
Sbjct: 238 SFGVL 242
|
Helianthus annuus (taxid: 4232) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (681), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 128/241 (53%), Positives = 179/241 (74%), Gaps = 2/241 (0%)
Query: 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSE 88
I +FS Q+KIATN F +N+IGEGGFG VYKG+L DGTI+AVK LS SKQG +EF++E
Sbjct: 609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668
Query: 89 VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
+ ++ ++ H NLVKL+G C++G +LVY+++ NNSL++ L G ++ + + W RR+
Sbjct: 669 IGMISALH--HPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRK 726
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
I +G+ RGLAY+HEE + +VHRDIK +N+LLD+ NPKISDFGL+KL E++THISTR+
Sbjct: 727 ICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRI 786
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINM 268
AGT GY+APEYA+ G LT K+DVYSFG++ LEIV GR+ + ++L+D V +
Sbjct: 787 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLRE 846
Query: 269 K 269
K
Sbjct: 847 K 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 125/235 (53%), Positives = 175/235 (74%), Gaps = 2/235 (0%)
Query: 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSE 88
I++FS Q+K+AT+ F +NKIGEGGFG V+KG + DGT++AVK LS +SKQG +EF++E
Sbjct: 657 ISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNE 716
Query: 89 VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
+A ++ + H +LVKL+G C++G +LVY+Y+ NNSL++ L G ++ + W R++
Sbjct: 717 IAMISALQ--HPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQK 774
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
I +GI RGLAY+HEE + +VHRDIK +N+LLD+ NPKISDFGL+KL E THISTRV
Sbjct: 775 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRV 834
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
AGT GY+APEYA+ G LT K+DVYSFGV+ LEIV G++ + ++L+D V
Sbjct: 835 AGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWV 889
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 127/239 (53%), Positives = 174/239 (72%), Gaps = 4/239 (1%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
F+Y++LK AT F SNK+GEGGFG VYKG+L DG VAVK+LSV S+QG+ +F++E+
Sbjct: 680 TFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIV 739
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
+++ V H NLVKL+G C +G R+LVY+Y+PN SL Q L GE + W R EI
Sbjct: 740 AISAVQ--HRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGE--KTLHLDWSTRYEIC 795
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+G+ RGL Y+HEE + +VHRD+K SNILLD PK+SDFGL+KL+ + THISTRVAG
Sbjct: 796 LGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAG 855
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 269
T+GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR D +++ + +L++ +++ K
Sbjct: 856 TIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEK 914
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 126/238 (52%), Positives = 174/238 (73%), Gaps = 4/238 (1%)
Query: 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
F+Y++LK AT F SNK+GEGGFG VYKG L DG +VAVK+LSV S+QG+ +F++E+ +
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
+++V H NLVKL+G C +G R+LVY+Y+PN SL Q L G+ + W R EI +
Sbjct: 742 ISSV--LHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGD--KTLHLDWSTRYEICL 797
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
G+ RGL Y+HEE +VHRD+K SNILLD P+ISDFGL+KL+ + THISTRVAGT
Sbjct: 798 GVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGT 857
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 269
+GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR D +++ + +L++ +++ K
Sbjct: 858 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 256 bits (655), Expect = 9e-68, Method: Compositional matrix adjust.
Identities = 125/231 (54%), Positives = 169/231 (73%), Gaps = 2/231 (0%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
+F+ Q+K ATN F NKIGEGGFG VYKG L DG +AVK LS +SKQG +EF++E+
Sbjct: 654 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 713
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
++ + H NLVKL+G CI+G +LVY+Y+ NNSL++ L G EK+R W R ++
Sbjct: 714 MISALQ--HPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVC 771
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+GI +GLAY+HEE + +VHRDIK +N+LLD + N KISDFGL+KL E THISTR+AG
Sbjct: 772 IGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAG 831
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
T+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++ ++ + +L+D
Sbjct: 832 TIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLD 882
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (653), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 125/231 (54%), Positives = 169/231 (73%), Gaps = 2/231 (0%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
+F+ Q+K ATN F NKIGEGGFG VYKG L DG +AVK LS +SKQG +EF++E+
Sbjct: 656 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 715
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
++ + H NLVKL+G CI+G +LVY+Y+ NNSL++ L G EK+R W R +I
Sbjct: 716 MISALQ--HPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKIC 773
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+GI +GLAY+HEE + +VHRDIK +N+LLD + N KISDFGL+KL + THISTR+AG
Sbjct: 774 IGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAG 833
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
T+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++ ++ + +L+D
Sbjct: 834 TIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLD 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 122/232 (52%), Positives = 169/232 (72%), Gaps = 3/232 (1%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
F+ Q+K AT+ F + KIGEGGFGSVYKG L +G ++AVK LS +S+QG +EF++E+
Sbjct: 665 TFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIG 724
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG-EEKRRAKFGWKARREI 149
++ + H NLVKL+G C++G ILVY+Y+ NN LS+ L G +E R K W R++I
Sbjct: 725 MISALQ--HPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKI 782
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
+GI +GL ++HEE + +VHRDIK SN+LLD++ N KISDFGL+KL + THISTR+A
Sbjct: 783 FLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIA 842
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
GT+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++ +F +L+D
Sbjct: 843 GTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLD 894
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 246 bits (628), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 119/216 (55%), Positives = 162/216 (75%), Gaps = 4/216 (1%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
FS+ QL+ ATN F +NK+GEGGFGSV+KG L DGTI+AVK LS +S QG +EF++E+
Sbjct: 660 CFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIG 719
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
++ +N H NLVKL+G C++ +LVY+YM NNSL+ L G+ K W AR++I
Sbjct: 720 MISGLN--HPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQNS--LKLDWAARQKIC 775
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+GI RGL ++H+ +VHRDIKT+N+LLD + N KISDFGL++L THIST+VAG
Sbjct: 776 VGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAG 835
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
T+GY+APEYA+ G+LT K+DVYSFGV+ +EIVSG++
Sbjct: 836 TIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKS 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 121/235 (51%), Positives = 164/235 (69%), Gaps = 5/235 (2%)
Query: 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
FSY +L ATNGF N +GEGGFG VYKG L DG +VAVK L + QG++EF +EV +
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVET 424
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
++ ++ H +LV + G CI G R+L+YDY+ NN L L GE ++ W R +I
Sbjct: 425 LSRIH--HRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGE---KSVLDWATRVKIAA 479
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
G RGLAY+HE+ P ++HRDIK+SNILL+ NF+ ++SDFGL++L + THI+TRV GT
Sbjct: 480 GAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGT 539
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSI 266
GY+APEYA SG+LT KSDV+SFGV+LLE+++GR VD LG+ LV+ R +
Sbjct: 540 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPL 594
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 272 | ||||||
| 224113013 | 345 | predicted protein [Populus trichocarpa] | 0.889 | 0.701 | 0.766 | 1e-107 | |
| 296086032 | 288 | unnamed protein product [Vitis vinifera] | 0.933 | 0.881 | 0.730 | 1e-105 | |
| 224097961 | 340 | predicted protein [Populus trichocarpa] | 0.871 | 0.697 | 0.757 | 1e-105 | |
| 225449074 | 449 | PREDICTED: probable LRR receptor-like se | 0.878 | 0.532 | 0.767 | 1e-104 | |
| 255577375 | 392 | ATP binding protein, putative [Ricinus c | 0.867 | 0.602 | 0.743 | 1e-101 | |
| 255557018 | 378 | ATP binding protein, putative [Ricinus c | 0.948 | 0.682 | 0.651 | 2e-94 | |
| 297741595 | 433 | unnamed protein product [Vitis vinifera] | 0.915 | 0.575 | 0.648 | 2e-91 | |
| 225439972 | 399 | PREDICTED: putative serine/threonine-pro | 0.915 | 0.624 | 0.648 | 2e-91 | |
| 449450984 | 364 | PREDICTED: putative serine/threonine-pro | 0.933 | 0.697 | 0.610 | 5e-88 | |
| 225461636 | 385 | PREDICTED: probable leucine-rich repeat | 0.933 | 0.659 | 0.550 | 3e-81 |
| >gi|224113013|ref|XP_002316361.1| predicted protein [Populus trichocarpa] gi|222865401|gb|EEF02532.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1014), Expect = e-107, Method: Compositional matrix adjust.
Identities = 187/244 (76%), Positives = 218/244 (89%), Gaps = 2/244 (0%)
Query: 19 TIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES 78
I G QIL+N++AFS+++LK+ATNGFR SNKIGEGGFGSVYKG LQDG IVA+K+LS ES
Sbjct: 2 VITGLQILQNVHAFSFDELKVATNGFRSSNKIGEGGFGSVYKGVLQDGRIVAIKMLSAES 61
Query: 79 KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
KQG +EFMSE+AS++N+N HENLV LHGGCIDGPC+ILVYDYM N SL+QTLLG E+ R
Sbjct: 62 KQGHREFMSEIASVSNIN--HENLVNLHGGCIDGPCKILVYDYMENGSLAQTLLGGEENR 119
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
A+FGW+ RR I +GI +GLAYIHEEI+PH+VHRDIK SNILLD+N PK+SDFGLSKLFP
Sbjct: 120 ARFGWETRRGISLGIAQGLAYIHEEIKPHIVHRDIKASNILLDKNLCPKVSDFGLSKLFP 179
Query: 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
EN TH+STRVAGTLGYLAPEYAISGRLTRK+DVYSFGVLLLEIVSGR A DFD +LGE++
Sbjct: 180 ENFTHVSTRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLEIVSGRKATDFDPELGEHY 239
Query: 259 LVDK 262
LV+K
Sbjct: 240 LVEK 243
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296086032|emb|CBI31473.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 387 bits (994), Expect = e-105, Method: Compositional matrix adjust.
Identities = 192/263 (73%), Positives = 220/263 (83%), Gaps = 9/263 (3%)
Query: 7 CFSFPSRVSAENTIGGEQI------LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYK 60
CF +PS + GG I L+N +AF+YN++KIAT GFR S+KIG+GGFGSVYK
Sbjct: 10 CF-YPSSDDLHDNNGGRVIKSGLPTLQNAHAFTYNEIKIATGGFRSSDKIGQGGFGSVYK 68
Query: 61 GRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120
GRLQDGT+VAVKVLS ESKQG++EFMSE+AS++N+N HENLVKLHGGC+ G R+LVYD
Sbjct: 69 GRLQDGTVVAVKVLSAESKQGDREFMSEMASISNIN--HENLVKLHGGCVHGARRMLVYD 126
Query: 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180
YM NNSLS TLL EKRRAKF WK RREI +GI RGLAYIHE+I PHVVHRDIK SNILL
Sbjct: 127 YMQNNSLSHTLLRGEKRRAKFSWKTRREICLGIARGLAYIHEDITPHVVHRDIKASNILL 186
Query: 181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 240
D +F PKISDFGLSKLF N THI+TRVAGTLGYLAPEYA+SG LTRKSDVYSFGVL+LE
Sbjct: 187 DGDFTPKISDFGLSKLFYTNITHITTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLILE 246
Query: 241 IVSGRTAVDFDVQLGEYHLVDKV 263
IVSGRTA+DFD+ LGE++LV KV
Sbjct: 247 IVSGRTAIDFDLDLGEHYLVQKV 269
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097961|ref|XP_002311099.1| predicted protein [Populus trichocarpa] gi|222850919|gb|EEE88466.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 385 bits (990), Expect = e-105, Method: Compositional matrix adjust.
Identities = 181/239 (75%), Positives = 216/239 (90%), Gaps = 2/239 (0%)
Query: 24 QILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK 83
Q+L+N++AFS+N+LK+ATNGFR SNKIGEGGFGSVYKG LQDG +VAVK+LS SKQG++
Sbjct: 2 QVLQNVHAFSFNELKVATNGFRSSNKIGEGGFGSVYKGILQDGRMVAVKMLSAGSKQGDR 61
Query: 84 EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW 143
EF+SE+AS++N+N HENLVKLHGGCIDGP +ILVYDYM N SL+QTLLG E++RAKF W
Sbjct: 62 EFISEIASVSNIN--HENLVKLHGGCIDGPYKILVYDYMENGSLAQTLLGSEEKRAKFRW 119
Query: 144 KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
+ RREI +GI +GLAYIHEEI+P +VHRDIK SNILLDQN PK+SDFGLSKLFPE+ TH
Sbjct: 120 ETRREISLGIAQGLAYIHEEIKPRIVHRDIKASNILLDQNLCPKVSDFGLSKLFPEDFTH 179
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
+STRVAGTLGYLAPEYAISGRLTRK+DVYSFGVLLL+I+ GR AVDFD +LGE++LV+K
Sbjct: 180 VSTRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLQIICGRKAVDFDPELGEHYLVEK 238
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449074|ref|XP_002274408.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 384 bits (986), Expect = e-104, Method: Compositional matrix adjust.
Identities = 185/241 (76%), Positives = 211/241 (87%), Gaps = 2/241 (0%)
Query: 22 GEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG 81
G L+N +AF+YN++KIAT GFR S+KIG+GGFGSVYKGRLQDGT+VAVKVLS ESKQG
Sbjct: 109 GLPTLQNAHAFTYNEIKIATGGFRSSDKIGQGGFGSVYKGRLQDGTVVAVKVLSAESKQG 168
Query: 82 EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKF 141
++EFMSE+AS++N+N HENLVKLHGGC+ G R+LVYDYM NNSLS TLL EKRRAKF
Sbjct: 169 DREFMSEMASISNIN--HENLVKLHGGCVHGARRMLVYDYMQNNSLSHTLLRGEKRRAKF 226
Query: 142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
WK RREI +GI RGLAYIHE+I PHVVHRDIK SNILLD +F PKISDFGLSKLF N
Sbjct: 227 SWKTRREICLGIARGLAYIHEDITPHVVHRDIKASNILLDGDFTPKISDFGLSKLFYTNI 286
Query: 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
THI+TRVAGTLGYLAPEYA+SG LTRKSDVYSFGVL+LEIVSGRTA+DFD+ LGE++LV
Sbjct: 287 THITTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLILEIVSGRTAIDFDLDLGEHYLVQ 346
Query: 262 K 262
K
Sbjct: 347 K 347
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577375|ref|XP_002529567.1| ATP binding protein, putative [Ricinus communis] gi|223530943|gb|EEF32801.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 375 bits (963), Expect = e-101, Method: Compositional matrix adjust.
Identities = 177/238 (74%), Positives = 209/238 (87%), Gaps = 2/238 (0%)
Query: 25 ILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE 84
IL+N++AFSY +LK+ATN F SNKIGEGGFGSVYKG L++G VAVKVLS ES+QG+KE
Sbjct: 54 ILQNVHAFSYRELKVATNSFHLSNKIGEGGFGSVYKGMLENGKFVAVKVLSAESRQGDKE 113
Query: 85 FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK 144
F+SE+AS+++++ HENLV LHG CIDGPCRILVYDYM N +L+Q LLG +K + KF W+
Sbjct: 114 FLSEIASLSSIS--HENLVILHGACIDGPCRILVYDYMENGNLAQILLGGDKIKRKFCWR 171
Query: 145 ARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
RREI +GI GLA+IHEEI+PH+VHRDIK SNILLDQNF PK+SDFGLSKLF +N THI
Sbjct: 172 VRREISLGIAEGLAHIHEEIKPHIVHRDIKASNILLDQNFAPKVSDFGLSKLFADNITHI 231
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
STRVAGTLGYLAPEYAISG LTRKSD+YSFGVLLLEIVSGRTAVDFD++LGE+ LV+K
Sbjct: 232 STRVAGTLGYLAPEYAISGHLTRKSDIYSFGVLLLEIVSGRTAVDFDLELGEHFLVEK 289
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557018|ref|XP_002519542.1| ATP binding protein, putative [Ricinus communis] gi|223541405|gb|EEF42956.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 351 bits (900), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 172/264 (65%), Positives = 218/264 (82%), Gaps = 6/264 (2%)
Query: 3 SIFS-CFSFPSRVSAENTIG-GEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYK 60
S FS C SFP+ A +TI GEQ N+ FS +L+IAT+ F SNK+GEG FGSVY
Sbjct: 5 SCFSFCSSFPNSRPAISTISTGEQKHGNLQIFSSRELEIATHDFSSSNKVGEGAFGSVYM 64
Query: 61 GRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118
G+L++G+IVAVKVLSVE S +GE+EF+SE+A++++++ HENLVKL G C+DG R LV
Sbjct: 65 GQLKNGSIVAVKVLSVELESMRGEREFISELAALSDIS--HENLVKLQGCCVDGANRYLV 122
Query: 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178
YDYM NNSL+QTLLG+E+ R KF W+ARR I G+ RGLAYIHEE++PH++HRDIK SNI
Sbjct: 123 YDYMENNSLTQTLLGKEQNRMKFSWEARRNISFGVARGLAYIHEEVKPHILHRDIKASNI 182
Query: 179 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 238
LLD++F PK++DFGLS++ +NT+H+STRVAGTLGYLAPEYA+SG LTRKSDVYSFGVLL
Sbjct: 183 LLDKDFTPKVADFGLSRILRDNTSHVSTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLL 242
Query: 239 LEIVSGRTAVDFDVQLGEYHLVDK 262
LEI+SGR+AVDFD++LGE+ LV K
Sbjct: 243 LEIISGRSAVDFDLELGEHFLVQK 266
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741595|emb|CBI32727.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 341 bits (875), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 164/253 (64%), Positives = 206/253 (81%), Gaps = 4/253 (1%)
Query: 13 RVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVK 72
R S+ G + FSY +LKIAT+ F SNKIGEGGFGSVYKG+L+DGT VAVK
Sbjct: 55 RSSSSGQETGGNTSEKFQVFSYKELKIATDSFHPSNKIGEGGFGSVYKGQLRDGTTVAVK 114
Query: 73 VLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 130
VLSVE S +GE+EF+SE++++ ++ HENLV L G C++G R LVYDYM NNSL+QT
Sbjct: 115 VLSVEIESMRGEREFVSELSALTDIK--HENLVTLQGCCVEGASRFLVYDYMENNSLAQT 172
Query: 131 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
LLG ++ R +FGW+ARR I +G+GRGLAY+HEE+QPH++HRDIK +NILLDQN PKISD
Sbjct: 173 LLGAKQNRMEFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANILLDQNLAPKISD 232
Query: 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250
FGLSKLF ++ +HISTRVAGTLGYLAPEYA+SGRLTRKSDVYSFGVLLLEI+SG + V++
Sbjct: 233 FGLSKLFVDSRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLLEIISGHSVVEY 292
Query: 251 DVQLGEYHLVDKV 263
D++ GE++LV+K
Sbjct: 293 DLEHGEHYLVEKA 305
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439972|ref|XP_002281059.1| PREDICTED: putative serine/threonine-protein kinase [Vitis vinifera] gi|147770086|emb|CAN69887.1| hypothetical protein VITISV_005073 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 341 bits (874), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 164/253 (64%), Positives = 206/253 (81%), Gaps = 4/253 (1%)
Query: 13 RVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVK 72
R S+ G + FSY +LKIAT+ F SNKIGEGGFGSVYKG+L+DGT VAVK
Sbjct: 21 RSSSSGQETGGNTSEKFQVFSYKELKIATDSFHPSNKIGEGGFGSVYKGQLRDGTTVAVK 80
Query: 73 VLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 130
VLSVE S +GE+EF+SE++++ ++ HENLV L G C++G R LVYDYM NNSL+QT
Sbjct: 81 VLSVEIESMRGEREFVSELSALTDIK--HENLVTLQGCCVEGASRFLVYDYMENNSLAQT 138
Query: 131 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190
LLG ++ R +FGW+ARR I +G+GRGLAY+HEE+QPH++HRDIK +NILLDQN PKISD
Sbjct: 139 LLGAKQNRMEFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANILLDQNLAPKISD 198
Query: 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250
FGLSKLF ++ +HISTRVAGTLGYLAPEYA+SGRLTRKSDVYSFGVLLLEI+SG + V++
Sbjct: 199 FGLSKLFVDSRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLLEIISGHSVVEY 258
Query: 251 DVQLGEYHLVDKV 263
D++ GE++LV+K
Sbjct: 259 DLEHGEHYLVEKA 271
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450984|ref|XP_004143242.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus] gi|449482501|ref|XP_004156301.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 330 bits (845), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 158/259 (61%), Positives = 205/259 (79%), Gaps = 5/259 (1%)
Query: 7 CFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG 66
C+S PS + E++ Q ++ +SYN+LK+ATNGF +NK+GEGGFG+VYKG L+D
Sbjct: 11 CYS-PSSTAMESSRHDRQDSESFRVYSYNELKLATNGFSGANKVGEGGFGTVYKGWLRDD 69
Query: 67 TIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124
+AVKVLS VES +GE+EF++E+ S++N+ HENLV+L G +DG R LVYDYM N
Sbjct: 70 RKIAVKVLSIEVESMRGEREFIAELTSLSNIR--HENLVELKGFYVDGSNRYLVYDYMEN 127
Query: 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184
NSL+ L G + R + W AR+EI++G+ RGLAY+HEE++PH+VHRDIK SNILLD NF
Sbjct: 128 NSLAYVLQGVRENRMRLRWIARKEILIGVARGLAYLHEEVEPHIVHRDIKASNILLDHNF 187
Query: 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
PK++DFGL+KL EN++H+STRVAGT+GYLAPEYA+SG LTRKSDVYSFGVLLLEIVSG
Sbjct: 188 KPKVADFGLAKLLRENSSHVSTRVAGTIGYLAPEYAVSGHLTRKSDVYSFGVLLLEIVSG 247
Query: 245 RTAVDFDVQLGEYHLVDKV 263
R VDFD++ GE+HLV +V
Sbjct: 248 RATVDFDLEHGEHHLVQRV 266
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461636|ref|XP_002285391.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 [Vitis vinifera] gi|302142911|emb|CBI20206.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 307 bits (787), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 148/269 (55%), Positives = 199/269 (73%), Gaps = 15/269 (5%)
Query: 5 FSCFSFPSR----------VSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGG 54
+CFSF R ++ + G ++N+N +SY +L+IAT F +NKIGEGG
Sbjct: 1 MTCFSFCFRKKVASSITRTAEVDDVVSG---IQNVNRYSYRELRIATQDFSLANKIGEGG 57
Query: 55 FGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114
FGSVYKG L+DGT+VA+KVLS +S+QG +EF++E++ ++ + HENLV+L+G C+D
Sbjct: 58 FGSVYKGTLRDGTVVAIKVLSAQSRQGLREFLTELSVISVIE--HENLVELYGCCVDEDQ 115
Query: 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174
RILVY Y+ NNSL+QTLL +F WK R +I +G+ RGLA++HEE+ PH+VHRDIK
Sbjct: 116 RILVYGYLENNSLAQTLLDGGHSGIQFSWKTRTKICIGVARGLAFLHEEVHPHIVHRDIK 175
Query: 175 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 234
SNILLD++ PKISDFGL+KL PE+ TH+STRVAGT GYLAPEYAI G+LTRK+D+YSF
Sbjct: 176 ASNILLDKDLTPKISDFGLAKLIPEDQTHVSTRVAGTTGYLAPEYAIRGQLTRKADIYSF 235
Query: 235 GVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
GVLLLEIV GR+ + + GE+ L++ V
Sbjct: 236 GVLLLEIVCGRSNKNTRLAYGEHFLLEMV 264
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 272 | ||||||
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.886 | 0.613 | 0.554 | 1.8e-71 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.827 | 0.576 | 0.569 | 4.3e-70 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.878 | 0.250 | 0.531 | 9.8e-66 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.860 | 0.223 | 0.525 | 5e-64 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.860 | 0.226 | 0.529 | 9.6e-64 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.841 | 0.221 | 0.541 | 3.4e-62 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.897 | 0.344 | 0.501 | 1.9e-60 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.783 | 0.219 | 0.555 | 7.3e-60 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.871 | 0.353 | 0.516 | 2.2e-59 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.794 | 0.200 | 0.536 | 2.8e-59 |
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 1.8e-71, P = 1.8e-71
Identities = 137/247 (55%), Positives = 183/247 (74%)
Query: 5 FSCFSFPSRVSAENTIG---GEQIL-KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYK 60
++CF + + +G E+I N+ FSYN L+ AT+ F +N+IG GG+G V+K
Sbjct: 3 YNCFGLLDMCNGSDRLGQREAEEICTNNVRVFSYNSLRSATDSFHPTNRIGGGGYGVVFK 62
Query: 61 GRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120
G L+DGT VAVK LS ESKQG +EF++E+ ++N++ H NLVKL G CI+G RILVY+
Sbjct: 63 GVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIH--HPNLVKLIGCCIEGNNRILVYE 120
Query: 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180
Y+ NNSL+ LLG R W R I +G GLA++HEE++PHVVHRDIK SNILL
Sbjct: 121 YLENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILL 180
Query: 181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 240
D NF+PKI DFGL+KLFP+N TH+STRVAGT+GYLAPEYA+ G+LT+K+DVYSFG+L+LE
Sbjct: 181 DSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVLE 240
Query: 241 IVSGRTA 247
++SG ++
Sbjct: 241 VISGNSS 247
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 4.3e-70, P = 4.3e-70
Identities = 131/230 (56%), Positives = 180/230 (78%)
Query: 20 IGGE-QILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES 78
+ GE + N+ + Y +++ AT+ F NKIGEGGFGSVYKG L+DG + A+KVLS ES
Sbjct: 16 VDGEIAAIDNVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAES 75
Query: 79 KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL--GEEK 136
+QG KEF++E+ ++ + HENLVKL+G C++G RILVY+++ NNSL +TLL G +
Sbjct: 76 RQGVKEFLTEINVISEIQ--HENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTR 133
Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
+F W +R I +G+ +GLA++HEE++PH++HRDIK SNILLD+ +PKISDFGL++L
Sbjct: 134 SGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARL 193
Query: 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
P N TH+STRVAGT+GYLAPEYA+ G+LTRK+D+YSFGVLL+EIVSGR+
Sbjct: 194 MPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRS 243
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 9.8e-66, P = 9.8e-66
Identities = 128/241 (53%), Positives = 179/241 (74%)
Query: 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSE 88
I +FS Q+KIATN F +N+IGEGGFG VYKG+L DGTI+AVK LS SKQG +EF++E
Sbjct: 609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668
Query: 89 VASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
+ ++ ++ H NLVKL+G C++G +LVY+++ NNSL++ L G ++ + + W RR+
Sbjct: 669 IGMISALH--HPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRK 726
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
I +G+ RGLAY+HEE + +VHRDIK +N+LLD+ NPKISDFGL+KL E++THISTR+
Sbjct: 727 ICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRI 786
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINM 268
AGT GY+APEYA+ G LT K+DVYSFG++ LEIV GR+ + ++L+D V +
Sbjct: 787 AGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLRE 846
Query: 269 K 269
K
Sbjct: 847 K 847
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 5.0e-64, P = 5.0e-64
Identities = 125/238 (52%), Positives = 174/238 (73%)
Query: 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
F+Y++LK AT F SNK+GEGGFG+VYKG L DG VAVK LS+ S+QG+ +F++E+ +
Sbjct: 698 FTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIA 757
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
+++V H NLVKL+G C +G R+LVY+Y+PN SL Q L G++ W R EI +
Sbjct: 758 ISSV--LHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLH--LDWSTRYEICL 813
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
G+ RGL Y+HEE ++HRD+K SNILLD PK+SDFGL+KL+ + THISTRVAGT
Sbjct: 814 GVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGT 873
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 269
+GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR D +++ G+ +L++ +++ K
Sbjct: 874 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEK 931
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 656 (236.0 bits), Expect = 9.6e-64, P = 9.6e-64
Identities = 126/238 (52%), Positives = 174/238 (73%)
Query: 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
F+Y++LK AT F SNK+GEGGFG VYKG L DG +VAVK+LSV S+QG+ +F++E+ +
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
+++V H NLVKL+G C +G R+LVY+Y+PN SL Q L G+ + W R EI +
Sbjct: 742 ISSV--LHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGD--KTLHLDWSTRYEICL 797
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
G+ RGL Y+HEE +VHRD+K SNILLD P+ISDFGL+KL+ + THISTRVAGT
Sbjct: 798 GVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGT 857
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 269
+GYLAPEYA+ G LT K+DVY+FGV+ LE+VSGR D +++ + +L++ +++ K
Sbjct: 858 IGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 3.4e-62, P = 3.4e-62
Identities = 125/231 (54%), Positives = 169/231 (73%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
+F+ Q+K ATN F NKIGEGGFG VYKG L DG +AVK LS +SKQG +EF++E+
Sbjct: 654 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 713
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
++ + H NLVKL+G CI+G +LVY+Y+ NNSL++ L G EK+R W R ++
Sbjct: 714 MISALQ--HPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVC 771
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+GI +GLAY+HEE + +VHRDIK +N+LLD + N KISDFGL+KL E THISTR+AG
Sbjct: 772 IGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAG 831
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261
T+GY+APEYA+ G LT K+DVYSFGV+ LEIVSG++ ++ + +L+D
Sbjct: 832 TIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLD 882
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 127/253 (50%), Positives = 172/253 (67%)
Query: 15 SAENTIGGEQILKNINA-FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKV 73
S ++ GG L N A FSY +L ATNGF N +GEGGFG VYKG L DG +VAVK
Sbjct: 350 SYQSQSGG---LGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQ 406
Query: 74 LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG 133
L + QG++EF +EV +++ ++ H +LV + G CI G R+L+YDY+ NN L L G
Sbjct: 407 LKIGGGQGDREFKAEVETLSRIH--HRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHG 464
Query: 134 EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193
E ++ W R +I G RGLAY+HE+ P ++HRDIK+SNILL+ NF+ ++SDFGL
Sbjct: 465 E---KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGL 521
Query: 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253
++L + THI+TRV GT GY+APEYA SG+LT KSDV+SFGV+LLE+++GR VD
Sbjct: 522 ARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQP 581
Query: 254 LGEYHLVDKVRSI 266
LG+ LV+ R +
Sbjct: 582 LGDESLVEWARPL 594
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 7.3e-60, P = 7.3e-60
Identities = 120/216 (55%), Positives = 161/216 (74%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
+FS QLK+ATN F NKIGEGGFGSVYKGRL DGT++AVK LS +S QG KEF++E+
Sbjct: 627 SFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIG 686
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
+A + H NLVKL+G C++ +LVY+Y+ NN LS L + K W R +I
Sbjct: 687 MIACLQ--HPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAG-RSCLKLEWGTRHKIC 743
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+GI RGLA++HE+ ++HRDIK +N+LLD++ N KISDFGL++L +N +HI+TRVAG
Sbjct: 744 LGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAG 803
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
T+GY+APEYA+ G LT K+DVYSFGV+ +EIVSG++
Sbjct: 804 TIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKS 839
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
Identities = 125/242 (51%), Positives = 169/242 (69%)
Query: 28 NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
N + F+Y++L IAT GF SN +G+GGFG V+KG L G VAVK L + S QGE+EF +
Sbjct: 296 NQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQA 355
Query: 88 EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
EV ++ V+ H +LV L G CI G R+LVY+++PNN+L L G K R W R
Sbjct: 356 EVDIISRVH--HRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHG--KGRPVLDWPTRV 411
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
+I +G RGLAY+HE+ P ++HRDIK +NILLD +F K++DFGL+KL +N TH+STR
Sbjct: 412 KIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTR 471
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSIN 267
V GT GYLAPEYA SG+L+ KSDV+SFGV+LLE+++GR +D ++ E LVD R +
Sbjct: 472 VMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEM-EDSLVDWARPLC 530
Query: 268 MK 269
+K
Sbjct: 531 LK 532
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 2.8e-59, P = 2.8e-59
Identities = 118/220 (53%), Positives = 165/220 (75%)
Query: 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVA 90
+FS QLK+AT+ F NKIGEGGFGSVYKGRL +GT++AVK LS +S QG KEF++E+
Sbjct: 664 SFSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIG 723
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
+A + H NLVKL+G C++ +LVY+Y+ NN L+ L G + K W+ R +I
Sbjct: 724 IIACLQ--HPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFG--RSGLKLDWRTRHKIC 779
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+GI RGLA++HE+ ++HRDIK +NILLD++ N KISDFGL++L ++ +HI+TRVAG
Sbjct: 780 LGIARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAG 839
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250
T+GY+APEYA+ G LT K+DVYSFGV+ +EIVSG++ ++
Sbjct: 840 TIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANY 879
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P85193 | PK01_HELAN | 2, ., 7, ., 1, 1, ., 1 | 0.5918 | 0.8602 | 0.9669 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 272 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-52
Identities = 73/196 (37%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHG 107
+GEGGFG+VY R + G VA+K++ E E + E+ + +N H N+VKL+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYG 58
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
D LV +Y SL LL ++ K I++ I GL Y+H
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKD-LL--KENEGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 168 VVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRL 225
++HRD+K NILLD N K++DFGLSKL + + + T V GT Y+APE + G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYY 171
Query: 226 TRKSDVYSFGVLLLEI 241
+ KSD++S GV+L E+
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-52
Identities = 72/221 (32%), Positives = 116/221 (52%), Gaps = 14/221 (6%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKL 105
K+G G FG+VYK + + G IVAVK+L S + ++ E+ + ++ H N+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS--HPNIVRL 63
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
D LV +Y L L R ++I + I RGL Y+H
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN-- 117
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
++HRD+K NILLD+N KI+DFGL+K ++++ ++T V GT Y+APE + G
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 226 -TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 265
K DV+S GV+L E+++G+ + L + L+ ++
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILG 216
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 7e-49
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKL 105
K+GEG FG VY R + G +VA+KV+ + + ++E + E+ + + H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK--HPNIVRL 62
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+ D LV +Y L L K+R + R + I L Y+H +
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK-- 116
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
+VHRD+K NILLD++ + K++DFGL++ + ++T V GT Y+APE +
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGY 173
Query: 226 TRKSDVYSFGVLLLEIVSGRT 246
+ D++S GV+L E+++G+
Sbjct: 174 GKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-48
Identities = 72/201 (35%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 49 KIGEGGFGSVYKGRL----QDGTI-VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL 102
K+GEG FG VYKG+L + VAVK L + S+Q +EF+ E M ++ H N+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD--HPNV 63
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
VKL G C + +V +YM L L K R K + I RG+ Y+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
+ + +HRD+ N L+ +N KISDFGLS+ ++ + + ++APE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
G+ T KSDV+SFGVLL EI +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-47
Identities = 71/201 (35%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 49 KIGEGGFGSVYKGRLQDG-----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL 102
K+GEG FG VYKG L+ VAVK L + S+Q +EF+ E M ++ H N+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD--HPNI 63
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
VKL G C + ++V +YMP L L + R + + I RG+ Y+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
+ + +HRD+ N L+ +N KISDFGLS+ ++ + + ++APE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
G+ T KSDV+SFGVLL EI +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-46
Identities = 75/207 (36%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 49 KIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
K+GEG FG VYKG L T VAVK L + + E+ EF+ E + M ++ H N+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS--HPNI 63
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
V+L G C G +V +YMP L L K K K ++ + I +G+ Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----AP 217
+ + VHRD+ N L+ +N KISDFGLS+ G L AP
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAP 173
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
E G+ T KSDV+SFGVLL EI +
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 70/208 (33%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 48 NKIGEGGFGSVYKGRLQDG----TIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENL 102
K+GEG FG VYKG+L+ T VAVK L S++ K+F+ E M + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNV 58
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
V+L G C + LV +YM L + ++ K + I +G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYL 215
Y+ + VHRD+ N L+ ++ KISDFGLS+ + + + G L ++
Sbjct: 119 EYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWM 174
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
APE G T KSDV+SFGVLL EI +
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-39
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHE 100
+ +G G FGSVY +D G ++AVK + + E + E+ ++++ H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--HP 59
Query: 101 NLVKLHGGCIDGPCR-ILVY-DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----I 153
N+V+ +G D + ++ +Y+ SLS L K+ K E ++ I
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKL-----PEPVIRKYTRQI 110
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTL 212
GLAY+H +VHRDIK +NIL+D + K++DFG +K + T T V GT
Sbjct: 111 LEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
++APE R +D++S G ++E+ +G+
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-35
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
F KIG+GGFG VYK R + G VA+KV+ +ESK+ +++ ++E+ + H N+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK--HPNI 59
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYI 160
VK +G + +V ++ SL LL + A +E++ G L Y+
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKG----LEYL 114
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H ++HRDIK +NILL + K+ DFGLS + T + GT ++APE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVI 169
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
K+D++S G+ +E+ G+
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-35
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSV-ESKQGEKEF-MSEVASMANVNVCHE 100
+ +IG+G FG VY R DG + +K + + + E+E ++EV + +N H
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--HP 59
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG----IGRG 156
N++K + + +V +Y LSQ + K++ K G E I+ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKI----KKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
L Y+H ++HRDIK NI L N K+ DFG+SK+ +T ++ V GT YL+
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGTPYYLS 171
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 265
PE + KSD++S G +L E+ + + + + L L K+
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKILK 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-34
Identities = 72/216 (33%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANV 95
I + K+G G FG V+ G T VAVK L K G + F+ E M +
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKL 58
Query: 96 NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
H+ LV+L+ C + +V +YM SL L E ++ + + + M I
Sbjct: 59 R--HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL----PQLVDMAAQI 112
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVAGT 211
G+AY+ + +HRD+ NIL+ +N KI+DFGL++L ++ T +
Sbjct: 113 AEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-- 167
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
+ + APE A GR T KSDV+SFG+LL EIV+ GR
Sbjct: 168 IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (310), Expect = 5e-33
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 19/221 (8%)
Query: 43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCH 99
+R K+GEG FG VY R D +VA+KVL+ + + + F+ E+ +A++N
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLN-HP 57
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N+VKL+ D LV +Y+ SL LL + R+ I+ I L Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 160 IHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTR-----VAGTLG 213
+H + ++HRDIK NILLD++ K+ DFGL+KL P+ + S GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 214 YLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
Y+APE + + SD++S G+ L E+++G + +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-33
Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 50 IGEGGFGSVYKGRL------QDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENL 102
+GEG FG V+ G D +VAVK L S K+F E + N HEN+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ--HENI 70
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----------IIM 151
VK +G C +G I+V++YM + L++ L A F I +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNK-FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
I G+ Y+ + H VHRD+ T N L+ + KI DFG+S+ + RV G
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGH 183
Query: 212 ----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ ++ PE + + T +SDV+SFGV+L EI +
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 47 SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLV 103
+ IG G FG VYKG L+ G VA+K +S+E + E K M E+ + N+ H N+V
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--HPNIV 62
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
K G ++ +Y N SL Q + K+ F + + +GLAY+HE+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
V+HRDIK +NIL ++ K++DFG++ + + ++ V GT ++APE I
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPE-VIEM 173
Query: 224 R-LTRKSDVYSFGVLLLEIVSGR 245
+ SD++S G ++E+++G
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-31
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 47 SNKIGEGGFGSVYKGR---LQDGT--IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHE 100
++GEG FG V R L D T VAVK L+ +Q +F E+ + ++ HE
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HE 66
Query: 101 NLVKLHGGCIDGPCRI--LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
N+VK G C R L+ +Y+P+ SL L ++ R + K I +G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMD 123
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLA 216
Y+ + +HRD+ NIL++ KISDFGL+K+ PE+ + + G + A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
PE + + + SDV+SFGV L E+ +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-31
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
F K+G G FG V++G ++ VA+K+L + +++F EV ++ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR--HKHLI 65
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAK------FGWKARREIIMGIGRGL 157
L C G ++ + M SL L E + + + G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYL 215
AY+ E+ + +HRD+ NIL+ ++ K++DFGL++L E+ + ++ +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-DKKIP--YKWT 171
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
APE A G + KSDV+SFG+LL E+ +
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-30
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
+G+G FG V R G + A+KVL + ++ + ++E ++ +N H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--HPFIVKL 58
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIH 161
H LV +Y P L + L +E R RA+F + A EI++ + Y+H
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARF-YAA--EIVLALE----YLH 110
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
+++RD+K NILLD + + K++DFGL+K + +T GT YLAPE +
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLL 166
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRT 246
+ D +S GVLL E+++G+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
K+G G FG V++G + T VAVK L + K+F++E M + H L++L+
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLR--HPKLIQLYAV 69
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
C +V + M SL + L G R K ++ + G+AY+ + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NY 124
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
+HRD+ N+L+ +N K++DFGL+++ E+ + + APE A+ R + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 229 SDVYSFGVLLLEIVS-GR 245
SDV+SFG+LL EIV+ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 71/203 (34%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 48 NKIGEGGFGSVYKG--RLQDGTI--VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENL 102
++G G FGSV KG ++ G VAVK L E G+KEF+ E + MA ++ H +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD--HPCI 58
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
V+L G C G +LV + P L + L K+R + +E+ + G+AY+
Sbjct: 59 VRLIGVCK-GEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYA 220
+ H VHRD+ N+LL KISDFG+S+ + + AG L + APE
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
G+ + KSDV+S+GV L E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+IG G FG V+ G + VA+K + E E++F+ E M + + H LV+L+
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVM--MKLSHPKLVQLY 65
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G C + LV+++M + LS L +R KF + + + + G+AY+
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESS--- 119
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
+V+HRD+ N L+ +N K+SDFG+++ ++ ST + + +PE + +
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 227 RKSDVYSFGVLLLEIVS-GRTAVD 249
KSDV+SFGVL+ E+ S G+T +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLH 106
+G+G G VYK R + G I A+K + V+ + K+ + E+ ++ + +VK +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPYVVKCY 65
Query: 107 GGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYI 160
G I +V +YM SL+ L K+ K E ++ I +GL Y+
Sbjct: 66 GAFYK-EGEISIVLEYMDGGSLADLL----KKVGKIP-----EPVLAYIARQILKGLDYL 115
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H + H++HRDIK SN+L++ KI+DFG+SK+ +T V GT+ Y++PE
Sbjct: 116 HTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERI 172
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
+ +D++S G+ LLE G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 45 RW--SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCH 99
RW NKIG G FG VY L G ++AVK + ++ + KE E+ + + H
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK--H 58
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
NLVK +G + + +Y +L + L E R R + + GLAY
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDE--HVIRVYTLQLLEGLAY 114
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG---YLA 216
+H +VHRDIK +NI LD N K+ DFG + NTT + V G Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 217 PEYAISGRLT---RKSDVYSFGVLLLEIVSGRT 246
PE G+ R +D++S G ++LE+ +G+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-28
Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 50 IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
IG+G FG V G + G VAVK L +S + F++E + M + H NLV+L G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLR--HPNLVQLLGVV 69
Query: 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 169
+ G +V +YM SL L + RA + + + G+ Y+ E+ + V
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 170 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKS 229
HRD+ N+L+ ++ K+SDFGL+K + S ++ + + APE + + KS
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKS 180
Query: 230 DVYSFGVLLLEIVS-GR 245
DV+SFG+LL EI S GR
Sbjct: 181 DVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 11/207 (5%)
Query: 43 GFRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVES-KQGEKE-FMSEVASMANVNVCH 99
F+ K+G+G +GSVYK RL D A+K + + S Q E+E ++E+ +A+VN H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN--H 58
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N++ +DG +V +Y P LS+ + +K+R + I + + RGL
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+HE+ ++HRD+K++NILL N KI D G+SK+ +N GT Y+APE
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEV 172
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRT 246
+ KSD++S G LL E+ +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 72/228 (31%), Positives = 108/228 (47%), Gaps = 31/228 (13%)
Query: 42 NGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMAN 94
N + IG+G FG V++ R + T+VAVK+L E S + +F E A MA
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 95 VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR----AKFGWKARRE-- 148
+ H N+VKL G C G L+++YM L++ L R + AR+
Sbjct: 65 FD--HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 149 ------------IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-K 195
I + G+AY+ E VHRD+ T N L+ +N KI+DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
++ + S A + ++ PE R T +SDV+++GV+L EI S
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-27
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 10/209 (4%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
+I R K+G+G FG V+ G T VA+K L + E F+ E M +
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLR- 59
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
HE LV+L+ + P I V +YM SL L GE + + ++ I G+
Sbjct: 60 -HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGM 115
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
AY+ + + VHRD++ +NIL+ +N K++DFGL++L +N + + AP
Sbjct: 116 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GR 245
E A+ GR T KSDV+SFG+LL E+ + GR
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 49 KIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
KIGEG G VYK G VA+K + + + E E+ M + H N+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCK--HPNIVDYYD 82
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYIHEEIQ 165
+ G +V +YM SL+ ++ + R A RE++ +GL Y+H
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVL----QGLEYLH---S 134
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEYAI 221
+V+HRDIK+ NILL ++ + K++DFG L+K + + V GT ++APE
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-----VVGTPYWMAPEVIK 189
Query: 222 SGRLTRKSDVYSFGVLLLEIVSG 244
K D++S G++ +E+ G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-27
Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLHG 107
KIG+G FG VYKG L+ T VAVK K F+ E + + H N+VKL G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD--HPNIVKLIG 59
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI--GRGLAYIHEEIQ 165
C+ +V + +P SL L R+ K ++ + M + G+ Y+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFL-----RKKKNRLTVKKLLQMSLDAAAGMEYLE---S 111
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAI 221
+ +HRD+ N L+ +N KISDFG+S+ E I T G + + APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 222 SGRLTRKSDVYSFGVLLLEIVSG 244
GR T +SDV+S+G+LL E S
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 23/208 (11%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENL 102
+IGEG +G VYK R + G +VA+K + +E+ EKE + ++ + + H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFP-ITAIREIKLLQKLRHPNI 60
Query: 103 VKLHG---GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
V+L G +V++YM ++ L+ L + KF + + + GL Y
Sbjct: 61 VRLKEIVTSKGKGSI-YMVFEYMDHD-LTGLL---DSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPE 218
+H ++HRDIK SNIL++ + K++DFGL++ + N+ + RV TL Y PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 219 YAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
+ + R + D++S G +L E+ G+
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 28/207 (13%)
Query: 50 IGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
IG G FG V +GRL+ VA+K L S ++ +F++E + M + H N+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD--HPNIIR 69
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
L G +++ +YM N SL + L + KF ++ GI G+ Y+ E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLSEM- 125
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF----PENTTH---ISTRVAGTLGYLAP 217
+ VHRD+ NIL++ N K+SDFGLS+ TT I R + AP
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAP 177
Query: 218 EYAISGR-LTRKSDVYSFGVLLLEIVS 243
E AI+ R T SDV+SFG+++ E++S
Sbjct: 178 E-AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 34/241 (14%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
IGEG F +V + + A+K+L + ++ K E + +N H ++KL
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG-HPGIIKL 67
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+ D V +Y PN L Q + ++ K R I L Y+H
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLH---S 120
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA---------------- 209
++HRD+K NILLD++ + KI+DFG +K+ N++ S +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 210 ---GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSI 266
GT Y++PE + SD+++ G ++ ++++G+ F EY K+ +
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP--FR-GSNEYLTFQKILKL 237
Query: 267 N 267
Sbjct: 238 E 238
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 50 IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
+G G FG V+ G+ + VA+K++ E E +F+ E M ++ H NLV+L+G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLS--HPNLVQLYGVC 68
Query: 110 ID-GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
P I V +YM N L L +R+ K G + ++ + + Y+
Sbjct: 69 TKQRPIFI-VTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESN---GF 121
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
+HRD+ N L+ ++ K+SDFGL++ L + T+ T+ + + PE R +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179
Query: 227 RKSDVYSFGVLLLEIVSG 244
KSDV+SFGVL+ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 70/203 (34%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKL 105
K+G G FG V+ G T VA+K L KQG F++E M + H LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQ--HPRLVRL 66
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGLAYIHEE 163
+ P I + +YM N SL L E + + I M I G+A+I +
Sbjct: 67 YAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIKLTI----NKLIDMAAQIAEGMAFIERK 121
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
+ +HRD++ +NIL+ + KI+DFGL++L +N + + APE G
Sbjct: 122 ---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 224 RLTRKSDVYSFGVLLLEIVS-GR 245
T KSDV+SFG+LL EIV+ GR
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 50 IGEGGFGSVYKGR---LQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
+G+G FGSV R LQD G +VAVK L + + ++F E+ + ++ H+N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ--HDNIVK 69
Query: 105 LHGGCIDGPCRI---LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
G C R LV +Y+P SL L +K R + + I +G+ Y+
Sbjct: 70 YKGVCY-SAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEY 219
+ VHRD+ T NIL++ KI DFGL+K+ P++ + R G + + APE
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
+ + SDV+SFGV+L E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-25
Identities = 71/209 (33%), Positives = 106/209 (50%), Gaps = 10/209 (4%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
+I + K+G G FG V+ G T VAVK L + E F+ E M +
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLR- 59
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
H+ LV+L+ + P I V +YM SL L E R K ++ + G+
Sbjct: 60 -HDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGM 115
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
AYI + + +HRD++++NIL+ KI+DFGL++L +N + + AP
Sbjct: 116 AYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GR 245
E A+ GR T KSDV+SFG+LL E+V+ GR
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 49 KIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
++GEG FG V+ QD +VAVK L S K+F E + N+ HE++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHI 69
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQ---------TLLGEEKRRAKFGWKARREIIMGI 153
VK +G C++G I+V++YM + L++ L+ E R A+ I I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTL 212
G+ Y+ + H VHRD+ T N L+ +N KI DFG+S+ ++ + + +
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
++ PE + + T +SDV+S GV+L EI +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 8e-25
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 42 NGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVC- 98
+++GEG GSV K RL G I A+K ++ + +K+ + E+ C
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEIN---KSCK 57
Query: 99 HENLVKLHGGCID-GPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
+VK +G +D I + +Y SL +KR + G K +I + +G
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
L+Y+H ++HRDIK SNILL + K+ DFG+S E ++ GT Y+A
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMA 171
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
PE + SDV+S G+ LLE+ R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-24
Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 49 KIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
++GEG FG V+ +D +VAVK L + K+F E + N+ HE++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHI 69
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQ----------TLLGEEKRRAK--FGWKARREII 150
VK +G C DG I+V++YM + L++ L+ + R+AK G I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVA 209
I G+ Y+ + H VHRD+ T N L+ N KI DFG+S+ ++ + +
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ ++ PE + + T +SDV+SFGV+L EI +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-24
Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 15/215 (6%)
Query: 44 FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
F NKIG+G FG V+K R D + A+K + + +++ +E + E +A ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD--SS 59
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR--AKFGWKARREIIMGIGRGLA 158
+++ + +D +V +Y N L + L + R W+ +I++G LA
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LA 115
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
++H + ++HRDIK+ N+ LD N KI D G++KL +NT +T V GT YL+PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPE 171
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253
KSDV++ GV+L E +G+ D + Q
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 2e-24
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 32/210 (15%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENL 102
K+GEG +G VYK R + G IVA+K + +++ E+E + E++ + + H N+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELK--HPNI 60
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
VKL LV++Y + L + L +KR + I+ + RGLAY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCH- 115
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE---- 218
++HRD+K NIL++++ K++DFGL++ F + V TL Y APE
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLG 172
Query: 219 ---YAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+ + D++S G + E+++G+
Sbjct: 173 SKHYSTA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-24
Identities = 61/199 (30%), Positives = 112/199 (56%), Gaps = 13/199 (6%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCH-ENLVKLH 106
IG G +G+VY+G+ + G +VA+K++++++ + + EVA ++ + N+ K +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G + GP ++ +Y S+ +TL+ K+ RE+++ L YIH+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVA----LKYIHKV--- 120
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL- 225
V+HRDIK +NIL+ N K+ DFG++ L +N++ ST V GT ++APE G+
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYY 179
Query: 226 TRKSDVYSFGVLLLEIVSG 244
K+D++S G+ + E+ +G
Sbjct: 180 DTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-24
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 16/220 (7%)
Query: 48 NKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+K+G G +G VY+G + VAVK L E +EF+ E A M + H NLV+L
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK--HPNLVQLL 68
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G C P ++ ++M +L L E R + + I + Y+ ++
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK--- 123
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT---LGYLAPEYAISG 223
+ +HRD+ N L+ +N K++DFGLS+L +T T AG + + APE
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180
Query: 224 RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDK 262
+ + KSDV++FGVLL EI + + + L + Y L++K
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-24
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCH 99
+ + ++G G G V K + G I+AVK + +E + K+ + E+ + N
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN--S 58
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
+V +G + + +YM SL + L + R + +I + + +GL Y
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLTY 115
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+HE + ++HRD+K SNIL++ K+ DFG+S + ++ GT Y+APE
Sbjct: 116 LHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPER 170
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGR 245
+ KSD++S G+ L+E+ +GR
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 6e-24
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 49 KIGEGGFGSVYKG--------RLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCH 99
K+G+G FG V +G + VAVK L + +F+ E A M +++ H
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIP----VAVKCLKSDKLSDIMDDFLKEAAIMHSLD--H 55
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
ENL++L+G + P +V + P SL L + F + + I G+ Y
Sbjct: 56 ENLIRLYGVVLTHPLM-MVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIANGMRY 112
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST----RVAGTLGYL 215
+ +HRD+ NILL + KI DFGL + P+N H +V +
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWC 167
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
APE + + SDV+ FGV L E+ +
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 6e-24
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 48 NKIGEGGFGSVYK-GRLQDGTIVAVKVLSVES-KQGEKEFM-SEVASMANVNVCHENLVK 104
IG+G FG+V K R DG I+ K + + + EK+ + SEV + + H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--HPNIVR 63
Query: 105 LHGGCIDGPCRIL--VYDYMPNNSLSQTL--LGEEKRRA--KFGWKARREIIMGIGRGLA 158
+ ID + L V +Y L+Q + +E++ +F W+ I+ + L
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLLALY 119
Query: 159 YIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
H P V+HRD+K +NI LD N N K+ DFGL+K+ +++ T V GT Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
PE KSD++S G L+ E+ +
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 9e-24
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 10/209 (4%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
+I R K+G+G FG V+ G T VA+K L + E F+ E M +
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLR- 59
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
H+ LV L+ + P I V ++M SL L + + K ++ I G+
Sbjct: 60 -HDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGM 115
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
AYI + + +HRD++ +NIL+ N KI+DFGL++L +N + + AP
Sbjct: 116 AYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GR 245
E A+ GR T KSDV+SFG+LL E+V+ GR
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 1e-23
Identities = 54/176 (30%), Positives = 95/176 (53%), Gaps = 18/176 (10%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKL 105
+IGEG G V+K + + G VA+K +++ +G + + E+ ++ H +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--HPYVVKL 64
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR---RAKFGWKARREIIMGIGRGLAYIHE 162
G +LV +YMP+ LS+ +L +E+R A+ + + M + +G+AY+H
Sbjct: 65 LDVFPHGSGFVLVMEYMPS-DLSE-VLRDEERPLPEAQ----VKSYMRM-LLKGVAYMHA 117
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
++HRD+K +N+L+ + KI+DFGL++LF E + + T Y APE
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-23
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 50 IGEGGFGSVYKG--RLQDGTI---VAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103
+G G FG+VYKG + + VA+KVL E+ + KE + E MA+V+ H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD--HPHVV 72
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+L G C+ L+ MP L + + G + + I +G++Y+ E+
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG---TLGYLAPEYA 220
+VHRD+ N+L+ + KI+DFGL+KL + G + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESI 183
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
+ T KSDV+S+GV + E+++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-23
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 50 IGEGGFGSVYKG-RLQDGTIVAVKVLSV-----ESKQGEKEFMSEVASMANVNVCHENLV 103
+G G FGSVY+G L DG AVK +S+ ++ K+ E+A ++ + H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL--QHPNIV 65
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGLAYI 160
+ G + + + +P SL++ L K+G I + I GL Y+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLL-------KKYGSFPEPVIRLYTRQILLGLEYL 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H+ + VHRDIK +NIL+D N K++DFG++K E + S G+ ++APE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173
Query: 221 IS-GRLTRKSDVYSFGVLLLEIVSGR 245
G +D++S G +LE+ +G+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-23
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
+W ++GEG FG V+ QD +VAVK L S+ ++F E + +
Sbjct: 9 LKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ- 65
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-----------GEEKRRAKFGWKAR 146
H+++V+ +G C +G ++V++YM + L++ L GE+ +
Sbjct: 66 -HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHIS 205
I I G+ Y+ H VHRD+ T N L+ Q KI DFG+S+ ++ + +
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
R + ++ PE + + T +SD++SFGV+L EI +
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-23
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 45 RWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNV 97
R+ ++GEG FG VYKG L T VA+K L + ++EF E M+++
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ- 66
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL----------GEEKRRAKFGWKARR 147
H N+V L G C ++++Y+ + L + L+ K
Sbjct: 67 -HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 148 --EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
I + I G+ Y+ H VHRD+ N L+ + KISDFGLS+ + +
Sbjct: 126 FLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADY 179
Query: 206 TRVAGT----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
RV + ++ PE + G+ T +SD++SFGV+L EI S
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 7e-23
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
KIGEG +G VYK R G IVA+K + + ES+ K + E+ + +N H N++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN--HPNIIKL 63
Query: 106 HGGCIDGPCRILVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
LV+++M + Q L E ++ + + +GLA+
Sbjct: 64 LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS---------YLYQLLQGLAFC 114
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PEN---TTHISTRVAGTLGYLA 216
H ++HRD+K N+L++ K++DFGL++ F T ++ TR Y A
Sbjct: 115 H---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRA 166
Query: 217 PEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
PE + + D++S G + E++S R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
IG G VY L + VA+K + +E Q + + EV +M+ N H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN--HPNVVKY 64
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM-----GIGRGLAYI 160
+ + G LV Y+ SL + ++ + E I+ + +GL Y+
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIM------KSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR---VAGTLGYLAP 217
H Q +HRDIK NILL ++ + KI+DFG+S + GT ++AP
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 218 EYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
E K+D++SFG+ +E+ +G
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-22
Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 50 IGEGGFGSVYKG-RLQDGTIVAVK--VLSVESKQGEKEFMSEVASMAN-----VNVCHEN 101
IG G FGSVY G G ++AVK L S + S + ++A + HEN
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+V+ G +D + +Y+P S+ LL F R + I +GL Y+H
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV-AALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA-----GTLGYLA 216
++HRDIK +NIL+D KISDFG+SK N+ T A G++ ++A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
PE TRK+D++S G L++E+++G+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-22
Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 32/216 (14%)
Query: 50 IGEGGFGSVYKGRLQD------GTI-VAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
+G G FG VY+G D G I VAVK L + EK EF+ E M+N N H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN--HPN 60
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG-----WKARREIIMGIGRG 156
+VKL G C+ + ++ + M L L R +FG K +I + + +G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD--ARVERFGPPLLTLKELLDICLDVAKG 118
Query: 157 LAYIHEEIQPHVVHRDIKTSNILL-----DQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
Y+ Q H +HRD+ N L+ D + KI DFGL++ ++ + R G
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172
Query: 212 ----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ ++APE + G+ T +SDV+SFGVL+ EI++
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-22
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 10/210 (4%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
+I + K+G G FG V+ T VAVK + S E F++E M +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQ- 59
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
H+ LVKLH P I+ ++M SL L +E + + I G+
Sbjct: 60 -HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGM 115
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
A+I Q + +HRD++ +NIL+ + KI+DFGL+++ +N + + AP
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
E G T KSDV+SFG+LL+EIV+ GR
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-22
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHENLVKL 105
++G+G FGSVY R + G +VA+K + + E E M+ EV S+ +N H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNE-HPNIVKL 63
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+ V++YM N L Q + + + F R II I +GLA+IH+
Sbjct: 64 KEVFRENDELYFVFEYMEGN-LYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH-- 118
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVAGTLGYLAPEYAI- 221
HRD+K N+L+ KI+DFGL++ P T ++STR Y APE +
Sbjct: 119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEILLR 172
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
S + D+++ G ++ E+ + R
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-22
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 23/206 (11%)
Query: 50 IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
IG G FG V +GRL+ VA+K L +++ ++F+SE + M + H N++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNIIH 69
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
L G +++ ++M N +L L + +F ++ GI G+ Y+ E
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEM- 125
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG------YLAPE 218
+ VHRD+ NIL++ N K+SDFGLS+ ++T+ + +LG + APE
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPE 181
Query: 219 YAISGR-LTRKSDVYSFGVLLLEIVS 243
AI+ R T SDV+S+G+++ E++S
Sbjct: 182 -AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-22
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
F K+GEG +GSVYK + G +VA+KV+ VE +E + E++ + + +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCD--SPYI 60
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLS------QTLLGEEKRRAKFGWKARREIIMGIGRG 156
VK +G +V +Y S+S L EE+ A I+ +G
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---------ILYQTLKG 111
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYL 215
L Y+H +HRDIK NILL++ K++DFG+S +L +T V GT ++
Sbjct: 112 LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWM 166
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
APE K+D++S G+ +E+ G+
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-21
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 50 IGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
+G+G FG VY+G + T VA+K ++ + E+ EF++E + M N CH ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CH-HV 71
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLG---EEKRRAKFGWKARREII-MG--IGRG 156
V+L G G ++V + M L L E + G ++ I M I G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYL 215
+AY+ + VHRD+ N ++ ++ KI DFG+++ ++ + + + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
APE G T KSDV+SFGV+L E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-21
Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 50 IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
IG G FG V++G L+ VA+K L +++ ++F+SE + M H N+++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF--SHHNIIR 70
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
L G +++ +YM N +L + L +F ++ GI G+ Y+ +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDM- 126
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
+ VHRD+ NIL++ N K+SDFGLS++ ++ T G + + APE AI+
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIA 183
Query: 223 GR-LTRKSDVYSFGVLLLEIVS 243
R T SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-21
Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 50 IGEGGFGSVYKGRLQ----DGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVK 104
IG G FG V GRL+ VA+K L +++ ++F+SE + M + H N++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIH 69
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
L G ++V +YM N SL L K +F ++ GI G+ Y+ +
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM- 125
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG--YLAPEYAIS 222
VHRD+ NIL++ N K+SDFGLS++ ++ T G + + APE
Sbjct: 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
+ T SDV+S+G+++ E++S
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 49 KIGEGGFGSVYKG---RLQDGTI-VAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLV 103
IGEG FG VY+G ++ I VAVK + +E F+ E M + H ++V
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD--HPHIV 70
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
KL G + P I V + P L L + + + + LAY+ +
Sbjct: 71 KLIGVITENPVWI-VMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
VHRDI N+L+ K+ DFGLS+ + + + +++ + ++APE
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
R T SDV+ FGV + EI+
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 66/241 (27%), Positives = 112/241 (46%), Gaps = 15/241 (6%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
+I + K+G G FG V+ G + T VAVK L + + F+ E M +
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQ- 59
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
H+ LV+L+ ++ +YM SL L +E + + I G+
Sbjct: 60 -HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGM 116
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
AYI + + +HRD++ +N+L+ ++ KI+DFGL+++ +N + + AP
Sbjct: 117 AYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLGEYHLVDKVRSINMKL 270
E G T KSDV+SFG+LL EIV+ G + D L + + ++ + +L
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233
Query: 271 Y 271
Y
Sbjct: 234 Y 234
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-21
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 27/204 (13%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+IG G +G VYK R + G +VA+KV+ +E + E++ + H N+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYF 66
Query: 107 GGCIDGPCRILVYDYMPNNSLS---QTLLG--EEKRRAKFGWKARREIIMGIGRGLAYIH 161
G + +V +Y SL Q G E + A RE + +GLAY+H
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVC----RETL----KGLAYLH 118
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEY 219
E +HRDIK +NILL ++ + K++DFG+S T I+ R + GT ++APE
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEV 172
Query: 220 A---ISGRLTRKSDVYSFGVLLLE 240
A G K D+++ G+ +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-21
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 48 NKIGEGGFGSVYKG--RLQDGTI----VAVKVL-SVESKQGEKEFMSEVASMANVNVCHE 100
+G G FG VY+G R +DG VAVK L S+Q E +F+ E M+ N H+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN--HQ 69
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGL 157
N+V+L G + R ++ + M L L R + ++++ + +G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSK-LFPENTTHISTRVAGTL 212
Y+ E H +HRDI N LL P KI+DFG+++ ++ + R +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
++ PE + G T K+DV+SFGVLL EI S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 5e-21
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
++G G FG V G+ + VA+K++ E E EF+ E M ++ HE LV+L+G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLS--HEKLVQLYGV 67
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
C +V +YM N L L E +R F E+ + G+AY+ +
Sbjct: 68 CTKQRPIYIVTEYMSNGCL-LNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
+HRD+ N L+D K+SDFGLS+ L E T+ + ++ + + PE + + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFS 179
Query: 227 RKSDVYSFGVLLLEIVS 243
KSDV++FGVL+ E+ S
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 6e-21
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 42/215 (19%)
Query: 50 IGEGGFGSVYKGRL---QDGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103
+GEG FG V DGT +VAVK L E +Q + E+ + + HEN+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY--HENIV 69
Query: 104 KLHGGCIDGPCRIL-----------VYDYMPNN--SLSQTLLGEEKRRAKFGWKARREII 150
K G C + + L + DY+P + +L+Q LL ++
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-------------- 115
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
I G+AY+H + H +HRD+ N+LLD + KI DFGL+K PE + R G
Sbjct: 116 --ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 211 T--LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ + A E + + SDV+SFGV L E+++
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 9e-21
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 43 GFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVC 98
F IG+G FG V + +D + A+K ++ K + ++E + +N
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-- 58
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
H LV L D LV D + L L ++ KF + + I I L
Sbjct: 59 HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALE 114
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
Y+H + ++HRDIK NILLD+ + I+DF ++ +T ++T +GT GY+APE
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
+ D +S GV E + G+
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 27/208 (12%)
Query: 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKL 105
N+IG G G+VYK + G + A+KV+ + ++ E+ + +VN H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN--HPNVVKC 137
Query: 106 HGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
H D G ++L+ ++M SL T + +E+ A R+I+ GI AY+H
Sbjct: 138 HD-MFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVA----RQILSGI----AYLHRR 187
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
H+VHRDIK SN+L++ N KI+DFG+S++ + ++ V GT+ Y++PE I+
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINT 242
Query: 224 RLTR------KSDVYSFGVLLLEIVSGR 245
L D++S GV +LE GR
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-20
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 50 IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLHGG 108
+G+G FG V+KG L+D T VAVK + Q K +F+SE + + H N+VKL G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD--HPNIVKLIGV 60
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
C +V + +P L K++ + K + + G+AY+ + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLESK---NC 114
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
+HRD+ N L+ +N KISDFG+S+ + S + + APE GR + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 229 SDVYSFGVLLLEIVS 243
SDV+S+G+LL E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 50 IGEGGFGSVYKGRL--QDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLV 103
+GEG FGSV +G+L DG+ VAVK + ++ + +EF+SE A M + + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD--HPNVM 64
Query: 104 KLHGGCIDG------PCRILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGR 155
KL G C + P +++ +M + L LL K + + ++ I
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGY 214
G+ Y+ + +HRD+ N +L ++ ++DFGLSK + R+A + +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+A E T KSDV++FGV + EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-20
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 41 TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSV----ESKQGEKEFMSEVASMANV 95
F+ KIG+G F VYK L DG +VA+K + + ++K + + E+ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEIDLLKQL 59
Query: 96 NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
+ H N++K I+ +V + LS+ + +K++ + + + +
Sbjct: 60 D--HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
L ++H + ++HRDIK +N+ + K+ D GL + F TT + V GT Y+
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEI 241
+PE KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-20
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCH-E 100
F IG+G FG VYK + +VA+KV+ +E + E E + E+ ++ C
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ---CRSP 59
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
+ K +G + G ++ +Y S L + K I+ + GL Y+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYL 114
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
HEE +HRDIK +NILL + + K++DFG+S + +T V GT ++APE
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVI 170
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
K+D++S G+ +E+ G
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-20
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 42 NGFRWSNKIGEGGFGSVY----KGRL---------QDG--TIVAVKVLSVE-SKQGEKEF 85
R K+GEG FG V+ +G DG +VAVK+L + +K +F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 86 MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
+ E+ M+ + + N+++L G C+ ++ +YM N L+Q L + + + F
Sbjct: 65 LKEIKIMSRLK--NPNIIRLLGVCVSDDPLCMITEYMENGDLNQ-FLSQREIESTF---T 118
Query: 146 RREIIMGIGRG-LAYIHEEIQP--------HVVHRDIKTSNILLDQNFNPKISDFGLSK- 195
I + L Y+ +I + VHRD+ T N L+ ++ KI+DFG+S+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
L+ + I R + ++A E + G+ T SDV++FGV L E+ +
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-20
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 50 IGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENL 102
+GEG FG V K T VAVK+L + E ++ +SE + VN H ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN--HPHV 65
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTL----------LGEEKRRAKFGWKA--RREII 150
+KL+G C +L+ +Y SL L LG + R R +
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 151 MG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
MG I RG+ Y+ E +VHRD+ N+L+ + KISDFGLS+ E +
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 203 HIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
++ ++ + ++A E T +SDV+SFGVLL EIV+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 5e-20
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 37/209 (17%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQ-----GEKEFMSEVASMANVNVCH 99
+G G FG V R + G A+K+LS V+ KQ EK + + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI--------RH 60
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGR 155
LV L+G D LV +Y+P L L ++ +F R ++++ +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLALE- 115
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
Y+H +V+RD+K N+LLD + KI+DFG +K T + GT YL
Sbjct: 116 ---YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYL 165
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSG 244
APE +S + D ++ G+L+ E+++G
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-20
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLV 103
+GEG +G V K R + G IVA+K + K+ E + + ++ V V HEN+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
L LV++Y+ L E A R I + + +AY H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH-- 117
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
+++HRDIK NIL+ ++ K+ DFG ++ T T Y APE +
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 224 RLTRKS-DVYSFGVLLLEIVSGR 245
K DV++ G ++ E++ G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-20
Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
IGEG FG+V +G G VAVK + + + F+ E A M ++ H+NLV+L G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLH--HKNLVRLLGV 67
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
+ I V + M +L L + RA + + + G+ Y+ + +
Sbjct: 68 ILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
VHRD+ NIL+ ++ K+SDFGL+++ + V T APE + + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177
Query: 229 SDVYSFGVLLLEIVS-GR 245
SDV+S+GVLL E+ S GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-20
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 50 IGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCH-ENLVKLH 106
+G G GSV K + GT++A KV+ + +K K+ + E+ M C +V +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE---CRSPYIVSFY 69
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G ++ + ++M SL + K+ + +I + + GL Y++
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVH-- 123
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
++HRDIK SNIL++ K+ DFG+S E I+ GT Y++PE G+ T
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 227 RKSDVYSFGVLLLEIVSGR 245
KSDV+S G+ ++E+ G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-19
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 49 KIGEGGFGSVY------------KGRLQDG-----TIVAVKVLSV-ESKQGEKEFMSEVA 90
K+GEG FG V+ K ++ +VAVKVL S ++F+ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
++ ++ N+ +L G C P ++ +YM N L+Q L ++
Sbjct: 72 ILSRLS--DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL-----QKHVAETSGLACNS 124
Query: 151 MGIGRG-LAYIHEEI--------QPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPEN 200
+ L Y+ +I + VHRD+ T N L+ +N+ KI+DFG+S+ L+ +
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ R + ++A E + G+ T KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-19
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 42/217 (19%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
I +G +G V+ + G I A+KV+ V+ E++ +S+ S
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-------- 52
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIG 154
+VKL+ LV +Y+P L+ L L E+ R EI++
Sbjct: 53 PYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA-- 105
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-------LFPENTTHISTR 207
L Y+H ++HRD+K NIL+D N + K++DFGLSK + + R
Sbjct: 106 --LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
+ GT Y+APE + ++ D +S G +L E + G
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
+G+G +G VY R L +A+K + + + E+A + + H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIA--LHSYLKHRNIVQYLGS 73
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGRGLAYIHEE 163
+ + + +P SLS L R+K+G E + I GL Y+H+
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 164 IQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
+VHRDIK N+L++ KISDFG SK T GTL Y+APE
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDK 183
Query: 223 GR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
G +D++S G ++E+ +G+ ++LGE
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 24/208 (11%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANV----NVCHENL 102
N+IGEG +G VY+ R G IVA+K + +++ E++ + ++S+ + N+ H N+
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDN---ERDGIP-ISSLREITLLLNLRHPNI 68
Query: 103 VKLH----GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
V+L G +D LV +Y + L+ L + F + +++ + RGL
Sbjct: 69 VELKEVVVGKHLDSI--FLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
Y+HE ++HRD+K SN+LL KI+DFGL++ + ++ +V TL Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 219 YAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
+ T D+++ G +L E+++ +
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 29/209 (13%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLVKLH 106
K+GEG + +VYKGR + G IVA+K + +++++G + E++ M + HEN+V+LH
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK--HENIVRLH 64
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA-------KFGWKARREIIMGIGRGLAY 159
+LV++YM + L + + R A F ++ + +G+A+
Sbjct: 65 DVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLKGIAF 115
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYLAP 217
HE V+HRD+K N+L+++ K++DFGL++ F P NT S V TL Y AP
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVV-TLWYRAP 169
Query: 218 EYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
+ + R S D++S G ++ E+++GR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 45/237 (18%)
Query: 44 FRWSNKIGEGGFGSVY--------------------KGRLQDGTIVAVKVLSVE-SKQGE 82
+ K+GEG FG V+ KGR +VAVK+L + +K
Sbjct: 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNAR 63
Query: 83 KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL----------- 131
+F+ EV ++ + N+++L G C+D ++ +YM N L+Q L
Sbjct: 64 NDFLKEVKILSRLK--DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 132 ----LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187
+ + + + + I G+ Y+ + VHRD+ T N L+ +N K
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIK 178
Query: 188 ISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
I+DFG+S+ L+ + I R + ++A E + G+ T SDV++FGV L EI+
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-19
Identities = 60/230 (26%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS-VESKQGEKE-----FMSEVASMANVNVCHENL 102
+G G F S Y+ R ++ GT++AVK ++ V + E+E E+ MA +N H ++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN--HPHI 65
Query: 103 VKLHGG-CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+++ G C D + V ++M S+S L + F + RGL+Y+H
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTT---HISTRVAGTLGYLAP 217
E ++HRD+K +N+L+D +I+DFG + T ++ GT+ ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSIN 267
E + R DV+S G +++E+ + + + + L+ K+ S
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 4e-19
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----------FMSEVASMANV 95
K+GEG + VYK R + G IVA+K + + ++ K+ + E+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK----- 60
Query: 96 NVCHENLVKL-----HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
H N++ L H I+ LV+++M + L + + K ++ A +
Sbjct: 61 ---HPNIIGLLDVFGHKSNIN-----LVFEFMETD-LEKVI----KDKSIVLTPADIKSY 107
Query: 151 MG-IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
M RGL Y+H ++HRD+K +N+L+ + K++DFGL++ F ++ +V
Sbjct: 108 MLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 210 GTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
T Y APE R D++S G + E++
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-19
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ---GEKEF---MSEVASMANVNVCHEN 101
+G+G +G+VY G G ++AVK + +++ EKE+ EV + ++ H N
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK--HVN 63
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+V+ G C+D + +++P S+S L R + I G+AY+H
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK---LFPENTTH--ISTRVAGTLGYLA 216
VVHRDIK +N++L N K+ DFG ++ + TH + + GT ++A
Sbjct: 120 NN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
PE RKSD++S G + E+ +G+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-19
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHG 107
IG G FG+V K + GTI+AVK + + E K + ++ + + C +VK +G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC-PYIVKFYG 70
Query: 108 GCI-DGPCRI--------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
+G C I VY+ + + + + +LG+ I +
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILGK--------------IAVA 115
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
+ L Y+ EE+ ++HRD+K SNILLD+N N K+ DFG+S ++ TR AG
Sbjct: 116 TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCR 171
Query: 213 GYLAPEYAISGRLTR---KSDVYSFGVLLLEIVSGR 245
Y+APE +SDV+S G+ L E+ +G+
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
N I G G+ YKG+ ++ + E SE+A M + H N+VKL G
Sbjct: 696 NVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPSSEIADMGKLQ--HPNIVKLIG 750
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
C L+++Y+ +LS+ L W+ RR+I +GI + L ++H P
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAISGRLT 226
VV ++ I++D P + L L + IS+ Y+APE + +T
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDIT 856
Query: 227 RKSDVYSFGVLLLEIVSGRTAVD 249
KSD+Y FG++L+E+++G++ D
Sbjct: 857 EKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMAN-----VNVCHENLV 103
+G+G FG VY D G +AVK V E EV ++ N+ HE +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVK--QVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 104 KLHGGCIDGPCRILVY-DYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGL 157
+ +G C+ + ++ +YMP S+ L L E R K R+I+ G+
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-----KYTRQIL----EGV 117
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTLGY 214
Y+H +VHRDIK +NIL D N K+ DFG SK + T + + V GT +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYW 173
Query: 215 LAPEYAISGR-LTRKSDVYSFGVLLLEIVS 243
++PE ISG RK+DV+S G ++E+++
Sbjct: 174 MSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-18
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 50 IGEGGFGSVYKGRL-QDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVK 104
+GEG FGSV +G+L QD +I VAVK + + ++ ++F+SE M + H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD--HPNVMR 64
Query: 105 LHGGCIDG------PCRILVYDYMPNNSLSQTLLGEEKRRAKFG-------WKARREIIM 151
L G C+ P +++ +M + L LL ++ G + + +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-----YSRLGDCPQYLPTQMLVKFMT 119
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
I G+ Y+ + +HRD+ N +L++N N ++DFGLSK + R+A
Sbjct: 120 DIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 212 -LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
+ ++A E T KSDV+SFGV + EI + G+T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT 213
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 31/234 (13%)
Query: 48 NKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHEN 101
+IGEG +G VYK R +D G +VA+K + +++ EKE + E+ + +N H N
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQLN--HRN 67
Query: 102 LVKLHGGCIDGPCRI----------LVYDYMPNNSLSQTLLG-EEKRRAKFGWKARREII 150
+V L D + LV++YM ++ L+G E F + +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFM 122
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+ GL Y H++ + +HRDIK SNILL+ K++DFGL++L+ + T
Sbjct: 123 KQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 211 TLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
TL Y PE + R DV+S G +L E+ + + + +L + L+ ++
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-18
Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 47/218 (21%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENL 102
KIGEG +G VYK R G IVA+K + +E+ E E + E++ + +N H N+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELN--HPNI 60
Query: 103 VKLHGGCIDGPCRILVYDYM-----------PNNSLSQTLLGEEKRRAKFGWKARREIIM 151
V+L LV++++ P L L+ + +
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI--------------KSYLY 106
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRV 208
+ +G+AY H V+HRD+K N+L+D+ K++DFGL++ F P T TH V
Sbjct: 107 QLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EV 160
Query: 209 AGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
TL Y APE + R D++S G + E+V+ R
Sbjct: 161 V-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 17/212 (8%)
Query: 50 IGEGGFGSV-YKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNV-----CHEN 101
+G G G+V R+ DG AVKV+ +E S+ + +EV + N + CHE+
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 102 LVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG--RGLA 158
K + I LV DY L Q E K RAK + RE G+ + L
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQ----EIKSRAKTN-RTFREHEAGLLFIQVLL 154
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAP 217
+H H++HRDIK++NILL N K+ DFG SK++ + + GT Y+AP
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
E ++K+D++S GVLL E+++ + D
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 50 IGEGGFGSVYKGRLQ------DGTIVAVKVL-SVESKQGEKEFMSEVASMANVNVCHENL 102
+G G FG V+ + + T+V VK L + + + EF E+ ++ H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS--HKNV 70
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW-----KARREIIMGIGRGL 157
V+L G C + ++ +Y L Q L + + K K + + I G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK------LFPENTTHISTRVAGT 211
++ VHRD+ N L+ K+S LSK + I R
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---- 183
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+LAPE + KSDV+SFGVL+ E+ +
Sbjct: 184 --WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-18
Identities = 51/205 (24%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 50 IGEGGFGSVYKGRLQDG--TIVAVKVLSV---ESKQGEKEFMSEVASMAN-VNVC----- 98
+G G FG VYK R ++ ++A+K ++V + ++E + + + V +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
H N+V+ + ++ +V D + L + ++++ +F + I + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
Y+H+E + +VHRD+ +NI+L ++ I+DFGL+K + T V GT+ Y PE
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPE 183
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVS 243
+ K+DV++FG +L ++ +
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-18
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 50 IGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLV 103
+GEG FG V R G VAVK L ES + E+ + N+ HEN+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIV 69
Query: 104 KLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
K G C + L+ +++P+ SL + L + + K K + + + I +G+ Y+
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEY 219
VHRD+ N+L++ KI DFGL+K + + + + + + + APE
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
I + SDV+SFGV L E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-18
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 50 IGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109
IG+G FG V G + G VAVK +++ + F++E + M + H NLV+L G
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLR--HSNLVQLLGVI 68
Query: 110 IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
++ + +V +YM SL L + R+ G + + + + Y+ +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
VHRD+ N+L+ ++ K+SDFGL+K ++T + ++ + + APE + + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 179
Query: 229 SDVYSFGVLLLEIVS-GR 245
SDV+SFG+LL EI S GR
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-18
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 40/218 (18%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-----HENLV 103
IGEG +G VYK R + G +VA+K++ + + E+E E N+ H N+
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEY------NILRKYSNHPNIA 66
Query: 104 KLHGGCIDGPCRI------LVYDYMPNNS---LSQTLLGEEKRRAKFGWKARREIIMGIG 154
+G I LV + S L + L ++ +R K W A I+
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAY--ILRETL 123
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTL 212
RGLAY+HE V+HRDIK NILL +N K+ DFG+S + + + R GT
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTP 177
Query: 213 GYLAPEYAISGRLTR------KSDVYSFGVLLLEIVSG 244
++APE I+ +SDV+S G+ +E+ G
Sbjct: 178 YWMAPE-VIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVN----VC--- 98
+G+GGFG V +++ G + A K L ++ ++GE+ ++E + V+ V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 99 -HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMG 152
E L C LV M L + G + RA F + A +II G
Sbjct: 61 AFETKDDL--------C--LVMTLMNGGDLKYHIYNVGEPGFPEARAIF-YAA--QIICG 107
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
L ++H+ +V+RD+K N+LLD + N +ISD GL+ AGT
Sbjct: 108 ----LEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTP 158
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
GY+APE D ++ G L E+++GR+
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+G GGFG V +++ A+K + VE+ Q ++ SE + N H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECN--HPFIVK 57
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAY 159
L+ D Y YM L + LG E + R F R I + Y
Sbjct: 58 LYRTFKDKK-----YIYM----LMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEY 108
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAPE 218
+H +++RD+K N+LLD N K+ DFG +K L T T GT Y+APE
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPE 162
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGR 245
++ D +S G+LL E+++GR
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 50 IGEGGFGSVYKG-RLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANV-NVCHENLVKL 105
+G G FG+V+KG + +G + + V +++ + G + F M + ++ H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
G C G LV P SL + + R + + I +G+ Y+ E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL-FPENTTHISTRVAGTLGYLAPEYAISGR 224
+VHR++ NILL + +I+DFG++ L +P++ + + + ++A E + GR
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 225 LTRKSDVYSFGVLLLEIVS 243
T +SDV+S+GV + E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 49 KIGEGGFGSVYKG--RLQDGTI-VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
++G G FG V KG +++ I VA+KVL E+++ + E M E M ++ + +V+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD--NPYIVR 59
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+ G C + +LV + L++ L G ++ + E++ + G+ Y+ +
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK- 114
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAIS 222
+ VHRD+ N+LL KISDFGLSK + ++ R AG L + APE
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
+ + +SDV+S+G+ + E S
Sbjct: 173 RKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G +G V K R + GTI+AVK + +V S++ ++ M SM +V V +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV--DCPYTVTFY 66
Query: 107 GGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
G +G I + + M + SL + + +I + I + L Y+H ++
Sbjct: 67 GALFREGDVWICM-EVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
V+HRD+K SN+L+++N K+ DFG+S ++ T AG Y+APE I+ L
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPE-RINPEL 179
Query: 226 TR-----KSDVYSFGVLLLEIVSGR 245
+ KSDV+S G+ ++E+ +GR
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 49 KIGEGGFGSVY----KGRLQ-------------DGTIVAVKVLSVES-KQGEKEFMSEVA 90
K+GEG FG V+ +G + +VAVK+L ++ K +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR---- 146
M+ + N+++L CI ++ +YM N L+Q L E + A
Sbjct: 72 IMSRLK--DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 147 ---REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTT 202
+ I G+ Y+ + VHRD+ T N L+ +N+ KI+DFG+S+ L+ +
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
I R + +++ E + G+ T SDV++FGV L EI++
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 59/221 (26%), Positives = 112/221 (50%), Gaps = 31/221 (14%)
Query: 44 FRW--SNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKE----------FMSEVA 90
F+W IG+G +G VY + G ++AVK + + + + SE+
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVY-DYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
++ +++ H N+V+ + G + ++ +Y+P S+ L + +F + R
Sbjct: 61 TLKDLD--HLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFF 113
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHIST 206
+ GLAY+H + ++HRD+K N+L+D + KISDFG+SK + N ++S
Sbjct: 114 TEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 207 RVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGR 245
+ G++ ++APE S + K D++S G ++LE+ +GR
Sbjct: 171 Q--GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 9/195 (4%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
++G G FG V+ G+ + VA+K ++ E E++F+ E M + + H LV+L+G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVM--MKLSHPKLVQLYGV 67
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
C +V ++M N L L +R+ K + + G+ Y+ +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRK 228
+HRD+ N L+ K+SDFG+++ ++ S+ + + PE + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 229 SDVYSFGVLLLEIVS 243
SDV+SFGVL+ E+ +
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 53/204 (25%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 50 IGEGGFGSVYK-GRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G FG V+ R D +V +K + VE +K +E + ++ H N+++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--HPNIIEYY 65
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
++ ++V +Y P +L++ + +++ + + I L ++H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---TK 120
Query: 167 HVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
++HRD+KT NILLD++ KI DFG+SK+ ++ + V GT Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPY 178
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVD 249
+KSD+++ G +L E+ S + A +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSV--ESKQGEKEFMS-EVASMANVNVCH 99
+R +G+G FG VY D G +AVK + ES + KE + E N+ H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 100 ENLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
E +V+ +G D R L ++MP S+ L K R+I+ G+
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGV 119
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS----TRVAGTLG 213
+Y+H + +VHRDIK +NIL D N K+ DFG SK T +S V GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPY 174
Query: 214 YLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
+++PE ISG RK+D++S G ++E+++ +
Sbjct: 175 WMSPE-VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-17
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVK----VLSVESKQGEKEFMSEVASMANVNVCHENLV 103
+IG G FG V+ GRL+ D T VAVK L + K +F+ E + + H N+V
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYS--HPNIV 56
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+L G C +V + + T L E R K K +++ G+ Y+ +
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKV--KELIQMVENAAAGMEYLESK 113
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEY 219
H +HRD+ N L+ + KISDFG+S+ E + G + + APE
Sbjct: 114 ---HCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
GR + +SDV+SFG+LL E S
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 39/215 (18%)
Query: 47 SNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE-SKQGEKEFM-SEVASMANVNVC-HENL 102
+IGEG +G+VYK R L G VA+K + V S++G E+A + + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 103 VKL----HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFG---WKARREIIMGIG 154
V+L HG D ++ LV++++ + L+ L + K G + ++ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL----SKCPKPGLPPETIKD-LMRQLL 117
Query: 155 RGLAYIHEEIQPH-VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTL 212
RG+ ++H H +VHRD+K NIL+ + KI+DFGL++++ + ++ T V TL
Sbjct: 118 RGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTL 170
Query: 213 GYLAPE------YAISGRLTRKSDVYSFGVLLLEI 241
Y APE YA D++S G + E+
Sbjct: 171 WYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-17
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 11/224 (4%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVK---VLSVESKQGEKEFMSEVASMANVNVCH 99
FR KIG G F VY+ L DG VA+K + + + + + E+ + +N H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--H 61
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N++K + I+ +V + LS+ + +K++ K + + + L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+H V+HRDIK +N+ + K+ D GL + F TT + V GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
KSD++S G LL E+ + ++ D ++ Y L K+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 44/224 (19%)
Query: 50 IGEGGFGSVYKGRL-----QDGTI-VAVKVLSVESKQGE-KEFMSEVASMANVNVCHENL 102
+GEG FG V K + T VAVK+L ++ + + + +SE+ M + H+N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNI 78
Query: 103 VKLHGGCI-DGPCRILV--------YDY-------MPNNSLSQTLLGEEKRRAK----FG 142
+ L G C +GP ++V D+ S EE K F
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
++ + RG+ ++ +HRD+ N+L+ ++ KI+DFGL++
Sbjct: 139 YQ--------VARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 203 HISTRVAGTLGY--LAPEYAISGRL-TRKSDVYSFGVLLLEIVS 243
+ T G L +APE A+ R+ T +SDV+SFGVLL EI +
Sbjct: 188 YRKT-TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-17
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 31/210 (14%)
Query: 50 IGEGGFGSVYKGRLQDG----TIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVK 104
IG+G FG VY G L D AVK L+ + + ++F+ E M + + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS--HPNVLS 60
Query: 105 LHGGCID---GPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRG 156
L G C+ P ++V YM + L + E K FG + + +G
Sbjct: 61 LLGICLPSEGSP--LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKG 110
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLG 213
+ Y+ + VHRD+ N +LD++F K++DFGL++ + + H T +
Sbjct: 111 MEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
++A E + + T KSDV+SFGVLL E+++
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-17
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 50 IGEGGFGSVYK------GRLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENL 102
+G G FG V + + VAVK+L + E+E MSE+ M+++ HEN+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN-HENI 101
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
V L G C G +++ +Y L L KR + + + +G+A++
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYLAPEY 219
+ + +HRD+ N+LL KI DFGL++ ++ ++ + R+ + ++APE
Sbjct: 160 K---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPES 214
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
+ T +SDV+S+G+LL EI S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-17
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 45 RWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVC 98
R+ ++GE FG +YKG L +VA+K L + + Q EF E + MA ++
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-- 65
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE---------- 148
H N+V L G ++++Y+ L + L+ + G + +
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPH-SDVGCSSDEDGTVKSSLDHG 124
Query: 149 ----IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTH 203
I + I G+ Y+ VH+D+ NIL+ + + KISD GLS+ ++ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ + + ++ PE + G+ + SD++SFGV+L EI S
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 50 IGEGGFGSVYKG-RLQDGTIV----AVKVLS-VESKQGEKEFMSEVASMANVNVCHENLV 103
+G G FG+VYKG + +G V A+K+L+ + EFM E MA+++ H +LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLV 72
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+L G C+ P LV MP+ L + + + G + + I +G+ Y+ E
Sbjct: 73 RLLGVCLS-PTIQLVTQLMPHGCLLDYV---HEHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYAIS 222
+VHRD+ N+L+ + KI+DFGL++L + + + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
+ T +SDV+S+GV + E+++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 67/204 (32%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V + DG AVKVL ++ K+ +K M+E + NV H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLK-NVKHPFLVGL 61
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
H V DY+ L L E + RA+F + A EI +G Y+H
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAA--EIASALG----YLHS 114
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYA 220
++++RD+K NILLD + ++DFGL K + TT + GT YLAPE
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPEVL 168
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
R D + G +L E++ G
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 48 NKIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLV 103
+IG+G FG V+KG R Q +VA+K++ +E + E E E+ ++ + + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VT 65
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
K +G + G ++ +Y+ S L R F ++ I +GL Y+H E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
+ +HRDIK +N+LL + + K++DFG++ + +T V GT ++APE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
K+D++S G+ +E+ G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 68/219 (31%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 44 FRWSNKIGEGGFGSV----YKGRLQDGTIVAVKVL---------SVESKQGEKEFMSEVA 90
FR +G G FG V YK G + A+K L VES EK
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGE--EKRRAKFGWKARR 147
S H LV L C + V +Y L + + + RA F + A
Sbjct: 58 SER-----HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-YAA-- 108
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHIS 205
+++G L Y+HE +V+RD+K N+LLD KI+DFGL K + + T S
Sbjct: 109 CVVLG----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
T GT +LAPE TR D + GVL+ E++ G
Sbjct: 160 T-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 55/202 (27%), Positives = 107/202 (52%), Gaps = 21/202 (10%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
++G+G FG VYK + ++ G + A KV+ +S++ +++M E+ +A N H +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN--HPYIVKLLG 76
Query: 108 GCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
DG I++ ++ P ++ +L ++ + + I + L Y+H
Sbjct: 77 AFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM--- 129
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGR 224
++HRD+K N+LL + + K++DFG+S +N + R + GT ++APE +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 225 LTR-----KSDVYSFGVLLLEI 241
+ K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
+G G +G VYKGR ++ G + A+KV+ V + E+E E+ +M H N+ +G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEI-NMLKKYSHHRNIATYYGA 81
Query: 109 CID-GPC-----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYI 160
I P LV ++ S++ + + K W A REI+ RGLA++
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL----RGLAHL 137
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H V+HRDIK N+LL +N K+ DFG+S +T + GT ++APE
Sbjct: 138 HAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 193
Query: 221 I-----SGRLTRKSDVYSFGVLLLEIVSG 244
+SD++S G+ +E+ G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 61/214 (28%), Positives = 114/214 (53%), Gaps = 28/214 (13%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVC--- 98
+ N+I EG +G VY+ R + G IVA+K L +E EKE F + S+ +N+
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGF--PITSLREINILLKL 61
Query: 99 -HENLVKLH----GGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
H N+V + G +D +I +V +Y+ ++ ++L+ K+ F + +++
Sbjct: 62 QHPNIVTVKEVVVGSNLD---KIYMVMEYVEHDL--KSLMETMKQP--FLQSEVKCLMLQ 114
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
+ G+A++H+ ++HRD+KTSN+LL+ KI DFGL++ + T++ TL
Sbjct: 115 LLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTL 170
Query: 213 GYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
Y APE + + + D++S G + E+++ +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-16
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
+G G +G VYKGR ++ G + A+KV+ V + E+E E+ +M H N+ +G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEI-NMLKKYSHHRNIATYYGA 71
Query: 109 CID-GPCRI-----LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLAYI 160
I P + LV ++ S++ + + K W A REI+ RGL+++
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL----RGLSHL 127
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H Q V+HRDIK N+LL +N K+ DFG+S +T + GT ++APE
Sbjct: 128 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 183
Query: 221 I-----SGRLTRKSDVYSFGVLLLEIVSG 244
KSD++S G+ +E+ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 68/253 (26%), Positives = 115/253 (45%), Gaps = 37/253 (14%)
Query: 50 IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
+GEG FG V K + ++ VAVK+L ++ + + + +SE+ M + H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HK 81
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
N++ L G C DGP ++V +Y +L + L ++ + R
Sbjct: 82 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
+ RG+ Y+ + +HRD+ N+L+ +N KI+DFGL++ N +
Sbjct: 141 SCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKT 196
Query: 208 VAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLGEYH 258
G L ++APE T +SDV+SFGVL+ EI + G + L E H
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 256
Query: 259 LVDKVRSINMKLY 271
+DK + +LY
Sbjct: 257 RMDKPANCTNELY 269
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-16
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 13/216 (6%)
Query: 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKL 105
+K+GEG + +V+KGR + +VA+K + +E ++G + EV+ + N+ H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTL 68
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
H C LV++Y+ ++ L Q L + K + + RGL+Y H+
Sbjct: 69 HDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI---FMFQLLRGLSYCHKR-- 122
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGR 224
++HRD+K N+L+++ K++DFGL++ T S V TL Y P+ + S
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260
+ D++ G +L E+ +GR E HL+
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-16
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 28/205 (13%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
KIGEG G V R + G VAVK++ + +Q + +EV M + H+N+V+++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HQNVVEMYK 85
Query: 108 GCIDGPCRILVYDYMPNNSL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+ G ++ +++ +L SQT L EE+ + + + L Y+H +
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT---------VCESVLQALCYLHSQ 136
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
V+HRDIK+ +ILL + K+SDFG +SK P+ + + GT ++APE
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPEV 188
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
+ D++S G++++E+V G
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-16
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 32/208 (15%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
KIGEG G V G VAVK + + +Q + +EV M + H N+V+++
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HPNIVEMY 82
Query: 107 GGCIDGPCRILVYDYMPNNSL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
+ G +V +++ +L + T + EE+ + + + + L+++H
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---------VCLAVLKALSFLHA 133
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPE 218
+ V+HRDIK+ +ILL + K+SDFG +SK P + + GT ++APE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPE 185
Query: 219 YAISGRLTRKS--DVYSFGVLLLEIVSG 244
IS RL + D++S G++++E+V G
Sbjct: 186 -VIS-RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-16
Identities = 60/239 (25%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 50 IGEGGFGS--VYKGRLQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
+G+G FG +Y+ R +D ++V K L+ S++ ++ ++E+ ++ + H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ--HPNIIAY 64
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQ-------TLLGEEKRRAKFGWKARREIIMGIGRGLA 158
+ +D ++ +Y +L L EE W + I ++
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM----VLW-----YLFQIVSAVS 115
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
YIH+ ++HRDIKT NI L + K+ DFG+SK+ + T V GT Y++PE
Sbjct: 116 YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL--------GEYHLVDKVRSINMK 269
+ KSD+++ G +L E+++ + D L G Y V V S +
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-16
Identities = 65/221 (29%), Positives = 112/221 (50%), Gaps = 21/221 (9%)
Query: 38 KIATNGFRWSNKIGEGGFGSVY----KGRLQDG--TIVAVKVLSVESKQGEK-EFMSEVA 90
++A S ++G+G FG VY KG ++D T VA+K ++ + E+ EF++E +
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARR 147
M N CH ++V+L G G +++ + M L ++L E + + +
Sbjct: 62 VMKEFN-CH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 148 EIIMGIGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
++I G G+AY++ VHRD+ N ++ ++F KI DFG+++ E T +
Sbjct: 120 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYY 175
Query: 205 STRVAGTLG--YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
G L +++PE G T SDV+SFGV+L EI +
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-16
Identities = 55/199 (27%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 48 NKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKL 105
+IG+G FG VYKG + +VA+K++ +E + E E E+ ++ + + + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--ITRY 67
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+G + G ++ +Y+ S + LL + REI+ +GL Y+H E +
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREIL----KGLDYLHSERK 122
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
+HRDIK +N+LL + + K++DFG++ + +T V GT ++APE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 226 TRKSDVYSFGVLLLEIVSG 244
K+D++S G+ +E+ G
Sbjct: 179 DFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF-----MSEVASMANVNVCHENL 102
K+GEG FG VYK R ++ G +VA+K + + + EK+ + E+ + + H N+
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLK--HPNV 69
Query: 103 VKLHGGCIDGP--------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
V L ++ P +V YM ++ LS L E K + ++ +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLL---ENPSVKLTESQIKCYMLQLL 125
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN----------TTHI 204
G+ Y+HE H++HRDIK +NIL+D KI+DFGL++ + T
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 205 STRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
T + T Y PE + R T D++ G + E+ + R
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-16
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
I +G FGSVY + + G A+KVL + +K +E A M + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-QGESPYVAKL 62
Query: 106 HGGCIDGPCRILVYDYMPNN---SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
+ LV +Y+ SL +TL G + AK + E+++G+ +H
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK---QYIAEVVLGVE----DLH- 114
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
Q ++HRDIK N+L+DQ + K++DFGLS+ + + GT YLAPE +
Sbjct: 115 --QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILG 167
Query: 223 GRLTRKSDVYSFGVLLLEIVSG 244
+ SD +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-16
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
+G+G FG VYK + + G A K++ +ES++ ++FM E+ ++ H N+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK--HPNIVGLYEA 70
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
++ ++ +L +L E+ R + + L ++H V
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SG 223
+HRD+K NILL + + K++DFG+S T + GT ++APE
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183
Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
K+D++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-16
Identities = 72/218 (33%), Positives = 111/218 (50%), Gaps = 35/218 (16%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGE------KEFMSEVASMA 93
FR +G+GGFG V +++ G + A K L ++ ++GE K+ + +V S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL--LGE---EKRRAKFGWKARRE 148
V++ + K D C LV M L + +GE E+ RA F + A
Sbjct: 62 VVSLAYAYETK------DALC--LVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAE-- 110
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
I GL +H+E +V+RD+K NILLD + + +ISD GL+ PE T I RV
Sbjct: 111 ----ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV 162
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
GT+GY+APE + R T D ++ G LL E+++G++
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-15
Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 31/225 (13%)
Query: 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKG--RLQDGTIVAVKVLSVESKQGEKEFMS 87
A SY L+ K+GEG + +VYKG R+ +G +VA+KV+S+++++G
Sbjct: 3 AATSYLNLE----------KLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAI 51
Query: 88 EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR- 146
AS+ + H N+V LH V++YM T L + + G
Sbjct: 52 REASLLK-GLKHANIVLLHDIIHTKETLTFVFEYM------HTDLAQYMIQHPGGLHPYN 104
Query: 147 -REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL--SKLFPENTTH 203
R + + RGLAYIH + H++HRD+K N+L+ K++DFGL +K P T
Sbjct: 105 VRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-- 159
Query: 204 ISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTA 247
S+ V TL Y P+ + + + D++ G + +E++ G+ A
Sbjct: 160 YSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
+GEG +G V K + ++ G IVA+K S + K +K M E+ + + HENLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--HENLVNL 65
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
LV++++ + T+L + EK R+ + I RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDH-----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH- 119
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG- 223
+++HRDIK NIL+ Q+ K+ DFG ++ + T T Y APE +
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 224 RLTRKSDVYSFGVLLLEIVSG 244
+ R D+++ G L+ E+++G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 43/231 (18%)
Query: 35 NQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMA 93
+ N +IG G G VYK R + G ++AVK + + G KE + +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRI--LM 62
Query: 94 NVNV---CHE--NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
+++V H+ +VK +G I D L T L + +R + E
Sbjct: 63 DLDVVLKSHDCPYIVKCYG------YFITDSDVFICMELMSTCLDKLLKRIQGPIP---E 113
Query: 149 IIMG-----IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
I+G I + L Y+ E+ V+HRD+K SNILLD + N K+ DFG+S ++
Sbjct: 114 DILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRK---------SDVYSFGVLLLEIVSGR 245
TR AG Y+APE R+ +DV+S G+ L+E+ +G+
Sbjct: 172 --TRSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG GGFG VY R D G + A+K L ++ KQGE ++E ++ V+ +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
P ++ + D M L L + F K R I GL ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
VV+RD+K +NILLD++ + +ISD GL+ F + H S GT GY+APE G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 225 LTRKS-DVYSFGVLLLEIVSGRT 246
S D +S G +L +++ G +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 50 IGEGGFGSVYKG-RLQDG----TIVAVKVLSVE-SKQGEKEFMSEVASMANVN---VCHE 100
+G G FG+VYKG + DG VA+KVL S + KE + E MA V VC
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC-- 72
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
+L G C+ + LV MP L + + + + G + + I +G++Y+
Sbjct: 73 ---RLLGICLTSTVQ-LVTQLMPYGCLLDYV---RENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEY 219
EE++ +VHRD+ N+L+ + KI+DFGL++L + T + ++A E
Sbjct: 126 -EEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
+ R T +SDV+S+GV + E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 49 KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLV 103
++G G FG+V KG + VAVK+L ++ + E + E M ++ + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD--NPYIV 59
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
++ G C + +LV + L++ L ++ + K E++ + G+ Y+ E
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTE--KNITELVHQVSMGMKYLEET 114
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT--LGYLAPEYAI 221
+ VHRD+ N+LL KISDFGLSK + + + G + + APE
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
+ + KSDV+SFGVL+ E S
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDG----TIVAVKVL-SVESKQGEKEFMSEVASMANVNV 97
F+ +G G FG+VYKG + +G VA+K L S + KE + E MA+V+
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 67
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
+ ++ +L G C+ + L+ MP L + + + G + + I +G+
Sbjct: 68 -NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGM 122
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
Y+ E +VHRD+ N+L+ + KI+DFGL+KL + + + + ++A
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
E + T +SDV+S+GV + E+++
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 49 KIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHEN 101
++G+G FG VY+G +D T VAVK ++ + E+ EF++E + M CH +
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CH-H 70
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG----EEKRRAKFGWKARREIIMG--IGR 155
+V+L G G ++V + M + L L E + + I M I
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--G 213
G+AY++ + VHRD+ N ++ +F KI DFG+++ E T + G L
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVR 186
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
++APE G T SD++SFGV+L EI S
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 45/202 (22%)
Query: 42 NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANV 95
+ + KIG+G FG V+K R + IVA+K + +E+ EKE E+ + +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLL 68
Query: 96 NVCHENLVKLHGGCIDGP-----CR---ILVYDY-------MPNNSLSQTLLGEEKRRAK 140
HEN+V L C + LV+++ + +N + L E K+
Sbjct: 69 K--HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--- 123
Query: 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--P 198
++ + GL YIH ++HRD+K +NIL+ ++ K++DFGL++ F
Sbjct: 124 --------VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 199 ENT--THISTRVAGTLGYLAPE 218
+N+ + RV TL Y PE
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 34/210 (16%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESK-QGEKEFMSEVASMANVNVC------HE 100
KIGEG +G+V+K + ++ IVA+K + ++ +G V S A +C H+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHK 59
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR-----RAKFGWKARREIIMGIGR 155
N+V+L+ LV++Y Q L K+ + + + + +
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEY-----CDQDL----KKYFDSCNGDIDPEIVKSFMFQLLK 110
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
GLA+ H +V+HRD+K N+L+++N K++DFGL++ F S V TL Y
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYR 166
Query: 216 APEYAISGRLTRKS-DVYSFGVLLLEIVSG 244
P+ +L S D++S G + E+ +
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-15
Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
K+GEG + +VYKG+ + +G +VA+KV+ ++ ++G AS+ + H N+V LH
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK-GLKHANIVLLHD 70
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
LV++Y+ + L Q + +K + + + + RGL+YIH Q +
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH---QRY 123
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLT 226
++HRD+K N+L+ K++DFGL++ +H + TL Y P+ + S +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 227 RKSDVYSFGVLLLEIVSGRTA 247
D++ G + +E++ G A
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 37/253 (14%)
Query: 50 IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
+GEG FG V K + VAVK+L ++ + + +SE+ M + H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK-HK 78
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------------ 147
N++ L G C DGP +LV +Y +L + L + + +
Sbjct: 79 NIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
+ RG+ Y+ + +HRD+ N+L+ ++ KI+DFGL++ N +
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKT 193
Query: 208 VAGTL--GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLGEYH 258
G L ++APE T +SDV+SFGVLL EI + G + L E H
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH 253
Query: 259 LVDKVRSINMKLY 271
+DK + +LY
Sbjct: 254 RMDKPANCTHELY 266
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-15
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 24/203 (11%)
Query: 49 KIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFM-SEVASMANVNVCHENLVKLH 106
KIG+G G+VY + G VA+K +++ +Q +KE + +E+ M H N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENK--HPNIVNYL 82
Query: 107 GGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
+ G +V +Y+ SL+ +T + E + A RE + + L ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-----VCRECL----QALEFLHS 133
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAI 221
V+HRDIK+ NILL + + K++DFG +++ PE + ST V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVT 188
Query: 222 SGRLTRKSDVYSFGVLLLEIVSG 244
K D++S G++ +E+V G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-15
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 50 IGEGGFGSVY----KGRLQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHEN 101
+G G +G V+ G G + A+KVL V+ + + +E + V C
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC-PF 66
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
LV LH L+ DY+ L L +R F R I I L ++H
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH 122
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
Q +++RDIK NILLD + ++DFGLSK F + GT+ Y+APE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 222 SGRLTRKS--DVYSFGVLLLEIVSG 244
G D +S GVL E+++G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 61/239 (25%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQ-----GEKEFMSEVASMANVNVCH 99
IG G FG V+ R G + A+KVL ++ Q E++ +++ S
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW------ 62
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGR 155
+VKL+ D LV +YMP L LL + A+F + A E+++ +
Sbjct: 63 --IVKLYYSFQDEEHLYLVMEYMPGGDL-MNLLIRKDVFPEETARF-YIA--ELVLAL-- 114
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---------------- 199
+H + +HRDIK NIL+D + + K++DFGL K +
Sbjct: 115 --DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 200 ------------NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
+ GT Y+APE + D +S GV+L E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 16/214 (7%)
Query: 43 GFRWSNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMA-NVNVC 98
+ IG G +G VYK + + DG A+K + +Q S +A +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 99 HENLVKLHGGCIDGPCRI--LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
HEN+V L ++ + L++DY ++ + +R + ++ I G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLF--PENTTHISTRVAG 210
+ Y+H V+HRD+K +NIL+ KI D GL++LF P V
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 211 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 243
T+ Y APE + R T+ D+++ G + E+++
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-15
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-----LV 103
IG+G FG VY+ R +D I A+KVLS + +KE + N+ V +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGER-NILVRTLLDESPFIV 59
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYI 160
L LV DYM L L E + RAKF + A E+++ L ++
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF-YIA--ELVLA----LEHL 112
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV-AGTLGYLAPEY 219
H+ +V+RD+K NILLD + + DFGLSK T + +T GT YLAPE
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEV 167
Query: 220 AISGR-LTRKSDVYSFGVLLLEIVSG 244
+ + T+ D +S GVL+ E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 42 NGFRWSNKIGEGGFGSVYKGRL-QDGTIV--AVKVLS-VESKQGEKEFMSEVASMANVNV 97
N ++ + IGEG FG V K R+ +DG + A+K + SK ++F E+ + +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRA-----KFGWKARREIIMG 152
H N++ L G C L +Y P+ +L L K R F +
Sbjct: 67 -HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLS 122
Query: 153 ----------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
+ RG+ Y+ Q +HRD+ NIL+ +N+ KI+DFGLS+
Sbjct: 123 SQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------- 172
Query: 203 HISTRVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
V T+G ++A E T SDV+S+GVLL EIVS
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-15
Identities = 70/204 (34%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V R + + AVKVL ++ K+ EK MSE + NV H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLK-NVKHPFLVGL 61
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
H V DY+ L L E + RA+F + A I L Y+H
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAE------IASALGYLH- 113
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAGTLGYLAPEYA 220
++V+RD+K NILLD + ++DFGL K EN H T GT YLAPE
Sbjct: 114 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
R D + G +L E++ G
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V L+ + AVKVL VE EK ++ H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK-------H 55
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGR 155
L +LH C R+ V +Y+ L Q ++ RA+F + A EI++G
Sbjct: 56 PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAA--EIVLG--- 108
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
L ++HE +++RD+K N+LLD + KI+DFG+ K + TT + GT
Sbjct: 109 -LQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPD 161
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
Y+APE D ++ GVLL E+++G++ + D
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVA---VKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
++IG G FG V G G A VK L + E+ F+ EV +N H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN--HPNVL 58
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK-ARREIIMGIGRGLAYIHE 162
+ G CI+ +LV ++ P L L A+ K + + + GL ++H
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYA- 220
Q +H D+ N L + + KI D+GL+ + +PE+ A L +LAPE
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 221 ------ISGRLTRKSDVYSFGVLLLEI 241
+ T+KS+++S GV + E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 44 FRWSNKIGEGGFGSVY------KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
+R +G+G FG VY GR V S E+ + E+ + N+
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ- 62
Query: 98 CHENLVKLHGGCIDGPCRILV--YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
HE +V+ +G D + L +YMP S+ L K R+I+
Sbjct: 63 -HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----E 117
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE---NTTHISTRVAGTL 212
G++Y+H + +VHRDIK +NIL D N K+ DFG SK + T I + V GT
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTP 173
Query: 213 GYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
+++PE ISG RK+DV+S G ++E+++ +
Sbjct: 174 YWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKL 105
K+GEG + +V+KGR + +VA+K + +E ++G + EV+ + ++ H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTL 69
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
H LV++Y+ + L Q + + + + I RGLAY H
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGR 224
V+HRD+K N+L+++ K++DFGL++ T S V TL Y P+ + S
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260
+ + D++ G + E+ SGR E HL+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG GGFG VY R D G + A+K L ++ KQGE ++E ++ V+ +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGRGLAYI 160
P ++ + D M L L + F R EII+G L ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILG----LEHM 113
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H VV+RD+K +NILLD++ + +ISD GL+ F + H S GT GY+APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRT 246
G S D +S G +L +++ G +
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 28/205 (13%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
KIGEG G V ++ G +VAVK + + +Q + +EV M + HEN+V+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYN 84
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+ G +V +++ +L+ T + EE+ A + + + + L+ +H +
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---------VCLAVLKALSVLHAQ 135
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
V+HRDIK+ +ILL + K+SDFG +SK P + + GT ++APE
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPEL 187
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
+ D++S G++++E+V G
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 50 IGEGGFGSVY-KGRLQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V R DG+ AVKVL ++ K+ + M+E + N+ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLK-NLKHPFLVGL 61
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
H V DY+ L L E + RA+F + A E+ IG Y+H
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAA--EVASAIG----YLHS 114
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYA 220
++++RD+K NILLD + ++DFGL K + PE TT + GT YLAPE
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVL 168
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
R D + G +L E++ G
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHEN 101
F ++G G G V K G I+A K++ +E K + + E+ + N +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY-- 60
Query: 102 LVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR--EIIMG-----I 153
+V +G DG I + ++M SL Q L KA R E I+G +
Sbjct: 61 IVGFYGAFYSDGEISICM-EHMDGGSLDQVLK-----------KAGRIPENILGKISIAV 108
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
RGL Y+ E+ + ++HRD+K SNIL++ K+ DFG+S ++ ++ GT
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 163
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y++PE T +SD++S G+ L+E+ GR
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 43/256 (16%)
Query: 50 IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHE 100
+GEG FG V K + T VAVK+L ++ + + + +SE+ M + H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 84
Query: 101 NLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK---------ARREII 150
N++ L G C DGP ++V +Y +L + L ++ + + ++++
Sbjct: 85 NIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 151 ---MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
+ RG+ Y+ + +HRD+ N+L+ ++ KI+DFGL++ + HI
Sbjct: 144 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196
Query: 208 VAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLG 255
T G ++APE T +SDV+SFGVLL EI + G + L
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256
Query: 256 EYHLVDKVRSINMKLY 271
E H +DK + +LY
Sbjct: 257 EGHRMDKPSNCTNELY 272
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 47/224 (20%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGE------KEFMSEVASMA 93
FR +G+GGFG V +++ G + A K L ++ ++GE K+ + +V S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 94 NVNVCHENLVKLHGGCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFG 142
V++ + K D C +L +Y+ G ++ RA F
Sbjct: 62 VVSLAYAYETK------DALCLVLTLMNGGDLKFHIYNMGNP--------GFDEERAVF- 106
Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
+ A EI G L +H E +V+RD+K NILLD + +ISD GL+ PE T
Sbjct: 107 YAA--EITCG----LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157
Query: 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
I RV GT+GY+APE + R T D + G L+ E++ G++
Sbjct: 158 -IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 38/212 (17%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVL-----SVESKQGEKEFMSEVASMANVNVCHEN 101
KIGEG F V K + + G A+K + S+E + + E+ ++ ++ H N
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSP-HPN 59
Query: 102 LVKLHGGCIDGP--CRILVYDYMPNNSLSQTLLGE--EKRRAKFGWKARREIIMGIGRGL 157
+++L D LV++ M N L E + R+ K + + + + L
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMN------LYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG-----LSKLFPENTTHISTRVAGTL 212
++H + + HRDIK NIL+ + K++DFG SK P T +ISTR
Sbjct: 114 DHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK--PPYTEYISTR----- 162
Query: 213 GYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVS 243
Y APE + G K D+++ G + EI+S
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 28/205 (13%)
Query: 49 KIGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
KIGEG G V G VAVK + + +Q + +EV M + + HEN+V ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HENVVDMYN 86
Query: 108 GCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+ G +V +++ +L+ T + EE+ + + + R L+Y+H +
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---------VCLSVLRALSYLHNQ 137
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG----LSKLFPENTTHISTRVAGTLGYLAPEY 219
V+HRDIK+ +ILL + K+SDFG +SK P+ + + GT ++APE
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-----LVGTPYWMAPEV 189
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSG 244
+ D++S G++++E++ G
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 49 KIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVK 104
KIG+G FG V+KG R Q +VA+K++ +E + E ++ E+ ++ + + + K
Sbjct: 11 KIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY--VTK 66
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+G + ++ +Y+ S L + REI+ +GL Y+H E
Sbjct: 67 YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-TILREIL----KGLDYLHSEK 121
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
+ +HRDIK +N+LL ++ K++DFG++ + +T V GT ++APE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 177
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
K+D++S G+ +E+ G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTI-----VAVKVLSVESKQGEKEFM-SEVA 90
+ I+ + S+ + EG FG ++ G L D V VK + + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILV-YDYMPNNSLSQTL----LGEEKRRAKFGWKA 145
+ ++ H+N++ + CI+ V Y YM +L L LGE +
Sbjct: 61 LLYGLS--HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHI 204
+ + I G++Y+H+ V+H+DI N ++D+ KI+D LS+ LFP + +
Sbjct: 119 LVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ ++A E ++ + SDV+SFGVLL E+++
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QG-------EKEFMSEVASMANVNVCH 99
KIGEG +G VYK R + +A+K + +E + +G E + E+ H
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--------H 60
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGL 157
N+V+L LV++Y L L F R + + I RG+
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF--PENT-THISTRVAGTLG 213
AY H V+HRD+K N+L+D+ N K++DFGL++ F P T TH TL
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLW 168
Query: 214 YLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
Y APE + R + D++S G + E+V+ + D ++ E
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 73/250 (29%), Positives = 109/250 (43%), Gaps = 29/250 (11%)
Query: 26 LKNINAF---------SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLS 75
KNI+ F +L++ F IG G FG V R + + A+K+LS
Sbjct: 18 NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS 77
Query: 76 VES--KQGEKEFM-SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL 132
K+ + F E MA+ N E +V+LH D +V +YMP L L+
Sbjct: 78 KFEMIKRSDSAFFWEERDIMAHAN--SEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLM 134
Query: 133 GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192
K+ E+++ L IH +HRD+K N+LLD++ + K++DFG
Sbjct: 135 SNYDIPEKWARFYTAEVVLA----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 193 LS-KLFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTA 247
K+ T V GT Y++PE S G R+ D +S GV L E++ G T
Sbjct: 188 TCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 248 VDFDVQLGEY 257
D +G Y
Sbjct: 247 FYADSLVGTY 256
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 31/229 (13%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQG-EKEFMSEVA 90
+I + R+ ++GE FG VYKG L + VA+K L +++ +EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE-- 58
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL----------GEEKRRAK 140
+M + H N+V L G +++ Y ++ L + L+ ++ + K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 141 FGWKARR--EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
+ I+ I G+ ++ HVVH+D+ T N+L+ N KISD G LF
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG---LFR 172
Query: 199 ENTTHISTRVAGT----LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
E ++ G + +++PE + G+ + SD++S+GV+L E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 64 QDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRIL-VY 119
G VA+K+L ++ + E + F E A A + H N+V L P + V+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY--HPNIVALLDSGEAPPGLLFAVF 58
Query: 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179
+Y+P +L + L + A G R +++ + LA H + +VHRD+K NI+
Sbjct: 59 EYVPGRTLREVLAADGALPA--GETGR--LMLQVLDALACAHNQ---GIVHRDLKPQNIM 111
Query: 180 L---DQNFNPKISDFGLSKLFP------ENTTHISTRVAGTLGYLAPEYAISGRLTRKSD 230
+ + K+ DFG+ L P T +T V GT Y APE +T SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 231 VYSFGVLLLEIVSGRTAV 248
+Y++G++ LE ++G+ V
Sbjct: 172 LYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-14
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHE 100
F+ KIGEG +G VYK R G +VA+K L E++ + E++ + +N H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 59
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGLA 158
N+VKL LV+++ L Q L G + + + +GLA
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYL 215
+ H V+HRD+K N+L++ K++DFGL++ F P T TH V TL Y
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYR 167
Query: 216 APEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
APE + + + D++S G + E+V+ R
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-14
Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 35/218 (16%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGE------KEFMSEVASMA 93
FR +G+GGFG V +++ G + A K L ++ ++GE K+ + +V S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL-----GEEKRRAKFGWKARRE 148
VN+ + K D C LV M L + G E+ RA F + A E
Sbjct: 62 VVNLAYAYETK------DALC--LVLTIMNGGDLKFHIYNMGNPGFEEERALF-YAA--E 110
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
I+ G L +H E + V+RD+K NILLD + +ISD GL+ PE + I RV
Sbjct: 111 ILCG----LEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV 162
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
GT+GY+APE + R T D + G L+ E++ G++
Sbjct: 163 -GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
IG G +G V + G VA+K +S + K + E+ + ++ HEN++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR--HENIIGLL 65
Query: 107 GGCIDGPCRI-------LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIG 154
I P +V + M + L + + L ++ + + I
Sbjct: 66 D--ILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQPLTDDHIQY---------FLYQIL 113
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVAGT 211
RGL Y+H +V+HRD+K SNIL++ N + KI DFGL++ + ++ V T
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 212 LGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
Y APE +S R T+ D++S G + E+++ +
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAG 210
I RGL YIH +V+HRD+K SN+LL+ N + KI DFGL+++ H T
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 211 TLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
T Y APE ++ + K+ D++S G +L E++S R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLH 106
++G G G V K + + G I+A K++ +E K + + E+ + N + +V +
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY--IVGFY 69
Query: 107 GGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII----MGIGRGLAYIH 161
G DG I + ++M SL Q L +E +R EI+ + + RGLAY+
Sbjct: 70 GAFYSDGEISICM-EHMDGGSLDQVL--KEAKRIP------EEILGKVSIAVLRGLAYLR 120
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
E+ Q ++HRD+K SNIL++ K+ DFG+S ++ ++ GT Y++PE
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQ 175
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
+ +SD++S G+ L+E+ GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 50 IGEGGFGSVYKGRL--QDGTI--VAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLV 103
+G+G FGSV + +L +DG+ VAVK+L + S +EF+ E A M + H N++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD--HPNVI 64
Query: 104 KLHGGCIDG------PCRILVYDYMPNNSLSQTLL----GEEKRRAKFGWKARREIIMGI 153
KL G + P +++ +M + L LL GEE R ++ I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR--FMIDI 122
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTL 212
G+ Y+ + + +HRD+ N +L++N ++DFGLS K++ + +
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
+LA E T SDV++FGV + EI++ G+T
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVE--SKQGEKEFMS---EVASMANVNV 97
+R +G G FG VY D G +AVK + + S++ KE + E+ + N+
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR- 62
Query: 98 CHENLVKLHGGCIDGPCR---ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
H+ +V+ +G C+ P + +YMP S+ L + R+I+ G+
Sbjct: 63 -HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV- 119
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS----TRVAG 210
+Y+H + +VHRDIK +NIL D N K+ DFG SK T +S V G
Sbjct: 120 ---SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTG 171
Query: 211 TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS 243
T +++PE ISG RK+DV+S ++E+++
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 48 NKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
+K+GEG + +VYKGR L D +VA+K + +E ++G + EV+ + ++ H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVT 68
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
LH LV++Y+ + L Q L + + + + RGL Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRR- 123
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SG 223
V+HRD+K N+L+++ K++DFGL++ T S V TL Y P+ + S
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
+ + D++ G + E+ +GR
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 33/227 (14%)
Query: 49 KIGEGGFGSVYKGR-LQDG-TIVAVKVLSVESKQGEKEFM-----SEVASMANVNVC-HE 100
+IGEG +G V+K R L++G VA+K + V Q +E M EVA + ++ H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 101 NLVKLHGGCI----DGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
N+V+L C D ++ LV++++ + L+ L ++ + ++++ + R
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLLR 121
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
GL ++H VVHRD+K NIL+ + K++DFGL++++ + T V TL Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176
Query: 216 APEYAISGRLTRKSDVYSFGVLLLE------IVSGRTAVDFDVQLGE 256
APE + D++S G + E + G + VD QLG+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 55/201 (27%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
++G+G FG VYK + ++ G + A KV+ +S++ +++M E+ +A+ + H N+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLD 69
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
++ ++ ++ +L E+ + R + L Y+HE
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTE---PQIRVVCKQTLEALNYLHEN---K 123
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGR- 224
++HRD+K NIL + + K++DFG+S +NT I R + GT ++APE +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 225 ----LTRKSDVYSFGVLLLEI 241
K+DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 46/216 (21%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLV-- 103
KIGEG +G V+K R ++ G IVA+K V S + +K + E+ + + H NLV
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--HPNLVNL 65
Query: 104 --------KLHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIG 154
KLH LV++Y T+L E EK ++II
Sbjct: 66 IEVFRRKRKLH----------LVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF----PENTTHISTRVAG 210
+ + + H + + +HRD+K NIL+ + K+ DFG +++ + T +++TR
Sbjct: 111 QAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR--- 164
Query: 211 TLGYLAPEYAISGRLTRKS--DVYSFGVLLLEIVSG 244
Y APE + G DV++ G + E+++G
Sbjct: 165 --WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-13
Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
KIG+G G+V+ + G VA+K ++++ + ++ ++E+ M + + N+V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK--NPNIVNFLD 83
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
+ G +V +Y+ SL+ + A+ R + + L ++H
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---Q 135
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
V+HRDIK+ N+LL + + K++DFG +++ PE + ST V GT ++APE
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVTRKAYG 193
Query: 227 RKSDVYSFGVLLLEIVSG 244
K D++S G++ +E+V G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 49 KIGEGGFGS--VYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVK 104
KIGEG FG + K + +DG +K +++ S + +E EVA ++N+ H N+V+
Sbjct: 7 KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK--HPNIVQ 63
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+ +V DY L + + +R F + + I L ++H+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHDR- 120
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
++HRDIK+ NI L ++ K+ DFG++++ +T ++ GT YL+PE +
Sbjct: 121 --KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENRP 177
Query: 225 LTRKSDVYSFGVLLLEIVSGRTA 247
KSD+++ G +L E+ + + A
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 50/220 (22%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHENL 102
KIGEG +G VYKGR + G IVA+K + +ES E+E + E++ + + H N+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQ--HPNI 61
Query: 103 VKLHGGCIDGPCRILVYDYM------------PNNSLSQTLLGEEKRRAKFGWKARREII 150
V L + L+++++ + L+ + +
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELV--------------KSYL 107
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV-- 208
I +G+ + H V+HRD+K N+L+D K++DFGL++ F I RV
Sbjct: 108 YQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYT 159
Query: 209 --AGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
TL Y APE + S R + D++S G + E+ + +
Sbjct: 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 41/215 (19%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G +G V G VA+K LS +S K E+ + +++ HEN++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD--HENVIGL- 79
Query: 107 GGCID--GPCRIL-----VYDYMP------NNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
+D P L VY NN + L ++ +F ++ I
Sbjct: 80 ---LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD--HIQF-------LVYQI 127
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTL 212
RGL YIH ++HRD+K SNI ++++ KI DFGL++ E T +++TR
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR----- 179
Query: 213 GYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
Y APE ++ + D++S G ++ E+++G+T
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 37/95 (38%), Positives = 59/95 (62%), Gaps = 10/95 (10%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGT 211
I RGL Y+H VVHRD+K SNIL+++N + KI DFGL+++ P+ T ++STR
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170
Query: 212 LGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 245
Y APE ++ + + D++S G + E++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 49 KIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQGEKEFMSEVASM-ANVNVCHENLVKLH 106
KIG+G G+VY + G VA+K ++++ + ++ ++E+ M N N N+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN---PNIVNYL 82
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
+ G +V +Y+ SL+ + + R + + L ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN--- 134
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
V+HRDIK+ NILL + + K++DFG +++ PE + ST V GT ++APE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVTRKAY 192
Query: 226 TRKSDVYSFGVLLLEIVSG 244
K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
+IG G FG+VY R +++ +VA+K +S KQ ++ + EV + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQ 79
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
G + LV +Y S S L +K + A + G +GLAY+H
Sbjct: 80 YRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH- 134
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS- 222
+++HRD+K NILL + K+ DFG + + P N GT ++APE ++
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAM 186
Query: 223 --GRLTRKSDVYSFGVLLLEI 241
G+ K DV+S G+ +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-13
Identities = 66/245 (26%), Positives = 116/245 (47%), Gaps = 29/245 (11%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIV--AVKVL-SVESKQGEKEFMSEVASMANVNVCHENLVKL 105
IGEG FG V K R++ DG + A+K + SK ++F E+ + + H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINL 61
Query: 106 HGGCIDGPCRILVYDYMPNNSL------SQTLLGEEKRRAKFGWKA---RREIIM---GI 153
G C L +Y P+ +L S+ L + + ++++ +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
RG+ Y+ ++ +HRD+ NIL+ +N+ KI+DFGLS+ + T +
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 176
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLGEYHLVDKVRSI 266
++A E T SDV+S+GVLL EIVS G T + +L + + ++K +
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236
Query: 267 NMKLY 271
+ ++Y
Sbjct: 237 DDEVY 241
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 68/255 (26%), Positives = 122/255 (47%), Gaps = 39/255 (15%)
Query: 45 RWSNKIGEGGFGSVYKGRLQ-DGTIV--AVKVL-SVESKQGEKEFMSEVASMANVNVCHE 100
++ + IGEG FG V + ++ DG + A+K+L S+ ++F E+ + + H
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH-HP 63
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSL------SQTLLGEEKRRAKFGWKA---RREII- 150
N++ L G C + + +Y P +L S+ L + + G + ++++
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 151 --MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
+ G+ Y+ E+ +HRD+ N+L+ +N KI+DFGLS+ V
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYV 173
Query: 209 AGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS-------GRTAVDFDVQLGE 256
T+G ++A E T KSDV+SFGVLL EIVS G T + +L +
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 257 YHLVDKVRSINMKLY 271
+ ++K R+ + ++Y
Sbjct: 234 GYRMEKPRNCDDEVY 248
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 33/206 (16%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EK--EFMSEVASMANVNVCHENLVK 104
+IG G FG+VY R ++ +VA+K +S KQ EK + + EV + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR--HPNTIE 79
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----IIMGIGRGLAY 159
G + LV +Y LG + K +E I G +GLAY
Sbjct: 80 YKGCYLREHTAWLVMEY---------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPE 218
+H +HRDIK NILL + K++DFG + L P N+ GT ++APE
Sbjct: 131 LHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPE 181
Query: 219 YAIS---GRLTRKSDVYSFGVLLLEI 241
++ G+ K DV+S G+ +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-13
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF--MSEVASMANVNVC-HENLVK 104
+IG G +G+VYK R G VA+K + V++ + + EVA + + H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 105 LHGGC----IDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR--REIIMGIGRGL 157
L C D ++ LV+++ + Q L + G A ++++ RGL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLA 216
++H +VHRD+K NIL+ K++DFGL++++ + ++ T V TL Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRA 175
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEI 241
PE + D++S G + E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-13
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 50 IGEGGFGSVYKGRLQ----DGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLV 103
+G G FG + +G L+ VA+ L KQ + F++E ++ + H N+V
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFD--HSNIV 69
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+L G G ++V +YM N +L L K + ++ G+ G+ Y+ E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYAI 221
VH+ + +L++ + KIS F +L + + I T ++G L APE
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
+ SDV+SFG+++ E++S
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-13
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVKLH 106
K+GEG + +VYKGR + G +VA+K + +E ++G + E + + ++ H N+V LH
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK--HANIVTLH 69
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
LV++Y+ + L Q + + R + + RGLAY H Q
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYCH---QR 122
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL--SKLFPENTTHISTRVAGTLGYLAPEYAI-SG 223
V+HRD+K N+L+ + K++DFGL +K P T S V TL Y P+ + S
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVV-TLWYRPPDVLLGST 179
Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
+ D++ G + E+ +GR
Sbjct: 180 EYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-13
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVK---VLSVESKQGEKEFMSEVASMANVNVCH 99
F+ KIG G F VY+ L D VA+K + + + ++ + E+ + +N H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN--H 61
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N++K I+ +V + LSQ + +K++ + + + + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+H V+HRDIK +N+ + K+ D GL + F TT + V GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
KSD++S G LL E+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVK 104
++G+GG+G V+ + +D G IVA+K + + + ++E + E LVK
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVK 65
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGE----EKRRAKFGWKARREIIMGIGRGLAYI 160
L D L +Y+P +TLL + A+F E + + L YI
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHE-LGYI 123
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
HRD+K N L+D + + K++DFGLSK + V G+ Y+APE
Sbjct: 124 ---------HRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVL 170
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
D +S G +L E + G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
+IG G FG+VY R ++ +VA+K +S KQ ++ + EV + + H N ++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK--HPNSIE 89
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
G + LV +Y S S L +K + A I G +GLAY+H
Sbjct: 90 YKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH- 144
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAIS- 222
+++HRDIK NILL + K++DFG + + P N+ GT ++APE ++
Sbjct: 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAM 196
Query: 223 --GRLTRKSDVYSFGVLLLEI 241
G+ K DV+S G+ +E+
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-13
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 54/221 (24%)
Query: 45 RWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVE-SKQGEKEFMSEVASM---------- 92
++ +G G G+VYK L I+AVKV+ ++ + + +K+ MSE+ +
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 93 --------ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK 144
+++C E + GG +D VY +P + L +
Sbjct: 64 FYGAFFVENRISICTE---FMDGGSLD------VYRKIPEHVLGR--------------- 99
Query: 145 ARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
I + + +GL Y+ ++HRD+K SN+L++ K+ DFG+S + I
Sbjct: 100 ----IAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSI 149
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
+ GT Y+APE + SDV+S G+ +E+ GR
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 50 IGEGGFGSVY-KGRLQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V R DG AVKVL V +++ +K M+E + NV H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK-NVKHPFLVGL 61
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYIHE 162
H V D++ L L E + RA+F I L Y+H
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLH- 113
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPEYA 220
++V+RD+K NILLD + ++DFGL K + +TT T GT YLAPE
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVI 168
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSG 244
D + G +L E++ G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 9e-13
Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASM-ANVNVCHENLVKLH 106
KIG+G G+VY + G VA++ ++++ + ++ ++E+ M N N N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---PNIVNYL 83
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
+ G +V +Y+ SL+ + + R + + L ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN--- 135
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL-SKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
V+HRDIK+ NILL + + K++DFG +++ PE + + + GT ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY 193
Query: 226 TRKSDVYSFGVLLLEIVSG 244
K D++S G++ +E++ G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 48 NKIGEGGFGSVY-KGRLQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLV 103
++IG G FG+VY +VAVK +S KQ ++ + EV + + H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK--HPNTI 84
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+ G + LV +Y S S L +K + A I G +GLAY+H
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH 140
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFG-LSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
+++HRDIK NILL + K++DFG SK P N+ GT ++APE ++
Sbjct: 141 ---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILA 191
Query: 223 ---GRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQLGEYHL 259
G+ K DV+S G+ +E+ + + + + YH+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-12
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 49 KIGEGGFGSVY--KGRLQDGTIVAVKVLSVESKQGEKEF-MSEVASMANVNVCHENLVKL 105
KIGEG FG +Y K + V ++ + EKE EV +A + H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK--HPNIVTF 64
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+ +V +Y L + + +R F + I GL +IH+
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 166 PHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
++HRDIK+ NI L +N K+ DFG+++ ++ ++ GT YL+PE +
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 225 LTRKSDVYSFGVLLLEIVS 243
K+D++S G +L E+ +
Sbjct: 179 YNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 50 IGEGGFGSVY--------KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC--H 99
+GEG FG V K R VAVK+L + +K+ ++ M + + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML--KDNATDKDLADLISEMELMKLIGKH 77
Query: 100 ENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLL------------GEEKRRAKFGWKAR 146
+N++ L G C +GP ++V +Y +L + L + + +K
Sbjct: 78 KNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
+ RG+ Y+ +HRD+ N+L+ ++ KI+DFGL++ I
Sbjct: 137 VSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDY 189
Query: 207 RVAGTLG-----YLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ G ++APE T +SDV+SFG+L+ EI +
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 55/205 (26%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 44 FRWSNKIGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHEN 101
F +++G G G V+K G I+A K++ +E K + + E+ + N +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-- 64
Query: 102 LVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
+V +G DG I + ++M SL Q L K+ + + ++ + + +GL Y+
Sbjct: 65 IVGFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
E+ + ++HRD+K SNIL++ K+ DFG+S ++ ++ GT Y++PE
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERL 174
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
+ +SD++S G+ L+E+ GR
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 42/224 (18%)
Query: 50 IGEGGFGSVYKGRL----QDGTIVAVKVL----------SVESKQGEKEFMSEVAS---M 92
+G G +G V+ R G + A+KVL + E + E++ + + +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 93 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
++ + KLH L+ DY+ L L +R +F +E+ +
Sbjct: 68 VTLHYAFQTDTKLH----------LILDYINGGELFTHL----SQRERF---KEQEVQIY 110
Query: 153 IGR---GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
G L ++H + +++RDIK NILLD N + ++DFGLSK F E+ +
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167
Query: 210 GTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD 251
GT+ Y+AP+ G + D +S GVL+ E+++G + D
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
FR +G+GGFG V +++ G + A K L ++ ++GE ++E + VN
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN--- 58
Query: 100 ENLVKLHGGCIDGPCRILV---YDYMPNNSLSQTLLGEEKRRAKF--------GWKARRE 148
R +V Y Y ++L L KF G+ +R
Sbjct: 59 --------------SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA 104
Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
I + GL + E +V+RD+K NILLD + +ISD GL+ PE T +
Sbjct: 105 IFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRG 160
Query: 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
RV GT+GY+APE + + T D + G L+ E++ G++
Sbjct: 161 RV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-12
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEK------EFMSEVASMANVNVCH 99
+G+GGFG V ++++ G + A K L ++ K GEK E + +V S VN+ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IGRGL 157
K H LV M L + +R G + R I I G+
Sbjct: 61 AFESKTH--------LCLVMSLMNGGDLKYHIYNVGER----GLEMERVIHYSAQITCGI 108
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
++H +V+RD+K N+LLD N ++SD GL+ + T T+ AGT GY+AP
Sbjct: 109 LHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAP 163
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
E + D ++ G + E+V+GRT
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSV---------ESKQGEKEFMSEVASMA 93
+G G FG V+ R + A+KV+++ + EK + EV+
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--- 59
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
H +++L D ++ +Y+P L L + +F I
Sbjct: 60 -----HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEI 110
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
L Y+H + +V+RD+K NILLD+ + K++DFG +K + T + GT
Sbjct: 111 VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL----CGTPE 163
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
YLAPE S + D ++ G+L+ E++ G
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMAN-----VNV 97
F +G G FG V + + G A+K L K+ E M +V +A + +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL----KKREILKMKQVQHVAQEKSILMEL 75
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIG 154
H +V + D + +++ L L + AKF + A E+++
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHA--ELVLA-- 130
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
Y+H + +++RD+K N+LLD + K++DFG +K P+ T + GT Y
Sbjct: 131 --FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL----CGTPEY 181
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
LAPE S + D ++ GVLL E ++G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 39/236 (16%)
Query: 50 IGEGGFGSVYK-GRLQDGTIVAVKVLSVESKQGEKEFMSE---VASMANVNVCHENLVKL 105
IG+G +G VYK +DG++ AVK+L S E E +E + S+ N H N+VK
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPN----HPNVVKF 84
Query: 106 HG------GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
+G + G LV + S+++ + G + I+ G GL +
Sbjct: 85 YGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE- 218
+H ++HRD+K +NILL K+ DFG+S +T V GT ++APE
Sbjct: 144 LHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEV 199
Query: 219 --------YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSI 266
Y+ R DV+S G+ +E+ G D L + H V + I
Sbjct: 200 IACEQQYDYSYDAR----CDVWSLGITAIELGDG------DPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
IG G + V RL+ + I A+KV+ ++ Q EK + +S +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-------N 55
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
LV LH C R+ LV +Y+ L + +R+ K + R I L
Sbjct: 56 PFLVGLHS-CFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALN 110
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
++HE +++RD+K N+LLD + + K++D+G+ K L P +TT + GT Y+A
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIA 164
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
PE D ++ GVL+ E+++GR+ D
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL---FPENTTHISTRVAGT 211
RGL YIH +V+HRD+K SN+L++++ +I DFG+++ P + T T
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 212 LGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGR 245
Y APE +S T D++S G + E++ GR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 45/191 (23%), Positives = 82/191 (42%), Gaps = 41/191 (21%)
Query: 96 NVCHENLVKLHGGCIDGP--CRIL------VYDYMPNNS----LSQTLLGEEKRRAKFGW 143
NV H +++++ + G C +L +Y Y+ S + Q L+
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALI----------- 161
Query: 144 KARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
I I GL Y+H ++HRD+KT NI ++ I D G ++ FP
Sbjct: 162 -----IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPA 212
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD--------VQLG 255
+AGT+ APE + K+D++S G++L E+++ + + D V+
Sbjct: 213 F-LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSC 271
Query: 256 EYHLVDKVRSI 266
HL+ + ++
Sbjct: 272 HSHLLKIISTL 282
|
Length = 357 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
F +IG G +G VYK R + G + A+KV+ +E + E+ M + H N+
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK--HSNI 68
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTL-LGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
V G + + ++ SL + ++ + +R + +GL Y+H
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEY 219
+ + +HRDIK +NILL N + K++DFG+S + T I+ R + GT ++APE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIGTPYWMAPEV 177
Query: 220 AI---SGRLTRKSDVYSFGVLLLEI 241
A G + D+++ G+ +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 50 IGEGGFGSVY---KGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
+G+G FG V+ K D G + A+KVL + + +++ V H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 106 HGGCIDGPCRILVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
H L+ D++ L + + EE KF + + L ++
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKF-------YLAELALALDHL 114
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPE 218
H +++RD+K NILLD+ + K++DFGLSK E+ H + GT+ Y+APE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPE 168
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
T+ +D +SFGVL+ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGT 211
I RGL Y+H ++HRDIK N+L++ N KI DFGL+++ P+ + H++ V T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 212 LGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
Y APE + S T D++S G + E++ R
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
IG G + V RL+ I A+KV+ ++ Q EK + ++ H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 55
Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
LV LH C R+ V +Y+ L + +R+ K + R I L
Sbjct: 56 PFLVGLHS-CFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
Y+HE +++RD+K N+LLD + K++D+G+ K L P +TT + GT Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
PE D ++ GVL+ E+++GR+ D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 50 IGEGGFGSVYKGRLQDGT-IVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
IG G + V L+ I A+KV+ ++ Q EK E AS H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVF-ETASN------H 55
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
LV LH C R+ V +++ L Q L EE R EI +
Sbjct: 56 PFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-----EISLA- 108
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGT 211
L ++HE +++RD+K N+LLD + K++D+G+ K + P +TT ST GT
Sbjct: 109 ---LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--ST-FCGT 159
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
Y+APE D ++ GVL+ E+++GR+ D
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 9/101 (8%)
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP----ENTTHIS 205
I I GL YIH +V+HRD+K N+L++ + KI DFGL++ F EN ++
Sbjct: 111 IYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 206 TRVAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGR 245
VA T Y APE +S + K+ DV+S G +L E++ +
Sbjct: 168 EYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 38/110 (34%), Positives = 62/110 (56%), Gaps = 18/110 (16%)
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN----- 200
+R I+ + + L YIH +V+HRD+K SNILL+ + K++DFGL++ E
Sbjct: 109 KRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 201 ----TTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
T +++TR Y APE + S R T+ D++S G +L E++ G+
Sbjct: 166 NPVLTDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HEN 101
+ ++G G +G VYK R L G + AVK++ +E G+ +F + V C H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGD-DFSLIQQEIFMVKECKHCN 67
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTL-LGEEKRRAKFGWKARREIIMGIGRGLAYI 160
+V G + + +Y SL + + + R + +GLAY+
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYL 122
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPE 218
H + + +HRDIK +NILL N + K++DFG++ + T I+ R + GT ++APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYWMAPE 176
Query: 219 YAI---SGRLTRKSDVYSFGVLLLEI 241
A +G + D+++ G+ +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 49 KIGEGGFGSVY----KGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
++G+G FG+VY K + + + +K + V + + + + H +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
H ++ ++ +Y L L + E + + G+ Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
++HRD+K NI L N KI DFG+S+L + ++T GT Y++PE
Sbjct: 126 --RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQG 181
Query: 225 LTRKSDVYSFGVLLLEI 241
KSD++S G +L E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 50 IGEGGFGSVYKGRLQDG-TIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106
IG G FG V +L++ + A+K+L+ K+ E E + VN ++ + LH
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL-VNGDNQWITTLH 67
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHE 162
D LV DY L L E R A+F E+++ I +H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF---YLAEMVIAIDS----VH- 119
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
Q H VHRDIK NIL+D N + +++DFG E+ T S+ GT Y++PE +
Sbjct: 120 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 223 -----GRLTRKSDVYSFGVLLLEIVSGRT 246
G+ + D +S GV + E++ G T
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAG 210
I GL ++H + +++RD+K N++LD + KI+DFG+ K +F TT G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCG 163
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
T Y+APE + D ++FGVLL E+++G+ D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-11
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
KIGEG +G VYK R G +VA+K L ++ + + E++ + ++ +V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES-IYIVRL 66
Query: 106 ----HGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
H +G P LV++Y+ ++ K + + + +G+A+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLFP---ENTTHISTRVAGTLGYLA 216
H+ V+HRD+K N+L+D+ KI+D GL + F ++ TH TL Y A
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYRA 179
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSG 244
PE + + D++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 16/237 (6%)
Query: 42 NGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVL--SVESKQGEKEFMSEVASMANVNVC 98
N F +GEG +G V K R ++ IVA+K S E+++ ++ + E+ + +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-- 58
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
EN+V+L LV++Y+ N L L EE K R I I + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYIYQLI-KAIH 114
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
+ H+ +VHRDIK N+L+ N K+ DFG ++ E + T T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV----RSINMKLY 271
+ + D++S G +L E+ G+ + ++ + + KV + MKL+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 65/263 (24%), Positives = 101/263 (38%), Gaps = 66/263 (25%)
Query: 45 RWSNKIGEGGFGSVYK------GRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNV 97
+ +G G FG V + + VAVK+L + E K M+E+ + ++
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH 69
Query: 98 CHENLVKLHGGCI--DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
H N+V L G C GP ++V +Y +LS L + + + + K+ R+ M
Sbjct: 70 -HLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE 127
Query: 156 GLA-----------------------YIHEEIQP-------------------------- 166
G EE +
Sbjct: 128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME 187
Query: 167 -----HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYA 220
+HRD+ NILL +N KI DFGL++ ++ ++ A L ++APE
Sbjct: 188 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
T +SDV+SFGVLL EI S
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-11
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE-NLVKL 105
+++G+G +GSVYK + G +A+K + +E E +F + + ++ +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDF 64
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+G + +YM SL + L R I + +GL ++ EE
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
++HRD+K +N+L++ N K+ DFG+S ++ G Y+APE SG
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGP 178
Query: 226 ------TRKSDVYSFGVLLLEIVSGR 245
T +SDV+S G+ +LE+ GR
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 50 IGEGGFGSVYKGRLQDGT-IVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V + R +D I A+K + + S+ ++E +A VN +K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
P ++ LV ++ L L +R +F R + L +H+
Sbjct: 61 ---SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAELLCALENLHKF- 112
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
+V++RD+K NILLD + + DFGL KL ++ +T GT YLAPE +
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHG 169
Query: 225 LTRKSDVYSFGVLLLEIVSG 244
T+ D ++ GVLL E+++G
Sbjct: 170 YTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 50 IGEGGFGSVYKGRL-QDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V RL + G + AVKVL VE EK +S + H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 55
Query: 100 ENLVKLHGGCIDGPCRIL-VYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGR 155
L +L+ C P R+ V +++ L Q ++ RA+F + A EI
Sbjct: 56 PFLTQLYC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAA--EIT----S 107
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
L ++H++ +++RD+K N+LLD + K++DFG+ K N ST GT Y+
Sbjct: 108 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYI 163
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSG 244
APE D ++ GVLL E++ G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
G+ +IHE+ V+HRDIK+ NI L QN K+ DFG ++L + T V GT Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
PE + KSD++S G +L E+ +
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V+ L+ A+K L VE EK +S H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-------H 55
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLS---QTLLGEEKRRAKFGWKARREIIMGIGRG 156
L L+ V +Y+ L Q+ + RA F + A EII G
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-YAA--EIICG---- 108
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
L ++H + +V+RD+K NILLD + + KI+DFG+ K T GT Y+A
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIA 164
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
PE + + D +SFGVLL E++ G++
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 50 IGEGGFGSVYKGRLQDGT--IVAVKVL---------SVESKQGEKEFMSEVASMANVNVC 98
+G+G FG V L+ GT + A+KVL V+ EK ++ A
Sbjct: 3 LGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK------- 54
Query: 99 HENLVKLHGGCIDGPCRIL-VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
H L LH C R+ V +Y+ L + + +R KF R + L
Sbjct: 55 HPFLTALHC-CFQTKDRLFFVMEYVNGGDL----MFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYL 215
++H + V++RD+K NILLD + K++DFG+ K + TT T GT Y+
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYI 163
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
APE D ++ GVL+ E+++G+ + D
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 72/257 (28%), Positives = 116/257 (45%), Gaps = 30/257 (11%)
Query: 23 EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLS---VES 78
E+I++ I +L++ + IG G FG V R + + A+K+LS +
Sbjct: 29 EKIVRKIR-----KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK 83
Query: 79 KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE--K 136
+ F E MA N +V+L D +V +YMP L + + +
Sbjct: 84 RSDSAFFWEERDIMAFAN--SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE 141
Query: 137 RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-K 195
+ AKF E+++ L IH ++HRD+K N+LLD++ + K++DFG K
Sbjct: 142 KWAKF---YTAEVVLA----LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
Query: 196 LFPENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
+ T V GT Y++PE S G R+ D +S GV L E++ G T D
Sbjct: 192 MDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250
Query: 252 VQLGEY-HLVDKVRSIN 267
+G Y ++D S+N
Sbjct: 251 SLVGTYSKIMDHKNSLN 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 31/100 (31%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
E + I L Y+HE+ H++HRD+KT N+ L + K+ D G++++ EN +++
Sbjct: 106 EWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMAST 161
Query: 208 VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247
+ GT Y++PE + KSDV++ G + E+ + + A
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 40/112 (35%), Positives = 65/112 (58%), Gaps = 11/112 (9%)
Query: 135 EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194
++ RA+F + A EII G L ++H++ +++RD+K N+LLD++ + KI+DFG+
Sbjct: 94 DEARARF-YAA--EIICG----LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMC 143
Query: 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
K ST GT Y+APE + D +SFGVLL E++ G++
Sbjct: 144 KENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 50 IGEGGFGSVYKGRLQDGT----IVAVKVLSVESKQGEKEFMSEVASMANV--NVCHENLV 103
+G+GG+G V++ R G I A+KVL + ++ + + N+ V H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRRAKFGWKARREIIMGIGRGLAYI 160
L G L+ +Y+ L L E + A F EI + + ++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF---YLSEISLALE----HL 116
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLAPE 218
H Q +++RD+K NILLD + K++DFGL K + TH GT+ Y+APE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSG 244
+ + D +S G L+ ++++G
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 33/93 (35%), Positives = 58/93 (62%), Gaps = 8/93 (8%)
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
GL ++H + +++RD+K N++LD++ + KI+DFG+ K +F +N ++ GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPD 161
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
Y+APE + T D +SFGVLL E++ G++
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106
IG G FG V ++++ G + A+K+L+ K+ E E + VN + LH
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL-VNGDRRWITNLH 67
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR-----AKFGWKARREIIMGIGRGLAYIH 161
D LV DY L TLL + + R A+F + A E+++ I +H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARF-YLA--EMVLAIDS----VH 119
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEY- 219
Q VHRDIK N+LLD+N + +++DFG +L + T + V GT Y++PE
Sbjct: 120 ---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEIL 175
Query: 220 -AI---SGRLTRKSDVYSFGVLLLEIVSGRT 246
A+ GR + D +S GV + E++ G T
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 27/160 (16%)
Query: 99 HENLVKLHGGCIDGPCR------ILVYDYMPNN-----SLSQTLLGEEKRRAKFGWKARR 147
HEN++ + + P R +VY+ M + SQTL + +
Sbjct: 63 HENVIAIKD-IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQY--------- 112
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
+ + RGL YIH +V+HRD+K SN+LL+ N + KI DFGL++ E ++
Sbjct: 113 -FLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168
Query: 208 VAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
V T Y APE ++ T DV+S G + E++ +
Sbjct: 169 VV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 49 KIGEGGFGSVYKGRLQDG---TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVK 104
+IG G FG V G + G V VK L V S Q + +F+ E ++ H NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ--HSNLLQ 59
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR---------REIIMGIGR 155
G C + +LV ++ P LG+ K + KA + + I
Sbjct: 60 CLGQCTEVTPYLLVMEFCP--------LGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL-FPENTTHISTRVAGTLGY 214
GL ++H+ + +H D+ N LL + KI D+GLS + E+ ++ L +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 215 LAPEYA--ISGRL-----TRKSDVYSFGVLLLEI 241
+APE + G L T++S+V+S GV + E+
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 50 IGEGGFGSVYKGRLQDGT-IVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106
IG G FG V +++ I A+K+L+ K+ E E ++ VN + + LH
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL-VNGDCQWITTLH 67
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIHE 162
D LV DY L L E R A+F I + IH
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY----------IAEMVLAIHS 117
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
Q H VHRDIK N+LLD N + +++DFG ++ T S+ GT Y++PE +
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 223 -----GRLTRKSDVYSFGVLLLEIVSGRT 246
G+ + D +S GV + E++ G T
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 40/215 (18%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLS---VESKQG------EKEFMSEVASMANVNVCH 99
+G+GGFG V +++ G + A K L+ ++ ++G EK +++V S V++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 100 ENLVK---------LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
K ++GG + R +Y+ N G + RA F + A+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDL----RYHIYNVDEENP------GFPEPRACF-YTAQ---- 105
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
I GL ++H Q +++RD+K N+LLD + N +ISD GL+ + + + AG
Sbjct: 106 --IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAG 159
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
T G++APE D ++ GV L E+++ R
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 36/219 (16%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
+G G G V+ D VAVK + + Q K + E+ + ++ H+N+VK++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVYEV 70
Query: 109 CIDGPCRI--------------LVYDYMPN---NSLSQTLLGEEKRRAKFGWKARREIIM 151
+ +V +YM N L Q L EE R F ++
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQ------- 122
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAG 210
+ RGL YIH +V+HRD+K +N+ ++ + KI DFGL+++ + +H G
Sbjct: 123 -LLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 211 TLG--YLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRT 246
+ Y +P +S T+ D+++ G + E+++G+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 50 IGEGGFGSVYKGRL----QDGTIVAVKVL----------SVESKQGEK---EFMSEVASM 92
+G G +G V+ R G + A+KVL +VE + E+ E + + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 93 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
++ + KLH L+ DY+ + L +R F R
Sbjct: 68 VTLHYAFQTEAKLH----------LILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGE 113
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
I L ++H + +V+RDIK NILLD + ++DFGLSK F + GT+
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 213 GYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSG 244
Y+APE I G+ + D +S G+L+ E+++G
Sbjct: 171 EYMAPE-IIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRVA 209
+ RG+ ++ +HRD+ NILL +N KI DFGL++ P+ S R+
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
L ++APE T +SDV+SFGVLL EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 34/100 (34%), Positives = 59/100 (59%), Gaps = 10/100 (10%)
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTR 207
+I I RGL YIH ++HRD+K SN+ ++++ KI DFGL++ + T +++TR
Sbjct: 125 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 208 VAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
Y APE ++ + D++S G ++ E+++GRT
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 34/229 (14%)
Query: 53 GGFGSVYKGRLQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENLVKLHGGCI 110
+ K + T+VAVK ++++S E K E+ + + H N++ I
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL--QHPNILPYVTSFI 69
Query: 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWK--ARREIIMGIGRGLAYIHEEIQPHV 168
+V M S L K G A I+ + L YIH +
Sbjct: 70 VDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYIHSK---GF 122
Query: 169 VHRDIKTSNILLDQNFNPKISDF---------GLSKLFPENTTHISTRVAGTLGYLAPEY 219
+HR +K S+ILL + +S G + + S + L +L+PE
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPEV 179
Query: 220 ---AISGRLTRKSDVYSFGVLLLEIVSGRTAVDF-DVQLGEYHLVDKVR 264
+ G KSD+YS G+ E+ +G V F D+ L++KVR
Sbjct: 180 LQQNLQG-YNEKSDIYSVGITACELANG--HVPFKDMPA-TQMLLEKVR 224
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 42 NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNV 97
F + +G G FG V R G I A+KV+ + +++ F E ++ N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE-----EKRRAKFGWKARREIIMG 152
+ +L D LV +Y P L +LL ++ A+F + A E+++
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQF-YLA--ELVLA 114
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
I H Q VHRDIK N+L+D+ + K++DFG + N S GT
Sbjct: 115 I-------HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 213 GYLAPEYAISGRLTRKS------DVYSFGVLLLEIVSGRT 246
Y+APE + K D +S GV+ E++ GR+
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAG 210
I L Y+H VV+RDIK N++LD++ + KI+DFGL K E + +T G
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
T YLAPE R D + GV++ E++ GR
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 36/100 (36%), Positives = 54/100 (54%), Gaps = 12/100 (12%)
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST- 206
EI+ +G Y+H VV+RD+K N++LD++ + KI+DFGL K E + +T
Sbjct: 103 EIVSALG----YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATM 152
Query: 207 -RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
GT YLAPE R D + GV++ E++ GR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 50 IGEGGFGSVYKG-RLQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G +GSV + G VA+K LS +S+ K E+ + ++ HEN++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--HENVIGLL 80
Query: 107 GGCIDGPCRILVYDY---MPNNSLS-QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
D+ MP Q ++G K + ++ + GL YIH
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIH- 134
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYAI 221
++HRD+K N+ ++++ KI DFGL++ E T ++ TR Y APE +
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 222 SG-RLTRKSDVYSFGVLLLEIVSGRT 246
+ + D++S G ++ E+++G+T
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
I L Y+H E +VV+RD+K N++LD++ + KI+DFGL K ++ + T GT
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 160
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
YLAPE R D + GV++ E++ GR
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVK-VLSVESKQGEKEF-------------MSEVASM 92
+GEG +G V K G IVA+K V +E + + E+ M
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 93 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
+ HEN++ L ++G LV D M ++ L + + R+ + + I++
Sbjct: 75 NEIK--HENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQ 127
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--------------P 198
I GL +H+ + +HRD+ +NI ++ KI+DFGL++ +
Sbjct: 128 ILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 199 ENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGR 245
+ ++++V TL Y APE + + + D++S G + E+++G+
Sbjct: 185 QRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 34/214 (15%)
Query: 50 IGEGGFGSVYKG---RLQDG-----TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101
+G+G F ++KG + D T V +KVL + + F E ASM + + H++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFF-EAASMMS-QLSHKH 60
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY-I 160
LV +G C+ G I+V +Y+ SL T L + K WK + + + LA+ +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLD-TYLKKNKNLINISWK------LEVAKQLAWAL 113
Query: 161 HEEIQPHVVHRDIKTSNILL-----DQNFNP---KISDFGLS-KLFPENTTHISTRVAGT 211
H + H ++ N+LL + NP K+SD G+S + P+ + R+
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERIP-- 169
Query: 212 LGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSG 244
++ PE + + L+ +D +SFG L EI SG
Sbjct: 170 --WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 28/77 (36%), Positives = 50/77 (64%), Gaps = 1/77 (1%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLT 226
++HRD+K++NI L K+ DFG SK + ++ + +++ GT YLAPE R +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 227 RKSDVYSFGVLLLEIVS 243
+K+D++S GV+L E+++
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 64/241 (26%), Positives = 102/241 (42%), Gaps = 51/241 (21%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCH 99
F+ +G+G G V+ RL+ G + A+KVL + + ++E +A ++ H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--H 60
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR-----AKFGWKARREIIMGIG 154
L L+ LV DY P L + L + + A+F + A E+++
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-YAA--EVLLA-- 115
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK------------------- 195
L Y+H +V+RD+K NILL ++ + +SDF LSK
Sbjct: 116 --LEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 196 ---------LFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
F E + S GT Y+APE ISG D ++ G+LL E++ G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
Query: 246 T 246
T
Sbjct: 230 T 230
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 50 IGEGGFGSV-YKGRLQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G +G+V + G VA+K L +S+ K E+ + ++ HEN++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK--HENVI--- 77
Query: 107 GGCID--GPCRIL-----VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
G +D P L Y MP T LG+ + K + ++ + +GL Y
Sbjct: 78 -GLLDVFTPDLSLDRFHDFYLVMP---FMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPE 218
IH ++HRD+K N+ ++++ KI DFGL++ E T ++ TR Y APE
Sbjct: 134 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPE 185
Query: 219 YAISG-RLTRKSDVYSFGVLLLEIVSGRT 246
++ T+ D++S G ++ E+++G+
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRV-AG 210
I GL ++H +++RD+K N++LD + KI+DFG+ K E+ ++TR G
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
T Y+APE + D +++GVLL E+++G+ D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL-FPENTTHIS-TRVAGTL 212
R L YIH +V HRD+K NIL + + KI DFGL+++ F + T I T T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 213 GYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGR 245
Y APE S + T D++S G + E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 20/230 (8%)
Query: 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLS---VESKQGEKEFMSEVASM 92
L++ + IG G FG V R + + A+K+LS + + F E M
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 93 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
A N +V+L D +V +YMP L L+ K+ E+++
Sbjct: 98 AFAN--SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLA 154
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGT 211
L IH +HRD+K N+LLD++ + K++DFG K+ E T V GT
Sbjct: 155 ----LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206
Query: 212 LGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257
Y++PE S G R+ D +S GV L E++ G T D +G Y
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTI--VAVKVLS----VESKQGEKEFMSEVAS 91
K+ F + +G G FG V ++ VA+K ++ KQ + F SE
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
+ +N H V L+G D LV +++ L ++ G +I++
Sbjct: 85 LNYIN--HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 152 GIGRGLAYIHEEIQP-HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
I E +Q ++V+RD+K N+LLD++ K++DFG +K+ T + G
Sbjct: 143 --------IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL----CG 190
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
T Y+APE ++ + +D ++ G+ + EI+ G
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-09
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVA---VKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
+IG G FG V + T VA VK L + E+ + + + H N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI-LQHPNILQC 60
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
G C++ +LV++Y L L E+ R + + I G+ ++H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-- 118
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPEYA---- 220
+ +H D+ N L + K+ D+G+ + E+ L +LAPE
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 221 ---ISGRLTRKSDVYSFGVLLLEI 241
I+ T+ S+V++ GV L E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 50 IGEGGFGSVYKGRLQ-------DGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHE 100
+G+G F ++YKG L+ G V V+ ++ ++ E AS+ + + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQ-LSHK 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
+LVKL+G C+ I+V +Y+ L L EK WK ++ + L Y+
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLD-VFLHREKNNVSLHWKL--DVAKQLASALHYL 117
Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
++ +VH ++ NIL+ N K+SD G+ P RV +
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVE-RIP 169
Query: 214 YLAPEY--AISGRLTRKSDVYSFGVLLLEIVSG 244
++APE LT +D +SFG LLEI S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 67/239 (28%), Positives = 103/239 (43%), Gaps = 56/239 (23%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLH 106
IG G FG V + +D G I A+K L +S+ EKE ++ V + ++ +N +VKL+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----EIIMGIGRGLAYIHE 162
D L+ +Y+P + TLL ++ F + R E I+ I IH
Sbjct: 68 YSFQDENYLYLIMEYLPGGDM-MTLL---MKKDTFTEEETRFYIAETILAI----DSIH- 118
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--------LFPENTTHI---------- 204
+ +HRDIK N+LLD + K+SDFGL F +H
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 205 ----STRVA---------------GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
S R A GT Y+APE + ++ D +S GV++ E++ G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 50 IGEGGFGSVYK-GRLQDGTIVAVKVLSV-----ESKQGEKEFMSEVASMANVNVCHENLV 103
IG+G +G V+K ++G+ AVK+L E + E + ++ H N+V
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD-------HPNVV 78
Query: 104 KLHG-----GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
K +G +G LV + S++ + G KR + I+ GL
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
++H +HRD+K +NILL K+ DFG+S +T GT ++APE
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPE 194
Query: 219 Y-----AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258
+ + DV+S G+ +E+ G D L + H
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG------DPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 32/76 (42%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG-TLGYLAPEYAISGRLTR 227
+HRD+ NILL +N KI DFGL++ ++ ++ A L ++APE T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 228 KSDVYSFGVLLLEIVS 243
+SDV+SFGVLL EI S
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 8/99 (8%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRV-AG 210
I GL ++H + +++RD+K N++LD + KI+DFG+ K EN ++T+ G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249
T Y+APE + D ++FGVLL E+++G+ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 25/183 (13%)
Query: 69 VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 128
V +KVL + F E AS+ + V H +L +HG C+ G I+V +++ + L
Sbjct: 47 VVLKVLDPSHRDIALAFF-ETASLMS-QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 129 QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL-----LDQN 183
L +EK R WK + + L+Y+ ++ ++VH ++ NIL L +
Sbjct: 105 -VCLRKEKGRVPVAWKI--TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158
Query: 184 FNP--KISDFGLSKLFPENTTHIS--TRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLL 238
+P K+SD G+S T +S RV + ++APE G L+ +D +SFG L
Sbjct: 159 TSPFIKLSDPGVS------FTALSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTL 211
Query: 239 LEI 241
LEI
Sbjct: 212 LEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 59/236 (25%)
Query: 49 KIGEGGFGSVYKGRLQD---GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENL 102
IG+GG G VY D VA+K + E+ +K F+ E A +A ++ H +
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLRE-AKIA-ADLIHPGI 64
Query: 103 VKLHGGCIDGPCRILVYDYMP----------------NNSLSQTLLGEEKRRAKFGWKAR 146
V ++ C DG VY MP SLS+ L EK A
Sbjct: 65 VPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKEL--AEKTSVG----AF 115
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK----------- 195
I I + Y+H + V+HRD+K NILL I D+G +
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 196 --------LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ T I ++ GT Y+APE + + +D+Y+ GV+L ++++
Sbjct: 173 IDVDERNICYSSMT--IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKL 105
+G+G FG V R + G A+K+L E +K ++E + N +K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 106 HGGCIDGPCRILVYDYMPNNSL----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
D C V +Y+ L S+ + E R +G EI+ L Y+H
Sbjct: 63 SFQTKDRLC--FVMEYVNGGELFFHLSRERVFSEDRTRFYG----AEIV----SALDYLH 112
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST--RVAGTLGYLAPEY 219
+V+RD+K N++LD++ + KI+DFGL K E T +T GT YLAPE
Sbjct: 113 ---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEV 166
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGR 245
R D + GV++ E++ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST-RVAGT 211
+ RG+ ++ + + VHRD+ N+LL Q KI DFGL++ ++ ++S
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ ++APE T SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-08
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHG 107
K+G G +G VYK + +DG K +++ +G MS +A + + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 108 GCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG----IGRGLAYIH 161
+ R L++DY ++ + K + R ++ I G+ Y+H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 162 EEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYL 215
V+HRD+K +NIL+ + KI+D G ++LF P V T Y
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 216 APEYAISGR-LTRKSDVYSFGVLLLEIVS 243
APE + R T+ D+++ G + E+++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN--LVKLH 106
IG G FG V + +D G I A+K+L ++ EKE ++ + + ++ V + +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
D L+ +++P + L+ ++ + E ++ I IH Q
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA----IH---QL 120
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL--------SKLFPENTTH--------------- 203
+HRDIK N+LLD + K+SDFGL F N TH
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 204 -----------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
++ GT Y+APE + + D +S GV++ E++ G
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 59/251 (23%), Positives = 98/251 (39%), Gaps = 73/251 (29%)
Query: 50 IGEGGFGSVYKGRLQDGTIV-AVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
IG G FG V R D + A+K L + E++ ++E +
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-------- 60
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRG 156
E +VKL+ D V DY+P + L+ E+ A+F I +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARF-------YIAELTCA 113
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL---------SKLFPENTTH---- 203
+ +H + +HRDIK NIL+D++ + K++DFGL SK + + H
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 204 -----------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSF 234
++ + GT Y+APE + T+ D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 235 GVLLLEIVSGR 245
GV+L E++ G+
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL--VKLH 106
IG G FG V + +D G + A+K+L ++ EKE + + + ++ V ++L VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
D L+ +++P + L+ ++ + E ++ I IH Q
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS----IH---QL 120
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGL--------------------------------- 193
+HRDIK N+LLD + K+SDFGL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 194 -SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
++ + N ++ GT Y+APE + + D +S GV++ E++ G
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGR 224
+HRD+ NILL KI DFGL++ ++ ++ V G + ++APE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNARLPVKWMAPESIFNCV 292
Query: 225 LTRKSDVYSFGVLLLEIVS 243
T +SDV+S+G+LL EI S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 30/79 (37%), Positives = 46/79 (58%), Gaps = 7/79 (8%)
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT----LGYLAPEYAISGR 224
VHRD+ N+L+ + KI DFGL++ ++ +IS G+ L ++APE +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GSTFLPLKWMAPESIFNNL 317
Query: 225 LTRKSDVYSFGVLLLEIVS 243
T SDV+SFG+LL EI +
Sbjct: 318 YTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 29/93 (31%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLG 213
RGL YIH ++HRD+K SN+ ++++ +I DFGL++ + T +++TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 214 YLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGR 245
Y APE ++ + D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT------HIS--TR- 207
L Y+H +VHRD+K N+L+ + K++DFGLSK+ + T HI TR
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 208 -----VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
V GT Y+APE + + D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 12/90 (13%)
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRV----AGT 211
LAY+H ++HRD+KT NI LD+ N + DFG + KL H T +GT
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL----DAHPDTPQCYGWSGT 250
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEI 241
L +PE K+D++S G++L E+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-07
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHG 107
K+G G +G VYK + +DG + +++ +G MS +A + + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65
Query: 108 GCIDGPCR--ILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+ R L++DY ++ K+ + + ++ I G+ Y+H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 162 EEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLF--PENTTHISTRVAGTLGYL 215
V+HRD+K +NIL+ + KI+D G ++LF P V T Y
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 216 APEYAISGR-LTRKSDVYSFGVLLLEIVS 243
APE + R T+ D+++ G + E+++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTL 212
G+ ++H ++HRD+K SNI++ + KI DFGL++ N T ++ TR
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---- 187
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
Y APE + D++S G ++ E+V G
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT- 211
+ +G+ ++ + + +HRD+ N+LL KI DFGL++ ++ ++ V G
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274
Query: 212 ---LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ ++APE T +SDV+S+G+LL EI S
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 59/252 (23%), Positives = 96/252 (38%), Gaps = 71/252 (28%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
+G G FG V R D + A+K L V + E++ ++E +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-------- 60
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
E +V+L+ D V DY+P + L+ R F R I + +
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVES 116
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---------------------- 197
+H + +HRDIK NIL+D++ + K++DFGL F
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 198 ------PENT---------------TH---ISTRVAGTLGYLAPEYAISGRLTRKSDVYS 233
P N H ++ + GT Y+APE + T+ D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 234 FGVLLLEIVSGR 245
GV+L E++ G+
Sbjct: 234 VGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 11/159 (6%)
Query: 42 NGFRWSNKIGEGGFGSV-YKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
F IG+G FG V + G I A+K L ++S+ +K+ ++ V + +V +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 101 N--LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
+ +V L+ D L+ +++P L L+ + F R + +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIE 115
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
+H + +HRDIK NIL+D+ + K+SDFGLS F
Sbjct: 116 AVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 59/253 (23%), Positives = 96/253 (37%), Gaps = 73/253 (28%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVL---------SVESKQGEKEFMSEVASMANVNVCH 99
+G G FG V D + A+K L V + E++ ++E +
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-------- 60
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
E +VKL+ D V DY+P + L+ R F R I + +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIES 116
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL---------SKLFPENTTHI------ 204
+H + +HRDIK NIL+D + + K++DFGL SK + + +HI
Sbjct: 117 VH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY-QKGSHIRQDSME 172
Query: 205 --------------------------------STRVAGTLGYLAPEYAISGRLTRKSDVY 232
+ + GT Y+APE + T+ D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 233 SFGVLLLEIVSGR 245
S GV+L E++ G+
Sbjct: 233 SVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 17/163 (10%)
Query: 87 SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
+E+ ++ +N HEN++K I+ R YM L A F WK R
Sbjct: 212 NEILALGRLN--HENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEA-FDWKDR 263
Query: 147 ------REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
R I+ + + YIH++ ++HRDIK NI L+ + + DFG + F +
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
GT+ +PE +D++S G++LL+++S
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 43/230 (18%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQDGT-IVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
++ N IG G FG VY+ D + VA+K + + + +E + M N+N H N+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLN--HINI 121
Query: 103 VKL----HGGCIDGPCRIL----VYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---- 150
+ L + C + + V +++P QT+ K A+ ++
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHIST 206
+ R LAYIH + + HRD+K N+L+D N + K+ DFG +K + ++I +
Sbjct: 177 YQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233
Query: 207 RVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV------SGRTAVD 249
R Y APE + + T D++S G ++ E++ SG+++VD
Sbjct: 234 RF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
G+ ++H ++HRD+K SNI++ + KI DFGL++ T+ + T T Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
APE + D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 22/131 (16%)
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNP-------------KISDF 191
+II G L Y H E+ H++H D+K NIL+ D +P +I D
Sbjct: 235 QIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251
G + H T + T Y +PE + +D++S G ++ E+ +G+ D
Sbjct: 293 GGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348
Query: 252 VQLGEYHLVDK 262
L HL++K
Sbjct: 349 DNLEHLHLMEK 359
|
Length = 467 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-05
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
G+ ++H ++HRD+K SNI++ + KI DFGL++ T+ + T T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS------GRTAVD 249
APE + D++S G ++ E+V GR +D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 2e-05
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 98 CHENLVKLHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
+ N +KL+ + +L+ DY+ + L L K+ K ++II +
Sbjct: 67 DNPNFIKLYY-SVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEA 121
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
L +H+ +++H DIK N+L D+ + D+GL K T S GTL Y
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTP--SCY-DGTLDYF 173
Query: 216 APEYAISGRLTRKS-DVYSFGVLLLEIVSG 244
+PE I G S D ++ GVL E+++G
Sbjct: 174 SPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV---AGT 211
R + Y+HE ++HRDIK NI ++ + + DFG + FP + + + AGT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDIN--ANKYYGWAGT 246
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
+ APE D++S G++L E+ + ++
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
++HRD+K SNI++ + KI DFGL++ T+ + T T Y APE +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 196
Query: 228 KSDVYSFGVLLLEIVSGR 245
D++S G ++ E++ G
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVAGTLGYLA 216
YIH E ++HRDIKT N+L++ + + DFG + F +T +AGT+ A
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGTVDTNA 330
Query: 217 PEYAISGRLTRKSDVYSFGVLLLE 240
PE T D++S G+++ E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 46/152 (30%)
Query: 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHR 171
G L+ Y P +S+ L+G I+ G RGL Y+H Q +HR
Sbjct: 84 GSANSLLKTYFPE-GMSEALIGN--------------ILFGALRGLNYLH---QNGYIHR 125
Query: 172 DIKTSNILLDQNFNPKISDFGLSKL---------------FPENTTHISTRVAGTLGYLA 216
+IK S+IL+ + +S GLS L FP+ +T + L +L+
Sbjct: 126 NIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV-------LPWLS 176
Query: 217 PEYA---ISGRLTRKSDVYSFGVLLLEIVSGR 245
PE + G KSD+YS G+ E+ +GR
Sbjct: 177 PELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 56/211 (26%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANV------------- 95
IG GGFG VY+ + D I V +E+ + E + E N+
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENET-IVMETLVYNNIYDIDKIALWKNIH 78
Query: 96 NVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
N+ H + K +G CR+ Y ++ L + KR K + I+ +
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMY-YRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLT 137
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA------ 209
L YIHE + H DIK NI++D N I D+G++ F + HI
Sbjct: 138 TLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHR 194
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 240
GTL Y + +TR+ D+ S G +L+
Sbjct: 195 GTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 38/236 (16%)
Query: 42 NGFRWSNKIGEGGFGSVY---KGRLQDGTIVAVKVLSVES-KQGEK-EFMSEVASMANVN 96
N + KIG G FG V+ R Q+ K +S K+ EK + + EV M +
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQE--FFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 97 VCHENLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
H+N+V+ ++ + L + ++ LS+ + K K A +I +
Sbjct: 71 --HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 155 RGLAYIHE-EIQPH---VVHRDIKTSNILLD-------------QNFN----PKISDFGL 193
LAY H + P+ V+HRD+K NI L N N KI DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 194 SK-LFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRT 246
SK + E+ H GT Y +PE + + KSD+++ G ++ E+ SG+T
Sbjct: 189 SKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
|
Length = 1021 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 44/206 (21%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 50 IGEGGFGSVYKGRLQDGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
I E S+YKG + V ++ K +E+ ++ ++ N++K++
Sbjct: 28 IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID--SNNILKIY 84
Query: 107 G---GCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
G +D R+ L+ +Y L + L E+ +K + ++ + +GL +++
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYK 140
Query: 163 EI-QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA- 220
+P+ +++ + + L+ +N+ KI GL K+ ++ V + Y + +
Sbjct: 141 YTNKPY---KNLTSVSFLVTENYKLKIICHGLEKIL---SSPPFKNV-NFMVYFSYKMLN 193
Query: 221 -ISGRLTRKSDVYSFGVLLLEIVSGR 245
I T K D+YS GV+L EI +G+
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 41/165 (24%)
Query: 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN------- 101
I G FG VY GR + + + AVKV+ + A M N N+ H+
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVV-------------KKADMINKNMVHQVQAERDAL 58
Query: 102 -------LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGW---KARREIIM 151
+V L+ LV +Y+ + L +G+ + + I
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL-------HIYGYFDEEMAVKYIS 111
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196
+ L Y+H + ++HRD+K N+L+ + K++DFGLSK+
Sbjct: 112 EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG-LSKLFPENTTHISTRVAGTLGYL 215
L +H E +V RD+ +NILLD + +++ F S++ + Y
Sbjct: 98 LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248
APE T D +S G +L E+++G+T V
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 272 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.98 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.95 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.94 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.65 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.29 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.27 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.9 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.83 | |
| PLN02236 | 344 | choline kinase | 97.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.72 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.63 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.62 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.36 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.31 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.13 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.89 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.86 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.86 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.82 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.72 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 96.7 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.56 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.47 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.14 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=320.81 Aligned_cols=217 Identities=29% Similarity=0.514 Sum_probs=195.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...+|.+.+.||.|+|++||+|+++ ++..||||.+... ..........|+.+++.++ |||||.+++++..++..+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~--H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK--HPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC--CcceeeEEEEEecCCeEE
Confidence 3568999999999999999999987 7899999999755 4556677899999999999 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC------CCeEEee
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN------FNPKISD 190 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~------~~~~l~D 190 (272)
+|||||+||+|.+++ +..+.+++..++..+.||+.|+++||++ +|+||||||.|||++.. ..+||+|
T Consensus 86 lVMEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 999999999999999 6667999999999999999999999999 99999999999999764 4589999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhcce
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSIN 267 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 267 (272)
||.++... ........+|++-|+|||++....|+.|+|+||+|+++|+|++|++||+..+..+.+..+++-..+.
T Consensus 159 FGfAR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~ 233 (429)
T KOG0595|consen 159 FGFARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV 233 (429)
T ss_pred cchhhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc
Confidence 99999876 3445677899999999999999999999999999999999999999999999888887766655543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=308.67 Aligned_cols=217 Identities=29% Similarity=0.431 Sum_probs=196.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
....++|++++.||+|+||+|++++.+ +++.+|+|+++.. .........+|..++..+. ||.|++++-.+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~--hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK--HPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC--CCcEeeeEEecccCC
Confidence 456788999999999999999999876 7999999998743 3345678889999999988 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..|+|+||+.||.|...+ ++++.|++..++.++..|+.||.|||++ ||+|||+||+|||++.+|+++|+|||+
T Consensus 99 kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred eEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecccc
Confidence 999999999999999999 7788999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhh
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVR 264 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 264 (272)
+..... ........+||+.|+|||++.+..++.++|.||||+++|+|++|.+||...+....++.|....
T Consensus 172 ~k~~~~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 172 CKEDLK-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred chhccc-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 984322 2223455899999999999999999999999999999999999999999999888888777766
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=319.83 Aligned_cols=216 Identities=26% Similarity=0.445 Sum_probs=196.4
Q ss_pred CCeeeeeeeeeccceEEEEEEe-CCCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+|...+.||+|||+.+|++++ .+|+.||+|++... .........+|+++.+++. |||||+++++|+++...||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~--HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK--HPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC--CCcEEeeeeEeecCCceEE
Confidence 5699999999999999999998 68999999999742 4556678999999999999 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
|.|+|+.++|..++ .++++++|.+++.++.||+.|+.|||++ +|+|||||..|+|++++.+|||+|||++...
T Consensus 96 vLELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 96 VLELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeee
Confidence 99999999999999 5789999999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhcce
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSIN 267 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 267 (272)
...... ....|||+.|+|||++.....+..+||||+||++|.|+.|++||+..+-.+.+..|..-....
T Consensus 169 e~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 169 EYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM 237 (592)
T ss_pred cCcccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc
Confidence 654332 344799999999999999999999999999999999999999999998888777776655543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=301.74 Aligned_cols=213 Identities=29% Similarity=0.438 Sum_probs=186.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeee-eEec-CC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHG-GCID-GP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~-~~~~-~~ 113 (272)
....+|+|.+.||.|.||+||++... +|..+|.|.+... +......+..|+..+++++ ||||+++++ .+.+ ..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~--HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN--HPNIVQYYAHSFIEDNE 93 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC--CchHHHHHHHhhhccch
Confidence 34567999999999999999999754 8999999998754 4445678899999999999 999999998 3444 44
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCCeEEeec
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
..+|+||+|.+|+|...+...+.....++|..+|.++.|++.||.++|++ ... +.||||||.|||++.+|.+||+||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccc
Confidence 58999999999999999999888999999999999999999999999993 114 899999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|++..+... ........|||.|++||.+.+.+|+.++||||+||++|+|+.-++||.+.+-.+
T Consensus 173 GL~r~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~ 235 (375)
T KOG0591|consen 173 GLGRFLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS 235 (375)
T ss_pred hhHhHhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH
Confidence 999977543 334556789999999999999999999999999999999999999999885444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=301.84 Aligned_cols=206 Identities=24% Similarity=0.379 Sum_probs=180.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-------cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-------KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
...+.|.+.+.||+|+||.|-+|..+ +|+.||||+++... ........+|++.+++++ ||+||++++++.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~--HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS--HPNIVRIKDFFE 246 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC--CCCEEEEeeeee
Confidence 36778999999999999999999876 89999999997431 112345679999999999 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCeE
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPK 187 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~~~~ 187 (272)
..+..|+||||++||.|.+.+ ..++.+.+.....+++||+.|+.|||++ ||+||||||+|||+..+ -.+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred cCCceEEEEEEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEE
Confidence 999999999999999999999 5667788899999999999999999999 99999999999999766 4589
Q ss_pred EeecCcccccCCCCccccccccccccccCccccccCCC---CCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL---TRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|.|||++...+ ........|||+.|.|||++.+... ..+.|+||+||++|-+++|.+||....+..
T Consensus 320 ItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 320 ITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred ecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 99999999765 3445667899999999999987653 348899999999999999999998766655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=295.79 Aligned_cols=213 Identities=30% Similarity=0.470 Sum_probs=187.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc-e
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-R 115 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~-~ 115 (272)
+..++.+.++.||+|..|+||++.++ +++.+|+|++... .....+++.+|++.++..+ ||+||.+++.|..+.. .
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~--spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ--SPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--CCCeeeEeEEEEeCCceE
Confidence 44557888999999999999999988 7999999999654 4455678999999999997 9999999999999884 9
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.|+||||++|+|+..+ ...+.++|..+..++.+++++|.|||+ + +|+||||||.|+||+..|.|||+|||.+
T Consensus 154 sI~mEYMDgGSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred EeehhhcCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccccc
Confidence 9999999999999999 344779999999999999999999996 6 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc--cCCCceehhhhh
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD--VQLGEYHLVDKV 263 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~ 263 (272)
..+-.. ......||..|+|||.+.+..|+.++||||||++++||.+|+.||... +....+.+...+
T Consensus 227 ~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I 294 (364)
T KOG0581|consen 227 GILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI 294 (364)
T ss_pred HHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence 866433 566788999999999999999999999999999999999999999875 233444444333
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=287.07 Aligned_cols=220 Identities=29% Similarity=0.405 Sum_probs=195.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
...++|++.+.||.|+||+|.+++.+ +|..+|+|++... ...+.....+|...++.+. ||.+++++..+.+.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~--~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS--HPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc--CceeEEEEEeeccCCe
Confidence 45678999999999999999999977 7899999998744 3345567888999999999 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||++||.|.+++ ...+.|++..++.++.||+.|++|||++ +|++|||||+|||++++|.++++|||.+
T Consensus 119 lymvmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred EEEEEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccce
Confidence 99999999999999999 6778999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhcceeeec
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMKLY 271 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 271 (272)
...... ..+.|||+.|+|||.+.+..+..++|-|+||+++|||+.|.+||-..++...+..|-..+-..++.|
T Consensus 192 K~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f 264 (355)
T KOG0616|consen 192 KRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF 264 (355)
T ss_pred EEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc
Confidence 976443 3457899999999999999999999999999999999999999999888666666555544444444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=296.62 Aligned_cols=219 Identities=26% Similarity=0.390 Sum_probs=190.4
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
+-..+..++|++++.||+|+||.||+|+.+ +|..+|+|+++.. ...+...++.|-.++.... +|.||+++-.|.
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d--s~~vVKLyYsFQ 211 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD--SPWVVKLYYSFQ 211 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC--CCcEEEEEEEec
Confidence 334567889999999999999999999876 7999999999743 3455677888888888866 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
+.+..|+||||++||++..++ .....|+++.++.++.+++-|+..+|+. |++||||||+|+|||..|++||.|
T Consensus 212 D~~~LYLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred CCCeeEEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 999999999999999999999 6778999999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCC-----------------------CCcc---c--------------------cccccccccccCccccccCC
Q 024118 191 FGLSKLFPE-----------------------NTTH---I--------------------STRVAGTLGYLAPEYAISGR 224 (272)
Q Consensus 191 fg~~~~~~~-----------------------~~~~---~--------------------~~~~~~~~~~~aPE~~~~~~ 224 (272)
||++..+.. .... . .....|||.|+|||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999953311 0000 0 11235999999999999999
Q ss_pred CCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 225 ~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
|+...|.||||||+|||+.|.+||...++.+.+..|.+
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n 402 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN 402 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999999999999998876665544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=297.53 Aligned_cols=221 Identities=26% Similarity=0.423 Sum_probs=193.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
....++|.+.+.||.|+|++|++|+.. ++..||||++... .....+.+..|-..+.++.. ||.|++++..|.+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~-hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSG-HPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhC-CCCeEEEEEEeeccc
Confidence 445679999999999999999999866 7999999998633 23344567778888888853 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..|+|+||.++|+|.+++ ..-+.|++...+.++.+|+.||+|||++ |||||||||+|||++.+++++|.|||.
T Consensus 148 sLYFvLe~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred ceEEEEEecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccc
Confidence 999999999999999999 5668999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc------------ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhh
Q 024118 194 SKLFPENTTH------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 194 ~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 261 (272)
+..+++.... ....+.||..|++||++.....++.+|+|+|||++|+|+.|.+||...++--.+..|.
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 9977532211 1144789999999999999999999999999999999999999999888877777776
Q ss_pred hhhcc
Q 024118 262 KVRSI 266 (272)
Q Consensus 262 ~~~~~ 266 (272)
.++.-
T Consensus 301 ~l~y~ 305 (604)
T KOG0592|consen 301 ALDYE 305 (604)
T ss_pred Hhccc
Confidence 66554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=294.18 Aligned_cols=217 Identities=26% Similarity=0.430 Sum_probs=187.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec----Cc-ccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE----SK-QGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~----~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
.....+|.+.+.||+|+||+|+.|.+. +|..||+|++... .. .....+.+|+..++.+.. ||||+++++++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~-HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS-HPNIIRLLEVFAT 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc-CCCEeEEEEEEec
Confidence 456778999999999999999999766 7999999976543 11 234566678988888876 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCeEEee
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISD 190 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~-~~~~l~D 190 (272)
....++||||+.||.|.+++ ...+++.|..++.++.|+++|+.|+|++ ||+||||||+|++++.+ +++||+|
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i----~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~D 164 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYI----VNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSD 164 (370)
T ss_pred CCeEEEEEEecCCccHHHHH----HHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEec
Confidence 99999999999999999999 4468899999999999999999999999 99999999999999999 9999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCC-CC-CCCceehHHHHHHHHHhCCCccccccCCCceehhhhh
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 263 (272)
||++.... .........+|++.|+|||++.+.. |+ .++|+||+|+++|.|++|+.||+..+....+..+...
T Consensus 165 FG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 165 FGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG 238 (370)
T ss_pred cccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC
Confidence 99999764 2233456689999999999999988 86 7999999999999999999999986655555444433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=279.81 Aligned_cols=209 Identities=24% Similarity=0.378 Sum_probs=184.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|+.+..+|+|++|.||+++++ +|+.||||.+.-. ++...+-.++|+++++++. |+|+|.++++|......++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk--H~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK--HENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc--cchHHHHHHHHHhcceeEEE
Confidence 46889999999999999999988 7999999998632 2334567899999999999 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+|||+..-|.++- .....++...+..+++|++.|+.|+|++ +++||||||+||||+.+|.+||||||.++.+.
T Consensus 80 FE~~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 80 FEYCDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred eeecchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9999877666654 4556789999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
. .....+....|..|.|||++.+ ..|...+|||++||++.||++|.+.|.+.+..+.+..|
T Consensus 153 ~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 153 A-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLI 214 (396)
T ss_pred C-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHH
Confidence 4 3444566788999999999998 56999999999999999999999999998876655444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=287.17 Aligned_cols=230 Identities=57% Similarity=0.946 Sum_probs=198.7
Q ss_pred cccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeee
Q 024118 28 NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
....|+++++....++|.-.+.||+|+||.||+|...+|..||||.+..........+.+|+..+.+++ |||++++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~--H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR--HPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC--CcCcccEEE
Confidence 677899999999999999999999999999999999988999999776443321556999999999999 999999999
Q ss_pred eEecCCc-eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCe
Q 024118 108 GCIDGPC-RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 108 ~~~~~~~-~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~ 186 (272)
+|.+.+. ..+|+||++.|+|.+.+...... ++++..+.+|+.+++.||+|||+.+...|+||||||.|||+|++.+.
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999984 99999999999999999553222 88999999999999999999999866679999999999999999999
Q ss_pred EEeecCcccccCC-CCccccccc-cccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhh
Q 024118 187 KISDFGLSKLFPE-NTTHISTRV-AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263 (272)
Q Consensus 187 ~l~Dfg~~~~~~~-~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 263 (272)
||+|||++...+. ... .... .||.+|+|||+......+.++||||+|+++.||+||+.|.+.....+...+.++.
T Consensus 217 KlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred EccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999999975543 221 1112 7899999999999888999999999999999999999999876655544455543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.20 Aligned_cols=226 Identities=26% Similarity=0.352 Sum_probs=197.9
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+..++|.+.+.||+|.||+|++|..+ +++.+|||+++.. ..+.....+.|..++.-.. .||.++.++..+...
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTK 441 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccC
Confidence 5678899999999999999999999876 7899999999854 3445556666777666665 499999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
++.+.||||+.||++... .....|++..++.+++.++.||.|||++ ||++||||.+|||+|.+|++||+|||
T Consensus 442 ~~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred CeEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence 999999999999993322 4668899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhcceeeecC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMKLYS 272 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (272)
++..-... .....+.+||+.|+|||++.+..|+.++|-|||||++|+|+.|..||.+.++++.++.|.......+++.|
T Consensus 514 lcKe~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls 592 (694)
T KOG0694|consen 514 LCKEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 592 (694)
T ss_pred cccccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 99854322 22456689999999999999999999999999999999999999999999999999999887777666544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=285.49 Aligned_cols=216 Identities=31% Similarity=0.449 Sum_probs=188.5
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC--
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-- 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~-- 112 (272)
..-...|+....||+|.||.||+|++. +|+.||+|.+..+. .....-..+|+.+++++. ||||+++.+...+.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~--HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD--HPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC--CCcccceeeEEEecCC
Confidence 344567889999999999999999865 89999999998664 445567888999999999 99999999988776
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...|+|+|||+. +|.-++ ......|++.++..++.||+.+|.|+|++ ||.|||||..|||||++|.+||+|||
T Consensus 191 ~siYlVFeYMdh-DL~GLl---~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLL---SSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred ceEEEEEecccc-hhhhhh---cCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence 689999999965 566666 23456899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
++..+........+...-|..|.|||++.|.. |+.+.|+||+|||+.||++|++.|.+.++.+.++.|-.
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence 99987766655566667799999999999875 99999999999999999999999999998776666543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=283.56 Aligned_cols=211 Identities=36% Similarity=0.602 Sum_probs=182.4
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcc--cHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+.+......+.+.+|.|+||+||++.+.+-..||+|.+...... ....+.+|+..+.+++ ||||+++++++...
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~--HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLR--HPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcCC
Confidence 4455556667777889999999999999985555999999754322 2568999999999999 99999999999998
Q ss_pred C-ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCCEEEcCCC-CeEEe
Q 024118 113 P-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-VVHRDIKTSNILLDQNF-NPKIS 189 (272)
Q Consensus 113 ~-~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-i~h~dl~p~nilv~~~~-~~~l~ 189 (272)
. ..+|||||+++|+|..++... ....++...+..++.||+.|+.|||++ + |+||||||.|+|++.++ ++||+
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEEC
Confidence 8 799999999999999999432 468899999999999999999999999 8 99999999999999998 99999
Q ss_pred ecCcccccCCCCccccccccccccccCccccc--cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|||++....... .......||..|+|||++. ...++.++|+||+|+++|+|+||+.||.....
T Consensus 187 DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 187 DFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred CCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 999998654322 2223367999999999999 56899999999999999999999999998775
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=284.12 Aligned_cols=208 Identities=24% Similarity=0.369 Sum_probs=177.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+..|+..+..+. ||+|+++++.+.+....++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~--~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD--SLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCeEEE
Confidence 47999999999999999999876 78999999986431 223346677888888888 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||++|++|.+++ .....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 79 v~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 79 IMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEcCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 99999999999998 3456799999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCc----------------------------------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh
Q 024118 198 PENTT----------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 198 ~~~~~----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t 243 (272)
..... .......||+.|+|||++.+..++.++|+||+||++|+|++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 21100 00123468999999999999999999999999999999999
Q ss_pred CCCccccccCCCcee
Q 024118 244 GRTAVDFDVQLGEYH 258 (272)
Q Consensus 244 g~~p~~~~~~~~~~~ 258 (272)
|+.||...+..+.+.
T Consensus 232 G~~Pf~~~~~~~~~~ 246 (363)
T cd05628 232 GYPPFCSETPQETYK 246 (363)
T ss_pred CCCCCCCCCHHHHHH
Confidence 999998766554433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=287.26 Aligned_cols=200 Identities=30% Similarity=0.479 Sum_probs=181.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|-+...||+|.||.||+|+-+ +.+.||+|.+... ..+..+.+.+|+++++.++ ||||+.+++++......++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk--Hpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK--HPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC--CcchhhHHHhhcccceEEEE
Confidence 46888999999999999999866 7999999998633 3345678999999999999 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
.||+.| +|..++ +.+..++|+.+..++.|+..||.|||+. +|.|||+||.||++..+|.+|++|||+++.+.
T Consensus 80 te~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 80 TEYAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred ehhhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 999976 999999 7889999999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.. ........||+.|+|||+..+..|+..+|+|||||++|+|++|++||-..+
T Consensus 152 ~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 152 TN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred cC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 43 334555789999999999999999999999999999999999999996544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=258.69 Aligned_cols=209 Identities=24% Similarity=0.417 Sum_probs=183.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.+|.-.+.||+|.||.||+|++. +|+.||||.++.... ......++|++.++.+. |+||+.+++++...+...+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~--h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK--HPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc--CcchhhhhhhccCCCceEEE
Confidence 46888999999999999999865 899999999986532 33567899999999999 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||++ .+|...+ +.....++..++..++.+++++++|||++ .|.|||+||.|+||+.+|.+||+|||+++.+.
T Consensus 80 fEfm~-tdLe~vI---kd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 80 FEFMP-TDLEVVI---KDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEecc-ccHHHHh---cccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 99994 6899988 35667899999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
........ ..-|..|.|||.+.|.. |+...|+||+||++.||+-|.+.|.+.+..+.+..|
T Consensus 153 ~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 153 SPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred CCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 54433322 35688999999988764 999999999999999999999999988876655443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=279.02 Aligned_cols=201 Identities=24% Similarity=0.414 Sum_probs=177.4
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++.+. ||||+++++.+..++..+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS--HPFIVNMMCSFQDENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEcCCEEE
Confidence 467999999999999999999876 7899999998743 2233456788999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
++|||+++++|.+.+ .....+++..+..++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++..
T Consensus 95 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 95 FLLEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEEcCCCCChHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 999999999999998 3456788999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
..... ....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 168 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 221 (329)
T PTZ00263 168 VPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF 221 (329)
T ss_pred cCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH
Confidence 53322 2346889999999999998999999999999999999999999766543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=277.37 Aligned_cols=209 Identities=27% Similarity=0.420 Sum_probs=190.1
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEe-CCCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+..-...+|++.+.||.|.+|.|-+|.. ..|+.||||.++.. +..+.-.+.+|++++..++ ||||++++++|..
T Consensus 47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN--HPhII~IyEVFEN 124 (668)
T KOG0611|consen 47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN--HPHIIQIYEVFEN 124 (668)
T ss_pred cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC--CCceeehhhhhcC
Confidence 4445678999999999999999999986 58999999998744 4455678899999999999 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
.+...|||||..+|.|.+++ ..++.+++..++.+++||.+|+.|+|.+ +++|||||.+|||++++++++|.||
T Consensus 125 kdKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred CceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 99999999999999999999 6788999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|++..+.... ....+||++.|.+||...+.+| .+..|.||||+++|.|..|.+||++.+...
T Consensus 198 GLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~ 260 (668)
T KOG0611|consen 198 GLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR 260 (668)
T ss_pred chhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence 9999875433 4566899999999999999997 489999999999999999999999887654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=282.58 Aligned_cols=209 Identities=28% Similarity=0.378 Sum_probs=177.5
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.....++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+..|+..++.+. ||||+++++.+..+
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~~~~ 115 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFCAFQDD 115 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEcC
Confidence 3455678999999999999999999876 6889999998632 2223445677888888888 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++. ...+++..+..++.|++.||.+||++ ||+||||||+||+++.++.++|+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999999983 23588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCC----CCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
++...............|++.|+|||++.+.. ++.++|+||+||++|+|++|+.||...+..+
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~ 254 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH
Confidence 99865432222223457899999999997643 7789999999999999999999998766543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.76 Aligned_cols=213 Identities=28% Similarity=0.363 Sum_probs=180.1
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.+...+..++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+..|...++.+. ||||+++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~ 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFYAF 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCeEEEEE
Confidence 3456677799999999999999999999877 7899999998632 2223345667888888887 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
..+...++||||+++++|.+++. ...+++..+..++.||+.||.+||++ ||+||||||+||+++.++.++|+
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999883 34588999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCC----CCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
|||++...............|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+....
T Consensus 185 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 255 (371)
T cd05622 185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (371)
T ss_pred eCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence 99999865433222233457899999999987543 78899999999999999999999987665433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=282.10 Aligned_cols=227 Identities=30% Similarity=0.482 Sum_probs=200.4
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+.+.+..+.+.+.+.||+|.||.||++.++....|++|.++.. .-....+.+|++.+++++ |++||+++++|..+
T Consensus 197 ~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~--H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 197 ARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLR--HEKLVKLYGVCTKQ 273 (468)
T ss_pred ccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCc--ccCeEEEEEEEecC
Confidence 377788888889999999999999999999998889999999855 334468889999999999 99999999999998
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...+||||||+.|+|.++++. .....++......++.||+++++||+++ ++|||||..+||||++++.+||+|||
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred CceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccc
Confidence 899999999999999999954 3567788999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehhhhhhcce
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSIN 267 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 267 (272)
+++...++.........-...|.|||.+....++.++||||+|++|+||+| |+.||...+..+....++.-.+++
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP 424 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence 999665555554444445677999999999999999999999999999999 999999888887666666655553
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=274.86 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=176.4
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..++.+. ||||+++++.+.++...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--HPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC--CCcHhhhHhhhccCCeEEE
Confidence 47999999999999999999876 79999999986432 223456778999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 79 LMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 99999999999998 3456789999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.... ....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+
T Consensus 152 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~ 205 (291)
T cd05612 152 RDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205 (291)
T ss_pred cCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 3321 22467899999999999889999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.67 Aligned_cols=204 Identities=27% Similarity=0.397 Sum_probs=175.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||.|+||.||+|.+. +|+.||+|++... .......+.+|+..++.+. ||||+++++.+..+...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD--NPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEcCCeEEE
Confidence 47999999999999999999876 7899999998743 2233456778999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++. ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 79 v~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 79 IMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 999999999999983 445789999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCcc-------------------------------------ccccccccccccCccccccCCCCCCCceehHHHHHHH
Q 024118 198 PENTTH-------------------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLE 240 (272)
Q Consensus 198 ~~~~~~-------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~ 240 (272)
...... ......||+.|+|||++.+..++.++|+|||||++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 211100 0112358999999999999899999999999999999
Q ss_pred HHhCCCccccccCC
Q 024118 241 IVSGRTAVDFDVQL 254 (272)
Q Consensus 241 l~tg~~p~~~~~~~ 254 (272)
|++|..||...+..
T Consensus 232 l~~G~~Pf~~~~~~ 245 (364)
T cd05599 232 MLVGYPPFCSDNPQ 245 (364)
T ss_pred hhcCCCCCCCCCHH
Confidence 99999999876543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.51 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=177.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+..|+..+..+. ||||+++++.+......++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC--CCCCccEEEEEEcCCEEEE
Confidence 47999999999999999999877 68999999987432 233456778999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~g~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 79 AMEYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 99999999999998 4456789999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.. ......|++.|+|||++.+..++.++|+||+||++|+|++|..||...+..+
T Consensus 152 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 205 (333)
T cd05600 152 VT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205 (333)
T ss_pred cc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH
Confidence 33 2234568899999999999899999999999999999999999998765544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=281.11 Aligned_cols=204 Identities=27% Similarity=0.365 Sum_probs=174.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+.|++++.||+|+||.||+|.+. +++.||+|++... .......+.+|+..++.+. ||+|+++++.+.+.+..++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC--CCCeeeeEEEEecCCEEEE
Confidence 36899999999999999999876 7899999998643 2233456788999999988 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 79 v~E~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 79 VMDYIPGGDMMSLL----IRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred EEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999999998 3445789999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCC----------------------------------------------ccccccccccccccCccccccCCCCCCCce
Q 024118 198 PENT----------------------------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDV 231 (272)
Q Consensus 198 ~~~~----------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 231 (272)
.... ........||..|+|||++.+..++.++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence 1000 000123468999999999998889999999
Q ss_pred ehHHHHHHHHHhCCCccccccCC
Q 024118 232 YSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 232 ~slG~il~~l~tg~~p~~~~~~~ 254 (272)
||+||++|+|++|+.||...+..
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~ 254 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPT 254 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHH
Confidence 99999999999999999876643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.00 Aligned_cols=205 Identities=26% Similarity=0.366 Sum_probs=174.4
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|.+.+.||.|+||.||++.+. +|+.||+|++... .......+.+|++.++.+. ||||+++++.+.+....++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--SPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCeeEE
Confidence 47999999999999999999876 7999999998643 1223456777899999988 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 79 v~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 79 IMEFLPGGDLMTML----IKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999998 3446789999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCc----------------------------------------------cccccccccccccCccccccCCCCCCCce
Q 024118 198 PENTT----------------------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDV 231 (272)
Q Consensus 198 ~~~~~----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 231 (272)
..... .......|++.|+|||++.+..++.++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 11000 00012458899999999999899999999
Q ss_pred ehHHHHHHHHHhCCCccccccCCC
Q 024118 232 YSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 232 ~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||+||++|+|++|.+||...+..+
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~ 255 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHE 255 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHH
Confidence 999999999999999997665433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=281.50 Aligned_cols=204 Identities=27% Similarity=0.398 Sum_probs=173.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++++.||+|+||.||+|... +++.||+|.+.... ......+.+|+..++.+. ||+|+++++.+..+...++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~--h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--NEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC--CCcCCeEEEEEEeCCEEEE
Confidence 36999999999999999999876 78999999986431 233456778999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+.+. ....+++..++.++.||+.||.+||++ ||+||||||+|||++.++.++|+|||++...
T Consensus 79 v~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 79 VMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 999999999999983 345789999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCC----------------------------------------------ccccccccccccccCccccccCCCCCCCce
Q 024118 198 PENT----------------------------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDV 231 (272)
Q Consensus 198 ~~~~----------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 231 (272)
.... ........|++.|+|||++.+..++.++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence 1000 000112468899999999999999999999
Q ss_pred ehHHHHHHHHHhCCCccccccCC
Q 024118 232 YSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 232 ~slG~il~~l~tg~~p~~~~~~~ 254 (272)
||+||++|+|++|++||...+..
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~ 254 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQTPL 254 (382)
T ss_pred EechHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.09 Aligned_cols=205 Identities=28% Similarity=0.384 Sum_probs=174.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+..++.+. ||+|+++++.+..++..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCEEEE
Confidence 47999999999999999999876 7899999998632 1223456778999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ .....+++..++.++.||+.||.+||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 79 v~E~~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 79 VMDYIPGGDMMSLL----IRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999998 3456788999999999999999999999 9999999999999999999999999997432
Q ss_pred CCCC------------------------------------------ccccccccccccccCccccccCCCCCCCceehHH
Q 024118 198 PENT------------------------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFG 235 (272)
Q Consensus 198 ~~~~------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 235 (272)
.... ........|++.|+|||++.+..++.++|+||+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 1000 0001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCccccccCCC
Q 024118 236 VLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 236 ~il~~l~tg~~p~~~~~~~~ 255 (272)
|++|+|++|+.||...+..+
T Consensus 232 vilyell~G~~Pf~~~~~~~ 251 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAE 251 (376)
T ss_pred ceeeehhhCCCCCCCCCHHH
Confidence 99999999999998766543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=276.96 Aligned_cols=204 Identities=24% Similarity=0.369 Sum_probs=177.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-C-CcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-D-GTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~-~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+..++|++.+.||.|+||.||+|.+. + +..||+|.+... .......+.+|+..++.+. ||||+++++++....
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN--HPFCVNLYGSFKDES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCCcceEEEEEeCC
Confidence 45667999999999999999999754 3 468999998633 2233456778999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..+++|||+++++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||+
T Consensus 105 ~~~lv~Ey~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred EEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCC
Confidence 999999999999999998 3456789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+...... .....|++.|+|||++.+..++.++|+||+||++|+|++|..||...++..
T Consensus 178 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 235 (340)
T PTZ00426 178 AKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL 235 (340)
T ss_pred CeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH
Confidence 9765322 223568899999999998889999999999999999999999998766543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=282.75 Aligned_cols=212 Identities=27% Similarity=0.420 Sum_probs=186.3
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
-|.+.+.||.|+.|.|-+|++. +|+.+|||++... .......+.+|+.+++-+. |||++.+++++.+....|+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~--HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE--HPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc--CCCeeeeeeeeccCceEEEE
Confidence 4899999999999999999876 8999999998644 3344567888999999888 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
.||++||.|.+++ ...+++++..+...+.||+.|+.|+|.. +|||||+||+|++++..+++||+|||++....
T Consensus 91 lEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999999 6789999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCccccccccccccccCccccccCCCC-CCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhccee
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINM 268 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 268 (272)
... .....||.+.|+|||++.|.+|+ .++||||.|+|+|.|+||+.||+..+- ..+..++++-.+
T Consensus 164 ~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~~G~f 229 (786)
T KOG0588|consen 164 PGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQRGVF 229 (786)
T ss_pred CCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHHcCcc
Confidence 433 35668999999999999999985 799999999999999999999995443 334444444433
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=264.59 Aligned_cols=213 Identities=25% Similarity=0.418 Sum_probs=183.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecC--Cc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PC 114 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~ 114 (272)
..++|+.++.|++|.||.||+|+++ +++.||+|.++.+.. .-.-..++|+.++.+++ |||||.+-++.... +.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~--H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR--HPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC--CCCeeeeEEEEeccccce
Confidence 3567999999999999999999977 899999999986532 22346789999999999 99999999987754 57
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.|+|||||+ -+|.+++ .....+|...++..+..|++.|++|||.+ .|+||||||+|+|+++.|.+|++|||++
T Consensus 152 iy~VMe~~E-hDLksl~---d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 152 IYIVMEYVE-HDLKSLM---ETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeeHHHHH-hhHHHHH---HhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence 999999996 4788887 33446899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
+.++...... +...-|..|.|||++.+.. |+++.|+||+|||+.+|+++++.|.+.++.+..+.|-+
T Consensus 225 R~ygsp~k~~-T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 225 REYGSPLKPY-TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred hhhcCCcccC-cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 9887664433 3345589999999998765 99999999999999999999999999998776665543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=269.75 Aligned_cols=203 Identities=31% Similarity=0.475 Sum_probs=173.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC--ceeE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRIL 117 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--~~~i 117 (272)
..+|...+.||+|+||.||++.+. +|...|||............+.+|+.++.+++ ||+||++++...... .+.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~--~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN--HPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC--CCCEEeeCCccccccCeeeEe
Confidence 566889999999999999999876 59999999987653333566889999999999 999999999744444 6889
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCeEEeecCcccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL 196 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-~~~~~l~Dfg~~~~ 196 (272)
+|||+++|+|.+++... ..++++..+...++|++++|.|||++ ||+||||||+|||++. ++.++|+|||++..
T Consensus 94 ~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999332 22799999999999999999999999 9999999999999999 79999999999987
Q ss_pred cCC--CCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 197 FPE--NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 197 ~~~--~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
... ..........||+.|+|||++.. ....+++|||||||++.+|+||.+||...
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 653 22223445789999999999985 33446999999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=280.64 Aligned_cols=211 Identities=29% Similarity=0.412 Sum_probs=184.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC-ce
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-CR 115 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~-~~ 115 (272)
..-++|.+.+.||-|.||.||+|+.. +|..||||..+.. ..+.+..-++|+..+++++. ||||+++.+++.+.+ ..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~-hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNP-HPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCC-CCcchhhHHHhhccCceE
Confidence 34578999999999999999999865 7999999988744 34556677889999999987 999999999999888 89
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||| ..+|..++. .++..|++..++.|..||+++|.|+|.+ |+.|||+||+|||+..+..+||+|||+++
T Consensus 86 ~fVfE~M-d~NLYqLmK---~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMK---DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeeHHhh-hhhHHHHHh---hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 9999999 578999984 4578999999999999999999999999 99999999999999988899999999999
Q ss_pred ccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
...... ..+.+..|..|.|||++... .|+.+.|+|++||+++|+.+-++.|.+.++.+.+-.
T Consensus 159 ev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K 221 (538)
T KOG0661|consen 159 EVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK 221 (538)
T ss_pred ccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH
Confidence 765432 24556789999999998755 589999999999999999999999998887665433
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.75 Aligned_cols=209 Identities=30% Similarity=0.399 Sum_probs=177.3
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+..++|++.+.||+|+||.||+|.+. ++..||+|.+... .......+..|+..++.+. ||+|+++++.+...
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~--h~~iv~~~~~~~~~ 115 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN--SEWIVQLHYAFQDD 115 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEecC
Confidence 3455678999999999999999999876 7899999998632 2223345677888999888 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++. +..+++..+..++.|++.||.|||++ ||+||||||+||+++.++.++|+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecc
Confidence 99999999999999999883 34588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccC----CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
++...............|++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 254 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH
Confidence 9976543322222345689999999998754 37889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=277.39 Aligned_cols=205 Identities=30% Similarity=0.410 Sum_probs=178.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|++|.||+|.+. +|+.||+|++... .......+..|+..+..+. ||+|+++++.+.++...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD--SPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC--CCCccchhhheecCCeEEE
Confidence 47999999999999999999876 7999999998743 2234456788899999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 79 VMEYMPGGDLMNLLI----RKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 999999999999983 346789999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC----------------------------ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 198 PENT----------------------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 198 ~~~~----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
.... ........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 4332 111233568899999999999999999999999999999999999998
Q ss_pred cccCCC
Q 024118 250 FDVQLG 255 (272)
Q Consensus 250 ~~~~~~ 255 (272)
..+...
T Consensus 232 ~~~~~~ 237 (350)
T cd05573 232 SDTLQE 237 (350)
T ss_pred CCCHHH
Confidence 766443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=273.62 Aligned_cols=198 Identities=29% Similarity=0.356 Sum_probs=170.6
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +|+.||+|++.... ........+|+..++.+. ||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR--HPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 46999999999999876 79999999987432 233456778899999988 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|.+.+ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.++|+|||++....... .
T Consensus 79 ~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 150 (323)
T cd05571 79 GGELFFHL----SRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-A 150 (323)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-C
Confidence 99999888 3456789999999999999999999999 99999999999999999999999999987432211 1
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 202 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH
Confidence 1233568999999999999999999999999999999999999997665443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=277.78 Aligned_cols=211 Identities=26% Similarity=0.442 Sum_probs=190.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
...|.....||+|+.|.||.|... +++.||||.+.........-+++|+..++..+ |+|||.+++.+...+..++||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~--H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH--HPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc--chHHHHHHHHhcccceeEEEE
Confidence 457888999999999999999755 78999999998887777888999999999999 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||++||+|.+.+ ....++|.+|..+.+++++||.|||.+ ||+|||||.+||+++.+|.+||+|||.|..+..
T Consensus 350 Eym~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 350 EYMEGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eecCCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999998 445599999999999999999999999 999999999999999999999999999987754
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
.... .....||++|+|||+.....|+++.||||||+++.||+.|.+||=..++...+.+|..
T Consensus 422 ~~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ 483 (550)
T KOG0578|consen 422 EQSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 483 (550)
T ss_pred ccCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence 4432 3345799999999999999999999999999999999999999988777766665544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=265.73 Aligned_cols=215 Identities=24% Similarity=0.378 Sum_probs=187.0
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEe-CCCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeee
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
......+..+.+.|++...||.|..++||+|+. +.++.||||.+..+... ....+.+|+..++.+. ||||++++.+
T Consensus 15 ~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~--HPNIv~~~~s 92 (516)
T KOG0582|consen 15 SSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID--HPNIVTYHCS 92 (516)
T ss_pred ccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC--CCCcceEEEE
Confidence 344556678889999999999999999999975 47899999999877433 4578889999999999 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
|..+...|+||+||.+|++.+.+... ....++|..|..+++++++||.|||.+ |.+|||+|+.||||+.+|.|+|
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEE
Confidence 99999999999999999999999654 334599999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCcc---ccccccccccccCccccccC--CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 189 SDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+|||.+..+-....+ ......|+++|+|||+++.. .|+.|+||||+|++..||.+|+.||.-..
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 999998766433211 12556899999999997654 59999999999999999999999997544
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=277.57 Aligned_cols=206 Identities=25% Similarity=0.373 Sum_probs=176.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|... +++.||+|++... .......+..|...+..+. ||+|+++++.+......++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD--GAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999876 7999999998643 2233456777888888888 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||++|++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 79 v~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 79 IMEFLPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 99999999999998 4456789999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCc----------------------------------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh
Q 024118 198 PENTT----------------------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 198 ~~~~~----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t 243 (272)
..... .......|++.|+|||++.+..++.++|+||+||++|+|++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 21100 00113468999999999999999999999999999999999
Q ss_pred CCCccccccCCCc
Q 024118 244 GRTAVDFDVQLGE 256 (272)
Q Consensus 244 g~~p~~~~~~~~~ 256 (272)
|++||...+....
T Consensus 232 G~~Pf~~~~~~~~ 244 (360)
T cd05627 232 GYPPFCSETPQET 244 (360)
T ss_pred CCCCCCCCCHHHH
Confidence 9999987765543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=270.74 Aligned_cols=204 Identities=25% Similarity=0.355 Sum_probs=172.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+|++.+.||+|+||.||+|... +++.||+|++... ..........|...+..+.. |++|+++++++...+..++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-PPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCC-CCceeeeEEEEEcCCEEEEE
Confidence 5899999999999999999876 6889999998743 22334566778888877762 45688899999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+.+ .....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 80 MEYVNGGDLMYHI----QQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred EcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999999888 3456788999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.... ......|+..|+|||++.+..++.++|+||+||++|+|++|+.||...+..+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~ 208 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 1111 1233568999999999999899999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=263.40 Aligned_cols=202 Identities=28% Similarity=0.416 Sum_probs=174.2
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..+..+. |++++++++.+..++..+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN--SRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC--CCcEEEEEEEEccCCeEEEE
Confidence 4889999999999999999875 79999999986432 223345778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+.+... ....+++..++.++.|++.|+.+||++ +|+|+||||+||++++++.++|+|||++....
T Consensus 79 ~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 79 LTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred EEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 9999999998887432 234689999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .....|+..|+|||++.+..++.++|+||+||++|+|++|+.||...+.
T Consensus 154 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 154 EGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred CCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 3221 2335688999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=270.06 Aligned_cols=204 Identities=24% Similarity=0.355 Sum_probs=171.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+|++.+.||+|+||.||+|.+. +++.||+|++.... .........|...+..... |++|+++++++...+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK-PPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC-CCeEeeEEEEEecCCEEEEE
Confidence 5899999999999999999877 68899999987432 2223345556666655532 89999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+.+ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|||++....
T Consensus 80 ~E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 80 MEYVNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred EcCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999999888 3446789999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.... ......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+...
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~ 208 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH
Confidence 2111 1233568899999999999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=270.17 Aligned_cols=221 Identities=28% Similarity=0.418 Sum_probs=184.0
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--------------cccHHHHHHHHHHhhcc
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--------------KQGEKEFMSEVASMANV 95 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--------------~~~~~~~~~e~~~~~~~ 95 (272)
.+.-.+.....+.|++.+.||+|.+|.|-+|++. +++.||||++.... ......+.+|+.+++++
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 3444556677889999999999999999999977 79999999985221 11235899999999999
Q ss_pred cccccceeEeeeeEecC--CceeEEEeecCCCCHhHHHhhccccccc-CChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 024118 96 NVCHENLVKLHGGCIDG--PCRILVYDYMPNNSLSQTLLGEEKRRAK-FGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172 (272)
Q Consensus 96 ~~~~~~i~~l~~~~~~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~d 172 (272)
. |||||+++++..+. +..|+|+|||..|.+...- ...+ +++.+++.+++++..+|+|||.+ ||+|||
T Consensus 166 ~--H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRD 235 (576)
T KOG0585|consen 166 H--HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRD 235 (576)
T ss_pred C--CcCeeEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccc
Confidence 9 99999999998764 6899999999988877654 3334 99999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEeecCcccccCCC----CccccccccccccccCccccccCC----CCCCCceehHHHHHHHHHhC
Q 024118 173 IKTSNILLDQNFNPKISDFGLSKLFPEN----TTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSG 244 (272)
Q Consensus 173 l~p~nilv~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~il~~l~tg 244 (272)
|||.|+|++++|++||.|||.+...+.. .........||+.|+|||...+.. .+.+.||||+|++||+|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999999866321 122233367999999999998733 35799999999999999999
Q ss_pred CCccccccCCCceehhh
Q 024118 245 RTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 245 ~~p~~~~~~~~~~~~~~ 261 (272)
+.||......+.++.|.
T Consensus 316 ~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIV 332 (576)
T ss_pred cCCcccchHHHHHHHHh
Confidence 99998887766655543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=266.35 Aligned_cols=203 Identities=25% Similarity=0.385 Sum_probs=175.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++.+.||+|++|.||+|+++ +++.||+|.+.... ......+.+|+..++.+. ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK--QENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC--CccccchhhhEecCCEEEEE
Confidence 47999999999999999999986 68899999987442 223456778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||++++.+.... .....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 79 FEYVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999988776554 3345789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
...........++..|+|||++.+..++.++|+||+||++|+|++|++||...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 3332223335678899999999988899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=270.78 Aligned_cols=198 Identities=28% Similarity=0.373 Sum_probs=170.6
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||++.+. +|..||+|++... .......+.+|+..++.+. ||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR--HPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999876 7999999998743 2234456778889999988 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|.+.+ .....+++..++.++.||+.||.|||++ ||+|+||||+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 79 GGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 99999887 3456789999999999999999999999 999999999999999999999999999875322111
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~ 202 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH
Confidence 1233568999999999998889999999999999999999999997665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.63 Aligned_cols=198 Identities=29% Similarity=0.365 Sum_probs=169.9
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||++... +|..||+|++... .......+..|+..++.+. ||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCcceeeEEecCCEEEEEEeCCC
Confidence 46999999999999876 7999999998743 2233456677899999998 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|...+ .....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++........
T Consensus 79 ~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 79 GGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 99999887 3456789999999999999999999999 999999999999999999999999999874322111
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 202 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 1223568899999999998889999999999999999999999998665443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.33 Aligned_cols=199 Identities=26% Similarity=0.380 Sum_probs=165.9
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +++.||+|+++... .........|...+.... .||||+++++.+......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999876 68899999987431 222334455555554432 29999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|...+ .....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++....... .
T Consensus 80 gg~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 80 GGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 99999888 3445789999999999999999999999 99999999999999999999999999987543222 2
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~ 203 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH
Confidence 2334568999999999998889999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=275.60 Aligned_cols=210 Identities=24% Similarity=0.392 Sum_probs=186.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCc-eeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-RIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~-~~i 117 (272)
++|..++.+|+|+||.++.++++ ++..+|+|.+..... .......+|+..++++. ||||+.+.+.+..++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~--hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL--HPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc--CCCeeeeccchhcCCceEEE
Confidence 57999999999999999999877 788999999986633 23346788999999988 9999999999999988 999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|+|++||++.+.+... +...++++.++.|+.|++.|+.|||++ +|.|||||+.|||++.++.|+|+|||++..+
T Consensus 82 vm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 99999999999999543 357799999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
..... ......||+.|++||.+.+.+|..++|+|||||++|+|++-+++|...+-.+....
T Consensus 157 ~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k 217 (426)
T KOG0589|consen 157 NPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK 217 (426)
T ss_pred CCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH
Confidence 65442 35568899999999999999999999999999999999999999998887664333
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=269.15 Aligned_cols=202 Identities=28% Similarity=0.395 Sum_probs=171.6
Q ss_pred CeeeeeeeeeccceEEEEEEe----CCCcEEEEEEEEec----CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 43 GFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~----~~~~~v~vK~~~~~----~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+|++.+.||+|+||.||+++. .++..||+|++... ..........|+..++.+.. ||+|+++++.+.....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ-SPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccC-CCCcccEEEEEecCCE
Confidence 589999999999999999975 26889999998632 22233456778888888853 8999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||+++++|.+.+ ..+..+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|||++
T Consensus 80 ~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 80 LHLILDYVSGGEMFTHL----YQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999998 3456789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...............|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 765333222233456899999999998654 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=270.11 Aligned_cols=205 Identities=28% Similarity=0.373 Sum_probs=173.0
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||++++. +++.||+|++... .......+..|...+..+. |++|+++++.+...+..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD--CQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999876 7889999998632 1223344666778787777 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||++|++|.+++.. ....+++..+..++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++...
T Consensus 79 v~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999832 245789999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
............|++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||...+..
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 4333222233568999999999875 45788999999999999999999999765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=269.51 Aligned_cols=204 Identities=27% Similarity=0.369 Sum_probs=172.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||++... +++.||+|++... .......+..|...++.+. |++|+++++++..+...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD--RRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCCCceEEEEecCCeEEE
Confidence 47999999999999999999876 6899999998632 2223345677888888877 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++.. ....+++..+..++.|++.||.+||++ +|+|+||||+||+++.++.++|+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999999832 345689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
............|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...+.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 4332222223468999999999863 3467899999999999999999999976554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=275.70 Aligned_cols=218 Identities=22% Similarity=0.291 Sum_probs=183.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc----cccceeEeeeeEecC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV----CHENLVKLHGGCIDG 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~----~~~~i~~l~~~~~~~ 112 (272)
....-+|+|.+.||+|+||.|.+|.+. +++.||||+++.. ..-......|+.++..++. ..-|+|.+++++...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 344458999999999999999999866 7999999999733 3334456667888888772 135799999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC--CeEEee
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF--NPKISD 190 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~--~~~l~D 190 (272)
...+||+|.+ ..+|.+++..+ ...+++...++.++.||+.+|..||+. +|||+||||+|||+.+.+ .+|++|
T Consensus 261 ~HlciVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence 9999999987 78999999664 445699999999999999999999999 999999999999997554 499999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhcc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSI 266 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 266 (272)
||+++....... ....+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.+.++.+.+..|.-+.-+
T Consensus 335 FGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 335 FGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred cccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 999997543222 466788899999999999999999999999999999999999999987777666554433
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=267.08 Aligned_cols=195 Identities=29% Similarity=0.389 Sum_probs=168.9
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
||+|+||.||+|.+. +++.||+|.+... .......+.+|+..++++. ||||+++++.+...+..++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 689999999999876 6889999998643 2334456778999999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 205 (272)
+|.+.+ .....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++....... ...
T Consensus 79 ~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 150 (312)
T cd05585 79 ELFHHL----QREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKT 150 (312)
T ss_pred cHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccc
Confidence 999998 3456789999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
....|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 199 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH
Confidence 3356899999999999999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=258.99 Aligned_cols=212 Identities=25% Similarity=0.433 Sum_probs=180.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccc-eeEeeeeEecCC---
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGP--- 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~-i~~l~~~~~~~~--- 113 (272)
...|+.++.||+|++|+||+|+.+ +|+.||+|.+..... .......+|+..++.++ |+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~--~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS--HANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC--CCcceEEEEeeeeeccccc
Confidence 455888888999999999999876 899999999986643 35567899999999999 988 999999998877
Q ss_pred ---ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 114 ---~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
..++|+||+ ..+|..++.........++...+..+.+||+.|+.|||++ +|+||||||.||+|++.|.+||+|
T Consensus 88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 788999999 5689888854433225677889999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
||++....-.... ......|..|.|||++.+. .|++..|+||+|||+.+|+++++.|.+.+..+....
T Consensus 164 FGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 164 FGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred cchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 9999965533332 3445678999999999887 699999999999999999999999998887444333
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=267.81 Aligned_cols=201 Identities=28% Similarity=0.376 Sum_probs=169.3
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHh---hcccccccceeEeeeeEecCCcee
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASM---ANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~---~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
|++.+.||+|++|.||+|.+. +|+.||+|+++... ......+.+|...+ ..+. ||||+++++++......+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~--hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER--HPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC--CCChhceeeEEEcCCEEE
Confidence 788999999999999999876 79999999987431 22234555555544 4445 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++++|...+ ....+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++..
T Consensus 79 lv~E~~~~~~L~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 79 FVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEcCCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 999999999998887 235689999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
..... .......|++.|+|||.+.+..++.++|+||+||++|+|++|+.||...+..+
T Consensus 151 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~ 208 (324)
T cd05589 151 GMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208 (324)
T ss_pred CCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 32211 12233568899999999999899999999999999999999999998766443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=271.41 Aligned_cols=205 Identities=26% Similarity=0.353 Sum_probs=174.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+..|+..++.+. ||+|+++++.+......++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--SPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceeeEEecCCeEEE
Confidence 47999999999999999999876 79999999987432 223455677888888877 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++.. ....+++..++.++.|++.||.+||++ +|+||||||+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 79 VMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 9999999999999832 235789999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCccccccccccccccCccccc------cCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAI------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
............+++.|+|||++. +..++.++|+||+||++|+|++|+.||...+..
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 215 (330)
T cd05601 153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215 (330)
T ss_pred CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence 443332233356889999999986 445778999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=267.96 Aligned_cols=200 Identities=28% Similarity=0.377 Sum_probs=168.2
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +++.||+|++.... .........|...+..+.. ||+|+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-HPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccC-CCCccceeeEEEcCCeEEEEEeCCC
Confidence 46899999999999876 68899999987431 2233455667777665532 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|...+ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 80 GGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 99999888 3456789999999999999999999999 999999999999999999999999999875322211
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
......|+..|+|||++.+..++.++|+||+||++|+|++|+.||...+..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 204 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH
Confidence 12335688999999999998999999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=267.09 Aligned_cols=203 Identities=25% Similarity=0.371 Sum_probs=171.3
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+|++.+.||+|+||.||+|.+. +|+.||+|++... ..........|...+..+.. |++|+++++++...+..++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-PPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC-CCchhheeeEEecCCEEEEE
Confidence 4788999999999999999876 7899999998743 12233456667777766652 67888999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 80 MEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999988 3446799999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.... ......|+..|+|||++.+..++.++|+||+||++|+|++|+.||...+..
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 2211 123356889999999999888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=267.56 Aligned_cols=200 Identities=26% Similarity=0.375 Sum_probs=168.6
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.++ +++.||+|++... ..........|...+..+.. ||+|+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccC-CCchhceeeEEEcCCEEEEEEcCCC
Confidence 46899999999999876 6899999998743 22334456667777765532 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|.+.+ .....+++..++.++.|++.||.+||++ |++||||||+||+++.++.++|+|||++........
T Consensus 80 ~g~L~~~i----~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 80 GGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred CchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 99999888 3456789999999999999999999999 999999999999999999999999999875322111
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 204 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 12335689999999999988899999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=267.20 Aligned_cols=206 Identities=27% Similarity=0.371 Sum_probs=172.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||++..+ +++.+|+|++... .......+..|...+..+. |++|+++++.+......++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--NQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCEEEE
Confidence 47999999999999999999876 6888999998632 1222334667777888777 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++.. ....+++..++.++.|++.|+.+||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 79 v~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 79 VMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999999999999832 245689999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
............|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...+..+
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~ 215 (332)
T cd05623 153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (332)
T ss_pred ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH
Confidence 3322222233568999999999863 457889999999999999999999998665433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=269.24 Aligned_cols=198 Identities=28% Similarity=0.363 Sum_probs=169.1
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||++.+. +|..||+|++... ..........|++.+..+. ||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~--hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999876 7999999998743 2223456677888888888 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
+++|...+ .....+++..++.++.|++.||.|||+ + ||+|+||||+||+++.++.++|+|||++........
T Consensus 79 ~~~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 79 GGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 99999887 345678999999999999999999997 7 999999999999999999999999999874322211
Q ss_pred cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|+..|+|||++.+..++.++|+||+||++|+|++|+.||...+...
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~ 203 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203 (325)
T ss_pred -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH
Confidence 1223568899999999998899999999999999999999999997765543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=279.12 Aligned_cols=209 Identities=22% Similarity=0.323 Sum_probs=180.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-C-CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-D-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~-~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
...|.+.+.||+|++|.||+|... + +..||+|.+..........+.+|+..++.+. ||||+++++.+...+..++|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD--HFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEEECCEEEEE
Confidence 344999999999999999999755 4 6789999876555555566778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+.+........++++..+..++.|++.||.+||++ +|+||||||.||+++.++.++|+|||++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999998865545566799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 199 ENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.... .......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 3221 1233456899999999999988999999999999999999999999876543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=262.60 Aligned_cols=206 Identities=27% Similarity=0.456 Sum_probs=173.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.++|++.+.||.|+||.||+|... ++..||+|.+.... ........+|+..++.+. ||||+++++++......++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC--CCCEeeEEEEEcCCCeEEEE
Confidence 467999999999999999999876 78999999987442 223456778999999998 99999999999998899999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++ +|.+++.. ....+++..+..++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 82 FEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred EeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 999975 88888732 334578999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
.... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|++||...+..+.
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 155 VPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred CCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2221 1223457889999999875 4588999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=246.63 Aligned_cols=218 Identities=25% Similarity=0.333 Sum_probs=188.2
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEe-CCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
..+-++.+||+|.+.||+|||+-||+++. .++..||+|.+.....++....++|+...+.+. |||++++++....+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~--s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN--SPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC--CcchHHHHHHHHHhh
Confidence 44567889999999999999999999985 478999999999888888899999999999999 999999998765443
Q ss_pred -----ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCCe
Q 024118 114 -----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 114 -----~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~~~~~~ 186 (272)
..|++++|...|+|.+.+...+.....+++.+++.|+.++++||++||+. . +.|+||||.||++.+.+.+
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~---~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK---EPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc---CCcccccCCCcceeEecCCCce
Confidence 48999999999999999987777777899999999999999999999998 6 9999999999999999999
Q ss_pred EEeecCcccccCCCCccc--------cccccccccccCcccccc---CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 187 KISDFGLSKLFPENTTHI--------STRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+|.|||.+...+-..... ......|..|.|||++.- ...++++|||||||++|.|+.|..||+..-+.+
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 999999998664322211 112346888999999964 457899999999999999999999999766655
Q ss_pred ce
Q 024118 256 EY 257 (272)
Q Consensus 256 ~~ 257 (272)
..
T Consensus 249 gS 250 (302)
T KOG2345|consen 249 GS 250 (302)
T ss_pred Ce
Confidence 43
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=267.57 Aligned_cols=213 Identities=27% Similarity=0.415 Sum_probs=172.3
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
+.+..++|++.+.||.|+||.||+|.+ .++..||+|.+.... ......+.+|+..+..+.. ||||+++++.+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN-HLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhcc-CcceeeEEeEe
Confidence 455678899999999999999999974 235689999986432 2334578889999998832 99999999987
Q ss_pred ecC-CceeEEEeecCCCCHhHHHhhcccc---------------------------------------------------
Q 024118 110 IDG-PCRILVYDYMPNNSLSQTLLGEEKR--------------------------------------------------- 137 (272)
Q Consensus 110 ~~~-~~~~iv~e~~~~~~L~~~~~~~~~~--------------------------------------------------- 137 (272)
... ...+++|||+++++|.+++......
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4578999999999999998543210
Q ss_pred -------cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc-cccccc
Q 024118 138 -------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVA 209 (272)
Q Consensus 138 -------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 209 (272)
..++++..+..++.|++.||.|||++ ||+|+||||.||+++.++.++|+|||++......... ......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 23478889999999999999999999 9999999999999999999999999999754322211 112233
Q ss_pred ccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 210 ~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
++..|+|||++.+..++.++|+||+|+++|+|++ |..||...+.
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 4578999999998889999999999999999997 9999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.14 Aligned_cols=198 Identities=26% Similarity=0.425 Sum_probs=168.9
Q ss_pred eeeeeeccceEEEEEEe----CCCcEEEEEEEEec----CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 47 SNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~----~~~~~v~vK~~~~~----~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++.||+|+||.||++.. .+++.||+|++... .......+..|+..++.+. ||||+++++.+..++..+++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK--HPFIVDLIYAFQTGGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC--CCchhceeeEEecCCeEEEE
Confidence 36899999999999975 25889999998742 2223345678899999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+.+ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 79 LEYLSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred EeCCCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 9999999999988 4456788999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 152 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~ 206 (323)
T cd05584 152 HEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206 (323)
T ss_pred cCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH
Confidence 211 1123356889999999999888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.31 Aligned_cols=217 Identities=27% Similarity=0.417 Sum_probs=185.8
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEE--ecCcccHHHHHHHHHHhhcccccccceeEeeeeEec-
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID- 111 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~--~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~- 111 (272)
.......+|...+.||.|++|.|+.|.++ +|+.||||.+. .......++..+|++.++.++ |+||+.+.+++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~--HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR--HENIIGLLDIFRPP 93 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc--CCCcceEEeecccc
Confidence 33445667777899999999999999876 89999999987 456667789999999999999 9999999998765
Q ss_pred ----CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 112 ----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 112 ----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
-...|+|+|+| +.+|...+ ..+..++++++...++|++.|+.|+|+. +++||||||.|++++.+..+|
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEE
Confidence 35689999999 77899888 4555699999999999999999999999 999999999999999999999
Q ss_pred EeecCcccccCCC-CccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 188 ISDFGLSKLFPEN-TTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 188 l~Dfg~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
++|||+++..... .....+....|..|.|||+... ..|+.+.||||+|||+.||++|++.|.+.+....+.++..
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 9999999976432 1222355677999999998864 5699999999999999999999999999988776666543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=264.26 Aligned_cols=202 Identities=26% Similarity=0.417 Sum_probs=176.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..++|++.+.||+|++|.||++.+. +|..+|+|.+.... ......+.+|++.++.+. ||||+++++++..++..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCEEEE
Confidence 4678999999999999999999877 78999999987542 233457889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++ .....+++..++.++.|++.|+.|||++ .+|+|+||||+||+++.++.++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 81 CMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred EeecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 99999999999998 3445689999999999999999999985 16999999999999999999999999998755
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... .....++..|+|||++.+..++.++|+||+||++|+|++|+.||...+
T Consensus 155 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 155 IDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3222 233468899999999998889999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=264.91 Aligned_cols=199 Identities=26% Similarity=0.366 Sum_probs=166.5
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +|..||+|.++... .........|...+..... ||+|+++++.+...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE-NPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccC-CCCccCeeEEEEeCCEEEEEECCCC
Confidence 47999999999999877 78999999987431 2233455566666654422 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|...+ .....+++..+..++.|++.||.+||++ ||+||||||+||+++.++.++|+|||++....... .
T Consensus 80 ~g~L~~~i----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 80 GGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 99999888 3446789999999999999999999999 99999999999999999999999999986432111 1
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|+..|+|||++.+..++.++|+||+||++|+|++|+.||...+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~ 203 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 2234568999999999999999999999999999999999999998665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=248.22 Aligned_cols=218 Identities=31% Similarity=0.456 Sum_probs=192.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
-..++|++.+.||.|-||.||+|+.+ ++..||+|++... .......+.+|+++-..++ ||||+++++++.++..
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~--hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR--HPNILRLYGYFHDSKR 96 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC--CccHHhhhhheeccce
Confidence 34567999999999999999999866 7889999998532 2334567888899888888 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.|+++||...|++...+.. .....+++...+.+..|++.|+.|+|.+ +++|||+||+|+|++..|.++++|||.+
T Consensus 97 iyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCce
Confidence 9999999999999999843 2556799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhcc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSI 266 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 266 (272)
...+... ....+||..|.+||...+...+...|+|++|++.|+++.|.+||...+..+.+..|..++--
T Consensus 172 V~~p~~k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~ 240 (281)
T KOG0580|consen 172 VHAPSNK---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK 240 (281)
T ss_pred eecCCCC---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc
Confidence 8765322 34578999999999999999999999999999999999999999999988877777666543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=263.87 Aligned_cols=199 Identities=27% Similarity=0.374 Sum_probs=166.4
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +++.||+|.++... .........|...+..... ||+|+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccC-CCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46999999999999876 68899999987431 2233455566666654422 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|.+.+ .....+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++....... .
T Consensus 80 ~g~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05619 80 GGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-A 151 (316)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-C
Confidence 99999988 3345788999999999999999999999 99999999999999999999999999987432111 1
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|+..|+|||++.+..++.++|+||+||++|+|++|+.||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~ 203 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 2233568899999999998889999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=258.25 Aligned_cols=206 Identities=26% Similarity=0.399 Sum_probs=172.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC-----cee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----CRI 116 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~-----~~~ 116 (272)
.|+-.+.+|+|+||.||+|... +++.||||..-.+.. -..+|++.++.+. ||||+.+.-++.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~--HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLD--HPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcC--CcCeeeEEEEEEecCCCchhHHH
Confidence 3888999999999999999865 689999998754432 3346788888777 999999998876432 234
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCeEEeecCccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSK 195 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~-~~~~l~Dfg~~~ 195 (272)
+||||++ .+|...++..-..+..++.-.+.-+.+||++|+.|||+. |||||||||.|+|||.+ |.+||+|||.+.
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 8999996 689999877666778899999999999999999999999 99999999999999876 889999999999
Q ss_pred ccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
....... ......+..|.|||++.+.. |+.+.||||.||++.||+-|++.|.+.+..+....|
T Consensus 175 ~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 175 VLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI 238 (364)
T ss_pred eeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence 7754443 24456788999999998765 999999999999999999999999987765554444
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=261.08 Aligned_cols=201 Identities=25% Similarity=0.452 Sum_probs=170.0
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.++|++.+.||.|+||.||+|... +++.||+|++.... ........+|+..++.+. ||||+++++++..+...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK--HANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC--CCCcCeEEEEEecCCeEEEE
Confidence 468999999999999999999877 78999999987442 233446778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||++ ++|.+.+. .....+++..++.++.|++.||.+||++ ||+|+||||+||++++++.++|+|||++....
T Consensus 82 ~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 82 FEYVH-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EECCC-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 99995 56777763 2345688999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
.... ......++..|+|||++.+. .++.++|+||+||++|+|++|..||...
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 155 VPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2221 12334578899999998754 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=258.45 Aligned_cols=218 Identities=26% Similarity=0.346 Sum_probs=185.8
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.....+..+.|++++.||+|.-|+||+|... ++..+|+|++..+ ......+...|.++|..+. ||.++.+|..+
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD--HPFlPTLYa~f 146 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD--HPFLPTLYASF 146 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC--CCccchhhhee
Confidence 3445566778999999999999999999987 5799999998644 3344566777888999999 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
..+...+++||||+||+|..++. ++....|++..++.++..++-||+|||.. ||++|||||+||||.++|++-|.
T Consensus 147 et~~~~cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred eccceeEEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEee
Confidence 99999999999999999999883 35567799999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCC---------------------------------C-C---------------------ccccccccccccc
Q 024118 190 DFGLSKLFPE---------------------------------N-T---------------------THISTRVAGTLGY 214 (272)
Q Consensus 190 Dfg~~~~~~~---------------------------------~-~---------------------~~~~~~~~~~~~~ 214 (272)
||.++..... . . ......+.||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 9998853310 0 0 0011224688999
Q ss_pred cCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 215 ~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
+|||++.|..-+.++|.|+||+.+|||+.|.+||.+.+..+.+.
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~ 345 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR 345 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH
Confidence 99999999999999999999999999999999999887766543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=262.80 Aligned_cols=195 Identities=26% Similarity=0.383 Sum_probs=166.1
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +++.||+|+++.. .......+..|...+..+.. ||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~-hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN-HPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC-CCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999876 7899999999743 22233456677777777733 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|.+.+ .....+++..++.++.|++.||.+||++ |++||||||+||+++.++.++|+|||++....... .
T Consensus 80 ~g~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 80 GGDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 99999887 3456799999999999999999999999 99999999999999999999999999986422111 1
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
......|+..|+|||++.+..++.++|+||+||++|+|++|+.||+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 223356899999999999989999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.31 Aligned_cols=197 Identities=26% Similarity=0.385 Sum_probs=167.1
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|... +++.||+|++.... ......+..|+..+.++.. ||+|+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-NPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcC-CCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 47999999999999876 68899999997432 2233456677777777643 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|...+ .....+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~~L~~~~----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 151 (327)
T cd05617 80 GGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-D 151 (327)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-C
Confidence 99999887 3446799999999999999999999999 99999999999999999999999999987432111 1
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~ 201 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITD 201 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCC
Confidence 12335689999999999999999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=276.10 Aligned_cols=214 Identities=28% Similarity=0.411 Sum_probs=179.4
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
......++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..+..+. |++++++++.+...
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~--h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD--FFSIVKCHEDFAKK 103 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC--CCcEEEeecceecc
Confidence 33445679999999999999999999865 79999999987542 233456777888888888 99999998766533
Q ss_pred C--------ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 113 P--------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 113 ~--------~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
. ..++||||+++++|.+.+.........+++..++.++.|++.+|.|||++ +|+||||||+||+++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence 2 36799999999999999866555567899999999999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 185 NPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.++|+|||++....... ........|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~ 251 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME 251 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999987654321 22233457899999999999989999999999999999999999999866543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.45 Aligned_cols=196 Identities=30% Similarity=0.418 Sum_probs=164.3
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHH-HhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~-~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||+|+||.||+|.+. +|+.||+|++.... ......+..|.. .++.+. ||||+++++.+...+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK--HPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC--CCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999876 78999999986432 122334445544 456666 999999999999999999999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|...+ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (321)
T cd05603 79 NGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE- 150 (321)
T ss_pred CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence 999998887 3456788999999999999999999999 99999999999999999999999999987432211
Q ss_pred cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.......|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence 122335688999999999988899999999999999999999999977653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.80 Aligned_cols=197 Identities=32% Similarity=0.438 Sum_probs=165.2
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHH-HhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~-~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||+|+||.||+|.+. +|+.||+|++.... ......+..|.. .++.+. ||||+++++.+...+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~--hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC--CCCCCCeeEEEEeCCEEEEEEcCC
Confidence 47999999999999876 79999999986431 122234445544 345666 999999999999999999999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|...+ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (323)
T cd05575 79 NGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS- 150 (323)
T ss_pred CCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence 999999888 4456789999999999999999999999 99999999999999999999999999987432211
Q ss_pred cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence 1223356889999999999989999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=261.09 Aligned_cols=194 Identities=27% Similarity=0.405 Sum_probs=164.9
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +++.||+|++... .......+..|...+.++.. ||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~-hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-HPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCC-CCcCCceeeEEEeCCEEEEEEeCCC
Confidence 46999999999999876 7889999998743 22233456667777766532 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|...+ .....+++..++.++.|++.|+.|||++ ||+||||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~~L~~~~----~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~ 151 (329)
T cd05618 80 GGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 151 (329)
T ss_pred CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-C
Confidence 99998887 3456799999999999999999999999 99999999999999999999999999987432211 1
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
......|+..|+|||++.+..++.++|+||+||++|+|++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 12335689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=263.31 Aligned_cols=198 Identities=33% Similarity=0.419 Sum_probs=164.9
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHH-HhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~-~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||+|+||.||+|.+. +++.||+|++.... ......+..|.. .++.+. ||||+++++.+...+..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--HPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC--CCCCCceeEEEEcCCeEEEEEeCC
Confidence 46999999999999876 68899999987432 122234444433 345666 999999999999999999999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|.+.+ .....+++..++.++.||+.||.+||++ ||+||||||+||+++.++.++|+|||++........
T Consensus 79 ~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 79 NGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 999999988 3456788999999999999999999999 999999999999999999999999999875322111
Q ss_pred cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 203 (325)
T cd05602 152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203 (325)
T ss_pred -CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH
Confidence 2233568999999999999999999999999999999999999998665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.25 Aligned_cols=198 Identities=31% Similarity=0.411 Sum_probs=165.8
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHH-HhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVA-SMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~-~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||+|+||.||+|.+. +|+.+|+|++... .......+..|.. .++.+. ||||+++++.+...+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC--CCCCccEEEEEecCCEEEEEEcCC
Confidence 46899999999999876 7999999998643 1222334455544 355566 999999999999999999999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|...+ .....+++..++.++.||+.||.|||++ ||+|+||||+||++++++.++|+|||++........
T Consensus 79 ~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 79 NGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 999999887 4556789999999999999999999999 999999999999999999999999999874322111
Q ss_pred cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......|+..|+|||++.+..++.++|+||+||++|+|++|..||...+..+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~ 203 (325)
T cd05604 152 -TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203 (325)
T ss_pred -CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH
Confidence 1233568899999999999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=255.04 Aligned_cols=202 Identities=30% Similarity=0.433 Sum_probs=173.7
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+|++.+.||+|++|.||++.+. ++..||+|.+.... ......+.+|+..++.++ ||+|+++++.+..++..+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC--CCCEeeeeeeecCCCeEEEE
Confidence 5899999999999999999876 78999999986432 122345677999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+.+.. .....+++..+..++.|++.|+.+||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 79 LTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999988743 2235689999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .....++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 154 EGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred CCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 2221 2234678899999999988899999999999999999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=261.56 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=167.9
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC-----Cc
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PC 114 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~-----~~ 114 (272)
+|++.+.||.|+||.||+|.+. +|..||+|.+... .......+.+|+..++.++ ||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC--CCCEeeecceEeccCCCCCce
Confidence 5999999999999999999876 7999999998632 2233456788999999998 99999999987543 24
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||+. ++|.+.+ .....+++..+..++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++
T Consensus 79 ~~lv~e~~~-~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 79 IYVVFELME-SDLHQVI----KANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEEEecCC-CCHHHHH----HhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 789999995 6888887 3445789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--cccccccccccccCcccccc--CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 195 KLFPENTT--HISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 195 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
........ .......++..|+|||++.+ ..++.++|+||+||++|+|++|++||...+
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 75432211 11233568899999999876 568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=262.57 Aligned_cols=214 Identities=27% Similarity=0.388 Sum_probs=189.2
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..-....|++.+.||.|.||.||++..+ +|+.+|+|.+..... .....+.+|+.+++++.. ||||+.+.+++...
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-HPNIVQLKDAFEDP 108 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-CCCEEEEEEEEEcC
Confidence 3455678999999999999999999987 699999999974432 244689999999999987 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CCeEE
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN----FNPKI 188 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~----~~~~l 188 (272)
...++|||++.||.|.+.+... .+++..+..++.|++.++.|||+. |++|+|+||+|+|+... +.+++
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEE
Confidence 9999999999999999999544 399999999999999999999999 99999999999999533 47999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhh
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 261 (272)
+|||++..... .......+||+.|+|||++....|+...|+||+|+++|.|++|.+||...+..+.+..+.
T Consensus 181 ~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~ 251 (382)
T KOG0032|consen 181 IDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL 251 (382)
T ss_pred eeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH
Confidence 99999998765 444666899999999999999999999999999999999999999999998776655433
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=254.82 Aligned_cols=197 Identities=26% Similarity=0.378 Sum_probs=168.7
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
||+|+||.||++.+. +|+.||+|.+..... .....+..|+..++.+. ||+|+++.+++......+++|||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH--SRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC--CCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 689999999999876 789999999864321 22345677888999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 205 (272)
+|.+.+.........+++..++.++.|++.|+.|||++ +|+|+||+|+||++++++.++|+|||.+........ ..
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~ 154 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KT 154 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cc
Confidence 99988754444556799999999999999999999999 999999999999999999999999999876543222 12
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 23467889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=263.77 Aligned_cols=198 Identities=29% Similarity=0.417 Sum_probs=169.9
Q ss_pred eeeeeccceEEEEEEe----CCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEee
Q 024118 48 NKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 121 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~----~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~ 121 (272)
+.||+|+||.||++.. .+|+.||+|++.... .........|++.++++. ||||+++++.+......++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN--HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC--CCCcccEEEEEEcCCEEEEEEcC
Confidence 6799999999999974 368999999987432 223345677899999998 99999999999999999999999
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
+++++|.+.+ .....+++..++.++.|++.||.|||++ ||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 80 LRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 9999999988 3456789999999999999999999999 99999999999999999999999999987543321
Q ss_pred ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 202 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.......|+..|+|||.+.+..++.++|+||+||++|+|++|+.||...+..+
T Consensus 153 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 205 (318)
T cd05582 153 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205 (318)
T ss_pred -CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH
Confidence 12233568899999999998889999999999999999999999998766443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=266.27 Aligned_cols=196 Identities=21% Similarity=0.281 Sum_probs=169.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+...+|++.+.||.|+||.||+|.+. +++.||+|... .....+|+..+++++ ||||+++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAIN--HPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCC--CCCCCCEeEEEEECCeeEE
Confidence 34578999999999999999999876 78999999743 234678999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
++|++. ++|..++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 161 v~e~~~-~~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 161 ILPRYK-TDLYCYL----AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred EEecCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 999985 6788777 3345688999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
............||+.|+|||++.+..++.++|+||+||++|+|++|+.||-.
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 32222223345789999999999998999999999999999999999987643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=260.83 Aligned_cols=199 Identities=28% Similarity=0.400 Sum_probs=167.3
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|.+. +++.||+|++... ..........|...+..+. .||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999876 6889999998743 1223345566777776664 29999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|...+ .....+++..+..++.|++.||.+||++ +|+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 80 GGDLMFHI----QRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 99999888 3445799999999999999999999999 999999999999999999999999999864321111
Q ss_pred ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......++..|+|||++.+..++.++|+||+||++|+|++|+.||...+...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~ 203 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH
Confidence 1223468899999999999999999999999999999999999998665433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=260.81 Aligned_cols=204 Identities=25% Similarity=0.421 Sum_probs=176.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+..++|++.+.||.|+||.||++.+. ++..+++|.+.... ......+.+|++.++.+. ||||+++++++..+...+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCcccceeEEEEECCEEE
Confidence 34678999999999999999999877 78899999887542 233456889999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
++|||+++++|.+++ .....+++..+..++.|++.++.|||+. .+++|+||||+||++++++.++|+|||++..
T Consensus 80 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 80 ICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 999999999999998 3445688999999999999999999974 1799999999999999999999999999875
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... .....++..|+|||++.+..++.++|+||+||++|+|++|+.||...+.
T Consensus 154 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 154 LIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred hhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 43221 2234678899999999988899999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=254.68 Aligned_cols=205 Identities=27% Similarity=0.440 Sum_probs=167.0
Q ss_pred CCeeeeeeeeeccceEEEEEEeC--CCcEEEEEEEEecC--cccHHHHHHHHHHhhccc-ccccceeEeeeeEe-----c
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVES--KQGEKEFMSEVASMANVN-VCHENLVKLHGGCI-----D 111 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~--~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~-----~ 111 (272)
++|++.+.||+|+||.||+|.+. ++..||+|.+.... ........+|+..++.+. ..||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999863 47889999987442 222345556666665552 12999999999875 2
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
....++++||++ ++|.+++... ....+++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456889999996 5888887432 234588999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
|++...... .......++..|+|||.+.+..++.++|+||+||++|+|++|++||...+..
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~ 215 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH
Confidence 999765432 1223356789999999998888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=263.08 Aligned_cols=208 Identities=24% Similarity=0.405 Sum_probs=186.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
...|.....||+|.||.||+|.+. +++.||+|++..+... ....+.+|+..+.++. ++||.++++.+..+...+|+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~--~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD--SPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC--cchHHhhhhheeecccHHHH
Confidence 445778899999999999999865 8999999999877444 4567888999999999 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||||.||++.+.+ .....+.+..+..++.+++.|+.|||++ +.+|+|||+.||++...|.++|+|||.+....
T Consensus 90 Mey~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence 9999999999999 5566668999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
...... ....||+.|+|||++....|+.++||||||++.++|.+|.+|+....+...+.
T Consensus 163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 555444 66789999999999998899999999999999999999999998877744333
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=250.68 Aligned_cols=207 Identities=25% Similarity=0.437 Sum_probs=176.0
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
.++|++.+.||+|+||.||++.++++..+++|.+... ......+.+|+..++.+. ||||+++++++......+++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLS--HPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCC--CCCceeEEEEEccCCCEEEEEE
Confidence 4679999999999999999999888888999987633 233457888999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+.+.. ....+++..++.++.|++.|+.+||++ |++|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 80 FMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred cCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999998843 234688999999999999999999999 9999999999999999999999999988755332
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
.........++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV 210 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 2222222234567999999988889999999999999999999 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=253.16 Aligned_cols=209 Identities=22% Similarity=0.375 Sum_probs=173.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+..++|++.+.||+|+||.||+|.+. .+..|++|.++... ......+.+|+..+..+. ||||+++++.+..+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD--HSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEecCC
Confidence 34678999999999999999999753 46789999987542 233456888999999987 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||+++++|.+++.. ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcc
Confidence 99999999999999999843 235689999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
................++..|+|||.+.+..++.++|+||+||++|++++ |..||...+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~ 216 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 76543221111112234567999999998899999999999999999775 999997665543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.30 Aligned_cols=213 Identities=30% Similarity=0.564 Sum_probs=183.3
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
+...|.+..+...+...||+|.||+||+|+|. | .||||++... ..+..+++.+|+..+++-+ |.||+-+.+++.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR--H~NIlLFMG~~~ 458 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR--HENILLFMGACM 458 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc--hhhheeeehhhc
Confidence 33788899999999999999999999999986 2 3899999866 4456689999999999999 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
.+.. .||..+|+|.+|..++. ..+.+|.....+.|++|+++++.|||.+ +|+|+|||..|||+.++++|+|+|
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlH---v~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLH---VQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred CCce-eeeehhccCchhhhhcc---chhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence 8877 99999999999999994 4568899999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCC-CccccccccccccccCccccccC---CCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 191 FGLSKLFPEN-TTHISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 191 fg~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
||++..-... ........-|...|+|||++..+ +|++.+||||+|+++|||++|..||........
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI 601 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI 601 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe
Confidence 9999754322 12223334567889999999743 589999999999999999999999995554443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=273.50 Aligned_cols=222 Identities=23% Similarity=0.299 Sum_probs=183.9
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCC-cEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDG-TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.+--....+...+++|.+.|.+|||+.||.|.+..+ ..||+|.....+......+.+|+..++.+.. |+|||.+++..
T Consensus 26 ~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~g-h~nIV~yidss 104 (738)
T KOG1989|consen 26 YFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSG-HKNIVSYIDSS 104 (738)
T ss_pred CCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcC-CCceeeEeccc
Confidence 334456678888999999999999999999998754 9999999887777888899999999999987 99999999932
Q ss_pred -ec------CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 024118 110 -ID------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 182 (272)
Q Consensus 110 -~~------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~ 182 (272)
.. .-.+.++||||+|+.|-+++..+.+ ..|++.++++|+.|+++|+.+||.+ ...|+|||||-+|||+..
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSA 181 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcC
Confidence 21 1356799999999999999966543 3499999999999999999999998 334999999999999999
Q ss_pred CCCeEEeecCcccccCCCCccc--------cccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 183 NFNPKISDFGLSKLFPENTTHI--------STRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 183 ~~~~~l~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
+|+.||||||.+...-...... .-....|+.|.|||++. +..+++|+|||+|||+||.||....||+..
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9999999999998543222110 00123588999999874 778999999999999999999999999876
Q ss_pred cCCCc
Q 024118 252 VQLGE 256 (272)
Q Consensus 252 ~~~~~ 256 (272)
.+..+
T Consensus 262 g~laI 266 (738)
T KOG1989|consen 262 GKLAI 266 (738)
T ss_pred cceeE
Confidence 54443
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.90 Aligned_cols=205 Identities=24% Similarity=0.373 Sum_probs=167.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC-----
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----- 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----- 112 (272)
....+|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+|+..++.+. ||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~--h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLN--HINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcC--CCCCcceeeeEeecccccC
Confidence 34578999999999999999999875 78999999875322 23446889999998 99999998876432
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEE
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKI 188 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l 188 (272)
...+++|||+++ +|.+++.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 245689999975 67777655445567899999999999999999999999 999999999999998665 6999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+|||++........ .....+++.|+|||++.+. .++.++|+||+||++|+|++|.+||...+..+
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 278 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999986543221 2234678899999998764 58999999999999999999999998766443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=250.11 Aligned_cols=209 Identities=30% Similarity=0.468 Sum_probs=177.9
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+..++|++.+.||.|++|.||+|...++..|++|.+.... .....+.+|+..++.+. |+||+++++.+......+++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQ--HDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCC--CCCeeeEEEEEcCCCCcEEE
Confidence 4567899999999999999999998888889999876432 23567888999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+++... ....+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 80 TEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred EecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecC
Confidence 9999999999988432 345678899999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
...........++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~ 212 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence 433222222334567999999988889999999999999999998 999997655433
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=251.40 Aligned_cols=199 Identities=29% Similarity=0.464 Sum_probs=175.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|++|.||++.+. +++.+++|++... .......+.+|++.++++. ||||+++++++......++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--HPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCccceeeEEEcCCeEEE
Confidence 47999999999999999999876 6899999998643 2234467888999999999 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++ .....+++..++.++.|++.+|.+||++ |++|+||+|.||++++++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 79 VMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 99999999999998 3446789999999999999999999999 9999999999999999999999999998865
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... .....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||...+.
T Consensus 152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 203 (290)
T cd05580 152 KGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203 (290)
T ss_pred CCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 433 2234578899999999888889999999999999999999999976653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.86 Aligned_cols=203 Identities=25% Similarity=0.355 Sum_probs=170.7
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC-----c
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----C 114 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~-----~ 114 (272)
+|++.+.||+|+||.||++.+. +|+.||+|.+... ......++.+|+..++.++ ||||+++++++.... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK--HDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC--CCCcCCHhheecCCCccccce
Confidence 4789999999999999999875 7999999988532 2233457888999999998 999999999988766 7
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++++||+. ++|.+.+ .....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++
T Consensus 79 ~~lv~e~~~-~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 79 IYVVTELMQ-SDLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEEEeeccc-cCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 899999996 5777776 3456789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
...............++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 765433222223345688899999988754 7899999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=248.17 Aligned_cols=209 Identities=30% Similarity=0.466 Sum_probs=177.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+..++|++.+.||.|++|.||+|.+.++..|++|.+.... .....+.+|+..+++++ |||++++++++......+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLR--HPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCC--CCCccceeEEEecCCCeeee
Confidence 4567899999999999999999998777889999986433 34557888999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+++.... ...+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 99999999999984321 34688999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
............+..|+|||.+.+..++.++|+||||+++++|++ |+.||...+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 212 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 322211111223457999999998889999999999999999999 999998765443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=258.00 Aligned_cols=201 Identities=26% Similarity=0.327 Sum_probs=169.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC--
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-- 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~-- 113 (272)
...++|++.+.||+|+||.||++.+. +|..||+|.+... .......+.+|+..++.+. ||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN--HKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC--CCCEeeeeeeeccCCCc
Confidence 45689999999999999999999876 7999999998643 2334457778999999998 999999999886443
Q ss_pred ----ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 114 ----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 114 ----~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
..+++|||+++ +|...+ ...+++..+..++.|++.||.+||++ ||+||||||+||+++.++.++|+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVI------HMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHH------hccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 46899999965 455554 13478899999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|||++....... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 166 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 166 DFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred cCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999987543221 12334678899999999999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=254.49 Aligned_cols=205 Identities=27% Similarity=0.445 Sum_probs=171.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|.+.+.||+|+||.||+|..+ ++..||+|.+.... ........+|+..++.++ ||||+++++++..++..+++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC--CCCcceEEEEEeeCCeEEEEE
Confidence 67999999999999999999876 78899999987443 223346778999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++ +|.+.+. .....+++..++.++.|++.||.+||++ ||+||||+|+||+++.++.++|+|||++.....
T Consensus 84 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 84 EYLDK-DLKQYMD---DCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred eCCCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99975 7777763 2334578999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
.... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||...+..+.
T Consensus 157 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 157 PTKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred Cccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 2211 122456888999998865 4578999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=248.19 Aligned_cols=206 Identities=29% Similarity=0.459 Sum_probs=174.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
..++|.+.+.||+|++|.||.+.+.++..+++|.+... ......+.+|+..++.+. ||||+++++++......+++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLS--HEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCC--CCCeeeEEEEEccCCCcEEEE
Confidence 35679999999999999999998877777999988633 233467889999999998 999999999999888899999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++... ...+++..++.++.|++.|+.+||+. |++|+||+|.||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 79 EYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999999998432 33689999999999999999999999 999999999999999999999999999875543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
..........++..|.|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 32221222334567999999988889999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=252.95 Aligned_cols=210 Identities=28% Similarity=0.474 Sum_probs=171.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCC-----------------CcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQD-----------------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~-----------------~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~ 101 (272)
..++|++.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+..+..+. |||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK--DPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC--CCC
Confidence 45689999999999999999997532 3469999987542 233457888999999998 999
Q ss_pred eeEeeeeEecCCceeEEEeecCCCCHhHHHhhccc---------------ccccCChHHHHHHHHHHHHHHHHHhhcCCC
Q 024118 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---------------RRAKFGWKARREIIMGIGRGLAYIHEEIQP 166 (272)
Q Consensus 102 i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ 166 (272)
|+++++++...+..+++|||+++++|.+++..... ....+++..++.++.|++.|+.+||+.
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 99999999999999999999999999998854321 113467889999999999999999999
Q ss_pred CeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh--
Q 024118 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-- 243 (272)
Q Consensus 167 ~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-- 243 (272)
||+|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++|+||||+++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999999875432211 11222344678999999988889999999999999999987
Q ss_pred CCCccccccCC
Q 024118 244 GRTAVDFDVQL 254 (272)
Q Consensus 244 g~~p~~~~~~~ 254 (272)
+..||...+..
T Consensus 238 ~~~p~~~~~~~ 248 (304)
T cd05096 238 KEQPYGELTDE 248 (304)
T ss_pred CCCCCCcCCHH
Confidence 56788765443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=248.21 Aligned_cols=215 Identities=25% Similarity=0.381 Sum_probs=188.2
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
.+.+.|++...||+|+|+.|+++.+. +|+.+++|.+... +...-+.+.+|+.+.+.++ ||||+.+.+.+.+....
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq--HP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC--CCcEeehhhhhccccee
Confidence 45677999999999999999998655 8999999988643 3446678889999999999 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCeEEeecC
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFG 192 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~~~~l~Dfg 192 (272)
++|+|++.|+.|..-+ ..+..++|..+-...+||++||.|+|.+ +|+|||+||.|+++... .-+||+|||
T Consensus 86 ylvFe~m~G~dl~~eI----V~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred EEEEecccchHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccc
Confidence 9999999999998777 4557789999999999999999999999 99999999999999533 348999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhh
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVR 264 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 264 (272)
++...+ .........|++.|+|||++...+|+..+|||+-|+++|-|+.|.+||-+.++...+..|.+-.
T Consensus 159 vAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~ 228 (355)
T KOG0033|consen 159 LAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA 228 (355)
T ss_pred eEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence 999876 4445677889999999999999999999999999999999999999999988877666555433
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=276.54 Aligned_cols=207 Identities=25% Similarity=0.337 Sum_probs=174.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .....++.+|+..++.+. ||||+++++++..++..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~--HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI--HPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC--CcCcCeEEEEEeeCCEEEE
Confidence 58999999999999999999876 68999999986432 223457888999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhccc-------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 118 VYDYMPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
+|||++|++|.+++..... ....++...++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEe
Confidence 9999999999998854211 123456778899999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCC-----------------ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 191 FGLSKLFPENT-----------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 191 fg~~~~~~~~~-----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
||++....... ........|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 99997652110 0011224689999999999999999999999999999999999999976443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=246.66 Aligned_cols=198 Identities=34% Similarity=0.568 Sum_probs=173.1
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHH--HHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEK--EFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~--~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
|++.+.||+|+||+||++... +++.||+|.+......... ...+|+..++++. ||+|+++++++......+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR--HPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT--BTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc--cccccccccccccccccccccc
Confidence 889999999999999999987 6778999999865433332 2345888999987 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
++++++|.+++ .....+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~- 150 (260)
T PF00069_consen 79 YCPGGSLQDYL----QKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE- 150 (260)
T ss_dssp EETTEBHHHHH----HHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-
T ss_pred ccccccccccc----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-
Confidence 99999999998 3567889999999999999999999999 999999999999999999999999999975421
Q ss_pred CccccccccccccccCccccc-cCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 201 TTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
.........++..|.|||++. +..++.++|+||+|+++++|++|..||...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 122233456788999999998 788999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=244.82 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=173.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-----ccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-----QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
++|++.+.||.|++|.||.+... +++.+++|.+..... .....+.+|++.++++. ||||+++++++......
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ--HERIVQYYGCLRDDETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEEccCCeE
Confidence 57999999999999999999875 789999999864321 12346778899999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++++||+++++|.+.+. ....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 80 SIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 99999999999999883 345688999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCcccc--ccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 196 LFPENTTHIS--TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 196 ~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.......... ....++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 5533221111 224567789999999998899999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=247.33 Aligned_cols=205 Identities=24% Similarity=0.384 Sum_probs=174.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
...+|++.+.||+|++|.||+|... +++.|++|++..........+.+|+..++++. ||||+++++.+......+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~--h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK--HCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcC--CCCeeeeeEEEEeCCEEEEE
Confidence 3567999999999999999999875 78999999987655455566778999999988 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+.+ ....++++..+..++.|++.++.+||+. +|+|+|++|.||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 85 MEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 9999999999988 3446789999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.... ......++..|+|||.+. ...++.++|+||+||++|+|++|+.||...++.
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 2221 112245778899999885 334678999999999999999999999655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=247.90 Aligned_cols=209 Identities=29% Similarity=0.443 Sum_probs=176.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+...+|++.+.||.|++|.||+|.+. ++..|++|.+... ......+.+|+..++.+. ||+|+++++.+..+...++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCC--CCChhheEEEEcCCCCcEE
Confidence 45567999999999999999999866 6889999988633 334567888999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++... ....+++..++.++.|++.++.+||++ |++|+||+|+||++++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 80 ITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 99999999999998432 234688999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.............+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 213 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 4332222222233567999999988889999999999999999998 999997665444
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=246.88 Aligned_cols=201 Identities=31% Similarity=0.434 Sum_probs=172.4
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+|++.+.||+|+||.||++.+. +++.||+|.+.... ......+.+|+..++.++ |++++++++.+...+..+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN--SRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC--CCCeeeeeEEEecCCEEEEE
Confidence 4788999999999999999876 78999999886432 122345678999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+.+... ....+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 79 LTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 9999999999888432 234688999999999999999999999 99999999999999999999999999987553
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... .....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 154 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 154 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 2221 123467889999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=247.36 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=173.4
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
..+|++.+.||+|++|.||++.++++..+++|.+... ......+.+|+..++.+. ||||+++++.+......++++|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLS--HPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCC--CCCEEEEEEEEcCCCceEEEEe
Confidence 4568999999999999999999887788999987532 223456788999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+++... ...+++..++.++.|++.++.+||++ |++|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 80 YMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred cCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999998432 34688999999999999999999999 9999999999999999999999999998755322
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.........++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence 2111111223457999999998889999999999999999999 899998765544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=246.13 Aligned_cols=208 Identities=31% Similarity=0.473 Sum_probs=175.9
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+..++|++.+.||+|++|.||+|..++++.|++|.+.... .....+.+|+..++.+. |||++++++++. ....++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQ--HPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcC--CcCeeeEEEEEc-cCCcEE
Confidence 45678899999999999999999998889999999987433 33457888999999998 999999998864 456899
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
++||+++++|.+++... ....+++..++.++.|++.||.+||+. |++|+||+|+||++++++.++|+|||++...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 99999999999988432 345688999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
............++..|+|||.+.+..++.++|+||+|+++|+|++ |++||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 4322222222334567999999988889999999999999999999 99999765543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=246.46 Aligned_cols=194 Identities=29% Similarity=0.396 Sum_probs=165.2
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
||+|+||.||++..+ +|+.|++|.+.... .........|++.++.+. ||||+++++.+..+...+++|||++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN--SPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC--CCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 689999999999876 79999999986321 122344566889999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 205 (272)
+|.+.+... ....+++..++.++.|++.|+.+||+. |++|+||+|+||++++++.++|+|||++........ .
T Consensus 79 ~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~ 151 (277)
T cd05607 79 DLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--I 151 (277)
T ss_pred CHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--e
Confidence 999887432 334588999999999999999999999 999999999999999999999999999876543221 2
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
....++..|+|||++.+..++.++|+||+||++|+|++|+.||....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 23467889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=276.68 Aligned_cols=216 Identities=26% Similarity=0.390 Sum_probs=177.1
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.+..+.....+|++.+.||.|+||.||+|.+. ++..+++|.+... .......+..|+..++.+. ||||+++++.+
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~--HPNIVrl~d~f 81 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK--HKNIVRYIDRF 81 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC--CCCcCeEEEEE
Confidence 45556677789999999999999999999876 6888999998743 2234467888999999999 99999999987
Q ss_pred ec--CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcC----CCCeEecCCCCCCEEEcC-
Q 024118 110 ID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI----QPHVVHRDIKTSNILLDQ- 182 (272)
Q Consensus 110 ~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~----~~~i~h~dl~p~nilv~~- 182 (272)
.. ....++||||+++++|.+++.........+++..++.|+.||+.||.|||+.. ..+|+|+||||.|||++.
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 54 35688999999999999998654444567999999999999999999999851 025999999999999964
Q ss_pred ----------------CCCeEEeecCcccccCCCCccccccccccccccCcccccc--CCCCCCCceehHHHHHHHHHhC
Q 024118 183 ----------------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSG 244 (272)
Q Consensus 183 ----------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~il~~l~tg 244 (272)
.+.++|+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 23489999999986543221 233568999999999865 3478999999999999999999
Q ss_pred CCcccccc
Q 024118 245 RTAVDFDV 252 (272)
Q Consensus 245 ~~p~~~~~ 252 (272)
..||...+
T Consensus 240 k~PF~~~~ 247 (1021)
T PTZ00266 240 KTPFHKAN 247 (1021)
T ss_pred CCCCCcCC
Confidence 99997544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=259.86 Aligned_cols=213 Identities=24% Similarity=0.433 Sum_probs=174.5
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcc-cccccceeEeee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHG 107 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~ 107 (272)
.+....++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+..++.+ . |+||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~--h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQ--HKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhcc--CCceeeEee
Confidence 44566778999999999999999999742 34579999987442 23345678899999888 5 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhccc---------------------------------------------------
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK--------------------------------------------------- 136 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------------------------------------------------- 136 (272)
.+......+++|||+++++|.+++.....
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 99999999999999999999998853211
Q ss_pred ---------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 137 ---------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 137 ---------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
...++++..++.++.|++.||.|||++ |++||||||.||++++++.++|+|||++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 113478889999999999999999999 99999999999999999999999999987553322
Q ss_pred cc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 202 TH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 202 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
.. ......++..|+|||++.+..++.++|+||+|+++|+|++ |+.||.....
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 11 1112234567999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=245.80 Aligned_cols=209 Identities=33% Similarity=0.509 Sum_probs=177.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++..++|++.+.||.|++|.||+|..+++..+++|.+.... .....+.+|+..++.+. |++|+++++.+......++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLR--HDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCC--CCCEeeeeeeeecCCceEE
Confidence 45678899999999999999999998888889999987433 34567889999999998 9999999999998889999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++... ....+++..+..++.|++.|+.+||++ +++|+||+|+||++++++.++|+|||.+...
T Consensus 79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence 99999999999998432 234688999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
.............+..|+|||.+.+..++.++|+||+|+++++|++ |+.||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 4322211122234567999999998889999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=246.04 Aligned_cols=202 Identities=29% Similarity=0.415 Sum_probs=173.0
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.|+..+.||.|+||+||++.+. +++.+|+|.+.... ......+.+|+..++.++ |++++++.+.+..++..+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN--SQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CcCceeEEEEEecCCEEEEE
Confidence 4788999999999999999876 78999999986432 222345678999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+.+.. .....+++..+..++.|++.+|.+||+. ||+|+||+|+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 79 LTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 999999999988743 2234699999999999999999999999 99999999999999999999999999887543
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....
T Consensus 154 ~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 154 EGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred CCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 2221 2334678999999999888899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.90 Aligned_cols=198 Identities=29% Similarity=0.382 Sum_probs=161.6
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhccc-ccccceeEeeeeEecCCceeEEEeecCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMPN 124 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~~~~~~~iv~e~~~~ 124 (272)
||+|+||.||+|++. +|+.||+|++..... ........|...+.... ..||+|+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 689999999999876 799999999863311 12223344444444332 1399999999999999999999999999
Q ss_pred CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccc
Q 024118 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204 (272)
Q Consensus 125 ~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~ 204 (272)
++|...+ .....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l----~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHL----QKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 9999888 3456789999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred cccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 205 STRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 205 ~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.....|+..|+|||++.+. .++.++|+||+||++|+|++|+.||...+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~ 204 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH
Confidence 2345689999999998765 47899999999999999999999997765443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=248.75 Aligned_cols=203 Identities=23% Similarity=0.404 Sum_probs=176.6
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
...+|++.+.||+|++|.||++.+. +++.+++|.+..........+.+|+..++.+. |||++++++.+..+...++|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC--CCCEeeEEEEEEeCCEEEEe
Confidence 4568999999999999999999865 78899999987655555567888999999888 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+++. +..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred ecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999999882 34578999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... .....++..|+|||.+.+..++.++|+||+||++|+|++|+.||...+.
T Consensus 168 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 168 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred ccccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22211 1224577889999999888889999999999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=246.06 Aligned_cols=208 Identities=31% Similarity=0.485 Sum_probs=174.6
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+..++|++.+.||+|++|.||+|..+++..+++|.+..... ....+.+|+..++++. |++++++++.+. ....++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~--~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLR--HDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcC--CCceEEEEeEEC-CCCcEE
Confidence 345678999999999999999999988888899999874433 3457889999999998 999999998875 456789
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++... ....+++..++.++.|++.|+.+||++ +++|+||+|.||++++++.++|+|||.+...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 78 VTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 99999999999998432 234588999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
............++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 4332222222334567999999988889999999999999999999 99999765543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=257.89 Aligned_cols=213 Identities=25% Similarity=0.420 Sum_probs=173.9
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
.+....++|++.+.||+|+||.||+|.+ .++..||+|+++... ......+.+|+..+..+.. ||||+++++.
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~-HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN-HINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcC-Ccceeeeeee
Confidence 3445567899999999999999999963 246689999986432 2344578889999998832 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhccc----------------------------------------------------
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEK---------------------------------------------------- 136 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~---------------------------------------------------- 136 (272)
+......++||||+++|+|.+++.....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 9999999999999999999998854211
Q ss_pred -------------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 137 -------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 137 -------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
....+++..++.++.|++.|+.|||++ +++|+||||.||+++.++.++|+|||++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence 112578889999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 198 PENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
...... ......++..|+|||++.+..++.++|+||+|+++|+|++ |..||....
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 432211 1112234567999999999899999999999999999998 899997543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=248.83 Aligned_cols=204 Identities=24% Similarity=0.407 Sum_probs=177.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..++|++.+.||.|++|.||++.+. +|+.|++|.+..........+.+|+..++.+. |||++++++.+..+...++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCEEEEe
Confidence 3478999999999999999999875 79999999987655555567788899998888 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+++. ...+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 95 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred ecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999982 34678899999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
..... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~ 221 (297)
T cd06656 167 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (297)
T ss_pred CCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 32221 22345778899999999888999999999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=249.78 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=173.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||+|++|.||++.+. ++..+++|.+.... ......+.+|++.++++. ||||+++++.+..++..++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN--SPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999876 78899999887542 223456788999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||+++++|.+++ .....+++..+..++.|++.++.|||+ . +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ey~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 79 EHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred eccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999998 344678999999999999999999997 5 89999999999999999999999999887543
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 152 DSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred ccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 221 2334678899999999888889999999999999999999999975553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=246.99 Aligned_cols=204 Identities=23% Similarity=0.419 Sum_probs=177.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..++|++.+.||.|++|.||++.+. +|+.|++|.+..........+.+|+..++.+. |||++++++.+......+++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK--NPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC--CCceeeeeeeEecCceEEEE
Confidence 3467999999999999999999865 79999999987655555667888999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|..++. ...+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 95 MEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999999872 34689999999999999999999999 99999999999999999999999999987553
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
..... .....++..|+|||.+.+..++.++|+||+||++|+|++|+.||...++.
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~ 221 (296)
T cd06655 167 PEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (296)
T ss_pred ccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 32221 12245778899999999888999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=245.97 Aligned_cols=208 Identities=33% Similarity=0.505 Sum_probs=173.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+..++|++.+.||+|++|.||+|.+.+...|++|.+.... .....+.+|+..++.+. ||||+++++.+. ....+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~--~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCC--CCCcceEEEEEC-CCCcEEE
Confidence 4567899999999999999999988766779999987433 23457888999999998 999999998764 4567899
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+++... ....+++..++.++.|++.||.+||+. +++|+||+|.||++++++.++|+|||.+....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 9999999999998432 234678999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
...........++..|+|||+..+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~ 211 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 211 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH
Confidence 333222222345667999999988889999999999999999999 898997665433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=256.42 Aligned_cols=201 Identities=30% Similarity=0.448 Sum_probs=167.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...++|++.+.||.|+||.||+|.+. +|+.||+|++.... ......+.+|++.++.+. |+||+++++++......+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN--HPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC--CCCcceeeeEeccCCeEE
Confidence 34567889999999999999999876 78999999986442 233457888999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
++|||+++++|.+.. ..++..+..++.||+.||.|||++ ||+|+||||+||+++.++.++|+|||++..
T Consensus 149 lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 149 VLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI 217 (353)
T ss_pred EEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999886532 345778889999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccccccccCccccccC-----CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
...... ......|+..|+|||.+... ..+.++|+|||||++|+|++|+.||.....
T Consensus 218 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 278 (353)
T PLN00034 218 LAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278 (353)
T ss_pred cccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 542221 12334688999999987432 245689999999999999999999984443
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=247.24 Aligned_cols=203 Identities=27% Similarity=0.420 Sum_probs=164.1
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhccc-ccccceeEeeeeEec-----CC
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVN-VCHENLVKLHGGCID-----GP 113 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~~-----~~ 113 (272)
+|++.+.||+|++|.||+|.+. +|+.||+|.+..... .......+|+..++.+. ..||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999876 789999999874321 22234455666665552 129999999998764 24
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+++ +|.+++... ....+++..++.++.|++.||.+||++ |++|+||+|+||++++++.++|+|||.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999974 788877332 234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+........ .....++..|+|||++.+..++.++|+||+||++|+|++|++||...+.
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 876542221 2234578889999999988899999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=257.28 Aligned_cols=203 Identities=24% Similarity=0.305 Sum_probs=170.2
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC---
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--- 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--- 112 (272)
...++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+..++.+. ||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC--CCCccccceeecccccc
Confidence 35688999999999999999999876 7889999998643 2334456778999999998 99999999877543
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...++||||+++ +|...+. ..+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence 357899999965 6666651 3478899999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|||++....... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||...+..+
T Consensus 169 DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 232 (364)
T cd07875 169 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232 (364)
T ss_pred eCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999997653322 1233467889999999999999999999999999999999999998766433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=244.05 Aligned_cols=204 Identities=25% Similarity=0.404 Sum_probs=176.0
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||.|++|.||+|.+. ++..|++|.+... .......+.+|+..++.+. |||++++++.+......++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN--HPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--CcceeeeeeeEEECCeEEE
Confidence 57999999999999999999876 7899999987642 2233456788999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
++||+++++|.+++.........+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999998865444556689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
...... .....++..|+|||.+.+..++.++|+||+|+++++|++|+.||...
T Consensus 157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cchhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 432221 12345778899999998888899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=265.20 Aligned_cols=205 Identities=23% Similarity=0.322 Sum_probs=164.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc----cccceeEeeeeEecC-
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV----CHENLVKLHGGCIDG- 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~----~~~~i~~l~~~~~~~- 112 (272)
...++|++.+.||+|+||.||+|.+. +++.||||+++... ........|+..++.+.. .|++++.+++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 44678999999999999999999876 68899999986322 222334455555555541 145688888887754
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCC-------
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNF------- 184 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~------- 184 (272)
...++||+++ +++|.+++ .....+++..++.++.||+.||.|||+ . ||+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l----~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWI----MKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence 4678899987 77888887 344679999999999999999999997 6 999999999999998765
Q ss_pred ---------CeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 185 ---------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 185 ---------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.++|+|||.+..... ......|+..|+|||++.+..++.++|||||||++|+|++|++||+..+..+
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 489999998764321 1234578999999999999999999999999999999999999998766544
Q ss_pred c
Q 024118 256 E 256 (272)
Q Consensus 256 ~ 256 (272)
.
T Consensus 353 ~ 353 (467)
T PTZ00284 353 H 353 (467)
T ss_pred H
Confidence 3
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=246.92 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=174.0
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||+|++|.||+|.+. ++..|++|.++.........+.+|+..++.+. ||||+++++.+......++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~--h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK--HSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCEEEEEE
Confidence 457999999999999999999875 78999999987665445556778889999888 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++ .....+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999999998 3456789999999999999999999999 999999999999999999999999999875533
Q ss_pred CCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
... ......++..|+|||++. ...++.++|+||+||++|+|++|+.||....
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 159 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 221 122346788999999874 4457889999999999999999999986443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=247.87 Aligned_cols=211 Identities=27% Similarity=0.474 Sum_probs=180.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
...+|++.+.||.|++|.||+|.+.++..+++|.+..........+..|+..++.++ ||||+++++++......+++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR--HKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCC--CcchhheeeeEecCCCeEEEE
Confidence 346799999999999999999998889999999987665545667888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++... ....+++..++.++.|++.|+.+||++ |++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 999999999998542 345688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.+.
T Consensus 157 ~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~ 215 (261)
T cd05148 157 DVYLS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215 (261)
T ss_pred ccccc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 32211 12334567999999988889999999999999999998 899998766544333
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=247.09 Aligned_cols=220 Identities=27% Similarity=0.349 Sum_probs=190.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
--++|..++.||+|.||.|.+++.+ +++.+|+|+++.+ ..+....-+.|-+.++..+ ||.+..+.-.+...++.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~--HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR--HPFLTSLKYSFQTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc--CcHHHHhhhhhccCceE
Confidence 4567889999999999999999977 8999999998754 2233345566777777777 99999998889999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+.||||..||.|...+ .....++++..+.+...|..||.|||++ +|++||+|.+|.+++.+|++|+.|||++.
T Consensus 244 CFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence 9999999999999888 6678899999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhcceee
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 269 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (272)
.--.. ......++||+.|+|||++....|+.+.|-|.+|+++|+|++|+.||-..+.+..+.+|.......++
T Consensus 317 E~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr 389 (516)
T KOG0690|consen 317 EEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR 389 (516)
T ss_pred hcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc
Confidence 53222 22345589999999999999999999999999999999999999999999999888887665544333
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=255.00 Aligned_cols=200 Identities=25% Similarity=0.304 Sum_probs=168.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC---
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--- 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--- 112 (272)
...++|++.+.||+|+||.||+|.+. +++.||+|.+... .........+|+..++.+. ||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC--CCchhceeeeeeccccc
Confidence 45679999999999999999999876 7899999998643 2233456778999999988 99999999987643
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...+++|||+++ +|...+ ...+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHH------hhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 346899999965 565555 13578899999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|||++....... ......++..|+|||++.+..++.++|+||+||++|+|++|+.||...+
T Consensus 162 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 162 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred eCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999997543322 1233567899999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=243.97 Aligned_cols=194 Identities=26% Similarity=0.416 Sum_probs=169.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||+|++|.||+|.+. +++.|++|.+... .......+.+|+..++++. ||||+++++.+......++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD--SPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEECCEEEEEE
Confidence 46899999999999999999865 7899999998654 2334456888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|..+. .+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999999987542 467889999999999999999999 999999999999999999999999999976532
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
.. .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred cc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 21 23346788999999999888999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=248.18 Aligned_cols=210 Identities=31% Similarity=0.517 Sum_probs=175.6
Q ss_pred hhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
..++|.+.+.||+|+||.||++.. .++..+++|.+..........+.+|+..++++. ||+|+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 80 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEGD 80 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEecCC
Confidence 467899999999999999999974 235678999886554455567889999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcc---------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 114 CRILVYDYMPNNSLSQTLLGEE---------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~---------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
..++++||+++++|.+++.... .....+++..++.++.|++.||.+||++ |++|+||+|+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999999985432 1223589999999999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 185 NPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999875432211 11222334667999999998889999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=247.29 Aligned_cols=195 Identities=21% Similarity=0.334 Sum_probs=165.9
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecCccc---HHHHHHHHHHhhcccccccceeEeeeeEec----CCceeEEEe
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG---EKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYD 120 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~~~~iv~e 120 (272)
..+|+|+++.||+|.. +|+.||+|.+....... ...+.+|+..+++++ ||||+++++++.+ ....+++||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID--SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC--CCCEEEEeeeEEecccCCCceEEEEE
Confidence 6799999999999988 58899999987543322 356779999999999 9999999998876 356789999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|+++++|.+++. ....+++.....++.|++.++.+||+ . +++|+||+|.||++++++.++|+|||++.....
T Consensus 103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999999983 34578899999999999999999997 5 888999999999999999999999999875432
Q ss_pred CCccccccccccccccCcccccc--CCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
.. ....++..|+|||++.+ ..++.++|+||+|+++|+|++|+.||...+..+.
T Consensus 176 ~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~ 230 (283)
T PHA02988 176 PP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230 (283)
T ss_pred cc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 21 12356788999999976 6789999999999999999999999987665443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=248.30 Aligned_cols=210 Identities=30% Similarity=0.506 Sum_probs=176.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.++|.+.+.||+|++|.||+|.+. ++..|++|.+...... ....+.+|++.++.+. ||||+++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ--HENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC--CCCchheeeEEecCC
Confidence 467999999999999999999763 3578999998754333 4568889999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcc----------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 114 CRILVYDYMPNNSLSQTLLGEE----------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
..+++|||+++++|.+++.... .....+++..+..++.|++.++.+||++ |++|+||+|+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 9999999999999999985432 2235688999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 184 FNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
+.++|+|||++........ .......++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~ 232 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999875432211 11222334678999999999899999999999999999998 999997655544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=246.00 Aligned_cols=203 Identities=25% Similarity=0.409 Sum_probs=173.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||.|++|.||+|.+. ++..+++|.+..........+.+|+..++.+. |||++++++.+..+...+++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN--HPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCcEeeeEEEEEeCCeEEEEE
Confidence 467999999999999999999876 68999999987665556677888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|...+.. ....+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 89 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 89 EFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred ecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999888732 345689999999999999999999999 999999999999999999999999998865322
Q ss_pred CCccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
... ......++..|+|||++.+ ..++.++|+||+||++|+|++|++||...+
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 163 TLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 211 1223456788999999853 346789999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=263.11 Aligned_cols=205 Identities=29% Similarity=0.431 Sum_probs=175.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecC------C
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------P 113 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~------~ 113 (272)
..|.....||+|+||.||+++++ +|+.||||.+... ......+..+|++.++++. |||||++.++-... .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn--h~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN--HPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC--chhhhhhcccCCccccCcccc
Confidence 34667799999999999999976 8999999999754 3345568889999999999 99999999875443 3
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--CC--eEEe
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN--FN--PKIS 189 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~--~~--~~l~ 189 (272)
...++||||.||+|...+.. +++...+++.+++.++.++..|+.|||++ ||+||||||.||++-.+ |+ .||+
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cceEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 56799999999999999854 35567899999999999999999999999 99999999999999433 33 5999
Q ss_pred ecCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
|||.++...++. ......||..|++||+.-. ..|+...|+||+||++|++.||..||......
T Consensus 167 DfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 167 DFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999999876655 4566889999999999985 77899999999999999999999999755544
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=248.60 Aligned_cols=203 Identities=26% Similarity=0.443 Sum_probs=171.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.++|++.+.||.|++|.||+|.+. ++..||+|.+.... ........+|+..++.+. ||||+++++++......+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC--CCCcceEEEEEecCCeEEEE
Confidence 467999999999999999999876 78999999987442 233456778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||++ ++|.+.+.. ....+++..++.++.|++.|+.+||++ |++|+||+|+||++++++.++|+|||++....
T Consensus 83 ~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 83 FEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred Eeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 99996 578877732 345688999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+.
T Consensus 156 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 156 IPTKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred CCCCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22211 1223467889999998754 478899999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=240.84 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=177.4
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||.|++|.||+|.+. ++..+++|.+..........+.+|+..++++. ||||+++++.+......+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC--CCChhceEEEEEeCCEEEEEE
Confidence 468999999999999999999876 68899999998665556678889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++.. ...++++..++.++.|++.++.+||++ +++|+||+|+||++++++.++|+|||.+.....
T Consensus 80 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 80 EYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred eCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999998832 236789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccC---CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 211 12234567889999999876 78899999999999999999999997655
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=240.35 Aligned_cols=204 Identities=25% Similarity=0.431 Sum_probs=177.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|++|.||+|... +|+.|++|.++.. .......+.+|+..++++. |++++++++.+......++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~--~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD--HPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999887 8999999988632 2233567888999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++.........+++..++.++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999999865444556789999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
...... .....++..|.|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 157 ~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 432211 22345778899999998888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=239.37 Aligned_cols=203 Identities=31% Similarity=0.487 Sum_probs=176.4
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|.+.+.||+|++|.||+|.+. ++..|++|.+... .......+.+|+..++.++ |||++++++.+......++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD--SSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC--CCCeehheeeeccCCEEEEEE
Confidence 5889999999999999999876 7899999998643 3344567888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++... ....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 79 EYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 999999999998542 245788999999999999999999999 999999999999999999999999999886543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .....++..|.|||++.+..++.++|+||||+++++|++|+.||...++
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 206 (256)
T cd08529 154 NTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206 (256)
T ss_pred ccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 3221 2234577889999999988899999999999999999999999986664
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=247.14 Aligned_cols=205 Identities=24% Similarity=0.401 Sum_probs=176.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||.|++|.||++.+. ++..+++|.+..........+.+|+..++++. |||++++++.+..+...+++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK--HPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEecCCeEEEEe
Confidence 457999999999999999999875 78999999998666666678889999999999 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++.. ....+++..++.++.|++.++.+||++ +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 82 EFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999832 345799999999999999999999999 999999999999999999999999998875432
Q ss_pred CCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
... ......++..|+|||.+. ...++.++|+||+|+++|+|++|+.||...+..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~ 214 (280)
T cd06611 156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214 (280)
T ss_pred ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH
Confidence 221 122345788899999875 334678999999999999999999999866543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=241.97 Aligned_cols=208 Identities=30% Similarity=0.476 Sum_probs=174.9
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+..++|++.+.||+|++|.||++...++..+++|.+... ......+.+|+..++.+. |++|+++++.+.. ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQ--HDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcC--CCCcceEEEEEcC-CCeEE
Confidence 4567899999999999999999998777788999987633 223457788999999998 9999999998877 77899
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++... ....++...+..++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||.+...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeec
Confidence 99999999999998432 234578889999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
............++..|+|||++....++.++|+||+|+++|++++ |+.||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 4322222222334567999999988888999999999999999999 99999865543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=240.14 Aligned_cols=203 Identities=25% Similarity=0.355 Sum_probs=174.7
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
+|++.+.||.|++|.||++.+. +++.+++|.+... .......+..|+..++.+. |||++++++.+..++..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK--HPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999876 7899999998643 2334456778888899888 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+++.. .....+++..++.++.|++.|+.+||++ |++|+||+|+||++++++.++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 79 YCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999988743 2345688999999999999999999999 9999999999999999999999999998755332
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.. ......++..|+|||++.+..++.++|+||+|+++|+|++|..||...+.
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 205 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205 (255)
T ss_pred cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH
Confidence 21 12234578889999999988899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=252.42 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=168.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC---
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--- 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--- 112 (272)
...++|++.+.||.|+||.||+|.+. ++..||+|.+.... ......+.+|+..++.+. ||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK--HENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC--CCchhhhhhhhcccccc
Confidence 45688999999999999999999865 78899999986432 223356778999999998 99999999877533
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...+++++++ +++|.+.+ ....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3468899987 78888876 345699999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|||++...... .....++..|+|||++.+ ..++.++|+||+||++|+|++|+.||...+
T Consensus 161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 161 DFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred CCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 99999865332 223467889999999877 468899999999999999999999997644
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=279.39 Aligned_cols=220 Identities=30% Similarity=0.388 Sum_probs=184.6
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.+.+++..++|+|++.||+|+||.|..++.+ +++.||+|++..- ......-++.|-..+.... .+=|+.+.-.|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n--s~Wiv~LhyAF 144 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN--SEWIVQLHYAF 144 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC--cHHHHHHHHHh
Confidence 4567788999999999999999999999876 7999999998631 2222333444444444444 78899999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
.+....|+|||||+||+|-+++ ....+++++.++.++..|.-||.-||+. |+||||+||+|||++..|+++|.
T Consensus 145 QD~~~LYlVMdY~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred cCccceEEEEecccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeec
Confidence 9999999999999999999999 3444899999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
|||.|-.+..+..-......|||.|++||++.. ..|++..|.||+|+++|+|+.|.+||-..+-.+.|..|..
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 999999887655555566789999999999863 3488999999999999999999999976666665555443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=242.48 Aligned_cols=207 Identities=30% Similarity=0.480 Sum_probs=173.5
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
.++|.+.+.||+|+||.||+|.+. +...|++|.+.... ......+.+|+..++.+. ||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD--HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC--CCCcceEeEEEecCCce
Confidence 467999999999999999999875 24579999886442 333457788999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+++|||+++++|.+++.. ....+++..++.++.|++.++.+||++ +|+|+||+|.||++++++.++|+|||++.
T Consensus 81 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 81 MIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence 999999999999999843 234789999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 196 LFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 196 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
........ ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~ 216 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence 76421111 1112234567999999998889999999999999999998 999997555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=244.11 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=175.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||.|++|.||+|.+. +++.|++|.+.... ......+.+|+..++.+. |+|++++++.+.++...++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--SPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC--CCCeeeeeEEEEECCeEEEEE
Confidence 47899999999999999999876 78999999987553 334456788999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++.. ..+++..++.++.|++.++.+||++ +++|+||+|+||++++++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 79 EYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999832 2789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...++
T Consensus 151 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~ 203 (274)
T cd06609 151 TMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203 (274)
T ss_pred ccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch
Confidence 322 12234577889999999988899999999999999999999999976553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=239.81 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=170.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-----cccHHHHHHHHHHhhcccccccceeEeeeeEecC--C
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--P 113 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~ 113 (272)
.+|++.+.||+|++|.||.+.+. +|..|++|.+.... ......+.+|+..++++. ||||+++++.+.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL--HERIVQYYGCLRDPMER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC--CCCeeeEEeEeccCCCc
Confidence 57999999999999999999876 68999999886432 122356778999999998 99999999987664 4
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+++++|.+++. ....+++..+..++.|++.+|.+||++ +++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred eEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcc
Confidence 6779999999999999883 345688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 194 SKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 194 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+........ .......++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 875432111 11222457788999999988889999999999999999999999997554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=249.19 Aligned_cols=206 Identities=28% Similarity=0.464 Sum_probs=170.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCc----EEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~----~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
...+|++.+.||+|+||.||+|.+. ++. .|++|.+.... ......+..|+..++.+. ||||+++++.+...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEcCC-
Confidence 4567999999999999999999864 343 48999986432 334567888999999998 99999999988765
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..+++++|+++++|.+++.. ....++...++.++.|++.||.|||++ ||+|+||||+||++++++.++|+|||+
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccc
Confidence 56799999999999999843 234588899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccc-cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 194 SKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
+.......... ......+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||+.....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 98664332211 112233567999999999899999999999999999998 99999865543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=258.86 Aligned_cols=200 Identities=29% Similarity=0.490 Sum_probs=172.3
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
|.+.-+...=++=||.|+.|.||+++.+ ++.||||.++. .-.-+++.++++. ||||+.+.++|.....++
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLk--H~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLK--HPNIITFKGVCTQSPCYC 188 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhcc--CcceeeEeeeecCCceeE
Confidence 3333333444577999999999999987 67799998641 1223578888888 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
||||||..|-|.+.+ ..+.++.......|..+|+.++.|||.+ .|+|||||.-||||..+..|||+|||-+..
T Consensus 189 IiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred EeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999999 5677888999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
...... .-.++||..|+|||++..++.++|+||||+||+||+|+||..||...++-.
T Consensus 262 ~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 262 LSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred hhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence 654322 223789999999999999999999999999999999999999997666543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=241.35 Aligned_cols=207 Identities=32% Similarity=0.479 Sum_probs=172.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+..++|++...||.|++|.||+|.+.++..+++|.+.... .....+.+|+..++.+. ||+++++++++. ....+++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLR--HDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCC--CCCeeeEEEEEc-CCCcEEE
Confidence 3456799999999999999999998877779999876433 33456788999999998 999999998875 4567899
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+++... ....+++..+..++.|++.||.+||+. |++|+||+|+||++++++.++|+|||.+....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 9999999999998432 234578999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
...........++..|+|||...+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 332222222345667999999988889999999999999999999 99999765543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=254.43 Aligned_cols=201 Identities=21% Similarity=0.262 Sum_probs=171.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC---CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
.....+|++.+.||.|++|.||++... .+..|++|.+... ....+|+..++.+. ||||+++++.+.....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~--h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTIS--HRAIINLIHAYRWKST 160 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcC--CCCccceeeeEeeCCE
Confidence 345668999999999999999999753 4678999987532 23457899999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++||++. ++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++
T Consensus 161 ~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred EEEEehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccc
Confidence 999999985 6777777 3456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
........ .......|+..|+|||++.+..++.++|+||+||++|+|++|+.||.....
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 76543322 122335689999999999998999999999999999999999999976543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=241.47 Aligned_cols=204 Identities=27% Similarity=0.468 Sum_probs=174.1
Q ss_pred CeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCc------ccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+|.+.+.||.|+||.||+|...+|+.+++|.+..... .....+.+|+..++.+. |+||+++++++......+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK--HVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC--CCCEeeEeeEeecCCeEE
Confidence 4888999999999999999888899999998864321 12245778899999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+++||+++++|.+++ ....++++..++.++.|++.++.+||+. +++|+||+|+||++++++.++|+|||.+..
T Consensus 79 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 79 IFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 999999999999998 3345688999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCC-----ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 197 FPENT-----THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 197 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 42211 111223457888999999998889999999999999999999999997655433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=242.92 Aligned_cols=202 Identities=25% Similarity=0.373 Sum_probs=172.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++.+.||.|++|.||+|.+. +|+.|++|.+.... ......+.+|+..++++. |||++++++.+..+...+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--HPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC--CCCEeeeeeEEeeCCEEEEE
Confidence 47999999999999999999877 68999999986442 223356778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.... .....+++..++.++.|++.++.+||++ |++|+||+|.||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 79 FEYCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EeccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecC
Confidence 9999998888776 3345689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.
T Consensus 152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 152 GPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred CCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 3221 1122346778999999876 4578899999999999999999999976554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=243.97 Aligned_cols=202 Identities=26% Similarity=0.448 Sum_probs=174.0
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.||+|.+. +|..|++|.+.... ......+.+|+..++++. ||||+++++.+..+...++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--HPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC--CCCCcceeeEEecCCeeEEEe
Confidence 5899999999999999999876 78999999987543 334567888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+ +++|.+++.. ....+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 79 EYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred ccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 999 9999998843 236789999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..........++..|+|||.+.+.. ++.++|+||+|+++++|++|.+||...+.
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 3322233356788899999987544 68999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=239.81 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=172.4
Q ss_pred eeeeeccceEEEEEE-eCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCC
Q 024118 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~ 126 (272)
..||+|+++.|-.+. ..+|..||||++.........+..+|++++.+.+. |+||+++++++.+++..|+|||.|.||+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqg-h~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQG-HKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcC-CccHHHHHHHhcccceEEEEEecccCch
Confidence 689999999998886 45899999999987777788899999999999987 9999999999999999999999999999
Q ss_pred HhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---eEEeecCcccccCC----
Q 024118 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLSKLFPE---- 199 (272)
Q Consensus 127 L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~---~~l~Dfg~~~~~~~---- 199 (272)
|...+ +.+..|++..+..++.+|+.||.+||.+ ||.|||+||+|||-.+... +||+||.+..-+..
T Consensus 163 lLshI----~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHI----QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHH----HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99998 6778899999999999999999999999 9999999999999976655 79999998875421
Q ss_pred --CCccccccccccccccCccccc---cC--CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 --NTTHISTRVAGTLGYLAPEYAI---SG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 --~~~~~~~~~~~~~~~~aPE~~~---~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.........+|+..|+|||+.. +. .|+.+.|+||||+++|-|++|++||.+..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 1222344467889999999753 33 38999999999999999999999997544
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=246.12 Aligned_cols=211 Identities=30% Similarity=0.518 Sum_probs=174.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCC-C-----cEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQD-G-----TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~-~-----~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.++|++.+.||+|++|.||+|.... + ..|++|.+.... ......+.+|+..+..+. ||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ--HPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC--CcccceEEEEEcCCC
Confidence 4579999999999999999997642 2 579999886432 233456788999999998 999999999999888
Q ss_pred ceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
..++++||+++++|.+++..... ....+++..++.++.|++.|+.+||++ +++|+||+|+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 99999999999999999854311 114688899999999999999999999 999999999999999
Q ss_pred CCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 182 QNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 182 ~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
+++.++|+|||++....... ........++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999987543221 112223445778999999988889999999999999999998 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=240.66 Aligned_cols=200 Identities=29% Similarity=0.413 Sum_probs=176.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+|++.+.||.|++|.||+|.+. ++..|++|.+.... ......+.+|++.++++. ||||+++++.+......+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN--HPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC--CCChHHHHHhhcCCCeEEEE
Confidence 5899999999999999999876 69999999987432 234567888999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+.+. ...++++..+..++.|+++++.+||++ +++|+||+|.||++++++.++|+|||.+....
T Consensus 79 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 79 VDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EeCCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 99999999999983 336889999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus 152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 152 PDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 332 12334577889999999888899999999999999999999999997764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=242.50 Aligned_cols=205 Identities=27% Similarity=0.421 Sum_probs=176.2
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+|++.+.||.|++|.||++.+. ++..+++|.+... .......+.+|+..++.+. ||||+++++.+..++..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc--CCchhhhhheeEeCCeEEE
Confidence 47899999999999999999865 8999999987643 2223457788999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
++||+++++|.+++.........+++..++.++.|++.++.+||++ |++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999998865444456789999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...... .....++..|+|||++.+..++.++|+||+|+++|+|++|..||....
T Consensus 157 ~~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 157 SSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 433221 223457888999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=237.65 Aligned_cols=204 Identities=24% Similarity=0.413 Sum_probs=176.7
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.+|.++.. +++.+++|.+... .......+.+|+..++++. |+||+++++++.+....++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ--HPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC--CCCeeEEEeEEecCCeEEEEE
Confidence 5999999999999999999865 7899999998754 2344567888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+.+... ....+++..+..++.|++.++.+||+. |++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 79 EYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 999999999998432 245689999999999999999999999 999999999999999999999999999886543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
... ......++..|.|||.+.+..++.++|+||+|+++++|++|..||...+..
T Consensus 154 ~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~ 207 (256)
T cd08221 154 EYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207 (256)
T ss_pred ccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 332 223355788999999998888899999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=242.20 Aligned_cols=202 Identities=25% Similarity=0.406 Sum_probs=172.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 121 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~ 121 (272)
-|++.+.||.|++|.||++.+. ++..+++|.+..........+.+|++.++.+. |||++++++.+..+...++++||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC--CCCeeeEEEEEeeCCEEEEEEEe
Confidence 3788999999999999999876 68889999986555555667888999999998 99999999999999999999999
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
+++++|...+.. ...++++..++.++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 84 CAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred cCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999988732 345789999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 202 THISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 202 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
. ......++..|+|||++. +..++.++|+||+||++|+|++|++||...+.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 158 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred c-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 1 122345788899999984 34477899999999999999999999986654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=253.30 Aligned_cols=214 Identities=27% Similarity=0.400 Sum_probs=175.0
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
..+....++|++.+.||.|+||.||+|.+. .+..||+|.+.... ......+.+|+..++++.. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~-HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGP-HLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCCeeeEEE
Confidence 355667889999999999999999999753 23579999986432 2234578889999998843 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhccc---------------------------------------------------
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK--------------------------------------------------- 136 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------------------------------------------------- 136 (272)
.+......++||||+++++|.+++.....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999988854211
Q ss_pred -----------------------------------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 137 -----------------------------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 137 -----------------------------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
....+++..+..++.|++.|+.|||+. +++|+||+|
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence 012477888999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
.||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 9999999999999999998755322211 1122345678999999998889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=243.51 Aligned_cols=212 Identities=27% Similarity=0.425 Sum_probs=172.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
.+..++|++.+.||+|++|.||+|.+. ++..|++|.+.... ......+.+|+..++.+. ||||+++++.+.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEc
Confidence 346788999999999999999998753 35679999875332 223446778899999988 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccc------cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKR------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
.....+++|||+++++|.+++...... ...++...+..++.|++.|+.+||++ +++|+||+|+||++++++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCC
Confidence 999999999999999999998542211 23467788999999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 185 NPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.+
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~ 228 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999998754322211 1112234677999999998889999999999999999999 78999765543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=244.01 Aligned_cols=208 Identities=31% Similarity=0.517 Sum_probs=174.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..+|.+.+.||+|++|.||+|... ++..+++|.+..........+.+|+..++++. ||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCc
Confidence 457999999999999999999742 35568888886555555567888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcc------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 024118 115 RILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 182 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~ 182 (272)
.+++|||+++++|.+++.... .....+++..++.++.|++.|+.+||++ |++|+||+|.||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 999999999999999985432 1234588999999999999999999999 9999999999999999
Q ss_pred CCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 183 NFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 183 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
++.++|+|||++........ .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999875433221 11223445678999999998889999999999999999999 9999966554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.19 Aligned_cols=215 Identities=25% Similarity=0.370 Sum_probs=185.7
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..-|.+.+.||+|-|+.|-+|++- +|..||||++... +......+.+|++.++-++ |||||++|++...+...|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ--HpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ--HPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc--CcCeeeeeehhcccceEEE
Confidence 345899999999999999999877 8999999999643 2233457889999999999 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-cCCCCeEEeecCcccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKL 196 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv-~~~~~~~l~Dfg~~~~ 196 (272)
|.|.=++|+|.+++. .....++|+.+..++.||+.|+.|+|.. .++||||||+|+.+ ...|-|||.|||.+..
T Consensus 95 iLELGD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEecCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999999994 4567799999999999999999999999 99999999999765 6778899999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCC-CCCceehHHHHHHHHHhCCCccccccCCCceehhhhhhc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 265 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 265 (272)
+.+ .......+|+..|.|||.+.+..|+ ++.||||||+|+|.|.+|++||.--+.-+.+..|...++
T Consensus 169 f~P--G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 169 FQP--GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred CCC--cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc
Confidence 653 3345668999999999999999986 799999999999999999999987666665555544433
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=245.66 Aligned_cols=207 Identities=28% Similarity=0.346 Sum_probs=175.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc---cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|++|.||+|... +++.|++|.+...... ....+..|++.+..+. ||+|+++++.+......++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC--CCCchhheeeeecCCEEEE
Confidence 47999999999999999999876 5999999998754322 3456788999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+.+++|.+++.. .....+++..++.++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 79 VMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 9999999999998842 2345789999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCcc----------------------------ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 198 PENTTH----------------------------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 198 ~~~~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
...... ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 321110 0112356788999999998889999999999999999999999997
Q ss_pred cccCCC
Q 024118 250 FDVQLG 255 (272)
Q Consensus 250 ~~~~~~ 255 (272)
..+...
T Consensus 234 ~~~~~~ 239 (316)
T cd05574 234 GSNRDE 239 (316)
T ss_pred CCchHH
Confidence 665443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=238.97 Aligned_cols=202 Identities=32% Similarity=0.526 Sum_probs=171.9
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc---------cHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---------GEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~---------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
+|.+.+.||.|++|.||+|.+. ++..+++|.+...... ....+.+|+..++.+. ||||+++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ--HENIVQYLGSSLDA 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC
Confidence 5888999999999999999875 6889999988643221 1246778899999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++++||+++++|.+++ .....+++..+..++.|++.|+.+||++ |++|+||+|+||++++++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred CccEEEEEecCCCCHHHHH----HhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence 9999999999999999998 3346788999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc-----cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 193 LSKLFPENTT-----HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 193 ~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.+........ .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 9886642111 111123467889999999888889999999999999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=250.31 Aligned_cols=212 Identities=27% Similarity=0.425 Sum_probs=171.2
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
|.+..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+..+.++.. |+||+++++.+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~-h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH-HLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhcc-CcchhheeeeE
Confidence 3455678999999999999999999632 35789999986432 2234567788999888832 99999999987
Q ss_pred ecC-CceeEEEeecCCCCHhHHHhhccc----------------------------------------------------
Q 024118 110 IDG-PCRILVYDYMPNNSLSQTLLGEEK---------------------------------------------------- 136 (272)
Q Consensus 110 ~~~-~~~~iv~e~~~~~~L~~~~~~~~~---------------------------------------------------- 136 (272)
... ...++++||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 644 567899999999999998854221
Q ss_pred -----ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccc-cccccc
Q 024118 137 -----RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAG 210 (272)
Q Consensus 137 -----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~ 210 (272)
...++++..+..++.|++.||.|||++ ||+|+||||.||++++++.++|+|||++.......... .....+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 123688999999999999999999999 99999999999999999999999999998653322211 122334
Q ss_pred cccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 211 ~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
+..|+|||++.+..++.++|+|||||++|+|++ |..||....
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 567999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=238.04 Aligned_cols=214 Identities=22% Similarity=0.311 Sum_probs=174.0
Q ss_pred cccccccCCChhHHHHhhCCeeee-eeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccc
Q 024118 24 QILKNINAFSYNQLKIATNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~ 101 (272)
+.++.-....+ .-....++|.+. +.||-|-.|.|..+.++ +|+++|+|++. +....++|++..-.... |||
T Consensus 44 ~~~~~~~~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~-h~~ 116 (400)
T KOG0604|consen 44 PPMSEESDMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASG-HPH 116 (400)
T ss_pred CCcchhhhcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcC-CCc
Confidence 33344444444 334567788887 78999999999999876 89999999985 23456677776655554 999
Q ss_pred eeEeeeeEec----CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 024118 102 LVKLHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 177 (272)
Q Consensus 102 i~~l~~~~~~----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~n 177 (272)
||.+++++.+ .....+|||+++||.|.+.+.. .....|+|.++..|..||..|+.|||+. +|.|||+||+|
T Consensus 117 iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpEN 191 (400)
T KOG0604|consen 117 IVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPEN 191 (400)
T ss_pred eEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhh
Confidence 9999998764 3567799999999999999843 3445699999999999999999999999 99999999999
Q ss_pred EEEcC---CCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 178 ILLDQ---NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 178 ilv~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
+|... +..+||+|||.+...... ......+-|+.|+|||++..+.|+...|+||+||++|-|+.|.+||=..
T Consensus 192 LLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 192 LLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred eeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 99964 344899999999865432 2244567899999999999999999999999999999999999999433
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=243.45 Aligned_cols=204 Identities=23% Similarity=0.331 Sum_probs=171.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||.|++|.||++.+. +++.|++|.+.... ......+.+|+..++.+. ||||+++++.+..+...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--NPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEEecCCEEEE
Confidence 47999999999999999999876 68899999886442 223346778888999888 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||++|++|.+++ .....+++..++.++.|++.|+.+||++ +++|+||+|.||+++.++.++|+|||++...
T Consensus 79 v~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 79 VMEYVEGGDCATLL----KNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 99999999999998 3345789999999999999999999999 9999999999999999999999999987632
Q ss_pred CCCC--------------ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENT--------------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~--------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.... ........++..|.|||.+.+..++.++|+||+|+++|+|++|..||...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1000 00011234677899999998888999999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=240.83 Aligned_cols=203 Identities=28% Similarity=0.461 Sum_probs=170.2
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.||+|... ++..|++|.+.... ......+.+|+..++.+. |||++++++.+..+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ--HPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC--CCCEeeeEEEEeeCCeEEEEE
Confidence 5899999999999999999876 79999999986442 223456788999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||++ ++|.+++.... ....+++..++.++.|++.||.+||++ +++|+||+|+||++++++.++|+|||++.....
T Consensus 79 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 79 EFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred ecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 9997 57887774322 235689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... ......++..|+|||.+.+. .++.++|+||+|+++++|++|++||...++
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 154 PVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred Ccc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 221 12223457889999988754 478899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=241.95 Aligned_cols=214 Identities=25% Similarity=0.354 Sum_probs=175.0
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe--
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-- 110 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~-- 110 (272)
++.+....++|++.+.||+|++|.||+|.+. ++..+++|++... ......+.+|+..++.+.. |||++++++.+.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSD-HPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhc-CCCeeeeeeeeeec
Confidence 4455567889999999999999999999876 6889999987632 2233466778888888732 999999999874
Q ss_pred ---cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 111 ---DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 111 ---~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
.+...+++|||+++++|.+++.........+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998754434456788999999999999999999999 999999999999999999999
Q ss_pred EeecCcccccCCCCccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|+|||++........ ......++..|+|||++.. ..++.++|+||+||++|+|++|+.||...+.
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 999999876543221 1223457889999998853 4478899999999999999999999976544
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=237.16 Aligned_cols=202 Identities=29% Similarity=0.457 Sum_probs=177.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||.|++|.||+|.+. +++.|++|.+..... .....+..|+..+..+. |++++++++.+......++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEccCCeEEEEE
Confidence 46899999999999999999877 699999999875543 44567888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||+++++|.+++. ...++++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 79 EYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999983 33778999999999999999999999 8 99999999999999999999999999998664
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... .....++..|.|||.+.+..++.++|+||||+++|+|++|+.||...++
T Consensus 152 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 205 (264)
T cd06623 152 NTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ 205 (264)
T ss_pred cCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 33222 1234567889999999888899999999999999999999999987753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=242.04 Aligned_cols=213 Identities=25% Similarity=0.408 Sum_probs=175.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
++..++|++.+.||+|++|.||++... ++..|++|.+.... ......+.+|+..++.+. ||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN--CHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEc
Confidence 355678999999999999999999754 24689999976432 233456778899999988 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccc------cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKR------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
.....+++|||+++++|.+++...... ...+++..++.++.|++.||.+||+. +++|+||+|.||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 999999999999999999998543221 23478889999999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 185 NPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.++|+|||++........ .......++..|.|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 229 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence 999999999875533221 11222345678999999988889999999999999999998 999997665444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=239.36 Aligned_cols=202 Identities=26% Similarity=0.471 Sum_probs=172.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc------ccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
+|+..+.||+|++|.||++... +++.+++|.+..... .....+.+|+..++.++ |+|++++++.+.+.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN--HPHIIRMLGATCEDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC--CCceehhhceeccCCeE
Confidence 5888999999999999999864 789999999874321 13457888999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEEeecCcc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLS 194 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~~ 194 (272)
++++||+++++|.+++. ...++++..++.++.|++.|+.+||++ |++|+||+|.||+++.++ .++|+|||.+
T Consensus 79 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 79 NLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred EEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 99999999999999983 345789999999999999999999999 999999999999998776 5899999998
Q ss_pred cccCCCCcc---ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTH---ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
......... ......++..|.|||.+.+..++.++|+||+|+++++|++|+.||...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 766433111 11224567889999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=235.57 Aligned_cols=203 Identities=23% Similarity=0.402 Sum_probs=172.0
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEec-CCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~-~~~~~iv 118 (272)
+|++.+.||.|++|.||++.+. +++.+++|.+.... ......+.+|++.+++++ |++++++++.+.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK--HPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC--CCCeeeeeeeecCCCCEEEEE
Confidence 5899999999999999999876 68899999986442 233456788899999998 9999999988764 4467899
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+.+... ....+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 79 MGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred ecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 9999999999988432 334689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... ......+++.|+|||++.+..++.++|+||+|+++++|++|+.||...+.
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 207 (257)
T cd08223 154 NQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 207 (257)
T ss_pred ccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 3222 22334578889999999998899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.09 Aligned_cols=217 Identities=25% Similarity=0.407 Sum_probs=177.3
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
..+.+..++|++.+.||+|++|.||++.+. ....+++|...... ......+.+|+..++.+.. |+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcC-CCCeeeEEE
Confidence 356677788999999999999999999754 23679999886432 2334567788888888822 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhcc------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
++..+...+++|||+++++|..++.... .....+++..++.++.|++.|+.+||+. +|+|+||+|
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 9999999999999999999999985421 2345688999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
.||++++++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||+||++|+|++ |..||...+.
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999999999865432211 1111234567999999988889999999999999999997 9999976554
Q ss_pred CC
Q 024118 254 LG 255 (272)
Q Consensus 254 ~~ 255 (272)
.+
T Consensus 241 ~~ 242 (293)
T cd05053 241 EE 242 (293)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=241.42 Aligned_cols=204 Identities=25% Similarity=0.410 Sum_probs=176.7
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|.+.+.||+|++|.||++... ++..|++|.+..........+.+|+..++.+. |||++++++.+......++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK--HPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC--CCCeeehhheeeeCCcEEEEE
Confidence 478999999999999999999865 78899999987555455567888999999988 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++. ...+++..+..++.|++.++.+||++ |++|+|++|+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 96 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred ecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999983 34578899999999999999999999 999999999999999999999999998875543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
... ......++..|++||.+.+..++.++|+||+|+++|+|++|+.||...+...
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 222 1222457788999999988888999999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=238.82 Aligned_cols=199 Identities=29% Similarity=0.443 Sum_probs=166.0
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
+.||+|++|.||+|.+. ++..+++|.+... .......+.+|++.++.+. ||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999876 7899999987533 2334467888999999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 205 (272)
+|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|.||+++.++.++|+|||++...........
T Consensus 79 ~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 79 DFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99999832 234688999999999999999999999 999999999999999999999999999875432211111
Q ss_pred -ccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 206 -TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 206 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~ 203 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence 11122456999999988889999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=241.48 Aligned_cols=208 Identities=28% Similarity=0.474 Sum_probs=172.0
Q ss_pred hCCeeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
.++|++.+.||+|+||.||+|.+ .++..+++|.+.... ......+.+|+..++.+. ||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH--HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCCc
Confidence 36799999999999999999974 246789999986432 233356788999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhccc-------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEK-------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
.+++|||+++++|.+++..... ....+++..+..++.|++.|+.|||++ |++|+||+|+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 9999999999999999843211 123578899999999999999999999 999999999999999
Q ss_pred CCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 182 QNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 182 ~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+++.++|+|||++....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999997653221 111222334567999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=240.13 Aligned_cols=208 Identities=29% Similarity=0.476 Sum_probs=172.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-C---CcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-D---GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~---~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..++|++.+.||.|+||.||+|.+. + +..+++|.+.... ......+..|+..++++. ||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCc
Confidence 3568999999999999999999764 2 3478999876432 233457888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||+++++|.+++.. ....+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 9999999999999999843 234688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccc--cccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 195 KLFPENTTHIST--RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
............ ...++..|+|||.+.+..++.++|+||+|+++|++++ |..||...+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~ 217 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH
Confidence 866433221111 1122457999999998889999999999999999886 999997665443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=240.87 Aligned_cols=202 Identities=27% Similarity=0.417 Sum_probs=173.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++.+.||+|++|.||+|.+. +++.|++|.+... .......+.+|++.++.+. |+||+++++.+..++..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR--HENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC--CCCeeehhheEEECCEEEEE
Confidence 47999999999999999999877 6889999988643 2233467889999999999 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||++++.+..+. .....+++..++.++.|++.++.+||+. +++|+|++|+||++++++.++|+|||.+....
T Consensus 79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 79 FEYVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 9999887776655 3345689999999999999999999999 99999999999999999999999999988665
Q ss_pred CCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...........++..|+|||++.+. .++.++|+||+|+++|+|++|++||...+
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4332223335567889999999888 78899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=236.47 Aligned_cols=204 Identities=30% Similarity=0.517 Sum_probs=173.0
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
..+|++.+.||.|++|.||++.+..+..+++|.+.... .....+.+|++.++++. ||+++++++.+......++++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLS--HPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCC--CCCeeeEEEEEccCCceEEEEE
Confidence 46799999999999999999988778889999876332 23457888999999998 9999999999999899999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+++.. ....++++.++.++.|++.++.+||+. +++|+||+|.||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 80 FMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred cCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999998832 234688999999999999999999999 9999999999999999999999999998755432
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
.........++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||+..+.
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 2211122234567999999988889999999999999999998 9999975543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=236.33 Aligned_cols=203 Identities=27% Similarity=0.392 Sum_probs=171.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-----CcccHHHHHHHHHHhhcccccccceeEeeeeEecC--C
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--P 113 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~ 113 (272)
.+|++.+.||+|++|.||+|.+. ++..|++|.+... .......+.+|++.++++. |++|+++++.+... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR--HDRIVQYYGCLRDPEEK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC--CCCcceEEEEEEcCCCC
Confidence 57999999999999999999876 6899999987532 1223357778999999998 99999999988654 4
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+++++|.+++. ....+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred EEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccc
Confidence 5789999999999999983 345688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC--ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENT--THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+....... ........++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence 97653211 1111234578889999999988889999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=239.80 Aligned_cols=202 Identities=26% Similarity=0.463 Sum_probs=169.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.++|++.+.||.|++|.||+|..+ +++.|++|.+.... ......+.+|+..++.+. ||||+++++++..+...++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK--HANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC--CcceeeEEEEEecCCeEEEE
Confidence 367999999999999999999876 78999999987442 222345678999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++ +|.+++.. ....+++..++.++.|+++||.+||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 82 FEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred EecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 999975 88888732 234688999999999999999999999 99999999999999999999999999987542
Q ss_pred CCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
..... .....++..|.|||.+.+ ..++.++|+||+|+++|+|++|+.||...+
T Consensus 155 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 155 VPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred CCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 21111 122345778999999875 457889999999999999999999996554
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=237.02 Aligned_cols=199 Identities=30% Similarity=0.454 Sum_probs=166.9
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCC
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~ 126 (272)
+.||+|++|.||++...++..+++|.+.... ......+.+|+..++.+. ||||+++++.+......+++|||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD--HPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 3689999999999998888999999886443 223446788999999988 9999999999999999999999999999
Q ss_pred HhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccc
Q 024118 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206 (272)
Q Consensus 127 L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~ 206 (272)
|.+++.. ....+++..++.++.|++.++.+||++ |++|+||+|+||++++++.++|+|||++............
T Consensus 79 L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 79 FLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9998832 234578999999999999999999999 9999999999999999999999999998754322221111
Q ss_pred cccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 207 RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 207 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
...++..|+|||++.+..++.++|+||+|+++|++++ |..||...+..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 1233567999999988888999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=242.21 Aligned_cols=205 Identities=26% Similarity=0.427 Sum_probs=172.0
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||+|++|.||++.+. ++..|++|.+... .......+.+|+..++++. ||||+++++.+......++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV--SPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC--CCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999877 7899999988754 2233457888999999988 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||+++++|..++... .....+++..+..++.|++.++.+||+ . +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 79 EYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred eecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999999887432 123478999999999999999999996 5 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccCccccccCC------CCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
... .....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...+...
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 155 ASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred CCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 221 22245677899999985443 4789999999999999999999997654433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=240.58 Aligned_cols=208 Identities=30% Similarity=0.481 Sum_probs=170.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCc----EEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~----~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
+..++|++.+.||+|++|.||+|.+. +|. .||+|..... .......+.+|+..+..+. ||||+++++.+...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG--SPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC--CCCCceEEEEEcCC
Confidence 34578999999999999999999854 454 4899988644 2334456778888888888 99999999988754
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
..+++++|+++++|.+.+.. ....+++..++.++.|++.|+.+||++ +++|+||+|+||++++++.++|+|||
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCC
Confidence 56789999999999999843 235689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccc-cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 193 LSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 193 ~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
++.......... .....++..|+|||...+..++.++|+|||||++|+|++ |..||+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 998664322211 111234567999999988889999999999999999998 999998655433
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=239.50 Aligned_cols=213 Identities=26% Similarity=0.365 Sum_probs=173.6
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC-
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG- 112 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~- 112 (272)
..+....++|++.+.||+|++|.||+|... +++.+++|++.... .....+.+|+..++++.. |||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~-h~ni~~~~~~~~~~~ 92 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPN-HPNVVKFYGMFYKAD 92 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcC-CCCeEEEEEEEEecc
Confidence 344445788999999999999999999875 78899999986332 234566678888887732 99999999988753
Q ss_pred ----CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 113 ----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 113 ----~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
...++++||+++++|.+++.........+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEE
Confidence 357899999999999998854444556789999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccC-----CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+|||++......... .....++..|+|||.+... .++.++|+||+||++|+|++|+.||...++
T Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 170 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred eecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999998765432211 1224577889999987543 367899999999999999999999976554
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=239.08 Aligned_cols=206 Identities=29% Similarity=0.522 Sum_probs=170.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CC---cEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DG---TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~---~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
.++|++.+.||+|++|.||+|... ++ ..|++|.+... .......+..|+..++.+. ||||+++++.+..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CcCcceEEEEECCCCce
Confidence 456999999999999999999865 33 36999998644 3334567888999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++++||+++++|.+++.. ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 81 MIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence 999999999999999843 235688999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCccc--ccccc--ccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 196 LFPENTTHI--STRVA--GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 196 ~~~~~~~~~--~~~~~--~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
......... ..... .+..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 553322111 11111 1346999999998889999999999999999886 99999765543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=236.41 Aligned_cols=203 Identities=28% Similarity=0.463 Sum_probs=176.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||.|++|.||++.+. ++..+++|.+..... ...+.+|+..++.+. |||++++++.+......++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCD--SPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCC--CCcEeeeeeeeecCCcEEEEE
Confidence 467999999999999999999987 588999999874432 568889999999997 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++. .....+++..++.++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||++.....
T Consensus 78 e~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 78 EYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred ecCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999999983 2346789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
... ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...++.
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 321 122244678899999998888999999999999999999999999865543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=244.62 Aligned_cols=214 Identities=26% Similarity=0.414 Sum_probs=172.9
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
+.+..++|.+.+.||+|+||.||+|.+. ++..+|+|.+.... ......+..|+..++.+.. ||||+++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~ 91 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HKNIINLLG 91 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcC-CCCEeeEEE
Confidence 3445578999999999999999999753 23579999987442 2334567788888888833 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
++......++++||+++++|.+++..... ....++...++.++.|++.||.+||++ |++|+||+|
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 99999999999999999999999954321 123588899999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999998754321111 1111223467999999988889999999999999999998 8899976554
Q ss_pred C
Q 024118 254 L 254 (272)
Q Consensus 254 ~ 254 (272)
.
T Consensus 249 ~ 249 (307)
T cd05098 249 E 249 (307)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=236.29 Aligned_cols=203 Identities=28% Similarity=0.404 Sum_probs=170.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-----cccHHHHHHHHHHhhcccccccceeEeeeeEec--CC
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GP 113 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~~ 113 (272)
.+|++.+.||+|++|.||+|.+. ++..|++|.+.... ......+.+|+..+++++ ||||+++++.+.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ--HERIVQYYGCLRDRAEK 79 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC--CCCeeeEEEEEEcCCCC
Confidence 46999999999999999999876 68999999886432 123346778999999998 9999999998765 35
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+++++|.+.+. ....+++..++.++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCC
Confidence 6789999999999999983 345688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+........ .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~ 214 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch
Confidence 875532111 111224467889999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=235.26 Aligned_cols=200 Identities=32% Similarity=0.503 Sum_probs=174.3
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc--cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||+|++|.||++... ++..|++|.+...... ....+..|+..++.+. |++|+++++........++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK--HPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC--CCChhheeeeEecCCEEEEEE
Confidence 6899999999999999999865 7899999998755442 5677888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++. ....+++..++.++.|++.++.+||+. |++|+||+|+||++++++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 79 EYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred ecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 9999999999983 345588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccc---ccccccccccCccccccCC---CCCCCceehHHHHHHHHHhCCCccccc
Q 024118 200 NTTHIS---TRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 200 ~~~~~~---~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
...... ....++..|+|||++.+.. .+.++|+||+|+++++|++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 332221 1345678899999998766 788999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=242.10 Aligned_cols=211 Identities=28% Similarity=0.484 Sum_probs=175.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
+...+|++.+.||+|+||.||++... ++..+++|.+..........+.+|++.++.+. |+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC--CCCCceEEEEEecC
Confidence 35678999999999999999999632 46688999876555555667889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhccc-----------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEK-----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
...++++||+++++|.+++..... ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 999999999999999999854321 113578999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 182 QNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 182 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
+++.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...++.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 231 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence 999999999999875432211 11122234577999999998889999999999999999998 99999655543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=250.94 Aligned_cols=206 Identities=30% Similarity=0.434 Sum_probs=183.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
.-...|.+.+.||.|.|+.|.++++. ++..||+|.+... .........+|++.++.+. ||||++++.+.......
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~--HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN--HPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC--Ccceeeeeeeeeeccee
Confidence 34567999999999999999999876 7999999998633 3333345889999999999 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||..++.+.+++ .......+..+...+.|+.+|++|||++ +|+|||||..|++++.+.+++|+|||.+.
T Consensus 131 ylV~eya~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred EEEEEeccCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccce
Confidence 9999999999999999 5666777899999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.+. ........+|++.|+|||++.+..+ .+.+|+||+|+++|.|+.|..||++.+-.+
T Consensus 204 ~~~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 204 FFD--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred eec--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 775 3444667899999999999999886 589999999999999999999999777544
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=242.77 Aligned_cols=209 Identities=30% Similarity=0.465 Sum_probs=169.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCc--EEEEEEEEec-CcccHHHHHHHHHHhhcc-cccccceeEeeeeEecCCc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT--IVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~--~v~vK~~~~~-~~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~~~~~~~~ 114 (272)
..++|++.+.||+|+||.||+|.++ ++. .+++|.+... .......+.+|+..+.++ . ||||+++++++..+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~--h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcC--CCCcceEEEEECCCCC
Confidence 3567999999999999999999875 454 3566665432 223345677899998888 5 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 024118 115 RILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 182 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~ 182 (272)
.++++||+++++|.+++..... ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence 9999999999999999854321 123588999999999999999999999 9999999999999999
Q ss_pred CCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 183 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 183 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
++.++|+|||++........ ......+..|+|||.+.+..++.++|+||+|+++|+|+| |.+||...+..+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 99999999999863221111 111223557999999988888999999999999999998 999997655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=239.17 Aligned_cols=208 Identities=27% Similarity=0.370 Sum_probs=171.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCC----CcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+..++|.+.+.||.|++|.||+|.+.+ ...|++|...... ......+.+|+..++.+. ||||+++++++.. .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD--HPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCchhceeEEEcC-C
Confidence 345679999999999999999997643 3468999886544 344567888999999998 9999999998775 4
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..+++|||+++++|.+++.. ....+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCce
Confidence 56799999999999999843 234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
+...............++..|+|||.+....++.++|+||||+++++|++ |..||...+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 216 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 87654332222222233457999999988889999999999999999986 999998766544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=235.09 Aligned_cols=199 Identities=30% Similarity=0.468 Sum_probs=173.2
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-----cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+|+..+.||.|++|.||+|... ++..|++|.+.... ......+.+|+..++.+. |++++++++.+......+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ--HPNIVQYLGTEREEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC--CCCchheeeeEecCCeEE
Confidence 5888899999999999999877 79999999987543 224467888999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+++||+++++|.+++. ....+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+..
T Consensus 79 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 79 IFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999999999999983 345688999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
..... ......++..|++||.+.... ++.++|+||+|+++|+|++|+.||...+
T Consensus 152 ~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 152 VVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 54322 123355788899999988776 8899999999999999999999997655
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=237.04 Aligned_cols=202 Identities=32% Similarity=0.512 Sum_probs=174.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
..++|++.+.||.|++|.||+|... |+.|++|.+..... ...++.+|+..++.+. |+|++++++.+......+++|
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLR--HPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcC--CcceeeeEEEEcCCCCeEEEE
Confidence 4678999999999999999999875 78899999875543 4567889999999998 999999999999889999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++... ....+++..++.++.|++.++.+||++ |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 80 EYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999998432 223689999999999999999999999 999999999999999999999999999986532
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
... ....+..|.|||.+.+..++.++|+||+|+++++|++ |..||...+..
T Consensus 155 ~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 155 GQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred ccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 211 2234567999999988888999999999999999997 99999766543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=236.49 Aligned_cols=202 Identities=35% Similarity=0.541 Sum_probs=172.5
Q ss_pred eeeeeccceEEEEEEeCC----CcEEEEEEEEecCccc-HHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~----~~~v~vK~~~~~~~~~-~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||.|+||.||+|.+.. +..+++|.+....... ...+.+|+..+..+. |++++++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC--CCChheeeeeecCCCceEEEEEec
Confidence 468999999999998763 8889999987554332 567888999999998 999999999999999999999999
Q ss_pred CCCCHhHHHhhcccc-----cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 123 PNNSLSQTLLGEEKR-----RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
++++|.+++...... ...+++..++.++.|++.|+.+||++ +++|+||+|+||++++++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 999999998543211 47799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 198 PENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
..... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 214 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE 214 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 53321 12233456788999999988889999999999999999999 69999876543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=235.12 Aligned_cols=207 Identities=27% Similarity=0.421 Sum_probs=176.0
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||.|++|+||+|... ++..+++|++.... ......+.+|+..++.+. |++++++++.+..+...++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN--HPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC--CCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999865 68899999986432 234567888999999988 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|++++++|.+.+.... ....+++..++.++.|++.|+.+||++ |++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 79 PYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred eccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999984321 124689999999999999999999999 999999999999999999999999999886643
Q ss_pred CCcc---ccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 200 NTTH---ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.... ......++..|+|||.+... ..+.++|+||+|+++++|++|+.||...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 3222 12334578889999998776 6889999999999999999999999765543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=233.69 Aligned_cols=205 Identities=27% Similarity=0.409 Sum_probs=177.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC----c----ccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES----K----QGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~----~----~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
-.-++|.-.+.||.|..+.|-++.++ +|..+++|++.... . ....+-.+|+.+++++.. ||+|+++.+++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~G-HP~II~l~D~y 92 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMG-HPYIIDLQDVY 92 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcC-CCcEEEeeeec
Confidence 44567888899999999999888766 78889999886321 1 123466778999999987 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
..+...++|+|.|+.|.|.+++ .....++++..+.|.+|+.+++.|||.+ +|+||||||+|||++++.+++|.
T Consensus 93 es~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence 9999999999999999999999 5667899999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCcccccc------CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|||.++.++... .....|||++|+|||.+.. ..|+...|+|+.|+++|.|+.|-+||=...|
T Consensus 166 DFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 166 DFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred ccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 999999876543 3455899999999998853 3478899999999999999999999955444
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=241.57 Aligned_cols=213 Identities=26% Similarity=0.419 Sum_probs=172.3
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
.+..++|++.+.||+|++|.||+|..+ .+..|++|.+.... ......+.+|+..++.+. ||||+++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT--CHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEc
Confidence 456789999999999999999998643 24579999875332 223346778888999988 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhccc------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
.....+++|||+++++|.+++..... ....++...+..++.|++.|+.+||++ +++|+||+|+||+++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~ 156 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF 156 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence 99999999999999999999954321 123456778899999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 185 NPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.++|+|||++........ .......++..|+|||.+.+..++.++|+||+||++|+|++ |..||...+.++
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~ 229 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999875432211 11111234567999999988889999999999999999998 788997655443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=242.95 Aligned_cols=198 Identities=24% Similarity=0.406 Sum_probs=159.5
Q ss_pred eeeeeeccceEEEEEEeC---CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec--CCceeEEEee
Q 024118 47 SNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDY 121 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~~~~~iv~e~ 121 (272)
.+.||+|+||.||+|... ++..||+|.+... .......+|+..++++. ||||+++++.+.. +...++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELK--HPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcC--CCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 5678999988533 23345778999999998 9999999998854 4567899999
Q ss_pred cCCCCHhHHHhhcc-----cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCCeEEeecC
Q 024118 122 MPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFG 192 (272)
Q Consensus 122 ~~~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv----~~~~~~~l~Dfg 192 (272)
+. ++|.+++.... .....+++..++.++.|++.||.|||++ ||+|+||||+||++ +..+.++|+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 57877764321 1223589999999999999999999999 99999999999999 456789999999
Q ss_pred cccccCCCCc--cccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 193 LSKLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
++........ .......+++.|+|||++.+. .++.++|+||+||++|+|++|++||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9986543221 112335678899999999874 58899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=239.70 Aligned_cols=204 Identities=37% Similarity=0.602 Sum_probs=168.1
Q ss_pred eeeeeeeeccceEEEEEEeC-----CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 45 RWSNKIGEGGFGSVYKGRLQ-----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 45 ~i~~~lg~G~~~~v~~~~~~-----~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.+.+.||.|.||.||+|.+. .+..|+||.++... ......+.+|++.+++++ ||||+++++++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR--HPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS--BTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc--cccccccccccccccccccc
Confidence 46789999999999999866 36789999996432 234678999999999997 99999999999988889999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+++... ....+++..++.++.|++.|+.|||++ +++|++|+++||+++.++.+||+|||++....
T Consensus 80 ~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 9999999999999432 246789999999999999999999999 99999999999999999999999999998662
Q ss_pred CC-CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 199 EN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 199 ~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.. .............|+|||.+.+..++.++||||+|+++|+|++ |+.||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22 1122233446678999999998889999999999999999999 789997665444
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=238.02 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=167.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..+|.+.+.||+|++|.||+|... +|..|++|.+.... ........+|+..++.+. |+||+++++++..+...+++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK--HANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC--CCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999875 78999999986443 223346778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+. ++|.+.+. .....+++..+..++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 82 FEYMH-TDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred Eeccc-CCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 99995 66766653 2234578888999999999999999999 99999999999999999999999999887543
Q ss_pred CCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... ......++..|+|||++.+. .++.++|+||+|+++|+|++|..||...+
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 2211 11223467889999998764 47889999999999999999999997544
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=237.82 Aligned_cols=199 Identities=31% Similarity=0.469 Sum_probs=165.7
Q ss_pred eeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecC--Cce
Q 024118 44 FRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCR 115 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~~ 115 (272)
|++.+.||.|+||.||++.. .++..|++|.+..... .....+.+|+..++.+. ||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY--HENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCCceE
Confidence 49999999999999988642 3678999999875432 34567788999999998 99999999987653 457
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+++|||+++++|.+++. ...+++..++.++.|++.|+.+||++ +++|+||+|+||++++++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 89999999999999983 34589999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 196 LFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 196 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 65432211 1122234566999999988889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=244.73 Aligned_cols=202 Identities=26% Similarity=0.424 Sum_probs=173.2
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
+.|.....||.|++|.||++... ++..|++|.+..........+.+|+..++.+. |||++++++.+..++..+++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC--CCcHHHHHHheecCCeEEEEEe
Confidence 44555678999999999999875 78999999987554455567888999999988 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+++. ...+++..++.++.|++.++.+||++ +++|+||+|.||++++++.++|+|||++......
T Consensus 100 ~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 100 FLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999999872 34688999999999999999999999 9999999999999999999999999998754322
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.. ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 21 122345788899999998888999999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=244.14 Aligned_cols=201 Identities=25% Similarity=0.429 Sum_probs=173.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
..|+....||.|+||.||++... ++..|++|.+..........+.+|+..+..+. |||++++++.+..+...++++|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCC--CCchhhhhhheeeCCeEEEEEe
Confidence 34555678999999999999876 78999999987655555667888999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+.+ ....+++..++.++.|++.|+.+||+. +++|+||+|.||+++.++.++|+|||++......
T Consensus 99 ~~~~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 99 FLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred cCCCCCHHHHH-----hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 99999999876 335688999999999999999999999 9999999999999999999999999998754332
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.. ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+.
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 222 (297)
T cd06659 171 VP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222 (297)
T ss_pred cc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 12234578899999999988899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=250.00 Aligned_cols=207 Identities=24% Similarity=0.354 Sum_probs=174.5
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.-+.+..+.|++++.||.||.+.||++...+.+.|++|.+... +.....-+.+|+..|.++.. |.+|++++++-..+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg-~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKG-HDKIIQLYDYEVTD 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcC-CceEEEEeeeeccC
Confidence 3455778889999999999999999999988888888876533 44556789999999999987 89999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
+..|+|||| ...+|...+.. .....+.-.++.++.||+.|+.++|.. ||||.||||.|+++- .|.+||+|||
T Consensus 433 ~~lYmvmE~-Gd~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 433 GYLYMVMEC-GDIDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred ceEEEEeec-ccccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeec
Confidence 999999995 45678888833 222333348999999999999999999 999999999999996 4699999999
Q ss_pred cccccCCCCcc-ccccccccccccCccccccCC-----------CCCCCceehHHHHHHHHHhCCCcccc
Q 024118 193 LSKLFPENTTH-ISTRVAGTLGYLAPEYAISGR-----------LTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 193 ~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-----------~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
.+..++.+... .....+||..|++||.+.... .++++||||||||+|+|+.|++||..
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 99988766544 345578999999999986432 46799999999999999999999973
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=239.42 Aligned_cols=206 Identities=28% Similarity=0.413 Sum_probs=166.7
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCc----EEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~----~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..+|++.+.||+|+||.||+|.+. ++. .+++|....... ....++..++..+.++. ||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~--h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD--HAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC--CCCcceEEEEECC-Cc
Confidence 457899999999999999999875 454 467777643221 22345666777778887 9999999998754 45
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++++||+++++|.+++.. ....+++..++.++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred cEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 7789999999999999842 345689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 195 KLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
......... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 765322211 1222445678999999988889999999999999999998 999998765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=241.50 Aligned_cols=207 Identities=29% Similarity=0.452 Sum_probs=168.4
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCc--EEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~--~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||.|+||.||+|..+ ++. .+++|.++.. .......+.+|+..+.++.. ||||+++++.+......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH-HPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcC-CCchhheEEEEccCCcceE
Confidence 67999999999999999999865 443 4788877632 23334567889998888832 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 024118 118 VYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
++||+++++|.+++..... ....+++..++.++.|++.|+.+||++ |++|+||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999854321 113588999999999999999999999 9999999999999999999
Q ss_pred eEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
++|+|||++........ ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999864321111 111222456999999988889999999999999999997 99999765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=239.66 Aligned_cols=213 Identities=25% Similarity=0.393 Sum_probs=175.5
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCC-----CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-----~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
.+..++|++.+.||+|+||.||+|.+.. +..|++|.+... .......+.+|+..++.+. ||||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~ 79 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS--HQNILPILHVCIE 79 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEec
Confidence 3567889999999999999999998764 688999987643 2334566788999999997 9999999998766
Q ss_pred -CCceeEEEeecCCCCHhHHHhhccccc----ccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCe
Q 024118 112 -GPCRILVYDYMPNNSLSQTLLGEEKRR----AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~~~~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~ 186 (272)
+...+++++|+++++|.+++....... ..+++..++.++.|++.|+.|||++ +++|+||+|+||++++++.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence 467889999999999999985532221 5689999999999999999999999 99999999999999999999
Q ss_pred EEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 187 KISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
+|+|||++..+...... ......++..|+|||++.+..++.++|+||+|+++|++++ |+.||...++.+
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 99999999755322211 1112334567999999998889999999999999999999 999998665443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=237.59 Aligned_cols=208 Identities=29% Similarity=0.488 Sum_probs=172.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CC---cEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DG---TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~---~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..++|+..+.||+|++|.||+|... ++ ..+++|.+.... ......+.+|++.++.+. |||++++.+++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS--HHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEccCCC
Confidence 3457899999999999999999865 33 379999886442 333456888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||+++++|.+++.. ....+++..+..++.|++.|+.+||+. |++|+|++|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 81 AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence 9999999999999999832 335688999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccc--cccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 195 KLFPENTTHIST--RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
............ ....+..|+|||++.+..++.++|+||+|+++|+|++ |+.||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~ 218 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 765432211111 1122356999999988888999999999999999997 999997665543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=238.88 Aligned_cols=202 Identities=25% Similarity=0.448 Sum_probs=174.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
..|+..+.||.|++|.||+|.+. ++..|++|.+.... ......+.+|+..++.+. ||+|+++++.+..+...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCEEEEEE
Confidence 46888999999999999999876 68899999987543 334567888999999988 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++. ..++++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 82 EYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999999883 34688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
... ......++..|.|||.+.+...+.++|+||+|+++|+|++|..||...++.
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 221 122245677899999998888999999999999999999999999765433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.29 Aligned_cols=224 Identities=29% Similarity=0.475 Sum_probs=189.9
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccce
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENL 102 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i 102 (272)
...+.....+...+.+..+.||+|+||+||+|... +..-||||.++..... ...++.+|++++..++ ||||
T Consensus 474 ~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~--H~nI 551 (774)
T KOG1026|consen 474 LNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ--HPNI 551 (774)
T ss_pred CCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc--CCCe
Confidence 33455556677888999999999999999999732 3567999999865444 6789999999999999 9999
Q ss_pred eEeeeeEecCCceeEEEeecCCCCHhHHHhhccc----------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 024118 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172 (272)
Q Consensus 103 ~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~d 172 (272)
|+++++|.+++-.++|+|||..|+|..+++...- ...+++..+.+.|+.||+.++.||-++ .++|||
T Consensus 552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRD 628 (774)
T KOG1026|consen 552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRD 628 (774)
T ss_pred EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccc
Confidence 9999999999999999999999999999965321 134488999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEeecCcccccC-CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccc
Q 024118 173 IKTSNILLDQNFNPKISDFGLSKLFP-ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDF 250 (272)
Q Consensus 173 l~p~nilv~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~ 250 (272)
|..+|+||.++..|||+|||+++..= .+-........-..+|+|||.+....+++++||||+||++||+++ |+.||.+
T Consensus 629 LATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 629 LATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred hhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence 99999999999999999999998542 222222223345678999999999999999999999999999999 9999998
Q ss_pred ccCCCcee
Q 024118 251 DVQLGEYH 258 (272)
Q Consensus 251 ~~~~~~~~ 258 (272)
.+.++-..
T Consensus 709 lSn~EVIe 716 (774)
T KOG1026|consen 709 LSNQEVIE 716 (774)
T ss_pred cchHHHHH
Confidence 88887433
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=238.41 Aligned_cols=208 Identities=25% Similarity=0.379 Sum_probs=173.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.++|++.+.||.|+||.||+|+.+ +...+++|.+...... ....+.+|+..++++. |+||+++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS--HKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC--CcceeeeEEEECCCC
Confidence 478999999999999999999854 3467999987644333 3467888999999998 999999999999989
Q ss_pred ceeEEEeecCCCCHhHHHhhccccc-----ccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRR-----AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~-----~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
..+++|||+++++|.+++....... ..+++..+..++.|++.+|.+||++ +++|+||+|+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 9999999999999999985433221 2689999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+|||.+...............++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~ 224 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence 9999886443222222233445677999999988888999999999999999999 8889965443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=239.86 Aligned_cols=197 Identities=24% Similarity=0.421 Sum_probs=165.9
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.||+|.+. +|..+++|.+.... ......+.+|+..++++. |||++++++++.+....++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC--CCCeeeHHHHhccCCceEEEE
Confidence 5899999999999999999876 79999999987432 223356778999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++ +|.+.+. .....+++..++.++.|+++|+.+||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 79 EYCDQ-DLKKYFD---SCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred ecCCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 99964 6777663 2345689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
.... .....++..|+|||.+.+.. ++.++|+||+||++|+|++|..|+.
T Consensus 152 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 152 PVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 2221 12234678899999987654 7899999999999999999988863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=234.52 Aligned_cols=204 Identities=28% Similarity=0.437 Sum_probs=174.4
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec--CCceeE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRIL 117 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~~~~~i 117 (272)
+|++.+.||.|++|.||+|.+. +|..+++|.+... .......+..|+..++.+. |||++++++.+.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--HPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC--CCccceeeeeeecCCCCEEEE
Confidence 5899999999999999999865 7899999998643 2333456778999999998 9999999997754 456789
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHh-----hcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-----EEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-----~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
++||+++++|.+++........++++..++.++.|++.++.+|| +. +++|+||+|+||++++++.++|+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence 99999999999998655445678999999999999999999999 77 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.+......... .....++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 156 LAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 99876433321 223457888999999988888999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=240.77 Aligned_cols=208 Identities=31% Similarity=0.421 Sum_probs=171.1
Q ss_pred CeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+..++.+. ||||+++++.+..+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN--HPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCCc
Confidence 5889999999999999999753 23568888876443 223457888999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhccc--------------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 116 ILVYDYMPNNSLSQTLLGEEK--------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
++++||+++++|.+++..... ....+++..++.++.|++.+|.+||+. +++|+||+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 999999999999998854221 124588999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+||++++++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998754322111 1122334567999999988889999999999999999998 9999987655
Q ss_pred CC
Q 024118 254 LG 255 (272)
Q Consensus 254 ~~ 255 (272)
++
T Consensus 236 ~~ 237 (290)
T cd05045 236 ER 237 (290)
T ss_pred HH
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=239.02 Aligned_cols=212 Identities=30% Similarity=0.445 Sum_probs=172.1
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..++|.+.+.||+|++|.||+|.+. .+..|++|...... ......+.+|+..++.+. |+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN--HQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEccC
Confidence 3567999999999999999999865 35678999876332 233456888999999998 99999999999988
Q ss_pred CceeEEEeecCCCCHhHHHhhccc---ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---Ce
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NP 186 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~---~~ 186 (272)
...+++|||+++++|.+++..... ....+++..+..++.||+.++.+||++ +++|+||+|+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 899999999999999999854321 123588999999999999999999999 999999999999998665 48
Q ss_pred EEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 187 KISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
+|+|||++......... .......+..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999865322111 1111223457999999998889999999999999999997 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=236.67 Aligned_cols=207 Identities=30% Similarity=0.457 Sum_probs=172.5
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC-----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~----- 113 (272)
..++|++.+.||+|++|.||+|.+. +++.+++|.+..... ....+.+|+..++++.. |+||+++++.+....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSN-HPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcC-CCChheEEEEEEecCCCCcc
Confidence 4578999999999999999999876 688999999874433 34578889998888833 999999999987544
Q ss_pred -ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 114 -CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 114 -~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
..+++|||+++++|.+++.........+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 48999999999999999854433456789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.+........ ......++..|+|||.+.. ..++.++|+||+|+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 9875533222 1223457888999998753 236789999999999999999999997543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=239.74 Aligned_cols=201 Identities=27% Similarity=0.424 Sum_probs=170.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++.+.||.|++|.||+|.++ +++.||+|.+..... .....+.+|++.++.+. ||||+++++++..+...+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--HENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC--CcchhhHHHhcccCCeEEEE
Confidence 47999999999999999999876 689999998753322 23456778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|..+. .....+++..++.++.|++.++.+||+. +++|+|++|+||++++++.++|+|||++....
T Consensus 79 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 79 FEFVDHTVLDDLE----KYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EecCCccHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 9999999888876 3344589999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
... .......++..|+|||.+.+. .++.++|+||+|+++++|++|++||...+
T Consensus 152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 152 APG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred CCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 322 112234567889999998754 46789999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=245.01 Aligned_cols=193 Identities=24% Similarity=0.363 Sum_probs=163.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
....+|++.+.||+|+||.||+|... ++..||+|..... ....|+..+++++ ||||+++++++......++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVN--HPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCC--CCCCcChhheEEeCCeeEE
Confidence 44567999999999999999999876 6788999974321 2346888899988 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
|+|++. ++|.+++. .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++...
T Consensus 135 v~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYS-SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccC-CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 999995 57777763 3446789999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
.... ......|+..|+|||++.+..++.++|+|||||++|+|+++..|+
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2211 122356889999999999989999999999999999999855544
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=236.56 Aligned_cols=205 Identities=28% Similarity=0.426 Sum_probs=170.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC------
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------ 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~------ 112 (272)
....|++.+.||.|++|.||+|.+. +++.|++|.+.... .....+.+|+..+.++.. |||++++++.+...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSH-HRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcC-CCCeeeEeeEEeecCCCCCC
Confidence 4567999999999999999999876 68899999986443 345577888888888733 99999999988653
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++++||+++++|.+++... ....+++..+..++.|++.++.+||++ +|+|+|++|.||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 4578999999999999998432 234688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
++........ ......++..|+|||++. +..++.++|+||+||++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9876533221 223356788899999986 3357889999999999999999999996544
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=239.62 Aligned_cols=202 Identities=26% Similarity=0.429 Sum_probs=174.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..++|++.+.||+|++|+||++.+. +|..|++|++.... ......+.+|++.++.+. ||||+++++.+......++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR--SPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC--CCCcceEeeeEecCCEEEE
Confidence 3567999999999999999999876 68999999886543 334567888999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
++||+++++|.+++. ....+++..+..++.+++.++.+||+ . +++|+||+|+||++++++.++|+|||++..
T Consensus 81 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 81 CMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 999999999999883 34578999999999999999999996 5 899999999999999999999999998865
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... .....++..|+|||++.+..++.++|+||+||++|+|++|+.||.....
T Consensus 154 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 154 LINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred hhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 42211 1234678899999999888899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=244.37 Aligned_cols=206 Identities=29% Similarity=0.422 Sum_probs=181.2
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.++.-+.|+..+.||+||||.||-++.. +|+-+|.|.+... ....+.-.++|..+++.++ .+.||.+--.+...
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~--s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS--SPFIVSLAYAFETK 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc--cCcEEEEeeeecCC
Confidence 3455677999999999999999999766 7999999987532 3445667888999999999 88999998889999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
+..++|+..|+||+|.-.+.+ ..++.|++..+..++.+|+.+|++||+. +|++||+||.|||+|+.|+++|.|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred CceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence 999999999999999988844 3346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
++..++.... .....||.+|+|||++.+..|+...|-|||||++|+|+.|+.||...
T Consensus 333 LAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 333 LAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred eEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 9998765433 33358999999999999999999999999999999999999999643
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=251.45 Aligned_cols=195 Identities=23% Similarity=0.280 Sum_probs=166.1
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
...+|.+.+.||.|+||.||+|.+. +++.|++|... .....+|++.++++. |+||+++++++..+...+++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~--HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLS--HPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCC--CCCCCcEEEEEEECCEEEEE
Confidence 3557999999999999999999876 68899999643 123567999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+|++. ++|.+++.. ....+++..++.++.|++.||.|||++ ||+|+||||+|||++.++.++|+|||++....
T Consensus 239 ~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 239 LPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 99995 678777732 234789999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 199 ENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 199 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
.... .......|+..|+|||++.+..++.++|+|||||++|+|++|..|+-
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 3221 11223568999999999999999999999999999999999887553
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.87 Aligned_cols=202 Identities=28% Similarity=0.408 Sum_probs=165.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHh-hcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASM-ANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~-~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++.+.||+|+||.||+|.+. +|..||+|.+.... .........|.... +... |||++++++.+..+...+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD--CPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcC--CCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999876 79999999987542 22344555565553 4444 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||++ ++|.+++.........+++..++.++.|++.|+.+||++ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99996 678877755444556799999999999999999999973 289999999999999999999999999987653
Q ss_pred CCCccccccccccccccCcccccc----CCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAIS----GRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
.... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||..
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 156 DSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 2211 122356778999998865 3468899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=236.90 Aligned_cols=202 Identities=29% Similarity=0.429 Sum_probs=169.8
Q ss_pred CeeeeeeeeeccceEEEEEEe----CCCcEEEEEEEEecC----cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 43 GFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+|++.+.||.|++|.||.|.. .+|..||+|++.... ......+..|+..++++.. |++|+++++.+..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-SPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhccc-CCChhceeeEeecCCe
Confidence 589999999999999999986 368899999986432 2234567778888888853 8999999999998889
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++++||+++++|.+++. ....+++..+..++.|++.|+.+||+. |++|+||+|+||++++++.++|+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 80 LHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999999983 445788999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccccC--CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 76543322222234578889999998753 46789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=239.72 Aligned_cols=202 Identities=24% Similarity=0.394 Sum_probs=170.1
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc-----cHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-----~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+|++.+.||.|++|.||+|.+. +|+.|++|.+...... ....+..|+..++.+. |+||+++++++......+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK--HPNIIGLLDVFGHKSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC--CCCChhhhheeecCCEEE
Confidence 5889999999999999999876 7899999998754322 3345677899999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+ +++|.+++... ...+++..++.++.|+++||.+||++ |++|+||+|+||+++.++.++|+|||++..
T Consensus 79 lv~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 999999 88999998321 13789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
....... .....++..|.|||.+.+ ..++.++|+||+||++++|++|.+||...+..
T Consensus 152 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 152 FGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred ccCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 5433211 122345678999998865 45788999999999999999998888765543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=235.62 Aligned_cols=206 Identities=29% Similarity=0.463 Sum_probs=168.4
Q ss_pred eeeeeeeeeccceEEEEEEeC-C---CcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc---
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-D---GTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--- 114 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~---~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~--- 114 (272)
|.+.+.||+|+||.||+|... + +..||+|.++... ......+.+|+..++.+. |||++++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD--HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEeeeccCCcccc
Confidence 578899999999999999754 2 4789999987542 233457888999999988 9999999998765543
Q ss_pred ---eeEEEeecCCCCHhHHHhhcc--cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 115 ---RILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 115 ---~~iv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
.++++||+++++|..++.... .....+++..++.++.|++.||.+||++ +++|+||+|+||++++++.++|+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 789999999999998885432 2234689999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 190 DFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 190 Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
|||++......... .......+..|+|||.+.+..++.++|+||+||++|+|++ |.+||...+..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~ 222 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99998865432211 1111234567999999988889999999999999999999 99999765543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.69 Aligned_cols=210 Identities=26% Similarity=0.417 Sum_probs=172.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
..+|++.+.||.|+||.||+|.+. ++..||+|++...... ....+..|+..+..+. ||||+++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ--HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEcCCC
Confidence 456889999999999999999753 3578999998744322 2345778888888888 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcc------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
..++++||+++++|.+++.... .....+++..++.++.|++.||.+||++ |++|+||||.||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 9999999999999999984321 1234578889999999999999999999 999999999999999
Q ss_pred CCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 182 QNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 182 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
+++.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999875532221 11222345678999999988889999999999999999998 888998765544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=241.26 Aligned_cols=215 Identities=24% Similarity=0.398 Sum_probs=173.6
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
+.+...+|.+.+.||+|++|.||+|.+. ....+++|.+... .......+..|+..++++.. ||||+++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~ 85 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK-HKNIINLLG 85 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccC-CCCeeeEEE
Confidence 3455678999999999999999999742 2457999987643 22334567788888888733 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
++......++++||+++++|.+++..... ....++...+..++.|++.||.+||++ |++|+||+|
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 99998899999999999999999855321 224588899999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+||++++++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999765432111 1111223457999999988889999999999999999999 8999976554
Q ss_pred CC
Q 024118 254 LG 255 (272)
Q Consensus 254 ~~ 255 (272)
.+
T Consensus 243 ~~ 244 (314)
T cd05099 243 EE 244 (314)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.20 Aligned_cols=201 Identities=28% Similarity=0.431 Sum_probs=169.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc----------cHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ----------GEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~----------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+|.+.+.||.|++|.||+|... +|+.+++|.+...... ....+.+|+..++.+. |||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD--HLNIVQYLGFETT 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC--CCCcceEEEEecc
Confidence 5889999999999999999865 7899999988632110 1235677889999998 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
....++|+||+++++|.+++. ....+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred CCceEEEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeec
Confidence 999999999999999999983 336789999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCcc-ccccccccccccCccccccCC--CCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 192 GLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|++......... ......++..|+|||.+.... ++.++|+||+|+++++|++|..||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 999765322111 122345678899999987655 7899999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=240.82 Aligned_cols=215 Identities=25% Similarity=0.414 Sum_probs=174.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
+.+...+|.+.+.||+|+||.||+|+.. ++..|++|..... .......+.+|+..++.+.. ||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhcc-CCCchheeE
Confidence 3466788999999999999999999631 3457999988643 23344678888998888832 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
.+......+++|||+++++|.+++..... ....++...+..++.|++.||.|||++ |++|+||||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 99999999999999999999999855321 124578889999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCccc-cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+||+++.++.++|+|||.+.......... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999999999999998654322111 122334567999999988889999999999999999998 8888876544
Q ss_pred CC
Q 024118 254 LG 255 (272)
Q Consensus 254 ~~ 255 (272)
.+
T Consensus 246 ~~ 247 (304)
T cd05101 246 EE 247 (304)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=235.97 Aligned_cols=202 Identities=30% Similarity=0.501 Sum_probs=168.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec--CC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~~ 113 (272)
.++|++.+.||+|+||.||++.. .++..|++|.+..........+.+|++.++.+. |||++++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCeeEEEEEEccCCCC
Confidence 45799999999999999999973 258899999987655555667889999999998 9999999987653 34
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 67899999999999999832 234688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccc--cccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 194 SKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 194 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
+.......... .....++..|+|||.+.+..++.++|+||+|+++++|++|..|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 98654322211 1112234458999999888899999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=234.63 Aligned_cols=196 Identities=30% Similarity=0.463 Sum_probs=162.2
Q ss_pred eeeeccceEEEEEEeC---CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 49 KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
.||+|+||.||+|.++ ++..+++|++..... .....+..|+..++.+. ||||+++++.+. ....+++|||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD--NPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC--CCCcceEEEEEc-CCCcEEEEecCC
Confidence 6899999999999643 578899999864432 23456788899999988 999999999875 456789999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|.+++ .....+++..++.++.|++.|+.+||++ |++|+||+|.||+++.++.++|+|||.+.........
T Consensus 79 ~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 79 LGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999998 3445789999999999999999999999 9999999999999999999999999999865433221
Q ss_pred c--cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 204 I--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 204 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
. .....++..|+|||.+....++.++|+||||+++|+|++ |..||...+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 205 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 1 111223468999999988888999999999999999998 99999865543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=239.93 Aligned_cols=206 Identities=26% Similarity=0.390 Sum_probs=170.4
Q ss_pred CeeeeeeeeeccceEEEEEEeC---CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecC--Cc
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PC 114 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~ 114 (272)
+|++.+.||+|++|.||+|... ++..||+|.+.... ........+|+..++.+. ||||+++++.+... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK--HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC--CCCccceEEEEeCCCCce
Confidence 5899999999999999999865 47899999987532 334467788999999998 99999999999988 78
Q ss_pred eeEEEeecCCCCHhHHHhhcccc-cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----CCCeEEe
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKR-RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ----NFNPKIS 189 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~----~~~~~l~ 189 (272)
.++|+||+++ +|.+.+...... ...+++..++.++.|++.|+.+||+. +|+|+||+|+||+++. ++.++|+
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 9999999965 566665433222 24789999999999999999999999 9999999999999999 8899999
Q ss_pred ecCcccccCCCCc--cccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 190 DFGLSKLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 190 Dfg~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
|||++........ .......++..|+|||.+.+. .++.++|+||+|+++++|++|++||...+..
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 9999886543222 112234567889999988764 5789999999999999999999999866554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=238.07 Aligned_cols=210 Identities=28% Similarity=0.467 Sum_probs=170.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-----------------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-----------------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-----------------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~ 101 (272)
..++|++.+.||+|+||.||++.+. ++..+++|.+.... ......+.+|+..++.+. |+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~--~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK--DPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCC
Confidence 3567999999999999999998532 24468999886442 233457888999999998 999
Q ss_pred eeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccc-------cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 024118 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR-------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174 (272)
Q Consensus 102 i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~ 174 (272)
|+++++++...+..+++|||+++++|.+++...... ...+++..++.++.|++.|+.+||++ |++|+||+
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 999999999999999999999999999998543211 13477889999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh--CCCccccc
Q 024118 175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFD 251 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~ 251 (272)
|+||+++.++.++|+|||++........ .......++..|++||...+..++.++|+||+||++|+|++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999875432221 11112233567999999888889999999999999999998 77888755
Q ss_pred cCC
Q 024118 252 VQL 254 (272)
Q Consensus 252 ~~~ 254 (272)
+..
T Consensus 238 ~~~ 240 (296)
T cd05095 238 SDE 240 (296)
T ss_pred ChH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=232.11 Aligned_cols=200 Identities=32% Similarity=0.474 Sum_probs=168.2
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCC
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~ 126 (272)
+.||.|++|.||++.+.+++.|++|.+...... ....+.+|++.++++. |++|+++++++......++++||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD--HPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999998777999999998754333 4567888999999998 9999999999999999999999999999
Q ss_pred HhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc-
Q 024118 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS- 205 (272)
Q Consensus 127 L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~- 205 (272)
|.+++.. ....+++..+..++.+++.++.+||++ +++|+||+|+||+++.++.++|+|||.+...........
T Consensus 79 l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 79 LLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9999843 234678999999999999999999999 999999999999999999999999999875432211111
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+...
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~ 203 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence 11223456999999988889999999999999999999 899997766443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=233.47 Aligned_cols=197 Identities=28% Similarity=0.460 Sum_probs=161.9
Q ss_pred eeeeccceEEEEEEeC---CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCC
Q 024118 49 KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~ 124 (272)
.||+|+||.||+|.+. ++..|++|.+..... .....+.+|+..++++. ||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD--NPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC--CCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999754 456799999865432 23456888999999998 999999999875 4578899999999
Q ss_pred CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccc
Q 024118 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204 (272)
Q Consensus 125 ~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~ 204 (272)
++|.+++.. ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 79 GPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999998842 345789999999999999999999999 99999999999999999999999999987554322211
Q ss_pred --cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 205 --STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 205 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 111223467999999988889999999999999999996 99999765543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=245.13 Aligned_cols=224 Identities=29% Similarity=0.430 Sum_probs=187.1
Q ss_pred cccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCccc-------HHHHHHHHHHhhcccc
Q 024118 26 LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG-------EKEFMSEVASMANVNV 97 (272)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~-------~~~~~~e~~~~~~~~~ 97 (272)
+.+-++..++..+...++|.++..||+|||+.||+|.+- .++.||+|+-.....+. .+...+|..+.+.+.
T Consensus 447 i~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD- 525 (775)
T KOG1151|consen 447 IHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD- 525 (775)
T ss_pred hcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-
Confidence 566688889999999999999999999999999999865 67889999866543332 245667888888888
Q ss_pred cccceeEeeeeEecC-CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 024118 98 CHENLVKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 176 (272)
Q Consensus 98 ~~~~i~~l~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ 176 (272)
||.||++|+++..+ +..+-|.|||+|.+|+.++ .....+++..++.|+.||+.||.||.+. ...|+|-||||.
T Consensus 526 -HpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPg 599 (775)
T KOG1151|consen 526 -HPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPG 599 (775)
T ss_pred -cceeeeeeeeeeeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCc
Confidence 99999999998754 5778999999999999999 5667889999999999999999999986 568999999999
Q ss_pred CEEEcC---CCCeEEeecCcccccCCCCccc------cccccccccccCccccccC----CCCCCCceehHHHHHHHHHh
Q 024118 177 NILLDQ---NFNPKISDFGLSKLFPENTTHI------STRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 177 nilv~~---~~~~~l~Dfg~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slG~il~~l~t 243 (272)
|||+-+ -|.++|.|||++..+.+..... .....||..|++||.|.-. .++.++|+||+|||+|.++.
T Consensus 600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 999954 4669999999999886554331 2335689999999998633 36889999999999999999
Q ss_pred CCCccccc-cCCCc
Q 024118 244 GRTAVDFD-VQLGE 256 (272)
Q Consensus 244 g~~p~~~~-~~~~~ 256 (272)
|+.||... ++++.
T Consensus 680 GrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDI 693 (775)
T ss_pred cCCCCCCchhHHHH
Confidence 99999854 34443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=230.65 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=173.3
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.+|.+... +|+.|++|.+... .......+.+|+..++.+. ||||+++++.+......++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK--HPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC--CCCeeeeEeeecCCCeEEEEE
Confidence 5899999999999999999876 7899999998743 2233457888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+.+.. .....+++..++.++.|++.++.+||++ +++|+||+|+||+++.++.++++|||.+.....
T Consensus 79 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 79 DYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred ecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 99999999998843 1234578999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... .....++..|+|||++.+...+.++|+||+|+++++|++|+.||...+
T Consensus 154 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 154 TVEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred chhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 2211 122456788999999988888999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=228.78 Aligned_cols=200 Identities=30% Similarity=0.500 Sum_probs=176.8
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 121 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~ 121 (272)
+|++.+.||.|++|.||++.+. ++..+++|.+..........+.+|+..++.+. |++++++++.+..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK--HPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCCeEEEEEec
Confidence 4889999999999999999876 78999999987655456678889999999999 99999999999999999999999
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
+++++|.+++... ...+++..++.++.|++.++.+||+. |++|+||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999998432 25789999999999999999999998 99999999999999999999999999998665433
Q ss_pred ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 202 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
. .....++..|++||.+.+...+.++|+||+|+++++|++|+.||...+
T Consensus 153 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 153 A--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred c--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 2 233567888999999988888999999999999999999999998663
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=235.95 Aligned_cols=213 Identities=27% Similarity=0.415 Sum_probs=172.3
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+........+.|++.+.||.|++|.||+|.+. +++.+++|++.... .....+..|+..+..+.. |+|++++++.+..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSH-HRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcC-CCcEEEEeeehhc
Confidence 33444445678999999999999999999875 78999999986443 233466778888877743 9999999998753
Q ss_pred ------CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 024118 112 ------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 112 ------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
....+++|||+++++|.+++... ....+++..++.++.|++.|+.+||++ +++|+|++|+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 45678999999999999988542 234578889999999999999999999 9999999999999999999
Q ss_pred eEEeecCcccccCCCCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++|+|||++........ ......++..|+|||.+. +..++.++|+||+|+++|+|++|..||...++
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 99999999875432211 122345788899999886 34578899999999999999999999975543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=241.97 Aligned_cols=199 Identities=23% Similarity=0.276 Sum_probs=163.3
Q ss_pred eeeeeeec--cceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 46 WSNKIGEG--GFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 46 i~~~lg~G--~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
+.+.||+| ++++||++..+ +|+.||+|.+.... ......+..|+..++.+. ||||+++++++..++..++|+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEECCEEEEEEe
Confidence 56789998 68899999876 89999999987542 233345667888888888 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+++... ....+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.+++.||+........
T Consensus 80 ~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 80 FMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred ccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 99999999998432 234588999999999999999999999 9999999999999999999999999865433211
Q ss_pred Ccc------ccccccccccccCcccccc--CCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 201 TTH------ISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 201 ~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
... ......++..|+|||++.+ ..++.++|+||+||++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 110 0111245667999999976 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=240.00 Aligned_cols=210 Identities=27% Similarity=0.435 Sum_probs=173.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcc-cccccceeEeeee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLHGG 108 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~~ 108 (272)
+....++|++.+.||+|+||.||++... ++..+++|.++... ......+.+|+..++++ . ||||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccC--CCCcceEEEE
Confidence 3456678999999999999999999741 35679999876432 23345678899999998 5 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
+...+..++++||+++++|.+++... ....+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++|
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999998432 223489999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 189 SDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+|||++......... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.....
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 999999765432211 1112334677999999998889999999999999999998 9999875443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=232.51 Aligned_cols=198 Identities=22% Similarity=0.327 Sum_probs=163.4
Q ss_pred HHhhCCeeeeeee--eeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 38 KIATNGFRWSNKI--GEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 38 ~~~~~~y~i~~~l--g~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
....++|++.+.+ |.|+||.||++..+ ++..+++|.+........ |......+ ..|||++++++.+...+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~-~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLM-KDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHh-hcCCCEEEEEEEEecCCe
Confidence 4445678888777 99999999999876 788999999864322111 11111111 129999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEEeecCc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGL 193 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~ 193 (272)
.++||||+++++|.+++. ....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++ .++|+|||.
T Consensus 84 ~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999983 334899999999999999999999999 999999999999999988 999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+....... ...++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 87654222 23567889999999988899999999999999999999999985543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=237.08 Aligned_cols=200 Identities=28% Similarity=0.461 Sum_probs=174.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+.+|++.++.+. ||||+++++.+......++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN--SPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC--CCchhhhheeeecCCEEEEEE
Confidence 46889999999999999999887 78999999987543 344567888999999988 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||+++++|.+++... ...+++..++.++.|++.++.+||+ . |++|+||+|+||++++++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 79 EYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999999998432 2678999999999999999999999 8 99999999999999999999999999987553
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... ....++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+
T Consensus 153 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 153 NSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred HHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 2211 11557788999999988889999999999999999999999997553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=233.44 Aligned_cols=204 Identities=33% Similarity=0.537 Sum_probs=171.0
Q ss_pred eeeeeeeeeccceEEEEEEeCC-----CcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~-----~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+++.+.||.|+||.||++.+.. +..+++|.+...... ....+..|+..+..+. |++++++++.+......++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD--HPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC--CCchheEEEEEcCCCeeEE
Confidence 4578899999999999998763 488999998755433 5668888999999997 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+.+.... ...+++..++.++.|++.|+.+||+. +++|+||+|+||++++++.++|+|||.+...
T Consensus 79 i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999984321 11289999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
............++..|+|||.+.+..++.++|+||+|+++++|++ |++||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~ 211 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE 211 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 4332211112235678999999988889999999999999999998 88998765443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=236.09 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=171.5
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCc----EEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~----~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
...+|++.+.||+|+||.||+|.++ +|. .+++|...... ......+.+|+..++.+. |||++++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD--HPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEec-C
Confidence 3567999999999999999999865 343 58888876443 234467888999999998 9999999999887 7
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+++++|.+++.. ....+++..++.++.|++.|+.+||++ +++|+||+|+||++++++.++|+|||.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred ceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcc
Confidence 88999999999999999832 344689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccc-cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 194 SKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
+.......... .....++..|+|||.+....++.++|+||+|++++++++ |+.||+..+.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 219 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 98654322211 111223457999999988888999999999999999998 999998766544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=257.12 Aligned_cols=208 Identities=21% Similarity=0.328 Sum_probs=162.3
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC--CCcEEEEEEEE-----------------ecCcccHHHHHHHHHHhhccc
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLS-----------------VESKQGEKEFMSEVASMANVN 96 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~v~vK~~~-----------------~~~~~~~~~~~~e~~~~~~~~ 96 (272)
......++|++.+.||+|+||.||++..+ ++...+.|.+. .........+.+|+..++++.
T Consensus 142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence 33455689999999999999999998654 23333332110 011122345778999999998
Q ss_pred ccccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcc-cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 97 VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 97 ~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
||||+++++++...+..+++++++. ++|.+++.... ..........++.++.|++.||.|||++ ||+||||||
T Consensus 222 --HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 222 --HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred --CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 9999999999999999999999985 56666653321 1122344677888999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCC-ccc
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT-AVD 249 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~-p~~ 249 (272)
+|||++.++.++|+|||++...............|+..|+|||++.+..++.++|||||||++|+|++|.. ||.
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999999999998665433333334578999999999999999999999999999999999875 444
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=234.29 Aligned_cols=203 Identities=30% Similarity=0.441 Sum_probs=173.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecC--CceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~~~i 117 (272)
++|+..+.||.|++|.||++.+. +++.+++|.+..... .....+.+|++.++.+. ||||+++++.+... ...++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK--SPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEccCCCeEEE
Confidence 47899999999999999999876 688999999874432 34567888999999998 99999999987643 46889
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++.........+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 9999999999988754444556789999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... .....++..|.|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 156 ~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (287)
T cd06621 156 VNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207 (287)
T ss_pred cccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 3221 122456778999999998889999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=240.73 Aligned_cols=203 Identities=27% Similarity=0.439 Sum_probs=181.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
...+-|.++..||+|++|.||+|.++ +|+.+|||.+.++ .+...+..|+.++.++. .|++|++|+.+......+|
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~--S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCK--SKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcC--CchhhhhhhhhccCCceEe
Confidence 34556889999999999999999876 8999999998654 45678999999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
|||||.-|+..+.+ +.+++++++..+..+++.-+.+|+|||.. .=+|||||..|||++.+|..+|.|||.+-.+
T Consensus 106 VMEYCGAGSiSDI~---R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 106 VMEYCGAGSISDIM---RARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred ehhhcCCCcHHHHH---HHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence 99999999999999 35778999999999999999999999998 8899999999999999999999999999765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.+..- ..+.+.||+-|+|||++..-.|+.++||||||++..+|..|++||...-
T Consensus 180 TDTMA-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 180 TDTMA-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred hhhHH-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 43222 2345789999999999999999999999999999999999999997543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=229.95 Aligned_cols=205 Identities=27% Similarity=0.462 Sum_probs=179.1
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.||++.+. ++..+++|.+..... .....+..|++.++.++ |||++++.+.+......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--HPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC--CCChhheEEEEecCCEEEEEE
Confidence 5899999999999999999876 789999999875533 45567888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|++++++|.+.+.........+++..++.++.+++.++.+||++ |++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999999999855433457899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.. .......+++.|+|||...+..++.++|+||+|+++++|++|+.||+..+.
T Consensus 156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 208 (258)
T cd08215 156 TV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208 (258)
T ss_pred Cc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence 32 123334678889999999888899999999999999999999999977653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=230.40 Aligned_cols=202 Identities=26% Similarity=0.434 Sum_probs=173.1
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||+|++|.||+|.+. +++.+++|.+... .......+.+|+..++.++ ||+++++++.+..+...++|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--HPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC--CCchhheeeeEecCCEEEEEE
Confidence 5999999999999999999875 7889999998754 2334567888999999998 999999999999899999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~~~~~~ 198 (272)
||+++++|.+++... ....+++..++.++.+++.++.+||++ |++|+||+|+||++++++ .++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 79 EYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred ecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999998432 234588999999999999999999999 999999999999998654 47999999998664
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .....++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+.
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 206 (256)
T cd08220 154 SKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206 (256)
T ss_pred CCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch
Confidence 3321 2224577889999999888889999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=231.89 Aligned_cols=201 Identities=30% Similarity=0.479 Sum_probs=168.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe-cCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~-~~~~~~i 117 (272)
+..++|++.+.||+|++|.||++... |..+++|..... .....+.+|+..++.+. |++++++++.+. .+...++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCC--CCCeeeEEEEEEcCCCceEE
Confidence 44568999999999999999999765 778999987533 23457888999999998 999999998754 5567899
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
++||+++++|.+++... ....+++..++.++.|++.+|.+||++ |++|+||+|+||++++++.++|+|||++...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 78 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence 99999999999998432 223578999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
.... .....+..|+|||++.+..++.++|+||+||++|+|++ |+.||...+.
T Consensus 153 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 153 SSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred cccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3222 12234567999999988889999999999999999997 9999975443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=242.80 Aligned_cols=217 Identities=25% Similarity=0.401 Sum_probs=174.8
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEe
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKL 105 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l 105 (272)
..+.+...+|++.+.||+|+||.||+|.+. .+..|++|.+.... ......+.+|++.++++.. ||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK-HKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcC-CCCeeee
Confidence 345666778999999999999999999742 12368999876432 2334578889999988832 9999999
Q ss_pred eeeEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 024118 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 173 (272)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl 173 (272)
++.+......++++||+++++|.+++..... ....++...+..++.|++.|+.+||++ |++|+||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dl 160 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDL 160 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccc
Confidence 9999999999999999999999999854321 223577889999999999999999999 9999999
Q ss_pred CCCCEEEcCCCCeEEeecCcccccCCCCccc-cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccc
Q 024118 174 KTSNILLDQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 251 (272)
Q Consensus 174 ~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~ 251 (272)
+|.||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999987654322111 111223457999999999889999999999999999998 89999765
Q ss_pred cCCC
Q 024118 252 VQLG 255 (272)
Q Consensus 252 ~~~~ 255 (272)
+..+
T Consensus 241 ~~~~ 244 (334)
T cd05100 241 PVEE 244 (334)
T ss_pred CHHH
Confidence 5444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=235.58 Aligned_cols=206 Identities=25% Similarity=0.366 Sum_probs=167.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc----
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC---- 114 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~---- 114 (272)
++|++.+.||.|++|.||+|.+. +|+.||+|...... ......+.+|+..++.+.. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE-SIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccC-CCCccceeeeEeecCCCCCc
Confidence 47999999999999999999876 79999999876442 2233567789999988863 6999999998876655
Q ss_pred -eeEEEeecCCCCHhHHHhhcccc-cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCeEEeec
Q 024118 115 -RILVYDYMPNNSLSQTLLGEEKR-RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDF 191 (272)
Q Consensus 115 -~~iv~e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-~~~~~l~Df 191 (272)
.+++|||+++ +|.+++...... ...+++..++.++.||+.||.+||++ |++|+||+|+||+++. ++.++|+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999976 788877543222 35689999999999999999999999 9999999999999998 889999999
Q ss_pred CcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|.+......... .....+++.|.|||.+.+ ..++.++|+||+|+++|+|++|..||...+.
T Consensus 156 g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 156 GLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred ccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 998754322111 122345778999998865 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.44 Aligned_cols=195 Identities=30% Similarity=0.406 Sum_probs=158.2
Q ss_pred eeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhccc-ccccceeEeeeeEecCCceeEEEeecC
Q 024118 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
.||+|+||.||++.+. ++..+|+|.+..... .......++...+..+. ..||+++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999876 689999998864321 11223334433333321 128999999999999899999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
+++|.+++ .....+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999888 3446799999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccccccccccccCccccc-cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 204 ISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.....++..|+|||.+. +..++.++|+||+||++|+|++|+.||...+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 12245788999999986 45688999999999999999999999975543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=232.33 Aligned_cols=204 Identities=31% Similarity=0.504 Sum_probs=177.7
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.||++.+. +++.+++|.+.... ......+..|+..++.++ |+||+++++.+......++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN--HPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC--CCCchhhhhhhccCCEEEEEe
Confidence 5899999999999999999866 78899999987432 233456778899999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++.........+++..++.++.|++.|+.+||+. |++|+||+|.||++++++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999999866544557789999999999999999999999 999999999999999999999999999986644
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
. ......++..|++||.+.+..++.++|+||+|+++++|++|+.||...+..
T Consensus 156 ~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 207 (256)
T cd08530 156 N---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207 (256)
T ss_pred C---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 3 222345778899999999888999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=238.41 Aligned_cols=200 Identities=25% Similarity=0.440 Sum_probs=171.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+.|++.+.||.|++|.||+|.+. ++..||+|.+.... ......+.+|+..++++. ||||+++++.+..+...++|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC--CCccHhhhcccccCCceEEEE
Confidence 45778899999999999999866 68899999986442 333456788999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+.+. ...+++..++.++.|++.|+.+||++ +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 82 EYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999998872 35688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
... ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 221 1122456788999999998889999999999999999999999997544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.81 Aligned_cols=204 Identities=27% Similarity=0.474 Sum_probs=171.7
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhccc-ccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.|++.+.||.|++|.||+|.+. ++..|++|.+... .......+.+|+..++.+. ..||+++++++.+..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999875 7899999998644 2333456777888777774 12999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++. ...+++..++.++.|++.++.+||+. |++|+||+|+||++++.+.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999872 23788999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+...
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 3321 223457888999998865 446889999999999999999999998765544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=234.97 Aligned_cols=204 Identities=28% Similarity=0.493 Sum_probs=171.3
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
+|++.+.||.|++|.||+|.+. +|..|++|.+.... ........+|+..++.+. ||||+++++.+...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK--HENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc--CCCEeeeeeeEeeCCcEEEEEe
Confidence 5899999999999999999986 78999999987543 223456778999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++ +|.+++.... ....+++..+..++.|++.|+.+||+. |++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 79 YMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred cCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9975 7887774332 235689999999999999999999999 9999999999999999999999999999754332
Q ss_pred CccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
... .....++..|++||.+.+. .++.++|+||+|+++|+|++|+.||...+..
T Consensus 154 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 154 VNT-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred ccc-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 211 1223457789999988664 4688999999999999999999999876644
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=241.63 Aligned_cols=215 Identities=25% Similarity=0.356 Sum_probs=181.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.+-..+|.++..||.|+||.|.+|.-+ +.+-+|||+++.+. .++..--+.|.+.+. +...-|.++++++.+..-+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLA-L~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA-LPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhhee-cCCCCchHHHHHHHhhhhh
Confidence 677889999999999999999999766 67889999987441 122222333434333 3333789999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
+.|.||||+.||+|-..+ ++-+.+-+..+..++..|+-+|.+||++ ||++||||.+||+++.+|+++|.|||+
T Consensus 424 RLyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred heeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence 999999999999999888 6778899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhh
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 261 (272)
+..--. ...-....+||+.|+|||.+.-++|+..+|.||+|+++|+|+.|++||++.++.+.+..|.
T Consensus 497 cKEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 497 CKENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM 563 (683)
T ss_pred cccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 984221 1222455899999999999999999999999999999999999999999999988766553
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=231.43 Aligned_cols=192 Identities=28% Similarity=0.419 Sum_probs=167.8
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
||.|++|.||+|.+. +++.+++|++.... ......+.+|+..++.+. ||||+++++.+..+...++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN--HPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC--CCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 689999999999876 68999999986432 234467888999999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 205 (272)
+|.+++ .....+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~ 149 (262)
T cd05572 79 ELWTIL----RDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KT 149 (262)
T ss_pred cHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cc
Confidence 999998 3345689999999999999999999999 99999999999999999999999999998664332 12
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
....++..|++||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 23457888999999988889999999999999999999999998766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=232.02 Aligned_cols=197 Identities=35% Similarity=0.525 Sum_probs=162.9
Q ss_pred eeeeeccceEEEEEEeC-C---CcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQ-D---GTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~---~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||+|++|.||+|... . +..+++|.+..... .....+.+|+..++.+. |||++++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD--HPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEc-CCceEEEEEeC
Confidence 46899999999999754 2 36899999874433 34567888999999988 999999999875 45679999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|.+++. ....+++..++.++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 78 PLGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999984 334789999999999999999999999 999999999999999999999999999986643322
Q ss_pred ccccc--ccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 203 HISTR--VAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 203 ~~~~~--~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
..... ..++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 11111 112357999999988889999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=236.31 Aligned_cols=209 Identities=28% Similarity=0.490 Sum_probs=172.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCC-----------------CcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQD-----------------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~-----------------~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~ 101 (272)
..++|++.+.||+|+||.||+|.+.. +..|++|.+.... ......+.+|++.++++. |||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS--DPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC--CCC
Confidence 45789999999999999999987542 2458999886443 234567788999999998 999
Q ss_pred eeEeeeeEecCCceeEEEeecCCCCHhHHHhhccc-------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 024118 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK-------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174 (272)
Q Consensus 102 i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~ 174 (272)
++++++++..++..++++|++++++|.+++..... ....+++..++.++.|++.||.+||++ +++|+||+
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 99999999999999999999999999999854321 123689999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh--CCCccccc
Q 024118 175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFD 251 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~ 251 (272)
|+||++++++.++|+|||.+........ .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999875432211 11223345678999999988889999999999999999998 77888765
Q ss_pred cC
Q 024118 252 VQ 253 (272)
Q Consensus 252 ~~ 253 (272)
+.
T Consensus 238 ~~ 239 (296)
T cd05051 238 TD 239 (296)
T ss_pred Ch
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=234.04 Aligned_cols=200 Identities=25% Similarity=0.410 Sum_probs=172.6
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 121 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~ 121 (272)
+|.-.+.||.|++|.||++.+. +++.+++|.+..........+.+|+..++.+. |||++++++.+...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~--h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC--CCChheEEEEEEcCCeEEEEEec
Confidence 4566789999999999999865 78999999987555555566888999999988 99999999999999999999999
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
+++++|.+++. ..++++..++.++.|++.++.+||++ |++|+||+|.||+++.++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 98 LEGGALTDIVT-----HTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred cCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999883 25688999999999999999999999 99999999999999999999999999876543322
Q ss_pred ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 202 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.. .....++..|+|||.+.+..++.++|+||+|+++++|++|+.||...++
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~ 220 (285)
T cd06648 170 PR-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220 (285)
T ss_pred cc-cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence 11 2224578889999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=235.23 Aligned_cols=199 Identities=30% Similarity=0.494 Sum_probs=166.5
Q ss_pred CCeeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC--C
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--P 113 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~ 113 (272)
+.|++++.||+|++|.||.+.. .++..|++|.+.... ......+.+|+..++.+. |||++++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEecCCCC
Confidence 4578999999999999999973 258899999986442 333457888999999998 99999999988765 5
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..+++|||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 68899999999999999832 234588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcc
Q 024118 194 SKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 194 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
+......... ......++..|+|||.+.+..++.++|+||||+++|+|+++..|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 9865432211 112244566799999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=238.02 Aligned_cols=197 Identities=24% Similarity=0.408 Sum_probs=158.2
Q ss_pred eeeeeccceEEEEEEeC---CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec--CCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~~~~~iv~e~~ 122 (272)
+.||+|+||.||+|... ++..||+|.+... .......+|+..++.+. ||||+++++++.. +...++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELK--HPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCC--CCCeeeEEEEEeccCCCeEEEEEeee
Confidence 68999999999999865 4578999987533 23346778999999998 9999999998753 45778999998
Q ss_pred CCCCHhHHHhhcc-----cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCCeEEeecCc
Q 024118 123 PNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGL 193 (272)
Q Consensus 123 ~~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv----~~~~~~~l~Dfg~ 193 (272)
+ ++|.+.+.... .....+++..++.++.|++.||.+||++ +|+|+||||+||++ +.++.++|+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 6 46776663221 1223588999999999999999999999 99999999999999 5667899999999
Q ss_pred ccccCCCCcc--ccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 194 SKLFPENTTH--ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 194 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+......... ......++..|+|||.+.+. .++.++|+||+||++|+|++|++||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9865432211 12234678899999998764 47899999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=238.13 Aligned_cols=206 Identities=29% Similarity=0.466 Sum_probs=170.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc--cHHHHHHHHHHhhcccccccceeEeeeeEecC--Cc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PC 114 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~ 114 (272)
..++|++.+.||.|++|.||+|.+. +|+.||+|.+...... ......+|+..+++++ |+|++++++++... +.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR--HPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC--CCCCcceEEEEecCCCCe
Confidence 3568999999999999999999876 7999999998754322 2335667999999998 99999999998755 46
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++|+||+.+ +|.+++.. ....+++..++.++.|++.|+.+||+. |++|+||+|+||++++++.++|+|||.+
T Consensus 83 ~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEEEEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcccee
Confidence 7999999964 78887733 236789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||...+..+
T Consensus 156 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~ 216 (309)
T cd07845 156 RTYGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216 (309)
T ss_pred eecCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 866433211 122234677999999875 457899999999999999999999998666544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.06 Aligned_cols=195 Identities=27% Similarity=0.375 Sum_probs=165.8
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
||+|+||+||+|... +|+.|++|.+.... ......+..|+..++.++ ||+++++++.+...+..++|+||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS--SRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC--CCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 689999999999866 78999999986432 223445677999999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 205 (272)
+|.+++... ....+++..++.++.|++.++.+||++ |++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 79 ~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 151 (277)
T cd05577 79 DLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KI 151 (277)
T ss_pred cHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cc
Confidence 999998432 224689999999999999999999999 99999999999999999999999999987654321 12
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
....++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+.
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 224567789999999888899999999999999999999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=234.19 Aligned_cols=204 Identities=26% Similarity=0.444 Sum_probs=176.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..+.|++.+.||+|++|.||++.+. ++..+++|++..... ....+..|+..++.+. |+|++++++.+......+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCK--HPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCC--CCCeeEEEEEEEECCEEEEE
Confidence 4567999999999999999999877 789999999875544 4567888999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++++|.+++.... ..++...++.++.|++.++.+||+. |++|+|++|+||+++.++.++|+|||.+....
T Consensus 94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999994321 3789999999999999999999998 99999999999999999999999999887543
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... ......++..|++||.+.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 2211 11223467789999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=236.89 Aligned_cols=204 Identities=25% Similarity=0.432 Sum_probs=170.5
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc--cHHHHHHHHHHhhcccccccceeEeeeeEecC--Cce
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCR 115 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~~ 115 (272)
.++|++.+.||.|++|.||+|.++ ++..+++|.++..... ......+|+..++++. ||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--HPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC--CCCEEEEEEEEEecCCCcE
Confidence 357999999999999999999877 6899999998754322 2335677899999998 99999999988877 889
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++++||++ ++|.+.+.. ....+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~lv~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 82 YMVMEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred EEEehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 99999996 488888733 223689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
........ .....++..|+|||.+.+.. ++.++|+||+|+++++|++|++||...+..
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 155 EYGSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred eccCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 66443211 22234678899999987654 688999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=240.17 Aligned_cols=201 Identities=28% Similarity=0.405 Sum_probs=166.4
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC-----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----- 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~----- 113 (272)
.++|++.+.||+|++|.||+|.+. +|+.||+|.+... ......++..|+..++.++ ||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK--HENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC--CCCcCchhheeecccccccc
Confidence 478999999999999999999876 7999999998633 2233456778999999998 999999998766543
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+. ++|...+ ....+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 82 DVYIVQELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred eEEEEehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 4789999996 4777766 335789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc--ccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 194 SKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 194 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+......... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765322111 1223457888999998765 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.45 Aligned_cols=208 Identities=28% Similarity=0.474 Sum_probs=169.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCC---------------CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQD---------------GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVK 104 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~---------------~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~ 104 (272)
..+|++.+.||+|+||.||++.... ...|++|.+... .......+.+|++.++++. |||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK--NPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCcCe
Confidence 4689999999999999999987542 235899988644 2233456888999999998 999999
Q ss_pred eeeeEecCCceeEEEeecCCCCHhHHHhhccc--------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 024118 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK--------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 176 (272)
Q Consensus 105 l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ 176 (272)
+++++......+++|||+++++|.+++..... ....+++..++.++.|++.|+.+||++ |++|+||+|+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 99999999999999999999999999854321 112468889999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh--CCCccccccC
Q 024118 177 NILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFDVQ 253 (272)
Q Consensus 177 nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~~~ 253 (272)
||++++++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+.
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999875432211 11122334568999999988889999999999999999998 6778876554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=232.91 Aligned_cols=200 Identities=30% Similarity=0.485 Sum_probs=168.0
Q ss_pred eeeeeccceEEEEEEeCC--C--cEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQD--G--TIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~--~--~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||.|++|.||+|.+.+ + ..|++|.+..... .....+.+|+..++++. ||||+++++.+.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD--HENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC--CCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998642 3 3689999876554 55678889999999998 9999999999888 8889999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|.+.+..... ..+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999999854322 5689999999999999999999999 999999999999999999999999999986643221
Q ss_pred c--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 203 H--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 203 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
. ......++..|+|||.+.+..++.++|+||||+++++|++ |+.||...+..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 1122345678999999988889999999999999999999 999997554433
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=240.16 Aligned_cols=200 Identities=25% Similarity=0.309 Sum_probs=168.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC---
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--- 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--- 112 (272)
...++|++.+.||+|++|.||+|.+. +|..||+|.+... .......+.+|+..++.+. ||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN--HKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC--CCCCcceeeeeccCCCc
Confidence 45688999999999999999999876 7999999998532 2233456778999999998 99999999987643
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...++|+||+. ++|.+.+. . .+++..+..++.|++.||.+||++ |++|+||+|+||+++.++.++|+
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~----~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQ----M--DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHh----h--cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 35689999995 47777762 1 288999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|||++........ .....++..|+|||.+.+..++.++|+||+||++|+|++|+.||...+
T Consensus 161 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 161 DFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred cCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999986543221 223456788999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=232.47 Aligned_cols=203 Identities=25% Similarity=0.446 Sum_probs=170.7
Q ss_pred CeeeeeeeeeccceEEEEEEeCC--CcEEEEEEEEecC----------cccHHHHHHHHHHhhc-ccccccceeEeeeeE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQD--GTIVAVKVLSVES----------KQGEKEFMSEVASMAN-VNVCHENLVKLHGGC 109 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~~--~~~v~vK~~~~~~----------~~~~~~~~~e~~~~~~-~~~~~~~i~~l~~~~ 109 (272)
+|++.+.||.|++|.||++.+.. +..+++|.+.... .....++.+|+..+.+ +. ||||+++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~--h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR--HPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCC--CCCeeeEEeeE
Confidence 48899999999999999998764 7889999876321 1223445667776654 45 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
..+...++++||+++++|.+++.........+++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEE
Confidence 99999999999999999999886544455679999999999999999999996 5 8999999999999999999999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|+|++|+.||...+
T Consensus 156 ~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 156 TDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999998654332 2233457888999999998889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=232.60 Aligned_cols=200 Identities=25% Similarity=0.432 Sum_probs=171.1
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
-|++.+.||.|+||.||+|.+. ++..+|+|...... ......+.+|+..++++. ||||+++++.+..+...++|+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC--CCCEeEEEEEEEeCCeEEEEEE
Confidence 4778899999999999999875 78999999876432 233456778899999988 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|..++. ...+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 83 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999999882 34688999999999999999999999 9999999999999999999999999998755332
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.. ......++..|+|||.+.+...+.++|+||+||++++|++|..||...+.
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 206 (277)
T cd06641 155 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206 (277)
T ss_pred hh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch
Confidence 21 12224567889999999888889999999999999999999999975443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=241.54 Aligned_cols=211 Identities=26% Similarity=0.407 Sum_probs=169.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
....++|++.+.||.|+||.||+|.+ .+++.||+|.+.... ......+.+|+..+.++.. ||||+++++.+.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~ 81 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNVVNLLGACT 81 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccC-CccHhhhcceee
Confidence 34567899999999999999999973 257889999987442 2234567889999999843 899999999876
Q ss_pred cC-CceeEEEeecCCCCHhHHHhhccc-----------------------------------------------------
Q 024118 111 DG-PCRILVYDYMPNNSLSQTLLGEEK----------------------------------------------------- 136 (272)
Q Consensus 111 ~~-~~~~iv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 136 (272)
.. ...+++|||+++++|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 467899999999999999854211
Q ss_pred ----------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-ccc
Q 024118 137 ----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HIS 205 (272)
Q Consensus 137 ----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~ 205 (272)
....++...+..++.|++.||.|||++ ||+|+||||.||+++.++.++|+|||++........ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 012467888899999999999999999 999999999999999999999999999875432211 111
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||....
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 12234567999999988889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=231.39 Aligned_cols=194 Identities=27% Similarity=0.386 Sum_probs=160.7
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhh-cccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMA-NVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~-~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
+.||.|++|.||+|... +|+.||+|.+..... ........|...+. ... |+|++++++.+..++..++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCC--CCCeeeeeeeEEcCCeEEEEEecc
Confidence 57899999999999876 689999999864321 11223334433332 334 999999999999999999999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|.+++ .....+++..+..++.|++.||.+||+. +++|+||+|.||++++++.++|+|||++.....
T Consensus 80 ~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 80 NGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred CCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 999999998 3445789999999999999999999999 999999999999999999999999998875332
Q ss_pred cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+...
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 200 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 222456788999999988888999999999999999999999997665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=231.62 Aligned_cols=192 Identities=24% Similarity=0.377 Sum_probs=158.7
Q ss_pred eeeeeccceEEEEEEeCC-------------CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 48 NKIGEGGFGSVYKGRLQD-------------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~-------------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+.||+|++|.||++...+ ...+++|++..........+..++..+..+. ||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~--hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS--HKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCC
Confidence 368999999999997532 2358888876554445557778888888888 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-------eE
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-------PK 187 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~-------~~ 187 (272)
.+++|||+++++|..++. .....+++..++.++.|++.|+.|||++ +|+|+||+|+||+++.++. ++
T Consensus 79 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 999999999999998873 2345689999999999999999999999 9999999999999987664 89
Q ss_pred EeecCcccccCCCCccccccccccccccCccccc-cCCCCCCCceehHHHHHHHHH-hCCCcccccc
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIV-SGRTAVDFDV 252 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~il~~l~-tg~~p~~~~~ 252 (272)
++|||++...... ....++..|+|||.+. +..++.++|+||+||++|+|+ +|..||....
T Consensus 153 l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 153 LSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred eCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999988654221 2234677899999886 456889999999999999997 5888887554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=231.46 Aligned_cols=203 Identities=26% Similarity=0.379 Sum_probs=162.9
Q ss_pred eeeeeccceEEEEEEeC---CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|... ++..+++|.+.... ......+.+|+..++++. ||||+++++.+.+....+++|||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ--HSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999754 35678999876443 233457788999999998 9999999999999899999999999
Q ss_pred CCCHhHHHhhccc-ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 124 NNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 124 ~~~L~~~~~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
+++|.+++..... .....++..+..++.|++.|+.+||++ +++|+||||+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999854322 223456778889999999999999999 999999999999999999999999999875432211
Q ss_pred -cccccccccccccCccccccC-------CCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 203 -HISTRVAGTLGYLAPEYAISG-------RLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 203 -~~~~~~~~~~~~~aPE~~~~~-------~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.......++..|+|||++.+. .++.++|+||+|+++|+|++ |+.||...+..+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 217 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 111223456789999998643 35789999999999999996 999997655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=235.46 Aligned_cols=205 Identities=26% Similarity=0.450 Sum_probs=175.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|.+.+.||.|++|.||++... +|+.|++|++... .......+..|+..++++.. ||||+++++++..+...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG-HPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhccc-CCCchhHHHHhcCCceEEE
Confidence 47999999999999999999876 7999999998642 22334567778888888763 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+||++++++|.+.+ .....+++..++.++.|++.++.+||+. |++|+|++|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 80 VLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999998 3445799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCc-------------------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENTT-------------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
..... .......++..|+|||...+..++.++|+||||++++++++|+.||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 43221 1122245678899999998888899999999999999999999999877643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=230.33 Aligned_cols=203 Identities=26% Similarity=0.365 Sum_probs=168.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++......||+|+||.||+|.+. ++..|++|.+..........+.+|+..++.++ |+||+++++.+..++..++++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK--HRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC--CCCeeeeeeeeccCCEEEEEE
Confidence 334445578999999999999866 68889999887655556667889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccC--ChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCeEEeecCcccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKF--GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL 196 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-~~~~~l~Dfg~~~~ 196 (272)
||+++++|.+++... ...+ ++..+..++.|++.|+.+||++ ||+|+||+|.||+++. ++.++|+|||.+..
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999998432 2334 7888999999999999999999 9999999999999976 67899999999876
Q ss_pred cCCCCccccccccccccccCccccccCC--CCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||...+
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 532221 122234678899999986543 7889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=233.33 Aligned_cols=206 Identities=28% Similarity=0.475 Sum_probs=165.8
Q ss_pred eeeeeeeeeccceEEEEEEeCC-Cc--EEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC------
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQD-GT--IVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------ 112 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~-~~--~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~------ 112 (272)
+.+.+.||.|++|.||+|.+.. +. .+++|.++.. .......+..|+..++.++ ||||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD--HPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEccCCcccCC
Confidence 3577899999999999998763 33 5899987643 2334567788999999998 99999999876432
Q ss_pred CceeEEEeecCCCCHhHHHhhcc--cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
...++++||+++++|.+++.... .....+++..+..++.|++.|+.+||++ +|+|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence 24689999999999998874322 1234588999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 191 FGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 191 fg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
||++......... ......++..|++||...+..++.++|+||+|+++|+|++ |+.||...+..
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 221 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999865432211 1122234667999999998889999999999999999999 89999765443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=227.01 Aligned_cols=200 Identities=31% Similarity=0.495 Sum_probs=175.0
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||+|++|.+|++.+. +++.|++|.+..... .....+.+|++.++++. ||+++++++++..+...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--HPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC--CCCccEEEEEEEeCCEEEEEE
Confidence 5899999999999999999876 688999999875533 34567888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++ .....+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 79 EYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred ecCCCCcHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 999999999998 3346789999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... .....++..|+|||...+...+.++|+|++|+++++|++|+.||...+
T Consensus 152 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 152 VSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred Cccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3321 223457888999999988788999999999999999999999997554
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=235.47 Aligned_cols=206 Identities=27% Similarity=0.426 Sum_probs=167.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCC--
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-- 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~-- 113 (272)
...++|++.+.||+|++|.||+|... +++.||+|.+.... ........+|+..++++. ||+|+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKATP 86 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC--CCCccceEEEEeccccc
Confidence 34567999999999999999999876 79999999886442 222345667899999998 999999999877543
Q ss_pred ------ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 114 ------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 114 ------~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
..++++||+. ++|.+.+. .....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK 159 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence 3489999996 47777762 2334689999999999999999999999 999999999999999999999
Q ss_pred EeecCcccccCCCCcc---ccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 188 ISDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|+|||++......... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999765332211 112234677899999887654 68899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=252.04 Aligned_cols=212 Identities=23% Similarity=0.376 Sum_probs=188.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCC-CcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+..++++++..||-||||.|=+++... ...+|+|+++.. ...++..+..|-.++...+ .|.|+++|..+.++..
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~--s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR--SDFIVRLYRTFRDSKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC--chHHHHHHHHhccchh
Confidence 456778889999999999999998653 335888887633 4556678888999999988 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.|++||-|-||.|+..+ ..++.|++.....++..+++|+.|||++ ||++|||||+|.+++.+|-+||.|||.+
T Consensus 495 vYmLmEaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred hhhhHHhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhH
Confidence 99999999999999999 6778899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhh
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 261 (272)
..+..... .-.++||+.|.|||.+.+...+.++|.|+||+++|+|++|.+||.+.++-..+.+|-
T Consensus 568 Kki~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 568 KKIGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred HHhccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 98765444 344799999999999999999999999999999999999999999999877666553
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=234.90 Aligned_cols=205 Identities=24% Similarity=0.306 Sum_probs=154.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-C---CcEEEEEEEEecCccc--H---------HHHHHHHHHhhccccccccee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-D---GTIVAVKVLSVESKQG--E---------KEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~---~~~v~vK~~~~~~~~~--~---------~~~~~e~~~~~~~~~~~~~i~ 103 (272)
+..++|.+.+.||+|+||.||+|.+. + +..+++|......... + .....+...+..+. |++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~--h~~i~ 86 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID--HLGIP 86 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC--CCCCC
Confidence 45678999999999999999999865 3 4567777654332111 1 11122223344445 99999
Q ss_pred EeeeeEecCC----ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 024118 104 KLHGGCIDGP----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179 (272)
Q Consensus 104 ~l~~~~~~~~----~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nil 179 (272)
.+++.+.... ..+++++++ ..++.+.+ ......++..++.++.|++.|+.+||++ +|+||||||+||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil 158 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIF----KRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM 158 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehh-ccCHHHHH----HhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 9998765443 235777766 34566665 2233467888999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeecCcccccCCCCc------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 180 LDQNFNPKISDFGLSKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 180 v~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++.++.++|+|||++........ .......||+.|+|||++.+..++.++|+||+||++++|++|..||...+.
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999999999999976532211 111224689999999999999999999999999999999999999987744
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=233.06 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=159.4
Q ss_pred eeeeeccceEEEEEEeC---CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||+|... ....+++|.+.... ......+.+|+..++.+. ||||+++++.+......+++|||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN--HPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC--CCCcceEEEEECCCCceEEEEEeCC
Confidence 36899999999999644 24568888765332 223456778898888887 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccc-cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 124 NNSLSQTLLGEEKR-RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 124 ~~~L~~~~~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
+++|.+++...... ....++..+..++.||+.|+.|||++ +|+|+||||.||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99999998554322 23456788899999999999999999 999999999999999999999999999865422211
Q ss_pred c-ccccccccccccCcccccc-------CCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 203 H-ISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 203 ~-~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
. ......++..|+|||++.. ..++.++|+||+|+++|+|++ |..||...+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 1 1122334567999998743 346789999999999999999 8889976553
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=262.70 Aligned_cols=215 Identities=30% Similarity=0.494 Sum_probs=182.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC--CCc----EEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ--DGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~----~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+...+..+.+.||+|.||.||.|... +|. .|++|.+... +......+++|+..++.+. ||||+++++++..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~--HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD--HPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC--CcceeeEEEeecC
Confidence 44778899999999999999999754 343 4888887644 4556689999999999999 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhccc---ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
....+|++|||+||+|..++++... ....++...+..++.|+++++.||+++ +++||||..+|+|++....+|+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 9999999999999999999965421 245688999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCccc-cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 189 SDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
+|||+++.+-...... .........|+|||.+....++.++||||+||++||++| |..||...+..+.+.
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 9999999443322222 222234568999999999999999999999999999999 999999888776555
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=235.85 Aligned_cols=207 Identities=30% Similarity=0.466 Sum_probs=170.5
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCC-
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP- 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~- 113 (272)
....++|++.+.||.|++|.||+|.++ +|+.|++|.+.... ........+|+..++.++ |||++++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN--HRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC--CCCeeeeeheecCcch
Confidence 456788999999999999999999876 68999999987543 233356678899999998 999999999887654
Q ss_pred ---------ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 114 ---------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 114 ---------~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
..++++||+++ ++...+. .....+++..++.++.|++.||.+||+. ||+|+||+|+||++++++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLE---SGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG 153 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 78999999976 6666652 2245789999999999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.++|+|||.+...............++..|+|||.+.+. .++.++|+||+||++++|++|++||...+.
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999986543332222223456779999988654 468899999999999999999999986554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=248.53 Aligned_cols=222 Identities=31% Similarity=0.450 Sum_probs=186.4
Q ss_pred ccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC--CC--cE-EEEEEEEec---CcccHHHHHHHHHHhhccccccc
Q 024118 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ--DG--TI-VAVKVLSVE---SKQGEKEFMSEVASMANVNVCHE 100 (272)
Q Consensus 29 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~--~~-v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~ 100 (272)
..+.....|.+.-++..+.+.||+|+||.||+|... ++ .. ||+|..+.. .......+++|++.+++++ ||
T Consensus 144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~--H~ 221 (474)
T KOG0194|consen 144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN--HP 221 (474)
T ss_pred cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC--CC
Confidence 356777778888888888899999999999999755 22 23 899998852 4667789999999999999 99
Q ss_pred ceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 101 ~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
||++++++.....-.++|||+|.||+|.+++... ...++..+....+.+.+.+++|||++ +++||||..+|+|+
T Consensus 222 NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~ 295 (474)
T KOG0194|consen 222 NVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLY 295 (474)
T ss_pred CEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHhee
Confidence 9999999999999999999999999999999432 23689999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeecCcccccCCCCccccc-cccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 181 DQNFNPKISDFGLSKLFPENTTHIST-RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
..++.+|++|||++..-.. ..... .......|+|||.+....+++++||||+|+++||+++ |..||.+.+..+...
T Consensus 296 ~~~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~ 373 (474)
T KOG0194|consen 296 SKKGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA 373 (474)
T ss_pred cCCCeEEeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH
Confidence 9998899999999874321 11111 1124578999999999999999999999999999999 888998877654433
Q ss_pred hh
Q 024118 259 LV 260 (272)
Q Consensus 259 ~~ 260 (272)
.+
T Consensus 374 kI 375 (474)
T KOG0194|consen 374 KI 375 (474)
T ss_pred HH
Confidence 33
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=230.63 Aligned_cols=195 Identities=30% Similarity=0.411 Sum_probs=158.2
Q ss_pred eeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhccc-ccccceeEeeeeEecCCceeEEEeecC
Q 024118 49 KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
.||+|++|.||+|.+. +++.||+|.+..... ........+...++.++ ..||+|+++++.+...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999875 689999999864321 11222333333333221 128999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
|++|..++ .....+++..++.++.|++.|+.+||+. +++|+|++|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l----~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999887 3446799999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 204 ISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 2234678899999998754 588999999999999999999999986643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=244.01 Aligned_cols=213 Identities=25% Similarity=0.415 Sum_probs=174.4
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
.+.+..++|.+.+.||+|+||.||+|.+. .+..||+|++...... ....+.+|+..+..+.. ||||+++++.
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~-H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGP-HLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCC-CCCeEEEEEE
Confidence 46777788999999999999999999853 3468999999754322 23467889999988854 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhccc----------------------------------------------------
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEK---------------------------------------------------- 136 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~---------------------------------------------------- 136 (272)
+......++|+||+++++|.+++.....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9998999999999999999999854321
Q ss_pred ------------------------------------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 024118 137 ------------------------------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174 (272)
Q Consensus 137 ------------------------------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~ 174 (272)
....+++..++.++.|++.||.|||++ +++|+||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence 112467778899999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
|.||++++++.++|+|||++........ .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999975432211 11122345678999999988889999999999999999998 899997544
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=233.27 Aligned_cols=201 Identities=28% Similarity=0.462 Sum_probs=170.3
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC--CceeEE
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILV 118 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~~~iv 118 (272)
|++.+.||.|++|.||+|.+. +|+.+++|.+.... ......+.+|+..++.+. |||++++++++... ...+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR--HPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc--CCCeeeheeeEecCCCCcEEEE
Confidence 688999999999999999877 58899999997553 334456788999999998 99999999999887 789999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++ +|.+.+.. ....+++..++.++.|++.|+.+||+. |++|+||+|+||++++++.++|+|||.+....
T Consensus 79 ~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 79 FEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred eccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 999975 78887732 225789999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
...........++..|+|||.+.+. .++.++|+||+|+++++|++|+.||...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4332222334457789999987654 578999999999999999999999976654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=232.64 Aligned_cols=202 Identities=28% Similarity=0.460 Sum_probs=169.4
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.||+|.+. +|+.|++|.+.... ......+.+|++.+++++ ||||+++++++..+...+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC--CCCCcchhhhcccCCcEEEEe
Confidence 5899999999999999999876 78999999886442 223357888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+. ++|.+++.. .....+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 79 EFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred eccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9995 578887743 2345688999999999999999999999 999999999999999999999999999875533
Q ss_pred CCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|+||+.||...+.
T Consensus 153 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 206 (284)
T cd07860 153 PVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206 (284)
T ss_pred Cccc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 2211 12234577899999887654 58899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=231.60 Aligned_cols=200 Identities=31% Similarity=0.468 Sum_probs=162.2
Q ss_pred eeeeeccceEEEEEEeC-CCc--EEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~--~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|++|.||+|..+ ++. .+++|.+... .......+.+|+..+.++.. ||||+++++.+......+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-HPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhcc-CCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999876 444 4688877632 23344577889999988832 9999999999999999999999999
Q ss_pred CCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 124 NNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 124 ~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
+++|.+++..... ....+++..++.++.|++.|+++||++ |++|+||+|+||+++.++.++|+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999854321 123578999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
|++....... .......+..|+|||++....++.++|+||+|+++++|++ |..||...+.
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 217 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH
Confidence 9985322111 1111223456999999988889999999999999999997 9999975543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=233.84 Aligned_cols=198 Identities=29% Similarity=0.427 Sum_probs=167.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|++.+.||.|++|.||+|.+. +|+.|++|.+.... ......+.+|+..++.+. |||++++++++..+...+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR--HPNTIEYKGCYLREHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEEeCCeEE
Confidence 466999999999999999999876 78999999986432 223356788999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+|+||++ +++.+.+. .....+++..+..++.|++.++.+||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 92 lv~e~~~-g~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 92 LVMEYCL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEHHhhC-CCHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9999996 56666653 2335689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... ....++..|+|||.+. ...++.++|+||+|+++|+|++|+.||...+
T Consensus 165 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 165 VSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred cCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 4322 2245677899999875 3457889999999999999999999997544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=235.49 Aligned_cols=209 Identities=33% Similarity=0.495 Sum_probs=172.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
...+|++.+.||+|+||.||+|.+. ++..+++|.+.... ......+.+|+..++.+. ||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--HPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC--CCchheEEEEEcCC
Confidence 4567999999999999999999853 46789999886442 233456888999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcc------------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEE------------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~------------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~ 174 (272)
...++++||+++++|.+++.... .....+++..++.++.|++.||.+||++ +++|+||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999985421 1123578899999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
|.||+++.++.++|+|||.+........ ........+..|+|||.+.+..++.++|+||+||++|+|++ |..||...+
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999875432211 11112233567999999988889999999999999999998 888886554
Q ss_pred C
Q 024118 253 Q 253 (272)
Q Consensus 253 ~ 253 (272)
.
T Consensus 238 ~ 238 (288)
T cd05050 238 H 238 (288)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=231.51 Aligned_cols=197 Identities=27% Similarity=0.430 Sum_probs=168.3
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
||.|++|.||++.+. +|+.+++|.+..... .....+.+|++.++++. ||||+++++.+......++++||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ--SPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC--CcchhHHHHheecCcEEEEEEecCCCC
Confidence 588999999999877 599999999864432 34567888899999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc---
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT--- 202 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~--- 202 (272)
+|.+++. ....+++..++.++.|++++|.+||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 79 DLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9999983 334789999999999999999999999 999999999999999999999999999875432211
Q ss_pred ----cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 203 ----HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 203 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.......++..|++||...+...+.++|+||+|+++++|++|..||...+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 208 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 01223456778999999988888999999999999999999999998666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=249.17 Aligned_cols=194 Identities=30% Similarity=0.465 Sum_probs=170.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+.|+-++.||.|+||.||-|++. +.+.||||..... ......+++.|+..+.++. |||++.+-+++.....+|+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~--HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR--HPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc--CCCcccccceeeccchHHH
Confidence 44777899999999999999866 8899999998633 3344568999999999999 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||| -|+-.+.+ ....+++.+-.|..|..+.+++|.|||+. +.+|||||..|||+++.|.|||+|||.+...
T Consensus 104 VMEYC-lGSAsDll---eVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 104 VMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHH-hccHHHHH---HHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence 99999 45677776 34568899999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
.+ .+.+.|||.|+|||++. ...|+-++||||||++..+|...++|+-
T Consensus 177 ~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 177 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred Cc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 33 44578999999999986 3458999999999999999999999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=225.50 Aligned_cols=201 Identities=29% Similarity=0.432 Sum_probs=175.8
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecC--CceeE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRIL 117 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~~~i 117 (272)
+|.+.+.||+|++|.||+|.+. ++..+++|.+..... .....+.+|+..++++. ||+|+++++.+... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--HPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC--CCCEeeEEEEEecCCCCeEEE
Confidence 5889999999999999999887 789999999875542 44567888999999999 99999999999988 88999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
++||+++++|.+++. ....+++..++.++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||.+...
T Consensus 79 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 79 FLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 999999999999983 334889999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 198 PENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...... ......++..|.|||.+.+...+.++|+||+|+++++|++|..||...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 543220 1223457788999999988889999999999999999999999997665
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=238.62 Aligned_cols=201 Identities=26% Similarity=0.408 Sum_probs=168.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC-----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----- 112 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----- 112 (272)
..+|.+.+.||.|++|.||+|.+. ++..|++|.+... .........+|+..++.+. ||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD--HENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC--CCCccchHHheeccccccc
Confidence 467999999999999999999876 7999999998643 2333456778999999988 99999999987644
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++++||+. ++|.+.+ .....+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 82 NDVYIVYELMD-TDLHQII----RSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred CcEEEEEeCCC-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 34789999995 6788887 3446799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
++....... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||...+
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 998654322 12233456788999998865 458899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=232.69 Aligned_cols=204 Identities=27% Similarity=0.441 Sum_probs=167.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++.+.||.|++|.||+|.+. +|+.|++|.+..... .....+.+|++.++++. ||||+++++.+..+...++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--HGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc--CCCEeeEEEEEecCCeEEEE
Confidence 57999999999999999999876 789999999864322 23356778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCeEEeecCccccc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLF 197 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-~~~~~l~Dfg~~~~~ 197 (272)
+||++ ++|.+.+... ....+++..++.++.||+.||.+||++ +++|+||+|+||+++. ++.++|+|||++...
T Consensus 80 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 80 FEYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred Eeccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99996 4777776322 223467889999999999999999999 9999999999999985 456899999999765
Q ss_pred CCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
..... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...++.
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 154 GIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred CCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 33221 12223567889999988664 5788999999999999999999999866543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=229.95 Aligned_cols=200 Identities=30% Similarity=0.470 Sum_probs=167.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
.++|++.+.||+|++|.||++.. +++.+++|...... ....+.+|+..++.+. |||++++++.+..+ ..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLH--HKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCC--CCCcCeEEEEEcCC-CcEEEEE
Confidence 46799999999999999999864 57789999886432 3357788999999998 99999999988654 4789999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+++... ....+++..++.++.|++.|+.+||+. |++|+|++|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 79 LMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999999998432 234578999999999999999999999 9999999999999999999999999998754321
Q ss_pred CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
. .....+..|.|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 1 11233567999999988889999999999999999998 999997665433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=239.20 Aligned_cols=202 Identities=27% Similarity=0.392 Sum_probs=172.7
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCC-----c
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-----C 114 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~-----~ 114 (272)
+|++.+.||.|++|.||+|.+. +|+.|++|.+.... ......+..|+..++.+. ||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR--HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC--CcchhhhhhhhcccCcccccc
Confidence 6899999999999999999976 58999999987543 344567888999999998 999999999887765 7
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||++ ++|.+.+ ....++++..++.++.|++.|+.+||+. |++|+||+|.||+++.++.++|+|||.+
T Consensus 79 ~~lv~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 79 VYIVTELME-TDLHKVI----KSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred eEEEecchh-hhHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 899999996 5788877 3344899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--cccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 195 KLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 195 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
........ .......++..|+|||.+.+. .++.++|+||+|+++++|++|++||...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 87654321 112334567889999999887 7899999999999999999999999766643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=228.95 Aligned_cols=192 Identities=28% Similarity=0.449 Sum_probs=160.0
Q ss_pred eeeeeccceEEEEEEeCC-C----------cEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 48 NKIGEGGFGSVYKGRLQD-G----------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~-~----------~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+.||+|+||.||+|.+.+ + ..+++|.+...... ...+.+|+..++.+. ||||+++++.+.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~--h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLS--HKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCC--CcchhheeeEEec-CCcE
Confidence 468999999999998763 3 25778876544333 678888999999998 9999999999888 7789
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-------CeEEe
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-------NPKIS 189 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-------~~~l~ 189 (272)
+++||+++++|.+++... ...+++..+..++.|++.||.+||++ ||+|+||+|+||+++.++ .++|+
T Consensus 77 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999998432 22688999999999999999999999 999999999999999887 79999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccC--CCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
|||.+..... .....++..|+|||++.+. .++.++|+||+|+++++|++ |..||...+..
T Consensus 151 Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 151 DPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred CCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 9999886432 1223456679999999876 68899999999999999999 68888776533
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=230.82 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=163.2
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC--CceeEEE
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--PCRILVY 119 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~~~~iv~ 119 (272)
|.+.+.||+|++|.||+|... ++..|++|.++... .........|+..+.++.. |+|++++++++..+ +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP-HPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCC-CCCccceEEEEecCCCCcEEEEE
Confidence 678999999999999999866 78999999886432 2223344567777777743 99999999999887 8899999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++ +|.+.+.. ....+++..++.++.|++.||.+||+. |++|+||+|+||+++. +.++|+|||++.....
T Consensus 80 e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 99975 67776632 235789999999999999999999999 9999999999999999 9999999999986543
Q ss_pred CCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
... .....++..|+|||.+.. ..++.++|+||+||++|+|++|..||...+..
T Consensus 152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~ 205 (282)
T cd07831 152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL 205 (282)
T ss_pred CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence 221 122346788999997654 45788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=233.93 Aligned_cols=197 Identities=25% Similarity=0.432 Sum_probs=169.7
Q ss_pred eeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCC
Q 024118 46 WSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~ 124 (272)
-...||.|++|.||++... +|+.|++|.+..........+.+|+..++.+. |+|++++++.+...+..+++|||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC--CcchhheeeEEEeCCEEEEEEecCCC
Confidence 3478999999999999875 79999999986554445567888999999988 99999999999999999999999999
Q ss_pred CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccc
Q 024118 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204 (272)
Q Consensus 125 ~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~ 204 (272)
++|.+.+ ....+++..++.++.|++.++.+||+. |++|+||+|.||+++.++.++|+|||.+........ .
T Consensus 102 ~~L~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 102 GALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred CcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 9999877 234688999999999999999999999 999999999999999999999999998875543221 1
Q ss_pred cccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 205 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.....++..|++||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~ 221 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2224577889999999888889999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=229.79 Aligned_cols=201 Identities=22% Similarity=0.378 Sum_probs=159.4
Q ss_pred eeeeeccceEEEEEEeCCC---cEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQDG---TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~---~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.||+|+||.||++...++ ..+++|.+.... ......+.+|+..++.++ ||||+++++.+......+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ--HPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC--CcchhheEEEecCCCccEEEEecCC
Confidence 3689999999999975432 356667665332 234567888888888888 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC-c
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-T 202 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~-~ 202 (272)
+++|.+++..........++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999865433345567788899999999999999999 99999999999999999999999999876422111 1
Q ss_pred cccccccccccccCcccccc-------CCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 203 HISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
.......++..|+|||++.. ..++.++|+||+|+++|+|++ |..||...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 11223456788999998753 235789999999999999997 5778865544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=235.37 Aligned_cols=205 Identities=29% Similarity=0.501 Sum_probs=167.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCc----EEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~----~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
..++|+..+.||+|++|.||+|.+. +|. .+++|.+..... .....+.+|+..++.+. ||||+++++.+...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcccEEEEEcCC-
Confidence 3567899999999999999999864 454 478887764322 22346778889999988 99999999988654
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++++||+++++|.+++.. ....+++..++.++.|++.||.+||++ +++|+||+|+||++++++.++|+|||+
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccc
Confidence 46789999999999999832 234688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 194 SKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9865432211 1122334568999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=249.87 Aligned_cols=200 Identities=28% Similarity=0.448 Sum_probs=172.4
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~ 126 (272)
-.||+|.+|+||.|++. +....|||.+..........+..|+...++++ |.|||++++.+.+++..-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr--HkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR--HKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh--hHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 47999999999999987 45679999987666566678889999999999 9999999999999999999999999999
Q ss_pred HhHHHhhcccccccC--ChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCeEEeecCcccccCCCCcc
Q 024118 127 LSQTLLGEEKRRAKF--GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTH 203 (272)
Q Consensus 127 L~~~~~~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~-~~~~~~l~Dfg~~~~~~~~~~~ 203 (272)
|.++++. .=+++ ++..+-.+..||+++|.|||.+ .|+|||||-+|++|+ -.|-+||.|||-+.++..- ..
T Consensus 659 LSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP 731 (1226)
T KOG4279|consen 659 LSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NP 731 (1226)
T ss_pred HHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cc
Confidence 9999943 34566 7889999999999999999999 999999999999996 5577999999999876532 33
Q ss_pred ccccccccccccCccccccC--CCCCCCceehHHHHHHHHHhCCCccc-cccCCCc
Q 024118 204 ISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVD-FDVQLGE 256 (272)
Q Consensus 204 ~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~-~~~~~~~ 256 (272)
....+.||.-|+|||++... .|..++||||+||++.+|.||++||- ..+++..
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA 787 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA 787 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh
Confidence 45667899999999999754 48999999999999999999999995 4444433
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=237.83 Aligned_cols=203 Identities=25% Similarity=0.373 Sum_probs=169.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEec----CC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~ 113 (272)
..+|++.+.||.|++|.||+|... +|..|++|.+.... ......+.+|+..++.+. ||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK--HDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC--CCCccCHHHhccccCCCCc
Confidence 478999999999999999999866 79999999987542 234456778999999998 9999999987753 34
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++|+||+. ++|.+.+ .....+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.
T Consensus 82 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 82 DVYVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred eEEEEEehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 6789999995 5788887 3445689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENTTH---ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+......... ......++..|.|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 8765332211 1123467888999999865 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=230.34 Aligned_cols=201 Identities=28% Similarity=0.458 Sum_probs=168.2
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
|++.+.||.|++|.||+|.+. +|..|++|.+.... ......+.+|+..++.++ ||+++++++.+..+...++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN--HPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC--CCCccCHhheeccCCeEEEEEe
Confidence 678899999999999999876 79999999987543 223356788999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|++ ++|.+++... ....+++..++.++.|++.+|.+||++ +++|+|++|+||+++.++.++|+|||.+......
T Consensus 79 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 79 FLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred ccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 995 6888887332 124689999999999999999999999 9999999999999999999999999998755322
Q ss_pred CccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|++||...+.
T Consensus 153 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 153 VRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred ccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 211 1223457789999988664 468899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=227.08 Aligned_cols=203 Identities=25% Similarity=0.445 Sum_probs=172.5
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|++.+.||.|++|.||++..+ +|..+++|.+.... ......+.+|+..++.++ |+|++++++.+......++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK--HPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC--CCChhhhhheeccCCeEEEEE
Confidence 5899999999999999999876 68899999986532 233456778999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-eEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-PKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~-~~l~Dfg~~~~~~ 198 (272)
||+++++|.+++... ....+++..+..++.|++.|+.+||+. +++|+|++|.||++++++. ++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 79 EYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred ecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 999999999988432 233578999999999999999999999 9999999999999988865 6999999987654
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... ......++..|+|||++.+..++.++|+||+|+++++|++|..||...+.
T Consensus 154 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 207 (257)
T cd08225 154 DSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207 (257)
T ss_pred CCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 3222 12224578889999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=252.19 Aligned_cols=204 Identities=22% Similarity=0.372 Sum_probs=179.7
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.+-|+|+..||-|+||.||+|.++ ++-..|-|++..........++-|+.++..+. ||+|+++++.+...+..+|+.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd--HP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD--HPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC--ChHHHHHHHHHhccCceEEEE
Confidence 345788999999999999999887 56677888887777778889999999999999 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|||.||..+..+. .....+.+.+|..+.+|++.||.|||++ +|+|||||..|||++.+|.++|.|||.+.....
T Consensus 109 EFC~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred eecCCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999999999884 5678899999999999999999999999 999999999999999999999999999864321
Q ss_pred CCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.......+.||++|+|||+.+ ..+|+.++||||||+++.+|..+.+|-+-.++
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 112234478999999999865 55799999999999999999999999876554
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=230.46 Aligned_cols=201 Identities=30% Similarity=0.426 Sum_probs=168.6
Q ss_pred CeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecC----cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+|++.+.||.|++|.||++... ++..|++|.+.... ......+..|+..+.++.. ||+|+++++.+..+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~-~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR-CPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccC-CcchhhhheeeecCCE
Confidence 4889999999999999999742 57889999986331 2233467788888888853 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||+++++|.+.+. ....+++..++.++.|++.+|.+||+. +++|+||+|.||+++.++.++|+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 80 LHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999999883 345688999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccccCC--CCCCCceehHHHHHHHHHhCCCccccc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
...............++..|+|||.+.+.. .+.++|+||+|+++++|++|..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 765433222222345788899999987655 688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=230.66 Aligned_cols=203 Identities=31% Similarity=0.516 Sum_probs=170.5
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-----CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEec--C
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-----DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCID--G 112 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-----~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~ 112 (272)
.+.|++.+.||+|+||.||+|... ++..+|+|.+...... ....+.+|++.++.+. ||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~--~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC--CCChheEEeeeecCCC
Confidence 356888999999999999999753 4788999998755443 4567888999999998 9999999998877 5
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...+++|||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence 578999999999999999843 233689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 193 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
.+......... ......++..|++||.+.+..++.++|+||+|+++++|++|..|+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 99876532211 111223455699999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=232.25 Aligned_cols=204 Identities=28% Similarity=0.465 Sum_probs=165.7
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc--cHHHHHHHHHHhhcccccccceeEeeeeEecCC----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ--GEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---- 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~---- 113 (272)
.++|++.+.||.|++|.||+|.+. +++.+++|.+...... ......+|++.++.++ ||||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK--HPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC--CCCccchhhheeccccccc
Confidence 578999999999999999999876 7899999998654322 2345678999999998 999999998775433
Q ss_pred ----ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 114 ----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 114 ----~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
..++++||+.+ +|...+. .....+++..++.++.|+++||.+||++ |++|+|++|+||++++++.++|+
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 46899999864 5666552 2345799999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccc----------cccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 190 DFGLSKLFPENTTHI----------STRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|||++.......... .....++..|.|||.+.+. .++.++|+||+|+++|+|++|++||...+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999997553222111 1123456779999988654 478999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=227.75 Aligned_cols=207 Identities=25% Similarity=0.363 Sum_probs=178.8
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
...+.+..++|.+++.||+|+++.|.+++++ +.+.+|+|+++.+ ..++..-...|.-...+..+ ||.++-+...+
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn-~pflvglhscf 320 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-NPFLVGLHSCF 320 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccC-CCeEEehhhhh
Confidence 3667788899999999999999999999866 7899999998743 33333333344444444443 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
....+.+.|.||++||+|-..+ +++.++++++++.+...|.-||.|||++ ||++||||.+|++++..|++||.
T Consensus 321 qtesrlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred cccceEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeec
Confidence 9999999999999999998887 7788999999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
|+|++..--. .......++||+.|.|||.+.+..|....|.|+||+++++|+.|+.||+
T Consensus 394 dygmcke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 394 DYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ccchhhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 9999984322 2233456899999999999999999999999999999999999999997
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=235.76 Aligned_cols=205 Identities=27% Similarity=0.372 Sum_probs=168.8
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
...+-...++|++.+.||+|++|.||++... +|+.||+|.+.... ........+|+..+++++ ||||+++++++.
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~iv~~~~~~~ 86 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFT 86 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC--CCcccceeeeee
Confidence 3445566789999999999999999999865 78999999886432 223456778999999998 999999999875
Q ss_pred cC------CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 111 DG------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 111 ~~------~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
.. ...+++++++ +++|.+.+ ....+++..++.++.|++.|+.+||++ |++|+||+|+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 3467778776 78898876 234689999999999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999998754322 223456788999998876 4578899999999999999999999976544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=230.79 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=170.6
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
|++.+.||.|++|.||+|... +|+.+++|.+..... .....+..|+..++.+. |++|+++++.+..+...++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN--HPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc--CCCcchHHHhhccCCCEEEEEe
Confidence 678899999999999999876 789999999864432 24467778999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++ +|.+.+.. ....+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 79 FMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred ccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 9975 77777632 235789999999999999999999999 9999999999999999999999999999866543
Q ss_pred CccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.. ......++..|.|||.+.+. .++.++|+||+|+++|+|++|+.||...+..
T Consensus 152 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 205 (283)
T cd05118 152 VR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205 (283)
T ss_pred cc-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 31 12224467789999998876 6889999999999999999999999766643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=230.14 Aligned_cols=193 Identities=25% Similarity=0.408 Sum_probs=157.0
Q ss_pred eeeeccceEEEEEEeCC-------------------------CcEEEEEEEEecCcccHHHHHHHHHHhhccccccccee
Q 024118 49 KIGEGGFGSVYKGRLQD-------------------------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~~-------------------------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
.||+|+||.||+|.... ...|++|.+..........+..++..++.+. ||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~--h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS--HIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC--CCCee
Confidence 58999999999987421 1358888876444444456777888888888 99999
Q ss_pred EeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 104 ~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
++++++......++||||+++++|..++.. ....+++..+..++.|++.|+.|||++ +|+|+||+|+||+++..
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 999999999999999999999999988832 345688999999999999999999999 99999999999999764
Q ss_pred C-------CeEEeecCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHH-hCCCccccccCC
Q 024118 184 F-------NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIV-SGRTAVDFDVQL 254 (272)
Q Consensus 184 ~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~-tg~~p~~~~~~~ 254 (272)
+ .+++.|||.+...... ....++..|+|||.+.+ ..++.++|+||+|+++|+|+ +|+.||...+..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred CcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4 3799999987643211 11345677999998875 45789999999999999984 799999766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=235.91 Aligned_cols=206 Identities=25% Similarity=0.395 Sum_probs=169.5
Q ss_pred hhCCeee-eeeeeeccceEEEEEEeC-CCcEEEEEEEEecCccc--------------HHHHHHHHHHhhccccccccee
Q 024118 40 ATNGFRW-SNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQG--------------EKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 40 ~~~~y~i-~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~--------------~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
..++|.. .+.||.|++|.||+|.+. +++.||+|.+....... ...+.+|++.++.+. ||||+
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv 83 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK--HENIM 83 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC--Cccee
Confidence 3456764 577999999999999876 79999999986432221 124678999999998 99999
Q ss_pred EeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 104 ~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
++++++......+++|||+. ++|.+.+ .....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVV----DRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSK 155 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCC
Confidence 99999999999999999996 5888887 3456789999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCcccccCCCC-------------ccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccc
Q 024118 184 FNPKISDFGLSKLFPENT-------------THISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
+.++|+|||.+....... ........++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999997654110 11112234577899999987654 6889999999999999999999998
Q ss_pred cccCCC
Q 024118 250 FDVQLG 255 (272)
Q Consensus 250 ~~~~~~ 255 (272)
..++.+
T Consensus 236 ~~~~~~ 241 (335)
T PTZ00024 236 GENEID 241 (335)
T ss_pred CCCHHH
Confidence 776543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=235.80 Aligned_cols=201 Identities=24% Similarity=0.391 Sum_probs=166.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC-------
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------- 112 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~------- 112 (272)
..+|++.+.||.|++|.||+|... +|..|++|.+..........+.+|+..++.++ ||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC--CCcchhhHhhhcccccccccc
Confidence 478999999999999999999876 78999999987666566677888999999998 99999999776543
Q ss_pred -------CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCC
Q 024118 113 -------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNF 184 (272)
Q Consensus 113 -------~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~-~~~ 184 (272)
...++++||++ ++|.+.+ ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++ +++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVL-----EQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 34689999996 5888777 234688999999999999999999999 999999999999997 455
Q ss_pred CeEEeecCcccccCCCCcc--ccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 185 NPKISDFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.++|+|||.+......... ......++..|.|||.+.+ ..++.++|+|||||++|+|++|+.||...+
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6899999998765322111 1122346778999998754 457889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=240.61 Aligned_cols=195 Identities=29% Similarity=0.458 Sum_probs=170.8
Q ss_pred eeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCC
Q 024118 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~ 124 (272)
+.||.|.||+||-+.++ +|+.||||++... ....+...++|+.+++.+. ||.|+.+--.++..++.++|||.+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~--HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH--HPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC--CCCeeEEEEeecCCceEEEEehhhcc
Confidence 89999999999999877 8999999999643 4556678999999999999 99999999999999999999999966
Q ss_pred CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCeEEeecCcccccCCCC
Q 024118 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFGLSKLFPENT 201 (272)
Q Consensus 125 ~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~~~~l~Dfg~~~~~~~~~ 201 (272)
.-|.-.+. ...+.+++..-..++.||+.||.|||-+ +|+|+||||+|||+.+. .++||+|||.++.++...
T Consensus 648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 55555552 4557799999999999999999999999 99999999999999654 458999999999876433
Q ss_pred ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 202 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
....+.||+.|+|||++..+.|.+.-|+||+|+|+|--++|..||+-..
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 2345789999999999999999999999999999999999999997443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=241.32 Aligned_cols=222 Identities=27% Similarity=0.356 Sum_probs=182.2
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEE-eCCCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEe
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKL 105 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l 105 (272)
+...++--.+.-+-|..++.||-|+||.|.+++ ..+...||+|.+... ...+......|-.+|.... ++-+|++
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD--n~WVVrL 694 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD--NEWVVRL 694 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC--CcceEEE
Confidence 333444445666778889999999999999996 446788999988633 2233445666777777766 8899999
Q ss_pred eeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 024118 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
+-.|.+++..|.||+|++||++-+++ -+.+-|+|..++.++..+..|++..|+. |++||||||+|||||.+|+
T Consensus 695 yySFQDkdnLYFVMdYIPGGDmMSLL----IrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGH 767 (1034)
T KOG0608|consen 695 YYSFQDKDNLYFVMDYIPGGDMMSLL----IRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGH 767 (1034)
T ss_pred EEEeccCCceEEEEeccCCccHHHHH----HHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCc
Confidence 99999999999999999999999998 4557789999999999999999999999 9999999999999999999
Q ss_pred eEEeecCcccccCCC---Ccc--------------------------------------ccccccccccccCccccccCC
Q 024118 186 PKISDFGLSKLFPEN---TTH--------------------------------------ISTRVAGTLGYLAPEYAISGR 224 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~---~~~--------------------------------------~~~~~~~~~~~~aPE~~~~~~ 224 (272)
+||.|||+|.-+... ... ......||+.|+|||++....
T Consensus 768 IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g 847 (1034)
T KOG0608|consen 768 IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG 847 (1034)
T ss_pred eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC
Confidence 999999999643110 000 001135899999999999999
Q ss_pred CCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 225 LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 225 ~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
++...|.||.|+|||+|+.|++||...++.+....+
T Consensus 848 ~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 848 YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeee
Confidence 999999999999999999999999988877655443
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=231.73 Aligned_cols=197 Identities=28% Similarity=0.432 Sum_probs=165.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+.|...+.||+|+||.||++.+. ++..+++|.+.... ......+..|++.++.+. |||++++++++..+...++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK--HPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC--CCCEEEEEEEEeeCCeEEE
Confidence 34788999999999999999876 78999999986432 223356788999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||++| +|.+.+. ....++++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 103 v~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 103 VMEYCLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred EEeCCCC-CHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 9999975 6766653 2345689999999999999999999999 9999999999999999999999999988754
Q ss_pred CCCCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
... ....++..|+|||++. +..++.++|+||+|+++|+|++|+.||...+
T Consensus 176 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 176 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred CCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 321 2245678899999974 3457889999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=229.55 Aligned_cols=201 Identities=32% Similarity=0.503 Sum_probs=164.8
Q ss_pred eeeeeccceEEEEEEeCC-------CcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 48 NKIGEGGFGSVYKGRLQD-------GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~-------~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+.||.|++|.||++.+.+ +..+++|.+.... ......+.+|+..++.+. ||||+++++++......++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN--HPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC--CCCeeeEeeeecCCCCeEEEE
Confidence 368999999999998642 3679999875432 234567888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhccc---ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----CeEEeec
Q 024118 120 DYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-----NPKISDF 191 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-----~~~l~Df 191 (272)
||+++++|.+++..... ....+++..+..++.|++.++.+||++ +++|+||+|+||+++.++ .++|+||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999854322 224578899999999999999999999 999999999999999887 7999999
Q ss_pred CcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 192 GLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
|++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~ 219 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH
Confidence 99875532211 11112234578999999998889999999999999999998 9999975543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=267.45 Aligned_cols=204 Identities=30% Similarity=0.404 Sum_probs=175.4
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.-+|+-...||.|.||.||.|.+. +|.-.|+|.++.. .......+..|...+..+. |||++.++++=.+.+..+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln--HpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN--HPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc--CccccccCceeecHHHHHH
Confidence 346777799999999999999866 7999999998744 3344467778899999999 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
.||||++|+|.+.+ +..+-.++.....+..|++.++.|||++ ||||||+||.||+++.+|.+|++|||.+...
T Consensus 1312 FMEyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999 4555667778888899999999999999 9999999999999999999999999999877
Q ss_pred CCCCcc---ccccccccccccCccccccCC---CCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 198 PENTTH---ISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..+..+ ..+...||+-|+|||++.+.. -..++|||||||++.||+||+.||...+.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 654322 234467999999999998654 45799999999999999999999975543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=230.66 Aligned_cols=194 Identities=25% Similarity=0.384 Sum_probs=159.1
Q ss_pred eeeeeccceEEEEEEeC-CC-------cEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 48 NKIGEGGFGSVYKGRLQ-DG-------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~-~~-------~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+.||.|+||.||+|.+. .+ ..+++|.+..........+..|+..++.+. |||++++++.+..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS--HKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC--CCChhheeeEEEeCCCcEEEE
Confidence 36899999999999764 22 348888876444444567788888888888 999999999999989999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC--------eEEeec
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--------PKISDF 191 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~--------~~l~Df 191 (272)
||+++++|.+++.. ....+++..+..++.|++.|+.+||++ ||+|+||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999843 234688999999999999999999999 9999999999999987765 589999
Q ss_pred CcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhC-CCccccccCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQL 254 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~ 254 (272)
|.+...... ....++..|+|||++.+. .++.++|+||+|+++|+|++| ..||...+..
T Consensus 153 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 153 GISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred ccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 988654321 224567789999999864 578999999999999999998 4676655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=209.27 Aligned_cols=207 Identities=25% Similarity=0.438 Sum_probs=175.8
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+|.-.+.||+|.+|+||++++. +++.||+|.+..++ .......++|+..++.+. |+||++++++...+....+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk--hknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh--hcceeehhhhhccCceeEEeH
Confidence 4556788999999999999876 79999999998663 334567899999999999 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|||. ..|..+. ...++.++.+.++....|++.++.++|++ ++.|||+||.|.+|+.+|.++|.|||+++.++.
T Consensus 81 e~cd-qdlkkyf---dslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 81 EFCD-QDLKKYF---DSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred HHhh-HHHHHHH---HhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9994 5666665 46778899999999999999999999999 999999999999999999999999999998765
Q ss_pred CCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHh-CCCccccccCCCceeh
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL 259 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~ 259 (272)
....... ..-|..|.+|.++.+.. |++..|+||.||++.++.. |++.|.+.+-.+....
T Consensus 154 pvrcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkr 214 (292)
T KOG0662|consen 154 PVRCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_pred ceEeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHH
Confidence 5443333 34588899999998876 8999999999999999988 6777776665444333
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=227.17 Aligned_cols=207 Identities=25% Similarity=0.368 Sum_probs=170.5
Q ss_pred hhCCeeeeeeeeeccceEEEEEEe-CC----CcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEec-
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRL-QD----GTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID- 111 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~-~~----~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~- 111 (272)
....|++.+.||+|.+|.||+|.- ++ ...+|+|.++.+. ........+|+..++.++ |||++.+..++..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~--h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK--HPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc--CCcchhHHHHHhcc
Confidence 345699999999999999999953 22 2368999987542 123346778999999999 9999999998877
Q ss_pred CCceeEEEeecCCCCHhHHHhhc-ccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CCe
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN----FNP 186 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~----~~~ 186 (272)
+...++++||.+. +|+..+... ......++...+..|+.||++++.|||++ -|.||||||.||+|..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 7789999999975 566565443 33445789999999999999999999999 99999999999999877 899
Q ss_pred EEeecCcccccCCCCccc--cccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 187 KISDFGLSKLFPENTTHI--STRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
||+|+|+++.+...-... ...+.-|..|.|||++.|.. |+++.|+|++|||+.||++-.+.|.+..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999999876543322 34456788999999999876 9999999999999999999999997654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=232.58 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=167.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCC---
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--- 113 (272)
..++|++.+.||+|++|.||++.+. +|..||+|.+.... ......+.+|+..++.+. ||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK--HENVIGLLDVFTPDLSLD 90 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCCccceeeeecCCcccc
Confidence 5678999999999999999999865 79999999885332 223346778999999998 999999999887543
Q ss_pred ---ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 114 ---~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
..++++||+ +++|.+.+ ....+++..++.++.|++.|+.+||+. ||+|+||+|.||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLM-----KHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 77898887 235689999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9998754322 122356788999999876 3578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=231.75 Aligned_cols=200 Identities=29% Similarity=0.398 Sum_probs=168.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec-CCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~-~~~ 114 (272)
...++|++.+.||.|++|.||+|... +|..|++|.+... .......+..|+..++.+. |||++++++++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR--HENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC--CCCeeeEeeeEecCCCc
Confidence 35678999999999999999999866 7999999987532 2233456778999999998 9999999998865 567
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++++||+ +++|...+ ...++++..+..++.|+++|+.+||++ +++|+||+|.||++++++.++|+|||.+
T Consensus 85 ~~lv~e~~-~~~L~~~~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLL-----TSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 88999998 56888877 234678899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
....... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||...+.
T Consensus 156 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 156 RIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred cccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7543211 22345778999998765 5688999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=235.19 Aligned_cols=204 Identities=28% Similarity=0.426 Sum_probs=167.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcc-cccccceeEeeeeEecC--C
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDG--P 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~~~~~~--~ 113 (272)
..++|++.+.||.|++|.||+|.+. +|..+++|.+... .......+..|+..++++ . ||||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--HPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcC--CCCccceeeeeccCCCc
Confidence 4678999999999999999999876 6889999987532 223344667789999999 6 99999999987654 3
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++|+||++ ++|.+.+. . ..+++..++.++.|++.+|.+||+. ||+|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~----~-~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIR----A-NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred eEEEEecccc-cCHHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 5789999996 58888872 2 2778899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc----cccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 194 SKLFPENTT----HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 194 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
+........ .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~ 219 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH
Confidence 986543221 12233457888999998865 45788999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=225.46 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=166.1
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhccc-ccccceeEeeeeEecCCc-----
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVN-VCHENLVKLHGGCIDGPC----- 114 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~~~~~----- 114 (272)
|++.+.||.|++|.||+|.++ +++.|++|.+..... .......+|+..++++. ..||+++++++.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999987 589999999874322 22334556666665553 229999999999987776
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++++||+++ +|.+++... ....+++..++.++.|++.||.+||+. +++|+|++|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999964 788877432 223689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
........ .....++..|.|||.+.+..++.++|+||+|+++|+|++|.+||...+..
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~ 212 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA 212 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH
Confidence 76543221 12234677899999999888999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=227.75 Aligned_cols=195 Identities=29% Similarity=0.438 Sum_probs=164.2
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
|...+.||+|++|.||+|++. +|..|++|.+..... .....+.+|+..++.++ |||++++++++......+++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK--HPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC--CCCCccEEEEEEeCCEEEEEE
Confidence 667788999999999999876 789999999864322 23346778999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+. +++.+.+. ....++++..++.++.|++.++.+||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 101 e~~~-~~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 101 EYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred ecCC-CCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 9996 46666663 2345688999999999999999999999 999999999999999999999999998864321
Q ss_pred CCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.....++..|+|||++. +..++.++|+||+|+++|+|++|..||...+
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22345778899999985 3457889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=228.44 Aligned_cols=204 Identities=28% Similarity=0.382 Sum_probs=165.2
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|+..+.||.|++|.||++.+. +++.+++|.+.... ......+.+|+..+.++.. ||||+++++.+......+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD-CPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcC-CCCEeeeeeEEecCCcEEEEE
Confidence 46777889999999999999876 68999999986432 2344567788888877743 899999999999888999999
Q ss_pred eecCCCCHhHHHhh-cccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 120 DYMPNNSLSQTLLG-EEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 120 e~~~~~~L~~~~~~-~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||+. .++.++... .......+++..+..++.|++.|+.+||+ . +++|+||+|+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9985 455554321 11234678999999999999999999996 5 9999999999999999999999999998754
Q ss_pred CCCCccccccccccccccCccccccC---CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
..... .....++..|+|||.+.+. .++.++|+||+|+++++|++|+.||....
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 159 VDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred ccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 33221 1223567889999998766 58899999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=225.83 Aligned_cols=207 Identities=27% Similarity=0.428 Sum_probs=166.2
Q ss_pred eeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCC----
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---- 113 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~---- 113 (272)
|.+.+.||+|++|.||+|... +++.|++|.+.... ......+.+|++.++.+. |||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD--HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCCCCc
Confidence 677899999999999999753 47889999987542 334556788999999998 999999999876432
Q ss_pred --ceeEEEeecCCCCHhHHHhhccc--ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 114 --CRILVYDYMPNNSLSQTLLGEEK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 114 --~~~iv~e~~~~~~L~~~~~~~~~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
..++++||+++++|.+++..... ....+++..++.++.|++.++.+||++ ||+|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 24688899999999988743221 223578899999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 190 DFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 190 Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
|||.+........ .......++..|++||.+.+..++.++|+||+|+++|+|++ |.+||...+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 9999886532221 11122234567999999988888999999999999999999 899997665443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=223.93 Aligned_cols=197 Identities=29% Similarity=0.464 Sum_probs=157.3
Q ss_pred eeeeeccceEEEEEEeC----CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEe-cCCceeEEEee
Q 024118 48 NKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-DGPCRILVYDY 121 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~-~~~~~~iv~e~ 121 (272)
+.||+|+||.||+|.+. ++..+++|.+... .......+.+|+..++.+. |||++++++.+. .+...++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS--HPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC--CCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999753 2457999987532 2334567788888898888 999999999765 45568899999
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
+.+++|.+++.. .....++..+..++.|++.|+.+||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 79 MKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999999842 233456778889999999999999999 99999999999999999999999999987543211
Q ss_pred c---cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 202 T---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 202 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
. .......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1 11112334667999999988889999999999999999999 566676443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=237.75 Aligned_cols=229 Identities=27% Similarity=0.432 Sum_probs=197.1
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC---C--CcEEEEEEEEec-CcccHHHHHHHHHHhhccccccccee
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ---D--GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~---~--~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
..-+.+..++..+...+.+.||.|.||.||+|... . ...||||..+.+ ..+....+++|+.+++.+. ||||+
T Consensus 377 ~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd--HphIi 454 (974)
T KOG4257|consen 377 STPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD--HPHII 454 (974)
T ss_pred cCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC--Ccchh
Confidence 33444566677777778899999999999999632 2 346999998864 4556789999999999999 99999
Q ss_pred EeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 104 ~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
+++++|.+.. .+||||.++.|.|..++ +.+...++...+..+.+||..|+.|||+. .++||||..+||||...
T Consensus 455 kLIGv~~e~P-~WivmEL~~~GELr~yL---q~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp 527 (974)
T KOG4257|consen 455 KLIGVCVEQP-MWIVMELAPLGELREYL---QQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSP 527 (974)
T ss_pred heeeeeeccc-eeEEEecccchhHHHHH---HhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCc
Confidence 9999998865 79999999999999999 34556788999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehhhh
Q 024118 184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~ 262 (272)
..|||+|||+++.+.+..............|+|||-+.-..++.++|+|.+|+++|++++ |..||.+....+-...+++
T Consensus 528 ~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn 607 (974)
T KOG4257|consen 528 QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN 607 (974)
T ss_pred ceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC
Confidence 999999999999988777665555556778999999998899999999999999999877 9999999998888888877
Q ss_pred hhcce
Q 024118 263 VRSIN 267 (272)
Q Consensus 263 ~~~~~ 267 (272)
-.+++
T Consensus 608 GeRlP 612 (974)
T KOG4257|consen 608 GERLP 612 (974)
T ss_pred CCCCC
Confidence 76653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=229.69 Aligned_cols=201 Identities=28% Similarity=0.372 Sum_probs=164.0
Q ss_pred CeeeeeeeeeccceEEEEEEeC-C--CcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC----C
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-D--GTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----P 113 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~--~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----~ 113 (272)
+|.+.+.||+|+||.||++... + +..||+|.+... .......+.+|+..++++.. ||||+++++..... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG-HKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCChheeeeeeeeccccCC
Confidence 5899999999999999999866 4 789999998643 22234567788888888843 99999999865432 4
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..+++++++. ++|.+.+ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~~~~e~~~-~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 80 ELYLYEELME-ADLHQII----RSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred cEEEEEeccc-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 5678888885 6888887 3456789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 194 SKLFPENTTH---ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 194 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+......... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...+
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 9865432211 1223457888999998765 468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=221.66 Aligned_cols=194 Identities=30% Similarity=0.473 Sum_probs=167.6
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
||.|++|.||++.+. +++.+++|.+..... .....+..|+..++.+. ||+++++++.+..+...+++|||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--HPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC--CCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 689999999999876 689999999864422 24457788889999998 999999999999999999999999999
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~ 205 (272)
+|.+++ .....+++..++.++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~ 150 (250)
T cd05123 79 ELFSHL----SKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RT 150 (250)
T ss_pred cHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cc
Confidence 999998 3344689999999999999999999999 999999999999999999999999999986543221 12
Q ss_pred ccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 206 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
....++..|.+||.+.+...+.++|+||||+++|+|++|..||...+.
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 198 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 334567889999999888889999999999999999999999976664
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=208.55 Aligned_cols=209 Identities=25% Similarity=0.359 Sum_probs=175.5
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..+......-...||+|++|.|-+.++. +|...|+|.+... ....+++.+.++...++... +|.++.+++.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~-CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVD-CPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCC-CCeEEEeehhhhcccc
Confidence 5566677777899999999999888866 8999999998754 34455778888888776654 8999999999888899
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+|.||.| ..+|+-+.++--......+|..+-+|+..+..|+.+||++ ..++|||+||+|||++..|++|+||||.+
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccc
Confidence 99999998 6788888777667888999999999999999999999987 59999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccC----CCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISG----RLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
-.+.+..- .+...|-..|+|||.+..+ .|+.++|+||||.++.||.+++.||+..
T Consensus 197 G~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 197 GYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 86643321 1113455679999998633 5889999999999999999999999844
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=233.40 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=168.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc--
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC-- 114 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~-- 114 (272)
..++|++.+.||.|++|.||+|.+. +++.|++|.+... .......+.+|+..++.+. |||++++++.+.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD--HENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc--CCCHHHHHHHhhcccccc
Confidence 4678999999999999999999876 6889999987643 2223356677899999988 9999999987765544
Q ss_pred ----eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 115 ----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 115 ----~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
.++++||+ +++|.+++. ...+++..++.++.|++.|+.+||+. |++|+||+|+||++++++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 88999998 678998873 35789999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||.+...... .....++..|.|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 223 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999865332 223456778999998865 357889999999999999999999997665443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=225.52 Aligned_cols=204 Identities=28% Similarity=0.419 Sum_probs=165.3
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
....++|++.+.||.|++|.||+|.+. +++.|++|.+..... ........++..+..... ||||+++++.+..+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD-CPYIVKCYGYFITDSDV 89 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccC-CCchHhhheeeecCCeE
Confidence 455678999999999999999999987 589999999874422 233445556655544432 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
+++|||++ ++|.+.+.. ....+++..+..++.|++.++.+||+ . ||+|+||+|+||++++++.++|+|||.+
T Consensus 90 ~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 90 FICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred EEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccc
Confidence 99999984 577777632 23478999999999999999999996 6 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccccCC----CCCCCceehHHHHHHHHHhCCCccccc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
........ .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||...
T Consensus 163 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 163 GRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred hhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 75532221 12234667899999987554 788999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=224.91 Aligned_cols=201 Identities=29% Similarity=0.467 Sum_probs=170.4
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
|++.+.||.|++|.||+|... +++.+++|.+.... ......+..|+..++.+. |++++++++++......++++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK--HPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC--CCCHHHHHhhhhcCCceEEEec
Confidence 678899999999999999876 69999999987542 333456778999999988 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|++ ++|.+++... ...+++..++.++.|++.++.+||++ |++|+||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 79 YCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred CcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 997 5899988332 25789999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 201 TTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.. .......+..|+|||.+.+. .++.++|+||+|+++++|++|++||...+..
T Consensus 152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 205 (282)
T cd07829 152 LR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205 (282)
T ss_pred cc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 22 12223456779999998776 7889999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=221.89 Aligned_cols=203 Identities=24% Similarity=0.389 Sum_probs=167.8
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-----CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+|.+.+.||.|++|.||++.+. .+..+++|+.+.. ..........|+..++.+. |||++++++.+......+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD--HPAIVKFHASFLERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC--CCcHHHHHHHHhcCCceE
Confidence 5899999999999999999876 4455666665421 1223345667888888888 999999999999889999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+++||+++++|.+.+.........+++..++.++.|++.|+.+||+. |++|+|++|+||++++ +.++|+|||.+..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceee
Confidence 99999999999999865545567899999999999999999999999 9999999999999975 5799999999876
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus 155 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 155 LMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred cCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 533221 1223456788999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-33 Score=239.92 Aligned_cols=206 Identities=26% Similarity=0.450 Sum_probs=172.9
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEe----cCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc--e
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSV----ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--R 115 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~----~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~--~ 115 (272)
-......||+|+|-+||+|.+. +|..||=-.++. .......++..|+.+++.++ ||||++++++|.+... .
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~--H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK--HPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC--CCceeeeeeheecCCCcee
Confidence 3455689999999999999876 677666443331 23445578999999999999 9999999999987655 6
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCeEEeecCcc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLS 194 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~-~~~~~~l~Dfg~~ 194 (272)
.+|+|.+..|+|..++ ...+.++...+..|++||+.+|.|||++ ...|+|||||=+||||+ ..|.|||+|+|++
T Consensus 119 n~iTEL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 119 NFITELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred eeeeecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence 7899999999999998 5566788899999999999999999997 77999999999999996 5588999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc-cccCCCceeh
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD-FDVQLGEYHL 259 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~-~~~~~~~~~~ 259 (272)
....... ...+.|||.|+|||+.. ..|+..+||||+|+++.+|.|+.-||. +.++...|+.
T Consensus 194 tl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK 255 (632)
T KOG0584|consen 194 TLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK 255 (632)
T ss_pred HHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH
Confidence 9765333 34478999999999886 889999999999999999999999997 4445544443
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=229.18 Aligned_cols=197 Identities=25% Similarity=0.374 Sum_probs=163.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCC----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---- 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~---- 113 (272)
..+|.+.+.||+|++|.||+|.+. +|+.||+|.+.... ......+.+|+..++.+. ||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--HENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC--CCCccchhheecccccCCC
Confidence 468999999999999999999875 79999999986432 223346778999999998 999999999876543
Q ss_pred --ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 114 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 114 --~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
..++++||+. .+|.... ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred CceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 4589999985 4666554 23688999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|++...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.
T Consensus 162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~ 220 (342)
T cd07879 162 GLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220 (342)
T ss_pred CCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 998754321 122456788999999876 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=235.39 Aligned_cols=212 Identities=29% Similarity=0.478 Sum_probs=181.1
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccH-HHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
-.....+...++++||+|.||.|.++....+..||+|.++....... ..+..|++.+.+++ ||||+.++++|..++-
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk--hPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLK--HPNIVELLGVCVQDDP 609 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccC--CCCeeEEEeeeecCCc
Confidence 34566788999999999999999999988889999999987755544 78999999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
+++|+||++.|+|-+++..+.. ..........++.||+++++||.+. +++|||+.+.|+|++.++++|++|||++
T Consensus 610 icmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 9999999999999999954422 2245566777999999999999999 9999999999999999999999999999
Q ss_pred ccc-CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh--CCCccccccCC
Q 024118 195 KLF-PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS--GRTAVDFDVQL 254 (272)
Q Consensus 195 ~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t--g~~p~~~~~~~ 254 (272)
+-+ ...............+|+|+|.+.-.+++.++|+|++|+++||+++ ...||+-.+.+
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 843 3333333444556789999999999999999999999999999765 78899755543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=226.20 Aligned_cols=199 Identities=22% Similarity=0.243 Sum_probs=159.9
Q ss_pred eeeeeeeccceEEEEEEeCCCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.+.+|.|+++.++++.. +++.||+|.+... .......+..|+..++.++ ||||+++++++......+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ--HPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC--CcchhhhhheeecCCeEEEEEeccC
Confidence 344444444444444433 6999999998754 3345567888999999998 9999999999999999999999999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT- 202 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~- 202 (272)
+++|.+++... ....+++..+..++.|++.||.|||++ +|+|+||+|+||+++.++.++++||+.+........
T Consensus 83 ~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 83 YGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 99999998432 234688999999999999999999999 999999999999999999999999998875432111
Q ss_pred -----cccccccccccccCccccccC--CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 203 -----HISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 203 -----~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.......++..|.|||.+.+. .++.++|+||+|+++++|++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 011223456789999998763 57899999999999999999999997544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=226.88 Aligned_cols=213 Identities=23% Similarity=0.324 Sum_probs=177.5
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhccccccc----ceeEeeee
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE----NLVKLHGG 108 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~----~i~~l~~~ 108 (272)
+.......++|.+++.+|+|.||.|.++.+. .+..||+|+++ .......+.+-|++.+.++....| .++++.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik-~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK-NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHH-HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3445566899999999999999999999765 68899999987 333445567778888888854343 37888899
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-------
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD------- 181 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~------- 181 (272)
+...+..+||+|.+ |.++.+++.. +...+++..+++.+++|+++++.+||+. +++|.||||+||++-
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 99999999999977 7899999954 3556799999999999999999999999 999999999999992
Q ss_pred -------------CCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcc
Q 024118 182 -------------QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 182 -------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
.+..++++|||.+....... .....|..|.|||++.+-.++...|+||+||||+|+++|...|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 23458999999998543222 3356788999999999999999999999999999999999999
Q ss_pred ccccCCCce
Q 024118 249 DFDVQLGEY 257 (272)
Q Consensus 249 ~~~~~~~~~ 257 (272)
...+..+-+
T Consensus 310 qtHen~EHL 318 (415)
T KOG0671|consen 310 QTHENLEHL 318 (415)
T ss_pred ccCCcHHHH
Confidence 988765544
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=227.61 Aligned_cols=198 Identities=25% Similarity=0.344 Sum_probs=159.7
Q ss_pred eeeeec--cceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 48 NKIGEG--GFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G--~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
..||.| ++++||+|.+. +|+.||+|+..... ......+.+|+..++.+. ||||+++++++..++..++++||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR--HPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcceEeeeEecCCceEEEEecc
Confidence 455655 89999999876 79999999987542 223356777888888888 999999999999999999999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
++++|.+++.... ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++.+++.||+.+........
T Consensus 82 ~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 82 AYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 9999999885432 24588999999999999999999999 999999999999999999999999976543321111
Q ss_pred cc------cccccccccccCccccccC--CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 203 HI------STRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 203 ~~------~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.. .....++..|+|||++.+. .++.++|+||+||++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 00 0011234569999999764 47899999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=225.08 Aligned_cols=198 Identities=28% Similarity=0.431 Sum_probs=165.5
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...|...+.||.|++|.||+|.+. ++..+++|.+... ......++.+|++.++.+. |++++++++++......+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC--CCCcccEEEEEEcCCeeE
Confidence 344888899999999999999876 6889999988642 2223346778999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+|+||+. ++|.+.+.. ...++++..+..++.|++.++.+||++ +++|+||+|.||+++.++.++|+|||++..
T Consensus 92 lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 92 LVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccccee
Confidence 9999996 577766632 335688999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCccccccccccccccCcccccc---CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... ....++..|+|||.+.+ ..++.++|+||+||++++|++|..||...+
T Consensus 165 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 165 MAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred ecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 4322 22456788999999753 457889999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=221.86 Aligned_cols=201 Identities=29% Similarity=0.430 Sum_probs=165.7
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEee
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 121 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~ 121 (272)
|++.+.||.|++|.||+|... +++.|++|.+..... .......+|+..++++.. ||+++++++.+..++..+++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE-HPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccC-CCCchhHHHHhhcCCcEEEEEec
Confidence 678999999999999999976 688999998764322 233344567777777754 99999999999999999999999
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
+ +++|.+.+... ....+++..+..++.|++.++.+||++ +++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 77888887432 124689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 202 THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 202 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
. .....++..|+|||.+.+ ..++.++|+||+|+++++|++|++||...+.
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 1 223456778999998854 4578999999999999999999999976654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=215.81 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=166.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...++.+++..||.|..|.|++++.+ +|...|||...... ....++++..+........ .|+||+.+++|..+...+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~d-cpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHD-CPYIVQCFGYFITNTDVF 167 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccC-CCeeeeeeeEEeeCchHH
Confidence 34556778899999999999999876 79999999987543 3444666666665544332 699999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
|.||.| ...++.++ +....+++|..+-.+...+.+||.||..++ +|+|||+||+|||+++.|++||+|||.+-.
T Consensus 168 IcMelM-s~C~ekLl---krik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 168 ICMELM-STCAEKLL---KRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHH-HHHHHHHH---HHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccce
Confidence 999987 44455454 234567999999999999999999999874 999999999999999999999999999987
Q ss_pred cCCCCccccccccccccccCccccccC---CCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+-+..- .....|-+.|+|||.+.-. .|+.++|+||||+++++|.||+.||.+.+
T Consensus 242 lvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 242 LVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred eecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 654332 2334567789999999744 58899999999999999999999998644
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=244.03 Aligned_cols=225 Identities=27% Similarity=0.470 Sum_probs=196.0
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-C---CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-D---GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~---~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.+..+...|.+.||.|.||.|++++.+ . ...||||.++.. ..++..+++.|+.++-++. ||||+.+-++....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd--HPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC--CCcEEEEEEEEecC
Confidence 455667789999999999999999866 2 457999999866 4456678999999999999 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
.-..||.|||+.|+|+.+++. .++.|+..++.-.++.|+.++.||-+. +++||||..+||||+.+...|+.|||
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence 989999999999999999954 457799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcccccccc--ccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehhhhhhcceee
Q 024118 193 LSKLFPENTTHISTRVA--GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSINMK 269 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 269 (272)
+++.+.++......... -..+|.|||.+...+++.++|+||+|+++||.++ |..||=.-+.++-++.|+.-.++++.
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP 856 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence 99988665533322221 2468999999999999999999999999999776 99999888888888888888888765
Q ss_pred e
Q 024118 270 L 270 (272)
Q Consensus 270 ~ 270 (272)
|
T Consensus 857 m 857 (996)
T KOG0196|consen 857 M 857 (996)
T ss_pred C
Confidence 4
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=215.94 Aligned_cols=180 Identities=22% Similarity=0.221 Sum_probs=150.7
Q ss_pred ccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCHhHHH
Q 024118 53 GGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL 131 (272)
Q Consensus 53 G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~ 131 (272)
|.++.||+|.+. +++.||+|.+..... ...+...+.... ||||+++++.+......+++|||+++++|.+.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHC--VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcC--CCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999876 789999999864321 223333333334 999999999999999999999999999999998
Q ss_pred hhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccccccccc
Q 024118 132 LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211 (272)
Q Consensus 132 ~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 211 (272)
. ....+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||.+....... ....++
T Consensus 77 ~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~ 145 (237)
T cd05576 77 S----KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVE 145 (237)
T ss_pred H----HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcC
Confidence 3 334689999999999999999999999 99999999999999999999999999876543221 223446
Q ss_pred ccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 212 ~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
..|+|||.+.+..++.++|+||+|+++|+|++|+.|+..
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 679999999888889999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-34 Score=224.11 Aligned_cols=212 Identities=25% Similarity=0.362 Sum_probs=174.5
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.+.....+.+-+..||.|+||+|++..++ .|+..|||.+..... ..+.+++.|....++-.. .|+||++++.+...+
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~-cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSN-CPNIVKFYGALFSEG 136 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcC-CcHHHHHhhhhhcCC
Confidence 34456667788899999999999999876 899999999986643 566788888888877664 899999999999999
Q ss_pred ceeEEEeecCCCCHhHHH-hhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 114 CRILVYDYMPNNSLSQTL-LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~-~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
.++|.||.| ..+|+-+. ..+..+...++|..+..|+.....||.||... ..|+|||+||+|||++..|.+||+|||
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeeccc
Confidence 999999998 45665443 22345667899999999999999999999976 499999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccC--CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.+-.+.... ..+...|-..|+|||.+... .|+.++|+||||+++||+.||..||...+.
T Consensus 214 IcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 214 ICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred chHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 997553221 12223455679999999743 489999999999999999999999986654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=249.65 Aligned_cols=198 Identities=30% Similarity=0.453 Sum_probs=161.6
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec----
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID---- 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~---- 111 (272)
..-..+|+.+..||+||||.||+|+++ ||+.||||.+... .......+.+|+..+.++. |||+|.++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn--HpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN--HPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC--CcceeeeehhhhccCCc
Confidence 345667889999999999999999999 9999999999755 3334467889999999999 9999999864432
Q ss_pred --------------------------------------------------------------------------------
Q 024118 112 -------------------------------------------------------------------------------- 111 (272)
Q Consensus 112 -------------------------------------------------------------------------------- 111 (272)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ---------------------------C--------CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHH
Q 024118 112 ---------------------------G--------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156 (272)
Q Consensus 112 ---------------------------~--------~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~a 156 (272)
. ...||-||||+..+|.+.+..+...+ .....|+++++|++|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEG 709 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHH
Confidence 0 12468899998888888873332211 477899999999999
Q ss_pred HHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC-----------------CCCccccccccccccccCccc
Q 024118 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP-----------------ENTTHISTRVAGTLGYLAPEY 219 (272)
Q Consensus 157 l~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~-----------------~~~~~~~~~~~~~~~~~aPE~ 219 (272)
|.|+|++ ||+||||||.|||++.++.|+|+|||++.... .......+...||.-|+|||+
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999998621 011112344679999999999
Q ss_pred cccCC---CCCCCceehHHHHHHHHHh
Q 024118 220 AISGR---LTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 220 ~~~~~---~~~~~Di~slG~il~~l~t 243 (272)
+.+.. |+.|+|+||||++++||+.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc
Confidence 98655 9999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=210.20 Aligned_cols=198 Identities=33% Similarity=0.499 Sum_probs=171.1
Q ss_pred eeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEee
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 121 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~ 121 (272)
|.+.+.||.|+++.||++... +++.+++|.+...... ....+.+|+..++.+. |++++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK--HPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC--CCChhhheeeeecCCceEEEEec
Confidence 578899999999999999877 4899999999755444 5678888999999997 99999999999999999999999
Q ss_pred cCCCCHhHHHhhccccccc-CChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 122 MPNNSLSQTLLGEEKRRAK-FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
+++++|.+++.. ... +++..++.++.+++.++.+||++ +++|+|++|.||+++.++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 79 CEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred cCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 999999999833 233 88999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccccccccCcccc-ccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 201 TTHISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
.........++..|++||.+ ....++.++|+|++|+++++|++|+.||..
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 21122334567789999998 666678899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=241.50 Aligned_cols=146 Identities=27% Similarity=0.404 Sum_probs=129.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|.+.+.||.|+||.||+|.+. +++.||+|++.... ......+..|+..+..+. ||+|++++..+......+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC--CCCcCeEEEEEEECCEEE
Confidence 468999999999999999999877 78999999987432 222356777888888888 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+||||+++++|.+++. ....+++..++.++.||+.||.|||++ +|+|+||||+|||++.++.++|+|||++.
T Consensus 81 lVmEy~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999983 345688999999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=233.37 Aligned_cols=198 Identities=28% Similarity=0.394 Sum_probs=164.3
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
+.+.|++...+|.|+|+.+-.+.+. +++..++|++..... ....|+..+..... ||||+++.+++.++...++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~-h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRD-HPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcC-CCcceeecceecCCceeeee
Confidence 4678999999999999999888765 789999999874411 12234434433333 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-cCCCCeEEeecCccccc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKLF 197 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv-~~~~~~~l~Dfg~~~~~ 197 (272)
||.+.|+.+.+.+. ..+.+. ..+..|+.+|+.|+.+||++ |++||||||+|||+ ++.++++|+|||.+...
T Consensus 395 ~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999999888872 223333 77778999999999999999 99999999999999 69999999999999866
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
+.. ....+-|..|.|||+.....+++++|+||||+++|+|++|+.||......
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 544 33346688899999999999999999999999999999999999855544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=231.97 Aligned_cols=201 Identities=24% Similarity=0.322 Sum_probs=169.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC----ccc----HHHHHHHHHHhhccc-ccccceeEeeee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES----KQG----EKEFMSEVASMANVN-VCHENLVKLHGG 108 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~----~~~----~~~~~~e~~~~~~~~-~~~~~i~~l~~~ 108 (272)
-...+|...+.+|.|+||.|++|.++ .+..|+||.+..+. .+. .-..-.|++++..+. ..|+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34567999999999999999999877 57789999986331 111 112345777777775 339999999999
Q ss_pred EecCCceeEEEeec-CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 109 CIDGPCRILVYDYM-PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 109 ~~~~~~~~iv~e~~-~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
+++++.+|+++|-- +|-+|.+++ +..+.++|..+..|+.|++.++++||++ ||+|||||.+|+.++.+|-++
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEE
Confidence 99999999999953 466888998 7788899999999999999999999999 999999999999999999999
Q ss_pred EeecCcccccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccc
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
|+|||.+......+ ...+.||..|+|||++.|.+| ...-|||+||+++|.+.....||=
T Consensus 711 lidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999998764433 445789999999999999987 567899999999999999888873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=233.15 Aligned_cols=224 Identities=29% Similarity=0.436 Sum_probs=196.9
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+.|.+...+......||.|.+|.||.+.|+ -...||||.++ ++.-....++.|+..++.+. |||+|+++++|....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeik--HpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhc--CccHHHHhhhhccCC
Confidence 788888999999999999999999999987 57789999997 33345568999999999999 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
-.|||.|||..|+|.++++. ..+..++.-.++..+.||.+|++||..+ +++||||..+|.||.++..||+.|||+
T Consensus 337 PFYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CeEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999999954 3455677788899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehhhhhhcc
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSI 266 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 266 (272)
++.+..+..+.-....-...|.|||-+.-..++.++|+|++|+++|++.| |..||.+.+.-..+.+.++-.++
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM 485 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM 485 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc
Confidence 99998777665444444677999999999999999999999999999998 99999988877766666655443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=209.82 Aligned_cols=231 Identities=18% Similarity=0.307 Sum_probs=187.0
Q ss_pred ccCCCCCCcccccccccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEe-CCCcEEEEEEEEecCcccHHHHHHHHH
Q 024118 12 SRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVA 90 (272)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~ 90 (272)
.++.+.........+++..+...+-+ ..++|++++.+|+|.++.||.|.+ .+++.++||++++- ..+.+.+|+.
T Consensus 10 ARvya~vn~~rp~eYWdYE~~~i~wg--~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREik 84 (338)
T KOG0668|consen 10 ARVYADVNEERPREYWDYESLVIDWG--NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIK 84 (338)
T ss_pred hhhhhhccccCchhhcchhheeeecc--ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHH
Confidence 45556666777777888888665555 678999999999999999999975 47899999998733 4467889999
Q ss_pred HhhcccccccceeEeeeeEecC--CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCe
Q 024118 91 SMANVNVCHENLVKLHGGCIDG--PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168 (272)
Q Consensus 91 ~~~~~~~~~~~i~~l~~~~~~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i 168 (272)
++..++. +|||++++++..+. ....+|+||++..+..... ..++...++..+.+++.||.|+|+. ||
T Consensus 85 IL~nL~g-g~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GI 153 (338)
T KOG0668|consen 85 ILQNLRG-GPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GI 153 (338)
T ss_pred HHHhccC-CCCeeehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---Cc
Confidence 9999987 99999999988765 4678999999877666554 6788999999999999999999999 99
Q ss_pred EecCCCCCCEEEcCCC-CeEEeecCcccccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCC
Q 024118 169 VHRDIKTSNILLDQNF-NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRT 246 (272)
Q Consensus 169 ~h~dl~p~nilv~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~ 246 (272)
.|||+||.|++|+... .++|+|+|++....+... .+-...+..|.-||++..-. |+..-|+||+||++..|+..+.
T Consensus 154 mHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrke 231 (338)
T KOG0668|consen 154 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 231 (338)
T ss_pred ccccCCcceeeechhhceeeeeecchHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccC
Confidence 9999999999998654 489999999987754433 23344567788999998654 8999999999999999999888
Q ss_pred ccc-cccCCCceehh
Q 024118 247 AVD-FDVQLGEYHLV 260 (272)
Q Consensus 247 p~~-~~~~~~~~~~~ 260 (272)
||- +.+..+.+..|
T Consensus 232 pFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 232 PFFHGHDNYDQLVKI 246 (338)
T ss_pred cccCCCCCHHHHHHH
Confidence 884 44444433333
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=235.87 Aligned_cols=220 Identities=26% Similarity=0.409 Sum_probs=186.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC--CCc--EEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ--DGT--IVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~--~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
-+..+...+.+.||+|.||.|++|.|. +|. .||||++...... ....+++|+..+.+++ |+|++++|++..+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~--H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ--HPHLIRLYGVVLD- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc--CcceeEEeeeecc-
Confidence 355667788999999999999999876 454 6999999866443 6679999999999999 9999999999887
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...-+|+|.+++|+|.+.++. .....|....+..++.||+.|+.||.++ ++|||||..+|+++.....|||+|||
T Consensus 183 qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence 567799999999999999965 4667888999999999999999999999 99999999999999998899999999
Q ss_pred cccccCCCC--ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehhhhhhc
Q 024118 193 LSKLFPENT--THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRS 265 (272)
Q Consensus 193 ~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~ 265 (272)
+.+.++... +.+.....-...|+|||.+....++.++|+|++||++|||+| |..||-+......++.++.-.+
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er 333 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER 333 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc
Confidence 999876433 222222333556999999999999999999999999999999 8899998887777666664333
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=245.25 Aligned_cols=191 Identities=30% Similarity=0.550 Sum_probs=158.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
...+...+.||+|+||.||+|... ++..||+|.+...... ...|++.+++++ ||||+++++++......++||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~--HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQ--HPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCC--CCCcceEEEEEEcCCCCEEEE
Confidence 355777889999999999999875 7999999988633221 123477788887 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++. .+++..+..++.|++.|+.|||..+..+++|||+||+||+++.++..++. ++.......
T Consensus 763 Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 763 EYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred eCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 9999999999982 37889999999999999999995444599999999999999988887764 554432211
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
.....++..|+|||++.+..++.++||||+||++|+|++|+.||+.
T Consensus 835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1123567899999999998999999999999999999999999953
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=216.33 Aligned_cols=212 Identities=23% Similarity=0.356 Sum_probs=174.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---- 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---- 112 (272)
...+.+-.+.||.|+||.||.+++. +|+.|++|.+..- .-...+++.+|.+++..++ |.|++..++...-.
T Consensus 51 qq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk--HdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 51 QQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR--HDNVLSLLDILQPANPSF 128 (449)
T ss_pred ccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc--cccHHHHHHhcCCCCchH
Confidence 3455667799999999999999877 8999999987522 3345578999999999999 99999988876543
Q ss_pred -CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 113 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
...|++.|.+ ..+|...+ .....++.+++.-.++||+.+|.|||+. +|.||||||.|.+++.+-.+||+||
T Consensus 129 FqEiYV~TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 129 FQELYVLTELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHHHHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence 2456777776 56676666 5567789999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCceehhh
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 261 (272)
|+++..........+...-|..|.|||.++|.. |+.+.||||+||++.||+..+..|...++.+.+.+|.
T Consensus 201 GLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 201 GLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred ccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 999876543333233344578899999999875 9999999999999999999999999888776665553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=214.81 Aligned_cols=196 Identities=31% Similarity=0.478 Sum_probs=163.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC----Cc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----~~ 114 (272)
-..++.++.+.||+|.||.||+|.|+ |+.||||++.. .++..+.+|.++.+.+-.+|+||+.++..=..+ +.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 45678899999999999999999998 78899999963 345677788888877766699999998753322 36
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-----IQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-----~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
.++|.+|-+.|+|.|++ .+..++.+...+++..++.+|.+||.. +...|.|||||..||+|+.+|...|+
T Consensus 284 LwLvTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 78999999999999999 558899999999999999999999953 45689999999999999999999999
Q ss_pred ecCcccccCCCCcc---ccccccccccccCccccccCC----C-C-CCCceehHHHHHHHHHh
Q 024118 190 DFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAISGR----L-T-RKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 190 Dfg~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~----~-~-~~~Di~slG~il~~l~t 243 (272)
|+|++......... ..+...||.+|+|||++...- + + ..+||||+|.++||+..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999876544322 244578999999999997543 1 1 36999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=223.86 Aligned_cols=221 Identities=23% Similarity=0.260 Sum_probs=186.4
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhccccc----ccceeEee
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC----HENLVKLH 106 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~----~~~i~~l~ 106 (272)
+.+.-+.++-.+|.+....|+|-|++|..|.+. -|+.||||++.. .....+.-+.|+++|+.+... --|++.++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 456677899999999999999999999999876 588999999973 334556778899999998743 35788899
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN- 185 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~- 185 (272)
..|......|+|+|.+ .-+|.+++.... .+..+...++..+++|+.-||..|..+ ||+|.||||+||||++...
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 9999999999999977 678999886653 456788999999999999999999999 9999999999999987654
Q ss_pred eEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhh
Q 024118 186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 261 (272)
++|||||.+.....+.- +.+.-+.-|.|||.+.|.+|+...|+||+||+||+|.||+..|.+.+....+.+..
T Consensus 576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 79999999987654332 22333556899999999999999999999999999999999999998877665543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=225.84 Aligned_cols=201 Identities=24% Similarity=0.312 Sum_probs=142.1
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-C----CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee------
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-D----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------ 108 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~----~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~------ 108 (272)
..++|++.+.||+|+||.||+|.+. + +..||+|.+..... ......+ .+.... +.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~--~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRAC--PNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhc--hhhHHHHHHhhhcccc
Confidence 5678999999999999999999876 5 78999998753211 1111111 111111 2222221111
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhccc----------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEK----------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~----------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~d 172 (272)
.......++++||+++++|.+++..... ......+..+..++.|++.+|.|||++ +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 2455678999999999999998843211 001122445778999999999999999 999999
Q ss_pred CCCCCEEEcC-CCCeEEeecCcccccCCCCccccccccccccccCccccccCC----------------------CCCCC
Q 024118 173 IKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR----------------------LTRKS 229 (272)
Q Consensus 173 l~p~nilv~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----------------------~~~~~ 229 (272)
|||+|||++. ++.++|+|||++...............+++.|+|||.+.... +..++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 578999999999865443333344467889999999764322 23456
Q ss_pred ceehHHHHHHHHHhCCCccc
Q 024118 230 DVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 230 Di~slG~il~~l~tg~~p~~ 249 (272)
||||+||++|+|+++..+++
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999999877654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=218.71 Aligned_cols=207 Identities=23% Similarity=0.329 Sum_probs=149.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEe-----------------CCCcEEEEEEEEecCcccHHHH--------------HHH
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRL-----------------QDGTIVAVKVLSVESKQGEKEF--------------MSE 88 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~-----------------~~~~~v~vK~~~~~~~~~~~~~--------------~~e 88 (272)
..++|++.+.||+|+||.||+|.. ..++.||||.+..........+ ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999863 2356799999865433222222 234
Q ss_pred HHHhhcccc---cccceeEeeeeEec--------CCceeEEEeecCCCCHhHHHhhccc--------------------c
Q 024118 89 VASMANVNV---CHENLVKLHGGCID--------GPCRILVYDYMPNNSLSQTLLGEEK--------------------R 137 (272)
Q Consensus 89 ~~~~~~~~~---~~~~i~~l~~~~~~--------~~~~~iv~e~~~~~~L~~~~~~~~~--------------------~ 137 (272)
+..+.++.. .+.+++++++++.. ....++|+||+++++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 555555541 02233556555542 3467899999999999998853210 1
Q ss_pred cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCc
Q 024118 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217 (272)
Q Consensus 138 ~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aP 217 (272)
...+++..++.++.|++.++.+||+. +|+|+||||.||+++.++.++|+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346678899999999999999999 999999999999999999999999999975433222111112347889999
Q ss_pred cccccCC--------------------C--CCCCceehHHHHHHHHHhCCC-ccc
Q 024118 218 EYAISGR--------------------L--TRKSDVYSFGVLLLEIVSGRT-AVD 249 (272)
Q Consensus 218 E~~~~~~--------------------~--~~~~Di~slG~il~~l~tg~~-p~~ 249 (272)
|.+.... + ..+.|+||+||++++|++|.. ||.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9876432 1 124699999999999999886 775
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=222.38 Aligned_cols=211 Identities=27% Similarity=0.431 Sum_probs=179.6
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
..++.++-....|+|...+|.|.+|.||++++. +++.+|+|+..... +.+..+..|.++++.... |||++..++++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~-hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSH-HPNVATFYGAFI 86 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccC-CCCcceEEEEEE
Confidence 345556666788999999999999999999876 78889999876443 344567778888887765 999999999876
Q ss_pred -----cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 024118 111 -----DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 111 -----~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
.++..|+|||||.||+..+++.... ...+.|+.+..|+..++.++.+||.+ .++|||+|-.|||++.++.
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence 3578999999999999999997765 77899999999999999999999999 9999999999999999999
Q ss_pred eEEeecCcccccCCCCccccccccccccccCccccccC-----CCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
|||+|||.+....... .......||+.|+|||++... .|+..+|+||||++..+|--|.+|+-.
T Consensus 162 VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred EEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 9999999998664433 334557899999999999743 367899999999999999999999853
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=212.53 Aligned_cols=199 Identities=31% Similarity=0.521 Sum_probs=164.5
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC----cee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~----~~~ 116 (272)
....++.+.+|+|.||.||+|... ++.||||++... ....+..|.++.+-..+.|+||++++..-...+ .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 555778899999999999999876 589999998633 344667777777777777999999987655444 789
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc------CCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE------IQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~------~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
+|++|.+.|+|.+++ .....++....+++..|+++|+|||+- ....|+|||||.+||||.++++..|+|
T Consensus 285 LVt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 999999999999999 556789999999999999999999965 244799999999999999999999999
Q ss_pred cCcccccCCCC-ccccccccccccccCccccccCC-CC-----CCCceehHHHHHHHHHhCCCcc
Q 024118 191 FGLSKLFPENT-THISTRVAGTLGYLAPEYAISGR-LT-----RKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 191 fg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~Di~slG~il~~l~tg~~p~ 248 (272)
||++-.+.... ........||.+|+|||++.+.. .. .+.||||+|.++|||++.-..+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99998775432 22334478999999999997653 22 3799999999999999965544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=226.36 Aligned_cols=214 Identities=30% Similarity=0.460 Sum_probs=180.5
Q ss_pred eeeeeeeeeccceEEEEEEeC-C----CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQ-D----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~-~----~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
....++||+|+||+||++.|- . ..+|++|++... ..+....++.|+..+.++. |||++++++++..+. .-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld--Hpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD--HPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC--CchHHHHhhhcccch-HHH
Confidence 445689999999999999753 3 357899988643 3445678999999999999 999999999998877 778
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
|.+|+++|+|.++++ ..+..+.....+.|..||++++.|||.+ +++||||-.+|+||+....+++.|||++...
T Consensus 775 vtq~mP~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHhcccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999995 4667788999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCccccc-cccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehhhhhhcc
Q 024118 198 PENTTHIST-RVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVDKVRSI 266 (272)
Q Consensus 198 ~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~ 266 (272)
......... ...-.+.|+|-|.+....++.++||||+||++||++| |..|+++..-.+.-++.+.-.++
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL 919 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL 919 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC
Confidence 654332221 1222456899999999999999999999999999998 99999998888877777665554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=200.09 Aligned_cols=186 Identities=31% Similarity=0.505 Sum_probs=162.6
Q ss_pred cceEEEEEEeC-CCcEEEEEEEEecCccc-HHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCHhHHH
Q 024118 54 GFGSVYKGRLQ-DGTIVAVKVLSVESKQG-EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL 131 (272)
Q Consensus 54 ~~~~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~ 131 (272)
++|.||+|.+. +|+.+++|++....... ...+.+|++.++.+. |++++++++.+......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLK--HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCC--CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 57899999987 58999999987554433 678889999999997 999999999999999999999999999999998
Q ss_pred hhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccccccccc
Q 024118 132 LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211 (272)
Q Consensus 132 ~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 211 (272)
.. ...++...++.++.+++.++.+||+. +++|+|++|.||++++++.++++|||.+....... ......++
T Consensus 79 ~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 79 KK----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred Hh----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 32 23388999999999999999999999 99999999999999999999999999998664332 22334567
Q ss_pred ccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 212 ~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
..|++||.+.+..++.++|+|++|+++++|++|..||..
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 889999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-31 Score=207.82 Aligned_cols=214 Identities=27% Similarity=0.479 Sum_probs=174.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC-----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----- 112 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----- 112 (272)
.+.|+-...+|+|.||.||+|+.+ +|+.|++|.+-.+ ...-....++|+.++..+. |+|++.+++.|...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk--Henv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc--chhHHHHHHHHhhccCCcc
Confidence 345777899999999999999866 6888888865432 2333457788999999999 99999999877642
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...++|+++|+ -+|.-.+ .+....++..+|..+..+++++|.|+|+. .|+|||+|+.|++|+.+|.++|.
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlL---sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLL---SNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHh---cCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 34789999996 4677676 23446789999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCc---cccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhh
Q 024118 190 DFGLSKLFPENTT---HISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263 (272)
Q Consensus 190 Dfg~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 263 (272)
|||+++.+..... .......-|..|.+||.+.+.. ++++.|+|+.||++.+|+++.+-+.+.+.+...++|..+
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 9999976542221 1122234488999999998764 899999999999999999999999999988877776654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=202.52 Aligned_cols=206 Identities=25% Similarity=0.340 Sum_probs=172.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---- 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---- 112 (272)
...+|.-++.+|.|+. .|..|.+. .+++|++|..... .....++..+|...+..+. |+||++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~--~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN--HKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc--ccceeeeeeccCccccHH
Confidence 4567888999999999 67677665 7899999987643 3344567788999999999 99999999988754
Q ss_pred --CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 113 --PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 113 --~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
...|+|||+| ..+|...+. ..++-..+..++.|++.|+++||+. ||+||||||+||+++.+..+|+.|
T Consensus 92 ~~~e~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 92 EFQEVYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHHhHHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence 3578999999 567887772 4567789999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
||++...... -..+....+..|.|||++.+..+.+.+||||+||++.+|++|+..|.+.+..+.+..+
T Consensus 162 fg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki 229 (369)
T KOG0665|consen 162 FGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI 229 (369)
T ss_pred chhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence 9999865433 2345567788999999999999999999999999999999999999988876655443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=221.04 Aligned_cols=213 Identities=30% Similarity=0.426 Sum_probs=179.2
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC----C----CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ----D----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH 106 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~----~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~ 106 (272)
.+.+..++..+.+.||.|.||.|++|... . ...||||.++.. .......+..|++.++.+.. |+|++.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~-H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGK-HPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcC-Ccchhhhe
Confidence 78888888899999999999999999632 1 457999998744 33456788889999998876 99999999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhcc---ccc---------ccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEE---KRR---------AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~---------~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~ 174 (272)
+.+..+...++|+||+..|+|.++++..+ ... ..++...++.++.||+.+++||++. .++||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence 99999999999999999999999997654 111 2388999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeecCcccccCCCCcccccccc--ccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccc
Q 024118 175 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA--GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 251 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~ 251 (272)
.+|||++.+..++++|||+++.............. ....|+|||.+....++.++|+||+|+++|+++| |..||.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999865443332212111 3456999999999999999999999999999999 99999863
Q ss_pred c
Q 024118 252 V 252 (272)
Q Consensus 252 ~ 252 (272)
.
T Consensus 526 ~ 526 (609)
T KOG0200|consen 526 P 526 (609)
T ss_pred C
Confidence 3
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-29 Score=196.68 Aligned_cols=216 Identities=18% Similarity=0.355 Sum_probs=168.3
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee-EecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-CIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~-~~~~~~~~i 117 (272)
..+.|.|.+.||+|.||.+-++.++ ++..+|+|.+. ........+.+|.-.--.+.. |.||+.-|++ +...+.++.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~-H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSP-HQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeecc-chhhhHHHHHHhhcCceEEE
Confidence 3466999999999999999999988 68889999875 334456788888877777765 8999998886 455677889
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCCeEEeecCccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSK 195 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~--~~~~~~l~Dfg~~~ 195 (272)
++||++.|+|.+-+ ....+.|.....++.|+++|+.++|++ +++|||||.+||||- +..++||+|||+..
T Consensus 100 ~qE~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999999887 346788999999999999999999999 999999999999993 34479999999997
Q ss_pred ccCCCCccccccccccccccCccccccCC-----CCCCCceehHHHHHHHHHhCCCccccc--cCCCceehhhhhhccee
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGR-----LTRKSDVYSFGVLLLEIVSGRTAVDFD--VQLGEYHLVDKVRSINM 268 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~Di~slG~il~~l~tg~~p~~~~--~~~~~~~~~~~~~~~~~ 268 (272)
..+.... ...-...|.+||...... ..+..|+|.+|+++|.++||.+||.-. .....-...++.++.++
T Consensus 172 k~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 172 KVGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred ccCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence 5432221 122345688998875332 467899999999999999999999722 23333334444444443
Q ss_pred e
Q 024118 269 K 269 (272)
Q Consensus 269 ~ 269 (272)
+
T Consensus 248 ~ 248 (378)
T KOG1345|consen 248 A 248 (378)
T ss_pred c
Confidence 3
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=191.50 Aligned_cols=219 Identities=21% Similarity=0.313 Sum_probs=182.1
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+...+..-.|.+.++||+|+||.++.+++- +|+.||||.....+ ....+..|.+..+.+.. .++|+.++-+...+-
T Consensus 21 s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g-~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 21 SGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGG-TEGIPQVYYFGQEGK 97 (449)
T ss_pred CCceEecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcC-CCCCCceeeeccccc
Confidence 344567788999999999999999999866 89999999865333 33456667777777764 899999999988888
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----CeEE
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-----NPKI 188 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-----~~~l 188 (272)
.-.+|+|.+ |.+|.++. +--...|+...+..++.||+.-++++|++ .+|+|||||+|+||...+ .+.+
T Consensus 98 ~NiLVidLL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred hhhhhhhhh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEE
Confidence 889999977 99999987 45677899999999999999999999999 999999999999996444 3899
Q ss_pred eecCcccccCCCC------ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 189 SDFGLSKLFPENT------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 189 ~Dfg~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
+|||++..+.+.. ........||.+|++-..+.+...++++|+-|||.++++.+-|..||.+..-.-.....++
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK 250 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK 250 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence 9999999875543 2223446699999999999999999999999999999999999999997765544444444
Q ss_pred h
Q 024118 263 V 263 (272)
Q Consensus 263 ~ 263 (272)
|
T Consensus 251 I 251 (449)
T KOG1165|consen 251 I 251 (449)
T ss_pred h
Confidence 4
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=183.33 Aligned_cols=216 Identities=21% Similarity=0.296 Sum_probs=177.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEe-CCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+...+|.+++.||.|+||.+|+|.. .+|+.||||+.+... ....+..|......++. ...|+.+..+..+...-++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~-g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQG-GVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhcc-CCCCchhhhhcccccccee
Confidence 4567899999999999999999975 589999999976432 22356677777777774 5678888888889999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCeEEeecCcc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFGLS 194 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~~~~l~Dfg~~ 194 (272)
||+.+ |.+|.++.. .-...++..+++.++.|++.-++|+|.+ +++||||||+|+++.-+ ..+.|+|||++
T Consensus 89 VMdLL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeecc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 99977 999999883 3556789999999999999999999999 99999999999999643 45899999999
Q ss_pred cccCCCC------ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhhhh
Q 024118 195 KLFPENT------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVR 264 (272)
Q Consensus 195 ~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 264 (272)
..+.+.. ........||.+|++-..+.+...++++|+-|+|.++.+.--|..||.+..........+.+.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 8764432 223344679999999999988888999999999999999999999999877655544444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=194.91 Aligned_cols=206 Identities=22% Similarity=0.283 Sum_probs=166.9
Q ss_pred CeeeeeeeeeccceEEEEEEeCC--CcEEEEEEEEecCcccHHHHHHHHHHhhcccc--cccceeEeeeeE-ecCCceeE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNV--CHENLVKLHGGC-IDGPCRIL 117 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~--~~~~i~~l~~~~-~~~~~~~i 117 (272)
+|.+.+.||+|+||.||.|.... ...+|+|+...........+..|...+..+.. ..++++.+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999998764 35899999876533332255566666666652 246899999988 47778899
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----CeEEeecC
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-----NPKISDFG 192 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-----~~~l~Dfg 192 (272)
||+.+ |.+|.++..... ...++..++..++.|++.+|++||+. |++||||||.|+++.... .+.|+|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99977 999999875443 57899999999999999999999999 999999999999998653 58999999
Q ss_pred ccc--ccCCCCc-----c-c-cccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 193 LSK--LFPENTT-----H-I-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 193 ~~~--~~~~~~~-----~-~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
++. ....... . . .....||..|+++..+.+...++++|+|||+.++.+++.|..||...+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 998 3321111 1 1 22355999999999999999999999999999999999999999766643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=193.62 Aligned_cols=138 Identities=21% Similarity=0.335 Sum_probs=115.5
Q ss_pred HHHhh-CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhccccc------ccceeEeeee
Q 024118 37 LKIAT-NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC------HENLVKLHGG 108 (272)
Q Consensus 37 ~~~~~-~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~------~~~i~~l~~~ 108 (272)
+.++. .+|-+.++||=|-|++||+|.+. +.+.||+|+.+.. .......+.|++++++++.. ..+||++++.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 33444 89999999999999999999876 6788999998743 33446788899999998743 3569999998
Q ss_pred Eec----CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 109 CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 109 ~~~----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
|.. +...++|+|++ |.+|..++.. ..-..++...+.+|.+|++.+|.|||+.+ ||+|.||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 764 56889999988 8888888854 34567889999999999999999999886 99999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=179.18 Aligned_cols=183 Identities=38% Similarity=0.626 Sum_probs=156.6
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCH
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 127 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L 127 (272)
||.|++|.||++... +|+.+++|.+...... ....+.+|+..++.+. |++++++++.+......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC--CCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 688999999999876 4899999998755332 3467889999999998 89999999999999999999999999999
Q ss_pred hHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCeEEeecCcccccCCCCccccc
Q 024118 128 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHIST 206 (272)
Q Consensus 128 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 206 (272)
.+++... ...++...++.++.+++.++.+||+. |++|+|++|.||+++. ++.++|+||+.+........ ...
T Consensus 79 ~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 79 KDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 9998322 14688999999999999999999999 9999999999999999 89999999999986544321 122
Q ss_pred cccccccccCccccccC-CCCCCCceehHHHHHHHH
Q 024118 207 RVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEI 241 (272)
Q Consensus 207 ~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l 241 (272)
...+...|.+||.+... ..+.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 24567789999999877 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-27 Score=208.91 Aligned_cols=195 Identities=27% Similarity=0.373 Sum_probs=155.1
Q ss_pred eeeeeccce-EEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCC
Q 024118 48 NKIGEGGFG-SVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126 (272)
Q Consensus 48 ~~lg~G~~~-~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~ 126 (272)
+.+|.|+.| .||+|... |+.||||.+-.+ ......+|+..++.-.. ||||++++..-.++...||..|.| ..+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~-H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDE-HPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccC-CCceEEEEeeccCCceEEEEehHh-hhh
Confidence 567788876 56778764 788999987522 23356678888877665 999999998888888999999999 579
Q ss_pred HhHHHhhcccccccC-ChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---C--CCeEEeecCcccccCCC
Q 024118 127 LSQTLLGEEKRRAKF-GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---N--FNPKISDFGLSKLFPEN 200 (272)
Q Consensus 127 L~~~~~~~~~~~~~l-~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~---~--~~~~l~Dfg~~~~~~~~ 200 (272)
|.+++... ...... .....+.++.|+++||++||+. +|+||||||.||||.. + .+++|.|||++..+...
T Consensus 589 L~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 589 LQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred HHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 99999542 111111 1256688999999999999999 9999999999999965 3 35799999999988654
Q ss_pred Ccc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhC-CCcccccc
Q 024118 201 TTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDV 252 (272)
Q Consensus 201 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~ 252 (272)
... ......||.+|.|||++.+..-+.++||||+||++|+.++| ..||+..-
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 322 24457799999999999998888899999999999999886 89997543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=191.05 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=166.9
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
..+...+.|.++.+||.|.|+.||++... .+..||+|.+... ....++..|++.+..+.. +.||+++.+.+..
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG-~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGG-SDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhcc-chhhhcchhhhcc
Confidence 35667788999999999999999999643 4778999998644 344578899999999886 8999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCeEEee
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISD 190 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~-~~~~l~D 190 (272)
++...+|+||++.....++. ..++...+..++..++.||.++|.+ ||+|||+||.|++.+.. +.-.|+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 99999999999999888887 3466899999999999999999999 99999999999999754 4578999
Q ss_pred cCcccccCCC--------------C-----------------------------ccccccccccccccCccccccCC-CC
Q 024118 191 FGLSKLFPEN--------------T-----------------------------THISTRVAGTLGYLAPEYAISGR-LT 226 (272)
Q Consensus 191 fg~~~~~~~~--------------~-----------------------------~~~~~~~~~~~~~~aPE~~~~~~-~~ 226 (272)
||++...... . ........||++|.|||++..-+ .+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9999722000 0 00011145899999999987654 67
Q ss_pred CCCceehHHHHHHHHHhCCCccc
Q 024118 227 RKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 227 ~~~Di~slG~il~~l~tg~~p~~ 249 (272)
++.|+||.|+++..+++++.||-
T Consensus 257 taiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred Cccceeeccceeehhhccccccc
Confidence 89999999999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=188.16 Aligned_cols=188 Identities=18% Similarity=0.209 Sum_probs=140.2
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeC--CCcEEEEEEEEec-----CcccHHHHHHHHHHhhcccccccceeE-
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVK- 104 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~v~vK~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~~i~~- 104 (272)
.-++.+....+|++.+.||+|+||.||+|.+. +++.+|||..... .......+.+|++.++.+. |+++++
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~--h~~iv~~ 86 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR--GIGVVPQ 86 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc--CCCCCcE
Confidence 34556677889999999999999999999865 5788899986532 1223456889999999998 999885
Q ss_pred eeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCC
Q 024118 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI-KTSNILLDQN 183 (272)
Q Consensus 105 l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl-~p~nilv~~~ 183 (272)
+++ ....++||||++|++|.... ... ...++.+++++|.+||++ ||+|||| ||.||+++.+
T Consensus 87 l~~----~~~~~LVmE~~~G~~L~~~~-----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 87 LLA----TGKDGLVRGWTEGVPLHLAR-----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPD 148 (365)
T ss_pred EEE----cCCcEEEEEccCCCCHHHhC-----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCC
Confidence 443 24579999999999996321 111 145788999999999999 9999999 9999999999
Q ss_pred CCeEEeecCcccccCCCCccc-------cccccccccccCccccccCC------CCCCCceehHHHHHHHHHhCCCcc
Q 024118 184 FNPKISDFGLSKLFPENTTHI-------STRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
+.++|+|||++.......... .....++..|.|||.+.... .+..+|.| +.||..-+
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW--------~~TGDlg~ 218 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW--------LATGKKVY 218 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE--------EeCCCEEE
Confidence 999999999998664322111 12345677799999886442 23456655 44666554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-27 Score=205.67 Aligned_cols=202 Identities=24% Similarity=0.400 Sum_probs=179.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
...+|++.+.+|.|.+|.||++++. +++..|+|+++.+...+..-.-+|+-+++..+ ||||+.+++.+...+..+|.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~--h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR--HPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC--CcChHHHHhhhhhhcCcEEE
Confidence 4678999999999999999999876 89999999999888888778888999999988 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||||.||+|++.. +..+++++.++....+..++++.|||+. |=+|||||-.||++++.|++++.|||.+..+.
T Consensus 91 MEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 91 MEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 9999999999987 7788999999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
.... ....+.||+.|+|||+-. ...|....|+|++|.+..++-.-++|....
T Consensus 164 ati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl 218 (829)
T KOG0576|consen 164 ATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL 218 (829)
T ss_pred hhhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc
Confidence 3322 234478999999999864 445889999999999999988877776433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=190.65 Aligned_cols=229 Identities=21% Similarity=0.287 Sum_probs=183.9
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEe
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKL 105 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l 105 (272)
..+.+.+-..++++...+-+|.||.||.|.|. +.+.|.+|.++.. +.-+...+++|...+..+. |||+.++
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s--H~nll~V 352 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS--HPNLLSV 352 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc--CCCccce
Confidence 45566777888999999999999999999654 2456777877633 3445567888888888888 9999999
Q ss_pred eeeEecC-CceeEEEeecCCCCHhHHHhhcc----cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 106 HGGCIDG-PCRILVYDYMPNNSLSQTLLGEE----KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 106 ~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
.+++.++ +..+++++++..++|..++..-+ ..-..++..++...+.|++.|+.|||++ |++|.||..+|.+|
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI 429 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence 9987654 67888999999999999995211 1223466778888999999999999999 99999999999999
Q ss_pred cCCCCeEEeecCcccccCCCCccc-cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 181 DQNFNPKISDFGLSKLFPENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
++..++||+|-.+++..-+..... .........|++||.+....++.++|+||+|+++|||+| |+.||.-.++.+...
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 999999999999998654332222 222334667999999999999999999999999999998 999999888887776
Q ss_pred hhhhhhcc
Q 024118 259 LVDKVRSI 266 (272)
Q Consensus 259 ~~~~~~~~ 266 (272)
.+..-+++
T Consensus 510 ylkdGyRl 517 (563)
T KOG1024|consen 510 YLKDGYRL 517 (563)
T ss_pred HHhcccee
Confidence 66554444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=171.81 Aligned_cols=174 Identities=14% Similarity=0.155 Sum_probs=133.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHH---------HHHHHHHhhcccccccceeEeeee
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKE---------FMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~---------~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
.....+|++.+.+|.|+||.||++.. ++..+|+|++.......... +.+|+..+.++. ||+|..+.+.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~--~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR--SEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH--HCCCCcceEe
Confidence 37789999999999999999999755 57789999997553333322 567888889998 9999999887
Q ss_pred EecC--------CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 109 CIDG--------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 109 ~~~~--------~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
+... ...+++|||++|.+|.+.. .+++ ....++..++..+|+. |++|+|++|+||++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 5533 3578999999999998774 1222 2456899999999999 99999999999999
Q ss_pred cCCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh
Q 024118 181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t 243 (272)
+.+| ++|+|||.......... . ..+.....+..++|+|+||+++.....
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a-----~--------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKA-----K--------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred eCCC-EEEEECCCcccccchhh-----H--------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9888 99999998864321110 0 013344456689999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=197.44 Aligned_cols=205 Identities=19% Similarity=0.211 Sum_probs=173.5
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
....+....|.|.+.+|.|++|.||.|...+|+.||+|+-++...+.-.-..+....|+ ... -+.|..+.......+.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~-~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-PQM-LPSIMHISSAHVFQNA 768 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-hhh-hcchHHHHHHHccCCc
Confidence 34556688899999999999999999998889999999988777766555555555555 222 4677777777788888
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------CCCeE
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-------NFNPK 187 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-------~~~~~ 187 (272)
.++|+||.+.|+|.+++ +..+.+++..+..+..||+..+.+||.. +||||||||+|+++.. .--++
T Consensus 769 S~lv~ey~~~Gtlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 99999999999999999 5778899999999999999999999999 9999999999999942 23389
Q ss_pred EeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcc
Q 024118 188 ISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
|+|||.+..+.-... ......++|-.|-.+|...|.+|+..+|.|+++.+++.|+.|+..-
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 999999997754332 3566678899999999999999999999999999999999998654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=161.43 Aligned_cols=139 Identities=16% Similarity=0.178 Sum_probs=106.9
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcc--c-------H-----------------HHHHHHHHHhhccccccc
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ--G-------E-----------------KEFMSEVASMANVNVCHE 100 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~--~-------~-----------------~~~~~e~~~~~~~~~~~~ 100 (272)
...||+|++|.||+|...+|+.||+|+++..... . . .....|++.+..+. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV--TA 79 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH--HC
Confidence 4689999999999999889999999999754211 1 0 12234888888887 55
Q ss_pred ceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCCEE
Q 024118 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI-HEEIQPHVVHRDIKTSNIL 179 (272)
Q Consensus 101 ~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~i~h~dl~p~nil 179 (272)
++....... ....++||||++|+++.... ....++++..+..++.|++.++.++ |+. ||+|+||||.||+
T Consensus 80 ~v~~p~~~~--~~~~~iVmE~i~g~~l~~~~----~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl 150 (190)
T cd05147 80 GIPCPEPIL--LKSHVLVMEFIGDDGWAAPR----LKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL 150 (190)
T ss_pred CCCCCcEEE--ecCCEEEEEEeCCCCCcchh----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 553322221 12348999999988776553 2345788999999999999999999 688 9999999999999
Q ss_pred EcCCCCeEEeecCccccc
Q 024118 180 LDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 180 v~~~~~~~l~Dfg~~~~~ 197 (272)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=198.24 Aligned_cols=144 Identities=17% Similarity=0.147 Sum_probs=107.3
Q ss_pred cceeEeeeeE-------ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 024118 100 ENLVKLHGGC-------IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172 (272)
Q Consensus 100 ~~i~~l~~~~-------~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~d 172 (272)
+||+.+++.+ ......+.++|++ +++|.+++. .....+++..++.++.||+.||.|||++ ||+|||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrD 105 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD---NPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHN 105 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh---cccccccHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 4566666655 2234566778877 669999983 2345699999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEe-------------------ecCcccccCCCCc---------------cccccccccccccCcc
Q 024118 173 IKTSNILLDQNFNPKIS-------------------DFGLSKLFPENTT---------------HISTRVAGTLGYLAPE 218 (272)
Q Consensus 173 l~p~nilv~~~~~~~l~-------------------Dfg~~~~~~~~~~---------------~~~~~~~~~~~~~aPE 218 (272)
|||+|||++..|.++++ |||++........ .......+|+.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999765555555 5554432110000 0001134678899999
Q ss_pred ccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 219 YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 219 ~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
++.+..++.++||||+||++|+|++|.+|+..
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=165.49 Aligned_cols=202 Identities=34% Similarity=0.552 Sum_probs=169.2
Q ss_pred eeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcc---cHHHHHHHHHHhhccccccc-ceeEeeeeEecCCceeEEE
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~---~~~~~~~e~~~~~~~~~~~~-~i~~l~~~~~~~~~~~iv~ 119 (272)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+..+..+. |+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLN--HPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHcc--CCcceeeEEEEEecCCEEEEEE
Confidence 788999999999999999877 77899988754332 3667888899889888 77 7999999997777789999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~~~~~~ 198 (272)
+++.++++.+.+...... ..+++.....+..|++.++.++|+. +++|||+||.||+++..+ .++++|||.+....
T Consensus 78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999666322111 3788999999999999999999999 999999999999999988 69999999998554
Q ss_pred CCCcc-----ccccccccccccCcccccc---CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTH-----ISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~-----~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... ......++..|.+||.+.+ ...+...|+|++|++++++++|..||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 33221 2355678999999999988 5788999999999999999999999776553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=154.79 Aligned_cols=141 Identities=16% Similarity=0.195 Sum_probs=108.4
Q ss_pred eeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcc--c------------------------HHHHHHHHHHhhcccccc
Q 024118 46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ--G------------------------EKEFMSEVASMANVNVCH 99 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~--~------------------------~~~~~~e~~~~~~~~~~~ 99 (272)
+...||+|++|.||+|.+.+|+.||+|++...... . ......|...+.++. +
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY--E 78 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH--h
Confidence 35789999999999999878999999998754211 0 112345777788877 6
Q ss_pred cceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCE
Q 024118 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNI 178 (272)
Q Consensus 100 ~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~ni 178 (272)
+++......... ..++||||++|+++.... .....+++..+..++.|++.++.++|+ . ||+|+||||.||
T Consensus 79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~----l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI 149 (190)
T cd05145 79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPR----LKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI 149 (190)
T ss_pred CCCCCceEEEec--CCEEEEEEecCCCchhhh----hhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence 765333222222 248999999988654432 123567888999999999999999999 8 999999999999
Q ss_pred EEcCCCCeEEeecCcccccC
Q 024118 179 LLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 179 lv~~~~~~~l~Dfg~~~~~~ 198 (272)
+++ ++.++|+|||++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE-CCCEEEEEcccceecC
Confidence 998 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-23 Score=189.27 Aligned_cols=198 Identities=24% Similarity=0.312 Sum_probs=160.1
Q ss_pred CeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEee
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDY 121 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~ 121 (272)
++...+.||.+.|=+|.+|+++.|. |+||++-... .-....+.+++...+.....+||.+++..+...+...|+|.+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6888999999999999999998888 8899986443 3445556666555554445599999998887788888999999
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc--CC
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PE 199 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~--~~ 199 (272)
. ..+|.|.+ ..++-+..-+...|+.|++.|+..+|+. ||||||||.+||||+..+-+.|.||...+.. +.
T Consensus 103 v-khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 V-KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred H-hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 8 56899998 6778888889999999999999999999 9999999999999999999999999877522 11
Q ss_pred -C---CccccccccccccccCccccccC----------C-CCCCCceehHHHHHHHHHh-CCCccc
Q 024118 200 -N---TTHISTRVAGTLGYLAPEYAISG----------R-LTRKSDVYSFGVLLLEIVS-GRTAVD 249 (272)
Q Consensus 200 -~---~~~~~~~~~~~~~~~aPE~~~~~----------~-~~~~~Di~slG~il~~l~t-g~~p~~ 249 (272)
+ ............+|+|||.|... . .+++.||||+||++.||++ |++||+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1 12223334456789999998642 1 5689999999999999988 788886
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=151.50 Aligned_cols=108 Identities=23% Similarity=0.226 Sum_probs=93.4
Q ss_pred CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccc
Q 024118 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204 (272)
Q Consensus 125 ~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~ 204 (272)
|+|.+++.. ...++++..++.++.|++.||.|||++ + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 578888832 245699999999999999999999998 6 999999999999998 99887553322
Q ss_pred cccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 205 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
..+++.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 257899999999999999999999999999999999999997554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=148.59 Aligned_cols=188 Identities=17% Similarity=0.090 Sum_probs=136.9
Q ss_pred eeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccH----HHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGE----KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 45 ~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~----~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
.+...|+.|+||+|+.+.. ++.+++.+.+........ ..+.+|++.++++.. ++++++++++ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~-~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG-LPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC-CCCCCEEEEE----cCEEEEEe
Confidence 4678999999999997755 688888887764433221 246789999999963 5889998875 45689999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCCCCeEEeecCcccccCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI-KTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl-~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|+.|.+|..... . . ...++.|+..++.++|++ ||+|+|| +|.||+++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~----~------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPP----R------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhh----h------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999999875431 1 1 134778999999999999 9999999 79999999999999999999985443
Q ss_pred CCcc----c--------cccccccccccCccccccC-CCC-CCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTH----I--------STRVAGTLGYLAPEYAISG-RLT-RKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~----~--------~~~~~~~~~~~aPE~~~~~-~~~-~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.... . ......++.+++|+...-. ..+ .+.+.++.|+-+|.++|++.|.-..+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 2210 0 0011134556666543221 122 56788899999999999988764443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=149.30 Aligned_cols=144 Identities=17% Similarity=0.109 Sum_probs=112.1
Q ss_pred CeeeeeeeeeccceEEEEEE--eCCCcEEEEEEEEecCcc------------------------cHHHHHHHHHHhhccc
Q 024118 43 GFRWSNKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQ------------------------GEKEFMSEVASMANVN 96 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~--~~~~~~v~vK~~~~~~~~------------------------~~~~~~~e~~~~~~~~ 96 (272)
-|++.+.||+|++|.||+|. ..+|+.||+|++...... .......|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48999999999999999998 458999999998743210 0123457888888887
Q ss_pred ccccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCC
Q 024118 97 VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-VVHRDIKT 175 (272)
Q Consensus 97 ~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-i~h~dl~p 175 (272)
.....++++++. ...++||||++|.+|.... .....+....+..++.|++.++.+||+. | ++|+|++|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 322344555543 2358999999998887654 2334566677889999999999999999 9 99999999
Q ss_pred CCEEEcCCCCeEEeecCcccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 7899999999987543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-21 Score=176.77 Aligned_cols=202 Identities=23% Similarity=0.327 Sum_probs=159.5
Q ss_pred eeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--Cccc----HHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 45 RWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQG----EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 45 ~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~----~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.-...+|.|++|.++.+... ....+..|.+... .... ...+..|+..-..+. ||+++..+....+.....-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~--h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS--HPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc--CCchhhhHHHHhhcccchh
Confidence 35678899999977777644 4444555544311 1111 122444555566666 9999988887777666666
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
.||||++ +|.+.+ .....++...+...+.|++.++.|+|+. ||.|||+||+|+++..+|.++++|||.+...
T Consensus 399 ~mE~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence 6999999 999998 3335788999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCc---cccccccccccccCccccccCCCCC-CCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 198 PENTT---HISTRVAGTLGYLAPEYAISGRLTR-KSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 198 ~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
..... ......+|+..|+|||.+.+..|++ ..|+||.|++++.|.+|+.||....+.+.
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 54433 4556678999999999999999875 79999999999999999999987665543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=151.56 Aligned_cols=208 Identities=20% Similarity=0.242 Sum_probs=132.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc---cHHHHHHHHHHhhcccc-c-------ccceeEeeeeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---GEKEFMSEVASMANVNV-C-------HENLVKLHGGC 109 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~~~~~~~-~-------~~~i~~l~~~~ 109 (272)
..+.....||.|+++.||.+++. +|+.+++|++...... ..+.+.+|......+.. . |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34667899999999999999987 7999999998755321 23344444444333221 0 22222222322
Q ss_pred e---------cC---C-----ceeEEEeecCCCCHhHHHhhc---ccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 024118 110 I---------DG---P-----CRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 169 (272)
Q Consensus 110 ~---------~~---~-----~~~iv~e~~~~~~L~~~~~~~---~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~ 169 (272)
. .. . ..+++|+-+ .++|.+++..- ......+.......+..|+.+.+++||+. |++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 2 11 1 235677766 66787775321 11222344455566779999999999999 999
Q ss_pred ecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCccccccC--------CCCCCCceehHHHHHHHH
Q 024118 170 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG--------RLTRKSDVYSFGVLLLEI 241 (272)
Q Consensus 170 h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Di~slG~il~~l 241 (272)
|+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999888765432211 2234668889876432 367899999999999999
Q ss_pred HhCCCccccccCCCce
Q 024118 242 VSGRTAVDFDVQLGEY 257 (272)
Q Consensus 242 ~tg~~p~~~~~~~~~~ 257 (272)
++|+.||+..+.....
T Consensus 244 WC~~lPf~~~~~~~~~ 259 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADP 259 (288)
T ss_dssp HHSS-STCCCGGGSTS
T ss_pred HHccCCCCCCCccccc
Confidence 9999999977655443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=143.22 Aligned_cols=138 Identities=18% Similarity=0.288 Sum_probs=106.0
Q ss_pred eeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc---cccceeEeeeeEecCC---c-eeE
Q 024118 46 WSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---CHENLVKLHGGCIDGP---C-RIL 117 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~---~~~~i~~l~~~~~~~~---~-~~i 117 (272)
-.+.||+|+++.||. ++ ++.. +||+...........+.+|+..++.+.. .||||+++++++..+. . ..+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 54 4444 6898876545556788999999999842 3899999999998764 2 237
Q ss_pred EEee--cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCCEEEcCC----CCeEEee
Q 024118 118 VYDY--MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL-AYIHEEIQPHVVHRDIKTSNILLDQN----FNPKISD 190 (272)
Q Consensus 118 v~e~--~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al-~~LH~~~~~~i~h~dl~p~nilv~~~----~~~~l~D 190 (272)
|+|| +++++|.+++.. ..+++. ..++.+++.++ .|||++ +|+|+||||+||+++.. +.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 557999999932 235555 35577777777 999999 99999999999999743 3799999
Q ss_pred -cCcccc
Q 024118 191 -FGLSKL 196 (272)
Q Consensus 191 -fg~~~~ 196 (272)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 665443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=138.17 Aligned_cols=134 Identities=21% Similarity=0.293 Sum_probs=108.9
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecCcc--------cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ--------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~--------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+.||+|++|.||+|.+ +|..+++|........ ...+..+|+..+..+. +++++....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR--KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH--HCCCCCCeEEEEeCCCCEEEE
Confidence 5789999999999987 6778999986533211 1235667888888887 777766665666677889999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
||++|++|.+.+.. .. . ....++.+++.++.++|+. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998832 11 1 7888999999999999999 999999999999999 78899999998875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.3e-18 Score=134.68 Aligned_cols=139 Identities=20% Similarity=0.188 Sum_probs=107.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcc----------------------cHHHHHHHHHHhhccccc
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ----------------------GEKEFMSEVASMANVNVC 98 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~----------------------~~~~~~~e~~~~~~~~~~ 98 (272)
...|.+.+.||.|++|.||++...+|+.|++|++...... .......|...+..+.
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 91 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-- 91 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH--
Confidence 3348899999999999999999888999999987643210 1112456777777776
Q ss_pred cc--ceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 024118 99 HE--NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 176 (272)
Q Consensus 99 ~~--~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ 176 (272)
++ .+++.++ ....+++|||++|++|..... ......++.+++.++.++|+. |++|+||+|.
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~ 154 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEF 154 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcc
Confidence 44 3444443 245589999999999876541 134567889999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeecCcccccC
Q 024118 177 NILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 177 nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||+++.++.++|+|||.+....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-20 Score=162.45 Aligned_cols=187 Identities=28% Similarity=0.354 Sum_probs=154.0
Q ss_pred eeeeccceEEEEEE----eCCCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeec
Q 024118 49 KIGEGGFGSVYKGR----LQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 49 ~lg~G~~~~v~~~~----~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
.+|+|.+|.|++++ ...|.-+++|+.+.... ........|...+..++. ||.++++...+..+...+++.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~-~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHN-TPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccC-CCceeeeeeeeccccchhHhhhhc
Confidence 37899999999885 33578899998764321 111134445555555544 899999999999999999999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~ 202 (272)
.|+.|...+ .....+.+.........++-++.++|+. +|+|+|+|++||+++.+|++++.|||++...-....
T Consensus 80 rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 80 RGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred ccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999998887 5667777888888899999999999999 999999999999999999999999999985422221
Q ss_pred cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 203 HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 203 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
.+|+..|+|||.+. ....++|.||+|+++++|+||..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28899999999997 567899999999999999999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=132.40 Aligned_cols=131 Identities=22% Similarity=0.315 Sum_probs=101.7
Q ss_pred eeeeccceEEEEEEeCCCcEEEEEEEEecCc-c-------cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESK-Q-------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~-~-------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
.||+|++|.||++.+ +|..+++|....... . ...+..+|++.+..+. ++++....-........+++||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR--KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH--HCCCCCCEEEEEECCCCEEEEE
Confidence 379999999999985 567899998653211 1 1245667888888887 6554433333445666789999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
|++|++|.+.+... .. .++.+++.++.+||+. |++|+|++|.||+++ ++.++++|||.+...
T Consensus 78 ~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999887321 11 7889999999999999 999999999999999 789999999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.2e-19 Score=139.24 Aligned_cols=211 Identities=21% Similarity=0.371 Sum_probs=161.6
Q ss_pred ccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEee
Q 024118 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106 (272)
Q Consensus 29 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~ 106 (272)
-+....+...+.-+...+..+|.....|..|+++|+.+. ++.|++.... ......+..|.-.++.+. ||||++++
T Consensus 177 rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifs--hpnilpvl 253 (448)
T KOG0195|consen 177 RDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFS--HPNILPVL 253 (448)
T ss_pred cccccccccCcchhhhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeec--CCchhhhh
Confidence 344444455566666777888999999999999998555 5557765442 223356778888999999 99999999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCe
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~ 186 (272)
+.|.......++..||+.++|.+.+.. ......+..++...+.+++.++.|||+. ..-|.---|+...++|+++.+.
T Consensus 254 gacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedlta 330 (448)
T KOG0195|consen 254 GACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTA 330 (448)
T ss_pred hhccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhh
Confidence 999999999999999999999999943 3455577889999999999999999987 3334445688999999998876
Q ss_pred EEe--ecCcccccCCCCccccccccccccccCccccccCCCC---CCCceehHHHHHHHHHhCCCccccccC
Q 024118 187 KIS--DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 187 ~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+|. |--.+. ......-.+.|++||.+...+.+ +++|+||+++++++|.|...||...++
T Consensus 331 rismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 331 RISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred heecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 653 211111 01112235779999999877643 589999999999999999999986665
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=149.80 Aligned_cols=141 Identities=19% Similarity=0.251 Sum_probs=110.9
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEec--Cc------ccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SK------QGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--~~------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
......|...+.||+|+||.||++.+.++. +++|..... .. ....++.+|++.++.+. |++++......
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~ 405 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR--RAGVPTPVIYD 405 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc--ccCCCeeEEEE
Confidence 333445567899999999999999876444 333432211 11 12346778999999998 88888776666
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
......++||||++|++|.+.+. ....++.+++.++.+||+. |++|||+||.||++ +++.++|+
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEE
Confidence 66677889999999999999872 3467899999999999999 99999999999999 57789999
Q ss_pred ecCccccc
Q 024118 190 DFGLSKLF 197 (272)
Q Consensus 190 Dfg~~~~~ 197 (272)
|||++...
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99999753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-17 Score=127.64 Aligned_cols=140 Identities=20% Similarity=0.192 Sum_probs=97.0
Q ss_pred eeeeeeeccceEEEEEEeCCCcEEEEEEEEecCccc--HHH----------------------HHHHHHHhhcccccccc
Q 024118 46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG--EKE----------------------FMSEVASMANVNVCHEN 101 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~--~~~----------------------~~~e~~~~~~~~~~~~~ 101 (272)
+.+.||+|++|.||+|...+|+.||+|++....... ... ...|...+..+......
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 357899999999999998889999999987432111 111 12344444444421222
Q ss_pred eeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEE
Q 024118 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 102 i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv 180 (272)
+++.+.. ...+++|||++++.+...... .... ...+..++.+++.++.++|+ . +|+|+|++|+||++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~----~~~~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLK----DVRL-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhh----hhhh-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 4444432 245899999998543221100 0001 16678899999999999999 8 99999999999999
Q ss_pred cCCCCeEEeecCcccccC
Q 024118 181 DQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~~~ 198 (272)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=120.50 Aligned_cols=137 Identities=18% Similarity=0.155 Sum_probs=111.6
Q ss_pred eeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
+++.||.|.++.||++...+ ..+++|....... ...+..|+..++.+......+++++......+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56889999999999998764 7799998754332 45678888888888731258888888887778899999999887
Q ss_pred CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 126 ~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
.+... +......++.+++.++..+|.....+++|+|++|.||++++.+.++++||+.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66643 4456677889999999999986334799999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.9e-18 Score=154.11 Aligned_cols=177 Identities=24% Similarity=0.328 Sum_probs=130.1
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
..-..+|..++.+.-|++|.||.++++ +.+++|+|+-+ + ..+++. ++.... +|.++
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-----q-~lilRn--ilt~a~--npfvv------------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-----Q-NLILRN--ILTFAG--NPFVV------------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhcccc-----c-chhhhc--cccccC--Cccee-------------
Confidence 345678999999999999999999987 68888885532 1 111111 111111 33333
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
|+-...+ ..-++++.+. +.+++|||+- ||+|+|+||+|.+|+.-|++++.|||+.+.
T Consensus 136 --------gDc~tll----k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 --------GDCATLL----KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred --------chhhhhc----ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhh
Confidence 2222333 2223443333 6789999999 999999999999999999999999999974
Q ss_pred cCCCCc--------------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 197 FPENTT--------------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 197 ~~~~~~--------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
...... -....++||+.|.|||++..+.|...+|.|++|+++|+.+.|..||.+.++++.+...
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 321110 0123368999999999999999999999999999999999999999999988876543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-15 Score=122.92 Aligned_cols=135 Identities=18% Similarity=0.205 Sum_probs=100.7
Q ss_pred eeee-eccceEEEEEEeCCCcEEEEEEEEecC-------------cccHHHHHHHHHHhhcccccccc--eeEeeeeEec
Q 024118 48 NKIG-EGGFGSVYKGRLQDGTIVAVKVLSVES-------------KQGEKEFMSEVASMANVNVCHEN--LVKLHGGCID 111 (272)
Q Consensus 48 ~~lg-~G~~~~v~~~~~~~~~~v~vK~~~~~~-------------~~~~~~~~~e~~~~~~~~~~~~~--i~~l~~~~~~ 111 (272)
..|| .||.|++|.+... +..+++|.+.... .....+..+|+..+..+. +++ ++..++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~--~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY--EAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH--hCCCCCceeEeeeee
Confidence 4566 6788888888765 6678888875311 123356788999999998 655 4666665433
Q ss_pred CC----ceeEEEeecCC-CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCe
Q 024118 112 GP----CRILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 112 ~~----~~~iv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~ 186 (272)
.. ..++|+|+++| .+|.+++. ...+++.. +.+++.++.+||+. ||+|+||+|.|||++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence 22 23599999997 68988872 23444443 56889999999999 99999999999999988899
Q ss_pred EEeecCccccc
Q 024118 187 KISDFGLSKLF 197 (272)
Q Consensus 187 ~l~Dfg~~~~~ 197 (272)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.5e-15 Score=123.55 Aligned_cols=144 Identities=24% Similarity=0.351 Sum_probs=107.7
Q ss_pred cccceeEeeeeEec---------------------------CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHH
Q 024118 98 CHENLVKLHGGCID---------------------------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150 (272)
Q Consensus 98 ~~~~i~~l~~~~~~---------------------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~ 150 (272)
.||||+.+...|.+ ....|+||.-+ ..+|..++ .....+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl-----~~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYL-----WTRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHH-----hcCCCchHHHHHHH
Confidence 39999999875543 23457888876 45788887 33456677888899
Q ss_pred HHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCC--CeEEeecCcccccCCCCcc-----ccccccccccccCccccc
Q 024118 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNF--NPKISDFGLSKLFPENTTH-----ISTRVAGTLGYLAPEYAI 221 (272)
Q Consensus 151 ~~i~~al~~LH~~~~~~i~h~dl~p~nilv~--~~~--~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~ 221 (272)
.|+++|+.|||++ |+.|||+|.+||++. +++ .+++.|||.+-.-...... ..-...|....+|||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999993 333 3688999988643321111 112234677889999986
Q ss_pred cCC-----C-CCCCceehHHHHHHHHHhCCCcccc
Q 024118 222 SGR-----L-TRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 222 ~~~-----~-~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
..+ . =.++|.|+.|.+.||++....||=.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 443 1 2489999999999999999999954
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=127.37 Aligned_cols=143 Identities=22% Similarity=0.283 Sum_probs=97.8
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCccc----------------------------------------HHHHH
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG----------------------------------------EKEFM 86 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~----------------------------------------~~~~~ 86 (272)
.++||.|++|.||+|+.++|+.||||+.++..... +.++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986432111 01233
Q ss_pred HHHHHhhccccc---ccceeEeeeeE-ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHH-HHHHHh
Q 024118 87 SEVASMANVNVC---HENLVKLHGGC-IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR-GLAYIH 161 (272)
Q Consensus 87 ~e~~~~~~~~~~---~~~i~~l~~~~-~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~-al~~LH 161 (272)
+|+..+.++... +++ +.+-.++ ...+..+++|||++|.+|.+..... ....+ ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~-v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPG-VYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCC-EEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHH
Confidence 444444444321 222 2222222 2244578999999999998876321 11122 2334555554 467889
Q ss_pred hcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 162 ~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
.. |++|+|++|.||+++.++.++++|||++.....
T Consensus 275 ~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.3e-16 Score=134.35 Aligned_cols=123 Identities=25% Similarity=0.417 Sum_probs=105.5
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..+|.|++|...+|.+++... ......+......++.|++.++.| + +.+|+|++|.||+...+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 467999999999999999543 233456678899999999999999 6 999999999999999999999999999
Q ss_pred ccccCCCC-----ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh
Q 024118 194 SKLFPENT-----THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 194 ~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t 243 (272)
........ ........||..|++||++.+..|+.++|||+||++++++++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98775444 222333678999999999999999999999999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-16 Score=142.90 Aligned_cols=208 Identities=25% Similarity=0.360 Sum_probs=165.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC--CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~--~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...|.+.+.||+|+++.+-.+... ....++.|-+.... .........|...-+.+.. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~-h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSK-HSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccc-cccccccCCccCCCcccc
Confidence 445888899999999999888664 34456666654332 2222333335554444444 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccc-cCChHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCCEEEcCCC-CeEEeecCc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRA-KFGWKARREIIMGIGRGLAYIH-EEIQPHVVHRDIKTSNILLDQNF-NPKISDFGL 193 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~-~l~~~~~~~i~~~i~~al~~LH-~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~ 193 (272)
++.+|..|+++.+.+. .... ..+....-..+.|+..++.|+| .. ++.|+|++|+|.+++..+ .+++.|||+
T Consensus 98 ~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence 9999999999988873 2222 6677888889999999999999 88 999999999999999999 999999999
Q ss_pred ccccCC--CCccccccccc-cccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 194 SKLFPE--NTTHISTRVAG-TLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 194 ~~~~~~--~~~~~~~~~~~-~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+..... .........+| ++.|.|||...+.. ..+..|+||.|+++..+++|..||+......
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 997765 34444555677 99999999998854 5789999999999999999999998776544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-13 Score=106.52 Aligned_cols=139 Identities=15% Similarity=0.098 Sum_probs=101.6
Q ss_pred eeeeeeccceEEEEEEeCC-------CcEEEEEEEEecC----------------------cccHHH----HHHHHHHhh
Q 024118 47 SNKIGEGGFGSVYKGRLQD-------GTIVAVKVLSVES----------------------KQGEKE----FMSEVASMA 93 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~-------~~~v~vK~~~~~~----------------------~~~~~~----~~~e~~~~~ 93 (272)
...||.|--+.||.|...+ +..+|||+.+... ...... ..+|+..++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999997553 4789999985210 011122 236888888
Q ss_pred cccccccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHH-hhcCCCCeEecC
Q 024118 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI-HEEIQPHVVHRD 172 (272)
Q Consensus 94 ~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~i~h~d 172 (272)
++....-++++++.+ ...++||||+.+..+.... ..+..+++..+..+..+++.++..+ |+. |++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK----LKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh----hhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 887545667777754 5678999999765443221 1223455566778889999999998 888 999999
Q ss_pred CCCCCEEEcCCCCeEEeecCccccc
Q 024118 173 IKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 173 l~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
|++.||+++ ++.++++|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.6e-14 Score=122.98 Aligned_cols=153 Identities=32% Similarity=0.558 Sum_probs=125.5
Q ss_pred hcccccccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCe-Eec
Q 024118 93 ANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV-VHR 171 (272)
Q Consensus 93 ~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i-~h~ 171 (272)
+.+. |.|+.++++.+.++...++|.+||..|+|.+.+.. ....++........++++.++.|||+. .| .|+
T Consensus 2 ~~l~--h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg 73 (484)
T KOG1023|consen 2 RQLD--HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHG 73 (484)
T ss_pred cccc--hhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeee
Confidence 3455 99999999999999999999999999999999943 456778888999999999999999987 55 999
Q ss_pred CCCCCCEEEcCCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCC-------CCCCCceehHHHHHHHHHh
Q 024118 172 DIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGR-------LTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 172 dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Di~slG~il~~l~t 243 (272)
.++..|.+++....+||.|||+........ ...........-|.|||.+.+.. .+.+.|+||+|++++++++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 999999999999999999999998664211 11111122345689999987642 3567999999999999999
Q ss_pred CCCccccccC
Q 024118 244 GRTAVDFDVQ 253 (272)
Q Consensus 244 g~~p~~~~~~ 253 (272)
.+.||+....
T Consensus 154 r~~~~~~~~~ 163 (484)
T KOG1023|consen 154 RSGPFDLRNL 163 (484)
T ss_pred ccCccccccc
Confidence 9999986443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-13 Score=120.99 Aligned_cols=166 Identities=16% Similarity=0.200 Sum_probs=128.1
Q ss_pred eCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCC
Q 024118 63 LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142 (272)
Q Consensus 63 ~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~ 142 (272)
..++.+|.|...+...........+.++.++.++ ||+|+++++.+...+..|+|+|-+ ..|..++. .+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR--HP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk-------~l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLR--HPNILSYLDTTEEEGTLYLVTERV--RPLETVLK-------ELG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhcc--CchhhhhhhhhcccCceEEEeecc--ccHHHHHH-------HhH
Confidence 3478888888887665545566788899999999 999999999999999999999976 45776762 223
Q ss_pred hHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCcccccc
Q 024118 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222 (272)
Q Consensus 143 ~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 222 (272)
...+...+.||+.||.+||..+ +++|+++....|+|+..|..+|++|.++........ ..........|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 6777888999999999998553 999999999999999999999999999975433221 1122222334566665433
Q ss_pred CCCCCCCceehHHHHHHHHHhC
Q 024118 223 GRLTRKSDVYSFGVLLLEIVSG 244 (272)
Q Consensus 223 ~~~~~~~Di~slG~il~~l~tg 244 (272)
.. -..|.|.|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 346999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.3e-13 Score=103.90 Aligned_cols=132 Identities=14% Similarity=0.074 Sum_probs=93.6
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCC
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~ 126 (272)
.+.++.|..+.+|++... +..+++|....... .......|+..++.+.. ...+++++... ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~-~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAE-AGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHH-hCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 567889999999999875 77899998753321 22345677777777752 22234455443 334579999999987
Q ss_pred HhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI--QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 127 L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+.... .....++.+++.++..||+.. ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76431 111235678999999999881 11259999999999998 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.8e-14 Score=124.28 Aligned_cols=148 Identities=17% Similarity=0.197 Sum_probs=97.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCC-CcEEEEEEEEecCccc--------------------------------------
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQG-------------------------------------- 81 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~v~vK~~~~~~~~~-------------------------------------- 81 (272)
-..|+. +.||.|++|.||+|+.++ |+.||||+.++.....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 899999999999999886 9999999987431110
Q ss_pred --HHHHHHHHHHhhccccc--ccceeEeeeeEe-cCCceeEEEeecCCCCHhHHHh--hcccccccCChHHHHHHHHHHH
Q 024118 82 --EKEFMSEVASMANVNVC--HENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLL--GEEKRRAKFGWKARREIIMGIG 154 (272)
Q Consensus 82 --~~~~~~e~~~~~~~~~~--~~~i~~l~~~~~-~~~~~~iv~e~~~~~~L~~~~~--~~~~~~~~l~~~~~~~i~~~i~ 154 (272)
+.++.+|+....++... +...+.+-+++. ..+..+++|||++|+.+.+... ........+.+..+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 11234455444444321 222233333332 2456789999999999987531 1111112344444444455543
Q ss_pred HHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CeEEeecCcccccCC
Q 024118 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKISDFGLSKLFPE 199 (272)
Q Consensus 155 ~al~~LH~~~~~~i~h~dl~p~nilv~~~~----~~~l~Dfg~~~~~~~ 199 (272)
.. |++|+|++|.||+++.+| .++++|||++.....
T Consensus 278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999888 899999999987643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.3e-12 Score=97.25 Aligned_cols=143 Identities=23% Similarity=0.300 Sum_probs=104.4
Q ss_pred eeeeeeeccceEEEEEEeCCCcEEEEEEEEec--------CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--------~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
....+.+|+-+.|+++.+. |+.++||.-... ..-...+..+|++.+.++..---..+.++ +.+.....|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~--~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI--FIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE--EEecCCCeE
Confidence 5678889999999999886 777888864322 11223567788888888763222333333 456667789
Q ss_pred EEeecCC-CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---eEEeecCc
Q 024118 118 VYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGL 193 (272)
Q Consensus 118 v~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~---~~l~Dfg~ 193 (272)
+|||++| .++.+++... .............+..+-+.+..||.. +|+|+||..+||++..+|. +.++|||+
T Consensus 88 ~ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EEEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecc
Confidence 9999987 4778887543 223333444478899999999999999 9999999999999976554 58999999
Q ss_pred ccc
Q 024118 194 SKL 196 (272)
Q Consensus 194 ~~~ 196 (272)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 974
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.9e-12 Score=97.00 Aligned_cols=131 Identities=23% Similarity=0.330 Sum_probs=95.7
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEec--------CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--------~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
..+++|+-+.++.+.+. |..+++|.-... ..-...+..+|+..+..+...--+.+.++ ..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~--dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVY--DVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEE--EEcCCCCEEEE
Confidence 35788999999999765 444777765322 11122456678888887763333334444 44666778999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
||++|..|.+.+... ...++..+-..+..||.. ||+|+||+++||.+... .+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 999999999888332 244666777778999999 99999999999999866 499999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.7e-12 Score=100.07 Aligned_cols=145 Identities=18% Similarity=0.241 Sum_probs=105.8
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecC---CceeEEEeec
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---PCRILVYDYM 122 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---~~~~iv~e~~ 122 (272)
.+.|+.|..+.+|++...+|..+++|....... .......+|++.++.+...+..+++++.+.... +..+++|||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367889999999999877678899998753322 134567888888888874334566677665553 2568999999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE--------------------------------------- 163 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~--------------------------------------- 163 (272)
+|.++.+.+. ...+++.....++.+++.++..||+.
T Consensus 83 ~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9998877651 13456666666777777777777742
Q ss_pred --------------CCCCeEecCCCCCCEEEcC--CCCeEEeecCcccc
Q 024118 164 --------------IQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKL 196 (272)
Q Consensus 164 --------------~~~~i~h~dl~p~nilv~~--~~~~~l~Dfg~~~~ 196 (272)
....++|+|++|.||+++. ++.+.++||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0236799999999999988 56688999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-12 Score=113.36 Aligned_cols=205 Identities=24% Similarity=0.289 Sum_probs=161.6
Q ss_pred HHHhhCCeeeeeeeee--ccceEEEEEEe--C-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 37 LKIATNGFRWSNKIGE--GGFGSVYKGRL--Q-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~--G~~~~v~~~~~--~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.....+.+.+.+.+|. |.+|.+|.+.. . ++..+++|.-+.. ......+-.+++...+.+.. |++.++....+
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~-~~~~v~~~~~~ 187 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDS-HENPVRDSPAW 187 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCc-cccccccCccc
Confidence 3455677889999999 99999999975 4 7888999984422 33444555667777777765 99999988888
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCCEEEcCC-C
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR----GLAYIHEEIQPHVVHRDIKTSNILLDQN-F 184 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~----al~~LH~~~~~~i~h~dl~p~nilv~~~-~ 184 (272)
...+..++-.|.+ +.+|..+.. .....+++..++..+.+..+ |+.++|+. +++|.|++|.||+...+ .
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence 9999999999988 577777762 33445889999999999999 99999999 99999999999999988 8
Q ss_pred CeEEeecCcccccCCCC-ccc---cccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 185 NPKISDFGLSKLFPENT-THI---STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~-~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
..+++|||+...+.... ... .....+...|++||... ..++.++|++++|-++.+-.++..+...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence 89999999999876543 111 11225677799999764 4568899999999999998887766543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.3e-11 Score=92.05 Aligned_cols=127 Identities=21% Similarity=0.245 Sum_probs=83.4
Q ss_pred EEEEEEeCCCcEEEEEEEEec--------------Cc------------ccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 57 SVYKGRLQDGTIVAVKVLSVE--------------SK------------QGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 57 ~v~~~~~~~~~~v~vK~~~~~--------------~~------------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
.||.|...+|..+|+|..+.. .. .......+|.+.+..+....-++++++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999888999999997521 00 01245667889998887544457777654
Q ss_pred cCCceeEEEeecC--CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 111 DGPCRILVYDYMP--NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY-IHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 111 ~~~~~~iv~e~~~--~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~-LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
...++||||++ |..+..+. ...++.+....++.+++..+.. +|+. ||+|||+++.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~------~~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK------DVDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH------HCGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHH------hccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24579999998 65555443 1112244556677777774444 5788 99999999999999887 999
Q ss_pred EeecCccccc
Q 024118 188 ISDFGLSKLF 197 (272)
Q Consensus 188 l~Dfg~~~~~ 197 (272)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.9e-11 Score=97.52 Aligned_cols=162 Identities=25% Similarity=0.325 Sum_probs=123.3
Q ss_pred HHHHHHHHHHhhcccccccceeEeeeeEecC-----CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHH
Q 024118 82 EKEFMSEVASMANVNVCHENLVKLHGGCIDG-----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156 (272)
Q Consensus 82 ~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~a 156 (272)
......-...+-++- |.||++.+.++.+. .+...+.||+..+++..+++........+......+|.-||++|
T Consensus 111 eek~~~vFdnllqlv--HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 111 EEKRRAVFDNLLQLV--HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHH--HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 334444445555556 99999998877643 45778999999999999998888888889999999999999999
Q ss_pred HHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-c---ccccccccccccCccccccCCCCCCCcee
Q 024118 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-H---ISTRVAGTLGYLAPEYAISGRLTRKSDVY 232 (272)
Q Consensus 157 l~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~ 232 (272)
|.|||+. ..-|+|+++.-+.|++..+|-++++ .+.......... . ......+.++|.+||.-...+.+.++|||
T Consensus 189 l~yLhs~-~PpiihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy 266 (458)
T KOG1266|consen 189 LSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIY 266 (458)
T ss_pred hhhhhcc-CCccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhh
Confidence 9999996 7789999999999999988877763 322222111111 0 11112356789999987777778899999
Q ss_pred hHHHHHHHHHhCCCc
Q 024118 233 SFGVLLLEIVSGRTA 247 (272)
Q Consensus 233 slG~il~~l~tg~~p 247 (272)
++|.+..+|..+..-
T Consensus 267 ~fgmcAlemailEiq 281 (458)
T KOG1266|consen 267 KFGMCALEMAILEIQ 281 (458)
T ss_pred hhhHHHHHHHHheec
Confidence 999999999887653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-10 Score=98.22 Aligned_cols=170 Identities=22% Similarity=0.330 Sum_probs=128.2
Q ss_pred cceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe----cCCceeEEEeecCCC-CH
Q 024118 54 GFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI----DGPCRILVYDYMPNN-SL 127 (272)
Q Consensus 54 ~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~----~~~~~~iv~e~~~~~-~L 127 (272)
...+.|++... ||..|++|.++.......-.....++.++++. |+|+|++.+++. .+...++|++|.++. +|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~--h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLC--HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhc--cCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 34688999765 89999999995333333334556678888888 999999999877 345678999998754 67
Q ss_pred hHHHhhcc-----------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 128 SQTLLGEE-----------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 128 ~~~~~~~~-----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
.++..... ......+|..+|.++.|+..||..+|+. |+..+-|.|.+|+++.+.+++|...|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 76654322 2335678999999999999999999999 999999999999999888899887776654
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~ 246 (272)
...+.. +| +. -..+.|.-.||.++..|.||..
T Consensus 443 l~~d~~-------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPT-------------EP--LE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCC-------------cc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence 432220 00 10 1236799999999999999844
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.6e-10 Score=90.42 Aligned_cols=135 Identities=11% Similarity=0.040 Sum_probs=94.1
Q ss_pred eEEEEEEeCCCcEEEEEEEEecCc-----------ccHHHHHHHHHHhhcccccccceeEeeeeEec-----CCceeEEE
Q 024118 56 GSVYKGRLQDGTIVAVKVLSVESK-----------QGEKEFMSEVASMANVNVCHENLVKLHGGCID-----GPCRILVY 119 (272)
Q Consensus 56 ~~v~~~~~~~~~~v~vK~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~-----~~~~~iv~ 119 (272)
..|.++.. +|+.+.||....... .......+|...+..+....-..++++.+... ....++|+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34556544 577899996642211 11113667777777775323334444444432 23578999
Q ss_pred eecCCC-CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------CCCeEEeec
Q 024118 120 DYMPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-------NFNPKISDF 191 (272)
Q Consensus 120 e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-------~~~~~l~Df 191 (272)
|++++. +|.+++.... ..+.++.....++.+++..+..||.. ||+|+|++++|||++. ++.+.|+||
T Consensus 115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 999886 7988873221 24456677889999999999999999 9999999999999975 467899999
Q ss_pred Ccccc
Q 024118 192 GLSKL 196 (272)
Q Consensus 192 g~~~~ 196 (272)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98863
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.5e-10 Score=89.28 Aligned_cols=138 Identities=19% Similarity=0.136 Sum_probs=99.6
Q ss_pred CeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEec------------------Cc----ccHHHHHHHHHHhhccccccc
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE------------------SK----QGEKEFMSEVASMANVNVCHE 100 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~------------------~~----~~~~~~~~e~~~~~~~~~~~~ 100 (272)
=+.+...||-|--+.||.|..+.|.++|+|.=+.. .. .......+|.+.+.++...--
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35677999999999999999999999999974211 00 012456678888888763223
Q ss_pred ceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 101 ~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
.+++.++. +..++|||+++|..|...- +..+....++..|+.-+..+-.. |++|+|+++-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 55555433 5678999999987666443 12344444555555555655567 99999999999999
Q ss_pred cCCCCeEEeecCcccc
Q 024118 181 DQNFNPKISDFGLSKL 196 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~ 196 (272)
+++|.++++||-.+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999977653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.4e-10 Score=93.48 Aligned_cols=196 Identities=14% Similarity=0.158 Sum_probs=127.4
Q ss_pred eeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeee----e--E-ecCCceeE
Q 024118 45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG----G--C-IDGPCRIL 117 (272)
Q Consensus 45 ~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~----~--~-~~~~~~~i 117 (272)
...+.||+|+-+.+|..-.-.+ .+-|++........... +..+..... ||-+-.=+. . . ..+....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aqk---~a~la~~p~-~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQK---VAELAATPD-APLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCchHHHHH---HHHhccCCC-CcchhhhhcccHHHhhCCCccceeEE
Confidence 3568899999999997632222 24466653333332222 222222221 332211011 0 1 12233667
Q ss_pred EEeecCCCC-HhHHHhh--cccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 118 VYDYMPNNS-LSQTLLG--EEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 118 v~e~~~~~~-L~~~~~~--~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
+|+.+.|.. ...+... +.+.-....++.+.+.++.++.+...||.. |.+-+|++++|+||.+++.+.|+|-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 888876652 2222211 112224467889999999999999999999 9999999999999999999999986655
Q ss_pred cccCCCCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhC-CCccccc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSG-RTAVDFD 251 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg-~~p~~~~ 251 (272)
..- ..........|...|.+||... +-.-+...|.|.||+++++++.| +.||.+.
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 432 2233333456889999999875 33456789999999999999887 9999754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.7e-10 Score=100.36 Aligned_cols=143 Identities=18% Similarity=0.206 Sum_probs=95.3
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecCcc----------------------------------------cHHHHHH
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ----------------------------------------GEKEFMS 87 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~----------------------------------------~~~~~~~ 87 (272)
.+++.++-|.||+|+.++|+.||||+.++.-.. .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 788899999999999999999999998532111 1233455
Q ss_pred HHHHhhccccc---ccceeEeeee-EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc
Q 024118 88 EVASMANVNVC---HENLVKLHGG-CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163 (272)
Q Consensus 88 e~~~~~~~~~~---~~~i~~l~~~-~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~ 163 (272)
|+..+.+++.+ .+.+ .+-.+ +...+...++|||++|..+.+.... ....++...+...+.++.- ..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f~--~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAFL--RQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHHH--HHHHhc
Confidence 55555555421 2222 12222 2334567899999999999888522 2234444444444333322 222223
Q ss_pred CCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 164 ~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|++|+|.+|.||+++.+|++.+.|||+...+..
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.4e-11 Score=103.04 Aligned_cols=208 Identities=22% Similarity=0.211 Sum_probs=151.2
Q ss_pred cccCCChhH-HHHhhCCeeeeeeeeeccceEEEEEEeC--CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccce
Q 024118 28 NINAFSYNQ-LKIATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENL 102 (272)
Q Consensus 28 ~~~~~~~~~-~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i 102 (272)
..+-+.-.. ......+|..+..||.|.|+.++.+..+ ++..|++|.....- ......-+.|+-+...+.. |.+.
T Consensus 250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~-~~~~ 328 (524)
T KOG0601|consen 250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGS-HLPS 328 (524)
T ss_pred hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhc-cccc
Confidence 334444444 4455678999999999999999998643 68889999875332 2222334445555555544 8888
Q ss_pred eEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 024118 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 182 (272)
Q Consensus 103 ~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~ 182 (272)
+.....+...+..+|--|||+++++.... .....+.+...+.+..|++.++.++|+. .++|.|++|.||++..
T Consensus 329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISN 401 (524)
T ss_pred CCCCCCccccccccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeecc
Confidence 88888888888888999999999887665 3445677889999999999999999999 9999999999999987
Q ss_pred C-CCeEEeecCcccccCCCCcccccccccccccc--CccccccCCCCCCCceehHHHHHHHHHhCCCc
Q 024118 183 N-FNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247 (272)
Q Consensus 183 ~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p 247 (272)
+ +.-+++||+....+.-.... .....++. ++.......+-.+.|+++||..+.+.+++...
T Consensus 402 ~~~~~~~~~~~~~t~~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWTRLAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred chhhhhccccccccccceeccc----ccccccccccchhhccccccccccccccccccccccccCccc
Confidence 6 66788899888642111110 11122233 44444455677899999999999999887653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-09 Score=85.01 Aligned_cols=110 Identities=17% Similarity=0.184 Sum_probs=84.5
Q ss_pred cHHHHHHHHHHhhcccccccceeEeeeeEecC----CceeEEEeecCCC-CHhHHHhhcccccccCChHHHHHHHHHHHH
Q 024118 81 GEKEFMSEVASMANVNVCHENLVKLHGGCIDG----PCRILVYDYMPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGR 155 (272)
Q Consensus 81 ~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----~~~~iv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 155 (272)
...+..+|...+..+....-..++.+.+.... ...++|+|++++. +|.+++.. ....+......++.+++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALAR 129 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHH
Confidence 34567777777777764444455666655542 2457999999874 79988833 222667778899999999
Q ss_pred HHHHHhhcCCCCeEecCCCCCCEEEcCCC---CeEEeecCccccc
Q 024118 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGLSKLF 197 (272)
Q Consensus 156 al~~LH~~~~~~i~h~dl~p~nilv~~~~---~~~l~Dfg~~~~~ 197 (272)
.+..||.. ||+|+|+++.|||++.++ .+.++||+.+...
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 999999999999999887 7999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.9e-11 Score=108.67 Aligned_cols=213 Identities=20% Similarity=0.261 Sum_probs=151.6
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.+.-...+.+.+.+-.|.++.++.+.-. .|.....|+..... ..+.....++-......+ +|.++...-.+.-.
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~--~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR--SPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC--CCceecccCCCCCC
Confidence 5567788999999999999999988644 45545555443221 111111222222221112 34444433333345
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
.-.+++++|..+++|...+ +..+..+++..+.....+..+.++||+. .+.|+|++|.|.++..+|+..+.|++
T Consensus 877 sP~~L~~~~~~~~~~~Skl----~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKL----HNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CCcchhhHHhccCCchhhh----hcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence 5678999999999999998 4555677777788888889999999998 79999999999999999999999987
Q ss_pred cccccCC------C---------------C-----c----cccccccccccccCccccccCCCCCCCceehHHHHHHHHH
Q 024118 193 LSKLFPE------N---------------T-----T----HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIV 242 (272)
Q Consensus 193 ~~~~~~~------~---------------~-----~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~ 242 (272)
....... . . . .......+++.|.+||...+......+|.|++|+++++.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 3321100 0 0 0 0012245789999999999999999999999999999999
Q ss_pred hCCCccccccCCCcee
Q 024118 243 SGRTAVDFDVQLGEYH 258 (272)
Q Consensus 243 tg~~p~~~~~~~~~~~ 258 (272)
+|.+||+..+++..+.
T Consensus 1030 ~g~pp~na~tpq~~f~ 1045 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFE 1045 (1205)
T ss_pred cCCCCCCCcchhhhhh
Confidence 9999999999887663
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.9e-09 Score=94.44 Aligned_cols=145 Identities=18% Similarity=0.174 Sum_probs=97.9
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecC-------------------------------------cccHHHHHHHH
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-------------------------------------KQGEKEFMSEV 89 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~-------------------------------------~~~~~~~~~e~ 89 (272)
.+.||..+.+.|++|+.++|+.||||+-++.- -..+.++.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 37899999999999999999999999975321 11233466666
Q ss_pred HHhhccccc--ccc------eeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHh
Q 024118 90 ASMANVNVC--HEN------LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161 (272)
Q Consensus 90 ~~~~~~~~~--~~~------i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH 161 (272)
+...+++.. |-+ |++++ +.......++|||++|..+.+.-. -....++...+..-+.+...-..+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~---i~~~gi~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDA---IDKRGISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHH---HHHcCCCHHHHHHHHHHHHHHHHHhc
Confidence 666655432 223 33333 223456789999999997776642 23344555555555544433333333
Q ss_pred hcCCCCeEecCCCCCCEEEcC----CCCeEEeecCcccccCCCC
Q 024118 162 EEIQPHVVHRDIKTSNILLDQ----NFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 162 ~~~~~~i~h~dl~p~nilv~~----~~~~~l~Dfg~~~~~~~~~ 201 (272)
|++|+|.+|.||+++. ++.+.+.|+|+...+....
T Consensus 321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 9999999999999984 5679999999998765444
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.6e-08 Score=77.38 Aligned_cols=139 Identities=15% Similarity=0.125 Sum_probs=101.2
Q ss_pred eccceEEEEEEeCCCcEEEEEEEEec------CcccHHHHHHHHHHhhcccccccceeEeeeeEec----CCceeEEEee
Q 024118 52 EGGFGSVYKGRLQDGTIVAVKVLSVE------SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPCRILVYDY 121 (272)
Q Consensus 52 ~G~~~~v~~~~~~~~~~v~vK~~~~~------~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~~~~iv~e~ 121 (272)
.||-+.|+..... |..+.+|.-... .+.....+.+|...+..+....-.++++...... .-...||+|-
T Consensus 28 rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 28 RNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 3888889887654 446888875411 1335678999999999887444445555522221 1246689997
Q ss_pred cCC-CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC--eEEeecCcccc
Q 024118 122 MPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFGLSKL 196 (272)
Q Consensus 122 ~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~--~~l~Dfg~~~~ 196 (272)
++| .+|.+++... ...+.++.....++.+++.++..||+. |+.|+|+.+.||+++.+|. +.++||..+..
T Consensus 107 L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 743 4788887321 123567778889999999999999999 9999999999999986777 99999998763
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.1e-08 Score=78.95 Aligned_cols=140 Identities=15% Similarity=0.139 Sum_probs=91.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHH---------HHHHHHhhcccc-cccceeEeee-
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEF---------MSEVASMANVNV-CHENLVKLHG- 107 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~---------~~e~~~~~~~~~-~~~~i~~l~~- 107 (272)
+...+|.+.+.+.......|.+... +|..+++|.........++.+ .+.+.....+.. .-....+++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 6678899999999887777766554 578899999875433222222 122222222221 0111112111
Q ss_pred ----eEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 108 ----GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 108 ----~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
.+.-....+++|||++|..|.+... +++ .+...+.+++..||+. |+.|+|++|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 1222345568999999988876641 222 2445677789999999 99999999999999865
Q ss_pred CCeEEeecCccc
Q 024118 184 FNPKISDFGLSK 195 (272)
Q Consensus 184 ~~~~l~Dfg~~~ 195 (272)
.++++|++...
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 59999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-08 Score=80.89 Aligned_cols=161 Identities=15% Similarity=0.147 Sum_probs=108.4
Q ss_pred cccccCCChhHHHHhhCCeeeee---eeeeccceEEEEEEeCCCcEEEEEEEEecCcc----------------------
Q 024118 26 LKNINAFSYNQLKIATNGFRWSN---KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ---------------------- 80 (272)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~y~i~~---~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~---------------------- 80 (272)
-.-++..+...+....++..+.. .|++|--+.||+|...++..+|+|+++.....
T Consensus 29 ~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr 108 (268)
T COG1718 29 DEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR 108 (268)
T ss_pred hhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence 33456677777777777777664 45567788999998888999999998632110
Q ss_pred --cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHH
Q 024118 81 --GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158 (272)
Q Consensus 81 --~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~ 158 (272)
.......|+..|+++...+-.+++.+.+ ....++||++..... -. -.-...++..+....+..++++.+.
T Consensus 109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~--pA--P~LkDv~~e~~e~~~~~~~~v~~~~ 180 (268)
T COG1718 109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGL--PA--PRLKDVPLELEEAEGLYEDVVEYMR 180 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCC--CC--CCcccCCcCchhHHHHHHHHHHHHH
Confidence 0122344666666665434344444433 234699999854311 11 1123334444467778888888888
Q ss_pred HHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 159 YIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 159 ~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
.|-. . +++|+||+.-|||+. ++.+.++|++.+....
T Consensus 181 ~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 181 RLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 8876 5 999999999999999 7789999999887554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.5e-08 Score=77.56 Aligned_cols=142 Identities=17% Similarity=0.177 Sum_probs=84.7
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCC-
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS- 126 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~- 126 (272)
.++|.|..+.+|+. .|..+++|..... .......+|.+.+..+....-.+++++.+........++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 2556788887532 23445788888888876323335777877777777889999999973
Q ss_pred HhHHHhhc------------------cccc-ccCChHHHHH-HHH----------HHHHH-HHHHhhc-CCCCeEecCCC
Q 024118 127 LSQTLLGE------------------EKRR-AKFGWKARRE-IIM----------GIGRG-LAYIHEE-IQPHVVHRDIK 174 (272)
Q Consensus 127 L~~~~~~~------------------~~~~-~~l~~~~~~~-i~~----------~i~~a-l~~LH~~-~~~~i~h~dl~ 174 (272)
+...+... .... ...+...... +.. .+... ..+|.+. ....++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111000 0000 0001010000 000 00011 1111111 13367999999
Q ss_pred CCCEEEcCCCCeEEeecCccc
Q 024118 175 TSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~ 195 (272)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-07 Score=76.64 Aligned_cols=80 Identities=14% Similarity=0.148 Sum_probs=56.2
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe---cCCceeEEEeecC
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI---DGPCRILVYDYMP 123 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~---~~~~~~iv~e~~~ 123 (272)
++.++.|..+.+|++...+ ..+++|..... ........|...++.+......++.++.... .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 5789999999999999877 58999986533 3445677787887777632234566665332 2334689999999
Q ss_pred CCCHhH
Q 024118 124 NNSLSQ 129 (272)
Q Consensus 124 ~~~L~~ 129 (272)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.2e-09 Score=94.80 Aligned_cols=112 Identities=28% Similarity=0.452 Sum_probs=84.9
Q ss_pred HHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCcccccc--------ccccccccCccccccC
Q 024118 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--------VAGTLGYLAPEYAISG 223 (272)
Q Consensus 152 ~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~--------~~~~~~~~aPE~~~~~ 223 (272)
+.+.|+.++|.. .+++|+++.|++|.++.++..||..|+.+.-........... ......|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344889999976 599999999999999999999999999887554422211110 1135679999999998
Q ss_pred CCCCCCceehHHHHHHHHH-hCCCccccccCCCceehhhhhhc
Q 024118 224 RLTRKSDVYSFGVLLLEIV-SGRTAVDFDVQLGEYHLVDKVRS 265 (272)
Q Consensus 224 ~~~~~~Di~slG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~~ 265 (272)
..+.++|+||+|+++|.+. .|+.-+........+........
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~ 227 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN 227 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc
Confidence 8899999999999999999 56666766666555544444433
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.9e-07 Score=73.80 Aligned_cols=142 Identities=15% Similarity=0.078 Sum_probs=84.7
Q ss_pred eeeeccc-eEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCH
Q 024118 49 KIGEGGF-GSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 127 (272)
Q Consensus 49 ~lg~G~~-~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L 127 (272)
.|..|.. +.||++... +..+++|...... .....+|+..++.+... --+++++......+..++||++++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~-~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGK-LPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhc-CCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 4455555 788998764 4678888865332 33456777777777643 4577777777766678999999999887
Q ss_pred hHHHhh----------------cccc---cccCChH--HHHHHHH--------------------HHHHHHHHHhh----
Q 024118 128 SQTLLG----------------EEKR---RAKFGWK--ARREIIM--------------------GIGRGLAYIHE---- 162 (272)
Q Consensus 128 ~~~~~~----------------~~~~---~~~l~~~--~~~~i~~--------------------~i~~al~~LH~---- 162 (272)
...... -... ..++... ....... .....+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 644210 0000 0011100 0000000 01111222211
Q ss_pred cCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 163 ~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
.....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 112369999999999999987667899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.48 E-value=7e-06 Score=64.44 Aligned_cols=136 Identities=20% Similarity=0.289 Sum_probs=93.0
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecC----------------cccHHHHHHHHHHhhccc----ccccceeEee
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES----------------KQGEKEFMSEVASMANVN----VCHENLVKLH 106 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~----------------~~~~~~~~~e~~~~~~~~----~~~~~i~~l~ 106 (272)
...||+|+.-.+| .++++...+||+..... ........+|+.....+. ..+.+|.+++
T Consensus 6 ~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4678999999887 45566678899887554 112334445544444433 2268899999
Q ss_pred eeEecCCceeEEEeecCC------CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 107 GGCIDGPCRILVYDYMPN------NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~------~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
++...+....+|+|.+.. .+|.+++ ....+++ .+...+.++ ..+|-+. +|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~~L~~f---~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQALDEF---KRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHHHHHHH---HHHHHHc---CCeecCCCcccEEE
Confidence 999999999999997632 2677777 3344555 444444444 5677777 99999999999999
Q ss_pred cCCC----CeEEee-cCcccc
Q 024118 181 DQNF----NPKISD-FGLSKL 196 (272)
Q Consensus 181 ~~~~----~~~l~D-fg~~~~ 196 (272)
...+ .++|+| ||....
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EecCCCceEEEEEeCCCCccc
Confidence 5433 477887 665554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.5e-06 Score=65.78 Aligned_cols=131 Identities=16% Similarity=0.191 Sum_probs=90.1
Q ss_pred eeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
.++.+.|++|..|.||++.+. |..+|+|+-..+ .....+..|++.+..+.. -.--++++.+..+ .+.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g-~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAG-EGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhh-cCCCceEEEechh----hhhhhhhc
Confidence 456789999999999999987 447888886543 344577788888877763 3334555544333 34599999
Q ss_pred CCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC-CCCEEEcCCCCeEEeecCcccc
Q 024118 124 NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK-TSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 124 ~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~-p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
|..|.+..... +..++ ..++++---|... ||-|+.++ |...++-.++.+.|+||..+..
T Consensus 96 G~~L~~~~~~~-------~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG-------DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc-------cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98888776211 22333 3344555566776 99999986 4455555555999999999873
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.9e-05 Score=66.40 Aligned_cols=82 Identities=9% Similarity=-0.001 Sum_probs=58.9
Q ss_pred CeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccc-cceeEeeeeEec---CCceeEE
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCID---GPCRILV 118 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~i~~l~~~~~~---~~~~~iv 118 (272)
...-.+.||.|..+.||.....++ .+++|..+. ......+..|+..++.+.... -.++++++++.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 445568899999999999976666 477777542 112347788888888886432 467788876653 3668999
Q ss_pred EeecCCCCH
Q 024118 119 YDYMPNNSL 127 (272)
Q Consensus 119 ~e~~~~~~L 127 (272)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.3e-05 Score=65.00 Aligned_cols=76 Identities=17% Similarity=0.165 Sum_probs=48.0
Q ss_pred eeeeeeccceEEEEEEeCC--CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCC
Q 024118 47 SNKIGEGGFGSVYKGRLQD--GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPN 124 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~ 124 (272)
.+.|..|-.+.+|++...+ +..|++|....... ......+|+..+..+.. +.-.++++.... ..+++||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~-~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSK-HGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHh-CCCCCeEEEEeC----CcEEEEeeCC
Confidence 4567778888999998664 67899997653322 11233467777776652 222445544332 2489999998
Q ss_pred CCHh
Q 024118 125 NSLS 128 (272)
Q Consensus 125 ~~L~ 128 (272)
.++.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 7763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=2e-05 Score=75.37 Aligned_cols=81 Identities=11% Similarity=0.185 Sum_probs=55.4
Q ss_pred eeeeeeccceEEEEEEeCCC---cEEEEEEEEecC-cccHHHHHHHHHHhhcccc-cccceeEeeeeEecC---CceeEE
Q 024118 47 SNKIGEGGFGSVYKGRLQDG---TIVAVKVLSVES-KQGEKEFMSEVASMANVNV-CHENLVKLHGGCIDG---PCRILV 118 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~---~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~-~~~~i~~l~~~~~~~---~~~~iv 118 (272)
++.++.|.++.+|+....++ ..+++|...... ......+.+|++.++.+.. ....+++++..+.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57788899999999876643 467777654322 1233467788888888853 123347777776654 467899
Q ss_pred EeecCCCCH
Q 024118 119 YDYMPNNSL 127 (272)
Q Consensus 119 ~e~~~~~~L 127 (272)
||+++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.5e-05 Score=66.33 Aligned_cols=31 Identities=23% Similarity=0.305 Sum_probs=26.2
Q ss_pred CCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
.++||+|++|.||+++.+...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998654457999998863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-05 Score=67.92 Aligned_cols=146 Identities=12% Similarity=0.062 Sum_probs=81.3
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee------EecCCceeEEEe
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG------CIDGPCRILVYD 120 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~------~~~~~~~~iv~e 120 (272)
.+.+..|....+|++...+ ..+++|.... ........|+..+..+....-.+++++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567777778999987654 4688898753 23345556666666664322224444432 123456789999
Q ss_pred ecCCCCHhH----HHhh----------c-cccccc----CChHHH------------HHHHHHHHHHHHHHhh----cCC
Q 024118 121 YMPNNSLSQ----TLLG----------E-EKRRAK----FGWKAR------------REIIMGIGRGLAYIHE----EIQ 165 (272)
Q Consensus 121 ~~~~~~L~~----~~~~----------~-~~~~~~----l~~~~~------------~~i~~~i~~al~~LH~----~~~ 165 (272)
+++|..+.. .... . ...... ....-. ......+..++..+.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 0000 0 000000 000000 0011112233333332 112
Q ss_pred CCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
.++||+|++|.|+++++++.+.++||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999876678999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.5e-06 Score=66.11 Aligned_cols=75 Identities=15% Similarity=0.213 Sum_probs=45.5
Q ss_pred eeeeeccce-EEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhccccc-ccceeEeeeeEecC---CceeEEEeec
Q 024118 48 NKIGEGGFG-SVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDG---PCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~-~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~-~~~i~~l~~~~~~~---~~~~iv~e~~ 122 (272)
..++.|+.. .||+. +..+++|.... ........+|.+.+..+... .-.+++++...... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567766665 58876 23577887542 22344677888888777531 12344444443332 2347899999
Q ss_pred CCCCHh
Q 024118 123 PNNSLS 128 (272)
Q Consensus 123 ~~~~L~ 128 (272)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.9e-06 Score=68.45 Aligned_cols=141 Identities=11% Similarity=0.048 Sum_probs=75.5
Q ss_pred eeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCHh
Q 024118 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLS 128 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~ 128 (272)
.+..|-.+.+|+.. .++..+++|........-.....+|...++.+.. +.-.++++... ..++|+||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~-~g~~P~~i~~~----~~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSA-LGLAPKPILVN----EHWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHh-cCCCCceEEEe----CCEEEEEeccCcccc
Confidence 34567778899887 4567788887543221111134567777777652 21123344332 136899999987654
Q ss_pred HH--------------Hhh---cccccccCChH-HHHHHHHHH---------HHHHHHHhhc-----CCCCeEecCCCCC
Q 024118 129 QT--------------LLG---EEKRRAKFGWK-ARREIIMGI---------GRGLAYIHEE-----IQPHVVHRDIKTS 176 (272)
Q Consensus 129 ~~--------------~~~---~~~~~~~l~~~-~~~~i~~~i---------~~al~~LH~~-----~~~~i~h~dl~p~ 176 (272)
.. +.. ......+++.. .+.....++ ...+..+-.. ....+||+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 000 00011111111 111111111 1112222111 1236899999999
Q ss_pred CEEEcCCCCeEEeecCcccc
Q 024118 177 NILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 177 nilv~~~~~~~l~Dfg~~~~ 196 (272)
||++++++ +.++||+.+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.5e-05 Score=58.76 Aligned_cols=159 Identities=23% Similarity=0.346 Sum_probs=101.7
Q ss_pred cceeecCccCCCCCCcccccccccccCCChhHHHHhhCCeeeeeeeeeccc-eEEEEEEeCCCcEEEEEEEEe---cCc-
Q 024118 5 FSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGF-GSVYKGRLQDGTIVAVKVLSV---ESK- 79 (272)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~-~~v~~~~~~~~~~v~vK~~~~---~~~- 79 (272)
.+-++-+.++...++.........+.+|... ..+++.++.||.|.- |.||++... |..+|+|++.. ...
T Consensus 5 ~~~l~~~~~~~~~~~plp~~~gPKL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~ 78 (207)
T PF13095_consen 5 LSLLPLDQPPRKPPKPLPQCPGPKLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPD 78 (207)
T ss_pred cccccccCCCCCCCcccccCCCCCcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCc
Confidence 3444444444444444444455666777772 289999999999999 999999886 67999999431 000
Q ss_pred -----------------ccHHHHHHHHHHhhccccc-ccce--eEeeeeEecC------------------CceeEEEee
Q 024118 80 -----------------QGEKEFMSEVASMANVNVC-HENL--VKLHGGCIDG------------------PCRILVYDY 121 (272)
Q Consensus 80 -----------------~~~~~~~~e~~~~~~~~~~-~~~i--~~l~~~~~~~------------------~~~~iv~e~ 121 (272)
.....+..|.+...++... +.++ ++.+++..-. ....||-||
T Consensus 79 ~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~ 158 (207)
T PF13095_consen 79 YTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDF 158 (207)
T ss_pred cccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEee
Confidence 1122456676666666532 3344 7777765322 123577777
Q ss_pred cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 122 MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 122 ~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+... .+....+ .+|.+-+..+|.. ||+-+|+++.|.. + -+|+|||.+
T Consensus 159 v~~~~-------------~~~~~~~----~~~~~dl~~~~k~---gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 159 VPDDP-------------PLQIRDI----PQMLRDLKILHKL---GIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred cCCcc-------------ccchhHH----HHHHHHHHHHHHC---CeeeccCcccccc---C--CEEEecccC
Confidence 65432 2333333 4455567889999 9999999999987 2 388999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.10 E-value=0.00012 Score=61.87 Aligned_cols=146 Identities=16% Similarity=0.127 Sum_probs=79.3
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeE------ecCCceeEEEe
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC------IDGPCRILVYD 120 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~------~~~~~~~iv~e 120 (272)
.+.++.|....+|++...+| .+++|...... .......+.+.+..+....-.+++++... ...+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 46667777789999876555 57888765321 12334455566655542222244443321 12356789999
Q ss_pred ecCCCCHhH-----------HHhhcccccccCC-------hHHHH----------------HHHHHHHHHHHHHhh----
Q 024118 121 YMPNNSLSQ-----------TLLGEEKRRAKFG-------WKARR----------------EIIMGIGRGLAYIHE---- 162 (272)
Q Consensus 121 ~~~~~~L~~-----------~~~~~~~~~~~l~-------~~~~~----------------~i~~~i~~al~~LH~---- 162 (272)
|++|..+.. .+..-......++ ....| .....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865321 0000000000000 00000 001122233444432
Q ss_pred cCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 163 ~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
....++||+|+++.|++++.++...++||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123489999999999999988766899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.10 E-value=0.00017 Score=62.66 Aligned_cols=77 Identities=16% Similarity=0.144 Sum_probs=54.3
Q ss_pred eeeeeeccceEEEEEEeCCC-cEEEEEEEEec-----C--cccHHHHHHHHHHhhccccc-ccceeEeeeeEecCCceeE
Q 024118 47 SNKIGEGGFGSVYKGRLQDG-TIVAVKVLSVE-----S--KQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~-~~v~vK~~~~~-----~--~~~~~~~~~e~~~~~~~~~~-~~~i~~l~~~~~~~~~~~i 117 (272)
.+.||.|.++.||++...+| +.++||..... . +-...+...|.+.++.+... ...+++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 47899999999999998876 58999985321 1 12345677788888776432 2456777765 4456789
Q ss_pred EEeecCCC
Q 024118 118 VYDYMPNN 125 (272)
Q Consensus 118 v~e~~~~~ 125 (272)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.4e-05 Score=61.09 Aligned_cols=105 Identities=18% Similarity=0.166 Sum_probs=80.5
Q ss_pred HHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCC
Q 024118 87 SEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166 (272)
Q Consensus 87 ~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ 166 (272)
.|..+++.+.. .+++++++++|- ..++.||...+++...... ...-...++..+.+++.++++.+.+|+.....
T Consensus 8 ~E~lll~~l~~-~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQG-SEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCC-CCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 46677777774 359999999883 4688999976655432100 01223467899999999999999999985444
Q ss_pred CeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 167 ~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
.+.-+|++|+|+-++++++++++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6889999999999999999999999988754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00011 Score=62.02 Aligned_cols=144 Identities=20% Similarity=0.152 Sum_probs=82.3
Q ss_pred eeeeeeccceEEEEEEeCC-------CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 47 SNKIGEGGFGSVYKGRLQD-------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++.+..|-...+|++...+ ++.+++|+..... .......+|...+..+.... -.++++.... ..+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g-~~P~~~~~~~----~~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERN-LGPKLYGIFP----NGRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCC-CCCceEEEeC----CCchh
Confidence 3556667778999987654 5889999975432 22235566777777665322 2344554443 23689
Q ss_pred eecCCCCHhHHHhh-----------------cccc--cccC-ChHHHHH------------------------------H
Q 024118 120 DYMPNNSLSQTLLG-----------------EEKR--RAKF-GWKARRE------------------------------I 149 (272)
Q Consensus 120 e~~~~~~L~~~~~~-----------------~~~~--~~~l-~~~~~~~------------------------------i 149 (272)
+|++|.++...... .... .... ....++. .
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99988776431100 0000 0000 0011111 1
Q ss_pred HHHHHHHHHHHhh------cCCCCeEecCCCCCCEEEcCC----CCeEEeecCcccc
Q 024118 150 IMGIGRGLAYIHE------EIQPHVVHRDIKTSNILLDQN----FNPKISDFGLSKL 196 (272)
Q Consensus 150 ~~~i~~al~~LH~------~~~~~i~h~dl~p~nilv~~~----~~~~l~Dfg~~~~ 196 (272)
...+...+..+-. .....+||+|+.|.||+++++ +.+.++||..+..
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 1222222333332 123478999999999999874 7899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=9.6e-06 Score=67.43 Aligned_cols=138 Identities=15% Similarity=0.100 Sum_probs=96.3
Q ss_pred CeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEec------------------Ccc----cHHHHHHHHHHhhccccccc
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE------------------SKQ----GEKEFMSEVASMANVNVCHE 100 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~------------------~~~----~~~~~~~e~~~~~~~~~~~~ 100 (272)
=+.+.+.||-|--+.||.+....|.+.++|.=... ... ......+|...++.+...--
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46788999999999999999999999999963211 000 12344557777777753222
Q ss_pred ceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 101 ~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
-+++.++ -.+.++|||++.|-.|.... .. .....+...++..+-.|-++ |++|||++-=||+|
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~-------~v---~d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVR-------HV---EDPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeee-------ec---CChHHHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 3444433 35678999999887766443 11 12223445556667777777 99999999999999
Q ss_pred cCCCCeEEeecCccccc
Q 024118 181 DQNFNPKISDFGLSKLF 197 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~~ 197 (272)
++++.++++||-.+...
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999776543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00025 Score=59.64 Aligned_cols=145 Identities=18% Similarity=0.252 Sum_probs=88.4
Q ss_pred CCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEE-ecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC--ceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--CRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~-~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--~~~iv 118 (272)
.+..+++....|....+|..... +++++++... ...........+|...++.+...---....+..|..+. ..+.|
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CCCceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34455666655666666666554 8888888321 12334445666777777776543333445555665554 77999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHH-HHHHHHHHHHhhc----------------------------------
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREII-MGIGRGLAYIHEE---------------------------------- 163 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~-~~i~~al~~LH~~---------------------------------- 163 (272)
|+|++|..+.+...... .. ...+ ..+...|..||+-
T Consensus 104 ~~~veGe~~~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~ 174 (321)
T COG3173 104 MEWVEGEVVWSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG 174 (321)
T ss_pred EEEecceeccCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence 99999864443331100 00 1111 2344444444432
Q ss_pred ---------------------CCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 164 ---------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 164 ---------------------~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
....++|+|+++.|+++++++-+-++||+++..
T Consensus 175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 233689999999999999988899999999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0004 Score=60.36 Aligned_cols=76 Identities=9% Similarity=0.062 Sum_probs=51.4
Q ss_pred eeeeeeeccceEEEEEEeCCCcEEEEEEEEec----Cc---ccHHHHHHHHHHhhcccccc-cceeEeeeeEecCCceeE
Q 024118 46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE----SK---QGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~----~~---~~~~~~~~e~~~~~~~~~~~-~~i~~l~~~~~~~~~~~i 117 (272)
-.+.+|.|....||++... +..++||..... .. ....+...|+..++...... ..+++++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 4688899999999999875 456889976411 11 13445556666666654322 36777877766 45678
Q ss_pred EEeecCC
Q 024118 118 VYDYMPN 124 (272)
Q Consensus 118 v~e~~~~ 124 (272)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00022 Score=60.55 Aligned_cols=142 Identities=17% Similarity=0.186 Sum_probs=94.8
Q ss_pred eeeeeeeeccceEEEEEEeCCCcEEEEEEEEec------------------------CcccHH--HHHHHHHHhhccccc
Q 024118 45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE------------------------SKQGEK--EFMSEVASMANVNVC 98 (272)
Q Consensus 45 ~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~------------------------~~~~~~--~~~~e~~~~~~~~~~ 98 (272)
.|..+|..|--+.||.|...+|..+|||+++.. .+...- ....|++.++++.
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-- 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-- 224 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH--
Confidence 355788899999999999999999999998521 000111 2233566666665
Q ss_pred ccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 024118 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178 (272)
Q Consensus 99 ~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ni 178 (272)
...| +.-+-... ....+||+++.. +-+ ..-......++...+..+-.+++.-+..|-..+ ++||.||+--|+
T Consensus 225 ~aGI-P~PePIlL-k~hVLVM~FlGr-dgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~ 296 (520)
T KOG2270|consen 225 NAGI-PCPEPILL-KNHVLVMEFLGR-DGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL 296 (520)
T ss_pred hcCC-CCCCceee-ecceEeeeeccC-CCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence 2222 11111111 235689999842 211 111235566777888888888888888876654 999999999999
Q ss_pred EEcCCCCeEEeecCccccc
Q 024118 179 LLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 179 lv~~~~~~~l~Dfg~~~~~ 197 (272)
|+- +|.+.++|.+.+...
T Consensus 297 Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred eEE-CCEEEEEEccccccC
Confidence 995 568999999888654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00036 Score=59.96 Aligned_cols=148 Identities=15% Similarity=0.197 Sum_probs=80.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeCC-----CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+...+ +.+..|-...+|++...+ +..|++|+...... ..-...+|...++.+.. +.--++++..+...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~-~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSR-HGQGPRLLGRFPNG---- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHH-cCCCCceEEEECCc----
Confidence 33444 455557888999987532 36899998764332 22234567777766653 22234455544322
Q ss_pred EEEeecCCCCHhHHHhh--------------cccccc-----cCChHHHHHHHHHH-----------------HHHHHHH
Q 024118 117 LVYDYMPNNSLSQTLLG--------------EEKRRA-----KFGWKARREIIMGI-----------------GRGLAYI 160 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~--------------~~~~~~-----~l~~~~~~~i~~~i-----------------~~al~~L 160 (272)
.|.+|+++.+|...-.. -..... ....+.+..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 57999988776421000 000000 01112222332111 1112222
Q ss_pred h----h-cCCCCeEecCCCCCCEEEcC-CCCeEEeecCcccc
Q 024118 161 H----E-EIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL 196 (272)
Q Consensus 161 H----~-~~~~~i~h~dl~p~nilv~~-~~~~~l~Dfg~~~~ 196 (272)
. . .....+||+|+++.||++++ ++.+.++||..+..
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 1 11237899999999999976 46799999998874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00057 Score=56.82 Aligned_cols=31 Identities=26% Similarity=0.475 Sum_probs=25.7
Q ss_pred CCeEecCCCCCCEEEcCCCCe-EEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNP-KISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~-~l~Dfg~~~~ 196 (272)
..++|+|++|.||++++++.+ -++||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 368999999999999875664 5999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=1.1e-05 Score=72.33 Aligned_cols=187 Identities=18% Similarity=0.135 Sum_probs=127.9
Q ss_pred eeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccc-eeEeeeeEecCCceeEEEeec
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-i~~l~~~~~~~~~~~iv~e~~ 122 (272)
++....+++++.+.+++.+..-.+....+.+.. .....-+++++.+++ ||| .+..++-+...+..++.++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n--~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVN--NPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHcc--CCCCcccccccCCcccccchhhhhh
Confidence 444566678888888888754333333444432 245566788899999 999 666666667777888999998
Q ss_pred CCC-CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCC
Q 024118 123 PNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201 (272)
Q Consensus 123 ~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~ 201 (272)
.++ +-...+. ...-.+.+.+...+.+.=+..++++|+. -=+|+| ||+..+ +..++.|++....+....
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc
Confidence 766 2221111 1222344455566666667778888876 446777 777765 578899999887654332
Q ss_pred ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 202 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
......+++.++|||+.....+....|.|++|.-..+|.-|-+|=..
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 23345678999999999999999999999999876677767666543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00097 Score=55.64 Aligned_cols=78 Identities=17% Similarity=0.193 Sum_probs=48.8
Q ss_pred eeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhccccc-ccceeEeeeeEecCCceeEEEeec
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYM 122 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~-~~~i~~l~~~~~~~~~~~iv~e~~ 122 (272)
.+-.+.++.|..+.+|+.. .+++.+.+|+-. ......+..|++.++.+... .-.+++++.+...++..++++||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445888889999999887 567889999865 22334567788888777432 445788888888777889999998
Q ss_pred CCC
Q 024118 123 PNN 125 (272)
Q Consensus 123 ~~~ 125 (272)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0012 Score=56.57 Aligned_cols=74 Identities=16% Similarity=0.179 Sum_probs=49.4
Q ss_pred eeeeccceEEEEEEeCCC-cEEEEEEEEe------cC-cccHHHHHHHHHHhhccccccc-ceeEeeeeEecCCceeEEE
Q 024118 49 KIGEGGFGSVYKGRLQDG-TIVAVKVLSV------ES-KQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 49 ~lg~G~~~~v~~~~~~~~-~~v~vK~~~~------~~-~~~~~~~~~e~~~~~~~~~~~~-~i~~l~~~~~~~~~~~iv~ 119 (272)
.+|-|....||++..++| ..++||-... .+ +-...+...|...++......| .+++++. .+.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 578899999999997754 6899997531 11 2334566677787777654445 3555553 3555667999
Q ss_pred eecCC
Q 024118 120 DYMPN 124 (272)
Q Consensus 120 e~~~~ 124 (272)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0026 Score=53.74 Aligned_cols=29 Identities=28% Similarity=0.360 Sum_probs=25.9
Q ss_pred CCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
.++||+|+++.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999987 678999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=55.99 Aligned_cols=143 Identities=13% Similarity=0.139 Sum_probs=75.6
Q ss_pred eeeeeccceEEEEEEeCC----CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecC
Q 024118 48 NKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMP 123 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~----~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~ 123 (272)
+.|..|=...+|++...+ +..|++|+...... ..-...+|...++.+.. +.--++++..+. . .+|.+|++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~-~gl~P~~l~~~~--~--G~i~~fi~ 93 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSA-AGFGAKLLGVFG--N--GMIQSFIN 93 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHh-cCCCCceeEEeC--C--cEeehhhc
Confidence 444447778899886542 34799998764322 22344566666666652 222244554442 2 25889988
Q ss_pred CCCHhHH-------H-------hhccccccc----C-ChHHHHHHHHH----------------------HHHHHHHHhh
Q 024118 124 NNSLSQT-------L-------LGEEKRRAK----F-GWKARREIIMG----------------------IGRGLAYIHE 162 (272)
Q Consensus 124 ~~~L~~~-------~-------~~~~~~~~~----l-~~~~~~~i~~~----------------------i~~al~~LH~ 162 (272)
|.+|... + ..-.....+ . ....+..+..+ +...+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 7765321 0 000000000 1 01122222211 1111222221
Q ss_pred c-----CCCCeEecCCCCCCEEEcC-CCCeEEeecCcccc
Q 024118 163 E-----IQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKL 196 (272)
Q Consensus 163 ~-----~~~~i~h~dl~p~nilv~~-~~~~~l~Dfg~~~~ 196 (272)
. ...-+||+|+.+.||++++ ++.++++||..+..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1124799999999999974 56899999999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00081 Score=53.53 Aligned_cols=29 Identities=28% Similarity=0.492 Sum_probs=21.2
Q ss_pred CeEecCCCCCCEEE-cCCCCeEEeecCccc
Q 024118 167 HVVHRDIKTSNILL-DQNFNPKISDFGLSK 195 (272)
Q Consensus 167 ~i~h~dl~p~nilv-~~~~~~~l~Dfg~~~ 195 (272)
.+||+|+.|.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 78999999999999 888899999999886
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0039 Score=52.75 Aligned_cols=31 Identities=19% Similarity=0.301 Sum_probs=28.4
Q ss_pred CCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
.++||+|+.++|++++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4899999999999999988999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.002 Score=55.82 Aligned_cols=76 Identities=16% Similarity=0.164 Sum_probs=52.4
Q ss_pred eeeeeeccceEEEEEEeCC-CcEEEEEEEE----ec-C-cccHHHHHHHHHHhhccccccc-ceeEeeeeEecCCceeEE
Q 024118 47 SNKIGEGGFGSVYKGRLQD-GTIVAVKVLS----VE-S-KQGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~-~~~v~vK~~~----~~-~-~~~~~~~~~e~~~~~~~~~~~~-~i~~l~~~~~~~~~~~iv 118 (272)
.+.||-|...-||++.+.+ +..++||-.. .. + +-...+...|.+.++......| .+++++. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 6889999999999998753 5679998643 11 1 2345677778888887654445 4555653 355667788
Q ss_pred EeecCC
Q 024118 119 YDYMPN 124 (272)
Q Consensus 119 ~e~~~~ 124 (272)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998853
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.021 Score=48.77 Aligned_cols=73 Identities=15% Similarity=0.065 Sum_probs=43.7
Q ss_pred ccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeee-----eEecCCceeEEEeecCCCC
Q 024118 53 GGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG-----GCIDGPCRILVYDYMPNNS 126 (272)
Q Consensus 53 G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~-----~~~~~~~~~iv~e~~~~~~ 126 (272)
+.-..||++...++..+++|+..... .....+..|...+..+....-.++.... ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 45678999988888889999875332 2444556666666665421111222111 1222456778999998764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.012 Score=50.05 Aligned_cols=139 Identities=16% Similarity=0.274 Sum_probs=77.7
Q ss_pred cceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccc-cceeEee-------eeEecCCceeEEEeecCCC
Q 024118 54 GFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLH-------GGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 54 ~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~i~~l~-------~~~~~~~~~~iv~e~~~~~ 125 (272)
.-..+|++...+|.. ++|+.... .....+..|...+..+...- +-.+++. .........+.+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 567799998887776 88987654 34445566666666665322 2222211 1111223778999999998
Q ss_pred CHhH-HHhh------------------cc----cccccCChH----H---------HHHHHHHHHHHHHHHhhc----CC
Q 024118 126 SLSQ-TLLG------------------EE----KRRAKFGWK----A---------RREIIMGIGRGLAYIHEE----IQ 165 (272)
Q Consensus 126 ~L~~-~~~~------------------~~----~~~~~l~~~----~---------~~~i~~~i~~al~~LH~~----~~ 165 (272)
.+.. .... .. .......+. . -.....++...+..+.+. .-
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7773 1000 00 000000010 0 000122333333333322 11
Q ss_pred CC---eEecCCCCCCEEEcCCCC-eEEeecCccc
Q 024118 166 PH---VVHRDIKTSNILLDQNFN-PKISDFGLSK 195 (272)
Q Consensus 166 ~~---i~h~dl~p~nilv~~~~~-~~l~Dfg~~~ 195 (272)
.+ +||+|+.|.||+++.+.. +-++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999998875 7899999886
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.89 E-value=8e-05 Score=73.13 Aligned_cols=150 Identities=12% Similarity=-0.018 Sum_probs=113.9
Q ss_pred ccceeEeeeeEe--cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCC--CeEecCCC
Q 024118 99 HENLVKLHGGCI--DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP--HVVHRDIK 174 (272)
Q Consensus 99 ~~~i~~l~~~~~--~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~--~i~h~dl~ 174 (272)
|+++.....-.. .+..-++.++++.+|.+.+.+..+-.....+.+.-+...-.+...+..-.|++.+. --+|++++
T Consensus 1288 h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lk 1367 (2724)
T KOG1826|consen 1288 HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLK 1367 (2724)
T ss_pred ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhh
Confidence 777776655443 23456788999999999999988877777777776666666656667777766322 35799999
Q ss_pred CCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 175 TSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
+.|.+|..+-+++++++|+..... +.........+++.|+.|+......++.++|+|..|+-+|....|..+|-
T Consensus 1368 f~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1368 FTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999999999999999999998222 22222333456777888888877788888999999999999999999884
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.013 Score=57.58 Aligned_cols=145 Identities=14% Similarity=0.196 Sum_probs=78.3
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhccccc-----ccceeEeee-----eEec-CC--c
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-----HENLVKLHG-----GCID-GP--C 114 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~-----~~~i~~l~~-----~~~~-~~--~ 114 (272)
+.|+ |..-..|++...+|..+++|+..... .......+.+.+..+... -|.+++-.+ .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 5564 45678899988888899999987442 222333344444444321 233333221 1111 12 4
Q ss_pred eeEEEeecCCCCHhHHHhhc-----------------------ccccccC-----------------ChHHHHHHHHHHH
Q 024118 115 RILVYDYMPNNSLSQTLLGE-----------------------EKRRAKF-----------------GWKARREIIMGIG 154 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~-----------------------~~~~~~l-----------------~~~~~~~i~~~i~ 154 (272)
.+.+++|++|..+.+..... ......+ .....+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 57789999998776521000 0000000 0111122223333
Q ss_pred HHHH-----HHhhcCCCCeEecCCCCCCEEEcCCC--CeE-EeecCcccc
Q 024118 155 RGLA-----YIHEEIQPHVVHRDIKTSNILLDQNF--NPK-ISDFGLSKL 196 (272)
Q Consensus 155 ~al~-----~LH~~~~~~i~h~dl~p~nilv~~~~--~~~-l~Dfg~~~~ 196 (272)
+.+. .+.+ ...++||+|+++.||+++.++ ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3222 1211 123899999999999998775 555 999998874
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.012 Score=46.95 Aligned_cols=78 Identities=15% Similarity=0.217 Sum_probs=55.9
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccc-cceeEeeeeEecCCceeEEEeecCCC
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
.+.+..|.....|.+.+ +..++.+|+- .......+..|+.-+..+.... -.+++++.+....+..++|+||++-+
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 35555666666665544 4567888873 3445567788888887776434 67888999999999999999999876
Q ss_pred CHh
Q 024118 126 SLS 128 (272)
Q Consensus 126 ~L~ 128 (272)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 554
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.02 Score=49.91 Aligned_cols=29 Identities=24% Similarity=0.233 Sum_probs=24.9
Q ss_pred CeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 167 ~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
.+||.|+.+.||+.++ +.+.++||..+..
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 7899999999999764 4699999998863
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.013 Score=46.58 Aligned_cols=118 Identities=17% Similarity=0.200 Sum_probs=73.1
Q ss_pred ccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCHhHHHh
Q 024118 53 GGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL 132 (272)
Q Consensus 53 G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~ 132 (272)
++.++...++.+-|.-+.-|+......-...-+..+...+.++. .|+++.. ...-.+.++.|.|.-...
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh----GilrL~N--Dn~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH----GILRLKN--DNNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh----heeEeec--CCCceeEEEEeeccCccc-----
Confidence 45555555554445544444443333324455677777777743 6777762 244467789998832110
Q ss_pred hcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 133 GEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 133 ~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
...-.+.+. +++|...|+. +.+..|||-.|+||+-+..|-+||.|-+..
T Consensus 142 -----------~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -----------NFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -----------chhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 011112222 3567888854 348999999999999999999999997644
|
The function of this family is unknown. |
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.035 Score=44.16 Aligned_cols=148 Identities=18% Similarity=0.111 Sum_probs=95.8
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..+.-....|...+.--.-+.+.||......+--+.+|... ......+..|...++.+....-...+++....+.+.
T Consensus 12 ~~~~~l~~g~~w~~v~~geS~~~v~rl~a~~r~g~~~k~~~---~~~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~ 88 (266)
T COG3231 12 PALRRLLSGRRWRRVTEGESGAGVFRLFADSRPGLYLKIAS---SGPAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQ 88 (266)
T ss_pred hhHHHhccCCccceeeccCCCCeEEEEeccCCCceEEEEec---CcchhhhhhHHHHHHHhcccCCCCCceEeeccCcch
Confidence 34444555565554433334457887766555556666643 334456778888888886544456666777777888
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc-------------------------------
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE------------------------------- 163 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~------------------------------- 163 (272)
.+++|+-++|.++...- ..++.+.++ .-++.+|..||..
T Consensus 89 ~wLl~salpG~~~s~~~-------~~~~p~r~v---~~la~aLR~LH~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesd 158 (266)
T COG3231 89 AWLLMSALPGEDASHPR-------YALDPKRAV---PLLAEALRRLHELPVEACPFDRRLARRLAKARARVRAGLVDESD 158 (266)
T ss_pred hHHhhhhcCCCcccchh-------hcCCHHHHH---HHHHHHHHHHhcCChhhCCcchHHHHHHHHHHHHHhccCCChhh
Confidence 99999999998876553 123333333 3456677888865
Q ss_pred ------------------------CCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 164 ------------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 164 ------------------------~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
...-++|+|-..-|++++.+.--=.+|+|-.-
T Consensus 159 fd~e~qgr~~~El~d~L~~~rp~~edLVv~HGDACLPN~i~d~~rf~GfIDlGrlG 214 (266)
T COG3231 159 FDEERQGRTAEELFDELEARRPAVEDLVVTHGDACLPNFILDGWRFSGFIDLGRLG 214 (266)
T ss_pred cChhhcCCCHHHHHHHHHhcCCchhhceeecCcccCcceEecCCceEEeeecCccc
Confidence 12247899999999999877444577877654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0069 Score=58.54 Aligned_cols=154 Identities=23% Similarity=0.247 Sum_probs=106.3
Q ss_pred HHHHHHHhhcccccccceeEeeeeEecCCcee----EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHH
Q 024118 85 FMSEVASMANVNVCHENLVKLHGGCIDGPCRI----LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160 (272)
Q Consensus 85 ~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~----iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~L 160 (272)
...|...+.... |+|+..++.+........ +..+++...++...+ +.-...+....+.+..+..+++.++
T Consensus 229 ~E~e~~~l~k~~--~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 229 TEIELESLSKIA--HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHhhc--cccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHH
Confidence 334556666666 999999998877654333 445777777787777 5567788999999999999999999
Q ss_pred hhcCCCCeEecCCCCC---CEEEcCCCCeEEe--ecCcccccCCCCccccccccccccccCccccccCCCC--CCCceeh
Q 024118 161 HEEIQPHVVHRDIKTS---NILLDQNFNPKIS--DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT--RKSDVYS 233 (272)
Q Consensus 161 H~~~~~~i~h~dl~p~---nilv~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~Di~s 233 (272)
|+. ...|.-+... +.-++..+.+... ||+.....+....... ...+..+.++|.......+ ...|+|.
T Consensus 303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHH
Confidence 998 5555555544 4444555556655 8887776544332221 2234456677777665544 4589999
Q ss_pred HHHHHHHHHhCCCccc
Q 024118 234 FGVLLLEIVSGRTAVD 249 (272)
Q Consensus 234 lG~il~~l~tg~~p~~ 249 (272)
+|.....+..|..+-.
T Consensus 378 lgll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISE 393 (1351)
T ss_pred HHHHHhhhhhcCcccc
Confidence 9999999998776543
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.021 Score=46.73 Aligned_cols=79 Identities=19% Similarity=0.150 Sum_probs=51.9
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeec-CCC
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM-PNN 125 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~-~~~ 125 (272)
...+..|..+.|+.++..+|.++++|+........ ........++... -...+++++.- .....+++|.+ ++.
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~--~E~~g~~~L~~w~--G~GaVrll~~d--~~~~AlLLErl~~g~ 80 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE--HEARGEAALRWWN--GRGAVRLLAAD--PERGALLLERLDPGR 80 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch--hhhhHHhHhheeC--CCCceeeeccc--cccchhhhhhccCCC
Confidence 35566788999999998899999999975332111 1111223466665 45678887653 34567888888 556
Q ss_pred CHhHHH
Q 024118 126 SLSQTL 131 (272)
Q Consensus 126 ~L~~~~ 131 (272)
+|.+..
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.014 Score=50.58 Aligned_cols=62 Identities=18% Similarity=0.122 Sum_probs=41.7
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
..++-+|.+|.++..++ .....+++....++.-..+|+..+--- .+++|.|++|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v-----~~~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFV-----KWKSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhh-----hcccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEec
Confidence 34666788888888887 333445556666666555555443322 289999999999999533
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 272 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-37 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-143
Identities = 102/245 (41%), Positives = 152/245 (62%), Gaps = 5/245 (2%)
Query: 23 EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG- 81
E L + FS +L++A++ F N +G GGFG VYKGRL DGT+VAVK L E QG
Sbjct: 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70
Query: 82 EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKF 141
E +F +EV ++ H NL++L G C+ R+LVY YM N S++ L + +
Sbjct: 71 ELQFQTEVEMISMAV--HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
W R+ I +G RGLAY+H+ P ++HRD+K +NILLD+ F + DFGL+KL
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 202 THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE--YHL 259
TH++T V GT+G++APEY +G+ + K+DV+ +GV+LLE+++G+ A D + L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 260 VDKVR 264
+D V+
Sbjct: 249 LDWVK 253
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-128
Identities = 106/261 (40%), Positives = 147/261 (56%), Gaps = 6/261 (2%)
Query: 6 SCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD 65
S +S + + + L+ ATN F IG G FG VYKG L+D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 66 GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125
G VA+K + ES QG +EF +E+ +++ H +LV L G C + IL+Y YM N
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCR--HPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 126 SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185
+L + L G + W+ R EI +G RGL Y+H ++HRD+K+ NILLD+NF
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177
Query: 186 PKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
PKI+DFG+SK E + TH+ST V GTLGY+ PEY I GRLT KSDVYSFGV+L E++
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 245 RTAVDFDVQLGEYHLVDKVRS 265
R+A+ + +L +
Sbjct: 238 RSAIVQSLPREMVNLAEWAVE 258
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-122
Identities = 102/248 (41%), Positives = 143/248 (57%), Gaps = 21/248 (8%)
Query: 28 NINAFSYNQLKIATNGFR------WSNKIGEGGFGSVYKGRLQDGTIVAVKVLS----VE 77
++FS+ +LK TN F NK+GEGGFG VYKG + + T VAVK L+ +
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 78 SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 137
+++ +++F E+ MA HENLV+L G DG LVY YMPN SL L +
Sbjct: 70 TEELKQQFDQEIKVMAKCQ--HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
W R +I G G+ ++HE H +HRDIK++NILLD+ F KISDFGL++
Sbjct: 128 -PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 198 PEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
+ T +++R+ GT Y+APE + G +T KSD+YSFGV+LLEI++G AVD
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REP 240
Query: 257 YHLVDKVR 264
L+D
Sbjct: 241 QLLLDIKE 248
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-78
Identities = 68/251 (27%), Positives = 104/251 (41%), Gaps = 26/251 (10%)
Query: 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
L + + G FG V+K +L VAVK+ ++ KQ + EV S
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 92 MANVNVCHENLVKLHGGCIDGPC----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
+ + HEN+++ G G L+ + SLS L + W
Sbjct: 72 LPGMK--HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELC 124
Query: 148 EIIMGIGRGLAYIHEEIQ-------PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
I + RGLAY+HE+I P + HRDIK+ N+LL N I+DFGL+ F
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 201 TTHI-STRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254
+ + GT Y+APE + D+Y+ G++L E+ S TA D V
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 255 GEYHLVDKVRS 265
+++
Sbjct: 245 YMLPFEEEIGQ 255
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-67
Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 34/253 (13%)
Query: 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
+ ++ + + + IG G +G+VYKG L D VAVKV S ++Q F++E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 92 MANVNVCHENLVKLHGGCIDGPCRI-----LVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
+ H+N+ + G LV +Y PN SL + L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 147 REIIMGIGRGLAYIHEEI------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
+ + RGLAY+H E+ +P + HRD+ + N+L+ + ISDFGLS N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 201 T-------THISTRVAGTLGYLAPEYA-------ISGRLTRKSDVYSFGVLLLEIVSGRT 246
+ + GT+ Y+APE ++ D+Y+ G++ EI T
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 247 AVDFDVQLGEYHL 259
+ + EY +
Sbjct: 234 DLFPGESVPEYQM 246
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-62
Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 8/201 (3%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
KIG G FG+V++ G+ VAVK+L + + EF+ EVA M + H N+V
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLF 99
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
G P +V +Y+ SL + LL + R + + R + + +G+ Y+H
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
P +VHR++K+ N+L+D+ + K+ DFGLS+ +T S AGT ++APE
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 226 TRKSDVYSFGVLLLEIVSGRT 246
KSDVYSFGV+L E+ + +
Sbjct: 217 NEKSDVYSFGVILWELATLQQ 237
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 5e-60
Identities = 70/214 (32%), Positives = 113/214 (52%), Gaps = 29/214 (13%)
Query: 48 NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGE-------KEFMSEVASMANVNVCH 99
+IG+GGFG V+KGRL D ++VA+K L + +GE +EF EV M+N+N H
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN--H 82
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N+VKL+G + P +V +++P L LL + W + +++ I G+ Y
Sbjct: 83 PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEY 137
Query: 160 IHEEIQPHVVHRDIKTSNILLDQ-----NFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
+ + P +VHRD+++ NI L K++DFGLS+ + H + + G +
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 215 LAPEYAISGRL---TRKSDVYSFGVLLLEIVSGR 245
+APE I T K+D YSF ++L I++G
Sbjct: 193 MAPE-TIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-59
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G FG V K + + VA+K + ES+ K F+ E+ ++ VN H N+VKL+G
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRVN--HPNIVKLYG 68
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
C++ C LV +Y SL +L + + + +G+AY+H
Sbjct: 69 ACLNPVC--LVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 168 VVHRDIKTSNILLDQNFN-PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
++HRD+K N+LL KI DFG + + T G+ ++APE +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 227 RKSDVYSFGVLLLEIVSGRT 246
K DV+S+G++L E+++ R
Sbjct: 182 EKCDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 9e-59
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVL----SVESKQGEKEFMSEVASMANVNVCHENLV 103
IG GGFG VY+ G VAVK + Q + E A + H N++
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--HPNII 69
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
L G C+ P LV ++ L++ L + + I RG+ Y+H+E
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 164 IQPHVVHRDIKTSNILLDQNFNP--------KISDFGLSKLFPENTTHISTRVAGTLGYL 215
++HRD+K+SNIL+ Q KI+DFGL++ + T AG ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWM 181
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
APE + ++ SDV+S+GVLL E+++G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-57
Identities = 53/227 (23%), Positives = 96/227 (42%), Gaps = 31/227 (13%)
Query: 27 KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKE 84
I+ + QL K+ E G ++KGR Q G + VKVL V S + ++
Sbjct: 5 SGID---FKQLNF-------LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD 53
Query: 85 FMSEVASMANVNVCHENLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFG 142
F E + + H N++ + G C P + +MP SL L E
Sbjct: 54 FNEECPRLRIFS--HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVD 109
Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT 202
+ + + RG+A++H +P + + + ++++D++ +IS + F
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF----- 163
Query: 203 HISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGR 245
S ++APE A+ + R +D++SF VLL E+V+
Sbjct: 164 -QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 7e-56
Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
+IG G FG+VYKG+ G VAVK+L+V + Q + F +EV + H N++
Sbjct: 30 QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLF 85
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
G I V + +SL L KF K +I RG+ Y+H
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPE---YAI 221
++HRD+K++NI L ++ KI DFGL+ + +H +++G++ ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
S + +SDVY+FG++L E+++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-55
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G+G +G V++G Q G VAVK+ S + EK + E V + HEN++
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 108 GCIDGPCRI----LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+ L+ Y SL L + + I++ I GLA++H E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYL 215
I +P + HRD+K+ NIL+ +N I+D GL+ + ++T + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 216 APE------YAISGRLTRKSDVYSFGVLLLEIVSG 244
APE ++ D+++FG++L E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-55
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+IG+G +G V+ G+ + G VAVKV E + E V + HEN++
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 108 GCIDGPCRI----LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
I G L+ DY N SL L + K+ ++ GL ++H E
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 164 I-----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYL 215
I +P + HRD+K+ NIL+ +N I+D GL+ F +T + GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 216 APEYAISGRL-------TRKSDVYSFGVLLLEIVSG 244
PE + L +D+YSFG++L E+
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-53
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
IG+G FG VY GR G VA++++ +E ++ K F EV + HEN+V
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTR--HENVVLF 94
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
G C+ P ++ +L + + R+I I +G+ Y+H
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---A 148
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL----FPENTTHISTRVAGTLGYLAPE--- 218
++H+D+K+ N+ D N I+DFGL + G L +LAPE
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 219 ------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
++ SDV++ G + E+ +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-53
Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 44 FRWS-----NKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV 97
FR S +G+G FG K + G ++ +K L ++ ++ F+ EV M +
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE- 65
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
H N++K G + +Y+ +L + +++ W R I G+
Sbjct: 66 -HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGM 121
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH-------------I 204
AY+H +++HRD+ + N L+ +N N ++DFGL++L + T
Sbjct: 122 AYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247
V G ++APE K DV+SFG++L EI+ A
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-52
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
IG+G FG V++G+ + G VAVK+ S + E+ + E V + HEN++
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 108 GCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
LV DY + SL L R + ++ + GLA++H E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 164 IQ-----PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYL 215
I P + HRD+K+ NIL+ +N I+D GL+ T I GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 216 APEYAISGRL-------TRKSDVYSFGVLLLEIVSG 244
APE + + +++D+Y+ G++ EI
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-44
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 45 RWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
++ ++G+G FGSV R G +VAVK L +++ ++F E+ + ++ H
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--H 70
Query: 100 ENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
+N+VK G C R L+ +Y+P SL L +K + + + I +G+
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGM 127
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYL 215
Y+ + +HRD+ T NIL++ KI DFGL+K+ P++ + G +
Sbjct: 128 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
APE + + SDV+SFGV+L E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-44
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 49 KIGEGGFGSVYKGRLQDGTI-VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLH 106
+IG G FG V+ GRL+ VAVK + +F+ E + + H N+V+L
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLI 178
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G C +V + + L A+ K +++ G+ Y+ +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY----LAPEYAIS 222
+HRD+ N L+ + KISDFG+S+ + G APE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNY 289
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
GR + +SDV+SFG+LL E S
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 48 NKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
++G+G FGSV R G +VAVK L +++ ++F E+ + ++ H+N+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNI 104
Query: 103 VKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
VK G C R L+ +Y+P SL L +K + + + I +G+ Y+
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPE 218
+ +HRD+ T NIL++ KI DFGL+K+ P++ + + G + APE
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVS 243
+ + SDV+SFGV+L E+ +
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-43
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 48 NKIGEGGFGSVYKGRLQDG-----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
+G G FG+VYKG VA+K L S + KE + E MA+V+ + +
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPH 78
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+ +L G C+ ++ + MP L + + + G + + I +G+ Y+
Sbjct: 79 VCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYA 220
+ +VHRD+ N+L+ + KI+DFGL+KL + ++A E
Sbjct: 135 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
+ T +SDV+S+GV + E+++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-43
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 45 RWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH 99
++ +++G+G FGSV R G +VAVK L +++F E+ + ++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH--S 83
Query: 100 ENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
+ +VK G + LV +Y+P+ L L ++ RA+ I +G+
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGM 140
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYL 215
Y+ VHRD+ NIL++ + KI+DFGL+KL P + + R G +
Sbjct: 141 EYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
APE +R+SDV+SFGV+L E+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-43
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 48 NKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
+GEG FG V R G VAVK L E + E+ + N+ HEN
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HEN 84
Query: 102 LVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
+VK G C + L+ +++P+ SL + L K + K K + + + I +G+ Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAP 217
+ VHRD+ N+L++ KI DFGL+K + + + + + AP
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS 243
E + + SDV+SFGV L E+++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 65/206 (31%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 48 NKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
+GEG FG V G +VAVK L + Q + E+ + + HE+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY--HEH 94
Query: 102 LVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
++K G C D LV +Y+P SL L R G I G+AY
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAY 149
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAP 217
+H + H +HRD+ N+LLD + KI DFGL+K PE + R G + AP
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS 243
E + SDV+SFGV L E+++
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-42
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 49 KIGEGGFGSVYKGRL--QDGTI-VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLVK 104
++G G FGSV +G + I VA+KVL +++ + E M E M ++ + +V+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVR 74
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
L G C + V + L + L+ +R + E++ + G+ Y+ E+
Sbjct: 75 LIGVCQAEALML-VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK- 129
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAIS 222
+ VHRD+ N+LL KISDFGLSK + ++ + R AG + APE
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
+ + +SDV+S+GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-42
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 49 KIGEGGFGSVYKGRLQDG---TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLV 103
++G G FG+V KG Q VAVK+L E + E ++E M ++ + +V
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIV 81
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
++ G C + V + L++ L ++ K E++ + G+ Y+ E
Sbjct: 82 RMIGICEAESWML-VMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL--GYLAPEYAI 221
+ VHRD+ N+LL KISDFGLSK + + + G + APE
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 222 SGRLTRKSDVYSFGVLLLEIVS 243
+ + KSDV+SFGVL+ E S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-42
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+IG G FG V+ G + VA+K + + E++F+ E M ++ H LV+L+G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS--HPKLVQLYG 70
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
C++ LV ++M + LS L +R F + + + + G+AY+ E
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGR 224
V+HRD+ N L+ +N K+SDFG+++ ++ T GT + +PE R
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSR 181
Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
+ KSDV+SFGVL+ E+ S G+
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQDG-----TIVAVKVLSVESKQGEK-EFMSEVASMANVNV 97
F+ +G G FG+VYKG VA+K L + E + E MA+V+
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 75
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
+ ++ +L G C+ ++ + MP L + + + G + + I +G+
Sbjct: 76 -NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLA 216
Y+ + +VHRD+ N+L+ + KI+DFGL+KL + ++A
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
E + T +SDV+S+GV + E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 49 KIGEGGFGSVYKGRLQ----DGTIVAVKVL---SVESKQGEKEFMSEVASMANVNVCHEN 101
K+G+G FG V +G VAVK L + + +F+ EV +M +++ H N
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRN 82
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
L++L+G + P ++ V + P SL L K + F + + G+ Y+
Sbjct: 83 LIRLYGVVLTPPMKM-VTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEY 219
+ +HRD+ N+LL KI DFGL + P+N H + + + APE
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 220 AISGRLTRKSDVYSFGVLLLEIVS 243
+ + SD + FGV L E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
++ +IG G F +VYKG + VA L +K + F E + + H
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HP 85
Query: 101 NLVKLHGGCIDGPCR----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
N+V+ + +LV + M + +L L KR K R I +G
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKG 141
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
L ++H P ++HRD+K NI + + KI D GL+ L + V GT ++
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFM 197
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
APE + DVY+FG+ +LE+ +
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 48 NKIGEGGFGSVYKGRLQDG-----TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN 101
+G G FG+V+KG V +KV+ +S +Q + + ++ +++ H +
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD--HAH 76
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+V+L G C ++ V Y+P SL + + R G + + I +G+ Y+
Sbjct: 77 IVRLLGLCPGSSLQL-VTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAPEYA 220
E +VHR++ N+LL +++DFG++ L P + + A T + ++A E
Sbjct: 133 EH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
G+ T +SDV+S+GV + E+++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 5e-41
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 28 NINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS 87
+ Y +I + ++G G FG V G+ + VA+K++ S E EF+
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIE 68
Query: 88 EVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR 147
E M N++ HE LV+L+G C ++ +YM N L L + R +F +
Sbjct: 69 EAKVMMNLS--HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLL 123
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR 207
E+ + + Y+ + +HRD+ N L++ K+SDFGLS+ ++ T
Sbjct: 124 EMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TS 177
Query: 208 VAGTL---GYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
G+ + PE + + + KSD+++FGVL+ EI S
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-41
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 49 KIGEGGFGSVYKGRL--QDGTI-VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVK 104
++G G FGSV +G + I VA+KVL K +E M E M ++ + +V+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVR 400
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
L G C + V + L + L+ +R + E++ + G+ Y+ E+
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYAIS 222
+ VHR++ N+LL KISDFGLSK + ++ + R AG APE
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 223 GRLTRKSDVYSFGVLLLEIVS 243
+ + +SDV+S+GV + E +S
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-40
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
++G G FG V G+ + VAVK++ E E EF E +M ++ H LVK +G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLS--HPKLVKFYGV 71
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
C +V +Y+ N L L E+ + G+A++
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYAISGRL 225
+HRD+ N L+D++ K+SDFG+++ ++ GT + APE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKY 182
Query: 226 TRKSDVYSFGVLLLEIVS 243
+ KSDV++FG+L+ E+ S
Sbjct: 183 SSKSDVWAFGILMWEVFS 200
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 48 NKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
+G G FG V GRL+ VA+K L V + ++ +F+ E + M + H N+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNI 108
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
++L G ++V +YM N SL L K A+F ++ GI G+ Y+ +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYA 220
VHRD+ NIL++ N K+SDFGL ++ ++ T G + +PE
Sbjct: 166 M---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
+ T SDV+S+G++L E++S
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 49 KIGEGGFGSVYKGRLQDG----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103
+GEG FG VY+G + VAVK + + +++FMSE M N++ H ++V
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD--HPHIV 76
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
KL G + P I + + P L L E+ + + I + +AY+
Sbjct: 77 KLIGIIEEEPTWI-IMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPEYA 220
+ VHRDI NIL+ K+ DFGLS+ + + + T +++PE
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESI 186
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
R T SDV+ F V + EI+S
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-40
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVK 104
KIG G F VY+ L DG VA+K + + K + E+ + +N H N++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIK 96
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+ I+ +V + LS+ + +K++ + + + + L ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
V+HRDIK +N+ + K+ D GL + F TT + V GT Y++PE
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212
Query: 225 LTRKSDVYSFGVLLLEIVSGRTA 247
KSD++S G LL E+ + ++
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-40
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
K+G G FG V+ T VAVK + + F++E M + H+ LVKLH
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQ--HDKLVKLHA 250
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
P I + ++M SL L + +K + I G+A+I + +
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG---YLAPEYAISGR 224
+HRD++ +NIL+ + KI+DFGL+++ +N T G + APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGS 361
Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
T KSDV+SFG+LL+EIV+ GR
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRI 384
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-40
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 48 NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
IG G G V GRL+ VA+K L + ++ +F+SE + M + H N+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNI 112
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
++L G G ++V +YM N SL L +F ++ G+G G+ Y+ +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL--APEYA 220
VHRD+ N+L+D N K+SDFGLS++ ++ T G + APE
Sbjct: 170 L---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
+ SDV+SFGV++ E+++
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 49 KIGEGGFGSVYKGRLQDGTI-----VAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
IG G FG VYKG L+ + VA+K L + ++ +F+ E M + H N+
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNI 108
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
++L G +++ +YM N +L + L ++ +F ++ GI G+ Y+
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY--LAPEYA 220
+ VHRD+ NIL++ N K+SDFGLS++ ++ T G + APE
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 221 ISGRLTRKSDVYSFGVLLLEIVS 243
+ T SDV+SFG+++ E+++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-39
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 49 KIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
IGEG FG V++G VA+K + + +F+ E +M + H ++V
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIV 79
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
KL G + P I + + L L R+ + + LAY+ +
Sbjct: 80 KLIGVITENPVWI-IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
VHRDI N+L+ N K+ DFGLS+ ++T + +++ + ++APE
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
R T SDV+ FGV + EI+
Sbjct: 193 RFTSASDVWMFGVCMWEILM 212
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 51/224 (22%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 39 IATNGFRWS--NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMAN 94
I+ G +S +IG GG V++ + I A+K +++E Q + +E+A +
Sbjct: 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 95 VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
+ + +++L+ I +V + N L+ L K++ R+ +
Sbjct: 64 LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNML 118
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLG 213
+ IH+ +VH D+K +N L+ K+ DFG++ +TT + GT+
Sbjct: 119 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 214 YLAPE-----------YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
Y+ PE +++ KSDV+S G +L + G+T
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-39
Identities = 69/205 (33%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
++G G FG V+ G T VAVK L S F++E M + H+ LV+L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQ--HQRLVRLYA 75
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
P I + +YM N SL L + K ++ I G+A+I E +
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAIS 222
+HRD++ +NIL+ + KI+DFGL++L +N T G APE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAK--FPIKWTAPEAINY 184
Query: 223 GRLTRKSDVYSFGVLLLEIVS-GRT 246
G T KSDV+SFG+LL EIV+ GR
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-39
Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 25/225 (11%)
Query: 38 KIATNGFRWS--NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMA 93
++ G +S +IG GG V++ + I A+K +++E Q + +E+A +
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
+ + +++L+ I +V + N L+ L K++ R+ +
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNM 136
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTL 212
+ IH+ +VH D+K +N L+ K+ DFG++ +TT + GT+
Sbjct: 137 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 213 GYLAPE-----------YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
Y+ PE +++ KSDV+S G +L + G+T
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-39
Identities = 55/240 (22%), Positives = 92/240 (38%), Gaps = 27/240 (11%)
Query: 36 QLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
+ I + + K+GEGGF V L DG A+K + +Q +E E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 95 VNVCHENLVKLHGGCIDGPCR----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
N H N+++L C+ L+ + +L + + + ++
Sbjct: 83 FN--HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA- 209
+GI RGL IH HRD+K +NILL P + D G + +
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 210 -------GTLGYLAPE------YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
T+ Y APE + + + ++DV+S G +L ++ G D Q G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-39
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V G + G VAVK + K + F++E + M + H NLV+L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLR--HSNLVQL 251
Query: 106 HGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
G + + +V +YM SL L + R+ G + + + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 308
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
+ VHRD+ N+L+ ++ K+SDFGL+K ++T + ++ + + APE +
Sbjct: 309 --NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 362
Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
+ KSDV+SFG+LL EI S GR
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRV 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-39
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 48 NKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQG---EKEFMSEVASMANVNVCHENLV 103
+K+G G +G VY+G + ++ VAVK L K+ +EF+ E A M + H NLV
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIK--HPNLV 279
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+L G C P ++ ++M +L L E R + + I + Y+ ++
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
+ +HR++ N L+ +N K++DFGLS+L +T + + APE
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
+ + KSDV++FGVLL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-38
Identities = 58/238 (24%), Positives = 91/238 (38%), Gaps = 16/238 (6%)
Query: 11 PSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIV 69
P RVS + L++ F+ +++G G +G V+K R +DG +
Sbjct: 28 PRRVSFRG--EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY 85
Query: 70 AVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 127
AVK + ++EV S V H V+L +G L + SL
Sbjct: 86 AVKRSMSPFRGPKDRARKLAEVGSHEKV-GQHPCCVRLEQAWEEGGILYLQTELC-GPSL 143
Query: 128 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187
Q E A + LA++H + +VH D+K +NI L K
Sbjct: 144 QQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
+ DFGL + G Y+APE + G +DV+S G+ +LE+
Sbjct: 198 LGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 48 NKIGEGGFGSVYKGRLQDGTI-VAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+K+G G +G VY+G + ++ VAVK L ++ + +EF+ E A M + H NLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK--HPNLVQLL 75
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G C P ++ ++M +L L E R + + I + Y+ ++
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK--- 130
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----APEYAI 221
+ +HRD+ N L+ +N K++DFGLS+L +T A APE
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLA 185
Query: 222 SGRLTRKSDVYSFGVLLLEIVS-GRT 246
+ + KSDV++FGVLL EI + G +
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 38 KIATNGFRWS--NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMA 93
I+ G +S +IG GG V++ + I A+K +++E Q + +E+A +
Sbjct: 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
+ + +++L+ I +V + N L+ L K++ R+ +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNM 164
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTL 212
+ IH+ +VH D+K +N L+ K+ DFG++ +TT + G +
Sbjct: 165 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 213 GYLAPEYAISGR------------LTRKSDVYSFGVLLLEIVSGRT 246
Y+ PE AI ++ KSDV+S G +L + G+T
Sbjct: 221 NYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
K+G+G FG V+ G T VA+K L + F+ E M + HE LV+L+
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR--HEKLVQLYA 246
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
+ P I V +YM SL L + + ++ I G+AY+ +
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
VHRD++ +NIL+ +N K++DFGL++L +N + + APE A+ GR T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 228 KSDVYSFGVLLLEIVS 243
KSDV+SFG+LL E+ +
Sbjct: 361 KSDVWSFGILLTELTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
K+G+G FG V+ G T VA+K L + F+ E M + HE LV+L+
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR--HEKLVQLYA 329
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
+ P I V +YM SL L + + ++ I G+AY+ +
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
VHRD++ +NIL+ +N K++DFGL++L +N + + APE A+ GR T
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 228 KSDVYSFGVLLLEIVS 243
KSDV+SFG+LL E+ +
Sbjct: 444 KSDVWSFGILLTELTT 459
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
KIGEG FG + +DG +K +++ S + +E EVA +AN+ H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--HPNIVQY 88
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+ +V DY L + + ++ F + + I L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR-- 144
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
++HRDIK+ NI L ++ ++ DFG++++ + GT YL+PE +
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY 202
Query: 226 TRKSDVYSFGVLLLEIVSGRTA 247
KSD+++ G +L E+ + + A
Sbjct: 203 NNKSDIWALGCVLYELCTLKHA 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 49 KIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
IGEG FG V++G VA+K + + +F+ E +M + H ++V
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIV 454
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
KL G + P I + + L L + R+ + + LAY+ +
Sbjct: 455 KLIGVITENPVWI-IMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
VHRDI N+L+ N K+ DFGLS+ ++T + +++ + ++APE
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
R T SDV+ FGV + EI+
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-38
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G+G FG V K R D A+K + ++ +SEV +A++N H+ +V+ +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN--HQYVVRYYA 69
Query: 108 GCIDGPCRI-------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
++ + + +Y N +L + + I
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQIL 126
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--------- 205
L+YIH + ++HRD+K NI +D++ N KI DFGL+K + +
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 206 ----TRVAGTLGYLAPE-YAISGRLTRKSDVYSFGVLLLEIVSG 244
T GT Y+A E +G K D+YS G++ E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-38
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 48 NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
IG G FG VY G L D AVK L+ + GE +F++E M + + H N+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNV 88
Query: 103 VKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+ L G C+ ++V YM + L + K + + +G+ Y+
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL------ 215
+ VHRD+ N +LD+ F K++DFGL++ + + V G
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWM 199
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVS 243
A E + + T KSDV+SFGVLL E+++
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-37
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V G + G VAVK + K + F++E + M + H NLV+L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLR--HSNLVQL 79
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
G ++ + +V +YM SL L + R+ G + + + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
+ VHRD+ N+L+ ++ K+SDFGL+K ++T + ++ + + APE +
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 190
Query: 225 LTRKSDVYSFGVLLLEIVS-GRT 246
+ KSDV+SFG+LL EI S GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101
++GEG FG V+ + +VAVK L S+ ++F E + + H++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ--HQH 104
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE-----------II 150
+V+ G C +G ++V++YM + L++ L +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+ G+ Y+ H VHRD+ T N L+ Q KI DFG+S+ RV G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRV-G 217
Query: 211 TLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
L PE + + T +SDV+SFGV+L EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 48 NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
IG+G FG VY G D A+K LS ++ + F+ E M +N H N+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN--HPNV 84
Query: 103 VKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+ L G + ++ YM + L Q + + K + + RG+ Y+
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL---GYLAPE 218
E+ VHRD+ N +LD++F K++DFGL++ + + + + A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVS 243
+ R T KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 48 NKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN 101
++GEG FG V+ +D +VAVK L + K+F E + N+ HE+
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEH 78
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE------------I 149
+VK +G C DG I+V++YM + L++ L R+ I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
I G+ Y+ + H VHRD+ T N L+ N KI DFG+S+ +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191
Query: 210 GTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
G L PE + + T +SDV+SFGV+L EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-37
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
++G+G FG VY+G + T VA+K ++ + E+ EF++E + M N
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CH 88
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARR------EIIMGIG 154
++V+L G G +++ + M L L A A ++ I
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
G+AY++ VHRD+ N ++ ++F KI DFG+++ E + G G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGL 201
Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
L +PE G T SDV+SFGV+L EI +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-37
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
K+G GG +VY VA+K + + ++ E K F EV + + ++ H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS--HQNIVS 75
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+ + C LV +Y+ +LS+ + + I G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
+VHRDIK NIL+D N KI DFG++K E + + V GT+ Y +PE A
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 225 LTRKSDVYSFGVLLLEIVSGR 245
+D+YS G++L E++ G
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-37
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 13/224 (5%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
IG G +G K R DG I+ K L ++ ++ +SEV + + H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRY 70
Query: 106 HGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE- 162
+ ID L V +Y L+ + K R + ++ + L H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 163 -EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
+ V+HRD+K +N+ LD N K+ DFGL+++ +T+ T V GT Y++PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 265
KSD++S G LL E+ + F + L K+R
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP--FTAF-SQKELAGKIRE 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-37
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 48 NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHEN 101
+GEG FGSV +G L+ VAVK + ++ S++ +EF+SE A M + + H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS--HPN 97
Query: 102 LVKLHGGCIDG-----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--IG 154
+++L G CI+ P +++ +M L LL + + I
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
G+ Y+ + +HRD+ N +L + ++DFGLSK + G +
Sbjct: 158 LGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210
Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ A E T KSDV++FGV + EI +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-36
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 44 FRWSNK--IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
++ +G+G +G VY GR L + +A+K + + + E+A ++ H+
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HK 79
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-----IGR 155
N+V+ G + + + +P SLS L R+K+G E +G I
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIGFYTKQILE 133
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
GL Y+H+ +VHRDIK N+L++ + KISDFG SK T GTL Y
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQY 189
Query: 215 LAPEYAISGRL---TRKSDVYSFGVLLLEIVSGR 245
+APE I + +D++S G ++E+ +G+
Sbjct: 190 MAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 32/213 (15%)
Query: 49 KIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
+G+G F ++KG ++ T V +KVL + + F + M+ ++ H+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS--HK 72
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
+LV +G C+ G ILV +++ SL L +K + + E+ + + ++
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP--------KISDFGLSKLFPENTTHISTRVAGTL 212
E ++H ++ NILL + + K+SD G+S + R+
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184
Query: 213 GYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVS 243
PE I L +D +SFG L EI S
Sbjct: 185 ---PPE-CIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 48 NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENL 102
IG G FG VY G L D AVK L+ + GE +F++E M + + H N+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNV 152
Query: 103 VKLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+ L G C+ ++V YM + L + K + + +G+ ++
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL-----A 216
+ VHRD+ N +LD+ F K++DFGL++ + T L A
Sbjct: 210 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMA 264
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVS 243
E + + T KSDV+SFGVLL E+++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 51/247 (20%), Positives = 100/247 (40%), Gaps = 37/247 (14%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLS-----------------VESKQGEKEFMSEVAS 91
+ +G F + +D A+K + K +F +E+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 92 MANVNVCHENLVKLHGGCIDGPCRI-LVYDYMPN----NSLSQTLLGEEKRRAKFGWKAR 146
+ ++ +E + G I + ++Y+YM N + ++ +
Sbjct: 97 ITDIK--NEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
+ II + +YIH + ++ HRD+K SNIL+D+N K+SDFG S+ + S
Sbjct: 154 KCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS- 210
Query: 207 RVAGTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
GT ++ PE S + K D++S G+ L + F +++ L + +
Sbjct: 211 --RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKISLVELFNNI 265
Query: 264 RSINMKL 270
R+ N++
Sbjct: 266 RTKNIEY 272
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 48 NKIGEGGFGSVYKGRLQDG----TIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHEN 101
+G+G FGSV + +L+ VAVK+L + + +EF+ E A M + H +
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD--HPH 86
Query: 102 LVKLHGGCIDG------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG--I 153
+ KL G + P +++ +M + L LL F + + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
G+ Y+ + +HRD+ N +L ++ ++DFGLS+ + G
Sbjct: 147 ACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 214 YL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
L A E T SDV++FGV + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-36
Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 48 NKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
+G G FG V + VAVK+L + E MSE+ + ++ H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHL 91
Query: 101 NLVKLHGGC--IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE---------- 148
N+V L G C GP ++V ++ +LS L + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
I + +G+ ++ +HRD+ NILL + KI DFGL++ ++
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203
Query: 207 RVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
V L APE T +SDV+SFGVLL EI S G +
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-36
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
F +G+G FG+VY R Q I+A+KVL +E E + EV +++ H
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--H 68
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N+++L+G D L+ +Y P ++ + L ++ +KF + I + L+Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 124
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
H + V+HRDIK N+LL KI+DFG S P + + GTL YL PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE- 177
Query: 220 AISGRL-TRKSDVYSFGVLLLEIVSGRT 246
I GR+ K D++S GVL E + G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 33/220 (15%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHE 100
++GE FG VYKG L VA+K L + +EF E A + H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ--HP 72
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE------------ 148
N+V L G +++ Y + L + L+ R
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
++ I G+ Y+ HVVH+D+ T N+L+ N KISD GL + +
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----K 185
Query: 209 AGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
L APE + G+ + SD++S+GV+L E+ S
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-35
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
+G+G FG+VY R Q+ I+A+KVL +E + E + E+ +++ H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR--HPNILRM 79
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+ RI L+ ++ P L + L ++ +F + + + L Y HE
Sbjct: 80 YN-YFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER- 133
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
V+HRDIK N+L+ KI+DFG S P T + GTL YL PE I G+
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE-MIEGK 187
Query: 225 L-TRKSDVYSFGVLLLEIVSGRT 246
K D++ GVL E + G
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMP 210
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
IG GGFG V+K + DG +K + ++ + EV ++A ++ H N+V +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLD--HVNIVHYN 70
Query: 107 GGCIDGPCRI----------------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
G + ++ +L Q + E++R K E+
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELF 128
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
I +G+ YIH + +++RD+K SNI L KI DFGL +N + G
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRSK-G 183
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
TL Y++PE S ++ D+Y+ G++L E++
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 34/222 (15%)
Query: 48 NKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVC 98
+GEG FG V VAVK+L ++ + + + +SE+ M +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-K 99
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE---------- 148
H+N++ L G C ++ +Y +L + L ++ + R
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 149 IIMG--IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
+ + RG+ Y+ + +HRD+ N+L+ +N KI+DFGL++
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DY 212
Query: 207 RVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
T G L APE T +SDV+SFGVL+ EI +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
+G GG V+ R L+D VAVKVL + + F E + A +N H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVA 76
Query: 105 LH-GGCIDGPCRILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
++ G + P L Y +Y+ +L + K E+I + L +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFS 132
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI--STRVAGTLGYLAPE 218
H+ ++HRD+K +NI++ K+ DFG+++ ++ + + V GT YL+PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGR 245
A + +SDVYS G +L E+++G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 48 NKIGEGGFGSVYKGRLQDG---TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHENLV 103
+ IGEG FG V K R++ A+K + + + + +F E+ + + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNII 89
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTL----LGEEKRRAKFGWKARREIIM-------- 151
L G C L +Y P+ +L L + E +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
+ RG+ Y+ ++ +HRD+ NIL+ +N+ KI+DFGLS+ V T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199
Query: 212 LGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
+G L A E T SDV+S+GVLL EIVS G T
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
+G G FG VY+G++ VAVK L + ++ +F+ E ++ N H+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQ 93
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII---MGIGRGL 157
N+V+ G + R ++ + M L L R ++ A +++ I G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 158 AYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
Y+ E H +HRDI N LL KI DFG+++ S G
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206
Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
L PE + G T K+D +SFGVLL EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-35
Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+G+GGF ++ + A K++ ++ Q EK E++ ++ H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA--HQHVVG 105
Query: 105 LHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
HG + + +V + SL + KRR R + I G Y+H
Sbjct: 106 FHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
V+HRD+K N+ L+++ KI DFGL+ + + GT Y+APE +S
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSK 215
Query: 224 RL-TRKSDVYSFGVLLLEIVSGR 245
+ + + DV+S G ++ ++ G+
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
+G G FG VY+G++ VAVK L + ++ +F+ E ++ N H+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQ 134
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM---GIGRGL 157
N+V+ G + R ++ + M L L R ++ A +++ I G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 158 AYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
Y+ E H +HRDI N LL KI DFG+++ G
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAM 247
Query: 215 L-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
L PE + G T K+D +SFGVLL EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-35
Identities = 50/242 (20%), Positives = 95/242 (39%), Gaps = 36/242 (14%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH 106
+G GGFG V++ + D A+K + + +++ +E M EV ++A + H +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYF 69
Query: 107 GGCIDGPC---------RILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
++ ++ +Y +L + + I + I
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHIFLQIA 128
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-----------PENTTH 203
+ ++H + ++HRD+K SNI + K+ DFGL P
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 204 ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
T GT Y++PE + K D++S G++L E+ F Q+ + V
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTDV 240
Query: 264 RS 265
R+
Sbjct: 241 RN 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-35
Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+G+GGF ++ + A K++ ++ Q EK E++ ++ H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA--HQHVVG 79
Query: 105 LHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
HG + + +V + SL + KRR R + I G Y+H
Sbjct: 80 FHG-FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
V+HRD+K N+ L+++ KI DFGL+ + + GT Y+APE +S
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSK 189
Query: 224 RL-TRKSDVYSFGVLLLEIVSGR 245
+ + + DV+S G ++ ++ G+
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 40/225 (17%)
Query: 48 NKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVC 98
+GEG FG V VAVK+L ++ + + + +SE+ M +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-K 145
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG------ 152
H+N++ L G C ++ +Y +L + L RR + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLR---ARRPPGMEYSYDINRVPEEQMTF 202
Query: 153 ---------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
+ RG+ Y+ + +HRD+ N+L+ +N KI+DFGL++
Sbjct: 203 KDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI--- 256
Query: 204 ISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
T G L APE T +SDV+SFGVL+ EI +
Sbjct: 257 -DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 35/247 (14%), Positives = 69/247 (27%), Gaps = 39/247 (15%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE------------------------ 84
+G+ + + + G V V +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 85 ----FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN--SLSQTLLGEEKRR 138
F+ + + V+L + R +Y M +N + + LL
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
AR ++ + + R LA +H +VH ++ +I+LDQ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 199 ENTTHISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253
+ R A +T D ++ G+ + I D
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 254 LGEYHLV 260
LG +
Sbjct: 323 LGGSEWI 329
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 40/225 (17%)
Query: 48 NKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
+G G FG V + VAVK+L + E+ MSE+ ++ + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHM 87
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-------- 152
N+V L G C G +++ +Y L L ++R F IM
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLR---RKRDSFICSKTSPAIMEDDELALDL 144
Query: 153 ---------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH 203
+ +G+A++ + + +HRD+ NILL KI DFGL++ +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKND--- 198
Query: 204 ISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
S V L APE + T +SDV+S+G+ L E+ S
Sbjct: 199 -SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 42/232 (18%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
+GEG FG V K T VAVK+L + E + +SE + VN H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HP 86
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSL------------SQTLLGEEKRRAKFGWKARRE 148
+++KL+G C +L+ +Y SL G + + R
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 149 IIMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200
+ MG I +G+ Y+ E +VHRD+ NIL+ + KISDFGLS+ E
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 201 TTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246
+ V + G + A E T +SDV+SFGVLL EIV+ G
Sbjct: 204 ----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 48 NKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVC 98
+GEG FG V T VAVK+L ++ + + + +SE+ M +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-K 133
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG------ 152
H+N++ L G C ++ +Y +L + L +R +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 153 --------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204
+ RG+ Y+ + +HRD+ N+L+ ++ KI+DFGL++
Sbjct: 192 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 244
Query: 205 STRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
T G L APE T +SDV+SFGVLL EI +
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 54/244 (22%), Positives = 93/244 (38%), Gaps = 32/244 (13%)
Query: 12 SRVSAENTIGGEQI-LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVA 70
S S E G E+ + + S+ + +G G G++ + D VA
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDV----------LGHGAEGTIVYRGMFDNRDVA 52
Query: 71 VKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQT 130
VK + + EV + + H N+++ D + + + +L +
Sbjct: 53 VKRI---LPECFSFADREVQLLRESDE-HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEY 107
Query: 131 LLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-----DQNFN 185
+ E++ ++ GLA++H ++VHRD+K NIL+
Sbjct: 108 V---EQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIK 161
Query: 186 PKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEY---AISGRLTRKSDVYSFGVLLLE 240
ISDFGL K S R V GT G++APE T D++S G +
Sbjct: 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221
Query: 241 IVSG 244
++S
Sbjct: 222 VISE 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-34
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
+G+G F VY+ + G VA+K++ + + +EV + H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK--HPSILEL 76
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFG-WKARREIIMGIGRGLAYIHEE 163
+ + + LV + N +++ L + R F +AR + I G+ Y+H
Sbjct: 77 YN-YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARH-FMHQIITGMLYLHSH 131
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
++HRD+ SN+LL +N N KI+DFGL+ T + GT Y++PE +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATR 186
Query: 224 RL-TRKSDVYSFGVLLLEIVSGR 245
+SDV+S G + ++ GR
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGR 209
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 68/231 (29%), Positives = 96/231 (41%), Gaps = 47/231 (20%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHE 100
IGEG FG V++ R T+VAVK+L E S + +F E A MA + +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NP 110
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE------------ 148
N+VKL G C G L+++YM L++ L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR---SMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 149 -----------IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
I + G+AY+ E VHRD+ T N L+ +N KI+DFGLS+
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR-- 222
Query: 198 PENTTHISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
N A + PE R T +SDV+++GV+L EI S
Sbjct: 223 --NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 48 NKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
+G G FG V + VAVK+L + EK MSE+ M+++ HE
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG-QHE 110
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR-------REIIM-- 151
N+V L G C G +++ +Y L L + + A R+++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 152 -GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+ +G+A++ + + +HRD+ N+LL KI DFGL++ + S +
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIVK 223
Query: 211 TLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
L APE T +SDV+S+G+LL EI S
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
++G G FG V++ + Q G AVK + +E + + E+ + A ++ +V L+
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLS--SPRIVPLY 116
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G +GP + + + SL Q + K+ + GL Y+H
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169
Query: 167 HVVHRDIKTSNILLDQNFNP-KISDFGLSKLFPENTTHISTR----VAGTLGYLAPEYAI 221
++H D+K N+LL + + + DFG + + S + GT ++APE +
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VV 228
Query: 222 SGR-LTRKSDVYSFGVLLLEIVSGR 245
G+ K D++S ++L +++G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 33/239 (13%), Positives = 69/239 (28%), Gaps = 50/239 (20%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE------------------------ 84
+G+ + + + G V V +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 85 ----FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN--SLSQTLLGEEKRR 138
F+ + + V+L + R +Y M +N + + LL
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
AR ++ + + R LA +H +VH ++ +I+LDQ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 199 ENTTHISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRT 246
+ + G+ PE +T D ++ G+++ I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 48 NKIGEGGFGSVYKGRLQDG------TIVAVKVLSVESKQGEK-EFMSEVASMANVNVCHE 100
+G G FG V VAVK+L ++ E+ MSE+ M + HE
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-SHE 109
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSL-----------SQTLLGEEKRRAKFGWKARREI 149
N+V L G C L+++Y L S+ + E ++ + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 150 IMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
+ +G+ ++ + VHRD+ N+L+ KI DFGL++ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225
Query: 202 THISTRVAGTLGYL-----APEYAISGRLTRKSDVYSFGVLLLEIVS 243
S V L APE G T KSDV+S+G+LL EI S
Sbjct: 226 ---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH 106
++G GGFG V + G VA+K E +E + E+ M +N H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAR 78
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
+L +Y L + L + + R ++ I L Y+
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
HE ++HRD+K NI+L KI D G +K + + V GTL YLAP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAP 192
Query: 218 EYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
E + + T D +SFG L E ++G
Sbjct: 193 E-LLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-33
Identities = 49/226 (21%), Positives = 92/226 (40%), Gaps = 28/226 (12%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANV 95
+ + + S+ +G+G +V++GR + G + A+KV + S + M E + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 96 NVCHENLVKLHGGCIDGPCRILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
N H+N+VKL + ++ P SL +L E ++
Sbjct: 65 N--HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRD 120
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRV 208
+ G+ ++ E +VHR+IK NI+ D K++DFG ++ ++ +
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY 176
Query: 209 AGTLGYLAPEYAISGRLTR---------KSDVYSFGVLLLEIVSGR 245
GT YL P+ + R D++S GV +G
Sbjct: 177 -GTEEYLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 46/206 (22%), Positives = 77/206 (37%), Gaps = 28/206 (13%)
Query: 49 KIGEGGFGSVYKG---RLQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVK 104
I GG G +Y + +G V +K L + M+E +A V H ++V+
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--HPSIVQ 143
Query: 105 L-----HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
+ H P +V +Y+ SL + K ++ I L+Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLK------RSKGQKLPVAEAIAYLLEILPALSY 197
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+H +V+ D+K NI+L + K+ D G + GT G+ APE
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEI 248
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGR 245
T +D+Y+ G L +
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 34/221 (15%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKV--LSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
KIG G FGSV+K DG I A+K + E+ + EV + A + H ++V+
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-QHSHVVRY 76
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+ ++ +Y SL+ + + + F +++++ +GRGL YIH
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-- 134
Query: 166 PHVVHRDIKTSNILLDQNFNP-------------------KISDFGLSKLFPENTTHIST 206
+VH DIK SNI + + P KI D G
Sbjct: 135 -SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 207 RVAGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
G +LA E + K+D+++ + ++
Sbjct: 192 ---GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-32
Identities = 49/226 (21%), Positives = 92/226 (40%), Gaps = 28/226 (12%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANV 95
+ + + S+ +G+G +V++GR + G + A+KV + S + M E + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 96 NVCHENLVKLHGGCIDGPCRILVY---DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
N H+N+VKL + ++ P SL +L E ++
Sbjct: 65 N--HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRD 120
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRV 208
+ G+ ++ E +VHR+IK NI+ D K++DFG ++ ++ +
Sbjct: 121 VVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY 176
Query: 209 AGTLGYLAPEYAISGRLTR---------KSDVYSFGVLLLEIVSGR 245
GT YL P+ + R D++S GV +G
Sbjct: 177 -GTEEYLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 17/204 (8%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENLVK 104
+G GG G VY+ IVA+K++S E + + ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ--EPHVVP 98
Query: 105 LHG-GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+H G IDG + + L+ L +R+ I+ IG L H
Sbjct: 99 IHDFGEIDG-QLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAIS 222
HRD+K NIL+ + + DFG++ + T + GTL Y+APE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSE 209
Query: 223 GRLTRKSDVYSFGVLLLEIVSGRT 246
T ++D+Y+ +L E ++G
Sbjct: 210 SHATYRADIYALTCVLYECLTGSP 233
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 44 FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHEN 101
F +++G G G V+K G ++A K++ +E K + + E+ + N
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPY 92
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+V +G + ++M SL Q L K+ + + ++ + + +GL Y+
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
E+ ++HRD+K SNIL++ K+ DFG+S + ++ GT Y++PE
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQ 203
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
+ +SD++S G+ L+E+ GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 37 LKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVA-SMA 93
+++ + ++G G +G V K R + G I+AVK + E K + ++ SM
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
V+ V +G + + M + SL + + +I + I
Sbjct: 62 TVD--CPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTL 212
+ L ++H ++ V+HRD+K SN+L++ K+ DFG+S ++ AG
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCK 173
Query: 213 GYLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSGR 245
Y+APE I+ L + KSD++S G+ ++E+ R
Sbjct: 174 PYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 46/234 (19%), Positives = 88/234 (37%), Gaps = 45/234 (19%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+ EGGF VY+ + + G A+K L ++ + + EV M ++ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-HPNIVQFCS 93
Query: 108 GCIDGP----------------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
G C+ + +++ S+ L + F +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIF-----YQTC- 146
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF---PENTTHISTRV 208
R + ++H + +P ++HRD+K N+LL K+ DFG + P+ + R
Sbjct: 147 ---RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 209 A--------GTLGYLAPE-YAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD 251
T Y PE + K D+++ G +L + + F+
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FE 254
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 27/228 (11%), Positives = 59/228 (25%), Gaps = 39/228 (17%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCHENLVKL 105
+ G V+ R ++ A+KV ++ ++ E + A + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 106 HGGCI---------------------DGPCRILVYDYMPNNSLSQTLLGEE-----KRRA 139
+ D MP S+ LL R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 140 KFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199
G A + + R A + + +VH N+ + + + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 200 NTTHISTRVAGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
+ + Y E+ + T + + G+ + +
Sbjct: 247 RG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLH 106
+IG G +GSV K G I+AVK + + E K+ + ++ + + +V+ +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL-DVVMRSSDCPYIVQFY 87
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
G + + M + + +I + + L ++ E +
Sbjct: 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS-TRVAGTLGYLAPEYAISGRL 225
++HRDIK SNILLD++ N K+ DFG+S + I+ TR AG Y+APE I
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPE-RIDPSA 201
Query: 226 TR-----KSDVYSFGVLLLEIVSGR 245
+R +SDV+S G+ L E+ +GR
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGR 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
KIGEG G V R G VAVK++ + +Q + +EV M + H N+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HFNV 104
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
V+++ + G ++ +++ +L+ Q L EE+ + + + LA
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT---------VCEAVLQALA 155
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLA 216
Y+H + V+HRDIK+ +ILL + K+SDFG + + + R + GT ++A
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMA 209
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSG 244
PE + D++S G++++E+V G
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-30
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
+ KIG+G G+VY + G VA++ ++++ + ++ ++E+ M + N+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNI 79
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
V + G +V +Y+ SL+ +T + E + A + + L
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALE 130
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLA 216
++H V+HRDIK+ NILL + + K++DFG + T S R + GT ++A
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMA 184
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSG 244
PE K D++S G++ +E++ G
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHEN 101
F KIG+G FG V+KG + +VA+K++ +E + E E E+ ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPY 81
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLS----QTLLGEEKRRAKFGWKARREIIMGIGRGL 157
+ K +G + ++ +Y+ S L E + I+ I +GL
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---------ILREILKGL 132
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
Y+H E +HRDIK +N+LL ++ K++DFG++ + +T V GT ++AP
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSG 244
E K+D++S G+ +E+ G
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLV 103
+G+G FG V + G AVKV+S V+ K ++ + EV + ++ H N++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIM 89
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLA 158
KL+ D LV + G E R +F II + G+
Sbjct: 90 KLYEFFEDKGYFYLVGEVYT---------GGELFDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 159 YIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
Y+H+ +VHRD+K N+LL ++ N +I DFGLS F + GT Y+
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYI 195
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
APE + G K DV+S GV+L ++SG
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHEN 101
F + K+G G FG V+ G +K ++ S+ ++ +E+ + +++ H N
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD--HPN 81
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
++K+ D +V + L + ++ + R E++ + LAY H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 162 EEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
+ HVVH+D+K NIL + KI DFGL++LF + T AGT Y+APE
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE 196
Query: 219 YAISGRLTRKSDVYSFGVLL 238
+T K D++S GV++
Sbjct: 197 -VFKRDVTFKCDIWSAGVVM 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 50/261 (19%), Positives = 87/261 (33%), Gaps = 74/261 (28%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHENLVKLH 106
+G GGFG V++ + D A+K + + +++ +E M EV ++A + H +V+
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYF 70
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARRE--------------- 148
++ P + ++ K RR
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 149 -------IIMG-------------------------------IGRGLAYIHEEIQPHVVH 170
I M I + ++H + ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMH 187
Query: 171 RDIKTSNILLDQNFNPKISDFGLSK-----------LFPENTTHISTRVAGTLGYLAPEY 219
RD+K SNI + K+ DFGL L P T GT Y++PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 220 AISGRLTRKSDVYSFGVLLLE 240
+ K D++S G++L E
Sbjct: 248 IHGNNYSHKVDIFSLGLILFE 268
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 44/219 (20%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVL------SVESKQGEKEFMSEVASMANVNVC--HE 100
+G+GGFG+V+ G L D VA+KV+ EVA + V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 101 NLVKLHGGCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
+++L + + ++DY+ + LGE R F ++
Sbjct: 99 GVIRLLD-WFETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFF-----GQV 148
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRV 208
+ I + H VVHRDIK NIL+D + K+ DFG L +
Sbjct: 149 VAAI----QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--- 198
Query: 209 AGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
GT Y PE+ IS + V+S G+LL ++V G
Sbjct: 199 DGTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 48/235 (20%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS------EVASMANVNVCHENL 102
+G GGFGSVY G + D VA+K + + E + EV + V+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 103 VKLHGGCIDGPCRIL-----------VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
++L + P + ++D++ L EE R+ F +++
Sbjct: 111 IRLLD-WFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFF-----WQVLE 160
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAG 210
+ + H V+HRDIK NIL+D N K+ DFG L + G
Sbjct: 161 AV----RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DG 210
Query: 211 TLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGRTAVDFD----VQLGEYHL 259
T Y PE+ I R + V+S G+LL ++V G + F+ + G+
Sbjct: 211 TRVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFF 262
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 49/223 (21%), Positives = 83/223 (37%), Gaps = 34/223 (15%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G G+V G VAVK + + E+ + H N+++ +
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTES-DDHPNVIRYYC 76
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+ + N +L + + ++ ++ I G+A++H
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 134
Query: 165 QPHVVHRDIKTSNILLD-------------QNFNPKISDFGLSKLFPENTTHISTR---V 208
++HRD+K NIL+ +N ISDFGL K + T
Sbjct: 135 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 209 AGTLGYLAPE-------YAISGRLTRKSDVYSFGVLLLEIVSG 244
+GT G+ APE RLTR D++S G + I+S
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-29
Identities = 47/219 (21%), Positives = 74/219 (33%), Gaps = 28/219 (12%)
Query: 44 FRWSNKIGEG--GFGSVYKGR-LQDGTIVAVKVLSVESKQGE--KEFMSEVASMANVNVC 98
+ IG+G +V R G V V+ +++E+ E E+ N
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-- 84
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR--- 155
H N+V I +V +M S + F I I +
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLI------CTHFMDGMNELAIAYILQGVL 138
Query: 156 -GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPE----NTTH-ISTRV 208
L YIH VHR +K S+IL+ + +S + + H
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 209 AGTLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
L +L+PE KSD+YS G+ E+ +G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 55/234 (23%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS---------------------VESKQGEKEFMS 87
IG+G +G V D T A+KVLS +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 88 -----EVASMANVNVCHENLVKLHGGCIDGPCR---ILVYDYMPNNSL----SQTLLGEE 135
E+A + ++ H N+VKL +D P +V++ + + + L E+
Sbjct: 81 EQVYQEIAILKKLD--HPNVVKLVE-VLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 136 KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
+ R F +++I GI Y+H + ++HRDIK SN+L+ ++ + KI+DFG+S
Sbjct: 138 QARFYF-----QDLIKGI----EYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLT----RKSDVYSFGVLLLEIVSGR 245
F + +S GT ++APE ++S + DV++ GV L V G+
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVK 104
K+G G +G V R A+K++ S + + EVA + ++ H N++K
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--HPNIMK 100
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
L+ D LV + L ++ R KF II + G+ Y+H+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH- 155
Query: 165 QPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
++VHRD+K N+LL +++ KI DFGLS +F GT Y+APE +
Sbjct: 156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VL 210
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
+ K DV+S GV+L +++G
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGY 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HEN 101
F +G G +G VYKGR ++ G + A+KV+ V E+E E+ + H N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKY--SHHRN 82
Query: 102 LVKLHGGCIDGPCRI------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
+ +G I LV ++ S++ + + K W A I I R
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILR 140
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLG 213
GL+++H+ V+HRDIK N+LL +N K+ DFG+S + + R GT
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPY 194
Query: 214 YLAPEYAISGRLTR-----KSDVYSFGVLLLEIVSG 244
++APE KSD++S G+ +E+ G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLH 106
IG+G F V R + G VA+K++ + ++ EV M +N H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HPNIVKLF 80
Query: 107 GGCIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYI 160
I+ + L+ +Y + L + E++ R+KF R+I+ + Y
Sbjct: 81 E-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF-----RQIVSAV----QYC 130
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H++ +VHRD+K N+LLD + N KI+DFG S F + G Y APE
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE-L 184
Query: 221 ISGRL--TRKSDVYSFGVLLLEIVSGR 245
G+ + DV+S GV+L +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
+ +G+G FG V K + AVKV++ ++K + EV + ++ H
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLD--H 80
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIG 154
N++KL D +V + G E +R +F II +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYT---------GGELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
G+ Y+H+ ++VHRD+K NILL +++ + KI DFGLS F +N GT
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGT 186
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+APE + G K DV+S GV+L ++SG
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVCHEN 101
+ IG G V VA+K +++E Q + + E+ +M+ + H N
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH--HPN 74
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR----GL 157
+V + + LV + S+ + + I I R GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTR---VAGTLG 213
Y+H+ +HRD+K NILL ++ + +I+DFG+S L + GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 214 YLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
++APE R K+D++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 47/209 (22%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
+ ++G+G FG VYK + + G + A KV+ +S++ ++++ E+ +A + H +
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYI 78
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
VKL G ++ ++ P ++ ++ E R + + L ++H
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVD-AIMLELDRGLTEPQIQV--VCRQMLEALNFLHS 135
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYA 220
+ ++HRD+K N+L+ + +++DFG+S +N + R GT ++APE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 221 ISGRLTR-----KSDVYSFGVLLLEIVSG 244
+ + K+D++S G+ L+E+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-28
Identities = 39/233 (16%), Positives = 78/233 (33%), Gaps = 32/233 (13%)
Query: 36 QLKIATNGFRWSNKIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGEKEFMSEV 89
+ ++ + + +GEG F VY+ ++ +K V+ EF
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK---VQKPANPWEFYIGT 115
Query: 90 ASMANVN-VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL-LGEEKRRAKFGWKARR 147
M + +K + + +LV + +L + L +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 148 EIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL-----------DQNFNPKISDFGLS-- 194
M + + +H+ ++H DIK N +L D + + D G S
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 195 -KLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
KLFP+ T + T G+ E +S + + D + + ++ G
Sbjct: 233 MKLFPKGTIFTA--KCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLS-------------VESKQGEKEFMSEVASMA 93
K+G G +G V + + A+KV+ ++ +E +E++ +
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
+++ H N++KL D LV ++ L + ++ R KF I+ I
Sbjct: 102 SLD--HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQI 155
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAG 210
G+ Y+H+ ++VHRDIK NILL + N KI DFGLS F ++ + G
Sbjct: 156 LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLG 210
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
T Y+APE + + K DV+S GV++ ++ G
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-28
Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 30/245 (12%)
Query: 9 SFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGT 67
+ + TIGG++ + N ++G G G V+K R + G
Sbjct: 4 GSSGKQTGYLTIGGQR------------YQAEINDLENLGEMGSGTCGQVWKMRFRKTGH 51
Query: 68 IVAVKVLSVESKQGE-KEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNS 126
++AVK + + E K + ++ + + +V+ G I + + M
Sbjct: 52 VIAVKQMRRSGNKEENKRILMDLDVVLK-SHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109
Query: 127 LSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186
+ + + + ++ + I + L Y+ E+ V+HRD+K SNILLD+
Sbjct: 110 AEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQI 164
Query: 187 KISDFGLS-KLFPENTTHISTRVAGTLGYLAPE-----YAISGRLTRKSDVYSFGVLLLE 240
K+ DFG+S +L R AG Y+APE ++DV+S G+ L+E
Sbjct: 165 KLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 241 IVSGR 245
+ +G+
Sbjct: 222 LATGQ 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
F K+GEG +GSVYK + G IVA+K + VES +E + E++ M + ++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCD--SPHV 86
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
VK +G +V +Y S+S ++ + A I+ +GL Y+H
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVS-DIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHF 143
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
+HRDIK NILL+ + K++DFG++ + +T + GT ++APE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 223 GRLTRKSDVYSFGVLLLEIVSG 244
+D++S G+ +E+ G
Sbjct: 200 IGYNCVADIWSLGITAIEMAEG 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKLHG 107
+GEG +G V VAVK++ ++ E + E+ +N HEN+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYG 72
Query: 108 GCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
L +Y L + E + F +++ G+ Y+H
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQLMAGV----VYLH 122
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEY 219
+ HRDIK N+LLD+ N KISDFGL+ +F N ++ GTL Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177
Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGR 245
+ R DV+S G++L +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 26/199 (13%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
IG G +G V A K + + F E+ M +++ H N+++L+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD--HPNIIRLYE 73
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHE 162
D LV + G E + F I+ + +AY H+
Sbjct: 74 TFEDNTDIYLVMELCT---------GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+V HRD+K N L + K+ DFGL+ F GT Y++P+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ- 178
Query: 220 AISGRLTRKSDVYSFGVLL 238
+ G + D +S GV++
Sbjct: 179 VLEGLYGPECDEWSAGVMM 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 34/210 (16%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVC 98
+G G V + AVK++ E ++ + + EV + V+
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG- 82
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIG 154
H N+++L LV+D M GE + + K R+I+ +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKK--------GELFDYLTEKVTLSEKETRKIMRALL 134
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
+ +H+ ++VHRD+K NILLD + N K++DFG S + GT Y
Sbjct: 135 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSY 189
Query: 215 LAPE------YAISGRLTRKSDVYSFGVLL 238
LAPE ++ D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 30/202 (14%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVK 104
+G+G FG V K + AVKV++ ++K + EV + ++ H N++K
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLD--HPNIMK 85
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAY 159
L D +V + G E +R +F II + G+ Y
Sbjct: 86 LFEILEDSSSFYIVGELYT---------GGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
+H+ ++VHRD+K NILL +++ + KI DFGLS F +NT GT Y+A
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIA 191
Query: 217 PEYAISGRLTRKSDVYSFGVLL 238
PE + G K DV+S GV+L
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVIL 212
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-27
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES-KQGEKEFMS----EVASMANVNVC-HE 100
+IG G +G+VYK R G VA+K + V + G EVA + + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 101 NLVKL----HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
N+V+L D ++ LV++++ + L L ++ + ++++ R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIKDLMRQFLR 131
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTLG 213
GL ++H +VHRD+K NIL+ K++DFGL++++ T V TL
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLW 184
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y APE + D++S G + E+ +
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-27
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 26/199 (13%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G F V+ + G + A+K + + +E+A + + HEN+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK--HENIVTLED 73
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHE 162
LV + G E R + K +I + + Y+HE
Sbjct: 74 IYESTTHYYLVMQLVS---------GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+VHRD+K N+L ++N I+DFGLSK+ + GT GY+APE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEV 178
Query: 220 AISGRLTRKSDVYSFGVLL 238
++ D +S GV+
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-EVASMANVNVCHENLVKLHG 107
+GEG +G V VAVK++ ++ E + E+ +N HEN+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYG 72
Query: 108 GCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
L +Y L + E + F +++ G+ Y+H
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQLMAGV----VYLH 122
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEY 219
+ HRDIK N+LLD+ N KISDFGL+ +F N ++ GTL Y+APE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177
Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGR 245
+ R DV+S G++L +++G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVAS 91
+ + N F IG GGFG VY R D G + A+K L ++ KQGE ++E
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 92 MANVN-VCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKAR 146
++ V+ +V + P ++ + D M L L +F + A
Sbjct: 243 LSLVSTGDCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAA- 299
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
EII+G L ++H VV+RD+K +NILLD++ + +ISD GL+ F + H
Sbjct: 300 -EIILG----LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--A 349
Query: 207 RVAGTLGYLAPEYAISGRLTRKS-DVYSFGVLLLEIVSGRT 246
V GT GY+APE G S D +S G +L +++ G +
Sbjct: 350 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 44/218 (20%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVL--------SVESKQGEKEFMSEVASMANVNVCHE 100
+G G FG V+ + V VK + + E+A ++ V H
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE--HA 89
Query: 101 NLVKLHGGCIDGPCRI-LV----------YDYMPNNSLSQTLLGEEKRRAKFGWKARREI 149
N++K+ + LV + ++ L E F R++
Sbjct: 90 NIIKVLD-IFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIF-----RQL 139
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
+ + Y+ + ++HRDIK NI++ ++F K+ DFG + T
Sbjct: 140 VSAV----GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYT-FC 190
Query: 210 GTLGYLAPEYAISGRLTR--KSDVYSFGVLLLEIVSGR 245
GT+ Y APE + G R + +++S GV L +V
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 29/232 (12%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCH 99
+G G G V + VA++++S +E+ + +N H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN--H 199
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
++K+ D +V + M L ++ + + + + Y
Sbjct: 200 PCIIKIKN-FFDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQY 254
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
+HE ++HRD+K N+LL +++ KI+DFG SK+ E + + T GT YLA
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLA 309
Query: 217 PE---YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 265
PE + R D +S GV+L +SG F + L D++ S
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKDQITS 359
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 42/199 (21%), Positives = 79/199 (39%), Gaps = 15/199 (7%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKV-----LSVESKQGEKEFMSEVASMANVNVCHENL 102
IG+G F V + + G AVK+ + ++ E + + H ++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK--HPHI 88
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
V+L +V+++M L ++ + + I L Y H+
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+++HRD+K +LL + + K+ FG++ E+ RV GT ++APE
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 220 AISGRLTRKSDVYSFGVLL 238
+ DV+ GV+L
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 16/194 (8%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+GEG F K + AVK++S K+ E E+ ++ H N+VKLH
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCE-GHPNIVKLHE 73
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
D LV + + L + + ++ F I+ + ++++H+
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---G 126
Query: 168 VVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR 224
VVHRD+K N+L + N KI DFG ++L P + + T TL Y APE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 225 LTRKSDVYSFGVLL 238
D++S GV+L
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMA 93
+ + F +G GGFG V+ +++ G + A K L+ ++ ++G + M E +A
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 94 NVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARR----E 148
V+ +V L + + LV M + + ++ F +
Sbjct: 241 KVH--SRFIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRV 208
I+ G L ++H+ ++++RD+K N+LLD + N +ISD GL+ T
Sbjct: 298 IVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
GT G++APE + D ++ GV L E+++ R
Sbjct: 351 -GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCH 99
F +IG G FG+VY R +++ +VA+K +S KQ ++ + EV + + H
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--H 113
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N ++ G + LV +Y ++ LL K+ + A + G +GLAY
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAA--VTHGALQGLAY 169
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTLGYLAPE 218
+H +++HRD+K NILL + K+ DFG + + P N+ GT ++APE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPE 220
Query: 219 YAISGRLTR---KSDVYSFGVLLLEIVSG 244
++ + K DV+S G+ +E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 37/213 (17%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENL 102
K+GEG +G VYK + G IVA+K + +++ E E + E++ + ++ H N+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH--HPNI 81
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
V L C LV+++M + L + L ++ + + + + RG+A+ H+
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE- 218
++HRD+K N+L++ + K++DFGL++ F P + TH V TL Y AP+
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDV 190
Query: 219 ------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+ S D++S G + E+++G+
Sbjct: 191 LMGSKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 48/224 (21%), Positives = 80/224 (35%), Gaps = 54/224 (24%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+GEG +G V + + AVK+L GE E+ + + H+N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR--HKNVIQ 70
Query: 105 LH-------------------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
L G + + D +P + F
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE------MLDSVPEKRFP-----VCQAHGYF---- 115
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HI 204
++I G+ Y+H +VH+DIK N+LL KIS G+++
Sbjct: 116 -CQLIDGL----EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 205 STRVAGTLGYLAPEYAISGRLT---RKSDVYSFGVLLLEIVSGR 245
G+ + PE +G T K D++S GV L I +G
Sbjct: 168 CRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMS--EVASMANVNVCHEN 101
+ +GEG F +VYK R IVA+K + + + K+ + E+ + ++ H N
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPN 73
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
++ L LV+D+M + L + + + ++ +GL Y+H
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 218
+ ++HRD+K +N+LLD+N K++DFGL+K F P TH +V T Y APE
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRAPE 182
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 48 NKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVC-H 99
+IGEG +G V+K R G VA+K + V++ +E M EVA + ++ H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEH 73
Query: 100 ENLVKL----HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
N+V+L D ++ LV++++ + L+ L ++ + ++++ +
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLL 130
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENTTHISTRVAGTL 212
RGL ++H VVHRD+K NIL+ + K++DFGL++++ T V TL
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TL 183
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y APE + D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
+G G FG V G G VAVK+L+ + S + E+ ++ H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--HPHIIKL 76
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAY 159
+ I P +V +Y+ L + + E + R F ++I+ + Y
Sbjct: 77 YQ-VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-----QQILSAV----DY 126
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
H + VVHRD+K N+LLD + N KI+DFGLS + + + T G+ Y APE
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT-SCGSPNYAAPE- 180
Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGR 245
ISGRL + D++S GV+L ++ G
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+GEG F +V R A+K+L ++ + E M+ ++ H VK
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLD--HPFFVK 94
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
L+ D Y N L + + +F + A EI+ + Y+
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRF-YTA--EIVSALE----YL 146
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR-VAGTLGYLAPEY 219
H + ++HRD+K NILL+++ + +I+DFG +K+ + GT Y++PE
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRT 246
+ SD+++ G ++ ++V+G
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMA 93
+ N FR +G+GGFG V +++ G + A K L ++ ++GE ++E +
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 94 NVNVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSL-------SQTLLGEEKRRAKFGWKA 145
VN +V L + + LV M L Q E RA F + A
Sbjct: 240 KVN--SRFVVSLAY-AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--RAVF-YAA 293
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
EI G L +H E +V+RD+K NILLD + + +ISD GL+ PE T I
Sbjct: 294 --EICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IK 343
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
RV GT+GY+APE + R T D ++ G LL E+++G+
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 37/236 (15%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCH 99
+G G G V + VA+K++S +E+ + +N H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN--H 74
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGR 155
++K+ D +V + M GE +K + + +
Sbjct: 75 PCIIKIKN-FFDAEDYYIVLELMEG--------GELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
+ Y+HE ++HRD+K N+LL +++ KI+DFG SK+ E + + T GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTP 180
Query: 213 GYLAPE---YAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRS 265
YLAPE + R D +S GV+L +SG F + L D++ S
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKDQITS 234
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 33/209 (15%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLS--------VESKQGEKEFMSEVASMANVNVCH 99
IG G V + G AVK++ + ++ + E + V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG-H 159
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGR 155
+++ L LV+D M GE + + K R I+ +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRK--------GELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
++++H ++VHRD+K NILLD N ++SDFG S + GT GYL
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYL 266
Query: 216 APE------YAISGRLTRKSDVYSFGVLL 238
APE ++ D+++ GV+L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 23/181 (12%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS----EVASMANVNVCHENL 102
K+G G + +VYKG G VA+K + ++S++G S E++ M + HEN+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELK--HENI 65
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTL--LGEEKRRAKFGWKARREIIMGIGRGLAYI 160
V+L+ LV+++M N+ L + + + + +GLA+
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAP 217
HE ++HRD+K N+L+++ K+ DFGL++ F P NT + V TL Y AP
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAP 177
Query: 218 E 218
+
Sbjct: 178 D 178
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
IG+G FG V + D + A+K ++ VE + E+ M + H LV
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR-NVFKELQIMQGLE--HPFLVN 79
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
L D +V D + L + L + K + E++M L Y+
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKL-FIC--ELVMA----LDYL 131
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
+ ++HRD+K NILLD++ + I+DF ++ + P T + +AGT Y+APE
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 221 ISGRL---TRKSDVYSFGVLLLEIVSGRT 246
S + + D +S GV E++ GR
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 44/180 (24%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHEN 101
KIGEG +G+V+K + + IVA+K + ++ + E + E+ + + H+N
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELK--HKN 62
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+V+LH LV+++ + L + + + + + + +GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE 218
+V+HRD+K N+L+++N K+++FGL++ F P + V TL Y P+
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPD 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.9 bits (250), Expect = 5e-25
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHENL 102
KIGEG +G VYK + G A+K + +E E E + E++ + + H N+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELK--HSNI 62
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
VKL+ +LV++++ + L + L + + ++ + G+AY H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYLAPE- 218
V+HRD+K N+L+++ KI+DFGL++ F P TH + TL Y AP+
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDV 171
Query: 219 ------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+ + D++S G + E+V+G
Sbjct: 172 LMGSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 8e-25
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
+GEG +G V K R G IVA+K + S + K +K M E+ + + HENLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--HENLVN 88
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEE 163
L C LV++++ T+L + E ++ ++ + I G+ + H
Sbjct: 89 LLEVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
+++HRDIK NIL+ Q+ K+ DFG ++ VA T Y APE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-25
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVK--VLSVESKQGEKEFMSEVASMANVNVCHENLVK 104
KIGEG +G V+K R G IVA+K + S + +K + E+ + + H NLV
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--HPNLVN 66
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEE 163
L LV++Y T+L E ++ + + I + + + H+
Sbjct: 67 LLEVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
+ +HRD+K NIL+ ++ K+ DFG ++L + + VA T Y +PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
IG G FG R +VAVK + + E E+ + ++ H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLR--HPNIVRFKE- 83
Query: 109 CIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
I P + ++ +Y L + + E++ R F ++++ G+ +Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-----QQLLSGV----SYCHS 134
Query: 163 EIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
+ HRD+K N LLD + P KI DFG SK + + + V GT Y+APE
Sbjct: 135 M---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPE-V 188
Query: 221 ISGRL--TRKSDVYSFGVLLLEIVSGR 245
+ + + +DV+S GV L ++ G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 25/205 (12%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
+GEG V L AVK++ + EV + H N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-GHRNVLELIEF 79
Query: 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168
+ LV++ M S+ L +R F ++ + L ++H +
Sbjct: 80 FEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGI 132
Query: 169 VHRDIKTSNILL---DQNFNPKISDFGLSKLFPEN-------TTHISTRVAGTLGYLAPE 218
HRD+K NIL +Q KI DF L N T + T G+ Y+APE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPE 191
Query: 219 -----YAISGRLTRKSDVYSFGVLL 238
+ ++ D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 25/199 (12%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
++G G FG V++ G + K ++ + +E++ M ++ H L+ LH
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHD 115
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIH 161
D +L+ +++ G E K + GL ++H
Sbjct: 116 AFEDKYEMVLILEFLS---------GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
E +VH DIK NI+ + KI DFGL+ + T + APE
Sbjct: 167 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEI 221
Query: 220 AISGRLTRKSDVYSFGVLL 238
+ +D+++ GVL
Sbjct: 222 VDREPVGFYTDMWAIGVLG 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 59/225 (26%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKL 105
IG G FG VY+ +L D G +VA+K VL +K F + E+ M ++ H N+V+L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLD--HCNIVRL 112
Query: 106 H------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG------- 152
G D LV DY+P +T+ R A+ +A++ + +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP-----ETV----YRVARHYSRAKQTLPVIYVKLYMY 163
Query: 153 -IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTR 207
+ R LAYIH + HRDIK N+LLD + K+ DFG +K N ++I +R
Sbjct: 164 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 208 VAGTLGYLAPE-------YAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y APE Y T DV+S G +L E++ G+
Sbjct: 221 Y-----YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 30/208 (14%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
+G G FG V G+ G VAVK+L+ + S + E+ ++ H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR--HPHIIKL 81
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIGRGLAY 159
+ I P I +V +Y+ L + L E++ R F ++I+ G+ Y
Sbjct: 82 YQ-VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-----QQILSGV----DY 131
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
H + VVHRD+K N+LLD + N KI+DFGLS + + + T G+ Y APE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPE- 185
Query: 220 AISGRL--TRKSDVYSFGVLLLEIVSGR 245
ISGRL + D++S GV+L ++ G
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 13/193 (6%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
++G G FG V++ G A K + + ++ E+ +M+ + H LV LH
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHD 221
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
D +++Y++M L + + E K E + + +GL ++HE +
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 168 VVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
VH D+K NI+ + K+ DFGL+ + GT + APE A +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPV 333
Query: 226 TRKSDVYSFGVLL 238
+D++S GVL
Sbjct: 334 GYYTDMWSVGVLS 346
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 39/212 (18%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+GEG FG V + VA+K +S +S + E++ + + H +++K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLR--HPHIIK 73
Query: 105 LHGGCIDGPCRI-LV--------YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
L+ I P I +V +DY+ + + + E++ R F ++II I
Sbjct: 74 LYD-VITTPTDIVMVIEYAGGELFDYI----VEKKRMTEDEGRRFF-----QQIICAI-- 121
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
Y H + +VHRD+K N+LLD N N KI+DFGLS + + + T G+ Y
Sbjct: 122 --EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT-SCGSPNYA 174
Query: 216 APEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
APE I+G+L + DV+S G++L ++ GR
Sbjct: 175 APE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-24
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 25/200 (12%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
++G+G F V + G A K+++ + S + ++ E + H N+V+L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRL 70
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGLAYIH 161
H + LV+D + GE E R + I I +AY H
Sbjct: 71 HDSIQEESFHYLVFDLVTG--------GELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 162 EEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
+VHR++K N+LL + K++DFGL+ ++ AGT GYL+PE
Sbjct: 123 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE 177
Query: 219 YAISGRLTRKSDVYSFGVLL 238
++ D+++ GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 26/202 (12%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
++G G F V + G A K L + E + E+A + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-SCPRVINL 94
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGLAY 159
H + IL+ +Y GE + +I I G+ Y
Sbjct: 95 HEVYENTSEIILILEYAAG--------GEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 160 IHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
+H+ ++VH D+K NILL + KI DFG+S+ + + GT YLA
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEYLA 201
Query: 217 PEYAISGRLTRKSDVYSFGVLL 238
PE +T +D+++ G++
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-24
Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 24/183 (13%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEF----MSEVASMANVNVC 98
+ +K+GEG + +VYKG+ +VA+K + +E ++G + EV+ + ++
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK-- 58
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
H N+V LH LV++Y+ + L Q L + + + + RGLA
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLA 114
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-THISTRVAGTLGYL 215
Y H + V+HRD+K N+L+++ K++DFGL++ P T + V TL Y
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYR 167
Query: 216 APE 218
P+
Sbjct: 168 PPD 170
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-24
Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G FG V+K G +A K++ + ++E +E++ M ++ H NL++L+
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--HANLIQLYD 153
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIH 161
+LV +Y+ G E + I G+ ++H
Sbjct: 154 AFESKNDIVLVMEYVD---------GGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+ +++H D+K NIL KI DFGL++ + + GT +LAPE
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEV 259
Query: 220 AISGRLTRKSDVYSFGVLL 238
++ +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-24
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 47 SNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG G + + AVK++ +SK+ E E+ + H N++ L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRY-GQHPNIITL 81
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
DG +V + M L +L R+ F + ++ I + + Y+H +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ-- 135
Query: 166 PHVVHRDIKTSNILL-DQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
VVHRD+K SNIL D++ NP +I DFG +K + T T ++APE
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV-- 191
Query: 222 SGRLTRKS-----DVYSFGVLL 238
L R+ D++S GVLL
Sbjct: 192 ---LERQGYDAACDIWSLGVLL 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-24
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 46/218 (21%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVK-VLSVESKQGEKEFMS-EVASMANVNVCHENLVKLH 106
IG G FG V++ +L + VA+K VL +K F + E+ M V H N+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVK--HPNVVDLK 98
Query: 107 ------GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG-------- 152
G D LV +Y+P +T+ R ++ K ++ + M
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVP-----ETV----YRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-KISDFGLSKLF---PENTTHISTRV 208
+ R LAYIH + HRDIK N+LLD K+ DFG +K+ N ++I +R
Sbjct: 150 LLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 209 AGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
Y APE T D++S G ++ E++ G+
Sbjct: 207 -----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 8e-24
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVES--KQGEKE-FMSEVA 90
Q+++ F IG G FG V +L++ + A+K+L+ K+ E F E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKAR 146
+ N + + + LH D LV DY L L E R A+F + A
Sbjct: 127 VLVNGD--SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF-YLA- 182
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIST 206
E+++ I +H+ H VHRDIK NIL+D N + +++DFG E+ T S+
Sbjct: 183 -EMVIAID----SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 207 RVAGTLGYLAPE-----YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
GT Y++PE GR + D +S GV + E++ G T
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 45/201 (22%), Positives = 81/201 (40%), Gaps = 26/201 (12%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
++G+G F V + + G A +++ + S + ++ E + H N+V+L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK--HPNIVRL 75
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYI 160
H + L++D + G E R + I I + +
Sbjct: 76 HDSISEEGHHYLIFDLVT---------GGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
H+ VVHR++K N+LL + K++DFGL+ GT GYL+P
Sbjct: 127 HQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182
Query: 218 EYAISGRLTRKSDVYSFGVLL 238
E + D+++ GV+L
Sbjct: 183 EVLRKDPYGKPVDLWACGVIL 203
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 8e-24
Identities = 55/246 (22%), Positives = 85/246 (34%), Gaps = 54/246 (21%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKV-----LSVESKQGEKEFMSEVASMANVNVCHENL 102
IG+G +G V Q I A+K+ + + + + +EV M ++ H N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH--HPNI 90
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR---------------- 146
+L+ D LV + L L
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 147 --------------------REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL--DQNF 184
I+ I L Y+H + + HRDIK N L +++F
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207
Query: 185 NPKISDFGLSKLFPENTTHISTR---VAGTLGYLAPE--YAISGRLTRKSDVYSFGVLLL 239
K+ DFGLSK F + AGT ++APE + K D +S GVLL
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 240 EIVSGR 245
++ G
Sbjct: 268 LLLMGA 273
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 27/201 (13%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
++G+G F V + G A K+++ + S + ++ E + H N+V+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRL 93
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYI 160
H + LV+D + G E R + I I +AY
Sbjct: 94 HDSIQEESFHYLVFDLVT---------GGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 161 HEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
H +VHR++K N+LL + K++DFGL+ ++ AGT GYL+P
Sbjct: 145 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSP 199
Query: 218 EYAISGRLTRKSDVYSFGVLL 238
E ++ D+++ GV+L
Sbjct: 200 EVLKKDPYSKPVDIWACGVIL 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 31/185 (16%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS-----EVASMANVNVCHEN 101
K+GEG +G VYK VA+K + +E E+E + EV+ + + H N
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQ--HRN 94
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+++L L+++Y N+ L + + + + + + + G+ + H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP-----KISDFGLSKLF--PENT-THISTRVAGTLG 213
+HRD+K N+LL + KI DFGL++ F P TH + TL
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLW 202
Query: 214 YLAPE 218
Y PE
Sbjct: 203 YRPPE 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-23
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 54/228 (23%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMS--EVASMANVNVCHEN 101
KIG+G FG V+K R + G VA+K + +E+ EKE + E+ + + HEN
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLK--HEN 77
Query: 102 LVKLHGGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
+V L C LV+D+ ++ L+ L KF + ++ +
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRVMQML 133
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF--PENT-----THIST 206
GL YIH ++HRD+K +N+L+ ++ K++DFGL++ F +N+ T+
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN--- 187
Query: 207 RVAGTLGYLAPE-------Y--AISGRLTRKSDVYSFGVLLLEIVSGR 245
RV TL Y PE Y I D++ G ++ E+ +
Sbjct: 188 RVV-TLWYRPPELLLGERDYGPPI--------DLWGAGCIMAEMWTRS 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-23
Identities = 44/204 (21%), Positives = 84/204 (41%), Gaps = 34/204 (16%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G G V + + G A+K+L + EV + ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY---DS--PKARQEVDHHWQASG-GPHIVCILD 89
Query: 108 GCIDG----PCRILVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGL 157
+ C +++ + M GE E+ F + EI+ IG +
Sbjct: 90 VYENMHHGKRCLLIIMECMEG--------GELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 158 AYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
++H ++ HRD+K N+L +++ K++DFG +K +N + T T Y
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYY 195
Query: 215 LAPEYAISGRLTRKSDVYSFGVLL 238
+APE + + D++S GV++
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-23
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
++G G VY+ + A+KVL +K +E+ + ++ H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLS--HPNIIKLKE 115
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRGLAYIHE 162
LV + + G E + + + + + I +AY+HE
Sbjct: 116 IFETPTEISLVLELVT---------GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 163 EIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+VHRD+K N+L + KI+DFGLSK+ V GT GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEI 221
Query: 220 AISGRLTRKSDVYSFGVLL 238
+ D++S G++
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 30/205 (14%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSV------ESKQGEKEFMSEVASMANVNVCHEN 101
++G G F V K R G A K + +E EV+ + V H N
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL--HHN 76
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGL 157
++ LH + +L+ + + GE + ++ + I I G+
Sbjct: 77 VITLHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
Y+H + + H D+K NI+L P K+ DFGL+ + + GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLL 238
++APE L ++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
IG G FG V R + + A+K+LS ++ F E MA N +V+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFAN--SPWVVQ 133
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIH 161
L D +V +YMP L L+ + A+F + A E+++ + IH
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARF-YTA--EVVLALD----AIH 185
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE--- 218
+HRD+K N+LLD++ + K++DFG + GT Y++PE
Sbjct: 186 SM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 219 -YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
G R+ D +S GV L E++ G T
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 32/199 (16%), Positives = 71/199 (35%), Gaps = 26/199 (13%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G FG V++ K + V + E++ + H N++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIAR--HRNILHLHE 68
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEE------KRRAKFGWKARREIIMGIGRGLAYIH 161
+++++++ G + + + + + L ++H
Sbjct: 69 SFESMEELVMIFEFIS---------GLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
++ H DI+ NI+ + KI +FG ++ + Y APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEV 174
Query: 220 AISGRLTRKSDVYSFGVLL 238
++ +D++S G L+
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 53/246 (21%), Positives = 101/246 (41%), Gaps = 39/246 (15%)
Query: 21 GGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVK-VLSVES 78
G + N A + + + + F+ G+G FG+V G+ + G VA+K V+
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 79 -KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR--------ILVYDYMPNNSLSQ 129
+ E + M ++A + H N+V+L +V +Y+P
Sbjct: 62 FRNRELQIMQDLAVLH-----HPNIVQLQS-YFYTLGERDRRDIYLNVVMEYVP-----D 110
Query: 130 TLLGEEKRRAKFGWKARREIIMG--------IGRGLAYIHEEIQPHVVHRDIKTSNILLD 181
TL R + ++ + + R + +H +V HRDIK N+L++
Sbjct: 111 TL----HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVN 165
Query: 182 -QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLL 239
+ K+ DFG +K + +++ + + Y APE + T D++S G +
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEPNVAY-IC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFA 223
Query: 240 EIVSGR 245
E++ G
Sbjct: 224 EMMLGE 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 32/206 (15%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVL------SVESKQGEKEFMSEVASMANVNVCHEN 101
++G G F V K R G A K + S ++ EV+ + + H N
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPN 75
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEE-----KRRAKFGWKARREIIMGIGRG 156
++ LH + IL+ + + G E + + E + I G
Sbjct: 76 VITLHEVYENKTDVILILELVA---------GGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 157 LAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
+ Y+H + H D+K NI+L KI DFGL+ + GT
Sbjct: 127 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTP 181
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLL 238
++APE L ++D++S GV+
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-22
Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 30/205 (14%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVL------SVESKQGEKEFMSEVASMANVNVCHEN 101
++G G F V K R G A K + S +E EV + + H N
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR--HPN 69
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGL 157
++ LH + +L+ + + GE + + + + I G+
Sbjct: 70 IITLHDIFENKTDVVLILELVSG--------GELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
Y+H + + H D+K NI+L P K+ DFG++ + GT
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPE 176
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLL 238
++APE L ++D++S GV+
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 30/205 (14%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSV------ESKQGEKEFMSEVASMANVNVCHEN 101
++G G F V K R G A K + +E EV+ + V H N
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL--HPN 76
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE--EK--RRAKFGWKARREIIMGIGRGL 157
++ LH + +L+ + + GE + ++ + I I G+
Sbjct: 77 IITLHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLG 213
Y+H + + H D+K NI+L P K+ DFGL+ + + GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLL 238
++APE L ++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 51/227 (22%)
Query: 49 KIGEGGFGSVYKGRLQD---GTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHEN 101
K+G G +G VYK + +D A+K + S E + E+ H N
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK--------HPN 79
Query: 102 LVKLHGGCID-GPCRI-LVYDYMPNNSLSQTL-----LGEEKRRAKFGWKARREIIMGIG 154
++ L + ++ L++DY ++ L + K+ + + ++ I
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLF--PENT-THISTR 207
G+ Y+H V+HRD+K +NIL+ KI+D G ++LF P +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 208 VAGTLGYLAPE-------Y--AISGRLTRKSDVYSFGVLLLEIVSGR 245
V T Y APE Y AI D+++ G + E+++
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAI--------DIWAIGCIFAELLTSE 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG G F V +++ G + A+K+++ + + F E + N + + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQL 126
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYIH 161
H D LV +Y L L +R A+F + A EI+M I +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF-YLA--EIVMAID----SVH 179
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE--- 218
VHRDIK NILLD+ + +++DFG + T S GT YL+PE
Sbjct: 180 RL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 219 ----YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
+G + D ++ GV E+ G+T
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+G G FG V + ++ G A+K+L V+ KQ E ++E + VN LVK
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVN--FPFLVK 105
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
L D +V +Y+ + + L R A+F + A +I++ Y+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIGRFSEPHARF-YAA--QIVLT----FEYL 157
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H +++RD+K N+L+DQ +++DFG +K T T + GT LAPE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WT-LCGTPEALAPEII 210
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRT 246
+S + D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 43/204 (21%), Positives = 81/204 (39%), Gaps = 33/204 (16%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G G V + + A+K+L K EV + ++V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS-QCPHIVRIVD 122
Query: 108 GCIDGPCRI----LVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRGL 157
+ +V + + GE ++ F + EI+ IG +
Sbjct: 123 VYENLYAGRKCLLIVMECLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 158 AYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
Y+H ++ HRD+K N+L N K++DFG +K + + ++T T Y
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229
Query: 215 LAPEYAISGRLTRKSDVYSFGVLL 238
+APE + + D++S GV++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-21
Identities = 20/204 (9%), Positives = 50/204 (24%), Gaps = 49/204 (24%)
Query: 49 KIGEGGFGSVYKGRLQD---GTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCHENL 102
G ++ D VA+ + + + +E +S ++ ++ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID--KPGV 93
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIH 161
++ ++V +++ SL + A + + H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-------IRAMQSLAAAADAAH 146
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
V S + +S G L +
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA--- 179
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
+ D+ G L ++ R
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-21
Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 27/206 (13%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS----VESKQGEKEFMSEVASMANVNVCHENLVK 104
+G G FG V+ R + G A+KVL V KQ E E ++ V H +++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HTNDERLMLSIVT--HPFIIR 70
Query: 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLAYI 160
+ G D ++ DY+ L +LL + +R AKF + A E+ + L Y+
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELF-SLLRKSQRFPNPVAKF-YAA--EVCLA----LEYL 122
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H + +++RD+K NILLD+N + KI+DFG +K P+ T T + GT Y+APE
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YT-LCGTPDYIAPEVV 175
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRT 246
+ + D +SFG+L+ E+++G T
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 4e-21
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V + + AVK+L VE EK ++
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-------P 401
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
L +LH C R+ V +Y+ L + + A F + A EI +G
Sbjct: 402 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG--- 454
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
L ++ + +++RD+K N++LD + KI+DFG+ K ++ TT T GT
Sbjct: 455 -LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPD 507
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+APE + D ++FGVLL E+++G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V + + AVK+L VE EK ++
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-------P 80
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
L +LH C R+ V +Y+ L + + A F + A EI +G
Sbjct: 81 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG--- 133
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
L ++ + +++RD+K N++LD + KI+DFG+ K ++ TT T GT
Sbjct: 134 -LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPD 186
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+APE + D ++FGVLL E+++G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-20
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 41/214 (19%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
IG G + V RL+ I A++V+ ++ Q EK + ++ H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 112
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
LV LH C R+ V +Y+ L Q L EE A+F + A EI +
Sbjct: 113 PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA- 165
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGT 211
L Y+HE +++RD+K N+LLD + K++D+G+ K L P +TT T GT
Sbjct: 166 ---LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGT 216
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+APE D ++ GVL+ E+++GR
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-20
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 41/214 (19%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
IG G + V RL+ I A+KV+ ++ Q EK + ++ H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 69
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
LV LH C R+ V +Y+ L Q L EE A+F + A EI +
Sbjct: 70 PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA- 122
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGT 211
L Y+HE +++RD+K N+LLD + K++D+G+ K L P +TT T GT
Sbjct: 123 ---LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGT 173
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+APE D ++ GVL+ E+++GR
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V+ + A+K L VE EK +S H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-------H 77
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
L + + V +Y+ L + K RA F + A EII+G+
Sbjct: 78 PFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAA--EIILGLQ- 132
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
++H + +V+RD+K NILLD++ + KI+DFG+ K + + T +T GT
Sbjct: 133 ---FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTPD 183
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+APE + + D +SFGVLL E++ G+
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 37/212 (17%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V R+++ G + AVKVL VE EK +S + H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 83
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
L +L C P R+ V +++ L + + RA+F + A EII
Sbjct: 84 PFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAA--EIISA--- 136
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
L ++H++ +++RD+K N+LLD + K++DFG+ K + TT +T GT
Sbjct: 137 -LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPD 189
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y+APE D ++ GVLL E++ G
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEF---MSEVASMANVNVCHENLVKL 105
+G+G FG V + + G A+K+L E + E ++E + N H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTAL 213
Query: 106 HGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIH 161
R+ V +Y L L E RA+F + A EI+ L Y+H
Sbjct: 214 KY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGA--EIVSA----LDYLH 265
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
E VV+RD+K N++LD++ + KI+DFGL K ++ + T GT YLAPE
Sbjct: 266 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLE 322
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
R D + GV++ E++ GR
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 66/212 (31%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
IG+G FG V R + AVKVL + E+ + + NV H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-------NVKH 98
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
LV LH ++ V DY+ L L E RA+F + A EI +G
Sbjct: 99 PFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAA--EIASALG- 153
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
Y+H ++V+RD+K NILLD + ++DFGL K + +TT ST GT
Sbjct: 154 ---YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPE 204
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
YLAPE R D + G +L E++ G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 63/212 (29%), Positives = 88/212 (41%), Gaps = 38/212 (17%)
Query: 50 IGEGGFGSVYKGRLQD-GTIVAVKVLS---------VESKQGEKEFMSEVASMANVNVCH 99
+G+G FG V R + G A+K+L V E + N H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--------NTRH 64
Query: 100 ENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGR 155
L L R+ V +Y L L E RA+F + A EI+
Sbjct: 65 PFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIVSA--- 117
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLG 213
L Y+H VV+RDIK N++LD++ + KI+DFGL K + T T GT
Sbjct: 118 -LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-FCGTPE 170
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
YLAPE R D + GV++ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 30/209 (14%)
Query: 50 IGEGGFGSVY----KGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLV 103
+G+G FG V+ + A+KVL + + E + VN H +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIV 89
Query: 104 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREIIMGIGRGLA 158
KLH ++ L+ D++ L T L +E KF + A E+ + L
Sbjct: 90 KLHY-AFQTEGKLYLILDFLRGGDLF-TRLSKEVMFTEEDVKF-YLA--ELALA----LD 140
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYLA 216
++H +++RD+K NILLD+ + K++DFGLSK + E + + GT+ Y+A
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--S-FCGTVEYMA 194
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
PE T+ +D +SFGVL+ E+++G
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 45/240 (18%), Positives = 85/240 (35%), Gaps = 57/240 (23%)
Query: 49 KIGEGGFGSVYKGRLQD-GTIVAVK--------------------------VLSVESKQG 81
+G G FG V + + G A+K ++ G
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73
Query: 82 EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI------LVYDYMPNNSLSQTLLGEE 135
++E + + +N + ++ +Y+P TL
Sbjct: 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-----DTL---- 124
Query: 136 KRRAKFGWKARREI--------IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP- 186
+ K ++ R I I + R + +IH + HRDIK N+L++ N
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181
Query: 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
K+ DFG +K + ++ + + Y APE + T D++S G + E++ G+
Sbjct: 182 KLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 60/265 (22%), Positives = 108/265 (40%), Gaps = 39/265 (14%)
Query: 2 KSIFSCFSFPSRVSAENTIGGEQILKNINAFSYNQLKIATNGF----RWSN--KIGEGGF 55
I C F +V + K+ + +++ + F R+ N IG G
Sbjct: 16 VKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQ 75
Query: 56 GSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112
G V VA+K LS +++ K E+ M VN H+N++ L +
Sbjct: 76 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLN--VFT 131
Query: 113 PCR--------ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
P + LV + M N L Q + + + + ++ + G+ ++H
Sbjct: 132 PQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSA- 183
Query: 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAPEYAI 221
++HRD+K SNI++ + KI DFGL++ + T ++ TR Y APE +
Sbjct: 184 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVIL 236
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRT 246
D++S G ++ E+V +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 50 IGEGGFGSVY---KGRLQD-GTIVAVKVL---SVESKQGEKEF-MSEVASMANVNVCHEN 101
+G+GG+G V+ K + G I A+KVL + + +E + V H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--HPF 82
Query: 102 LVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGL 157
+V L ++ L+ +Y+ L L E A F + A EI M L
Sbjct: 83 IVDLIY-AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLA--EISMA----L 134
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK--LFPENTTHISTRVAGTLGYL 215
++H++ +++RD+K NI+L+ + K++DFGL K + TH T GT+ Y+
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH--T-FCGTIEYM 188
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
APE + R D +S G L+ ++++G
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-18
Identities = 47/207 (22%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
K+G G + V++ + + V VK+L K K+ E+ + N+ N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLR-GGPNIITLA 97
Query: 107 GGCIDGPCR--ILVYDYMPN---NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
D R LV++++ N L QTL + R + I + L Y H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF----------YMYEILKALDYCH 147
Query: 162 EEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
++HRD+K N+++D ++ ++ D+GL++ + + + RVA + + PE
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPELL 202
Query: 221 ISGRLTRKS-DVYSFGVLLLEIVSGRT 246
+ ++ S D++S G +L ++ +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.9 bits (196), Expect = 1e-17
Identities = 45/267 (16%), Positives = 86/267 (32%), Gaps = 54/267 (20%)
Query: 27 KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK------- 79
K FS+ + T + KIGEG FG V++ D T VA+K++++E
Sbjct: 8 KGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 80 -QGEKEFMSEVASM-------ANVNVCHENLVKLHGGCI----DGPCRILVYDYMPNNSL 127
+ +E + E+ V E + L+ P + +D+ +
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 128 SQ---------------------TLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
S + E+ R + I+ + LA +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
HRD+ N+LL + K+ K + + + +Y +S
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII--------DYTLSRLER 233
Query: 227 RKSDVYSFGVLLLEIVSGRTAVDFDVQ 253
V+ + ++ +G FD+
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDIY 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
IG G G V VA+K LS +++ K E+ M VN H+N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLL 90
Query: 107 GGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
+ P + +V + M N L Q + + + + ++ + G+
Sbjct: 91 N--VFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIK 141
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYL 215
++H ++HRD+K SNI++ + KI DFGL++ + T ++ TR Y
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YR 193
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
APE + D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-17
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 40/217 (18%)
Query: 50 IGEGGFGSVY---KGRLQD-GTIVAVKVLS----------VESKQGEKEFMSEVASMANV 95
+G G +G V+ K D G + A+KVL E + E++ + +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ---- 117
Query: 96 NVCHENLVKLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKR----RAKFGWKARREII 150
LV LH ++ L+ DY+ L T L + +R + + EI+
Sbjct: 118 ---SPFLVTLHY-AFQTETKLHLILDYINGGELF-THLSQRERFTEHEVQI-YVG--EIV 169
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAG 210
+ L ++H+ +++RDIK NILLD N + ++DFGLSK F + T + G
Sbjct: 170 LA----LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 211 TLGYLAPEYAISGRL--TRKSDVYSFGVLLLEIVSGR 245
T+ Y+AP+ G + D +S GVL+ E+++G
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-17
Identities = 48/225 (21%), Positives = 87/225 (38%), Gaps = 48/225 (21%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVK--VLSVESKQGEKEFMS---------EVASMANVNV 97
I G +G+V G +G VA+K +V + E+ + + +
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH- 87
Query: 98 CHENLVKLHGGCIDGPCRI-------LVYDYMPNN-----SLSQTLLGEEKRRAKFGWKA 145
H N++ L I LV + M + + ++ + ++
Sbjct: 88 -HPNILGLRD--IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ--HIQY---- 138
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TT 202
+ I GL +HE VVHRD+ NILL N + I DF L++ + T
Sbjct: 139 ---FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 203 HISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
+++ R Y APE + T+ D++S G ++ E+ + +
Sbjct: 193 YVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 54/266 (20%), Positives = 87/266 (32%), Gaps = 73/266 (27%)
Query: 48 NKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEK-------EFMSEVASMAN 94
+G G FG V + VAVK+L + E + + + N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 95 VN----VC-----------------------HENLVKLHGGCIDGPCRILVYDYM----- 122
V C + G DY+
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 123 ----------PNNSLSQTLLGEEKRRAKFGWKARREIIMG--------------IGRGLA 158
+ S + + EEK + + E + + +G+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT-LGYLAP 217
++ +HRD+ NILL + KI DFGL++ ++ ++ A L ++AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVS 243
E T +SDV+SFGVLL EI S
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 38/215 (17%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVK 104
+G G +GSV + G VA+K LS +S+ K E+ + ++ HEN++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIG 87
Query: 105 LHGGCIDGPCRI--------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
L + P LV +M + E+ + ++ +
Sbjct: 88 LLD--VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY----------LVYQM 135
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTL 212
+GL YIH VVHRD+K N+ ++++ KI DFGL++ E T ++ TR
Sbjct: 136 LKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW---- 188
Query: 213 GYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
Y APE +S + D++S G ++ E+++G+T
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 31/210 (14%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G +G+V + G VA+K L +S+ K E+ + ++ HEN++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLL 90
Query: 107 GGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
+ P LV +M + L + + + K G + ++ + +GL
Sbjct: 91 D--VFTPDETLDDFTDFYLVMPFMGTD-LGKLM-----KHEKLGEDRIQFLVYQMLKGLR 142
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGYLAP 217
YIH ++HRD+K N+ ++++ KI DFGL++ E T ++ TR Y AP
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAP 194
Query: 218 EYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
E ++ R T+ D++S G ++ E+++G+T
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKL 105
+ IGEG +G V + VA+K +S E + + + E+ + HEN++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGI 90
Query: 106 HGGCIDGPCRI-------LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
+ I I +V D M + L +Q L + + I
Sbjct: 91 ND--IIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHL---SNDHICY-------FLYQI 137
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN-------TTHIST 206
RGL YIH +V+HRD+K SN+LL+ + KI DFGL+++ + T +++T
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 207 RVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
R Y APE ++ T+ D++S G +L E++S R
Sbjct: 195 R-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-15
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 27/227 (11%)
Query: 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
S L + N FR KIG G FG + G+ L VA+K +E + +
Sbjct: 1 SMGVLMVGPN-FRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYR 56
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYM-PNNSLSQTLLGEEKRRAKFGWKARREII 150
+ + +++ G +V + + P SL L R F K I
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP--SLED-LFDLCDR--TFSLKTVLMIA 111
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK-----ISDFGLSKLF--PENTTH 203
+ + + Y+H + ++++RD+K N L+ + N I DF L+K + PE H
Sbjct: 112 IQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
Query: 204 ISTR----VAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
I R + GT Y G+ +R+ D+ + G + + + G
Sbjct: 169 IPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL-- 105
+G GG G V+ VA+K + + Q K + E+ + ++ H+N+VK+
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVFE 75
Query: 106 -----HGGCIDGPCRI-------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREII 150
D + +V +YM N L Q L EE A+ +
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE--HARL-------FM 126
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLF---PENTTHIST 206
+ RGL YIH +V+HRD+K +N+ ++ ++ KI DFGL+++ + H+S
Sbjct: 127 YQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 207 RVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRT 246
+ T Y +P +S T+ D+++ G + E+++G+T
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 52/226 (23%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSV-ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+GEG +G V G IVA+K + + + E+ + + HEN++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK--HENIITIF 75
Query: 107 GGCIDGPCRI-------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
I P ++ + M + +S +L ++ ++ I R
Sbjct: 76 N--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD--HIQY-------FIYQTLRA 124
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--------------TT 202
+ +H +V+HRD+K SN+L++ N + K+ DFGL+++ E+
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 203 HISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGR 245
++TR Y APE + S + +R DV+S G +L E+ R
Sbjct: 182 FVATR-----WYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G +GSV + G VAVK LS +S K E+ + ++ HEN++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLL 94
Query: 107 GGCIDGPCRI--------LVYDYMP---NNSLSQTLLGEEKRRAKFGWKARREIIMGIGR 155
+ P R LV M NN + L ++ +F +I I R
Sbjct: 95 D--VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD--HVQF-------LIYQILR 143
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK-LFPENTTHISTRVAGTLGY 214
GL YIH ++HRD+K SN+ ++++ KI DFGL++ E T +++TR Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195
Query: 215 LAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRT 246
APE ++ + D++S G ++ E+++GRT
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 38/222 (17%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKE-----FMSEVASMANVNVCH 99
K+G G F +V+ + + + T VA+K++ + + E E +++ + ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 100 ENLVKL------HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR--AKFGWKARREIIM 151
+++KL G +V++ L + LL K+ ++I
Sbjct: 86 NHILKLLDHFNHKGPNGVHVV--MVFE-----VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLD------QNFNPKISDFGLSKLFPEN-TTHI 204
+ GL Y+H ++H DIK N+L++ KI+D G + + E+ T I
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
TR Y +PE + +D++S L+ E+++G
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-14
Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 35/228 (15%)
Query: 44 FRWSNKIGEGGFGSVYKG-RLQDGTIVAVKVLSVESKQG-----EKEFMSEVASMANVNV 97
+ KIG GGFG +Y A V+ VE ++ E +F VA +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 98 CHENLVKLHGG-----------CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR 146
E + G R +V + + L + + F
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS----GQNGTFKKSTV 153
Query: 147 REIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI--SDFGLSKLFPENTTHI 204
++ + + L YIHE VH DIK +N+LL ++ +D+GLS + N H
Sbjct: 154 LQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 205 ------STRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
GT+ + A G L+R+SDV G +L + G+
Sbjct: 211 QYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 32/162 (19%), Positives = 60/162 (37%), Gaps = 33/162 (20%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLS-VESKQGEKEFMSEVASMANVNVCHENLVKLH 106
+G G G V + + A+K+L + E E + ++V++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-------CPHIVRIV 77
Query: 107 GGCIDGPCRI----LVYDYMPNNSLSQTLLGE------EKRRAKFGWKARREIIMGIGRG 156
+ +V + + GE ++ F + EI+ IG
Sbjct: 78 DVYENLYAGRKCLLIVMECLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 157 LAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK 195
+ Y+H ++ HRD+K N+L N K++DFG +K
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 38/264 (14%), Positives = 85/264 (32%), Gaps = 50/264 (18%)
Query: 18 NTIGGEQILKNINAFSYNQLKIATNGFRW--SNKIGEGGFGSVYKGR---------LQDG 66
+ + + ++ A + +G +W + G +Y+
Sbjct: 16 ENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQK 75
Query: 67 TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG------------GCIDGPC 114
++K +++K G A + KL+ G
Sbjct: 76 QKFSLK---LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKY 132
Query: 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174
R LV + SL Q+ L + ++ ++ + L ++HE VH ++
Sbjct: 133 RFLVLPSL-GRSL-QSALDVSPKH-VLSERSVLQVACRLLDALEFLHEN---EYVHGNVT 186
Query: 175 TSNILLDQNFNPKI--SDFGLSKLFPENTTHISTR------VAGTLGYLAPEYA-----I 221
NI +D ++ + +G + + + H++ G E+
Sbjct: 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHK 241
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGR 245
+R+SD+ S G +L+ + G
Sbjct: 242 GCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 51/275 (18%), Positives = 94/275 (34%), Gaps = 74/275 (26%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-----EKEFMSEVASMANVNVCHENL 102
K+G G F +V+ +Q VA+KV+ E + V + + E +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 103 VKLHGG-CIDGP-----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
V+L I G C +V++ + + L + ++ + ++II + +G
Sbjct: 104 VQLLDDFKISGVNGTHIC--MVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQG 158
Query: 157 LAYIHEEIQPHVVHRDIKTSNILL------------------------------------ 180
L Y+H + ++H DIK NILL
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 181 -------------DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR 227
+ KI+D G + ++ T T Y + E I
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 228 KSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262
+D++S + E+ +G F+ GE + D+
Sbjct: 273 PADIWSTACMAFELATGDYL--FEPHSGEEYTRDE 305
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-13
Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 30/217 (13%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG----EKEFMSEVASMANVNVC 98
+R KIG G FG +Y G + G VA+K+ V++K E + + +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGI--- 67
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
+ +G ++V + + SL KF K + + +
Sbjct: 68 ----PTIRWCGAEGDYNVMVMELL-GPSLEDLF---NFCSRKFSLKTVLLLADQMISRIE 119
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPK---ISDFGLSKLF--PENTTHISTR----VA 209
YIH + + +HRD+K N L+ I DFGL+K + HI R +
Sbjct: 120 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 210 GTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
GT Y A G +R+ D+ S G +L+ G
Sbjct: 177 GTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 31/225 (13%)
Query: 36 QLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESK----QGEKEFMSEVA 90
+ ++ N FR KIG G FG +Y G +Q VA+K+ +V++K E + +
Sbjct: 2 EPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
+ + ++G +LV D + SL K K +
Sbjct: 61 GGTGI-------PNVRWFGVEGDYNVLVMDLL-GPSLEDLF---NFCSRKLSLKTVLMLA 109
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK---ISDFGLSKLF--PENTTHIS 205
+ + ++H + +HRDIK N L+ I DFGL+K + HI
Sbjct: 110 DQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
Query: 206 TR----VAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
R + GT Y A G +R+ D+ S G +L+ + G
Sbjct: 167 YRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-13
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
++ +IGEG FG +++G L + VA+K E ++ + + + + +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
++ +G +LV D + SL L + KF K + + IHE
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLG-PSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPK-----ISDFGLSKLF--PENTTHISTR----VAGT 211
+ +V+RDIK N L+ + + + DFG+ K + P HI R ++GT
Sbjct: 125 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 212 LGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
Y GR +R+ D+ + G + + + G
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 46/236 (19%), Positives = 82/236 (34%), Gaps = 44/236 (18%)
Query: 42 NGFRWSNKIGEGGFGSVYKGRLQDGTIV------AVKVLSVESKQ--GEKEFMSEVASMA 93
++ IG+GGFG +Y + V VKV ++ E +F A
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 94 NVNVCHENLVKLHGG-----------CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFG 142
+ + G R ++ D + L Q + + +F
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL-QKIYEANAK--RFS 150
Query: 143 WKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI--SDFGLSKLF--P 198
K ++ + I L YIHE VH DIK SN+LL+ ++ D+GL+ +
Sbjct: 151 RKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 199 ENTTHISTR----VAGTLGYLAPEYA-----ISGRLTRKSDVYSFGVLLLEIVSGR 245
+ GT E+ +R+ D+ G +++ ++G
Sbjct: 208 GVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 43/194 (22%), Positives = 80/194 (41%), Gaps = 33/194 (17%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVKL 105
IG G +G VY VA+K ++ E K + E+ + + + +++L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK--SDYIIRL 90
Query: 106 HGGCIDGPCRI-------LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGI 153
+ + P + +V + ++ L + L EE K I+ +
Sbjct: 91 YD--LIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEE--HIKT-------ILYNL 138
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS-KLFPENTTHISTRVAGTL 212
G +IHE ++HRD+K +N LL+Q+ + K+ DFGL+ + E T+I +
Sbjct: 139 LLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 213 GYLAPEYAISGRLT 226
+ +LT
Sbjct: 196 EPGPHNKNLKKQLT 209
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 38/189 (20%), Positives = 75/189 (39%), Gaps = 40/189 (21%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVK-VLSVESKQGE-KEFMSEVASMANVNVCHENLVKL 105
IG G +G V + + +VA+K +L V + K + E+A + +N H+++VK+
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN--HDHVVKV 117
Query: 106 HGGCIDGPCRI-------LVYDYMP---------NNSLSQTLLGEEKRRAKFGWKARREI 149
I P + +V + L++ + K +
Sbjct: 118 LD--IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI-------KT-------L 161
Query: 150 IMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVA 209
+ + G+ Y+H ++HRD+K +N L++Q+ + K+ DFGL++ S
Sbjct: 162 LYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 210 GTLGYLAPE 218
Sbjct: 219 SPREDDMNL 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 29/191 (15%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSV--ESKQGEKEFMSEVASMANVNVCHENLVK 104
K+G+G +G V+K + G +VAVK + ++ + E+ + ++ HEN+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-GHENIVN 73
Query: 105 LHGGCIDGPCRI----LVYDYMPNNSL-----SQTLLGEEKRRAKFGWKARREIIMGIGR 155
L + LV+DYM + L + L E ++ ++ + +
Sbjct: 74 LLN--VLRADNDRDVYLVFDYMETD-LHAVIRANIL---EPVHKQY-------VVYQLIK 120
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
+ Y+H ++HRD+K SNILL+ + K++DFGLS+ F +
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 216 APEYAISGRLT 226
LT
Sbjct: 178 ENFDDDQPILT 188
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 40/215 (18%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVNVCHENLVKL 105
IG+G FG V K + VA+K++ + + +Q +E + + L L
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----------IRI----LEHL 150
Query: 106 HGGCIDGPCRIL-VYDY--------MPNNSLSQTL--LGEEKRRAKFGWKARREIIMGIG 154
D ++ + + M LS L L ++ + F R+ I
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPEN-TTHISTRVAGT 211
+ L +H+ ++H D+K NILL Q K+ DFG S + T+I +R
Sbjct: 211 QCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--- 264
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
Y APE + R D++S G +L E+++G
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 45/217 (20%), Positives = 82/217 (37%), Gaps = 38/217 (17%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVNVCHENLV 103
+ IG+G FG V K + VA+K++ + ++ Q + E V + L
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----------VRL----LE 105
Query: 104 KLHGGCIDGPCRIL-VYDY--------MPNNSLSQTL--LGEEKRRAKFGWKARREIIMG 152
++ + I+ + + + LS L L R+
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPEN-TTHISTRVA 209
+ L ++ + ++H D+K NILL KI DFG S + +I +R
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
Y +PE + D++S G +L+E+ +G
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 7e-07
Identities = 37/217 (17%), Positives = 73/217 (33%), Gaps = 62/217 (28%)
Query: 96 NVCHENLVKLHGGCIDGPCRILV---------------YDYMPNNSLSQTLLGEEKRR-- 138
NV + + C+IL+ ++ + S TL +E +
Sbjct: 252 NVQNAKAWNA----FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 139 AKF-GWKA---RREIIMGIGRGLAYIHEEIQPHVVHRD-------------IKTS-NILL 180
K+ + RE++ R L+ I E I+ + D I++S N+L
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY---AISGRLTRKSDV------ 231
+ +FP + HI T + + + + + +L + S V
Sbjct: 368 PAEYRKMFDRLS---VFPPS-AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 232 --YSFGVLLLEIVSGRTAVDFDVQLGEYH--LVDKVR 264
S + LE+ + ++ + L H +VD
Sbjct: 424 STISIPSIYLEL---KVKLENEYAL---HRSIVDHYN 454
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 47/246 (19%), Positives = 82/246 (33%), Gaps = 82/246 (33%)
Query: 49 KIGEGGFGSVYKG--RLQDGTIVAVKVL-SVES--KQGEKE--FMSEVASMANVNVCHEN 101
+GEG FG V + + + VA+K++ +V + E + ++ N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL-- 83
Query: 102 LVKL-----HGG--CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
V + G CI G ++++ N+ + R +
Sbjct: 84 CVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQP-----------YPLPHVRHMA 129
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-------------------KISDF 191
+ L ++HE + H D+K NIL + +++DF
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 192 GLSKLFPENTTH---ISTRVAGTLGYLAPE--------YAISGRLTRKSDVYSFGVLLLE 240
G S F ++ H ++TR Y PE DV+S G +L E
Sbjct: 187 G-SATF-DHEHHTTIVATRH-----YRPPEVILELGWAQPC--------DVWSIGCILFE 231
Query: 241 IVSGRT 246
G T
Sbjct: 232 YYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 54/249 (21%), Positives = 94/249 (37%), Gaps = 84/249 (33%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVNVCHENLVK 104
K+G+G FG V + + + AVKV+ +++ + + E + + N ++ + N+VK
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINNNNIVK 100
Query: 105 LHGG-------CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
HG C+ GP +Y+ + N F + + + I
Sbjct: 101 YHGKFMYYDHMCLIFEPLGPS---LYEIITRN-----------NYNGFHIEDIKLYCIEI 146
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-------------------------KI 188
+ L Y+ + + H D+K NILLD + K+
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 189 SDFGLSKLFPENTTH---ISTRVAGTLGYLAPE--------YAISGRLTRKSDVYSFGVL 237
DFG F ++ H I+TR Y APE + D++SFG +
Sbjct: 204 IDFG-CATF-KSDYHGSIINTRQ-----YRAPEVILNLGWDVSS--------DMWSFGCV 248
Query: 238 LLEIVSGRT 246
L E+ +G
Sbjct: 249 LAELYTGSL 257
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-05
Identities = 54/246 (21%), Positives = 86/246 (34%), Gaps = 82/246 (33%)
Query: 49 KIGEGGFGSVYKG--RLQDGTIVAVKVL-SVES--KQGEKEFMSEVASMANVN----VCH 99
+GEG FG V + G VAVK++ +V+ + SE+ + ++N
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 100 ENLVKLHGG-------CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARRE 148
V++ CI G YD++ N F R+
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLS---TYDFIKEN-----------GFLPFRLDHIRK 122
Query: 149 IIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP-------------------KIS 189
+ I + + ++H + H D+K NIL Q+ K+
Sbjct: 123 MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 190 DFGLSKLFPEN-TTHISTRVAGTLGYLAPE--------YAISGRLTRKSDVYSFGVLLLE 240
DFG + E+ +T +STR Y APE DV+S G +L+E
Sbjct: 180 DFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPC--------DVWSIGCILIE 226
Query: 241 IVSGRT 246
G T
Sbjct: 227 YYLGFT 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 272 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.55 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.79 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.76 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.66 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.54 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.89 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.88 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.94 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.6 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.18 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=351.32 Aligned_cols=211 Identities=23% Similarity=0.385 Sum_probs=188.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|++.+.||+|+||+||+|++. +|+.||+|++... .......+.+|++.+++++ ||||+++++++.+++..+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEEE
Confidence 467999999999999999999976 7999999999743 2345578899999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||++||+|.+++ ...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++..
T Consensus 109 ivmEy~~gG~L~~~i----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 109 FGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp EEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 999999999999999 4557899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCC-CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 197 FPEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 197 ~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
.... ........+||+.|+|||++.+..++.++|+|||||++|+|++|++||...+..+.+..+
T Consensus 182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 246 (311)
T 4aw0_A 182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246 (311)
T ss_dssp CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 6533 233345578999999999999999999999999999999999999999887765544433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=349.21 Aligned_cols=207 Identities=25% Similarity=0.410 Sum_probs=185.4
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.+.|++.+.||+|+||.||+|.+. +|+.||||++..........+.+|+.+++.++ ||||+++++++..++..+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999987 79999999998665556667889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|||+||+|.+++. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++.....
T Consensus 151 Ey~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 151 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999883 35699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+..+.+.
T Consensus 223 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 280 (346)
T 4fih_A 223 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 280 (346)
T ss_dssp SSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 322 2345789999999999999999999999999999999999999998766554433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=349.55 Aligned_cols=209 Identities=25% Similarity=0.411 Sum_probs=177.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++++.||+|+||.||+|++. +|+.||||++... .......+.+|+..+++++ ||||+++++++.+++..+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--HPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC--CCCCCcEEEEEEECCEEEEE
Confidence 68999999999999999999976 7999999999754 2334567889999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
||||+||+|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++....
T Consensus 102 mEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 102 MDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999999843 2345678999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+..+.+.
T Consensus 177 ~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 235 (350)
T 4b9d_A 177 ST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235 (350)
T ss_dssp HH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 22 112344679999999999999999999999999999999999999998876554433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=350.92 Aligned_cols=207 Identities=25% Similarity=0.410 Sum_probs=185.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.+.|++.+.||+|+||.||+|.+. +|+.||||++..........+.+|+.+++.++ ||||+++++++..++..||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC--CCCCCceEEEEEECCEEEEEE
Confidence 357999999999999999999987 79999999998766666677899999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|||+||+|.+++. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++.....
T Consensus 228 Ey~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 228 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp ECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999983 35699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+..+.+.
T Consensus 300 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~ 357 (423)
T 4fie_A 300 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 357 (423)
T ss_dssp SCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 322 2345789999999999999999999999999999999999999998766554433
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=333.95 Aligned_cols=204 Identities=27% Similarity=0.433 Sum_probs=167.2
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++.++ ||||+++++++..++..++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR--HPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCEEEE
Confidence 58999999999999999999976 7999999998743 2344567899999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+ +|+|.+.+ ....++++..++.++.||+.||.|||++ ||+||||||+|||++.++++||+|||++...
T Consensus 91 vmEy~-~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 91 VIEYA-GNELFDYI----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEECC-CEEHHHHH----HHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEeCC-CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 99999 67899888 4557899999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
.... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|++||...+....+
T Consensus 163 ~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 163 TDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 4322 2344689999999999998886 57999999999999999999999876654433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=343.02 Aligned_cols=210 Identities=26% Similarity=0.383 Sum_probs=176.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
.++|++.+.||+|+||+||+|++. +++.||+|++... ......++.+|+..+++++ ||||+++++++.+++.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIVKLHYAFQTEGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC--CTTEECEEEEEEETTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEECCE
Confidence 467999999999999999999863 5789999998633 2223346788999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||++||+|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||++
T Consensus 101 ~~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EEEEECCCTTCEEHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEEEEcCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999 4567899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
....... ......+||+.|+|||++.+..++.++|+||+||++|+|++|++||...+..+.+..+
T Consensus 174 ~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 238 (304)
T 3ubd_A 174 KESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238 (304)
T ss_dssp EC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 8543322 2234468999999999999999999999999999999999999999987765544433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=339.24 Aligned_cols=207 Identities=21% Similarity=0.311 Sum_probs=178.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..+.|++.+.||+|+||.||+|+++ +|+.||||+++.+.. ..+|+..++.++ ||||+++++++.+++..+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~--HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLS--SPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEE
Confidence 4567999999999999999999986 799999999974422 246899999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEEeecCccccc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSKLF 197 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~~~~~ 197 (272)
|||++|++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+|||++.+| .+||+|||++...
T Consensus 129 mEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 129 MELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp ECCCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 9999999999999 4556899999999999999999999999 999999999999999887 5999999999876
Q ss_pred CCCCcc----ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 198 PENTTH----ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 198 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
...... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||...+..+....+
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i 268 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 432211 123357999999999999999999999999999999999999999887766544433
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=333.96 Aligned_cols=217 Identities=29% Similarity=0.486 Sum_probs=184.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
+..++|.+.+.||+|+||+||+|.+. ++..||||.++.........+.+|++.+++++ ||||+++++++.++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEG 87 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC--CCCCccEEEEEeeC
Confidence 34578999999999999999999863 47889999997666666678999999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcc---------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEE---------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~---------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
+..++|||||++|+|.+++.... .....+++..+..++.|++.|+.|||++ +|+||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 99999999999999999995432 2235799999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehh
Q 024118 184 FNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 260 (272)
+.+||+|||++........ .......||+.|+|||++.+..++.++||||+||++|||+| |+.||...+..+....+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999986543222 22333568999999999999999999999999999999999 99999887665544333
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=323.97 Aligned_cols=198 Identities=29% Similarity=0.453 Sum_probs=171.6
Q ss_pred CCe-eeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec----CC
Q 024118 42 NGF-RWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP 113 (272)
Q Consensus 42 ~~y-~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~ 113 (272)
.+| ++.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+..+++++ ||||+++++++.. +.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEEEETTEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEeeccCCCc
Confidence 344 78889999999999999887 7999999998743 2334567889999999999 9999999998864 34
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcC-CCCeEEee
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQ-NFNPKISD 190 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~~-~~~~~l~D 190 (272)
..++|||||+||+|.+++ .....+++..++.++.||+.||.|||++ + |+||||||+|||++. +|.+||+|
T Consensus 103 ~~~lvmEy~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred EEEEEEeCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEe
Confidence 578999999999999999 4557899999999999999999999998 7 999999999999974 78999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
||++...... .....+||+.|+|||++.+ .++.++|||||||++|+|+||++||...+
T Consensus 176 FGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 176 LGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999754332 2345689999999998865 59999999999999999999999997544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=333.48 Aligned_cols=217 Identities=27% Similarity=0.478 Sum_probs=180.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
+..+++.+.+.||+|+||.||+|+++ ++..||||.++.........+.+|++.+++++ ||||+++++++.+.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~--HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCTEG 115 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEEC
Confidence 45678999999999999999999864 47899999997666666678999999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhccc-----------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEK-----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
...+||||||++|+|.+++..... ...++++..++.++.|++.|+.|||++ +|+||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 999999999999999999855321 235699999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceeh
Q 024118 182 QNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL 259 (272)
Q Consensus 182 ~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~ 259 (272)
+++.+||+|||++....... ........||+.|+|||++.+..++.++||||+||++|||+| |+.||...+..+....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998654322 222344678999999999999999999999999999999999 9999987766554443
Q ss_pred h
Q 024118 260 V 260 (272)
Q Consensus 260 ~ 260 (272)
+
T Consensus 273 i 273 (329)
T 4aoj_A 273 I 273 (329)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=325.93 Aligned_cols=207 Identities=29% Similarity=0.486 Sum_probs=173.8
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.|.+..+++++.+.||+|+||+||+|++++ .||||+++.. .......+.+|+..+++++ ||||+++++++.. +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~--HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR--HVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEC-C
Confidence 456778899999999999999999998753 5899998744 2334567899999999999 9999999998765 5
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..+||||||++|+|.+++. ....++++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 105 ~~~iVmEy~~gGsL~~~l~---~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp SCEEEEECCSSCBHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred eEEEEEEcCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence 6899999999999999983 2346799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-ccccccccccccccCccccccC---CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENT-THISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+....... ........||+.|+|||++.+. .++.++||||+||++|+|+||+.||...+.
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 98654322 2233456899999999999743 488999999999999999999999986554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=325.88 Aligned_cols=217 Identities=27% Similarity=0.420 Sum_probs=183.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+..+++++.+.||+|+||+||+|.+. +++.||||.++.. .......+.+|+..+++++ ||||+++++++..
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~--HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ--HPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC--CTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC--CCCCCCcceEEEE
Confidence 34567889999999999999999852 5788999998644 3344578999999999998 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcc------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nil 179 (272)
+...++|||||++|+|.+++.... .....+++..+..++.|++.|+.|||++ +|+||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 999999999999999999995432 1235689999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCce
Q 024118 180 LDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEY 257 (272)
Q Consensus 180 v~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~ 257 (272)
+++++.+||+|||++....... ........||+.|+|||++.+..++.++||||+||++|||+| |..||...+..+..
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999997653222 222344678999999999999999999999999999999998 89999887765544
Q ss_pred ehh
Q 024118 258 HLV 260 (272)
Q Consensus 258 ~~~ 260 (272)
..+
T Consensus 258 ~~i 260 (308)
T 4gt4_A 258 EMI 260 (308)
T ss_dssp HHH
T ss_pred HHH
Confidence 333
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=314.99 Aligned_cols=201 Identities=22% Similarity=0.412 Sum_probs=161.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCC-----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----- 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~----- 113 (272)
.++|++.+.||+|+||.||+|.++ +|+.||||.+..... .....+.+|+..+++++ ||||+++++++...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~--HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEecCccccc
Confidence 356999999999999999999986 799999999975543 34467889999999998 999999999987544
Q ss_pred -------ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCe
Q 024118 114 -------CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 114 -------~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~ 186 (272)
..+++|||++|++|.+++.... .....++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence 3689999999999999994321 123345677899999999999999999 99999999999999999999
Q ss_pred EEeecCcccccCCCCcc-----------ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 187 KISDFGLSKLFPENTTH-----------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
||+|||++......... .....+||+.|+|||++.+..++.++|||||||++|+|++ ||..
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999999866432211 1233579999999999999999999999999999999996 7754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=337.52 Aligned_cols=207 Identities=29% Similarity=0.404 Sum_probs=177.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHH---HHHhhcccccccceeEeeeeEec
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSE---VASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e---~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+..++|++.+.||+|+||.||+|++. +|+.||+|++... ..........| +..++.+. ||||+++++++.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~--HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD--CPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC--CTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC--CCCEeEEEEEEEE
Confidence 34578999999999999999999987 7999999999632 12223333343 45555566 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
.+..|+||||++||+|.+++ ...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|++||+||
T Consensus 264 ~~~lylVmEy~~GGdL~~~l----~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccc
Confidence 99999999999999999999 4567899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccc-cCCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAI-SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
|++....... ....+||+.|+|||++. +..|+.++|+|||||++|+|++|++||...+.....
T Consensus 337 GlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~ 400 (689)
T 3v5w_A 337 GLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400 (689)
T ss_dssp TTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH
T ss_pred ceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9998764332 34468999999999996 467999999999999999999999999876655443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=326.71 Aligned_cols=210 Identities=25% Similarity=0.400 Sum_probs=178.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec------
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------ 111 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~------ 111 (272)
.++|++++.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++ ||||+++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK--HDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC--CCCcceEeeeeeccccccc
Confidence 368999999999999999999986 8999999998643 2234467889999999998 9999999998753
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
....|+||||++ ++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.++|+||
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 357899999996 5788888 4567899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCC---CccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 192 GLSKLFPEN---TTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 192 g~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
|++...... ........+||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+..+.+..+
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I 275 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 275 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999865432 122344578999999999988764 689999999999999999999999887765544444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=321.49 Aligned_cols=220 Identities=25% Similarity=0.377 Sum_probs=186.6
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhccccccccee
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
++..+.|.+..++|++.+.||+|+||.||+|.+. .++.||||.+.... ......+.+|+..++++.. ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~h-hpnIV 131 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNVV 131 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCC-CCcEE
Confidence 4666778899999999999999999999999864 23679999987443 2345678899999999972 59999
Q ss_pred EeeeeEecC-CceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 024118 104 KLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 170 (272)
Q Consensus 104 ~l~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h 170 (272)
+++++|... ...+||||||++|+|.+++..... ....+++..+..++.|++.|+.|||++ +|+|
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence 999998764 568999999999999999965432 134589999999999999999999999 9999
Q ss_pred cCCCCCCEEEcCCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcc
Q 024118 171 RDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAV 248 (272)
Q Consensus 171 ~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~ 248 (272)
|||||+|||+++++.+||+|||++....... ........||+.|+|||++.+..++.++||||+||++|||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998664332 223344678999999999999999999999999999999998 99999
Q ss_pred ccccCC
Q 024118 249 DFDVQL 254 (272)
Q Consensus 249 ~~~~~~ 254 (272)
...+..
T Consensus 289 ~~~~~~ 294 (353)
T 4ase_A 289 PGVKID 294 (353)
T ss_dssp TTCCCS
T ss_pred CCCCHH
Confidence 876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=313.57 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=172.0
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
.++...++|++.+.||+|+||+||+|+++ +++.||+|.+... ....++.+|++.++.+.. ||||+++++++..
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~-h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGG-QDNVMGVKYCFRK 91 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCS-BTTBCCCSEEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcC-CCCCceEEEEEEE
Confidence 34456788999999999999999999753 4788999987533 345578889999888743 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCeEEee
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISD 190 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~-~~~~l~D 190 (272)
.+..++||||++|++|.+++ ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.++|+|
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 99999999999999999988 2489999999999999999999999 99999999999999876 7899999
Q ss_pred cCcccccCCCCc---------------------------cccccccccccccCccccccC-CCCCCCceehHHHHHHHHH
Q 024118 191 FGLSKLFPENTT---------------------------HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIV 242 (272)
Q Consensus 191 fg~~~~~~~~~~---------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~ 242 (272)
||++........ ......+||+.|+|||++.+. .++.++|+||+||++|+|+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999975432211 112335799999999999876 4899999999999999999
Q ss_pred hCCCccccc
Q 024118 243 SGRTAVDFD 251 (272)
Q Consensus 243 tg~~p~~~~ 251 (272)
+|+.||...
T Consensus 242 ~G~~Pf~~~ 250 (361)
T 4f9c_A 242 SGRYPFYKA 250 (361)
T ss_dssp HTCSSSSCC
T ss_pred HCCCCCCCC
Confidence 999999543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=309.18 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=162.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC----cee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----CRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~----~~~ 116 (272)
.++|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..+.+++ ||||+++++++..++ ..+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~--HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLR--HENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCC--CCCCCcEEEEEEecCCCceEEE
Confidence 35799999999999999999988 48899999986332 12222334555556667 999999999988654 468
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-----IQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-----~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
+||||+++|+|.+++. ..+++++.+..++.|++.||.|||++ ...+|+||||||+|||++.++.+||+||
T Consensus 78 lV~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999993 35689999999999999999999975 2348999999999999999999999999
Q ss_pred CcccccCCCCcc---ccccccccccccCccccccC------CCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 192 GLSKLFPENTTH---ISTRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 192 g~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
|++......... ......||+.|+|||++.+. .++.++||||+||++|||+||.+||...
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 999865433221 22335799999999999765 3577999999999999999998887543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=330.67 Aligned_cols=210 Identities=24% Similarity=0.385 Sum_probs=186.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||+|+||.||+|.++ +|+.||+|.+..........+.+|+..++.++ ||||+++++++..+...++||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC--CTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999987 79999999998666666678889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--CCeEEeecCccccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN--FNPKISDFGLSKLF 197 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~--~~~~l~Dfg~~~~~ 197 (272)
|||+||+|.+++. .....+++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||++...
T Consensus 234 E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 234 EFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp ECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred eecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999999883 2346799999999999999999999999 99999999999999854 78999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
..... ....+||+.|+|||++.+..++.++|+||+||++|+|++|++||...+..+.+..+
T Consensus 308 ~~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i 368 (573)
T 3uto_A 308 DPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368 (573)
T ss_dssp CTTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred cCCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 54322 34467999999999999999999999999999999999999999877765544433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=294.99 Aligned_cols=207 Identities=29% Similarity=0.362 Sum_probs=181.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|++... .........+|+..++.+. ||||+++++++......
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEECSSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC--CCcCcceEEEEEeCCEE
Confidence 3578999999999999999999877 7999999999743 2344567888999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||++|++|.+.+ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.+|.++|+|||++.
T Consensus 81 ~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 81 CFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchh
Confidence 9999999999999998 4456799999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
...... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+....
T Consensus 154 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 154 EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp CSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 543222 123446789999999999999999999999999999999999999987665443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=299.80 Aligned_cols=213 Identities=24% Similarity=0.376 Sum_probs=177.9
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.+..++|++.+.||+|+||.||+|++. +|+.||+|++... ..........|...++.+.. ||||+++++++....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~-hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQLFCCFQTPD 97 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSS
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Confidence 356789999999999999999999876 7999999999743 23344567788888887643 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||++|++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.+|.++|+|||+
T Consensus 98 ~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccc
Confidence 999999999999999998 4556799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
+....... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+.+..
T Consensus 171 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 235 (353)
T 3txo_A 171 CKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235 (353)
T ss_dssp CBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 97533222 223446799999999999998999999999999999999999999987766554433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=287.45 Aligned_cols=206 Identities=28% Similarity=0.477 Sum_probs=176.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+..++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+..+++++ ||||+++++++...+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS--HQNIVSMIDVDEEDDC 85 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC--BTTBCCEEEEEECSSE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC--CCCCceEEEeeeeCCe
Confidence 45788999999999999999999876 799999999864432 23457888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||+++++|.+++ ....++++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++
T Consensus 86 ~~lv~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp EEEEEECCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred EEEEEeCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 99999999999999998 4456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
...............|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 87654433334446789999999999999999999999999999999999999986654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=293.94 Aligned_cols=206 Identities=29% Similarity=0.423 Sum_probs=181.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|++... ......++.+|+..++.++ ||||+++++++......
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--HPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCEE
Confidence 34668999999999999999999985 8999999998744 3334567889999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||+++++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp EEEECCCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EEEEECCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 9999999999999998 4456799999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCccccccccccccccCccccccCCCC-CCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
...... .....+|++.|+|||++.+..+. .++|+||+||++|+|++|+.||...+..+
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 163 EFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp GGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 654322 23446789999999999988865 79999999999999999999998766443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=286.73 Aligned_cols=203 Identities=23% Similarity=0.399 Sum_probs=182.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+..........+.+|+..++.+. ||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC--CCCCCeEeEEEEECCEEEEE
Confidence 4578999999999999999999875 79999999998766666778899999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+++. ...+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999983 34689999999999999999999999 99999999999999999999999999988664
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... ......|++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 221 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3322 23345789999999999999999999999999999999999999976554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=293.21 Aligned_cols=224 Identities=46% Similarity=0.730 Sum_probs=191.7
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
..+....+....++|++.+.||+|+||.||+|.+.+|+.||+|.+..........+.+|+..++.++ ||||+++++++
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~ 104 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR--HPHLVSLIGFC 104 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC--CTTBCCEEEEC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCC--CCCEeeEEEEE
Confidence 3444555566788999999999999999999998889999999987665556678899999999998 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...+..++||||+++++|.+++.........+++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999999999855444445689999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 190 DFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 190 Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
|||++....... ........|++.|+|||++.+..++.++|+||||+++|+|++|+.||......+...
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 999997643222 222333568999999999998899999999999999999999999998766554443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=304.12 Aligned_cols=216 Identities=28% Similarity=0.373 Sum_probs=185.3
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
..+.+..++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|+..++.+. ||||+++++++.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFYAFQ 139 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC--CTTBCCEEEEEE
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC--CCCCCeEEEEEE
Confidence 445567789999999999999999999987 6899999998642 1223345778888898888 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
+....++||||++|++|.+++. ...+++..++.++.|++.||.|||++ ||+||||||+||+++.+|.++|+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEec
Confidence 9999999999999999999883 34689999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCC----CCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR----LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
||++..............+||+.|+|||++.+.. ++.++|+|||||++|+|++|++||...+..+.+..+
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 285 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence 9999876544333344568999999999998765 789999999999999999999999877655544333
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=294.06 Aligned_cols=212 Identities=25% Similarity=0.381 Sum_probs=180.3
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+..++|++.+.||+|+||.||+|+++ +|+.||+|+++... .........|...+..+.. ||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTK 90 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCC-CCCCCcEEEEEEeC
Confidence 3466789999999999999999999986 79999999997431 2344567778888776622 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||++|++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.+|.++|+|||
T Consensus 91 ~~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp SEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeECh
Confidence 9999999999999999998 3456799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
++....... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+.+
T Consensus 164 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 227 (345)
T 1xjd_A 164 MCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227 (345)
T ss_dssp TCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred hhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 997543221 1234467899999999999999999999999999999999999999877655443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.53 Aligned_cols=219 Identities=27% Similarity=0.372 Sum_probs=186.3
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
..+.+.+..++|++.+.||+|+||.||+|++. +++.||+|++... .......+.+|...+..+. ||||++++++
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~--hp~Iv~l~~~ 142 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--SKWITTLHYA 142 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC--TTTBCCEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC--CCCEEEEEEE
Confidence 34555677889999999999999999999987 6889999998742 1122234778888888887 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
+......++||||++|++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEE
Confidence 9999999999999999999999932 246799999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
+|||++..............+||+.|+|||++. ...++.++|+||+||++|+|++|++||...+..+.+..
T Consensus 217 ~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 292 (437)
T 4aw2_A 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292 (437)
T ss_dssp CCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred cchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh
Confidence 999999766544443344467999999999987 45689999999999999999999999987765544433
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=293.33 Aligned_cols=223 Identities=43% Similarity=0.814 Sum_probs=196.5
Q ss_pred ccccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC-cccHHHHHHHHHHhhccccccccee
Q 024118 25 ILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
..+.+..++.+.+....++|++.+.||+|+||.||+|...+|+.||+|.+.... ......+.+|+..++.+. ||||+
T Consensus 13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv 90 (326)
T 3uim_A 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV--HRNLL 90 (326)
T ss_dssp --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCC--CTTBC
T ss_pred ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhcc--CCCcc
Confidence 356678899999999999999999999999999999998889999999986442 223336889999999998 99999
Q ss_pred EeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 104 ~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
++++++......++||||+++++|.+++........++++..++.++.|++.||.+||+++..||+|+||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 99999999999999999999999999997665566679999999999999999999999766699999999999999999
Q ss_pred CCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
+.++|+|||++...............|++.|+|||.+.+..++.++|+||||+++|+|++|+.||+
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999999998765444444455668999999999998889999999999999999999999996
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=288.85 Aligned_cols=203 Identities=28% Similarity=0.455 Sum_probs=180.1
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|++.+.||+|+||.||+|+.. +|+.||+|++... .......+.+|...++.+. ||||+++++++......
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--BTTBCCEEEEEECSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC--CCCCceEeEEEEeCCEE
Confidence 3578999999999999999999886 7999999998743 2234567788999999988 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||++|++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.+|.++|+|||++.
T Consensus 82 ~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~ 154 (318)
T 1fot_A 82 FMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK 154 (318)
T ss_dssp EEEECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcce
Confidence 9999999999999998 3456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
..... ....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+
T Consensus 155 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 210 (318)
T 1fot_A 155 YVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210 (318)
T ss_dssp ECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 65432 234578999999999999999999999999999999999999998765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=295.26 Aligned_cols=206 Identities=26% Similarity=0.418 Sum_probs=181.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+..++.+. ||||+++++++.....
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--HPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCCE
Confidence 45678999999999999999999877 7899999998643 2334567889999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||++|++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.+|.++|+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a 162 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA 162 (384)
T ss_dssp EEEEECCCTTEEHHHHH----HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecccee
Confidence 99999999999999998 4556799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCcccccc---CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
....... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+...
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~ 224 (384)
T 4fr4_A 163 AMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224 (384)
T ss_dssp EECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC
T ss_pred eeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc
Confidence 8664332 2344679999999999974 458899999999999999999999998665544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=290.49 Aligned_cols=207 Identities=24% Similarity=0.357 Sum_probs=182.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc------cHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+...... ....+.+|+..++.+. ||||+++++++...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL--HPNIITLHDVYENR 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC--CTTBCCEEEEEECS
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC--CcCCCcEEEEEEeC
Confidence 4568999999999999999999887 7999999999754321 3467889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CeEE
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKI 188 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~----~~~l 188 (272)
...++||||++|++|.+++ .....+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|
T Consensus 88 ~~~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp SEEEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred CEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEE
Confidence 9999999999999999998 4456799999999999999999999999 999999999999998777 7999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
+|||++....... ......|++.|+|||++.+..++.++|+||+|+++|+|++|.+||...+..+.+
T Consensus 161 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~ 227 (361)
T 2yab_A 161 IDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227 (361)
T ss_dssp CCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred EecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999998764432 233457899999999999989999999999999999999999999876654433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=295.34 Aligned_cols=209 Identities=25% Similarity=0.372 Sum_probs=176.9
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.....+..++|++.+.||+|+||.||+|+++ +++.||+|+++... ......+..|...+.++.. ||||+++++++
T Consensus 44 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~-hp~Iv~l~~~~ 122 (396)
T 4dc2_A 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-HPFLVGLHSCF 122 (396)
T ss_dssp -----CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTT-CTTBCCEEEEE
T ss_pred ccccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCC-CCCcCeeEEEE
Confidence 3344566789999999999999999999977 68899999997442 2233456778888777632 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
......++||||++|++|...+ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.+|.++|+
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred EECCEEEEEEEcCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEe
Confidence 9999999999999999999998 4456799999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
|||++...... .......+||+.|+|||++.+..++.++|+|||||++|+|++|++||...
T Consensus 196 DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 196 DYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ecceeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99999753222 22234467999999999999999999999999999999999999999744
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=292.17 Aligned_cols=210 Identities=23% Similarity=0.336 Sum_probs=180.4
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.+..++|++.+.||+|+||.||+|.+. +|+.||+|++... ..........|...+..+.. ||+|+++++++....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~-hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-PPFLTQLHSCFQTMD 94 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTC-CTTBCCEEEEEECSS
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCC-CCEEeeEEEEEEcCC
Confidence 356788999999999999999999987 5889999999743 22345667788888887732 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||++|++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.+|.++|+|||+
T Consensus 95 ~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 999999999999999998 3446799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
+....... ......+||+.|+|||++.+..++.++|+|||||++|+|++|++||...+..+.
T Consensus 168 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 229 (353)
T 2i0e_A 168 CKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229 (353)
T ss_dssp CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH
Confidence 98533221 123446789999999999999999999999999999999999999987665443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=299.42 Aligned_cols=219 Identities=25% Similarity=0.339 Sum_probs=185.7
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.+...+..++|++.+.||+|+||.||+|+++ +|+.||+|++... .......+.+|...+..+. ||+|+++++++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~--hp~Iv~l~~~~ 130 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQLHFAF 130 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC--TTTBCCEEEEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC--CCCeeeEEEEE
Confidence 3455567889999999999999999999986 7999999998632 1222345677888888887 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
......++||||++|++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+||+++.+|+++|+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999999832 234799999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccc-------cCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
|||++..............+||+.|+|||++. +..++.++|+|||||++|+|++|++||...+..+.+..+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 282 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999876544333334467999999999997 356899999999999999999999999877665544333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.43 Aligned_cols=203 Identities=26% Similarity=0.377 Sum_probs=180.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|++.+.||+|+||.||+|++. +|+.||+|++... .......+.+|+..++.+. ||||+++++++......
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEcCCEE
Confidence 4578999999999999999999986 7999999998643 2234567888999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||++|++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.+|.++|+|||++.
T Consensus 117 ~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~ 189 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK 189 (350)
T ss_dssp EEEEECCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccce
Confidence 9999999999999998 3446799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
..... .....||+.|+|||++.+..++.++|+|||||++|+|++|++||...+..+
T Consensus 190 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 245 (350)
T 1rdq_E 190 RVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp ECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence 65432 233578999999999999999999999999999999999999998766544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=286.69 Aligned_cols=209 Identities=25% Similarity=0.397 Sum_probs=180.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++.++ ||||+++++++......
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR--HPHIIKLYDVITTPTDI 84 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEE
Confidence 4578999999999999999999975 7999999998643 2233457889999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||+ +++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|||++.
T Consensus 85 ~lv~E~~-~g~l~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp EEEECCC-CEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EEEEECC-CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 9999999 67888887 3456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
...... .....+|++.|+|||++.+..+ ++++|+||+|+++|+|++|+.||...........+
T Consensus 157 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 220 (336)
T 3h4j_B 157 IMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220 (336)
T ss_dssp TTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC
T ss_pred eccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 654332 2344578999999999988876 68999999999999999999999877655544433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=290.71 Aligned_cols=213 Identities=24% Similarity=0.391 Sum_probs=181.4
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
+.........++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..++.+. ||||++++++
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~ 96 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDS 96 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEE
Confidence 334444456778999999999999999999876 79999999997542 234467888999999998 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---C
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---N 185 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~---~ 185 (272)
+......++||||+++++|.+.+ .....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (362)
T 2bdw_A 97 IQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169 (362)
T ss_dssp EECSSEEEEEECCCCSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCC
T ss_pred EEeCCEEEEEEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence 99999999999999999999998 4456789999999999999999999999 999999999999997654 4
Q ss_pred eEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
++|+|||++........ .....|++.|+|||++.+..++.++|+|||||++|+|++|++||...+...
T Consensus 170 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 170 VKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp EEECCCTTCBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEeecCcceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999986643222 234578999999999999899999999999999999999999997765433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=280.45 Aligned_cols=207 Identities=26% Similarity=0.456 Sum_probs=181.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+..++|++.+.||+|+||.||+|.+. ++..||+|.+..........+.+|+..++.++ ||||+++++++..+...++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE--HPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CcCcccEEEEEecCCeeEE
Confidence 34678999999999999999999876 79999999986656666778999999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp EEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999999999842 356799999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCccc-------------cccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 198 PENTTHI-------------STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
....... .....|++.|+|||++.+..++.++||||+|+++|+|++|..||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 4322211 1135689999999999999999999999999999999999999975443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=278.14 Aligned_cols=209 Identities=27% Similarity=0.435 Sum_probs=183.4
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+..++|++.+.||+|+||.||+|.+.++..||+|++.... .....+.+|+..+++++ ||||+++++++......++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLS--HPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCceEE
Confidence 45678899999999999999999999888899999997443 34567889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred EEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceec
Confidence 9999999999999833 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
............++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence 5544333344456778999999999889999999999999999999 999998665443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=285.99 Aligned_cols=202 Identities=27% Similarity=0.392 Sum_probs=176.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|++.+.||+|+||.||+|+++ +|+.||+|++.... ......+.+|...++.+.. ||||+++++++......
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~-hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-HPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCC-CCccCeEEEEEEeCCEE
Confidence 4578999999999999999999987 78999999997542 2334567778888877632 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.+|.++|+|||++.
T Consensus 86 ~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp EEEECCCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccc
Confidence 9999999999999998 3456799999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
...... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 159 EGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 532221 123446789999999999999999999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=291.79 Aligned_cols=209 Identities=32% Similarity=0.412 Sum_probs=172.0
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHH-hhcccccccceeEeeeeEecC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVAS-MANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~-~~~~~~~~~~i~~l~~~~~~~ 112 (272)
....++|++.+.||+|+||.||+|+++ +++.||+|++.... ......+..|... ++.+. ||||+++++++...
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~--hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK--HPFLVGLHFSFQTA 111 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC--CTTBCCEEEEEECS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC--CCCCCCEEEEEEeC
Confidence 345678999999999999999999987 68999999997442 2233445556555 34556 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
+..++||||++|++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.+|.++|+|||
T Consensus 112 ~~~~lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp SEEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCc
Confidence 9999999999999999998 4456789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
++....... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.
T Consensus 185 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 247 (373)
T 2r5t_A 185 LCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247 (373)
T ss_dssp BCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH
T ss_pred cccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 997532221 123446789999999999999999999999999999999999999987665443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=286.17 Aligned_cols=207 Identities=26% Similarity=0.415 Sum_probs=171.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEe----CCCcEEEEEEEEecC----cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
+..++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+..++.+. ||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~ 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--HPFIVDLIYAFQ 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC--CTTBCCEEEEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC--CCCccceeEEEE
Confidence 4567899999999999999999986 478999999986432 233456778999999998 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
.....++||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+||||||+||+++.++.++|+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECC
T ss_pred cCCEEEEEEeCCCCCcHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEe
Confidence 999999999999999999998 4456789999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 165 fg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 228 (327)
T 3a62_A 165 FGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228 (327)
T ss_dssp CSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH
Confidence 99987543221 12334578999999999999889999999999999999999999998766543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=279.77 Aligned_cols=210 Identities=30% Similarity=0.489 Sum_probs=183.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+.+..++|++.+.||+|+||.||+|.+.++..||+|.+... ......+.+|+..+++++ ||||+++++++......+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCceE
Confidence 34567889999999999999999999988899999998743 334567899999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++++|.+++. .....+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp EEEECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEEeCCCCcHHHHHH---hcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccc
Confidence 9999999999999983 2345689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.............++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~ 215 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 65433333334556778999999998899999999999999999999 999998765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=286.56 Aligned_cols=208 Identities=21% Similarity=0.340 Sum_probs=180.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-----cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..++.+. ||||+++++++..+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK--HPHIVELLETYSSD 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC--CTTBCCEEEEEEET
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC--CCCCCcEEEEEEeC
Confidence 34568999999999999999999876 79999999986431 224567889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---eEEe
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKIS 189 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~---~~l~ 189 (272)
...++||||+++++|.+.+.........+++..++.++.|++.||.|||++ ||+|+||||+||+++.++. ++|+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEe
Confidence 999999999999999988865444455689999999999999999999999 9999999999999986655 9999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+
T Consensus 176 Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 176 GFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp CCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred cCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 9999987654322 2334578999999999999899999999999999999999999997643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=281.29 Aligned_cols=216 Identities=27% Similarity=0.461 Sum_probs=183.3
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
......+.+..++|++.+.||+|+||.||++.+.++..||+|++... ......+.+|+..++.+. ||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~ 89 (283)
T 3gen_A 13 GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLS--HEKLVQLYGVCT 89 (283)
T ss_dssp ---CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCC--CTTBCCEEEEEC
T ss_pred CCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCC--CCCEeeEEEEEe
Confidence 33445667788899999999999999999999998889999998743 334567889999999998 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
.....++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECS
T ss_pred cCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcc
Confidence 99999999999999999999832 346799999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
||++...............+++.|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+...
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred ccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 99998664433333333456778999999998899999999999999999998 999998765443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=283.52 Aligned_cols=204 Identities=16% Similarity=0.288 Sum_probs=179.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||+|+||.||+|.+. +++.||+|.+... ......+.+|+..++.+. ||||+++++++......++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIAR--HRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSC--CTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCC--CCCCCeEeEEEecCCEEEEEE
Confidence 578999999999999999999877 7899999998744 334556888999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCCeEEeecCccccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLF 197 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~--~~~~~l~Dfg~~~~~ 197 (272)
||++|++|.+++. .....+++..++.++.|++.||.|||++ ||+|+||||+||+++. ++.++|+|||++...
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999983 2335799999999999999999999999 9999999999999987 789999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
..... .....+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+..+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 155 KPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp CTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred CCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 43322 233568999999999998888999999999999999999999998766543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=283.55 Aligned_cols=205 Identities=28% Similarity=0.456 Sum_probs=177.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+..++.+. ||||+++++++......++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCeEEE
Confidence 4678999999999999999999887 799999999874432 23456788999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 83 FLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecccee
Confidence 99999999999998 4556799999999999999999999999 9999999999999999999999999999765
Q ss_pred CCC-CccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccC
Q 024118 198 PEN-TTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~-~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... .........|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 322 2222334678999999999987775 7789999999999999999999986554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.90 Aligned_cols=205 Identities=24% Similarity=0.351 Sum_probs=180.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc------ccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..++|++.+.||+|+||.||+|.+. +|..||+|++..... .....+.+|+..++.+. ||||+++++++...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENK 86 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECS
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEeC
Confidence 3467999999999999999999987 799999999975422 13567889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CeEE
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKI 188 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~----~~~l 188 (272)
...++||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++ .++|
T Consensus 87 ~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp SEEEEEEECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred CEEEEEEEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 9999999999999999998 3456799999999999999999999999 999999999999998887 7999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+|||++........ .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 160 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 224 (326)
T 2y0a_A 160 IDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224 (326)
T ss_dssp CCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred EECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 99999986643222 233568999999999998899999999999999999999999997665443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=278.15 Aligned_cols=213 Identities=26% Similarity=0.416 Sum_probs=185.5
Q ss_pred cCCChhHHHHhhC----------CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhccccc
Q 024118 30 NAFSYNQLKIATN----------GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98 (272)
Q Consensus 30 ~~~~~~~~~~~~~----------~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~ 98 (272)
..++..++....+ .|...+.||+|+||.||+|.+. +|+.||||++..........+.+|+..++.++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-- 100 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-- 100 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC--
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC--
Confidence 4556666554443 3888999999999999999987 79999999998666666778899999999998
Q ss_pred ccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 024118 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178 (272)
Q Consensus 99 ~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ni 178 (272)
||||+++++++...+..++||||+++++|.+++. ...+++..++.++.|++.||.+||++ ||+|+||||+||
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 9999999999999999999999999999999982 35689999999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 179 LLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 179 lv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+++.++.++|+|||++......... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999866433221 2345789999999999998899999999999999999999999976554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=287.93 Aligned_cols=213 Identities=15% Similarity=0.165 Sum_probs=176.9
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEE------eCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccc-cccceeEeee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNV-CHENLVKLHG 107 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~------~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~-~~~~i~~l~~ 107 (272)
..+.+..++|++.+.||+|+||.||+|. ..+++.||+|++.... ...+..|+..++.+.. .|++|+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445667889999999999999999994 3478999999986443 3345555555555542 2899999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhccc-ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK-RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---- 182 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~---- 182 (272)
.+...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ ||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence 99999999999999999999999954332 346799999999999999999999999 9999999999999988
Q ss_pred -------CCCeEEeecCcccccCC-CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 183 -------NFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 183 -------~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++.++|+|||++..... ..........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975431 122234456789999999999999999999999999999999999999965443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=280.33 Aligned_cols=209 Identities=24% Similarity=0.428 Sum_probs=177.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...++|++.+.||+|+||.||+|.+.+|+.||+|.+.... ......+.+|+..++.++ ||||+++++++......+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--HPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCC--CTTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcC--CCCEeeeeeEEccCCEEE
Confidence 3467899999999999999999999889999999986442 223467889999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++ +|.+.+. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++..
T Consensus 96 lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEEECCSE-EHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCC-CHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 99999975 7777763 3445699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
....... .....+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...+..+..
T Consensus 169 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 229 (311)
T 3niz_A 169 FGIPVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229 (311)
T ss_dssp TTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH
T ss_pred cCCCccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 5432222 233567999999999876 45899999999999999999999999877665543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=293.93 Aligned_cols=208 Identities=23% Similarity=0.328 Sum_probs=179.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
...++|++.+.||+|+||.||+|.+. +|+.+|+|.+.... ......+.+|+..++.+. ||||+++++++......
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK--HPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC--BTTBCCEEEEEECSSEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CcCCCeEEEEEEECCEE
Confidence 45678999999999999999999876 79999999987543 233456889999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCCeEEeecC
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFG 192 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~---~~~~~~l~Dfg 192 (272)
++||||++|++|.+.+ .....+++..++.++.||+.||.|||++ ||+||||||+||+++ .++.++|+|||
T Consensus 86 ~lv~E~~~gg~L~~~i----~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 86 YLIFDLVTGGELFEDI----VAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEECCCBCCBHHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 9999999999999998 4456799999999999999999999999 999999999999998 56789999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
++........ ......|++.|+|||++.+..++.++||||+||++|+|++|.+||...+..+.
T Consensus 159 ~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~ 221 (444)
T 3soa_A 159 LAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221 (444)
T ss_dssp SCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 9986643322 22346789999999999998999999999999999999999999977665443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=279.92 Aligned_cols=217 Identities=31% Similarity=0.505 Sum_probs=173.9
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
....+.+.+...+|++.+.||+|+||.||+|.+ +|..||+|++.... ......+.+|+..+++++ ||||++++++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~ 102 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR--HPNIVLFMGA 102 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC--CTTBCCEEEE
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEE
Confidence 455566667788999999999999999999987 58889999986443 233457888999999998 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCCe
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~~~~~~ 186 (272)
+......++||||+++++|.+++... .....+++..++.++.|++.||.+||++ | |+|+||||+||+++.++.+
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~ 178 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTV 178 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCE
T ss_pred EEECCceEEEEecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcE
Confidence 99999999999999999999998432 1223599999999999999999999999 9 9999999999999999999
Q ss_pred EEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 179 kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~ 246 (309)
T 3p86_A 179 KVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246 (309)
T ss_dssp EECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred EECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999997543322 12234568999999999999999999999999999999999999998765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=297.60 Aligned_cols=209 Identities=28% Similarity=0.368 Sum_probs=172.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.+..++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++.+. ||||+++++++...+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKYSFQTHD 221 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS--CTTSCCEEEEEEETT
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC--CCeEeeEEEEEeeCC
Confidence 345678999999999999999999876 7999999999743 2334456778899999988 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
..++||||+++++|.+.+ .....+++..++.++.|++.||.|||+ + ||+||||||+||+++.++.++|+|||
T Consensus 222 ~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp EEEEEECCCSSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EEEEEEeeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCC
Confidence 999999999999999998 445679999999999999999999998 8 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+....
T Consensus 295 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 357 (446)
T 4ejn_A 295 LCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357 (446)
T ss_dssp CCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 9975432222 23346789999999999999999999999999999999999999987665443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.43 Aligned_cols=204 Identities=22% Similarity=0.336 Sum_probs=179.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..........+.+|+..++.+. ||||+++++++......++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--STTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCC--CcCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999876 79999999998665555667889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCCeEEeecCccccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLF 197 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~--~~~~~l~Dfg~~~~~ 197 (272)
||+++++|.+++. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++. .+.++|+|||++...
T Consensus 128 E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999983 2334789999999999999999999999 9999999999999974 467999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
..... .....+|+.|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 202 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 202 NPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp CTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred CCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 43322 23346899999999999988999999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=294.82 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=183.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+..++|++.+.||+|+||.||+|++. +|+.||+|++... .......+.+|+..++.+. ||+|+++++++.....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--SRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC--CCCEeeEEEEEeeCCE
Confidence 34578999999999999999999986 7999999999743 2234567888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||++|++|.+++.........+++..++.++.||+.||.|||++ ||+||||||+||+++.+|.++|+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeeccee
Confidence 9999999999999999865444456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
........ .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 337 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 337 VELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp EECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred eeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 86643322 12335789999999999999999999999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=281.63 Aligned_cols=206 Identities=26% Similarity=0.402 Sum_probs=170.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
...++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+..++.+. ||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETP 86 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC--CTTBCCEEEEEEEEET
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC--CCCcceEEEeeeccCC
Confidence 35678999999999999999999975 799999999975422 23356788999999998 9999999999876544
Q ss_pred e----eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 115 R----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 115 ~----~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
. ++||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 159 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 159 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECC
T ss_pred CCcccEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEee
Confidence 3 8999999999999998 4456799999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 191 FGLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 191 fg~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
||++........ .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999986543221 222335689999999999999999999999999999999999999986654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=282.02 Aligned_cols=218 Identities=25% Similarity=0.355 Sum_probs=186.7
Q ss_pred ccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc---cccce
Q 024118 27 KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---CHENL 102 (272)
Q Consensus 27 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~---~~~~i 102 (272)
.+...+++..+....++|++.+.||+|+||.||+|.+. +++.||+|++.. ..........|+..++.+.. .||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34577889999999999999999999999999999885 789999999863 23344556677877777752 29999
Q ss_pred eEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 024118 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 182 (272)
Q Consensus 103 ~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~ 182 (272)
+++++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 99999999999999999999 99999998432 234589999999999999999999999 9999999999999975
Q ss_pred -------------------------CCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHH
Q 024118 183 -------------------------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 237 (272)
Q Consensus 183 -------------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~i 237 (272)
++.++|+|||++...... .....|++.|+|||++.+..++.++|+|||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 788999999999864332 233568999999999999999999999999999
Q ss_pred HHHHHhCCCccccccCCC
Q 024118 238 LLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 238 l~~l~tg~~p~~~~~~~~ 255 (272)
+|+|++|+.||...+..+
T Consensus 249 l~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHME 266 (360)
T ss_dssp HHHHHHSSCSCCCSSHHH
T ss_pred HHHHHHCCCCCCCCcHHH
Confidence 999999999998766544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=270.93 Aligned_cols=204 Identities=22% Similarity=0.308 Sum_probs=180.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
...++|++.+.||+|+||.||+|.+. ++..+++|.+..........+.+|+..++.+. ||||+++++++......++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD--HPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCeEEE
Confidence 34678999999999999999999877 68899999998665666778999999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCeEEeecCcc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLS 194 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv---~~~~~~~l~Dfg~~ 194 (272)
||||+++++|.+.+ .....+++..++.++.|++.|+.+||++ ||+|+||+|+||++ +.++.++|+|||++
T Consensus 84 v~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 84 VMELCTGGELFERV----VHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEECCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEeccCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 99999999999988 4456789999999999999999999999 99999999999999 78889999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
........ .....+++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...+..
T Consensus 157 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (277)
T 3f3z_A 157 ARFKPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213 (277)
T ss_dssp EECCTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeccCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence 86643322 2345689999999998665 899999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=284.39 Aligned_cols=220 Identities=20% Similarity=0.240 Sum_probs=184.3
Q ss_pred ccCCChhHHHHhhCCeeeeeeeeec--cceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhccccccccee
Q 024118 29 INAFSYNQLKIATNGFRWSNKIGEG--GFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 29 ~~~~~~~~~~~~~~~y~i~~~lg~G--~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
...-+...+....++|++.+.||+| +||.||+|.+. +|+.||+|.+.... ......+.+|+..++.+. ||||+
T Consensus 12 ~~~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv 89 (389)
T 3gni_B 12 LYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN--HPNIV 89 (389)
T ss_dssp SCCC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC--CTTBC
T ss_pred hhhhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC--CCCCC
Confidence 3344445555678889999999999 99999999987 79999999997542 334467778999999998 99999
Q ss_pred EeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 104 ~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
++++++......++||||+++++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~ 164 (389)
T 3gni_B 90 PYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD 164 (389)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cEeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 9999999999999999999999999998432 235689999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCcccccCCCC------ccccccccccccccCcccccc--CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 184 FNPKISDFGLSKLFPENT------THISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+.++|+|||.+....... ........|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+...
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred CCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999886442111 111222467889999999987 578999999999999999999999998765544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=280.89 Aligned_cols=210 Identities=20% Similarity=0.275 Sum_probs=179.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcc-cccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+..++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+|+..++.+ . ||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGS--GDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCS--CTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhC--CCCCCEEEEEEecCCccE
Confidence 34678999999999999999999975 799999999874432 23577899999998 5 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-----eEEeec
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-----PKISDF 191 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~-----~~l~Df 191 (272)
+||||+ +++|.+++.. ....+++..++.++.|++.||.+||++ ||+||||||+||+++.++. ++|+||
T Consensus 82 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred EEEEeC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 999999 9999999843 246799999999999999999999999 9999999999999998887 999999
Q ss_pred CcccccCCCCcc------ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 192 GLSKLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 192 g~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
|++......... ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~ 228 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER 228 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence 999865432211 12346789999999999999999999999999999999999999998765544333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=284.48 Aligned_cols=216 Identities=25% Similarity=0.423 Sum_probs=181.4
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcc-cccccceeEee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLH 106 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~-~~~~~~i~~l~ 106 (272)
+....++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+..++.+ . ||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCC--CTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcC--CCCEeeEE
Confidence 3456689999999999999999999752 45679999987442 23446788999999999 6 99999999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIK 174 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~ 174 (272)
+++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ ||+|||||
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlk 230 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA 230 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 999999999999999999999999954321 124588999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 175 TSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 175 p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
|+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++|+|||||++|+|++ |+.||...+
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999986543221 12233456788999999999999999999999999999999 999998766
Q ss_pred CCCce
Q 024118 253 QLGEY 257 (272)
Q Consensus 253 ~~~~~ 257 (272)
..+..
T Consensus 311 ~~~~~ 315 (370)
T 2psq_A 311 VEELF 315 (370)
T ss_dssp GGGHH
T ss_pred HHHHH
Confidence 55443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=273.41 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=171.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+..++.+. ||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC--CTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcC--CCCEeeeeeEEccCCeEEEEE
Confidence 57999999999999999999998899999999865432 23467889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++ +|.+++. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 80 EHLDQ-DLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp ECCSE-EHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EecCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 99975 8888873 2346789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 153 PVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 221 12334678999999999764 589999999999999999999999976553
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=272.36 Aligned_cols=197 Identities=23% Similarity=0.434 Sum_probs=170.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..+++++ ||||+++++++..+...++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC--CCCEeeEEeEEEeCCEEEEE
Confidence 58999999999999999999986 79999999997543 233467889999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++ +|.+.+. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 999976 4544442 3456799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCcc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
.... ......+++.|+|||++.+.. ++.++|+||+|+++|+|++|..||
T Consensus 153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 153 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp SCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred Cccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 3222 223356789999999998766 799999999999999999988875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=293.37 Aligned_cols=208 Identities=27% Similarity=0.434 Sum_probs=182.3
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+..++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..++.+. ||||+++++++...
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR--HPHIIKLYQVISTP 88 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC--CTTBCCEEEEEECS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEEC
Confidence 3455678999999999999999999987 89999999997432 233467889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||
T Consensus 89 ~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp SEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred CEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence 9999999999999999998 4456799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
++....... .....+|++.|+|||++.+..+ +.++|+||+||++|+|++|+.||...+...
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 162 LSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp SCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred chhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 998764322 2334578999999999988775 689999999999999999999998765443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=275.04 Aligned_cols=206 Identities=23% Similarity=0.354 Sum_probs=175.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC--c
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--C 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--~ 114 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..++.++ ||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCCcceEEEEeecCCCce
Confidence 34678999999999999999999887 69999999987432 334567789999999998 999999999988655 6
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCCeEEee
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISD 190 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv----~~~~~~~l~D 190 (272)
.++||||+++++|.+++.... ....+++..++.++.|++.||.+||++ ||+|+||||+||++ +.++.++|+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred EEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 789999999999999985431 223489999999999999999999999 99999999999999 7777899999
Q ss_pred cCcccccCCCCccccccccccccccCccccc--------cCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAI--------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
||++........ .....+++.|+|||++. +..++.++|+|||||++|+|++|+.||...+
T Consensus 160 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 160 FGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987644332 23356899999999986 4678899999999999999999999997544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=272.52 Aligned_cols=206 Identities=32% Similarity=0.501 Sum_probs=177.5
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|++.+.||+|++|.||+|.+. ++..||+|++... .......+.+|+..++.+. ||||+++++++......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC--CCCCcchhheEecCCEE
Confidence 4577999999999999999999876 6889999998643 2233567888999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+++|||+++++|.+.+ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~l~~~l----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 85 YLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp EEEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccc
Confidence 9999999999999998 4456799999999999999999999999 99999999999999999999999999886
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 216 (279)
T 3fdn_A 158 HAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216 (279)
T ss_dssp CC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred cCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 543222 23356889999999999989999999999999999999999999876654433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=303.32 Aligned_cols=212 Identities=23% Similarity=0.343 Sum_probs=181.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.+..++|++.+.||+|+||.||+|.+. +++.||||++... ..........|...+..+.. ||+|+++++++...+
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~-~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-PPFLTQLHSCFQTMD 415 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTC-CTTBCCEEEECBCSS
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEEEeCC
Confidence 456788999999999999999999877 7899999999743 23344567788888887743 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||++|++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.++|+|||+
T Consensus 416 ~~~lV~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEEEEEeCcCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecce
Confidence 999999999999999998 4456799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
+....... ......+||+.|+|||++.+..++.++|+||||+++|+|++|++||...+..+.+.
T Consensus 489 a~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~ 552 (674)
T 3pfq_A 489 CKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552 (674)
T ss_dssp CEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 98543222 12344679999999999999999999999999999999999999998876654433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=276.17 Aligned_cols=205 Identities=24% Similarity=0.369 Sum_probs=180.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc------cHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+...... ....+.+|+..++.+. ||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL--HHNVITLHDVYENR 87 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECS
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC--CCCcceEEEEEecC
Confidence 4567999999999999999999987 7999999999754321 3567889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CeEE
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKI 188 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~----~~~l 188 (272)
...++||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++ .++|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp SEEEEEECCCCSCBHHHHH----HTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred CEEEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEE
Confidence 9999999999999999998 3456789999999999999999999999 999999999999999888 7999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+|||++........ .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 161 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 225 (321)
T 2a2a_A 161 IDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (321)
T ss_dssp CCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999986654322 233568999999999999899999999999999999999999998765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=279.70 Aligned_cols=210 Identities=30% Similarity=0.500 Sum_probs=177.4
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.+..++|++.+.||+|+||.||+|.+. .+..||+|.+... .......+.+|+..++.+. ||||+++++++...
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD--HPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeC
Confidence 356788999999999999999999875 3446999998744 3334567889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred CccEEEeeCCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCC
Confidence 99999999999999999983 2345799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 193 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
++......... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 262 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99876543221 1222345678999999998899999999999999999999 999997665443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=282.18 Aligned_cols=203 Identities=25% Similarity=0.386 Sum_probs=167.3
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..++|++.+.||+|+||.||++++. +++.||+|++.... .....+.+|+..++.++ ||||+++++++......++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCC--CCCCCcEEEEEeeCCEEEEE
Confidence 4678999999999999999999987 89999999997443 33457889999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC--eEEeecCcccc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDFGLSKL 196 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~--~~l~Dfg~~~~ 196 (272)
|||+++++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++. ++|+|||++..
T Consensus 95 ~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 95 MEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999998 3456799999999999999999999999 9999999999999987765 99999999874
Q ss_pred cCCCCccccccccccccccCccccccCCCCCC-CceehHHHHHHHHHhCCCccccccCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRK-SDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
..... ......|++.|+|||++.+..++.+ +|+|||||++|+|++|+.||...+..
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 32221 2233568999999999988887655 89999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=293.78 Aligned_cols=206 Identities=31% Similarity=0.438 Sum_probs=181.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+..++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++.+. ||||+++++++.....
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC--CCCEeeEEEEEeeCCE
Confidence 45678999999999999999999886 7999999998643 2334567888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||++|++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.+|.++|+|||++
T Consensus 259 l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccc
Confidence 99999999999999998432 234599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
........ .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 334 ~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 334 VHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp EECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred eecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 87643322 2335789999999999998999999999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=272.61 Aligned_cols=214 Identities=30% Similarity=0.469 Sum_probs=183.3
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+--+.+.+..++|++.+.||+|+||.||+|.+.++..||+|.+... ......+.+|+..++.+. ||||+++++++..
T Consensus 3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQ--HQRLVRLYAVVTQ 79 (279)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECS
T ss_pred cchhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCC--CcCcceEEEEEcC
Confidence 3445677788999999999999999999999888889999998643 334567889999999998 9999999998764
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
+..+++|||+++++|.+++... ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+||
T Consensus 80 -~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df 153 (279)
T 1qpc_A 80 -EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 153 (279)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred -CCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCC
Confidence 5688999999999999998431 223689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
|++...............++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 217 (279)
T 1qpc_A 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (279)
T ss_dssp TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred cccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence 9998765443333334456778999999988889999999999999999999 99999865543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.43 Aligned_cols=217 Identities=29% Similarity=0.462 Sum_probs=186.5
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.++..+.+.+..++|++.+.||+|+||.||+|.+.++..||||.++... .....+.+|+..++.++ ||||+++++++
T Consensus 176 ~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--h~~iv~l~~~~ 252 (454)
T 1qcf_A 176 KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQ--HDKLVKLHAVV 252 (454)
T ss_dssp CCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCC--CTTBCCEEEEE
T ss_pred ccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCC--CCCEeeEEEEE
Confidence 3455677888899999999999999999999999888999999987443 45678999999999998 99999999988
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
. ....++||||+++++|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEEC
T ss_pred e-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEe
Confidence 6 56789999999999999999432 234688999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
|||++...............++..|+|||++....++.++|+||||+++|+|++ |+.||...+..+
T Consensus 327 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~ 393 (454)
T 1qcf_A 327 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 393 (454)
T ss_dssp STTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999998664332222233445678999999998889999999999999999999 999998765444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=272.29 Aligned_cols=208 Identities=30% Similarity=0.485 Sum_probs=181.3
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+..++|++.+.||+|++|.||+|.+.++..||+|.+.... .....+.+|+..++.+. ||||+++++++......++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCC--CTTBCCEEEEECSSSSCEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEccCCCeEE
Confidence 35567899999999999999999999888899999987443 34467889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+|||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccc
Confidence 9999999999999832 345689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
............++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence 4332222333456778999999998889999999999999999999 99999866543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=269.59 Aligned_cols=204 Identities=24% Similarity=0.403 Sum_probs=178.6
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
..++|++.+.||+|++|.||+|.+. +|+.||+|++.... ......+.+|+..++.++ ||||+++++++......+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC--CCCcCeEEEEEEcCCEEE
Confidence 4688999999999999999999876 69999999987542 233466788999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---eEEeecCc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGL 193 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~---~~l~Dfg~ 193 (272)
++|||+++++|.+.+ .....+++..++.++.|++.|+.+||++ ||+|+||+|+||+++.++. ++|+|||.
T Consensus 82 ~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 82 LVFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEECCCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 999999999999888 4456799999999999999999999999 9999999999999976655 99999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 213 (284)
T 3kk8_A 155 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213 (284)
T ss_dssp CEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence 986543322 23356899999999999999999999999999999999999999765543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=276.23 Aligned_cols=208 Identities=25% Similarity=0.426 Sum_probs=163.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..++.+. ||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK--HENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC--BTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC--CCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999876 79999999997543 234467889999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhccc--ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 119 YDYMPNNSLSQTLLGEEK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
|||++ ++|.+++..... ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99997 589888854321 224589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
....... .....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+
T Consensus 158 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 216 (317)
T 2pmi_A 158 FGIPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216 (317)
T ss_dssp TTSCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cCCCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 5432221 2335678999999999764 58999999999999999999999998765443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=272.10 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=170.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--------------------------ccHHHHHHHHHH
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--------------------------QGEKEFMSEVAS 91 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--------------------------~~~~~~~~e~~~ 91 (272)
+..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34678999999999999999999876 789999999864321 112467889999
Q ss_pred hhcccccccceeEeeeeEec--CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 024118 92 MANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 169 (272)
Q Consensus 92 ~~~~~~~~~~i~~l~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~ 169 (272)
++.+. ||||+++++++.. ....++||||+++++|.++. ....+++..++.++.|++.||.+||++ ||+
T Consensus 90 l~~l~--h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iv 159 (298)
T 2zv2_A 90 LKKLD--HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KII 159 (298)
T ss_dssp HHTCC--CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred HHhCC--CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 99998 9999999999886 56789999999999998865 345799999999999999999999999 999
Q ss_pred ecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCccccccCC---CCCCCceehHHHHHHHHHhCCC
Q 024118 170 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRT 246 (272)
Q Consensus 170 h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~ 246 (272)
|+||||+||+++.++.++|+|||++........ ......|++.|+|||++.+.. .+.++|+||||+++|+|++|+.
T Consensus 160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999999999999999999999986543322 223457899999999998765 3678999999999999999999
Q ss_pred cccccc
Q 024118 247 AVDFDV 252 (272)
Q Consensus 247 p~~~~~ 252 (272)
||...+
T Consensus 239 pf~~~~ 244 (298)
T 2zv2_A 239 PFMDER 244 (298)
T ss_dssp SSCCSS
T ss_pred CCCCcc
Confidence 997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=268.60 Aligned_cols=208 Identities=27% Similarity=0.445 Sum_probs=159.9
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..++.+. ||||+++++++.....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK--HPSILELYNYFEDSNY 85 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC--CTTBCCEEEEEECSSE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC--CCCeEeEEEEEccCCe
Confidence 34567999999999999999999875 79999999986432 223467888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||+++++|.+++. ....++++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++
T Consensus 86 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA 159 (278)
T ss_dssp EEEEEECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecce
Confidence 999999999999999983 2346789999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 160 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 219 (278)
T 3cok_A 160 TQLKMPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-
T ss_pred eeccCCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH
Confidence 865432221 223567899999999998889999999999999999999999998765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=275.22 Aligned_cols=216 Identities=29% Similarity=0.457 Sum_probs=188.3
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
++.+.+..++|++.+.||+|++|.||+|.+. ++..||+|.+... ......+.+|+..+++++ ||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCC--CTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCC--CCCEeeEEEEEccC
Confidence 3456678889999999999999999999987 6889999998643 344567889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++.. .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence 999999999999999999843 2345689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCce
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEY 257 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~ 257 (272)
++...............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~ 222 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 998766544444444556788999999998899999999999999999999 99999876655433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=283.46 Aligned_cols=210 Identities=27% Similarity=0.423 Sum_probs=167.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC-
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP- 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~- 113 (272)
....++|++.+.||+|+||.||+|.+. +|+.||+|.+... ......+..+|+..++.+.. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG-HENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccC-CCCCCeeeeEEecCCC
Confidence 345789999999999999999999876 7999999998533 33445677889998888864 999999999987544
Q ss_pred -ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 114 -CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 114 -~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
..++||||++ ++|...+. ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.++|+|||
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999997 58888873 35789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCC--------------------CccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 193 LSKLFPEN--------------------TTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 193 ~~~~~~~~--------------------~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
++...... .........||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99765321 1112233578999999999986 56899999999999999999999999877
Q ss_pred cCCCce
Q 024118 252 VQLGEY 257 (272)
Q Consensus 252 ~~~~~~ 257 (272)
+....+
T Consensus 235 ~~~~~~ 240 (388)
T 3oz6_A 235 STMNQL 240 (388)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 654433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=276.48 Aligned_cols=222 Identities=29% Similarity=0.398 Sum_probs=185.4
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeE
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVK 104 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~ 104 (272)
.....+.+..++|.+.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+..++.+. ||||++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~ 90 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPHVIK 90 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC--CTTBCC
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCceee
Confidence 34455667788999999999999999999986 245889999987432 334467888999999998 999999
Q ss_pred eeeeEecCCceeEEEeecCCCCHhHHHhhccc--------------------ccccCChHHHHHHHHHHHHHHHHHhhcC
Q 024118 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK--------------------RRAKFGWKARREIIMGIGRGLAYIHEEI 164 (272)
Q Consensus 105 l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~ 164 (272)
+++++......++||||+++++|.+++..... ....+++..++.++.|++.||.+||++
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~- 169 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM- 169 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-
Confidence 99999999999999999999999999965432 124589999999999999999999999
Q ss_pred CCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh
Q 024118 165 QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 165 ~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t 243 (272)
||+|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 170 --~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 170 --KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp --TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred --CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999986543322 12223456788999999998889999999999999999999
Q ss_pred -CCCccccccCCCcee
Q 024118 244 -GRTAVDFDVQLGEYH 258 (272)
Q Consensus 244 -g~~p~~~~~~~~~~~ 258 (272)
|..||...+......
T Consensus 248 ~g~~p~~~~~~~~~~~ 263 (314)
T 2ivs_A 248 LGGNPYPGIPPERLFN 263 (314)
T ss_dssp TSCCSSTTCCGGGHHH
T ss_pred CCCCCCCCCCHHHHHH
Confidence 999998776655433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.54 Aligned_cols=208 Identities=23% Similarity=0.312 Sum_probs=167.6
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+..++.+. ||||+++++++..+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ--EPHVVPIHDFGEID 106 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEET
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC--CCCeeEEEEEEeeC
Confidence 3445688999999999999999999976 789999999864422 22367888999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++++||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+|||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp TEEEEEEECCCCEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred CeEEEEEEecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999999998 3446799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++...............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp C----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred cCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 9986654333333445688999999999998899999999999999999999999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=282.59 Aligned_cols=219 Identities=25% Similarity=0.395 Sum_probs=184.0
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcc-cccccc
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHEN 101 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~-~~~~~~ 101 (272)
.....+.+..++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|++.++.+ . |||
T Consensus 59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hpn 136 (382)
T 3tt0_A 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKN 136 (382)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC--CTT
T ss_pred ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcC--Cch
Confidence 334456777899999999999999999999852 24579999987442 33446788999999998 5 999
Q ss_pred eeEeeeeEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 024118 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVV 169 (272)
Q Consensus 102 i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~ 169 (272)
|+++++++......++||||+++++|.+++..... ....+++..++.++.|++.||.+||++ ||+
T Consensus 137 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 213 (382)
T 3tt0_A 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCI 213 (382)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred hhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEe
Confidence 99999999999999999999999999999954321 124589999999999999999999999 999
Q ss_pred ecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCc
Q 024118 170 HRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTA 247 (272)
Q Consensus 170 h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p 247 (272)
|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 214 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986543221 22233456788999999999999999999999999999999 9999
Q ss_pred cccccCCC
Q 024118 248 VDFDVQLG 255 (272)
Q Consensus 248 ~~~~~~~~ 255 (272)
|...+..+
T Consensus 294 ~~~~~~~~ 301 (382)
T 3tt0_A 294 YPGVPVEE 301 (382)
T ss_dssp STTCCHHH
T ss_pred CCCCCHHH
Confidence 98765444
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=273.15 Aligned_cols=204 Identities=22% Similarity=0.394 Sum_probs=171.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP---- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~---- 113 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..+++++ ||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE--HPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC--CTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC--CCCEeeEEEEEEEeccchh
Confidence 4567999999999999999999987 89999999997543 334567899999999998 999999999876543
Q ss_pred -----------------------------------------------------ceeEEEeecCCCCHhHHHhhccccccc
Q 024118 114 -----------------------------------------------------CRILVYDYMPNNSLSQTLLGEEKRRAK 140 (272)
Q Consensus 114 -----------------------------------------------------~~~iv~e~~~~~~L~~~~~~~~~~~~~ 140 (272)
..+++|||+++++|.+++.... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~ 160 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLED 160 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGG
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccc
Confidence 2789999999999999985432 2344
Q ss_pred CChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-----------ccccccc
Q 024118 141 FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-----------HISTRVA 209 (272)
Q Consensus 141 l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~ 209 (272)
.++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++........ .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 56778999999999999999999 999999999999999999999999999987654321 1123356
Q ss_pred ccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 210 ~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
|++.|+|||++.+..++.++|+||||+++|+|++|..|+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 8999999999999999999999999999999999988874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=286.64 Aligned_cols=216 Identities=27% Similarity=0.410 Sum_probs=183.0
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
...+.+.+..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+..++.+. ||||+++++++
T Consensus 104 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~ 181 (377)
T 3cbl_A 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVC 181 (377)
T ss_dssp CCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC--CTTBCCEEEEE
T ss_pred ccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEE
Confidence 334566777889999999999999999999987 79999999986432 223346788999999998 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
......++||||+++++|.+++.. ....+++..++.++.|++.|+.|||++ ||+||||+|+||+++.++.++|+
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~ 255 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKIS 255 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEEC
Confidence 999999999999999999999842 345689999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCcccc-ccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 190 DFGLSKLFPENTTHIS-TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
|||++........... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 256 DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~ 323 (377)
T 3cbl_A 256 DFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323 (377)
T ss_dssp CGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH
T ss_pred cCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999986443222111 11234677999999998889999999999999999998 999998765443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=277.80 Aligned_cols=203 Identities=25% Similarity=0.381 Sum_probs=163.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
....++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+|+..++.+. ||||+++++++......+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLS--HPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCC--CTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCC--CCCCcceeeeEecCCeEE
Confidence 345678999999999999999999987 68899999987432 3456778999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCeEEeecCc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGL 193 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~---~~~~~l~Dfg~ 193 (272)
+||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++. ++.++|+|||+
T Consensus 125 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 125 LVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEECCCCSCBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 999999999999998 3456789999999999999999999999 9999999999999975 88999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+....... ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 198 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 198 SKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred ccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 98654322 12335689999999999998999999999999999999999999975443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=272.70 Aligned_cols=211 Identities=27% Similarity=0.403 Sum_probs=170.0
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-----ccHHHHHHHHHHhhccc-ccccceeEeeeeE
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-----QGEKEFMSEVASMANVN-VCHENLVKLHGGC 109 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~ 109 (272)
+.+..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+|+..++.+. ..||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3466789999999999999999999975 799999999874321 12235556666555543 1299999999998
Q ss_pred ecCC-----ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 024118 110 IDGP-----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 110 ~~~~-----~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~ 184 (272)
.... ..+++|||++ ++|.+++... ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 8765 4789999996 5999988432 223499999999999999999999999 999999999999999999
Q ss_pred CeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.++|+|||++........ .....+++.|+|||++.+..++.++|+|||||++|+|++|++||...+..+
T Consensus 158 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 226 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226 (308)
T ss_dssp CEEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred CEEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999986543222 234578999999999999999999999999999999999999998766544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=275.74 Aligned_cols=201 Identities=26% Similarity=0.394 Sum_probs=155.5
Q ss_pred hCCeeee---eeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWS---NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~---~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|++. +.||+|+||.||+|.+. +|+.||+|++... ......+|+..++.+.. ||||+++++++......+
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~-h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEG-HPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcC-CCCeeEEEEEEEcCCEEE
Confidence 4568876 88999999999999886 7999999998632 44567788888888764 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---CeEEeecCc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDFGL 193 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~---~~~l~Dfg~ 193 (272)
+||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++ .++|+|||+
T Consensus 83 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 83 LVMELLNGGELFERI----KKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp EEECCCCSCBHHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred EEEEccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 999999999999998 4456799999999999999999999999 999999999999997766 799999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+........ ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 156 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 156 ARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp CEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 986543322 22345679999999999999999999999999999999999999986553
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=281.00 Aligned_cols=222 Identities=24% Similarity=0.375 Sum_probs=185.7
Q ss_pred ccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEe-----C-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccc
Q 024118 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL-----Q-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 29 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~-----~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~ 101 (272)
..++....+.+..++|++.+.||+|+||.||+|.+ . +++.||+|.+.... ......+.+|+..+.++.. |||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hpn 87 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLN 87 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTT
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcC-Ccc
Confidence 35677788889999999999999999999999973 2 56899999997432 2334678899999999943 999
Q ss_pred eeEeeeeEecCCc-eeEEEeecCCCCHhHHHhhcccc-------------------------------------------
Q 024118 102 LVKLHGGCIDGPC-RILVYDYMPNNSLSQTLLGEEKR------------------------------------------- 137 (272)
Q Consensus 102 i~~l~~~~~~~~~-~~iv~e~~~~~~L~~~~~~~~~~------------------------------------------- 137 (272)
|+++++++...+. .++||||+++++|.+++......
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999887654 89999999999999999654321
Q ss_pred -------------------cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 138 -------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 138 -------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
...+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 12289999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 199 ENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 199 ~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 322 222334567889999999999999999999999999999998 99999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=268.28 Aligned_cols=206 Identities=22% Similarity=0.361 Sum_probs=177.9
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc------ccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+..++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+|+..++.+. ||||+++++++..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR--HPNIITLHDIFEN 79 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEEC
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC--CCCeeehhheecC
Confidence 34567999999999999999999987 799999999875421 23567889999999998 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CeE
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPK 187 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~----~~~ 187 (272)
....+++|||+++++|.+++ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++ .++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEE
T ss_pred CCeEEEEEeecCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceE
Confidence 99999999999999999998 3456799999999999999999999999 999999999999998877 799
Q ss_pred EeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|+|||.+........ .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 153 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 218 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218 (283)
T ss_dssp ECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred EEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence 999999986543222 233468899999999998889999999999999999999999998765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=273.44 Aligned_cols=206 Identities=24% Similarity=0.358 Sum_probs=173.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.++|++.+.||+|++|.||+|.+. +|+.||+|.+..... .....+.+|+..++++. ||||+++++++......++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--HPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC--CCCccchhheeecCCeEEE
Confidence 468999999999999999999986 699999998864432 23456778999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 80 VFEYCDHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEECCSEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 99999999999887 4456799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
..... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+.
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 211 (311)
T 4agu_A 153 TGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ 211 (311)
T ss_dssp C-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 43222 1233568899999999976 5679999999999999999999999987665443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=268.88 Aligned_cols=206 Identities=27% Similarity=0.405 Sum_probs=175.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ......+.+|++.++.+. ||||+++++++......++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD--HPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC--CchHHhHHHheecCCeEEE
Confidence 3467999999999999999999876 78999999987543 334578889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCeEEeecCcc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLS 194 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv---~~~~~~~l~Dfg~~ 194 (272)
||||+++++|.+.+.........+++..++.++.|++.||.+||++ ||+|+||+|+||++ +.++.++|+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999866555567899999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
........ .....+++.|+|||.+. ..++.++|+||||+++|+|++|+.||...+.
T Consensus 175 ~~~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 175 ELFKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp CC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 76543222 23356899999999885 4678999999999999999999999986554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=269.83 Aligned_cols=209 Identities=21% Similarity=0.286 Sum_probs=177.6
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..+..++|++.+.||+|++|.||+|.+. +|+.||+|++.... ....+.+|+..++.+.. |++++++++++......
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~-~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAG-CTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTT-CTTCCCEEEEEEETTEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhc-CCCCCeEEeecCCCcee
Confidence 3456788999999999999999999875 79999999986432 22356778888888843 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-----eEEee
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-----PKISD 190 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~-----~~l~D 190 (272)
+++|||+ +++|.+++.. ...++++..++.++.|++.||.+||++ ||+|+||||+||+++.++. ++|+|
T Consensus 82 ~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 9999999 9999999842 245699999999999999999999999 9999999999999987776 99999
Q ss_pred cCcccccCCCCc------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++........ .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 225 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 225 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc
Confidence 999986643322 12334568999999999999999999999999999999999999998765443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=288.86 Aligned_cols=202 Identities=25% Similarity=0.308 Sum_probs=168.6
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC---
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--- 113 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|++... ......++.+|+..++.+. ||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC--CCCCCcEEEEEccCCccc
Confidence 4688999999999999999999876 7999999999743 3344567889999999998 999999999987553
Q ss_pred ---ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 114 ---~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
..++||||++++ |.+.+ ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~------~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCeEEEEEeCCCCC-HHHHH------hhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 469999999764 55555 23488999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++....... ......||+.|+|||++.+..++.++|+||+||++|+|++|++||.+.+..+
T Consensus 208 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~ 270 (464)
T 3ttj_A 208 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270 (464)
T ss_dssp CCCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99998654322 2344678999999999999999999999999999999999999998766433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=273.14 Aligned_cols=206 Identities=22% Similarity=0.325 Sum_probs=172.9
Q ss_pred hhCCeeee-eeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..++|++. +.||+|+||.||+|.+. +++.||+|++..........+.+|+..+.++.. ||||+++++++...+..++
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG-HRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEEE
Confidence 45789996 78999999999999876 799999999986666667788999999988532 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---eEEeecCcc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---PKISDFGLS 194 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~---~~l~Dfg~~ 194 (272)
||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++. ++|+|||++
T Consensus 89 v~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 89 VFEKMRGGSILSHI----HKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 99999999999998 3456799999999999999999999999 9999999999999988776 999999998
Q ss_pred cccCCCC------ccccccccccccccCcccccc-----CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENT------THISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
....... ........|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 7553211 111223458999999999875 4578999999999999999999999986653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.03 Aligned_cols=201 Identities=24% Similarity=0.384 Sum_probs=171.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
...++|++.+.||+|+||.||+|.++ +|+.||+|++...... ..+|++.+.++.. ||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~-hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQ-HPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTT-STTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcC-CCCcCeEEEEEEcCCEEEE
Confidence 45678999999999999999999887 7999999999744322 2356666666632 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-C---CeEEeecCc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-F---NPKISDFGL 193 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~-~---~~~l~Dfg~ 193 (272)
||||++|++|.+.+ .....+++..++.++.|++.||.|||++ ||+||||||+||++.+. + .++|+|||+
T Consensus 94 v~E~~~gg~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 94 VTELMKGGELLDKI----LRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp EECCCCSCBHHHHH----HTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 99999999999998 4456799999999999999999999999 99999999999998543 2 499999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+........ .....++++.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 167 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 167 AKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp CEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred cccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 986543322 2234578999999999988888999999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=268.49 Aligned_cols=205 Identities=28% Similarity=0.453 Sum_probs=179.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
...++|++.+.||+|++|.||+|.+. ++..||+|++... .......+.+|+..++.+. ||||+++++++.....
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR--HPNILRMYNYFHDRKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC--CCCEeeEEEEEEcCCE
Confidence 44578999999999999999999877 6889999998643 2233467888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||+++++|.+++ .....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 161 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS 161 (284)
T ss_dssp EEEEECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccc
Confidence 99999999999999998 3445789999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 162 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 219 (284)
T 2vgo_A 162 VHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219 (284)
T ss_dssp EECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH
Confidence 7654322 233568899999999999889999999999999999999999998665433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.27 Aligned_cols=215 Identities=27% Similarity=0.286 Sum_probs=176.8
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-----CcccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-----SKQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
..+....++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+..++.++ ||||++++++
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~ 96 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH--HPNIARLYEV 96 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC--CTTBCCEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC--CCCcceeehh
Confidence 345567889999999999999999999876 7899999998643 2344568889999999998 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhccc------------------------------------ccccCChHHHHHHHHH
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEK------------------------------------RRAKFGWKARREIIMG 152 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------------------------------~~~~l~~~~~~~i~~~ 152 (272)
+......++||||+++++|.+++..... ....+++..++.++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 9999999999999999999998842111 1234568889999999
Q ss_pred HHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC--CeEEeecCcccccCCC---CccccccccccccccCcccccc--CCC
Q 024118 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF--NPKISDFGLSKLFPEN---TTHISTRVAGTLGYLAPEYAIS--GRL 225 (272)
Q Consensus 153 i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~--~~~l~Dfg~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~--~~~ 225 (272)
++.||.+||++ ||+|+||+|+||+++.++ .++|+|||++...... .........+++.|+|||++.+ ..+
T Consensus 177 i~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 177 IFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 99999999999 999999999999998776 7999999999855321 1112334568999999999975 568
Q ss_pred CCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 226 ~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
+.++|+||||+++|+|++|+.||...+..
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~ 282 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChH
Confidence 89999999999999999999999765543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=270.73 Aligned_cols=204 Identities=25% Similarity=0.309 Sum_probs=167.6
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
......++|++.+.||+|+||+||+|.+. +|+.||||++.... .........|+..+..+.. ||||+++++++...
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~-h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ-HPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcC-CCcEEEEEEEEEeC
Confidence 34456678999999999999999999987 79999999876432 2333455556655555522 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+ +++|.+.+.. ....+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred CEEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999 6788888733 345799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
++........ .....|++.|+|||++.+ .++.++|+||+|+++|+|++|..|+..
T Consensus 203 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 203 LLVELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp TCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred eeeecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9876543222 233568999999999876 689999999999999999999766543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=279.70 Aligned_cols=204 Identities=24% Similarity=0.343 Sum_probs=172.9
Q ss_pred hCCeee--eeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 41 TNGFRW--SNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 41 ~~~y~i--~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+.|.+ .+.||+|+||.||+|.+. +|+.||+|++..........+.+|+..++.+. ||||+++++++......++
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--HANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEE
Confidence 345666 578999999999999876 79999999998666556678899999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE--cCCCCeEEeecCccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL--DQNFNPKISDFGLSK 195 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv--~~~~~~~l~Dfg~~~ 195 (272)
||||+++++|.+.+.. ....+++..++.++.|++.||.|||++ ||+|+||||+||++ +.++.++|+|||++.
T Consensus 164 v~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 164 VMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp EEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred EEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 9999999999988842 345689999999999999999999999 99999999999999 567789999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
....... .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 238 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 294 (373)
T 2x4f_A 238 RYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294 (373)
T ss_dssp ECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7643322 23346899999999999888999999999999999999999999876544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=274.25 Aligned_cols=218 Identities=22% Similarity=0.322 Sum_probs=185.4
Q ss_pred cCCChhHHHHhhCCeeee-eeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEe
Q 024118 30 NAFSYNQLKIATNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l 105 (272)
.+..+.......++|.+. +.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++.+.. ||||+++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~iv~~ 94 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS-CPRVINL 94 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT-CTTBCCE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC-CCCEEEE
Confidence 567778888889999998 89999999999999877 7999999998743 33446788889999988863 7999999
Q ss_pred eeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---
Q 024118 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ--- 182 (272)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~--- 182 (272)
++++......++||||+++++|.+++.. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTT
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCC
Confidence 9999999999999999999999998832 2346799999999999999999999999 9999999999999987
Q ss_pred CCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 183 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 183 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
++.++|+|||++........ .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp BCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 78999999999986643222 233568999999999999999999999999999999999999997765543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=280.53 Aligned_cols=208 Identities=28% Similarity=0.436 Sum_probs=175.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEe----CCCcEEEEEEEEecC----cccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
.+..++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+..++.+.. ||||+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~ 128 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-SPFLVTLHYAF 128 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-CTTBCCEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccC-CCceeEEEEEE
Confidence 34557899999999999999999987 378999999986331 2233456678888887743 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
......++||||+++++|.+++ .....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred eeCceEEEEeecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEe
Confidence 9999999999999999999998 3446799999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccC--CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG--RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|||++...............|++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.
T Consensus 202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 9999986543333334446789999999999863 478899999999999999999999976543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=268.33 Aligned_cols=204 Identities=23% Similarity=0.392 Sum_probs=179.1
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|.+.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+..++.+. ||||+++++++...+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA--HQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC--CCCEeeeeeeeccCCEE
Confidence 4578999999999999999999987 6889999998744 2234567788999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+++|||+++++|.+++ .....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||.+.
T Consensus 91 ~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 91 FVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp EEEEECCTTCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCce
Confidence 9999999999999988 3456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 220 (294)
T 2rku_A 164 KVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220 (294)
T ss_dssp ECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6543222 12335688999999999988899999999999999999999999986554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=265.83 Aligned_cols=206 Identities=28% Similarity=0.448 Sum_probs=179.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...++|++.+.||+|++|.||+|.+. +++.||+|.+.... ......+.+|+..++.+. ||||+++++++......+
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC--CCCceeeeeEEEcCCEEE
Confidence 35678999999999999999999987 79999999987443 234567888999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+|+||+++++|.+++ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 999999999999998 4456799999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC-ccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccC
Q 024118 197 FPENT-THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 197 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... ........+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 53221 122334568899999999987765 6789999999999999999999986554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=272.75 Aligned_cols=206 Identities=28% Similarity=0.506 Sum_probs=173.4
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec-
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID- 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~- 111 (272)
.+..++|++.+.||+|+||.||+|+. .+++.||+|.+..........+.+|+..++.++ ||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecC
Confidence 45678899999999999999999983 268999999997666566678899999999998 9999999998864
Q ss_pred -CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 112 -GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
....++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 3568999999999999999843 334689999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 191 FGLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 191 fg~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 999986643321 1122344667799999999999999999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=273.81 Aligned_cols=205 Identities=23% Similarity=0.386 Sum_probs=179.9
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
...++|.+.+.||+|+||.||++.+. +++.|++|++... .......+.+|+..++.+. ||||+++++++...+.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA--HQHVVGFHGFFEDNDF 115 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEecCCe
Confidence 34578999999999999999999887 6889999998744 2234567888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++|||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+|||++
T Consensus 116 ~~lv~e~~~~~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 116 VFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp EEEEECCCTTCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCCCCCHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCc
Confidence 99999999999999988 3456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
........ ......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 189 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 246 (335)
T 2owb_A 189 TKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246 (335)
T ss_dssp EECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH
Confidence 86543222 12335688999999999998899999999999999999999999986553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=288.38 Aligned_cols=204 Identities=29% Similarity=0.447 Sum_probs=177.1
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++++. ||||+++++++......+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC--CCCcCeEEEEEEcCCEEE
Confidence 5678999999999999999999987 7999999998643 2345678899999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCCeEEeecCc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGL 193 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~---~~~~~~l~Dfg~ 193 (272)
+||||+++++|.+.+ .....+++..++.++.|++.||.|||++ ||+||||||+||+++ .++.++|+|||+
T Consensus 98 lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 98 IVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEECCCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 999999999999988 3456799999999999999999999999 999999999999995 456799999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+....... ......|++.|+|||++.+ .++.++|+||+||++|+|++|++||...+..+
T Consensus 171 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 229 (486)
T 3mwu_A 171 STCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (486)
T ss_dssp TTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 98654332 2334578999999999876 48999999999999999999999998766544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=288.33 Aligned_cols=209 Identities=28% Similarity=0.411 Sum_probs=178.3
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-------------ccHHHHHHHHHHhhcccccccce
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-------------QGEKEFMSEVASMANVNVCHENL 102 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~~~i 102 (272)
.....++|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+..++++. ||||
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpni 108 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD--HPNI 108 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC--CTTB
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC--CCCC
Confidence 3446788999999999999999999987 789999999874321 23467889999999998 9999
Q ss_pred eEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 024118 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 182 (272)
Q Consensus 103 ~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~ 182 (272)
+++++++......++||||+++++|.+.+ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQI----INRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLEN 181 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESS
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEec
Confidence 99999999999999999999999999988 3456799999999999999999999999 9999999999999987
Q ss_pred CC---CeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 183 NF---NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 183 ~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
++ .++|+|||++........ .....|++.|+|||++.+ .++.++|+||+||++|+|++|.+||...+..+..
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 76 599999999986644322 334578999999999864 5899999999999999999999999877655433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=275.86 Aligned_cols=212 Identities=31% Similarity=0.464 Sum_probs=175.0
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..+.+..++|++.+.||+|+||.||+|++. ++.||+|++.... ........|+..+++++ ||||+++++++.....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMK--HENILQFIGAEKRGTS 92 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECS
T ss_pred cccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCC--CCCchhhcceeccCCC
Confidence 344566788999999999999999999876 7899999986432 33345566888888888 9999999999887543
Q ss_pred ----eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc-------CCCCeEecCCCCCCEEEcCC
Q 024118 115 ----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-------IQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 115 ----~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-------~~~~i~h~dl~p~nilv~~~ 183 (272)
.++||||+++++|.+++. ...+++..++.++.|++.||.|||+. +..||+|+||||+||+++.+
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred CCceEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 689999999999999983 34589999999999999999999974 12389999999999999999
Q ss_pred CCeEEeecCcccccCCCCc-cccccccccccccCccccccC-----CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 184 FNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISG-----RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
+.++|+|||++........ .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9999999999976543322 123335689999999999863 45678899999999999999999998765443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=271.61 Aligned_cols=203 Identities=26% Similarity=0.430 Sum_probs=176.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
...++|.+.+.||+|+||.||+|.+. +|+.||+|.+..........+.+|+..++.+. ||||+++++++......++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK--HENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC--CTTBCCEEEEEECSSEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC--CCCeeehhhhcccCCEEEE
Confidence 34678999999999999999999986 79999999998655445567889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCeEEeecCcc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLS 194 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv---~~~~~~~l~Dfg~~ 194 (272)
+|||+++++|.+.+ .....+++..++.++.|++.||.+||++ |++|+||+|+||++ +.++.++|+|||++
T Consensus 84 v~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 84 VMQLVSGGELFDRI----LERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp EECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEEcCCCccHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999999998 3456789999999999999999999999 99999999999999 78889999999998
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 157 KMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp CCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred eecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 754322 12334688999999999998899999999999999999999999976554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=271.82 Aligned_cols=211 Identities=27% Similarity=0.353 Sum_probs=166.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+.+..++|++.+.||+|+||.||+|.+. .+..|++|..... .......+.+|+..++.+. ||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCccceEEEEEc-
Confidence 4556788999999999999999999864 2457999987643 2334467888999999998 999999999874
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcc
Confidence 4568899999999999999832 334689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
|++...............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~ 226 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH
Confidence 9998665433322333456778999999998889999999999999999997 9999987665543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=274.96 Aligned_cols=217 Identities=25% Similarity=0.417 Sum_probs=166.8
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCc---EEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGT---IVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~---~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
..+.+..++|++.+.||+|+||.||+|.+. ++. .||+|++... .......+.+|+..++.++ ||||++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~ 93 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD--HPHVAKLVGV 93 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC--CTTBCCCCEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC--CCceehhhce
Confidence 445567789999999999999999999866 333 7999998754 3345578889999999998 9999999999
Q ss_pred EecCCce------eEEEeecCCCCHhHHHhhccc--ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 109 CIDGPCR------ILVYDYMPNNSLSQTLLGEEK--RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 109 ~~~~~~~------~iv~e~~~~~~L~~~~~~~~~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
+...... +++|||+++++|.+++..... ....+++..++.++.|++.||.+||++ ||+|+||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence 8877655 899999999999999854332 222689999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 181 DQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
+.++.++|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999999986543221 12223446778999999999999999999999999999999 9999987665543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.96 Aligned_cols=206 Identities=30% Similarity=0.443 Sum_probs=180.9
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
....++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++++. ||||+++++++....
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD--HPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSS
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC--CCCCCcEEEEEEeCC
Confidence 356678999999999999999999987 8999999998643 2345678899999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCeEEee
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISD 190 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv---~~~~~~~l~D 190 (272)
..++||||+.+++|.+.+ .....+++..++.++.|++.||.|||++ ||+||||||+||++ +.++.++|+|
T Consensus 100 ~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp EEEEEECCCCSCBHHHHH----HTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 999999999999999988 4456799999999999999999999999 99999999999999 5678899999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++........ .....|++.|+|||++.+ .++.++|+||+||++|+|++|++||...+..+
T Consensus 173 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 234 (484)
T 3nyv_A 173 FGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234 (484)
T ss_dssp TTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999986643322 233568999999999876 68999999999999999999999998766544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=266.63 Aligned_cols=207 Identities=27% Similarity=0.416 Sum_probs=172.2
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
.+.+..++|++.+.||+|++|.||+|.+. +|+.||+|++... .......+.+|+..++.+. ||||+++++++..
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR--HPHIIKLYQVIST 82 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEEC
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC--CCCEeEEEEEEec
Confidence 44566789999999999999999999987 7999999998743 2234567888999999998 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
....+++|||+++++|.+++ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999999998 3446789999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|++........ .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.
T Consensus 156 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 216 (276)
T 2h6d_A 156 GLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216 (276)
T ss_dssp CGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 99986543221 233467899999999987765 6899999999999999999999976543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=277.63 Aligned_cols=202 Identities=22% Similarity=0.319 Sum_probs=163.3
Q ss_pred hhCCeeee-eeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec----CC
Q 024118 40 ATNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP 113 (272)
Q Consensus 40 ~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~ 113 (272)
..++|.+. +.||.|+||.||+|.+. +|+.||+|++.. .....+|+..+.+... ||||+++++++.. ..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~-hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQ-CPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTT-STTBCCEEEEEEEEETTEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcC-CCCcceEeEEEeecccCCc
Confidence 45678777 79999999999999876 799999999862 2355677777654432 9999999998865 56
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCeEEee
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISD 190 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~---~~~~~l~D 190 (272)
..++||||++|++|.+++... ....+++..++.++.|++.||.|||++ ||+||||||+||+++. ++.++|+|
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 789999999999999998432 234689999999999999999999999 9999999999999987 78899999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 208 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 208 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp CTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred cccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 99998654322 123457899999999999999999999999999999999999999866543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=269.76 Aligned_cols=219 Identities=25% Similarity=0.383 Sum_probs=175.3
Q ss_pred ccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccce
Q 024118 27 KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENL 102 (272)
Q Consensus 27 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i 102 (272)
+....+.........++|++.+.||+|+||.||+|.+. +|..||+|.+... .......+.+|+..++.++ ||||
T Consensus 17 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i 94 (310)
T 2wqm_A 17 QPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNV 94 (310)
T ss_dssp ---CCCCGGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC--CTTB
T ss_pred ChhhcCCCCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC--CCCE
Confidence 34455556666677789999999999999999999875 7999999998743 2334567888999999998 9999
Q ss_pred eEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 024118 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ 182 (272)
Q Consensus 103 ~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~ 182 (272)
+++++++......+++|||+++++|.+++.........+++..++.++.|++.||.+||++ |++|+||+|+||+++.
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~ 171 (310)
T 2wqm_A 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITA 171 (310)
T ss_dssp CCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcC
Confidence 9999999999999999999999999999865555567799999999999999999999999 9999999999999999
Q ss_pred CCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 183 NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 183 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 172 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 172 TGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp TSCEEECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999876543221 123346788999999999988999999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=286.86 Aligned_cols=206 Identities=28% Similarity=0.416 Sum_probs=174.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
...++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+..++.+. ||||+++++++......
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--HPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC--CCCCCeEEEEEEeCCEE
Confidence 34567999999999999999999987 78999999987442 334567889999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCeEEeecC
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKISDFG 192 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~~~~l~Dfg 192 (272)
++||||+++++|.+.+ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.. +.++|+|||
T Consensus 112 ~lv~e~~~~g~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 112 YLVMECYKGGELFDEI----IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 9999999999999988 4456799999999999999999999999 99999999999999764 449999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
++....... ......|++.|+|||++. ..++.++|+||+||++|+|++|++||...+..+.
T Consensus 185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998654332 233457899999999886 4689999999999999999999999987765443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=274.56 Aligned_cols=208 Identities=26% Similarity=0.407 Sum_probs=178.0
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc--------cHHHHHHHHHHhhcccccccceeEee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ--------GEKEFMSEVASMANVNVCHENLVKLH 106 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~--------~~~~~~~e~~~~~~~~~~~~~i~~l~ 106 (272)
......++|++.+.||.|++|.||+|.+. +|+.||||++...... ....+.+|+..++.+.. ||||++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~ 166 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG-HPHIITLI 166 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT-CTTBCCEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC-CCCEeEEE
Confidence 34455678999999999999999999986 7999999998754311 13456788888888832 99999999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCe
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~ 186 (272)
+++......++||||++|++|.+++ .....+++..++.++.|++.||.+||+. ||+|+||+|+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999998 3456799999999999999999999999 99999999999999999999
Q ss_pred EEeecCcccccCCCCccccccccccccccCccccccC------CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+|+|||++........ .....|++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 310 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence 9999999986653322 2346789999999998643 578899999999999999999999976543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=277.78 Aligned_cols=216 Identities=32% Similarity=0.470 Sum_probs=181.2
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
..+....++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+..++.+. ||||+++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~ 117 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLG 117 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEEEEEE
Confidence 345567789999999999999999999874 34889999987442 334567889999999998 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhcccc--------------------cccCChHHHHHHHHHHHHHHHHHhhcCCCC
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKR--------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPH 167 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~--------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ 167 (272)
++......++||||+++++|.+++...... ...+++..++.++.|++.||.+||++ |
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 999999999999999999999999553211 25789999999999999999999999 9
Q ss_pred eEecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CC
Q 024118 168 VVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GR 245 (272)
Q Consensus 168 i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~ 245 (272)
|+|+||||+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999976532211 12233457888999999998889999999999999999999 99
Q ss_pred CccccccCCC
Q 024118 246 TAVDFDVQLG 255 (272)
Q Consensus 246 ~p~~~~~~~~ 255 (272)
.||...+..+
T Consensus 275 ~p~~~~~~~~ 284 (343)
T 1luf_A 275 QPYYGMAHEE 284 (343)
T ss_dssp CTTTTSCHHH
T ss_pred CcCCCCChHH
Confidence 9998665433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=269.76 Aligned_cols=194 Identities=20% Similarity=0.349 Sum_probs=169.5
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec--CCcee
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCRI 116 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~~~~~ 116 (272)
..++|++.+.||+|+||.||+|.+. +++.||+|++.. .....+.+|+..++.+.. ||||+++++++.. ....+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~-~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRG-GPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTT-STTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCC-CCCEEEeeeeeccCCCCceE
Confidence 4578999999999999999999875 799999999863 334678889999998864 9999999999987 56789
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEEeecCccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLSK 195 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~~~ 195 (272)
++|||+++++|.+++ ..+++..++.++.|++.||.+||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus 110 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999999887 2488999999999999999999999 999999999999999776 79999999998
Q ss_pred ccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 6543322 233567889999999987 568999999999999999999999994
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=275.52 Aligned_cols=204 Identities=26% Similarity=0.438 Sum_probs=167.0
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc-cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||+|+||.||+|.+. +++.||+|.+...... ....+.+|+..++.+. ||||+++++++......++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC--CTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC--CCCCCeeeeEEeeCCEEEEEe
Confidence 57999999999999999999987 7999999998643221 1123456899999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||++ ++|.+++. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 80 EYLD-KDLKQYLD---DCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp ECCS-EEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cccc-cCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 9997 48888873 2345689999999999999999999999 999999999999999999999999999975543
Q ss_pred CCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
... ......+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||...+..+
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 153 PTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred Ccc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 222 1233467899999999876 568999999999999999999999998766544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=287.17 Aligned_cols=214 Identities=32% Similarity=0.497 Sum_probs=178.3
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+.+.+..++|++.+.||+|+||.||+|.+.++..||||.+.... .....+.+|+..+++++ ||||+++++++..
T Consensus 175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE- 250 (452)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-
T ss_pred CccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEcC-
Confidence 3566778889999999999999999999999888889999987443 34567899999999998 9999999999876
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++.. .....+++..++.++.|++.||.|||++ ||+||||+|+||+++.++.++|+|||
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CceEEEehhhcCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence 678999999999999999943 2335689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
++...............++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 389 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 389 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 998664433222333446778999999998899999999999999999999 999998665433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.39 Aligned_cols=216 Identities=28% Similarity=0.453 Sum_probs=186.8
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.+.+.+..++|++.+.||+|+||.||+|.+. ++..||||.+... ......+.+|+..+++++ ||||+++++++...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcC--CCCEeeEEEEEecC
Confidence 3456677888999999999999999999987 5889999998744 334678999999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++... ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence 9999999999999999999432 335689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCce
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEY 257 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~ 257 (272)
++...............++..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+..
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 998765443333333445678999999998889999999999999999999 99999876655433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=276.19 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=178.1
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
.+..++|++.+.||+|+||.||+|.+. +|..||+|++... .......+.+|+..++.+. ||||+++++++..+...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC--CTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC--CCCEEEEeEEEEECCEE
Confidence 455788999999999999999999887 7999999999755 2334567889999999998 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
++||||+++++|.+++ .....+++..++.++.|++.+|.+||+ + ||+|+||||+||+++.++.++|+|||++
T Consensus 107 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEEECCCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEECCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999999998 345679999999999999999999998 5 8999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 180 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 180 GQLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp HHHHH---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ccccc---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 64421 112335689999999999999999999999999999999999999976553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=281.90 Aligned_cols=214 Identities=28% Similarity=0.418 Sum_probs=178.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
.+..++|++.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|+..++.++ ||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC--CCCCCeEEEEEe
Confidence 455788999999999999999999842 5778999998643 3344557888999999998 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhccc---ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF--- 184 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~--- 184 (272)
.....++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence 99999999999999999999955331 224589999999999999999999999 999999999999998555
Q ss_pred CeEEeecCcccccCCC-CccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 185 NPKISDFGLSKLFPEN-TTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
.++|+|||++...... .........+++.|+|||++.+..++.++|+|||||++|+|++ |..||...+..+.
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~ 295 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4999999999744211 1112223456889999999999999999999999999999998 9999987665443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=265.13 Aligned_cols=201 Identities=32% Similarity=0.517 Sum_probs=165.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC----cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
+..++|++.+.||+|+||.||+|.+. |..||+|++.... ......+.+|+..++.++ ||||+++++++.....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--HPNIIALRGVCLKEPN 80 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCC--CTTBCCEEEEECCC--
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC--CCCEeeEEEEEecCCc
Confidence 35678999999999999999999975 8889999986432 223467888999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC---eEecCCCCCCEEEcC--------C
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH---VVHRDIKTSNILLDQ--------N 183 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~---i~h~dl~p~nilv~~--------~ 183 (272)
.++||||+++++|.+++ ....+++..++.++.|++.|+.+||++ | ++|+||||+||+++. +
T Consensus 81 ~~lv~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp CEEEEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred eEEEEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccC
Confidence 99999999999999998 345799999999999999999999999 7 999999999999986 6
Q ss_pred CCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+.++|+|||++....... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 153 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp CCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred cceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 789999999998654322 2235688999999999998999999999999999999999999986553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=268.42 Aligned_cols=206 Identities=28% Similarity=0.461 Sum_probs=174.6
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
.....++|++.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+..++.++ ||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC--CTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC--CCCeeeeeeEEe
Confidence 334466799999999999999999983 36899999998744 3344567889999999998 999999999988
Q ss_pred cC--CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 111 DG--PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 111 ~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
.. ...+++|||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl 167 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKI 167 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEE
Confidence 76 668999999999999999832 345699999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 189 SDFGLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+..
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 99999987654332 223335677889999999998899999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=276.84 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=168.3
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC---
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--- 113 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+... ......++.+|+..++.++ ||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--BTTBCCCSEEECSCSSTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC--CcCCCCceeeEecCCccc
Confidence 3578999999999999999999876 7999999998543 2233467889999999998 999999999987653
Q ss_pred ---ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 114 ---~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
..++||||+ +++|.+++. ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred cCceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence 459999999 889999983 35789999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++...... .....++..|+|||++.+ ..++.++|+||+||++++|++|++||...+..+
T Consensus 172 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 233 (367)
T 1cm8_A 172 FGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233 (367)
T ss_dssp CTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999865432 233567899999999987 678999999999999999999999998766543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.50 Aligned_cols=203 Identities=22% Similarity=0.312 Sum_probs=176.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--------ccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--------QGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+|+..++.+. ||||+++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~ 98 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE--HANIIKVLDIF 98 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC--CTTBCCEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC--CCCEeeEEEEE
Confidence 45678999999999999999999876 799999999975421 12335677999999998 99999999999
Q ss_pred ecCCceeEEEeecCCC-CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 110 IDGPCRILVYDYMPNN-SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
......++||||+.++ +|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 171 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKL 171 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHH----HTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred eeCCEEEEEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEE
Confidence 9999999999998666 999998 4556799999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCcccccc
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+|||++........ .....|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||....
T Consensus 172 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 172 IDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp CCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred eecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 99999986644322 233568999999999988876 789999999999999999999997543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=273.59 Aligned_cols=214 Identities=26% Similarity=0.414 Sum_probs=178.6
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEec-CcccHHHHHHHHHHhhcc-cccccceeEeee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHG 107 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~ 107 (272)
.+.+..++|++.+.||+|+||.||+|.+ .++..||+|.+... .......+.+|+..++++ . ||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCC--CTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcC--CCCeeeEEE
Confidence 4567789999999999999999999986 24668999998743 233446788999999999 6 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhcccc-------------------cccCChHHHHHHHHHHHHHHHHHhhcCCCCe
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKR-------------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i 168 (272)
++...+..++||||+++++|.+++...... ...+++..++.++.|++.||.+||++ ||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 193 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 999999999999999999999999543211 13478999999999999999999999 99
Q ss_pred EecCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCC
Q 024118 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRT 246 (272)
Q Consensus 169 ~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~ 246 (272)
+|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986543222 12233456788999999999899999999999999999998 999
Q ss_pred ccccccCC
Q 024118 247 AVDFDVQL 254 (272)
Q Consensus 247 p~~~~~~~ 254 (272)
||...+..
T Consensus 274 p~~~~~~~ 281 (344)
T 1rjb_A 274 PYPGIPVD 281 (344)
T ss_dssp SSTTCCCS
T ss_pred CcccCCcH
Confidence 99876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=275.24 Aligned_cols=205 Identities=23% Similarity=0.371 Sum_probs=170.5
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
.+..++|++.+.||+|+||.||++.+.+++.||+|++..... .....+.+|+..++.+...||||+++++++......
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 345778999999999999999999998899999999975432 334678889999999983349999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
++||| +.+++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++ ++.++|+|||++.
T Consensus 85 ~lv~e-~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEC-CCSEEHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEe-CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 99999 5588999998 4456799999999999999999999999 999999999999997 5689999999998
Q ss_pred ccCCCCcc-ccccccccccccCcccccc-----------CCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 196 LFPENTTH-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 196 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 66433221 2334578999999999865 56788999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.18 Aligned_cols=209 Identities=28% Similarity=0.493 Sum_probs=167.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+..++|++.+.||+|+||.||+|.+. ++..||+|.++.. .......+.+|+..++++. ||||+++++++....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD--HPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCC
Confidence 45678999999999999999999864 5778999998754 2334567889999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||+
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred ceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999842 345789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccc--cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 194 SKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 194 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
+.......... .....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~ 258 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 98664332211 111234667999999999999999999999999999998 999997655433
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=269.82 Aligned_cols=219 Identities=26% Similarity=0.422 Sum_probs=174.3
Q ss_pred ccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEe
Q 024118 27 KNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKL 105 (272)
Q Consensus 27 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l 105 (272)
.+.+.+....+....++|++.+.||+|+||.||+|.+. +|+.||+|++.... .....+.+|+..++++.. ||||+++
T Consensus 9 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~-h~~i~~~ 86 (326)
T 2x7f_A 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSH-HRNIATY 86 (326)
T ss_dssp -------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCC-STTBCCE
T ss_pred CcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccC-CCCeeee
Confidence 44566667777778899999999999999999999975 79999999987443 344678889999988832 9999999
Q ss_pred eeeEec------CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 024118 106 HGGCID------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179 (272)
Q Consensus 106 ~~~~~~------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nil 179 (272)
++++.. ....++||||+++++|.+++... ....+++..++.++.|++.||.+||++ |++|+||+|+||+
T Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl 161 (326)
T 2x7f_A 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVL 161 (326)
T ss_dssp EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEE
T ss_pred eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEE
Confidence 999876 46789999999999999998542 245789999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeecCcccccCCCCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 180 LDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 180 v~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++.++.++|+|||++........ ......+++.|+|||++. +..++.++|+||||+++|+|++|+.||...+.
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 162 LTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp ECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 99999999999999876543221 123356889999999987 45688999999999999999999999976543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=277.01 Aligned_cols=206 Identities=22% Similarity=0.335 Sum_probs=170.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC----
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---- 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---- 112 (272)
....++|++.+.||+|+||.||+|.+. +|+.||+|.+...... ..+|+..++.+. ||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLD--HVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCC--CTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcC--CCCccchhheeeecCccc
Confidence 345678999999999999999999875 8999999998644322 236889999998 99999999988432
Q ss_pred ----------------------------------CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHH
Q 024118 113 ----------------------------------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158 (272)
Q Consensus 113 ----------------------------------~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~ 158 (272)
...++||||++ ++|.+.+.........+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34789999997 5888887655556678999999999999999999
Q ss_pred HHhhcCCCCeEecCCCCCCEEEc-CCCCeEEeecCcccccCCCCccccccccccccccCccccccCC-CCCCCceehHHH
Q 024118 159 YIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGV 236 (272)
Q Consensus 159 ~LH~~~~~~i~h~dl~p~nilv~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~ 236 (272)
|||++ ||+||||||+||+++ .++.++|+|||++........ .....+++.|+|||++.+.. ++.++|+||+||
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 999999999999997 678999999999986543322 23356789999999988754 899999999999
Q ss_pred HHHHHHhCCCccccccCCC
Q 024118 237 LLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 237 il~~l~tg~~p~~~~~~~~ 255 (272)
++|+|++|++||...+..+
T Consensus 231 il~ell~g~~pf~~~~~~~ 249 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSID 249 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHH
T ss_pred HHHHHHhCCCCCCCCChHH
Confidence 9999999999998766544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=269.73 Aligned_cols=211 Identities=25% Similarity=0.345 Sum_probs=178.2
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe---
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI--- 110 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~--- 110 (272)
+.+.+..++|++.+.||+|+||.||+|.+. +|+.||+|.+..........+.+|+..++.+. ||||+++++++.
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN--HPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC--CCCeeeEEEEEEecc
Confidence 444567789999999999999999999975 79999999997766666778889999999998 999999999886
Q ss_pred -cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 111 -DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 111 -~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
.....++|+||+++++|.+++.........+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEE
Confidence 33478899999999999999966545567899999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCcc--------ccccccccccccCccccccCC---CCCCCceehHHHHHHHHHhCCCcccc
Q 024118 190 DFGLSKLFPENTTH--------ISTRVAGTLGYLAPEYAISGR---LTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 190 Dfg~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
|||.+......... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 99988754321110 011234688999999987654 68899999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=268.40 Aligned_cols=209 Identities=26% Similarity=0.403 Sum_probs=177.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEe--cCCc
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DGPC 114 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~--~~~~ 114 (272)
..++|++.+.||+|++|.||+|.+. +|+.||+|.+.... ......+.+|+..+++++ ||||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEEGGGTE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC--CCCCCeEEEEEecCCCce
Confidence 3578999999999999999999886 79999999997543 334467888999999998 999999999875 3567
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCCEEEcCCCCeEEe
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH-----VVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-----i~h~dl~p~nilv~~~~~~~l~ 189 (272)
.++||||+++++|.+++.........+++..++.++.|++.||.+||++ + ++|+||+|+||+++.++.++|+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 8999999999999999966544556699999999999999999999999 8 9999999999999999999999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 222 (279)
T 2w5a_A 159 DFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222 (279)
T ss_dssp CCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH
Confidence 9999986543221 122346788999999999888999999999999999999999999876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=280.12 Aligned_cols=208 Identities=18% Similarity=0.180 Sum_probs=162.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccc-cccceeEee-------ee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNV-CHENLVKLH-------GG 108 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~-~~~~i~~l~-------~~ 108 (272)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+..++.+.. .||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999975 7999999999743 33345678889854444421 299999998 55
Q ss_pred EecCC-----------------ceeEEEeecCCCCHhHHHhhcccc---cccCChHHHHHHHHHHHHHHHHHhhcCCCCe
Q 024118 109 CIDGP-----------------CRILVYDYMPNNSLSQTLLGEEKR---RAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168 (272)
Q Consensus 109 ~~~~~-----------------~~~iv~e~~~~~~L~~~~~~~~~~---~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i 168 (272)
+...+ ..+++|||+ +++|.+++...... ...+++..++.++.|++.||.|||++ ||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 378999999 67999998432111 12233488889999999999999999 99
Q ss_pred EecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCccccccC-----------CCCCCCceehHHHH
Q 024118 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-----------RLTRKSDVYSFGVL 237 (272)
Q Consensus 169 ~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di~slG~i 237 (272)
+||||||+|||++.++.++|+|||++..... ......| +.|+|||++.+. .++.++|+|||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 2234566 899999999887 79999999999999
Q ss_pred HHHHHhCCCccccccCCCce
Q 024118 238 LLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 238 l~~l~tg~~p~~~~~~~~~~ 257 (272)
+|+|++|+.||...+.....
T Consensus 303 l~elltg~~Pf~~~~~~~~~ 322 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS 322 (377)
T ss_dssp HHHHHHSSCCC------CCS
T ss_pred HHHHHHCCCCCcccccccch
Confidence 99999999999876655433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=263.77 Aligned_cols=203 Identities=25% Similarity=0.432 Sum_probs=178.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..++|++.+.||+|++|.||+|.+. +++.||+|++.... ......+.+|+..++.+. ||||+++++++......++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCCeEEE
Confidence 3567999999999999999999876 79999999997543 344577889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ ...++++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||.+...
T Consensus 98 v~e~~~~~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 98 IMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEECCTTEEHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceec
Confidence 99999999999998 235789999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 170 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 224 (303)
T 3a7i_A 170 TDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224 (303)
T ss_dssp BTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred Ccccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH
Confidence 43321 12335688999999999998999999999999999999999999976543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=273.18 Aligned_cols=210 Identities=28% Similarity=0.444 Sum_probs=170.5
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcE----EEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTI----VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~----v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
..++|++.+.||+|+||.||+|.+. +++. |++|.+... .......+.+|+..+++++ ||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC--BTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCC
Confidence 4577999999999999999999865 4544 577776533 3345578899999999998 999999999998754
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
.+++++++++++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||+
T Consensus 91 -~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred -eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcc
Confidence 7789999999999999843 346799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 194 SKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 194 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
+......... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+......
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 230 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH
Confidence 9866433221 2223445778999999999999999999999999999999 999998776555433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=268.21 Aligned_cols=201 Identities=25% Similarity=0.391 Sum_probs=173.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CC-------cEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DG-------TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~-------~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
+..++|++.+.||+|+||.||+|.+. ++ ..||+|.+..........+.+|+..++.++ ||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS--HKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC--CTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEE
Confidence 45678999999999999999999865 34 479999987666666778999999999998 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-----
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN----- 185 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~----- 185 (272)
.++..++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTB
T ss_pred eCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccc
Confidence 99999999999999999999943 334589999999999999999999999 9999999999999998887
Q ss_pred ---eEEeecCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 186 ---PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 186 ---~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
++|+|||++..... .....++..|+|||++.+ ..++.++|+||+|+++|+|++ |.+||...+
T Consensus 157 ~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 99999999874422 122457888999999987 668999999999999999999 555665443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=277.00 Aligned_cols=204 Identities=23% Similarity=0.360 Sum_probs=171.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+...+|++.+.||+|+||.||+|.+.+++.||||++.... ......+.+|+..++.+...||||+++++++......+
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4456799999999999999999998889999999997543 33446788999999999744699999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||| +.+++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+||+++ ++.++|+|||++..
T Consensus 133 lv~E-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEE-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred EEEe-cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 9999 56889999983 445788999999999999999999999 999999999999996 57999999999986
Q ss_pred cCCCCc-cccccccccccccCcccccc-----------CCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 197 FPENTT-HISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 197 ~~~~~~-~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 643322 12334578999999999875 35788999999999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.25 Aligned_cols=200 Identities=23% Similarity=0.339 Sum_probs=167.5
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---- 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---- 112 (272)
..++|++.+.||+|+||.||+|.+. +|+.||||.+... ......++.+|+..++.++ ||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK--SDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCTTT
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC--CCCcceEEEEEecCCCCc
Confidence 3578999999999999999999876 7899999998643 3334568889999999998 99999999998765
Q ss_pred -CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 113 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
...++||||++ ++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.++|+||
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLF----KTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEecCC-cCHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence 56899999985 5899988 4456799999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCc---------------------cccccccccccccCcccc-ccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 192 GLSKLFPENTT---------------------HISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 192 g~~~~~~~~~~---------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
|++........ .......||+.|+|||++ .+..++.++|+||+||++|+|++|..||.
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 99986643221 122446789999999986 45669999999999999999998555543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=268.21 Aligned_cols=215 Identities=25% Similarity=0.424 Sum_probs=181.8
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecCc-ccHHHHHHHHHHhhcc-cccccceeEee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESK-QGEKEFMSEVASMANV-NVCHENLVKLH 106 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~-~~~~~~i~~l~ 106 (272)
..+.+..++|++.+.||+|+||.||+|.+ .++..||+|.+..... .....+.+|+..++++ . ||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~i~~~~ 93 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HMNIVNLL 93 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC--CTTBCCEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhccc--CCCeeeEE
Confidence 44567778999999999999999999974 2578899999874432 3446788999999999 6 99999999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhccc--------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK--------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~d 172 (272)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.+||++ ||+|+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d 170 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence 999999999999999999999999854321 123589999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccc
Q 024118 173 IKTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDF 250 (272)
Q Consensus 173 l~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~ 250 (272)
|||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||..
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999866543321 2233456778999999999899999999999999999999 9999986
Q ss_pred ccCC
Q 024118 251 DVQL 254 (272)
Q Consensus 251 ~~~~ 254 (272)
.+..
T Consensus 251 ~~~~ 254 (313)
T 1t46_A 251 MPVD 254 (313)
T ss_dssp CCSS
T ss_pred ccch
Confidence 6543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=268.02 Aligned_cols=202 Identities=26% Similarity=0.433 Sum_probs=166.1
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec----CC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~ 113 (272)
....++|++.+.||+|+||.||+|.+ +|+.||+|++... .......|.+.+......||||+++++++.. ..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 35678899999999999999999988 6889999998632 3445556666665533339999999998654 34
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCEEEcCCCC
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--------EEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
..++||||+++++|.+++ ....+++..++.++.|++.||.||| ++ +|+|+||||+||+++.++.
T Consensus 80 ~~~lv~e~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEECCCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred eeEEehhhccCCCHHHHH-----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 578999999999999998 3457999999999999999999999 88 9999999999999999999
Q ss_pred eEEeecCcccccCCCCccc---cccccccccccCccccccC------CCCCCCceehHHHHHHHHHhC----------CC
Q 024118 186 PKISDFGLSKLFPENTTHI---STRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSG----------RT 246 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~il~~l~tg----------~~ 246 (272)
++|+|||++.......... .....|++.|+|||++.+. .++.++|+||+|+++|+|++| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999997554332221 2234789999999999876 445799999999999999999 88
Q ss_pred ccccc
Q 024118 247 AVDFD 251 (272)
Q Consensus 247 p~~~~ 251 (272)
||...
T Consensus 232 pf~~~ 236 (301)
T 3q4u_A 232 PFYDV 236 (301)
T ss_dssp TTTTT
T ss_pred ccccc
Confidence 88543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=272.13 Aligned_cols=212 Identities=26% Similarity=0.449 Sum_probs=173.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcE----EEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTI----VAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~----v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
..++|++.+.||+|+||.||+|.+. +++. |++|.+.... ......+.+|+..++.+. ||||+++++++. +.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD--HAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC--CTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEc-CC
Confidence 4578999999999999999999875 5554 7777765332 233346678888899888 999999999886 45
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++|+||+++++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||+
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred ccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCc
Confidence 68899999999999999842 346799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehh
Q 024118 194 SKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 194 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 260 (272)
+......... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+.......+
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 230 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 9876543322 2333556778999999998899999999999999999999 99999877655544333
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=271.05 Aligned_cols=205 Identities=26% Similarity=0.425 Sum_probs=173.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+|+..++.+. ||||+++++++......+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--HENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC--CCCEeeEEEEeecCCEEE
Confidence 3567999999999999999999987 699999999864432 23455778999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++++|.++. .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+|||++..
T Consensus 101 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 101 LVFEFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp EEEECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 999999999998886 4456799999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
...... ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...+..
T Consensus 174 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 174 LAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 543222 22335688999999999875 6899999999999999999999999876643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.93 Aligned_cols=204 Identities=25% Similarity=0.372 Sum_probs=165.9
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--------cccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
....++|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..++++. ||||++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~ 208 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKNF 208 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC--CTTBCCCCEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC--CCCEeeEEEE
Confidence 356789999999999999999999876 78999999987431 112234778999999998 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---C
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---N 185 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~---~ 185 (272)
+.. ...++||||+++++|.+.+ .....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .
T Consensus 209 ~~~-~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 209 FDA-EDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp EES-SEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCC
T ss_pred Eec-CceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcce
Confidence 754 4578999999999999988 4556799999999999999999999999 999999999999997554 4
Q ss_pred eEEeecCcccccCCCCccccccccccccccCcccccc---CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++|+|||++....... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.....
T Consensus 281 ~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 281 IKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp EEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred EEEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 9999999998654322 2334678999999999864 4578899999999999999999999976543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=283.25 Aligned_cols=203 Identities=22% Similarity=0.344 Sum_probs=158.3
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---- 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---- 112 (272)
..++|++.+.||+|+||.||+|.+. +|+.||||.+... ......++.+|+..++.++ ||||+++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN--HDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCTTT
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC--CCCCCceEEEEecCCccc
Confidence 3478999999999999999999876 7999999998643 2334567889999999998 99999999998433
Q ss_pred -CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 113 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
...++||||+ +++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+||
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEEecc-ccchhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence 5689999988 57888888 4456799999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCc--------------------------cccccccccccccCcccc-ccCCCCCCCceehHHHHHHHHHh-
Q 024118 192 GLSKLFPENTT--------------------------HISTRVAGTLGYLAPEYA-ISGRLTRKSDVYSFGVLLLEIVS- 243 (272)
Q Consensus 192 g~~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~il~~l~t- 243 (272)
|++........ .......||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99986542211 122345679999999986 45669999999999999999999
Q ss_pred ----------CCCcccccc
Q 024118 244 ----------GRTAVDFDV 252 (272)
Q Consensus 244 ----------g~~p~~~~~ 252 (272)
|+++|.+.+
T Consensus 281 ~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp STTTCSSGGGCCCSCC---
T ss_pred ccccccccccccccCCCCc
Confidence 777776544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=273.72 Aligned_cols=206 Identities=26% Similarity=0.411 Sum_probs=173.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC-----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----- 112 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----- 112 (272)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..++.+. ||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC--CTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc--CCCcccHhheeeccccccc
Confidence 467999999999999999999985 79999999986442 233457788999999998 99999999998763
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...++||||+++ +|.+.+. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred cCCceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 468899999975 6666662 3445799999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCC---ccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 190 DFGLSKLFPENT---THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 190 Dfg~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|||++....... ........+++.|+|||++.+. .++.++|+|||||++|+|++|++||...+...
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 236 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999998654221 1222345679999999998764 57999999999999999999999998766543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=272.15 Aligned_cols=216 Identities=25% Similarity=0.425 Sum_probs=179.6
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcc-cccccceeE
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVK 104 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~-~~~~~~i~~ 104 (272)
..+.+..++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+..++.+ . ||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCC--CTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhc--CCCEee
Confidence 344567789999999999999999999863 46789999987442 23446788899999998 5 999999
Q ss_pred eeeeEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 024118 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRD 172 (272)
Q Consensus 105 l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~d 172 (272)
+++++......++||||+++++|.+++..... ....+++..++.++.|++.||.+||++ ||+|+|
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 182 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 182 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence 99999999999999999999999999954321 123488999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcccc
Q 024118 173 IKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDF 250 (272)
Q Consensus 173 l~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~ 250 (272)
|||+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||..
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 999999999999999999999986643322 11223446778999999998889999999999999999999 9999987
Q ss_pred ccCCC
Q 024118 251 DVQLG 255 (272)
Q Consensus 251 ~~~~~ 255 (272)
.+..+
T Consensus 263 ~~~~~ 267 (334)
T 2pvf_A 263 IPVEE 267 (334)
T ss_dssp CCHHH
T ss_pred CCHHH
Confidence 65443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=276.57 Aligned_cols=207 Identities=21% Similarity=0.337 Sum_probs=166.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCC------CcEEEEEEEEecCccc-----------HHHHHHHHHHhhcccccccc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKVLSVESKQG-----------EKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~v~vK~~~~~~~~~-----------~~~~~~e~~~~~~~~~~~~~ 101 (272)
...++|++.+.||+|+||.||+|.+.. ++.||+|++....... ......++..+..+. |||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~--h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK--YLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS--CCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc--CCC
Confidence 445689999999999999999998763 4789999986443211 112233344455555 999
Q ss_pred eeEeeeeEecC----CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 024118 102 LVKLHGGCIDG----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 177 (272)
Q Consensus 102 i~~l~~~~~~~----~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~n 177 (272)
|+++++++... ...++||||+ +++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 99999998764 4578999999 9999999832 346799999999999999999999999 99999999999
Q ss_pred EEEc--CCCCeEEeecCcccccCCCCcc------ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 178 ILLD--QNFNPKISDFGLSKLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 178 ilv~--~~~~~~l~Dfg~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
|+++ .++.++|+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998 8899999999999765422111 1123458999999999999999999999999999999999999998
Q ss_pred cccCC
Q 024118 250 FDVQL 254 (272)
Q Consensus 250 ~~~~~ 254 (272)
.....
T Consensus 263 ~~~~~ 267 (364)
T 3op5_A 263 DNLKD 267 (364)
T ss_dssp GGTTC
T ss_pred ccccC
Confidence 65433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=272.06 Aligned_cols=206 Identities=24% Similarity=0.397 Sum_probs=166.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc--ccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK--QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.....++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+..++.++ ||||+++++++....
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--HRNIIELKSVIHHNH 106 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC--CTTBCCEEEEEEETT
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC--CCCcceEEEEEecCC
Confidence 3455678999999999999999999876 799999999864432 22456778999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-----CCCCeEE
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-----QNFNPKI 188 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~-----~~~~~~l 188 (272)
..++||||+++ +|.+++ .....+++..++.++.|++.||.+||++ ||+|+||||+||+++ ..+.++|
T Consensus 107 ~~~lv~e~~~~-~L~~~~----~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp EEEEEEECCSE-EHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred EEEEEEecCCC-CHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEE
Confidence 99999999975 899888 4456799999999999999999999999 999999999999994 4445999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+|||++........ ......++..|+|||++.+.. ++.++|+|||||++|+|++|+.||...+.
T Consensus 179 ~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 179 GDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp CCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 99999986543222 123346789999999998754 89999999999999999999999976654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=263.17 Aligned_cols=220 Identities=45% Similarity=0.708 Sum_probs=186.9
Q ss_pred cccCCChhHHHHhhCCeeee------eeeeeccceEEEEEEeCCCcEEEEEEEEec----CcccHHHHHHHHHHhhcccc
Q 024118 28 NINAFSYNQLKIATNGFRWS------NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNV 97 (272)
Q Consensus 28 ~~~~~~~~~~~~~~~~y~i~------~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~----~~~~~~~~~~e~~~~~~~~~ 97 (272)
....++...+.....+|... +.||+|+||.||+|.. ++..||+|.+... .......+.+|+..++.+.
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ- 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-
Confidence 45678888888888887776 9999999999999987 5889999998643 2233567889999999998
Q ss_pred cccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 024118 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSN 177 (272)
Q Consensus 98 ~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~n 177 (272)
||||+++++++......+++|||+++++|.+++... ....++++..++.++.|++.||.+||++ |++|+||+|+|
T Consensus 89 -h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 89 -HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp -CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred -CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 999999999999999999999999999999998543 2345689999999999999999999999 99999999999
Q ss_pred EEEcCCCCeEEeecCcccccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 178 ILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 178 ilv~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|+++.++.++|+|||++......... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+...
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999865433221 2233568999999998865 47899999999999999999999998766544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=272.10 Aligned_cols=221 Identities=25% Similarity=0.408 Sum_probs=185.0
Q ss_pred ccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccc
Q 024118 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 29 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~ 101 (272)
.+.+..+.+.+..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+..++.+. |||
T Consensus 12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ 89 (322)
T 1p4o_A 12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHH 89 (322)
T ss_dssp CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC--CTT
T ss_pred ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCC
Confidence 344666777888899999999999999999999754 47889999986432 233456888999999998 999
Q ss_pred eeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccc------cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 102 i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
|+++++++......++||||+++++|.+++...... ...+++..++.++.|++.||.+||++ ||+|+||||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp 166 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSG
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCcc
Confidence 999999999999999999999999999998543211 14578999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 999999999999999999975432211 11223456788999999998889999999999999999999 8999987654
Q ss_pred C
Q 024118 254 L 254 (272)
Q Consensus 254 ~ 254 (272)
.
T Consensus 247 ~ 247 (322)
T 1p4o_A 247 E 247 (322)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=263.81 Aligned_cols=202 Identities=35% Similarity=0.613 Sum_probs=171.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccH-------HHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGE-------KEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~-------~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+........ ..+.+|+..++.+. ||||+++++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~ 93 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN--HPNIVKLYGLMH 93 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC--CTTBCCEEEEET
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC--CCCchhhheeec
Confidence 45678999999999999999999876 799999999864432211 57888999999998 999999999886
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCC---
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFN--- 185 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~~~~~--- 185 (272)
... ++||||+++++|.+.+. .....+++..++.++.|++.|+.+||++ | |+|+||||+||+++.++.
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCS
T ss_pred CCC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCc
Confidence 654 69999999999988873 3445799999999999999999999999 8 999999999999988776
Q ss_pred --eEEeecCcccccCCCCccccccccccccccCccccc--cCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 186 --PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI--SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 186 --~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
++|+|||++..... ......+++.|+|||++. ...++.++|+||||+++|+|++|+.||...+..
T Consensus 166 ~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp CCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred eeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 99999999975432 233356899999999984 445788999999999999999999999865543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=262.59 Aligned_cols=202 Identities=25% Similarity=0.373 Sum_probs=173.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcc-cccccceeEeeeeEecCCc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~~~~~~~~ 114 (272)
...++|++.+.||+|++|.||+|.+. +++.||+|.+... .......+.+|+..+..+ . ||||+++++++...+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~--h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVVRYFSAWAEDDH 85 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCS--CTTBCCEEEEEEETTE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCC--CCCeeeeeeeeecCCe
Confidence 34678999999999999999999987 7999999998754 233456788888888888 5 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-----------
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN----------- 183 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~----------- 183 (272)
.++||||+++++|.+++.........+++..++.++.|++.||.+||++ ||+|+||||+||+++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccc
Confidence 9999999999999999965544457799999999999999999999999 99999999999999844
Q ss_pred --------CCeEEeecCcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 184 --------FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 184 --------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
..++|+|||.+....... ...+++.|+|||.+.+. .+++++|+||||+++|+|++|.+|+..
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998654322 23588999999999866 566899999999999999999987653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=261.84 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=172.2
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec----
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID---- 111 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~---- 111 (272)
.....|.+.+.||+|+||.||+|.+. ++..|++|.+... .......+.+|+..++.++ ||||+++++++..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKG 100 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEESSS
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC--CCCeeeeeeeeccccCC
Confidence 34556999999999999999999876 7889999998744 2334567888999999998 9999999998765
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCCeEE
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLD-QNFNPKI 188 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~-~~~~~~l 188 (272)
....++||||+++++|.+++ .....+++..++.++.|++.||.+||++ + ++|+||+|+||+++ .++.++|
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred CceEEEEEEecCCCCHHHHH----HHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEE
Confidence 35588999999999999998 3446789999999999999999999999 8 99999999999997 7889999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
+|||++....... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||....
T Consensus 174 ~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 174 GDLGLATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CCTTGGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred eeCCCcccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999997544322 233568999999998864 58999999999999999999999997643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=280.31 Aligned_cols=210 Identities=29% Similarity=0.450 Sum_probs=178.6
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC-
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP- 113 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~- 113 (272)
+.+.+..++|++.+.||+|+||.||++.+. |+.||||+++... ....+.+|+..+++++ ||||+++++++....
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKG 260 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCC--CTTBCCEEEEEECTTS
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhcc--CCCEEEEEEEEEcCCC
Confidence 345577889999999999999999999886 7799999986433 4567899999999998 999999999987665
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||+++++|.+++... ....+++..++.++.|++.|+.|||++ +|+||||+|+||+++.++.++|+|||+
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 789999999999999999432 223478999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+...
T Consensus 336 a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 336 TKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp CEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred cccccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 98543221 12345788999999999999999999999999999998 999998776555433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=261.69 Aligned_cols=206 Identities=26% Similarity=0.372 Sum_probs=176.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---------ccHHHHHHHHHHhhcccccccceeEeee
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---------QGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---------~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
....++|++.+.||+|++|.||+|.+. +|+.||+|++..... .....+.+|+..++++.. ||||+++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~ 91 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG-HPNIIQLKD 91 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT-CTTBCCEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcC-CCCEeeeee
Confidence 345689999999999999999999986 789999999974421 223567788888888843 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
++......++||||+++++|.+++ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 164 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIK 164 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred eeccCCeEEEEEeccCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEE
Confidence 999999999999999999999998 3456799999999999999999999999 999999999999999999999
Q ss_pred EeecCcccccCCCCccccccccccccccCccccc------cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI------SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|+|||.+........ .....+++.|+|||++. ...++.++|+||||+++|+|++|+.||...+.
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 165 LTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 999999986543322 23356889999999985 34578899999999999999999999976554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=278.56 Aligned_cols=206 Identities=23% Similarity=0.350 Sum_probs=174.6
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC--c
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--C 114 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--~ 114 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+..++.++ ||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--HKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC--CTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC--CCCCCeEEEeeccCCCCe
Confidence 45678999999999999999999887 69999999987432 234567789999999998 999999999988655 6
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCCeEEee
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNFNPKISD 190 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv----~~~~~~~l~D 190 (272)
.++||||+++++|.+++.... ....+++..++.++.|++.||.|||++ ||+||||||+||++ +.++.++|+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred eEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEec
Confidence 799999999999999984321 223389999999999999999999999 99999999999999 7777799999
Q ss_pred cCcccccCCCCccccccccccccccCcccccc--------CCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
||++....... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+
T Consensus 160 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 160 FGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp GGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99998654332 2233568999999999875 457789999999999999999999997544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.03 Aligned_cols=211 Identities=27% Similarity=0.369 Sum_probs=176.6
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC--
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG-- 112 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~-- 112 (272)
..-..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+..++.+. ||||+++++++...
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRAPTI 99 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC--CTTBCCCCEEECCSST
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC--CCCCccceeEEecCCc
Confidence 3334578999999999999999999876 78899999987433 333467889999999998 99999999998654
Q ss_pred ---CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 113 ---PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
...++++||++ ++|.+++ ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l-----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred cccceEEEEEcccC-cCHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEE
Confidence 36889999996 5888887 235699999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCcc--ccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 190 DFGLSKLFPENTTH--ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 190 Dfg~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
|||++......... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|++||...+..+...
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 242 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence 99999865432211 1234578999999998764 458999999999999999999999998776555433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=271.00 Aligned_cols=199 Identities=28% Similarity=0.433 Sum_probs=172.0
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+|+..++.++ ||||+++++++......+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECCeEE
Confidence 356999999999999999999875 799999999875422 23356888999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||++ ++|.+.+. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||++..
T Consensus 131 lv~e~~~-g~l~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEECCS-EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEecCC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9999997 57777763 2346799999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... .....|++.|+|||++. +..++.++|+||||+++|+|++|+.||...+.
T Consensus 204 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 204 MAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp SSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 532 22356899999999985 45688999999999999999999999976543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.58 Aligned_cols=220 Identities=25% Similarity=0.386 Sum_probs=183.4
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecCc-ccHHHHHHHHHHhhccccccccee
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
++....+....++|++.+.||+|+||.||+|.+ .+++.||+|.+..... .....+.+|+..+..+.. ||||+
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv 94 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNVV 94 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhccc-CCCee
Confidence 456677788899999999999999999999974 2578999999874432 334578889999999843 99999
Q ss_pred EeeeeEecCC-ceeEEEeecCCCCHhHHHhhcccc------------cccCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 024118 104 KLHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKR------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 170 (272)
Q Consensus 104 ~l~~~~~~~~-~~~iv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h 170 (272)
++++++...+ ..+++|||+++++|.+++...... ...+++..++.++.|++.||.+||++ ||+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999987654 589999999999999999543321 12388999999999999999999999 9999
Q ss_pred cCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcc
Q 024118 171 RDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAV 248 (272)
Q Consensus 171 ~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~ 248 (272)
+||||+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986543322 22233557788999999999999999999999999999998 99999
Q ss_pred ccccCC
Q 024118 249 DFDVQL 254 (272)
Q Consensus 249 ~~~~~~ 254 (272)
...+..
T Consensus 252 ~~~~~~ 257 (316)
T 2xir_A 252 PGVKID 257 (316)
T ss_dssp TTCCCS
T ss_pred cccchh
Confidence 765543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=269.42 Aligned_cols=205 Identities=28% Similarity=0.459 Sum_probs=177.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe--cC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~--~~ 112 (272)
..++|++.+.||+|+||.||+|.+ .+++.||+|.+..........+.+|+..++.+. ||||+++++++. ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH--SDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC--CCceeEEEEEEecCCC
Confidence 457899999999999999999983 368899999997666666677899999999998 999999999876 44
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence 568899999999999999842 245699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 193 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
++......... ......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 99876533221 2233457788999999999889999999999999999999999996544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=265.59 Aligned_cols=210 Identities=28% Similarity=0.391 Sum_probs=173.6
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeCC----CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+.+..++|++.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+..++.+. ||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD--HPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC--CTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC--CCCcceEEEEEcC
Confidence 45567889999999999999999997542 346999998644 2334567888999999998 9999999998765
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
...+++|||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred -CCCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence 456899999999999999832 345689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
|++...............++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~ 222 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence 9998665433322333456788999999998889999999999999999998 999997655444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=272.97 Aligned_cols=201 Identities=24% Similarity=0.308 Sum_probs=165.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC---
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--- 113 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+... .......+.+|+..++.+. ||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEEECSCCSTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC--CCCccceEEeeccccccc
Confidence 4578999999999999999999876 7899999998753 2334467788999999998 999999999987654
Q ss_pred ---ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 114 ---~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
..++||||+++ +|.+.+. ..+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence 67999999975 6777762 3588999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
||++....... ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 171 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 232 (371)
T 2xrw_A 171 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232 (371)
T ss_dssp CCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99998654321 223356899999999999999999999999999999999999999876643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=271.48 Aligned_cols=210 Identities=24% Similarity=0.311 Sum_probs=171.2
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcc-----------cHHHHHHHHHHhhcccccccc
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ-----------GEKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~-----------~~~~~~~e~~~~~~~~~~~~~ 101 (272)
..+.+....++|++.+.||+|+||.||+|.+.+|..||+|.+...... ....+.+|+..+++++ |||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ 90 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH--HPN 90 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC--CTT
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC--CcC
Confidence 356777889999999999999999999999888999999998643221 1367889999999998 999
Q ss_pred eeEeeeeEec-----CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 024118 102 LVKLHGGCID-----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 176 (272)
Q Consensus 102 i~~l~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ 176 (272)
|+++++++.. ....++||||++ ++|.+.+. .....+++..++.++.|++.||.+||++ ||+|+||||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 163 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG 163 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence 9999998854 335789999997 57777773 3445799999999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeecCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 177 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 177 nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
||+++.++.++|+|||++........ .....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HEEEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999975433222 233567889999999887 6689999999999999999999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=263.80 Aligned_cols=204 Identities=29% Similarity=0.438 Sum_probs=172.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
....++|++.+.||.|+||.||+|.+. +|+.||+|.+.... ....+.+|+..++.+. ||||+++++++......+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCD--SPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCC--CCCCccEEEEEEeCCEEE
Confidence 356788999999999999999999876 69999999987432 3457889999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++++|.+++. .....+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+..
T Consensus 101 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 101 IVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999999983 2456789999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 175 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 175 LTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 543322 1233568899999999999889999999999999999999999997654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=267.32 Aligned_cols=214 Identities=28% Similarity=0.421 Sum_probs=175.4
Q ss_pred CChhHHHHhhCCeeeee-eeeeccceEEEEEEe--C-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEe
Q 024118 32 FSYNQLKIATNGFRWSN-KIGEGGFGSVYKGRL--Q-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKL 105 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~-~lg~G~~~~v~~~~~--~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l 105 (272)
.....+.+..++|++.+ .||+|+||.||+|.+ . +++.||+|++.... ......+.+|+..++.+. ||||+++
T Consensus 6 i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~ 83 (291)
T 1xbb_A 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRM 83 (291)
T ss_dssp -----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC--CTTBCCE
T ss_pred cCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC--CCCEEEE
Confidence 33445566778999998 999999999999954 2 57889999987543 223567889999999998 9999999
Q ss_pred eeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 024118 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
++++ ..+..++||||+++++|.+++ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.
T Consensus 84 ~~~~-~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~ 155 (291)
T 1xbb_A 84 IGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHY 155 (291)
T ss_dssp EEEE-ESSSEEEEEECCTTEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred EEEE-CCCCcEEEEEeCCCCCHHHHH----HhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCc
Confidence 9998 566789999999999999998 3446699999999999999999999999 9999999999999999999
Q ss_pred eEEeecCcccccCCCCccc--cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 186 PKISDFGLSKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
++|+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999998764433221 122335678999999998889999999999999999999 999998765443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=289.69 Aligned_cols=215 Identities=32% Similarity=0.498 Sum_probs=184.0
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+..+.+.+..++|++.+.||+|+||.||+|.+.++..||||++.... .....+.+|+..++.++ ||||+++++++..
T Consensus 257 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~ 333 (535)
T 2h8h_A 257 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE 333 (535)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC--CTTBCCEEEEECS
T ss_pred cCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCC--CCCEeeEEEEEee
Confidence 34566778889999999999999999999999888889999987443 34567899999999998 9999999999876
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
...++||||+++++|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.++|+||
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF 407 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 407 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCT
T ss_pred -ccceEeeehhcCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccc
Confidence 678999999999999999943 1234689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 408 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~ 472 (535)
T 2h8h_A 408 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472 (535)
T ss_dssp TSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH
T ss_pred ccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9998654322222223445678999999998889999999999999999999 999998665433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.38 Aligned_cols=210 Identities=28% Similarity=0.440 Sum_probs=170.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcE----EEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTI----VAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~----v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
..++|++.+.||+|+||.||+|.+. +++. |++|.+... .......+.+|+..++.+. ||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC--BTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC--CCCeeEEEEEEecCC
Confidence 4678999999999999999999865 5554 466666432 3445678899999999998 999999999988765
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
.+++++++++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||+
T Consensus 91 -~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred -ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 7889999999999999843 346799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 194 SKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 194 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
+........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+......
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 230 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 986643222 12222445778999999999999999999999999999999 999998776655433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.21 Aligned_cols=206 Identities=26% Similarity=0.390 Sum_probs=169.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc-----cHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-----~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|.+...... ....+.+|+..++.+. ||||+++++++...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHK 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC--CTTBCCEEEEECCT
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC--CCCCCeEEEEEeeC
Confidence 34678999999999999999999976 6999999998643221 1246778999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||+++ +|.+.+. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CceEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence 999999999976 7888773 3345789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
++........ ......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...+..
T Consensus 158 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 158 LAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp GGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 9986543222 22345689999999999764 4789999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=265.67 Aligned_cols=209 Identities=28% Similarity=0.446 Sum_probs=177.3
Q ss_pred HHhhCCeeeee-eeeeccceEEEEEEeC---CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 38 KIATNGFRWSN-KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 38 ~~~~~~y~i~~-~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.+..++|.+.+ .||+|+||.||+|.+. ++..||+|.+... .......+.+|+..++.+. ||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC--CCCEeEEEEEe-cC
Confidence 34567788887 9999999999999753 6788999999754 2334567889999999998 99999999998 45
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
+..++||||+++++|.+++. .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred CCcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccc
Confidence 67899999999999999983 2446699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 193 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 221 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99876433221 1222345788999999998889999999999999999998 999998766544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=266.86 Aligned_cols=206 Identities=21% Similarity=0.399 Sum_probs=173.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
...++|++.+.||+|+||.||+|.+. +|..|++|++..........+.+|+..++.+. ||||+++++++......++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC--CTTBCCEEEEEECC-CEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC--CCCEeeeeeeeeeCCeEEE
Confidence 35678999999999999999999987 69999999987666666778999999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 94 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999998832 346699999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
... ........+++.|+|||++. +..++.++|+||||+++|+|++|+.||...+.
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 168 LKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp HHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 111 11122346789999999984 56688999999999999999999999986554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=265.27 Aligned_cols=209 Identities=31% Similarity=0.511 Sum_probs=164.4
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
.+.+.+..++|++.+.||+|+||.||+|.+.. .||+|++.... ......+.+|+..++.++ ||||++++++. .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC--CCcEEEEEeec-c
Confidence 34456678899999999999999999998653 59999987543 334467889999999998 99999999964 5
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
....++||||+++++|.+++. .....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CCccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence 567899999999999999983 3456789999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCC-CccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 192 GLSKLFPEN-TTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|++...... .........+++.|+|||.+. +..++.++|+||||+++|+|++|+.||...+.
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 999755422 122233356899999999986 55678899999999999999999999976543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.53 Aligned_cols=202 Identities=23% Similarity=0.329 Sum_probs=164.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecCcc-----------cHHHHHHHHHHhhccccccccee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVESKQ-----------GEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~~~-----------~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
+..++|++.+.||+|+||.||+|.+. ++..+|+|........ ....+.+|+..+..+. ||||+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~--h~ni~ 111 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD--YLGIP 111 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS--CCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc--ccCcc
Confidence 44678999999999999999999875 5788999998744321 1123556677777777 99999
Q ss_pred EeeeeEec----CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 024118 104 KLHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179 (272)
Q Consensus 104 ~l~~~~~~----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nil 179 (272)
++++++.. ....++||||+ +++|.+++ .....+++..++.++.|++.||.|||++ ||+|+||||+||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 183 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS----GQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL 183 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHC----BGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence 99999887 67889999999 99999998 3444899999999999999999999999 9999999999999
Q ss_pred EcCCC--CeEEeecCcccccCCCC------ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 180 LDQNF--NPKISDFGLSKLFPENT------THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 180 v~~~~--~~~l~Dfg~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
++.++ .++|+|||++....... ........|+..|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 98877 99999999997653221 1112345789999999999998899999999999999999999999965
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.89 Aligned_cols=215 Identities=26% Similarity=0.443 Sum_probs=181.0
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CC-----cEEEEEEEEecC-cccHHHHHHHHHHhhcc-cccccceeEee
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DG-----TIVAVKVLSVES-KQGEKEFMSEVASMANV-NVCHENLVKLH 106 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~-----~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~-~~~~~~i~~l~ 106 (272)
..+.+..++|++.+.||+|+||.||+|.+. ++ ..||+|.+.... ......+.+|+..++.+ . ||||++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~ 116 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ--HENIVNLL 116 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC--CTTBCCEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcC--CCCeeeEE
Confidence 356778899999999999999999999865 33 479999987442 23456788999999999 6 99999999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhccc----------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEK----------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTS 176 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ 176 (272)
+++......++||||+++++|.+++..... ....+++..++.++.|++.||.+||++ ||+|+||||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 193 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 193 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence 999999999999999999999999854322 134689999999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 177 NILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 177 nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999986533222 12233456778999999998889999999999999999998 99999865543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=274.63 Aligned_cols=201 Identities=28% Similarity=0.392 Sum_probs=157.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecC----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---- 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---- 112 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+... ......++.+|+..++.++ ||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEecCCccc
Confidence 4588999999999999999999876 7999999998643 2234567889999999998 99999999998654
Q ss_pred --CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 113 --PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 113 --~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
...++++|++ +++|.+++. ...+++..++.++.||+.||.+||++ ||+||||||+||+++.++.++|+|
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp GCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence 5678999998 788988872 35799999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++...... .....++..|+|||++.+ ..++.++|+||+||++|+|++|++||...+..+
T Consensus 176 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 237 (367)
T 2fst_X 176 FGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999864322 233568999999999987 678999999999999999999999998766543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=266.05 Aligned_cols=215 Identities=28% Similarity=0.427 Sum_probs=172.7
Q ss_pred ccccccccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhccccccc
Q 024118 21 GGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100 (272)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 100 (272)
.......+-............++|++.+.||+|+||.||+|.+. |+.||+|++... .......+.+.+......||
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~ 91 (337)
T 3mdy_A 16 EQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHE 91 (337)
T ss_dssp HHHHHHCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCT
T ss_pred cccccCCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCC
Confidence 33333444556666777788899999999999999999999886 899999998633 33445556666655533499
Q ss_pred ceeEeeeeEecC----CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcC-----CCCeEec
Q 024118 101 NLVKLHGGCIDG----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI-----QPHVVHR 171 (272)
Q Consensus 101 ~i~~l~~~~~~~----~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~i~h~ 171 (272)
||+++++++... ...++||||+++++|.+++. ...+++..++.++.|++.||.+||++. ..||+|+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 166 (337)
T 3mdy_A 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166 (337)
T ss_dssp TBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS
T ss_pred CeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec
Confidence 999999998877 67899999999999999983 346899999999999999999999651 2389999
Q ss_pred CCCCCCEEEcCCCCeEEeecCcccccCCCCccc---cccccccccccCccccccCCCCCC------CceehHHHHHHHHH
Q 024118 172 DIKTSNILLDQNFNPKISDFGLSKLFPENTTHI---STRVAGTLGYLAPEYAISGRLTRK------SDVYSFGVLLLEIV 242 (272)
Q Consensus 172 dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~------~Di~slG~il~~l~ 242 (272)
||||+||+++.++.++|+|||++.......... .....|++.|+|||++.+...... +|+|||||++|+|+
T Consensus 167 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 246 (337)
T 3mdy_A 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246 (337)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH
Confidence 999999999999999999999997654332211 123568999999999988776665 99999999999999
Q ss_pred hC
Q 024118 243 SG 244 (272)
Q Consensus 243 tg 244 (272)
+|
T Consensus 247 tg 248 (337)
T 3mdy_A 247 RR 248 (337)
T ss_dssp TT
T ss_pred hc
Confidence 99
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=260.33 Aligned_cols=210 Identities=23% Similarity=0.312 Sum_probs=169.5
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee-EecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-CIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~-~~~~~~~~ 116 (272)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+|+..++.+. |++++..+.. .......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~--~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHT--TSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhc--CCCCCCeeeeecCCCCceE
Confidence 45678999999999999999999975 7999999987644322 24677888888888 6666655554 46677889
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCeEEeecCc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGL 193 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv---~~~~~~~l~Dfg~ 193 (272)
++|||+ +++|.+++. .....+++..++.++.|++.||.+||++ ||+|+||||+||++ +.++.++|+|||+
T Consensus 82 lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEECC-CCBHHHHHH---HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEcc-CCCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999999 999999983 2345799999999999999999999999 99999999999999 7889999999999
Q ss_pred ccccCCCCc------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 194 SKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 194 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
+........ .......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.......
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 986643322 122345789999999999999999999999999999999999999987665544333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=268.50 Aligned_cols=218 Identities=20% Similarity=0.308 Sum_probs=165.4
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
..+..+.+.+...+|++.+.||+|+||.||+|.+. +|+.||+|.+..........+.+|+..++++.. ||||++++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~~~ 94 (337)
T 3ll6_A 16 SDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-HPNIVQFCSA 94 (337)
T ss_dssp CSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTT-STTBCCEEEE
T ss_pred HHhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhcc-CCChhhcccc
Confidence 34445566677789999999999999999999976 799999999876666666788899999988854 9999999998
Q ss_pred Ee--------cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCE
Q 024118 109 CI--------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNI 178 (272)
Q Consensus 109 ~~--------~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~ni 178 (272)
+. .....++++||++ ++|.+++... .....+++..++.++.|++.||.+||++ | |+|+||||+||
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NI 169 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENL 169 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGC
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccE
Confidence 84 3345789999995 6888887432 2345699999999999999999999999 8 99999999999
Q ss_pred EEcCCCCeEEeecCcccccCCCCcc-----------ccccccccccccCcccc---ccCCCCCCCceehHHHHHHHHHhC
Q 024118 179 LLDQNFNPKISDFGLSKLFPENTTH-----------ISTRVAGTLGYLAPEYA---ISGRLTRKSDVYSFGVLLLEIVSG 244 (272)
Q Consensus 179 lv~~~~~~~l~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~~aPE~~---~~~~~~~~~Di~slG~il~~l~tg 244 (272)
+++.++.++|+|||++......... ......+++.|+|||++ .+..++.++|+||||+++|+|++|
T Consensus 170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 9999999999999999866432211 11134578899999998 566688999999999999999999
Q ss_pred CCccccccC
Q 024118 245 RTAVDFDVQ 253 (272)
Q Consensus 245 ~~p~~~~~~ 253 (272)
+.||...+.
T Consensus 250 ~~p~~~~~~ 258 (337)
T 3ll6_A 250 QHPFEDGAK 258 (337)
T ss_dssp SCCC-----
T ss_pred CCCCcchhH
Confidence 999976544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.57 Aligned_cols=219 Identities=27% Similarity=0.422 Sum_probs=172.4
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEee
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~ 106 (272)
....+.+..++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+..++.++ ||||++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~ 102 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS--HPNVIRLL 102 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC--CTTBCCCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC--CCCeeeee
Confidence 34556667889999999999999999999754 35589999987542 334467888999999998 99999999
Q ss_pred eeEecCC-----ceeEEEeecCCCCHhHHHhhcc--cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 024118 107 GGCIDGP-----CRILVYDYMPNNSLSQTLLGEE--KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179 (272)
Q Consensus 107 ~~~~~~~-----~~~iv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nil 179 (272)
+++.... ..+++|||+++++|.+++.... .....+++..++.++.|++.||.+||++ ||+|+||||+||+
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIl 179 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCM 179 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEE
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEE
Confidence 9987654 3589999999999999985432 2345699999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 180 LDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 180 v~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+....
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 99999999999999986543221 11223456778999999999899999999999999999999 9999987665543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=258.48 Aligned_cols=202 Identities=23% Similarity=0.388 Sum_probs=172.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC--C
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG--P 113 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~--~ 113 (272)
.+..++|++.+.||+|+||.||+|.+. |..||+|++.... ......+.+|+..+++++ ||||+++++++... .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--HPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS--CTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCchhheEEEEccCCCC
Confidence 345678999999999999999999986 8889999987543 334467889999999998 99999999999877 7
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCCeEEeec
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
..+++|||+++++|.+++... ....+++..++.++.|++.||.+||++ + ++|+||+|+||+++.++.+++.||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred CeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEec
Confidence 789999999999999999431 223589999999999999999999998 8 999999999999999999999998
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCC---CCceehHHHHHHHHHhCCCccccccC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTR---KSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+....... ....+++.|+|||.+.+..++. ++|+||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 158 DVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp GSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred cceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 88764322 2246789999999998766554 79999999999999999999976554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.35 Aligned_cols=210 Identities=30% Similarity=0.471 Sum_probs=173.2
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEE--EEEEEEec-CcccHHHHHHHHHHhhcc-cccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIV--AVKVLSVE-SKQGEKEFMSEVASMANV-NVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v--~vK~~~~~-~~~~~~~~~~e~~~~~~~-~~~~~~i~~l~~~~~~~~ 113 (272)
+..++|++.+.||+|+||.||+|.+. +|..+ ++|.+... .......+.+|+..++++ . ||||+++++++....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~--hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCC--CTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccC--CCchhhhceeeeeCC
Confidence 34578999999999999999999876 66654 88988643 233445688899999999 5 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcc------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
..++||||+++++|.+++.... .....+++..++.++.|++.||.+||++ ||+|+||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 9999999999999999985432 2234789999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 182 QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 182 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 99999999999987432211 1222345778999999998889999999999999999998 999997765433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=264.07 Aligned_cols=213 Identities=29% Similarity=0.452 Sum_probs=170.3
Q ss_pred ccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 29 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
.+.+....+.+..++|++.+.||+|++|.||++.+. |..||+|.+... .....+.+|+..++.+. ||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~--h~~iv~~~~~ 82 (278)
T 1byg_A 8 QDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLR--HSNLVQLLGV 82 (278)
T ss_dssp -------CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCC--CTTBCCEEEE
T ss_pred hhhhhhccccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCC--CCCEeeEEEE
Confidence 344555556677889999999999999999999875 889999998633 34567889999999998 9999999998
Q ss_pred EecC-CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 109 CIDG-PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 109 ~~~~-~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
+... ...+++|||+++++|.+++... ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 157 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 157 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEE
Confidence 7654 5789999999999999998432 223488999999999999999999999 999999999999999999999
Q ss_pred EeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
|+|||++....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 158 l~Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 158 VSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp ECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred Eeeccccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999987543221 22346788999999998889999999999999999998 999998765443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.83 Aligned_cols=209 Identities=28% Similarity=0.474 Sum_probs=171.4
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCC-----CcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-----~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
.+..++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+..++.+. ||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEec
Confidence 4567899999999999999999997652 2469999987442 234457888999999998 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
....++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence 9999999999999999999842 346789999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 192 GLSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 192 g~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
|++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 257 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999866433211 1122335678999999998889999999999999999999 99999765543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=258.81 Aligned_cols=205 Identities=24% Similarity=0.330 Sum_probs=172.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee-EecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-CIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~-~~~~~~~~i 117 (272)
..++|++.+.||+|++|.||+|.+. +|+.||+|++..... ...+.+|+..++.+. |+++++.+.. .......++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~--~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHT--TSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhh--cCCCCCccccccCCCCceEE
Confidence 4678999999999999999999975 899999999875433 235788999999988 7665555554 456777899
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCeEEeecCcc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLS 194 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv---~~~~~~~l~Dfg~~ 194 (272)
+|||+ +++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||||+||++ +.++.++|+|||++
T Consensus 83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 99999 9999999832 345799999999999999999999999 99999999999999 48889999999999
Q ss_pred cccCCCCcc------ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 195 KLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
......... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 866433221 1234568999999999999999999999999999999999999998765443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=269.08 Aligned_cols=206 Identities=22% Similarity=0.364 Sum_probs=177.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCccc-----------------HHHHHHHHHHhhcccccccc
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQG-----------------EKEFMSEVASMANVNVCHEN 101 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~-----------------~~~~~~e~~~~~~~~~~~~~ 101 (272)
...++|++.+.||+|+||.||+|.+ +|+.||+|.+....... ...+.+|+..++.+. |||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK--NEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC--CTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC--CCC
Confidence 4467899999999999999999998 89999999987432111 168899999999998 999
Q ss_pred eeEeeeeEecCCceeEEEeecCCCCHhHHHhh----cccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCC
Q 024118 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG----EEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTS 176 (272)
Q Consensus 102 i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~ 176 (272)
|+++++++...+..++||||+++++|.+++.. .......+++..++.++.|++.||.+||+ + |++|+||+|+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 99999999999999999999999999998311 11225779999999999999999999999 8 9999999999
Q ss_pred CEEEcCCCCeEEeecCcccccCCCCccccccccccccccCccccccC-CCCC-CCceehHHHHHHHHHhCCCccccccC
Q 024118 177 NILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTR-KSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 177 nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||||+++|+|++|+.||...+.
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999865432 23345688999999999877 5665 99999999999999999999987655
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=264.73 Aligned_cols=201 Identities=31% Similarity=0.500 Sum_probs=171.4
Q ss_pred hCCe-eeeeeeeeccceEEEEEEeC-----CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC-
Q 024118 41 TNGF-RWSNKIGEGGFGSVYKGRLQ-----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG- 112 (272)
Q Consensus 41 ~~~y-~i~~~lg~G~~~~v~~~~~~-----~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~- 112 (272)
.++| ++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+..++.++ ||||+++++++...
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY--HEHIIKYKGCCEDAG 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEEETT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC--CcchhhEEEEEecCC
Confidence 3445 99999999999999988642 68899999997543 234567889999999999 99999999999874
Q ss_pred -CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 113 -PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 113 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
...++||||+++++|.+++. ...+++..++.++.|++.+|.+||++ ||+|+||||+||+++.++.++|+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred CceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence 56789999999999999983 34589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 192 GLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 192 g~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
|++........ .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 99987654322 1223345677899999999988999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=265.32 Aligned_cols=204 Identities=24% Similarity=0.374 Sum_probs=170.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--------cccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--------~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..++.+. ||||+++++++
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~ 84 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN--HPCIIKIKNFF 84 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC--CTTBCCEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC--CCCCceEeeEE
Confidence 34578999999999999999999876 68999999986331 122345778999999998 99999999998
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---e
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---P 186 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~---~ 186 (272)
.... .++||||+++++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++. +
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCE
T ss_pred cCCc-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeE
Confidence 7655 89999999999999988 4456799999999999999999999999 9999999999999987665 9
Q ss_pred EEeecCcccccCCCCccccccccccccccCccccc---cCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI---SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
+|+|||++....... ......+++.|+|||++. ...++.++|+||||+++|+|++|+.||......
T Consensus 157 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 157 KITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp EECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred EEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 999999998654322 123346889999999974 456889999999999999999999999865543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=262.63 Aligned_cols=206 Identities=25% Similarity=0.341 Sum_probs=160.4
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-ccHHHHHH-HHHHhhcccccccceeEeeeeEecCCc
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-QGEKEFMS-EVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~-e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
.+..++|++.+.||+|+||.||+|.+. +|+.||+|.+..... ........ +...++.+. ||||+++++++.....
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD--CPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC--CCeEEEEeeeeeccCC
Confidence 456788999999999999999999975 799999999874422 22233333 344456666 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||+++ +|.+++.........+++..++.++.|++.||.+||++ .|++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 9999999974 88888765555667899999999999999999999984 29999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCcccc----ccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYA----ISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
........ .....+++.|+|||++ .+..++.++|+||+|+++|+|++|+.||..
T Consensus 158 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 158 GYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 76543322 2224688999999996 455688899999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=274.25 Aligned_cols=207 Identities=21% Similarity=0.275 Sum_probs=174.4
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc----cccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV----CHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~----~~~~i~~l~~~~~~~~ 113 (272)
....+|++.+.||+|+||.||+|.+. +++.||+|++... ........+|+..++.++. .|+||+++++.+....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 45678999999999999999999876 6899999998633 2333456667777766641 3789999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC--eEEeec
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN--PKISDF 191 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~--~~l~Df 191 (272)
..+++|||+. ++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++. ++|+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999995 6888888432 234589999999999999999999999 9999999999999999887 999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|++||...+..+.
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999754322 2235688999999999999999999999999999999999999987765443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=267.20 Aligned_cols=214 Identities=22% Similarity=0.361 Sum_probs=160.7
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+.+..++|++.+.||+|++|.||+|.+. +++.||+|.+.... ......+.+|+..++.+. ||||+++++++...
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH--HPNIVSYYTSFVVK 85 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCC--CTTBCCEEEEEESS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC--CCCEeeEEEEEeec
Confidence 345677899999999999999999999865 78999999886442 234456788999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhccc----ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEK----RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
+..++||||+++++|.+++..... ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence 999999999999999999853211 245689999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCC----ccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 189 SDFGLSKLFPENT----THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 189 ~Dfg~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+|||++....... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 9999987654321 111233568899999999876 5689999999999999999999999986544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=272.25 Aligned_cols=213 Identities=21% Similarity=0.290 Sum_probs=175.5
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc------cccceeEe
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV------CHENLVKL 105 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~------~~~~i~~l 105 (272)
.........++|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+..++.+.. .|+||+++
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 34445566789999999999999999999876 7899999998632 3345677888888888852 27889999
Q ss_pred eeeEe----cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 106 HGGCI----DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 106 ~~~~~----~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
++.+. .....++||||+ +++|.+.+.. .....+++..++.++.||+.||.|||+++ ||+||||||+||+++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~ 181 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEEC
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEe
Confidence 99887 556789999999 5556555532 22356999999999999999999999842 899999999999998
Q ss_pred CCC-------------------------------------------------CeEEeecCcccccCCCCccccccccccc
Q 024118 182 QNF-------------------------------------------------NPKISDFGLSKLFPENTTHISTRVAGTL 212 (272)
Q Consensus 182 ~~~-------------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (272)
.++ .++|+|||++...... .....+|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~ 257 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTR 257 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCG
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCC
Confidence 775 7999999999865432 23356899
Q ss_pred cccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 213 ~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 9999999999999999999999999999999999998766544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=259.52 Aligned_cols=205 Identities=29% Similarity=0.435 Sum_probs=176.7
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
....++|++.+.||+|++|.||+|.+. +++.||+|++... .......+.+|+..++++. ||||+++++++.....
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--HPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc--CCCccEEEEEEeCCCe
Confidence 345678999999999999999999987 7999999998744 2345678889999999998 9999999999999999
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---CeEEeec
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF---NPKISDF 191 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~---~~~l~Df 191 (272)
.++++||+++++|.+.+ .....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++ .++|+||
T Consensus 96 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 96 FYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEEECCCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEEccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEecc
Confidence 99999999999999888 3445789999999999999999999999 999999999999997544 6999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
|++........ .....+++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...+..
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (287)
T 2wei_A 169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (287)
T ss_dssp TGGGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CcceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99986543322 2234578899999998764 889999999999999999999999866543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=274.58 Aligned_cols=203 Identities=28% Similarity=0.387 Sum_probs=167.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC------
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------ 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~------ 112 (272)
...+|++.+.||+|+||.||+|.+. +|+.||||.+..... ...+|++.++.+. ||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~--hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCC--CTTBCCEEEEEEEEETTTTE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcC--CCCccceeeEEeccCCCCcc
Confidence 3457999999999999999999986 699999999864322 2336889999998 99999999987532
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CCeEEeec
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDF 191 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~-~~~~l~Df 191 (272)
...++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.++|+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence 235689999975 66666654445567899999999999999999999999 99999999999999955 56899999
Q ss_pred CcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
|++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..
T Consensus 202 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~ 263 (420)
T 1j1b_A 202 GSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 263 (420)
T ss_dssp TTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99986543222 2335689999999999765 6899999999999999999999999876643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=270.68 Aligned_cols=202 Identities=9% Similarity=0.062 Sum_probs=153.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEee-------eeE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLH-------GGC 109 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~-------~~~ 109 (272)
..+|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+..|+..++.+...||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999976 799999999986432 233455666444444432399988855 333
Q ss_pred ecC-----------------CceeEEEeecCCCCHhHHHhhcccccccCChHHH------HHHHHHHHHHHHHHhhcCCC
Q 024118 110 IDG-----------------PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKAR------REIIMGIGRGLAYIHEEIQP 166 (272)
Q Consensus 110 ~~~-----------------~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~------~~i~~~i~~al~~LH~~~~~ 166 (272)
... ...++||||++ ++|.+++... ...+++..+ +.++.|++.||.|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 322 23799999998 8999999432 334556666 78889999999999999
Q ss_pred CeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCcccccc--CCCCCCCceehHHHHHHHHHhC
Q 024118 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSG 244 (272)
Q Consensus 167 ~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~il~~l~tg 244 (272)
||+||||||+|||++.++.++|+|||++....... ....+++.|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998653221 13456699999999987 6789999999999999999999
Q ss_pred CCccccccC
Q 024118 245 RTAVDFDVQ 253 (272)
Q Consensus 245 ~~p~~~~~~ 253 (272)
+.||...+.
T Consensus 290 ~~Pf~~~~~ 298 (371)
T 3q60_A 290 FLPFGLVTP 298 (371)
T ss_dssp SCSTTBCCT
T ss_pred CCCCCCcCc
Confidence 999987743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.81 Aligned_cols=207 Identities=23% Similarity=0.308 Sum_probs=175.6
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEe-C-CCcEEEEEEEEecCcccHHHHHHHHHHhhccccccc------ceeEeee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRL-Q-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE------NLVKLHG 107 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~-~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~------~i~~l~~ 107 (272)
.+....++|++.+.||+|+||.||+|.+ . +|+.||+|++... ......+.+|+..++.+. |+ +++++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~--~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLN--TTDPNSTFRCVQMLE 84 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHH--HHCTTCTTCBCCEEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhh--hcCCCCceeeEeeec
Confidence 3445678999999999999999999987 3 6889999998632 334456778888888887 54 4999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ----- 182 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~----- 182 (272)
++......++||||+ +++|.+++... ...++++..++.++.|++.||.+||++ ||+|+||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 999999999999999 88999988432 224688999999999999999999999 9999999999999987
Q ss_pred --------------CCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcc
Q 024118 183 --------------NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 183 --------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
++.++|+|||++...... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 668999999999864332 22356899999999999999999999999999999999999999
Q ss_pred ccccCCC
Q 024118 249 DFDVQLG 255 (272)
Q Consensus 249 ~~~~~~~ 255 (272)
...+..+
T Consensus 235 ~~~~~~~ 241 (339)
T 1z57_A 235 PTHDSKE 241 (339)
T ss_dssp CCSCHHH
T ss_pred CCCChHH
Confidence 8766544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=268.00 Aligned_cols=213 Identities=23% Similarity=0.346 Sum_probs=164.9
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.......++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .......+++..+..+. ||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLH--HPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHC--CTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcC--CCCcccHHHhhhccc
Confidence 345667789999999999999999999986 79999999986443 23345667777778777 999999999986543
Q ss_pred c-------eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCCEEEcC-C
Q 024118 114 C-------RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--EEIQPHVVHRDIKTSNILLDQ-N 183 (272)
Q Consensus 114 ~-------~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--~~~~~~i~h~dl~p~nilv~~-~ 183 (272)
. .++||||+++ +|...+.........+++..++.++.|++.|+.+|| ++ ||+|+||||+||+++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 3 7899999976 555555443456678899999999999999999999 88 9999999999999996 8
Q ss_pred CCeEEeecCcccccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
+.++|+|||++........ .....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 240 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240 (360)
T ss_dssp TEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence 8999999999986653322 23356789999999987654 89999999999999999999999987665443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=265.37 Aligned_cols=205 Identities=28% Similarity=0.502 Sum_probs=175.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEe-----CCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRL-----QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
...++|++.+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+..++.++ ||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC--CTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEecC
Confidence 4567799999999999999999983 368999999987665556678899999999998 999999999876543
Q ss_pred --ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 114 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 114 --~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
..++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecC
Confidence 78999999999999999843 235689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 192 GLSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 192 g~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
|++......... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999876543321 122234667799999999888999999999999999999999998743
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=258.80 Aligned_cols=200 Identities=29% Similarity=0.475 Sum_probs=173.0
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec-----
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----- 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----- 111 (272)
.....+|++.+.||+|+||.||+|.+. +|+.||+|.+.... ..+.+|+..++.+. ||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLD--HVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCC--CTTBCCEEEEEEEEEEC-
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCC--CCCEEEEeeeEeccccCc
Confidence 345678999999999999999999987 79999999987543 24567899999998 9999999998754
Q ss_pred -----------CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 024118 112 -----------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL 180 (272)
Q Consensus 112 -----------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv 180 (272)
....+++|||+++++|.+++... ....+++..++.++.|++.||.+||++ ||+|+||+|+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFL 155 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEE
Confidence 34578999999999999998432 345789999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 181 DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 181 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
+.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++|..|+..
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred cCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 9999999999999986644322 2334688999999999998899999999999999999999998853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.83 Aligned_cols=206 Identities=25% Similarity=0.355 Sum_probs=168.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc---
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--- 114 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~--- 114 (272)
.....+|++.+.||+|+||.||+|++..+..+|+|.+...... ..+|+..++.+. ||||+++++++.....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~--h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVK--HPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCC--CTTBCCEEEEEEEESSSSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCC--CCCcceEEEEEEecCCCCC
Confidence 3456679999999999999999999876666888887643221 236888999998 9999999999864432
Q ss_pred ---eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCCeEEee
Q 024118 115 ---RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISD 190 (272)
Q Consensus 115 ---~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~-~~~~~~l~D 190 (272)
.++||||++++ +...+.........+++..++.++.|++.||.|||++ ||+||||||+||+++ .++.++|+|
T Consensus 110 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 110 EVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp CEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEee
Confidence 77999999764 4444433334567899999999999999999999999 999999999999998 789999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++........ .....+++.|+|||++.+. .++.++|+||+||++|+|++|++||...+..+
T Consensus 186 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 249 (394)
T 4e7w_A 186 FGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249 (394)
T ss_dssp CTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999986543222 2335678999999998765 48999999999999999999999998766443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=286.04 Aligned_cols=217 Identities=28% Similarity=0.445 Sum_probs=177.3
Q ss_pred hHHHHhhCCeeeee-eeeeccceEEEEEEeC---CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 35 NQLKIATNGFRWSN-KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 35 ~~~~~~~~~y~i~~-~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
..+.+..+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .......+.+|+..++.++ ||||+++++++
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~ 405 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVC 405 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC--CTTBCCEEEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC--CCCEeeEEEEe
Confidence 34455666777777 8999999999999764 4667999998754 2345678999999999998 99999999998
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
.. +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~ 478 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKIS 478 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEe
Confidence 76 568999999999999999832 356699999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCccc--cccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehh
Q 024118 190 DFGLSKLFPENTTHI--STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 260 (272)
|||++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+
T Consensus 479 DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 552 (613)
T 2ozo_A 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552 (613)
T ss_dssp CCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred eccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 999998664322211 112234578999999998899999999999999999998 99999877665544333
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.17 Aligned_cols=205 Identities=24% Similarity=0.377 Sum_probs=167.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe-------
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI------- 110 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~------- 110 (272)
...++|++.+.||+|++|.||+|.+. +|+.||+|.+..........+.+|+..++.+. ||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC--CCCeeEEEEeccccccccc
Confidence 35678999999999999999999987 69999999998666666678899999999998 999999998873
Q ss_pred -------cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-C
Q 024118 111 -------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-Q 182 (272)
Q Consensus 111 -------~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~-~ 182 (272)
.....++||||++ ++|.+++ ...++++..++.++.|++.||.+||++ ||+|+||||+||+++ +
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVL-----EQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE 156 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT
T ss_pred cccccccccCceeEEeeccC-CCHHHHh-----hcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC
Confidence 3467789999997 5899988 235789999999999999999999999 999999999999997 5
Q ss_pred CCCeEEeecCcccccCCCC--ccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 183 NFNPKISDFGLSKLFPENT--THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 183 ~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
++.++|+|||++....... ........++..|.|||.+.+ ..++.++|+||||+++|+|++|+.||...+..
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 6789999999998654321 111223456888999998875 56889999999999999999999999876643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=263.56 Aligned_cols=214 Identities=22% Similarity=0.369 Sum_probs=174.4
Q ss_pred ccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEee
Q 024118 29 INAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLH 106 (272)
Q Consensus 29 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~ 106 (272)
-+++.+..+.+..++|++.+.||+|+||.||+|.+.+++.||+|++.... ......+.+|+..++.+...||||++++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 35667777888889999999999999999999998889999999997543 3344678889999999984469999999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCe
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNP 186 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~ 186 (272)
+++......+++|| +.+++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||++++ +.+
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHH----HHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEE
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeE
Confidence 99999999999999 5688999998 3456789999999999999999999999 9999999999999965 799
Q ss_pred EEeecCcccccCCCCcc-ccccccccccccCcccccc-----------CCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 187 KISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAIS-----------GRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
+|+|||++......... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 99999999865433221 2233568999999999875 35788999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.44 Aligned_cols=211 Identities=27% Similarity=0.382 Sum_probs=175.3
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
............++|++.+.||+|+||.||+|.+ +|+.||+|++.. .....+.+|.+.+..+...||||+++++++
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 3455566677889999999999999999999988 489999999853 234566778887777433399999999999
Q ss_pred ecCC----ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCC
Q 024118 110 IDGP----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH--------EEIQPHVVHRDIKTSN 177 (272)
Q Consensus 110 ~~~~----~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~~i~h~dl~p~n 177 (272)
.... ..++||||+++++|.+++. ...+++..++.++.|++.||.+|| ++ +|+|+||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence 8776 7899999999999999983 346899999999999999999999 77 99999999999
Q ss_pred EEEcCCCCeEEeecCcccccCCCCcc---ccccccccccccCccccccCC------CCCCCceehHHHHHHHHHhC----
Q 024118 178 ILLDQNFNPKISDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSG---- 244 (272)
Q Consensus 178 ilv~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~il~~l~tg---- 244 (272)
|+++.++.++|+|||++......... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 99999999999999999765433221 123356899999999997653 33689999999999999999
Q ss_pred ------CCcccccc
Q 024118 245 ------RTAVDFDV 252 (272)
Q Consensus 245 ------~~p~~~~~ 252 (272)
..||....
T Consensus 258 ~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 258 GIHEDYQLPYYDLV 271 (342)
T ss_dssp TBCCCCCCTTTTTS
T ss_pred CcccccccCccccC
Confidence 77886543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.67 Aligned_cols=198 Identities=27% Similarity=0.394 Sum_probs=168.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCce-
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR- 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~- 115 (272)
..++|.+.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..++.++ ||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSST
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC--CCCchhhhhheeccCCcc
Confidence 4579999999999999999999876 79999999987442 233467888999999998 99999999999877654
Q ss_pred -----eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 116 -----ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 116 -----~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
+++|||+. ++|.+.+ ...+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred cceeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 99999996 5777776 23489999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
||++...... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 188 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 188 FGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp TTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999854322 233567899999999987 6789999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=260.60 Aligned_cols=201 Identities=29% Similarity=0.472 Sum_probs=164.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
..++|++.+.||+|+||.||++.+. ++.||+|.+.. ......+.+|+..++++. ||||+++++++.+ ..++||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVN--HPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCC--CTTBCCEEEBCTT--TTEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCC--CCCcCeEEEEEcC--CcEEEE
Confidence 4578999999999999999999885 78899999853 334567889999999998 9999999998764 478999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC-eEEeecCcccccC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN-PKISDFGLSKLFP 198 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~-~~l~Dfg~~~~~~ 198 (272)
||+++++|.+++.... ....+++..++.++.|+++||.+||+.+..||+|+||||+||+++.++. ++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp ECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999999985331 2235788999999999999999999932229999999999999998887 7999999997543
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
.. .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 22 123458899999999999899999999999999999999999997543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=259.54 Aligned_cols=210 Identities=28% Similarity=0.438 Sum_probs=172.2
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCC----CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEe-c
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI-D 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~-~ 111 (272)
.....+|++.+.||+|+||.||+|.+.+ +..+++|.+... .......+.+|+..++++. ||||+++++++. .
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC--CCCEeeeeeEEEcC
Confidence 4455679999999999999999998642 335888887643 2334467889999999998 999999999854 4
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
+...+++|||+++++|.+++. .....+++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred CCceEEEEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence 567899999999999999983 2345688999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCc---cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 192 GLSKLFPENTT---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 192 g~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
|++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 240 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 99986543221 11223456778999999999999999999999999999999 677777665544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=256.86 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=170.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
.+|.....||+|+||.||+|.+. ++..||+|.+..........+.+|+..++.+. ||||+++++++......++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK--HKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC--CCCEeeEeeEEEeCCcEEEEEE
Confidence 33445569999999999999876 78999999998665556678889999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCeEEeecCcccccCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISDFGLSKLFPE 199 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-~~~~~l~Dfg~~~~~~~ 199 (272)
|+++++|.+++... .....+++..++.++.|++.||.+||++ |++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 100 QVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred eCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999998432 1224567899999999999999999999 9999999999999987 88999999999986543
Q ss_pred CCccccccccccccccCccccccCC--CCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
... ......++..|+|||++.+.. ++.++|+||||+++|+|++|+.||...+
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 176 INP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred CCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 221 123356889999999997654 7889999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=263.85 Aligned_cols=203 Identities=24% Similarity=0.369 Sum_probs=170.7
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC-----
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----- 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----- 112 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..++.+. ||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK--HENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC--CTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc--CCCcCCeeeeecccccCcc
Confidence 4678999999999999999999876 79999999986432 334456788999999998 99999999987654
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...+++|||+. ++|.+++. ...+++..++.++.|++.||.+||++ ||+|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 67899999996 58888873 35789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc---------ccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 193 LSKLFPENTTH---------ISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 193 ~~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++......... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99866432211 1122467899999998764 6688999999999999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=257.34 Aligned_cols=205 Identities=29% Similarity=0.396 Sum_probs=169.4
Q ss_pred CeeeeeeeeeccceEEEEEEeC-C---CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce-e
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-D---GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR-I 116 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~---~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~-~ 116 (272)
.|.+.+.||+|+||.||+|.+. + +..+|+|.+... .......+.+|+..++.+. ||||+++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN--HPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC--CTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEecCCCCcE
Confidence 5677799999999999999854 2 337999988643 2334567889999999998 99999999999866655 8
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+++||+.+++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||||+||+++.++.++|+|||++..
T Consensus 100 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 99999999999999832 356788999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCC---ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 197 FPENT---THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 197 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
..... ........++..|.|||.+.+..++.++|+||||+++|+|++ |.+||...+...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~ 236 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence 53321 112233456889999999999999999999999999999999 555565554443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=268.38 Aligned_cols=199 Identities=16% Similarity=0.227 Sum_probs=168.5
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCC---------CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeE-------
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQD---------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVK------- 104 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~------- 104 (272)
.++|++.+.||+|+||.||+|.+.. ++.||+|.+... ..+.+|+..++.+. ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~--h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAA--KPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHC--CHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhc--ccchhhhhhhhcc
Confidence 5789999999999999999998763 789999998633 35778899999988 999887
Q ss_pred --------eeeeEec-CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 105 --------LHGGCID-GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 105 --------l~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.|++.||.+||++ ||+|+||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 5556655 67889999999 99999999432 246799999999999999999999999 999999999
Q ss_pred CCEEEcCCC--CeEEeecCcccccCCCCcc------ccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCc
Q 024118 176 SNILLDQNF--NPKISDFGLSKLFPENTTH------ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTA 247 (272)
Q Consensus 176 ~nilv~~~~--~~~l~Dfg~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p 247 (272)
+||+++.++ .++|+|||++......... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 8999999999765432111 12334789999999999998999999999999999999999999
Q ss_pred ccccc
Q 024118 248 VDFDV 252 (272)
Q Consensus 248 ~~~~~ 252 (272)
|....
T Consensus 268 f~~~~ 272 (352)
T 2jii_A 268 WTNCL 272 (352)
T ss_dssp TGGGT
T ss_pred cccCC
Confidence 98764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=260.46 Aligned_cols=207 Identities=27% Similarity=0.431 Sum_probs=170.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC--CCcEEEEEEEEecCc--ccHHHHHHHHHHhhccc-ccccceeEeeeeEe---
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVESK--QGEKEFMSEVASMANVN-VCHENLVKLHGGCI--- 110 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~v~vK~~~~~~~--~~~~~~~~e~~~~~~~~-~~~~~i~~l~~~~~--- 110 (272)
...++|++.+.||+|+||.||+|.+. +|+.||+|.+..... .....+.+|+..++.+. ..||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999873 688999999875422 22234556666666552 12999999999987
Q ss_pred --cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 111 --DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 111 --~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
.....+++|||++ ++|.+++... ....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence 4567889999997 5999988432 234589999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
+|||++....... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999997654221 23345688999999999998999999999999999999999999986654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=266.14 Aligned_cols=216 Identities=20% Similarity=0.257 Sum_probs=175.9
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc----cccceeEee
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV----CHENLVKLH 106 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~----~~~~i~~l~ 106 (272)
+....+....++|++.+.||+|+||.||+|.+. +++.||+|++... .........|+..++.+.. .+++|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 345556667889999999999999999999877 7889999998632 2333455667777666642 134599999
Q ss_pred eeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCC
Q 024118 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNF 184 (272)
Q Consensus 107 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~--~~~ 184 (272)
+.+......++||||++ ++|.+++... ....+++..++.++.|++.||.+||++ ..||+||||||+||+++ .++
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 99999999999999996 5999988432 224689999999999999999999942 22999999999999995 477
Q ss_pred CeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 185 NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
.++|+|||++...... .....+++.|+|||++.+..++.++|+|||||++|+|++|++||...+..+.
T Consensus 199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 8999999999865432 2335688999999999999999999999999999999999999987765443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=259.22 Aligned_cols=207 Identities=23% Similarity=0.317 Sum_probs=170.9
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC----cccHHHHHHHHHHhhcccccccceeEeeeeEe--cC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES----KQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~----~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~--~~ 112 (272)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..++.++ ||||+++++++. ..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR--HKNVIQLVDVLYNEEK 80 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEECC--
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC--CCCeeEEEEEEEcCCC
Confidence 4578999999999999999999976 78999999986432 234567889999999998 999999999984 45
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||++++ |.+.+... ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg 154 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALG 154 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccc
Confidence 6789999999876 66666332 345789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-ccccccccccccccCccccccCC--CCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 193 LSKLFPENT-THISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 193 ~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.+....... ........++..|+|||++.+.. .+.++|+||||+++|+|++|+.||...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY 219 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence 998664322 22233456889999999997654 377999999999999999999999875543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=264.92 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=174.5
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc------cHHHHHHHHHHhhcccccccce
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ------GEKEFMSEVASMANVNVCHENL 102 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~~~~~~~~~~~i 102 (272)
............++|++.+.||+|+||.||+|.+. +|+.||+|.+...... ....+.+|+..++.+...||||
T Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 33445566678899999999999999999999875 7899999998744221 2235567888888887447999
Q ss_pred eEeeeeEecCCceeEEEeecCC-CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 024118 103 VKLHGGCIDGPCRILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD 181 (272)
Q Consensus 103 ~~l~~~~~~~~~~~iv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~ 181 (272)
+++++++......++++|++.+ ++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID 183 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEe
Confidence 9999999999999999999976 8999998 3456789999999999999999999999 999999999999998
Q ss_pred -CCCCeEEeecCcccccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccc
Q 024118 182 -QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 182 -~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
+++.++|+|||++....... .....+++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred CCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 78899999999998664322 233568999999999987765 67899999999999999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=272.57 Aligned_cols=207 Identities=24% Similarity=0.343 Sum_probs=174.3
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..++|++.+.||+|+||.||+|.+. +++.||||++...... ..+..|+..++.+.. ++++..+..++......++|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~-~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQG-GTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTT-STTCCCEEEEEEETTEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcC-CCCCCeEEEEEeeCCEEEEE
Confidence 4678999999999999999999875 7999999988644332 246788888888873 46666676777788889999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCCeEEeecCccc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL---DQNFNPKISDFGLSK 195 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv---~~~~~~~l~Dfg~~~ 195 (272)
|||+ +++|.+++. .....+++..++.++.||+.||.|||++ ||+|+||||+|||+ +.++.++|+|||++.
T Consensus 82 me~~-g~sL~~ll~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 82 MDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EECC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EECC-CCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999 999999983 2356799999999999999999999999 99999999999999 688899999999998
Q ss_pred ccCCCCc------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 196 LFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 196 ~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
....... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~ 221 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence 6643322 112246789999999999999999999999999999999999999987665443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=265.23 Aligned_cols=213 Identities=28% Similarity=0.430 Sum_probs=173.8
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
.+..++|++.+.||+|+||.||+|.+ .++..||+|.+... .......+.+|+..++.+. ||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN--HQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC--CCCCCeEEEEEc
Confidence 35678899999999999999999983 25789999998633 3344567888999999997 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhccc---ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---C
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEK---RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---F 184 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~ 184 (272)
.....++||||+++++|.+++..... ....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.+ .
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 99999999999999999999954322 124588999999999999999999999 99999999999999844 4
Q ss_pred CeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 185 NPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
.++|+|||++....... ........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 253 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence 59999999997543222 112223456888999999998889999999999999999998 999998665443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=266.87 Aligned_cols=208 Identities=28% Similarity=0.439 Sum_probs=164.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC--CC--cEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec-CCc
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ--DG--TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPC 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~--~~--~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~-~~~ 114 (272)
...|++.+.||+|+||.||+|.+. ++ ..||+|.+... .......+.+|+..+++++ ||||+++++++.. +..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC--CTTBCCCCEEECCCSSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEEcCCCC
Confidence 345888999999999999999864 22 46888987643 2344567889999999998 9999999998754 457
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.++||||+++++|.+++. .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++
T Consensus 166 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp CEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccc
Confidence 889999999999999983 2345688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcc---ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 195 KLFPENTTH---ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 195 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~ 305 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH
Confidence 865332211 1222446778999999999999999999999999999999 7888987665543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=262.66 Aligned_cols=209 Identities=20% Similarity=0.289 Sum_probs=173.8
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CC-cEEEEEEEEecCcccHHHHHHHHHHhhcccccccc------eeEe
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DG-TIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN------LVKL 105 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~-~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~------i~~l 105 (272)
...+....++|++.+.||+|+||.||+|.+. ++ ..||+|++.. .......+.+|+..++.+. |++ ++.+
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~--~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIK--EKDKENKFLCVLM 87 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHH--HHCTTSCSCBCCE
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHh--hcCCCCceeEEEe
Confidence 3444556789999999999999999999875 44 7899999863 2334456778888888887 555 8999
Q ss_pred eeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-----
Q 024118 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----- 180 (272)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv----- 180 (272)
++++......++||||+ +++|.+.+.. .....+++..++.++.|++.||.+||++ ||+|+||||+||++
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccc
Confidence 99999999999999999 5666666632 2234689999999999999999999999 99999999999999
Q ss_pred --------------cCCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCC
Q 024118 181 --------------DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246 (272)
Q Consensus 181 --------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~ 246 (272)
+.++.++|+|||++...... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 56788999999999864322 233568999999999999999999999999999999999999
Q ss_pred ccccccCCC
Q 024118 247 AVDFDVQLG 255 (272)
Q Consensus 247 p~~~~~~~~ 255 (272)
||...+..+
T Consensus 238 pf~~~~~~~ 246 (355)
T 2eu9_A 238 LFQTHENRE 246 (355)
T ss_dssp SCCCSSHHH
T ss_pred CCCCCCHHH
Confidence 998766543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.49 Aligned_cols=204 Identities=31% Similarity=0.516 Sum_probs=160.1
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHH--hhcccccccceeEeeeeEec----
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS--MANVNVCHENLVKLHGGCID---- 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~--~~~~~~~~~~i~~l~~~~~~---- 111 (272)
.+..++|++.+.||+|+||.||+|+. +++.||+|++.... ......+.+. +..+. ||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~--h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLME--HDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECTT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc--CcchhhheecccccccC
Confidence 35678899999999999999999976 58999999986432 2233334433 34455 9999999975432
Q ss_pred -CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCCEEEcCCC
Q 024118 112 -GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI------QPHVVHRDIKTSNILLDQNF 184 (272)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------~~~i~h~dl~p~nilv~~~~ 184 (272)
....++||||+++++|.+++. ....++..++.++.|++.||.|||++. ..||+|+||||+||+++.++
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred CCceEEEEEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 235689999999999999983 334588999999999999999999752 22899999999999999999
Q ss_pred CeEEeecCcccccCCCC-------ccccccccccccccCcccccc-------CCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 185 NPKISDFGLSKLFPENT-------THISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
.++|+|||++....... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998654321 111223468999999999986 3466789999999999999999777754
Q ss_pred cc
Q 024118 251 DV 252 (272)
Q Consensus 251 ~~ 252 (272)
..
T Consensus 238 ~~ 239 (336)
T 3g2f_A 238 GE 239 (336)
T ss_dssp TS
T ss_pred cc
Confidence 33
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.35 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=166.1
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC--CCc--EEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEec
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ--DGT--IVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~--~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~ 111 (272)
+..++|++.+.||+|+||.||+|.+. ++. .||+|.+... .......+.+|+..++.+. ||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 92 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLT 92 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC--CTTBCCEEEEECS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC--CCCcccEEEEEcc
Confidence 44678999999999999999999853 333 6899988643 2334567889999999998 9999999999887
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
.. .++++||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+||
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred CC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccc
Confidence 65 8899999999999999843 346689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCC
Q 024118 192 GLSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQL 254 (272)
Q Consensus 192 g~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~ 254 (272)
|++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 231 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence 999876443221 1223456778999999998889999999999999999999 99999866543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=260.99 Aligned_cols=197 Identities=27% Similarity=0.399 Sum_probs=167.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCc---
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC--- 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~--- 114 (272)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+..++.++ ||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ--HENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCCcccHhheEeccccccc
Confidence 578999999999999999999876 79999999986432 223457788999999998 9999999999887654
Q ss_pred ---eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 115 ---RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 115 ---~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
.+++|||++ ++|.+.+ ...+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++.++|+||
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred ceeEEEEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 489999996 5777776 23589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
|++...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 171 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 171 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp TCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred ccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999754322 233567899999999887 6789999999999999999999999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=283.68 Aligned_cols=212 Identities=29% Similarity=0.412 Sum_probs=172.7
Q ss_pred HHHhhCCeeee-eeeeeccceEEEEEEeC---CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 37 LKIATNGFRWS-NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 37 ~~~~~~~y~i~-~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
+.+..+.+.+. +.||+|+||.||+|.+. ++..||||+++... ......+.+|+..++.++ ||||+++++++.
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~ 440 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICE 440 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC--CTTBCCEEEEEE
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEe
Confidence 33444455554 48999999999999643 56889999987542 234578999999999998 999999999986
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
. +..++||||+++++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.++|+|
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~D 512 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISD 512 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred c-CCEEEEEEccCCCCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEE
Confidence 4 5588999999999999999 4456799999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCcee
Q 024118 191 FGLSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYH 258 (272)
Q Consensus 191 fg~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~ 258 (272)
||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+...
T Consensus 513 FGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~ 583 (635)
T 4fl3_A 513 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 583 (635)
T ss_dssp TTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred cCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999986643321 12222345678999999999999999999999999999998 999998766554333
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=269.53 Aligned_cols=206 Identities=23% Similarity=0.401 Sum_probs=156.4
Q ss_pred hhCCeeee-eeeeeccceEEEEEEeC---CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe--cCC
Q 024118 40 ATNGFRWS-NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI--DGP 113 (272)
Q Consensus 40 ~~~~y~i~-~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~--~~~ 113 (272)
..+.|++. +.||+|+||.||+|.+. +++.||+|.+... .....+.+|+..++.+. ||||+++++++. ...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELK--HPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCC--CTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcC--CCCeeeEeeEEecCCCC
Confidence 34557774 58999999999999865 5789999998633 23346789999999998 999999999985 467
Q ss_pred ceeEEEeecCCCCHhHHHhhccc-----ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCC
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEK-----RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILL----DQNF 184 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~-----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv----~~~~ 184 (272)
..++||||++ ++|.+.+..... ....+++..++.++.||+.||.|||++ ||+||||||+||++ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 8899999996 477777643221 123599999999999999999999999 99999999999999 6778
Q ss_pred CeEEeecCcccccCCCCc--cccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 185 NPKISDFGLSKLFPENTT--HISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.++|+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...+.
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999986643211 223346789999999999874 489999999999999999999999976543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=254.23 Aligned_cols=195 Identities=27% Similarity=0.434 Sum_probs=161.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec-------
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------- 111 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~------- 111 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+... ......+.+|+..++.+. ||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLN--HQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcC--chHHHHHHHHHHhhcchhhh
Confidence 4568999999999999999999976 7999999998643 334567889999999998 9999999998764
Q ss_pred ------CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 024118 112 ------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 112 ------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
....++||||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 3467899999999999999943 345678899999999999999999999 9999999999999999999
Q ss_pred eEEeecCcccccCCCC-------------ccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHh
Q 024118 186 PKISDFGLSKLFPENT-------------THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~t 243 (272)
++|+|||++....... ........+++.|+|||++.+. .++.++|+||||+++|+|++
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999998654221 1112335688999999999865 68999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=259.70 Aligned_cols=207 Identities=27% Similarity=0.404 Sum_probs=162.6
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc------ccHHHHHHHHHHhhcccc--cccceeEe
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNV--CHENLVKL 105 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~~~~~~~--~~~~i~~l 105 (272)
.......++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+..+.++.. .||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 345667789999999999999999999875 789999999864422 122344567777777721 29999999
Q ss_pred eeeEecCCceeEEEee-cCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CC
Q 024118 106 HGGCIDGPCRILVYDY-MPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QN 183 (272)
Q Consensus 106 ~~~~~~~~~~~iv~e~-~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~-~~ 183 (272)
++++...+..++++|+ +.+++|.+++ .....+++..++.++.|++.||.+||++ ||+|+||+|+||+++ .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence 9999999999999999 7899999998 3456799999999999999999999999 999999999999998 88
Q ss_pred CCeEEeecCcccccCCCCccccccccccccccCccccccCCCC-CCCceehHHHHHHHHHhCCCccccc
Q 024118 184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT-RKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
+.++|+|||++....... .....++..|+|||++.+..+. .++|+||||+++|+|++|+.||...
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 899999999998664332 2335688999999999877654 5899999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.53 Aligned_cols=201 Identities=22% Similarity=0.341 Sum_probs=145.0
Q ss_pred HhhCCeeeee-eeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHH-hhcccccccceeEeeeeEec----
Q 024118 39 IATNGFRWSN-KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVAS-MANVNVCHENLVKLHGGCID---- 111 (272)
Q Consensus 39 ~~~~~y~i~~-~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~-~~~~~~~~~~i~~l~~~~~~---- 111 (272)
...++|++.+ .||+|+||.||+|.+. +|+.||+|++... . ...+++.. ++.+. ||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~----~~~~e~~~~~~~~~--h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P----KARQEVDHHWQASG--GPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H----HHHHHHHHHHHHTT--STTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H----HHHHHHHHHHHhcC--CCChHHHHHHHhhccCC
Confidence 4567899965 6999999999999987 7999999998632 1 22233332 33444 9999999998875
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CCeEE
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---FNPKI 188 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~~~~l 188 (272)
....++||||+++++|.+++... ....+++..++.++.|++.||.+||++ ||+|+||||+||+++.+ +.++|
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred CceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEE
Confidence 44588999999999999999432 234699999999999999999999999 99999999999999764 45999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
+|||++....... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 173 ~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 173 TDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp CCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 9999998654322 23356789999999998888999999999999999999999999765543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=281.83 Aligned_cols=213 Identities=26% Similarity=0.352 Sum_probs=175.5
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
...+.+..++|++.+.||+|+||.||+|.+. .+..||+|...... ......+.+|+..++.+. ||||++++++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~ 459 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGV 459 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC--CTTBCCEEEE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEE
Confidence 3456677889999999999999999999864 25679999876432 233467889999999998 9999999998
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKI 188 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l 188 (272)
+. .+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEE
Confidence 85 4568999999999999999842 334689999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCC
Q 024118 189 SDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLG 255 (272)
Q Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~ 255 (272)
+|||++...............+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 600 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999998765443322333456778999999998899999999999999999997 999998765443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=256.04 Aligned_cols=211 Identities=26% Similarity=0.363 Sum_probs=154.6
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHH-HhhcccccccceeEeeeeEec
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVA-SMANVNVCHENLVKLHGGCID 111 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~-~~~~~~~~~~~i~~l~~~~~~ 111 (272)
..+.+..++|++.+.||+|+||.||+|.+. +|+.||+|.+.... .........|+. .++.+. ||||+++++++..
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~--h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD--CPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCC--CTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCC--CCcEeeeeeEEEe
Confidence 344566789999999999999999999986 79999999997543 233345555655 455555 9999999999999
Q ss_pred CCceeEEEeecCCCCHhHHHhhc-ccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGE-EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
.+..++||||+++ +|.+++... ......+++..++.++.|++.|+.+||++ .||+|+||+|+||+++.++.++|+|
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEcc
Confidence 9999999999975 777776322 12356789999999999999999999984 2999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCcccc----ccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYA----ISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
||++........ .....+++.|+|||++ .+..++.++|+||||+++|+|++|+.||...+
T Consensus 170 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 170 FGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp CSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred CCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999976543222 2224688999999998 45568899999999999999999999997643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=259.39 Aligned_cols=214 Identities=25% Similarity=0.415 Sum_probs=174.1
Q ss_pred cCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeee
Q 024118 30 NAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 30 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
.......+.+..++|++.+.||+|+||.||+|.+.. .+++|.+.... ......+.+|+..++.++ ||||+++++
T Consensus 21 ~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~ 96 (319)
T 2y4i_B 21 TSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTR--HENVVLFMG 96 (319)
T ss_dssp -CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC--CTTBCCCCE
T ss_pred cccccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC--CCCEeEEEE
Confidence 445667777889999999999999999999998763 48999886432 223345678899999998 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
++......+++|||+++++|.+++.. ....+++..++.++.|++.||.+||++ |++|+||+|+||+++ ++.++
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCE
T ss_pred EEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEE
Confidence 99999999999999999999999832 334689999999999999999999999 999999999999998 67999
Q ss_pred EeecCcccccCCC----CccccccccccccccCcccccc---------CCCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 188 ISDFGLSKLFPEN----TTHISTRVAGTLGYLAPEYAIS---------GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 188 l~Dfg~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
|+|||++...... .........|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 249 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998654321 1112233458899999999875 34688999999999999999999999865543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=259.22 Aligned_cols=204 Identities=22% Similarity=0.315 Sum_probs=166.6
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc---------cccceeEeeeeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---------CHENLVKLHGGC 109 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~---------~~~~i~~l~~~~ 109 (272)
..++|++.+.||+|+||.||+|.+. +++.||+|++.. .......+.+|+..++.+.. .||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 4578999999999999999999975 799999999863 23344567778888777652 278999999988
Q ss_pred ecCC----ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc----
Q 024118 110 IDGP----CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---- 181 (272)
Q Consensus 110 ~~~~----~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~---- 181 (272)
.... ..+++||++ +++|.+++... ....+++..++.++.||+.||.+||++. ||+|+||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7643 688999999 89999998432 2355899999999999999999999831 899999999999994
Q ss_pred --CCCCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 182 --QNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 182 --~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
..+.++|+|||++...... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 3447999999999865432 2234689999999999999999999999999999999999999986653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=262.67 Aligned_cols=203 Identities=24% Similarity=0.308 Sum_probs=157.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
.+.|.+.+.||+|+||+||.+...+|+.||||.+... ......+|+..++.+.. ||||+++++++......++|||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~-HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDD-HPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTT-STTBCCEEEEEECSSEEEEEEC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccC-CCCcCeEEEEEecCCeEEEEEe
Confidence 3457778999999999998876678999999998643 23456788888877622 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhccccccc---CChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-------------C
Q 024118 121 YMPNNSLSQTLLGEEKRRAK---FGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN-------------F 184 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~---l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~-------------~ 184 (272)
|++ ++|.+++......... .++..++.++.|++.||.|||++ ||+||||||+||+++.. +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence 996 5999998543222111 23445678999999999999999 99999999999999754 4
Q ss_pred CeEEeecCcccccCCCCcc---ccccccccccccCcccccc-------CCCCCCCceehHHHHHHHHHh-CCCccccc
Q 024118 185 NPKISDFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAIS-------GRLTRKSDVYSFGVLLLEIVS-GRTAVDFD 251 (272)
Q Consensus 185 ~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~il~~l~t-g~~p~~~~ 251 (272)
.++|+|||++......... ......|++.|+|||++.+ ..++.++|+|||||++|+|++ |+.||...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 7999999999876543221 1234578999999999976 568899999999999999999 99999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=251.19 Aligned_cols=204 Identities=25% Similarity=0.408 Sum_probs=152.8
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc-cHHHHHHH-HHHhhcccccccceeEeeeeEecCC
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-GEKEFMSE-VASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e-~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.....++|++.+.||+|+||.||+|.+. +|+.||+|++...... .......+ ...++.+. ||||+++++++...+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD--CPYIVQCFGTFITNT 97 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT--CTTBCCEEEEEECSS
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCceeeEEEEEecCC
Confidence 3445678999999999999999999986 7999999999754322 22333333 34455556 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
..++||||+ ++.+..... .....+++..++.++.|++.||.+||+ + |++|+||+|+||+++.++.++|+|||
T Consensus 98 ~~~lv~e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp EEEEEECCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cEEEEEecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999 555655542 235678999999999999999999998 6 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccc
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFD 251 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~ 251 (272)
++........ .....+++.|+|||++. +..++.++|+||||+++|+|++|+.||...
T Consensus 171 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 171 ISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp TC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 9976543221 23346889999999985 456788999999999999999999999763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=276.84 Aligned_cols=199 Identities=23% Similarity=0.310 Sum_probs=169.2
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC--CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ--DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.+.+..++|++.+.||+|+||.||+|.+. +|+.||||.+... .......+.+|+..++.+. ||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--HPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC--CTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC--CCCcCeEeeeEeec
Confidence 44566789999999999999999999875 6899999988643 2334457788999999998 99999999998876
Q ss_pred Cc-----eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 113 PC-----RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 113 ~~-----~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
+. .++||||++|++|.+.+. ..+++..++.++.|++.+|.|||++ ||+|+||||+||+++.+ .++
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEE
Confidence 65 699999999999998762 2789999999999999999999999 99999999999999875 899
Q ss_pred EeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|+|||++...... ....||+.|+|||++.+.. +.++||||||+++|+|++|.+||....
T Consensus 222 l~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 222 LIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp ECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred EEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc
Confidence 9999999865432 3356899999999987654 889999999999999999999987543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=274.11 Aligned_cols=205 Identities=29% Similarity=0.416 Sum_probs=171.6
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec----
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID---- 111 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~---- 111 (272)
....++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+..++.+. ||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN--HPNVVSAREVPDGLQKL 87 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC--BTTBCCEEECCTTTCCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC--CCCCCceeeeecccccc
Confidence 344578999999999999999999875 7999999998643 3344567888999999998 9999999998765
Q ss_pred --CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC---e
Q 024118 112 --GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN---P 186 (272)
Q Consensus 112 --~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~---~ 186 (272)
....++||||++|++|.+++.... ....+++..++.++.|++.||.+||++ ||+|+||+|+||+++.++. +
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEE
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeE
Confidence 677899999999999999985421 223689999999999999999999999 9999999999999997765 8
Q ss_pred EEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 187 KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 187 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
+|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 164 KL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 164 KIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp EECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9999999987643322 2345789999999999999999999999999999999999999965
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=259.71 Aligned_cols=196 Identities=19% Similarity=0.233 Sum_probs=161.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--------cccHHHHHHHHHHhhcccc-------ccccee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--------KQGEKEFMSEVASMANVNV-------CHENLV 103 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--------~~~~~~~~~e~~~~~~~~~-------~~~~i~ 103 (272)
+..++|++.+.||+|+||.||+|++ +|+.||+|++.... ......+.+|+..++.++. .||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4567899999999999999999988 68999999998653 2233677888888777751 266666
Q ss_pred EeeeeE-----------------ec-------------CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHH
Q 024118 104 KLHGGC-----------------ID-------------GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153 (272)
Q Consensus 104 ~l~~~~-----------------~~-------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i 153 (272)
++.+++ .. ....++||||++++++.+.+ .+..+++..++.++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-----~~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-----TTTCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-----HhcCCCHHHHHHHHHHH
Confidence 665543 32 67899999999999766666 22568999999999999
Q ss_pred HHHHHHHh-hcCCCCeEecCCCCCCEEEcCCC--------------------CeEEeecCcccccCCCCccccccccccc
Q 024118 154 GRGLAYIH-EEIQPHVVHRDIKTSNILLDQNF--------------------NPKISDFGLSKLFPENTTHISTRVAGTL 212 (272)
Q Consensus 154 ~~al~~LH-~~~~~~i~h~dl~p~nilv~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (272)
+.||.||| ++ ||+||||||+|||++.++ .++|+|||++...... ...||+
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 89 999999999999999887 8999999999865322 247899
Q ss_pred cccCccccccCCCCCCCceehHHHH-HHHHHhCCCcccc
Q 024118 213 GYLAPEYAISGRLTRKSDVYSFGVL-LLEIVSGRTAVDF 250 (272)
Q Consensus 213 ~~~aPE~~~~~~~~~~~Di~slG~i-l~~l~tg~~p~~~ 250 (272)
.|+|||++.+.. +.++||||++++ .+++++|..||..
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999999998777 889999998777 7778999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=260.40 Aligned_cols=205 Identities=23% Similarity=0.300 Sum_probs=160.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+.+...+|++.+.||+|+||+|+.....+|+.||||.+...... ...+|+..++.+.. ||||+++++++......+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~-HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDE-HPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCC-CTTBCCEEEEEEETTEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccC-CCCcCeEEEEEecCCEEE
Confidence 34455679999999999999977666668999999998643322 24578888888732 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---C--CeEEeec
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN---F--NPKISDF 191 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~---~--~~~l~Df 191 (272)
+||||++ ++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+||+++.+ + .++|+||
T Consensus 95 lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred EEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 9999996 589998843 233455667789999999999999999 99999999999999532 2 4789999
Q ss_pred CcccccCCCCc--cccccccccccccCcccccc---CCCCCCCceehHHHHHHHHHh-CCCcccccc
Q 024118 192 GLSKLFPENTT--HISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVS-GRTAVDFDV 252 (272)
Q Consensus 192 g~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~il~~l~t-g~~p~~~~~ 252 (272)
|++........ .......||+.|+|||++.+ ..++.++|+|||||++|+|++ |..||....
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 99986643221 22334678999999999974 457789999999999999999 999996543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=243.29 Aligned_cols=184 Identities=10% Similarity=0.032 Sum_probs=156.4
Q ss_pred ChhHHH-HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeee
Q 024118 33 SYNQLK-IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 33 ~~~~~~-~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
....+. +..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+..+..+. ||||+++++
T Consensus 21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~ 98 (286)
T 3uqc_A 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID--KPGVARVLD 98 (286)
T ss_dssp CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC--CTTBCCEEE
T ss_pred cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC--CCCcceeeE
Confidence 334444 66788999999999999999999986 699999999875432 22367888999999998 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeE
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPK 187 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~ 187 (272)
++...+..++||||++|++|.+++.. . .....+..++.|++.||.|||++ ||+|+||||+||+++.+|.++
T Consensus 99 ~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 99 VVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp EEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEE
T ss_pred EEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEE
Confidence 99999999999999999999999832 2 35567888999999999999999 999999999999999999999
Q ss_pred EeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 188 ISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|++++ |++ .++.++|+|||||++|+|++|+.||...+...
T Consensus 170 l~~~~---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 170 LAYPA---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ECSCC---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred EEecc---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 87433 222 25788999999999999999999999776544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=237.31 Aligned_cols=180 Identities=21% Similarity=0.336 Sum_probs=149.1
Q ss_pred hhCCeeee-eeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec----CC
Q 024118 40 ATNGFRWS-NKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP 113 (272)
Q Consensus 40 ~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~ 113 (272)
..++|.+. +.||+|+||.||+|.+. +|+.||+|++.. .....+|+..+.+... ||||+++++++.. ..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~-h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQ-CPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTT-STTBCCEEEEEEEEETTEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhcc-CCCchhHHhhhhhhcCCCc
Confidence 34568887 78999999999999875 799999999862 2356677777644432 9999999999876 66
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCeEEee
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISD 190 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~---~~~~~l~D 190 (272)
..++||||+++++|.+++... ....+++..++.++.|++.||.+||++ ||+|+||||+||+++. ++.++|+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred eEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 789999999999999998432 234689999999999999999999999 9999999999999998 78899999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
||++.... +..++.++|+|||||++|+|++|+.||...+.
T Consensus 164 fg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 164 FGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp CTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred cccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 99886432 13356789999999999999999999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=251.48 Aligned_cols=205 Identities=19% Similarity=0.199 Sum_probs=155.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccc-cc---------ee---
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCH-EN---------LV--- 103 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~-~~---------i~--- 103 (272)
..+|.+.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|+..++.+. | ++ ++
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~--~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR--GIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST--TCCSHHHHHHHTCBCCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc--cCCCHHHHHHhcccccch
Confidence 345888999999999999999966 799999999873322 23567888888888876 3 11 11
Q ss_pred ---------EeeeeEec-----CCceeEEEeecCCCCHhHHHhhc---ccccccCChHHHHHHHHHHHHHHHHHhhcCCC
Q 024118 104 ---------KLHGGCID-----GPCRILVYDYMPNNSLSQTLLGE---EKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166 (272)
Q Consensus 104 ---------~l~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ 166 (272)
.+...... ....+++|+.+ +++|.+++... ......+++..++.++.|++.||.|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 11111111 12356667755 78898887322 22355688889999999999999999999
Q ss_pred CeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccccccccccccccCcccc----------ccCCCCCCCceehHHH
Q 024118 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA----------ISGRLTRKSDVYSFGV 236 (272)
Q Consensus 167 ~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Di~slG~ 236 (272)
||+||||||+|||++.++.++|+|||++...... .....| +.|+|||++ .+..++.++|+|||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999998764322 333566 899999999 5555788999999999
Q ss_pred HHHHHHhCCCccccccCCCc
Q 024118 237 LLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 237 il~~l~tg~~p~~~~~~~~~ 256 (272)
++|+|++|+.||...+..+.
T Consensus 306 il~elltg~~Pf~~~~~~~~ 325 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG 325 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC
T ss_pred HHHHHHHCCCCCCCcchhhh
Confidence 99999999999987665443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-32 Score=243.82 Aligned_cols=186 Identities=15% Similarity=0.141 Sum_probs=129.6
Q ss_pred eeeccceEEEEEEeC-CCcEEEEEEEEecC----------cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 50 IGEGGFGSVYKGRLQ-DGTIVAVKVLSVES----------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 50 lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~----------~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
...|+.+....++.. .|+.+++|++.... ......+.+|++.++++.. |+||+++++++.++...|||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~-~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPA-GFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCT-TCCCCCEEEEEECSSEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEECCEEEEE
Confidence 344555555554432 58899999986431 1223568889999999954 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||++|++|.+.+ ....++++. .|+.||+.||.|+|++ ||+||||||+|||++.+|.+||+|||++....
T Consensus 321 MEyv~G~~L~d~i----~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDML----AAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHH----HTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHH----HhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999 445667654 4789999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV 248 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~ 248 (272)
.... .....+||+.|+|||++.+. +..++|+|++|++++.|.++..++
T Consensus 391 ~~~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 4322 23446799999999999764 567899999999988776665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=212.01 Aligned_cols=185 Identities=18% Similarity=0.158 Sum_probs=142.9
Q ss_pred eeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcc--------cHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 45 RWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQ--------GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 45 ~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~--------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
...+.||+|+||.||++.. .+..+++|........ ...++.+|++.+++++ ||||+++..++......+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK--DFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG--GGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC--CCCcCceEEEEEeCCccE
Confidence 4467999999999999944 4777888886533211 1345789999999998 999996555555777789
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++++|.+++.. +..++.|++++|.|||++ ||+||||||+||+++. .++|+|||++..
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999832 568999999999999999 9999999999999998 999999999987
Q ss_pred cCCCCcc------ccccccccccccCcccccc--CCCCCCCceehHHHHHHHHHhCCCccc
Q 024118 197 FPENTTH------ISTRVAGTLGYLAPEYAIS--GRLTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 197 ~~~~~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
....... ......||+.|+|||++.. ..|+...|+|+...-..+-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 6543211 1234678999999999987 567888999999988888888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=179.24 Aligned_cols=139 Identities=17% Similarity=0.120 Sum_probs=110.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCc------------------ccHHHHHHHHHHhhccccc
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK------------------QGEKEFMSEVASMANVNVC 98 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~------------------~~~~~~~~e~~~~~~~~~~ 98 (272)
.......|++.+.||+|++|.||+|.+.+|+.||+|.+..... .....+.+|+..++.+.
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556677799999999999999988899999999863321 12456788999999987
Q ss_pred ccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 024118 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178 (272)
Q Consensus 99 ~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ni 178 (272)
|++++.+ +. .+..++||||++|++|.+ +. ......++.|++.|+.+||++ ||+|+||||.||
T Consensus 163 ~~~v~~~---~~-~~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 GLAVPKV---YA-WEGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp TSSSCCE---EE-EETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred CCCcCeE---Ee-ccceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 4544443 33 356799999999999988 41 123456999999999999999 999999999999
Q ss_pred EEcCCCCeEEeecCcccc
Q 024118 179 LLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 179 lv~~~~~~~l~Dfg~~~~ 196 (272)
+++ ++.++|+|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp EEE-TTEEEECCCTTCEE
T ss_pred EEE-CCcEEEEECCCCeE
Confidence 999 99999999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.7e-21 Score=156.17 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=105.9
Q ss_pred eeeeeeeeeccceEEEEEEe-CCCcE--EEEEEEEecCcc------------------------cHHHHHHHHHHhhccc
Q 024118 44 FRWSNKIGEGGFGSVYKGRL-QDGTI--VAVKVLSVESKQ------------------------GEKEFMSEVASMANVN 96 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~-~~~~~--v~vK~~~~~~~~------------------------~~~~~~~e~~~~~~~~ 96 (272)
|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999988 68988 999987533111 1135778899999887
Q ss_pred ccccc--eeEeeeeEecCCceeEEEeecCC-C----CHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHh-hcCCCCe
Q 024118 97 VCHEN--LVKLHGGCIDGPCRILVYDYMPN-N----SLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH-EEIQPHV 168 (272)
Q Consensus 97 ~~~~~--i~~l~~~~~~~~~~~iv~e~~~~-~----~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-~~~~~~i 168 (272)
|++ ++.++.. ...++||||+.+ + +|.+... ..++..+..++.|++.++.+|| ++ ||
T Consensus 129 --~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---gi 192 (258)
T 1zth_A 129 --EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEA---EL 192 (258)
T ss_dssp --HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTS---CE
T ss_pred --hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHC---CE
Confidence 654 3344432 357899999942 3 6665541 1235678889999999999999 88 99
Q ss_pred EecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 169 VHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 169 ~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
+||||||.|||++. .++|+|||++...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=153.43 Aligned_cols=135 Identities=14% Similarity=0.164 Sum_probs=97.1
Q ss_pred eeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCc--------------ccHHH--------HHHHHHHhhcccccccc
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK--------------QGEKE--------FMSEVASMANVNVCHEN 101 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~--------------~~~~~--------~~~e~~~~~~~~~~~~~ 101 (272)
|++.+.||+|++|.||+|...+|+.||||+++.... ..... ...|...+.++. +.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~--~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY--EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH--hcC
Confidence 999999999999999999999999999998752210 01111 123444444443 222
Q ss_pred e--eEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 024118 102 L--VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNIL 179 (272)
Q Consensus 102 i--~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nil 179 (272)
+ +..+.. ...++||||++|.+|.... ..+....++.|++.++.+||+. ||+||||||.|||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNIL 237 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEE
Confidence 2 112211 2347999999988876543 1123456889999999999999 9999999999999
Q ss_pred EcCCCC----------eEEeecCccccc
Q 024118 180 LDQNFN----------PKISDFGLSKLF 197 (272)
Q Consensus 180 v~~~~~----------~~l~Dfg~~~~~ 197 (272)
++++|. +.++||+.+...
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EeCCCCcccccccccceEEEEeCCcccC
Confidence 987763 899999988754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=3.1e-14 Score=116.27 Aligned_cols=147 Identities=16% Similarity=0.039 Sum_probs=113.3
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.....+|++...++.|+.+.||++... +..+++|............+.+|+..++.+.. +..+++++++....+..++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CCCCCeEEEEEecCCceEE
Confidence 344567999999999999999999754 67899999864322233457788888888865 6778889998888888999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE---------------------------------- 163 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~---------------------------------- 163 (272)
|||+++|.+|.+.+. +......++.+++.++..||+.
T Consensus 88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999887641 1122346788899999999981
Q ss_pred ----------------------CCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 164 ----------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 164 ----------------------~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
....++|+|++|.||++++++.+.++||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 00269999999999999875455699999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1e-12 Score=106.73 Aligned_cols=142 Identities=15% Similarity=0.139 Sum_probs=99.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
...++.+....+.|..+.||++...+|..+++|..... ....+.+|+..++.+....-.+++++.....++..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34556665554456679999998777888999997533 223466788888777632122566888877777889999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI----------------------------------- 164 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~----------------------------------- 164 (272)
||++|.+|. .. . .+ ...++.+++.++..||+..
T Consensus 95 e~i~G~~l~--~~---~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL--SS---H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT--TS---C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC--cC---c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999998884 21 0 11 1245666677777777641
Q ss_pred --------------------CCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 165 --------------------QPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 165 --------------------~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
..+++|+|++|.||++++++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01399999999999998765566999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-11 Score=105.09 Aligned_cols=146 Identities=14% Similarity=0.144 Sum_probs=106.8
Q ss_pred eeeeeeeeeccceEEEEEEeCCCcEEEEEEEE--ecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC---CceeE
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLS--VES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG---PCRIL 117 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~--~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~---~~~~i 117 (272)
..-.+.++.|.++.+|++...+ ..+++|... ... ......+.+|+..++.+...+..+++++..+.+. +..++
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3446788999999999998764 578888764 221 1223467778888888875456688888887765 45889
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI--------------------------------- 164 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--------------------------------- 164 (272)
|||+++|..+.+.. -..++......++.+++.+|..||+..
T Consensus 119 vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 99999998875422 134677888889999999999999720
Q ss_pred ----------------------CCCeEecCCCCCCEEEcCCCC--eEEeecCcccc
Q 024118 165 ----------------------QPHVVHRDIKTSNILLDQNFN--PKISDFGLSKL 196 (272)
Q Consensus 165 ----------------------~~~i~h~dl~p~nilv~~~~~--~~l~Dfg~~~~ 196 (272)
...++|+|++|.||+++.++. +.++||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987654 58999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.1e-11 Score=100.60 Aligned_cols=189 Identities=16% Similarity=0.178 Sum_probs=119.2
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhccccc-ccceeEeeeeEecCC---ceeEEEeec
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGP---CRILVYDYM 122 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~-~~~i~~l~~~~~~~~---~~~iv~e~~ 122 (272)
.+.++.|..+.+|++. ..+++|... .......+.+|+..++.+... .-.+++++....... ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568899999999864 458889854 223345778888888777421 112444444433332 457899999
Q ss_pred CCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 024118 123 PNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE--------------------------------------- 163 (272)
Q Consensus 123 ~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~--------------------------------------- 163 (272)
+|.+|..... ..++......++.+++..+..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9998875431 3466777777888888888888861
Q ss_pred ----------------CCCCeEecCCCCCCEEEcC--CCCeEEeecCcccccCCCCccccccccccccccCcccccc---
Q 024118 164 ----------------IQPHVVHRDIKTSNILLDQ--NFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS--- 222 (272)
Q Consensus 164 ----------------~~~~i~h~dl~p~nilv~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--- 222 (272)
....++|+|++|.||++++ ++.+.++||+.+..-..... ...... ...-..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~-~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLME-DDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCC-TTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHh-hccccCHHHHHHHHH
Confidence 1135899999999999987 44578999998864321110 000000 000012221110
Q ss_pred ---CC--------CCCCCceehHHHHHHHHHhCCCccc
Q 024118 223 ---GR--------LTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 223 ---~~--------~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
.. .....+.|+++.+++.+.+|+.+|-
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 0112578999999999999999884
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=2.3e-08 Score=81.58 Aligned_cols=144 Identities=16% Similarity=0.158 Sum_probs=100.8
Q ss_pred hhCCeeeeeeeeeccce-EEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFG-SVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~-~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
....|++.. +..|..+ .||+.... ++..+++|.... .....+.+|...++.+.. +--+++++.++...+..++
T Consensus 23 ~l~g~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~-~vPVP~v~~~~~~~~~~~l 97 (272)
T 4gkh_A 23 DLYGYRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTA-FMPLPTIKHFIRTPDDAWL 97 (272)
T ss_dssp HHTTCEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEE
T ss_pred cccCCeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhcc-CCCcCeEEEEEEECCeEEE
Confidence 334455543 3445444 68988765 567899998652 234467778888887765 3347888888888889999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE---------------------------------- 163 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~---------------------------------- 163 (272)
|||+++|.++.+..... ......+..++...+..||+.
T Consensus 98 vme~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 99999999888765221 122334566677777777753
Q ss_pred ---------------------CCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 164 ---------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 164 ---------------------~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
....++|+|++|.||++++++.+-|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 011379999999999999876667999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=1.1e-07 Score=79.23 Aligned_cols=138 Identities=16% Similarity=0.170 Sum_probs=89.9
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccc-cceeEeeeeEe-cCCceeEEEeecCC
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCI-DGPCRILVYDYMPN 124 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~i~~l~~~~~-~~~~~~iv~e~~~~ 124 (272)
.+.++.|....+|++ |..+++|.. ........+.+|+..++.+.... -.+++++.++. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 466788888999988 566888884 23334467888999998887421 23556666653 44567899999999
Q ss_pred CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 024118 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE----------------------------------------- 163 (272)
Q Consensus 125 ~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~----------------------------------------- 163 (272)
.++..... ..++......+..++...+..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 98876321 1122233333333333333333321
Q ss_pred ----------------CCCCeEecCCCCCCEEEcC---CCCe-EEeecCcccc
Q 024118 164 ----------------IQPHVVHRDIKTSNILLDQ---NFNP-KISDFGLSKL 196 (272)
Q Consensus 164 ----------------~~~~i~h~dl~p~nilv~~---~~~~-~l~Dfg~~~~ 196 (272)
....++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999987 4565 7999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=6.9e-08 Score=81.96 Aligned_cols=85 Identities=7% Similarity=-0.017 Sum_probs=55.4
Q ss_pred eeeeee-eeccceEEEEEEeC-------CCcEEEEEEEEecC---cccHHHHHHHHHHhhccccc-ccceeEeeeeEecC
Q 024118 45 RWSNKI-GEGGFGSVYKGRLQ-------DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDG 112 (272)
Q Consensus 45 ~i~~~l-g~G~~~~v~~~~~~-------~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~-~~~i~~l~~~~~~~ 112 (272)
...+.| +.|..+.+|++... ++..+++|...... ......+.+|+..++.+... ...+++++....+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345777 78888999998654 26789999864322 00123456777777776532 23466777766554
Q ss_pred ---CceeEEEeecCCCCHhH
Q 024118 113 ---PCRILVYDYMPNNSLSQ 129 (272)
Q Consensus 113 ---~~~~iv~e~~~~~~L~~ 129 (272)
+..++|||+++|.++.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.54 E-value=5.9e-07 Score=75.52 Aligned_cols=31 Identities=29% Similarity=0.424 Sum_probs=27.8
Q ss_pred CCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
..+||+|++|.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4899999999999998778899999998853
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.6e-06 Score=74.60 Aligned_cols=78 Identities=13% Similarity=0.085 Sum_probs=49.3
Q ss_pred eeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc-------ccHHHHHHHHHHhhccccccc-ceeEeeeeEecCCcee
Q 024118 46 WSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK-------QGEKEFMSEVASMANVNVCHE-NLVKLHGGCIDGPCRI 116 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~-~i~~l~~~~~~~~~~~ 116 (272)
-.+.+|.|..+.||++... ++..+++|....... ....+...|.+.++.+....+ .+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3578999999999999765 578899997642211 123355677777776643223 34455543 345578
Q ss_pred EEEeecCCC
Q 024118 117 LVYDYMPNN 125 (272)
Q Consensus 117 iv~e~~~~~ 125 (272)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.42 E-value=3.9e-06 Score=68.97 Aligned_cols=85 Identities=16% Similarity=0.187 Sum_probs=60.0
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccc-cceeEeeeeEecCCceeE
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~i~~l~~~~~~~~~~~i 117 (272)
.......-+..+|.|..+.||++...+|+.|++|+...........+..|+..++.+.... -.+++++.. +..++
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~l 87 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTL 87 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEE
T ss_pred hcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceE
Confidence 4456677789999999999999999999999999865443333445677888888775322 224444443 23478
Q ss_pred EEeecCCCCH
Q 024118 118 VYDYMPNNSL 127 (272)
Q Consensus 118 v~e~~~~~~L 127 (272)
+||++++...
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.33 E-value=6.2e-06 Score=68.60 Aligned_cols=78 Identities=14% Similarity=0.081 Sum_probs=60.1
Q ss_pred eeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhccccc-ccceeEeeeeEecCCceeEEEeecCC
Q 024118 46 WSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC-HENLVKLHGGCIDGPCRILVYDYMPN 124 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~-~~~i~~l~~~~~~~~~~~iv~e~~~~ 124 (272)
-.+.|+.|..+.+|++.. ++..+++|..... ....+..|+..++.+... ...+++++..+...+..++|||+++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 357888899999999976 4677889987532 345677888888887643 35678888888777889999999998
Q ss_pred CCH
Q 024118 125 NSL 127 (272)
Q Consensus 125 ~~L 127 (272)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.07 E-value=3.2e-05 Score=67.09 Aligned_cols=30 Identities=20% Similarity=0.385 Sum_probs=26.8
Q ss_pred CCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
..++|+|++|.||+++.++ +.++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3999999999999998776 99999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.07 E-value=7.5e-05 Score=62.09 Aligned_cols=161 Identities=11% Similarity=0.052 Sum_probs=82.9
Q ss_pred CChhHHHHhhCCeee-----eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEee
Q 024118 32 FSYNQLKIATNGFRW-----SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i-----~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~ 106 (272)
++...+.....+|.+ .+.|+.|....+|++...+| .+++|...... ....+..|...+..+....-.+++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444444444445544 35566688889999987655 58889876421 11234456666655542111233343
Q ss_pred ee------EecCCceeEEEeecCCCCHhH-----------H---Hhhc-cccccc----CChHHHHH-------------
Q 024118 107 GG------CIDGPCRILVYDYMPNNSLSQ-----------T---LLGE-EKRRAK----FGWKARRE------------- 148 (272)
Q Consensus 107 ~~------~~~~~~~~iv~e~~~~~~L~~-----------~---~~~~-~~~~~~----l~~~~~~~------------- 148 (272)
.. ....+..++++++++|..+.. . +... .....+ .... .|.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~-~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVD-GWKVLWDKSEERADEV 162 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHH-HHHHHHHHHGGGGGGT
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChH-HHHHHHHHHHHHHHhh
Confidence 21 122355789999999875421 0 0000 000000 0000 000
Q ss_pred ---HHHHHHHHHHHHhhc----CCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 149 ---IIMGIGRGLAYIHEE----IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 149 ---i~~~i~~al~~LH~~----~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+...+...+..+... ...+++|+|++|.||+++.++.+.++||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344444421 123899999999999998765557999998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.98 E-value=2.6e-05 Score=65.36 Aligned_cols=31 Identities=32% Similarity=0.376 Sum_probs=27.0
Q ss_pred CCeEecCCCCCCEEEcCC----CCeEEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQN----FNPKISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~----~~~~l~Dfg~~~~ 196 (272)
..++|+|+++.||+++.+ +.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 489999999999999874 6789999998874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.96 E-value=5.8e-05 Score=62.29 Aligned_cols=73 Identities=10% Similarity=0.075 Sum_probs=44.2
Q ss_pred eeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeec-CCC
Q 024118 47 SNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYM-PNN 125 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~-~~~ 125 (272)
.+.|+.|..+.+|++ ..+++|+....... .....+|+..++.+....- .++++.. ..+..++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~-~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGV-SPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTS-SCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCC-CCceEEE--ECCCCEEEEeecCCCc
Confidence 788988999999999 55888987533211 1123456666665542111 1455543 344467899999 776
Q ss_pred CHh
Q 024118 126 SLS 128 (272)
Q Consensus 126 ~L~ 128 (272)
++.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.89 E-value=1.1e-05 Score=70.29 Aligned_cols=75 Identities=19% Similarity=0.192 Sum_probs=48.4
Q ss_pred eeeeeeeccceEEEEEEeCC--------CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 46 WSNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
-.+.|+.|-...+|++...+ +..+++|+.... .....+..|...++.+.. +.-.++++..+.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~-~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSE-RHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHH-TTSSSCEEEEETT----EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHh-CCCCCcEEEEeCC----CE
Confidence 35677778889999998653 578999987421 121345578777777763 2223556654432 38
Q ss_pred EEeecCCCCH
Q 024118 118 VYDYMPNNSL 127 (272)
Q Consensus 118 v~e~~~~~~L 127 (272)
|++|++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=5.2e-05 Score=64.72 Aligned_cols=148 Identities=16% Similarity=0.152 Sum_probs=83.5
Q ss_pred CCeeeeeeeeeccceEEEEEEeC--------CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ--------DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~--------~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+.++ ++.+..|-...+|++... ++..+++|+.... ........+|...++.+.. +.-.++++..+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~-~gv~P~ll~~~~~-- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAE-RSLGPQLYGVFPE-- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHH-TTSSCCEEEEETT--
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHh-cCCCCeEEEEcCC--
Confidence 3444 356766888999999864 3578999986321 2234456678888877764 2223566655443
Q ss_pred ceeEEEeecCCCCHhHHH--------------hhccccc----ccC--ChHHHHHHHHHHHH------------------
Q 024118 114 CRILVYDYMPNNSLSQTL--------------LGEEKRR----AKF--GWKARREIIMGIGR------------------ 155 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~--------------~~~~~~~----~~l--~~~~~~~i~~~i~~------------------ 155 (272)
.+|+||++|.+|..-- ..-.... ... -...+..+..++..
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 3899999987654210 0000011 111 12445555544322
Q ss_pred -HHHHHh----hc-CCCCeEecCCCCCCEEEcCC----CCeEEeecCcccc
Q 024118 156 -GLAYIH----EE-IQPHVVHRDIKTSNILLDQN----FNPKISDFGLSKL 196 (272)
Q Consensus 156 -al~~LH----~~-~~~~i~h~dl~p~nilv~~~----~~~~l~Dfg~~~~ 196 (272)
.+..|. .. ....+||+|+.+.||+++.+ +.+.++||..+..
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 122222 11 12378999999999999876 6899999998863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00015 Score=60.35 Aligned_cols=78 Identities=10% Similarity=-0.017 Sum_probs=48.9
Q ss_pred eeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeee-----EecCCceeEEEeec
Q 024118 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG-----CIDGPCRILVYDYM 122 (272)
Q Consensus 48 ~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~-----~~~~~~~~iv~e~~ 122 (272)
..++ |....+|++...+|+.+++|...... .....+..|...+..+....-.+++++.. ....+..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 78889999877778789999975321 23445666777776665322223444432 11234567899999
Q ss_pred CCCCH
Q 024118 123 PNNSL 127 (272)
Q Consensus 123 ~~~~L 127 (272)
+|..+
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 88543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00014 Score=61.79 Aligned_cols=75 Identities=12% Similarity=0.092 Sum_probs=42.8
Q ss_pred eeeeeeccceEEEEEEeCC---------CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 47 SNKIGEGGFGSVYKGRLQD---------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
.+.++.|....+|++...+ +..+++|+...... .......|...++.+.. +.-.++++... ..++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~-~g~~P~~~~~~----~~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSK-YKIAPQLLNTF----NGGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHH-TTSSCCEEEEE----TTEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHh-cCCCCceEEec----CCcE
Confidence 4667778889999997653 26889998653221 11123466666666653 21144555433 2378
Q ss_pred EEeecCCCCH
Q 024118 118 VYDYMPNNSL 127 (272)
Q Consensus 118 v~e~~~~~~L 127 (272)
|++|++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999988644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00054 Score=59.99 Aligned_cols=75 Identities=9% Similarity=-0.069 Sum_probs=45.6
Q ss_pred eeeeeeccceEEEEEEeCC-CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCC
Q 024118 47 SNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNN 125 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~ 125 (272)
.+.|+.|-...+|++...+ +..+++|+...... ......+|...++.+.. +.-.++++..+. + .+|+||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~-~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYN-KNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTT-SSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHh-cCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 4677778889999998764 57899998743221 11122467777776653 222355666552 2 3699999876
Q ss_pred CH
Q 024118 126 SL 127 (272)
Q Consensus 126 ~L 127 (272)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0005 Score=57.76 Aligned_cols=31 Identities=26% Similarity=0.327 Sum_probs=27.5
Q ss_pred CCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 166 ~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
..++|+|+.|.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3799999999999999878899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0041 Score=53.75 Aligned_cols=75 Identities=5% Similarity=0.013 Sum_probs=46.2
Q ss_pred eeeeeeccceEEEEEEeCC--------CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 47 SNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++.+..|-...+|++...+ +..+++|+..... .......+|...++.+.. +.-.++++..+ ..+.|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~-~gi~P~l~~~~----~~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSN-INIAPNIIADF----PEGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHH-TTSSCCEEEEE----TTEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHh-cCCCCCEEEEc----CCCEE
Confidence 4666668889999998653 5789999864322 111233456666666653 22244555432 23789
Q ss_pred EeecCCCCH
Q 024118 119 YDYMPNNSL 127 (272)
Q Consensus 119 ~e~~~~~~L 127 (272)
++|++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0027 Score=49.35 Aligned_cols=99 Identities=12% Similarity=0.086 Sum_probs=64.2
Q ss_pred CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCCCccc
Q 024118 125 NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI 204 (272)
Q Consensus 125 ~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~~~ 204 (272)
.+|.+.+ ...+.+++++++|.+..|.+.++..+-.+. .-...=+.|..|++..+|+|.+.+ ..+.
T Consensus 33 vSL~eIL---~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEIL---RLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHH---HHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHH---HHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 3788888 456789999999999999999987763210 112445567899999999887653 1110
Q ss_pred cccccccccccCccccccCCCCCCCceehHHHHHHHHHh
Q 024118 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243 (272)
Q Consensus 205 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t 243 (272)
.....+.+||... ...+.+.=|||||+++|..+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123467888763 233456679999999998776
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0013 Score=56.57 Aligned_cols=30 Identities=30% Similarity=0.416 Sum_probs=25.4
Q ss_pred CeEecCCCCCCEEE------cCCCCeEEeecCcccc
Q 024118 167 HVVHRDIKTSNILL------DQNFNPKISDFGLSKL 196 (272)
Q Consensus 167 ~i~h~dl~p~nilv------~~~~~~~l~Dfg~~~~ 196 (272)
.+||+|+.+.||++ ++++.+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999 4456799999998863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.72 E-value=0.25 Score=38.32 Aligned_cols=83 Identities=7% Similarity=0.013 Sum_probs=57.6
Q ss_pred ccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCCC
Q 024118 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA-YIHEEIQPHVVHRDIKTSN 177 (272)
Q Consensus 99 ~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~-~LH~~~~~~i~h~dl~p~n 177 (272)
||++ -..+-...+...+.++--++..=...+ ..++....++++.+|+.... ++++ -.|--++|+|
T Consensus 49 ~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 49 DPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp CSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred CCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 7888 233335556655555533222111222 46778999999999988777 6664 4889999999
Q ss_pred EEEcCCCCeEEeecCccc
Q 024118 178 ILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 178 ilv~~~~~~~l~Dfg~~~ 195 (272)
++++.++.+++.-.|+..
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999998777654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.18 E-value=0.19 Score=38.89 Aligned_cols=84 Identities=10% Similarity=0.033 Sum_probs=59.8
Q ss_pred ccceeEeeeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 024118 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178 (272)
Q Consensus 99 ~~~i~~l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ni 178 (272)
+|++++. .+-...+...+.++. ......+- .-..++....++++.+|+....+++++ .|--++|.|+
T Consensus 44 ~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 44 SPYFIDA-ELTELRDSFQIHYDI--NDNHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CTTBCCE-EEEECSSEEEEEECC--CTTSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred CCcccce-EEEEcccEEEEEEEc--CcccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 7888876 454555554444443 23233332 235678899999999999988666644 8999999999
Q ss_pred EEcCCCCeEEeecCccc
Q 024118 179 LLDQNFNPKISDFGLSK 195 (272)
Q Consensus 179 lv~~~~~~~l~Dfg~~~ 195 (272)
+++.++.+++.--|+..
T Consensus 111 ~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp EECTTSCEEESCCEETT
T ss_pred EEcCCCCEEEEEccCcc
Confidence 99999999998766543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 272 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-23 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-65
Identities = 51/212 (24%), Positives = 101/212 (47%), Gaps = 13/212 (6%)
Query: 37 LKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EKEFMSEVASMAN 94
+++ + F +++G G G V+K G ++A K++ +E K + + E+ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 95 VNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
N +V +G + ++M SL Q L K+ + + ++ + +
Sbjct: 61 CN--SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVI 114
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
+GL Y+ E + ++HRD+K SNIL++ K+ DFG+S ++ GT Y
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSY 169
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
++PE + +SD++S G+ L+E+ GR
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-64
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVN 96
I +IG G FG+VYKG+ VAVK+L+V + Q + F +EV +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 97 VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
H N++ G P +V + +SL L KF +I +G
Sbjct: 63 --HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQG 116
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHISTRVAGTLGYL 215
+ Y+H ++HRD+K++NI L ++ KI DFGL+ + + +H +++G++ ++
Sbjct: 117 MDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 216 APEYA---ISGRLTRKSDVYSFGVLLLEIVSGR 245
APE + +SDVY+FG++L E+++G+
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-63
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 39 IATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVC 98
+ + ++G G FG V+ G T VAVK L + F++E M +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQ-- 66
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
H+ LV+L+ P ++ +YM N SL L + K ++ I G+A
Sbjct: 67 HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
+I E + +HRD++ +NIL+ + KI+DFGL++L +N + + APE
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGR 245
G T KSDV+SFG+LL EIV+
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHG 207
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 8e-62
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
+ +IG G FG V+ G + VA+K + E E++F+ E M ++ H LV
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLS--HPKLV 63
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+L+G C++ LV+++M + LS +R F + + + + G+AY+ E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE- 119
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
V+HRD+ N L+ +N K+SDFG+++ ++ ST + + +PE
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 224 RLTRKSDVYSFGVLLLEIVSGR 245
R + KSDV+SFGVL+ E+ S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEG 199
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-60
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 9/214 (4%)
Query: 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVAS 91
+ + +I R K+G+G FG V+ G T VA+K L + F+ E
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQV 65
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
M + HE LV+L+ + P +V +YM SL + + ++
Sbjct: 66 MKKLR--HEKLVQLYAVVSEEPI-YIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAA 120
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
I G+AY+ + + VHRD++ +NIL+ +N K++DFGL++L +N
Sbjct: 121 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
+ + APE A+ GR T KSDV+SFG+LL E+ +
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 211
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-59
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
+ ++G G FG V G+ + VA+K++ E E EF+ E M N++ HE LV
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLS--HEKLV 62
Query: 104 KLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE 163
+L+G C ++ +YM N L L + R +F + E+ + + Y+
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 164 IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISG 223
+HRD+ N L++ K+SDFGLS+ ++ S + + PE +
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 224 RLTRKSDVYSFGVLLLEIVS 243
+ + KSD+++FGVL+ EI S
Sbjct: 177 KFSSKSDIWAFGVLMWEIYS 196
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (475), Expect = 6e-59
Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 10/232 (4%)
Query: 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQD-GTIVAVKVLSVESKQGEKEFMSEVAS 91
+Y++ ++ +K+G G +G VY+G + VAVK L ++ + E EF+ E A
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
M + H NLV+L G C P ++ ++M +L L E R + +
Sbjct: 67 MKEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMAT 122
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
I + Y+ + + +HRD+ N L+ +N K++DFGLS+L +T
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE-YHLVDK 262
+ + APE + + KSDV++FGVLL EI + + + L + Y L++K
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 1e-57
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVNVCH 99
F +IG G FG+VY R +++ +VA+K +S KQ ++ + EV + + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--H 74
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N ++ G + LV +Y ++ + + G +GLAY
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+H +++HRD+K NILL + K+ DFG + + + + GT ++APE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 182
Query: 220 AIS---GRLTRKSDVYSFGVLLLEIVSGRT 246
++ G+ K DV+S G+ +E+ +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-57
Identities = 48/229 (20%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 23 EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG 81
E + +++N + + ++G+G FG VYK + + + A KV+ +S++
Sbjct: 2 EHVTRDLNP---------EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 52
Query: 82 EKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKF 141
+++M E+ +A+ + H N+VKL ++ ++ ++ + +
Sbjct: 53 LEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPL 107
Query: 142 GWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENT 201
+ + L Y+H+ ++HRD+K NIL + + K++DFG+S
Sbjct: 108 TESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164
Query: 202 THISTRVAGTLGYLAPEYAIS-----GRLTRKSDVYSFGVLLLEIVSGR 245
+ + GT ++APE + K+DV+S G+ L+E+
Sbjct: 165 QRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-57
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 10/210 (4%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHE 100
+ IG G +G K R DG I+ K L S + ++ +SEV + + H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HP 63
Query: 101 NLVKLHGGCIDGPCRIL--VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
N+V+ + ID L V +Y L+ + K R + ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 159 YIHE--EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
H + V+HRD+K +N+ LD N K+ DFGL+++ +T+ + GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMS 182
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
PE KSD++S G LL E+ +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (463), Expect = 6e-57
Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 29 INAFSYNQLKIATNGFRWS---------NKIGEGGFGSVYKGRL----QDGTIVAVKVLS 75
I+ F++ A F IG G FG V G L + VA+K L
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 76 VE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE 134
+++ ++F+SE + M + H N++ L G +++ ++M N SL
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFD--HPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---L 118
Query: 135 EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194
+ +F ++ GI G+ Y+ + VHRD+ NIL++ N K+SDFGLS
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 195 KLFPENTTHISTRVA----GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
+ ++T+ + A + + APE + T SDV+S+G+++ E++S
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-56
Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 16/225 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
F +G+G FG+VY R Q I+A+KVL +E E + EV +++ H
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--H 65
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
N+++L+G D L+ +Y P ++ + L ++ +KF + I + L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 121
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
H + V+HRDIK N+LL KI+DFG S P + + GTL YL PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVR 264
K D++S GVL E + G+ + + Y + +V
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 220
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-56
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 44 FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
++ +IG G F +VYKG + VA L +K + F E + + H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HP 68
Query: 101 NLVKLHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
N+V+ + C +LV + M + +L L KR K R I +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKG 124
Query: 157 LAYIHEEIQPHVVHRDIKTSNILL-DQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
L ++H P ++HRD+K NI + + KI D GL+ L + V GT ++
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFM 180
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
APE + DVY+FG+ +LE+ +
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSE 209
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-55
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106
KIG+G G+VY + G VA++ ++++ + ++ ++E+ M + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYL 83
Query: 107 GGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166
+ G +V +Y+ SL+ + + + L ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLT 226
V+HRDIK+ NILL + + K++DFG + ST V GT ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 227 RKSDVYSFGVLLLEIVSGR 245
K D++S G++ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-55
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHEN 101
+ +GEG +G V VAVK++ ++ + + E+ +N HEN
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HEN 64
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+VK +G +G + L +Y L + + + + G+ Y+H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLAPEYA 220
+ HRDIK N+LLD+ N KISDFGL+ +F N + ++ GTL Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 221 ISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFD 251
DV+S G++L +++G D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 2e-54
Identities = 69/241 (28%), Positives = 106/241 (43%), Gaps = 33/241 (13%)
Query: 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVE-SKQGEKEF 85
L+ N + IGEG FG V++ R + T+VAVK+L E S + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 86 MSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR-------- 137
E A MA + + N+VKL G C G L+++YM L++ L
Sbjct: 64 QREAALMAEFD--NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 138 ------------RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185
+ I + G+AY+ E VHRD+ T N L+ +N
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMV 178
Query: 186 PKISDFGLSK-LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG 244
KI+DFGLS+ ++ + A + ++ PE R T +SDV+++GV+L EI S
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 245 R 245
Sbjct: 239 G 239
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-54
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLV 103
+ IG+G FG V G G VAVK + + + F++E + M + H NLV
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLR--HSNLV 63
Query: 104 KLHGGCIDGPCRI-LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
+L G ++ + +V +YM SL L + R+ G + + + + Y+
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE- 120
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAIS 222
+ VHRD+ N+L+ ++ K+SDFGL+K + + APE
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALRE 174
Query: 223 GRLTRKSDVYSFGVLLLEIVSGR 245
+ + KSDV+SFG+LL EI S
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFG 197
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 9e-54
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 45 RWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVESKQGE-KEFMSEVASMANVNVCH 99
++ IG G FG VY G L D AVK L+ + GE +F++E M + + H
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--H 87
Query: 100 ENLVKLHGGCIDGP-CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
N++ L G C+ ++V YM + L K + + +G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN---TTHISTRVAGTLGYL 215
++ VHRD+ N +LD+ F K++DFGL++ + + H T + ++
Sbjct: 145 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
A E + + T KSDV+SFGVLL E+++
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-53
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 36 QLKIATNGFRWSN-KIGEGGFGSVYKGRLQ---DGTIVAVKVLSVESKQGE-KEFMSEVA 90
+L + + ++ ++G G FGSV +G + VA+KVL +++ + +E M E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 91 SMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREII 150
M ++ + +V+L G +LV + L + L+G +R + E++
Sbjct: 62 IMHQLD--NPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELL 115
Query: 151 MGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--V 208
+ G+ Y+ + + VHRD+ N+LL KISDFGLSK + ++ + R
Sbjct: 116 HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 209 AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
L + APE + + +SDV+S+GV + E +S
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 207
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-53
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 49 KIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
IG+G FG V++G+ G VAVK+ S + E+ + E V + HEN++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 109 CIDG----PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
LV DY + SL L R + ++ + GLA++H EI
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 165 -----QPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS---TRVAGTLGYLA 216
+P + HRD+K+ NIL+ +N I+D GL+ T I GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 217 PEYAIS------GRLTRKSDVYSFGVLLLEIVSGR 245
PE +++D+Y+ G++ EI
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-53
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 48 NKIGEGGFGSVYKGRLQD---GTIVAVKVLSVESKQGE--KEFMSEVASMANVNVCHENL 102
++G G FG+V KG Q VAVK+L E+ E ++E M ++ + +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYI 70
Query: 103 VKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE 162
V++ G + +LV + L++ L ++ K E++ + G+ Y+
Sbjct: 71 VRMIG-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE- 124
Query: 163 EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTR--VAGTLGYLAPEYA 220
+ + VHRD+ N+LL KISDFGLSK + + + + + APE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
+ + KSDV+SFGVL+ E S
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYG 207
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 8e-53
Identities = 59/227 (25%), Positives = 111/227 (48%), Gaps = 16/227 (7%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGT-----IVAVKVLSVESKQGEK-EFMSEVAS 91
+I + IG G FG VYKG L+ + VA+K L + ++ +F+ E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
M + H N+++L G +++ +YM N +L + ++ +F ++
Sbjct: 63 MGQFS--HHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLR 117
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN--TTHISTRVA 209
GI G+ Y+ + VHRD+ NIL++ N K+SDFGLS++ ++ T+ ++
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
+ + APE + T SDV+SFG+++ E+++ +++ E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 2e-52
Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 42 NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHE 100
+ + ++G G FG V++ G A K + + ++ E+ +M+ + H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HP 83
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
LV LH D +++Y++M L + + K E + + +GL ++
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
HE + VH D+K NI+ + K+ DFGL+ + T GT + APE
Sbjct: 141 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPE 195
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
A + +D++S GVL ++SG +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-52
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 22/220 (10%)
Query: 42 NGFRWSNKIGEGGFGSVYKGRLQDG---TIVAVKVLS-VESKQGEKEFMSEVASMANVNV 97
N ++ + IGEG FG V K R++ A+K + SK ++F E+ + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG- 68
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGE------------EKRRAKFGWKA 145
H N++ L G C L +Y P+ +L L + +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS 205
+ RG+ Y+ Q +HRD+ NIL+ +N+ KI+DFGLS+
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 206 TRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
T + ++A E T SDV+S+GVLL EIVS
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-52
Identities = 61/252 (24%), Positives = 100/252 (39%), Gaps = 32/252 (12%)
Query: 21 GGEQILKNINAFSYNQL-KIATNGFRWSNKIGEGGFGSVYKGRLQD------GTIVAVKV 73
E + + Y+ + + +G G FG V VAVK+
Sbjct: 15 DNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM 74
Query: 74 LSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL- 131
L ++ E+E MSE+ M + HEN+V L G C L+++Y L L
Sbjct: 75 LKEKADSSEREALMSELKMMTQLG-SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 132 ------------------LGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDI 173
L EE+ ++ + +G+ ++ VHRD+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190
Query: 174 KTSNILLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVY 232
N+L+ KI DFGL++ ++ + + + ++APE G T KSDV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 233 SFGVLLLEIVSG 244
S+G+LL EI S
Sbjct: 251 SYGILLWEIFSL 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-52
Identities = 56/254 (22%), Positives = 104/254 (40%), Gaps = 27/254 (10%)
Query: 21 GGEQILKNINAFSYN-QLKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKV 73
G + + Y+ + + N + +G G FG V + VAVK+
Sbjct: 1 GNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM 60
Query: 74 LSVESKQGEKE-FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLL 132
L + E+E MSE+ ++ + H N+V L G C G +++ +Y L L
Sbjct: 61 LKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119
Query: 133 GE--------------EKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178
+ E + + +G+A++ + + +HRD+ NI
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176
Query: 179 LLDQNFNPKISDFGLSKLFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVL 237
LL KI DFGL++ ++ + + + ++APE + T +SDV+S+G+
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
Query: 238 LLEIVSGRTAVDFD 251
L E+ S ++
Sbjct: 237 LWELFSLGSSPYPG 250
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-51
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 44 FRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLS---VESKQGEKEFMSEVASMANVN 96
R K+G+G FG V +G VAVK L + + +F+ EV +M +++
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 97 VCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
H NL++L+G + P ++ V + P SL K + F + + G
Sbjct: 70 --HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEG 123
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTH--ISTRVAGTLGY 214
+ Y+ +HRD+ N+LL KI DFGL + P+N H + +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVS 243
APE + + SD + FGV L E+ +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-51
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMA 93
K F++ +GEG F +V R L A+K+L + + E M+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
++ H VKL+ D Y N L + + ++ F R I
Sbjct: 64 RLD--HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEI 117
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTL 212
L Y+H ++HRD+K NILL+++ + +I+DFG +K+ PE+ + GT
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
Y++PE + SD+++ G ++ ++V+G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 4e-51
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 44 FRWSNKIGEGGFGSVYKGRLQD-----GTIVAVKVLS-VESKQGEKEFMSEVASMANVNV 97
F+ +G G FG+VYKG VA+K L S + KE + E MA+V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
+ ++ +L G C+ + L+ MP L L + + G + + I +G+
Sbjct: 70 -NPHVCRLLGICLTSTVQ-LITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF-PENTTHISTRVAGTLGYLA 216
Y+ +VHRD+ N+L+ + KI+DFGL+KL E + + + ++A
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
E + T +SDV+S+GV + E+++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFG 210
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (419), Expect = 7e-50
Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 13/201 (6%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
++G G FG V++ G + K ++ + +E++ M ++ H L+ LH
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHD 93
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
D +L+ +++ L + K + GL ++HE
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---S 147
Query: 168 VVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
+VH DIK NI+ + KI DFGL+ + T T + APE +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPV 205
Query: 226 TRKSDVYSFGVLLLEIVSGRT 246
+D+++ GVL ++SG +
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLS 226
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 8e-50
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 44 FRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLSVESKQGEKE-FMSEVASMANVNVC 98
IGEG FG V++G VA+K + +E F+ E +M +
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-- 66
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
H ++VKL G + ++ + L + R+ + + LA
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALA 122
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPE 218
Y+ VHRDI N+L+ N K+ DFGLS+ ++T + +++ + ++APE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 219 YAISGRLTRKSDVYSFGVLLLEIVSGRT 246
R T SDV+ FGV + EI+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (417), Expect = 2e-49
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 42 NGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNV 97
N F IG GGFG VY R G + A+K L ++ KQGE ++E ++ V+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 98 C-HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
+V + + D M L L + F R I G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 119
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLA 216
L ++H VV+RD+K +NILLD++ + +ISD GL+ F + H S GT GY+A
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 217 PEYAISGR-LTRKSDVYSFGVLLLEIVSGR 245
PE G +D +S G +L +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 1e-47
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 26/219 (11%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSV---------ESKQGEKEFMSEVASMA 93
+ +G G V + AVK++ V E ++ + + EV +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
V+ H N+++L LV+D M L L + K R+I+ +
Sbjct: 65 KVS-GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
+ +H+ ++VHRD+K NILLD + N K++DFG S V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174
Query: 214 YLAPEYAISGRL------TRKSDVYSFGVLLLEIVSGRT 246
YLAPE ++ D++S GV++ +++G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 5e-47
Identities = 45/214 (21%), Positives = 89/214 (41%), Gaps = 10/214 (4%)
Query: 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG-EKEFMSEVAS 91
+ Q + + + + + +G G F V + +VA+K ++ ++ +G E +E+A
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIM 151
+ + H N+V L G L+ + L + + + + +I
Sbjct: 61 LHKIK--HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIF 114
Query: 152 GIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGT 211
+ + Y+H+ H + LD++ ISDFGLSK+ + + GT
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGT 172
Query: 212 LGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
GY+APE ++ D +S GV+ ++ G
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-46
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 26/229 (11%)
Query: 39 IATNGFRWSNKIGEGGFGSVYKGRL--------QDGTIVAVKVLSVE-SKQGEKEFMSEV 89
+ + +GEG FG V T VAVK+L + +++ + +SE+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 90 ASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------------LGEEKR 137
M + H+N++ L G C ++ +Y +L + L
Sbjct: 70 EMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
+ K + RG+ Y+ +HRD+ N+L+ ++ KI+DFGL++
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 198 PENTTHISTRV-AGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
+ T + ++APE T +SDV+SFGVLL EI +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (391), Expect = 5e-46
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMANVNVCH 99
F+ +G G FG V+ R +G A+KVL V + + E ++ V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--H 63
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
++++ G D ++ DY+ L ++ +F + + L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFS----LLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+H +++RD+K NILLD+N + KI+DFG +K P+ T + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGR 245
+ + D +SFG+L+ E+++G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-46
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 39 IATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVESKQGEK-EFMSEVAS 91
+A S ++G+G FG VY+G + T VA+K ++ + E+ EF++E +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 92 MANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTL------LGEEKRRAKFGWKA 145
M N ++V+L G G +++ + M L L + A
Sbjct: 77 MKEFN--CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE-NTTHI 204
++ I G+AY++ VHRD+ N ++ ++F KI DFG+++ E +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
+ + +++PE G T SDV+SFGV+L EI +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-45
Identities = 33/201 (16%), Positives = 76/201 (37%), Gaps = 14/201 (6%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+G G FG V++ K + V+ + E++ + H N++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR--HRNILHLHE 68
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
+++++++ + + + + + + + L ++H +
Sbjct: 69 SFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 168 VVHRDIKTSNILLDQNFNP--KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
+ H DI+ NI+ + KI +FG ++ Y APE +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVV 180
Query: 226 TRKSDVYSFGVLLLEIVSGRT 246
+ +D++S G L+ ++SG
Sbjct: 181 STATDMWSLGTLVYVLLSGIN 201
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 7e-45
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 13/207 (6%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE---FMSEVASMANVNVCH 99
F +G+G FG V+ + A+K L + + + M E ++ H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEH 62
Query: 100 ENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAY 159
L + V +Y+ L + + KF I GL +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQF 118
Query: 160 IHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEY 219
+H +V+RD+K NILLD++ + KI+DFG+ K +T GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 220 AISGRLTRKSDVYSFGVLLLEIVSGRT 246
+ + D +SFGVLL E++ G++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 9e-45
Identities = 53/207 (25%), Positives = 81/207 (39%), Gaps = 18/207 (8%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE------FMSEVASMANVNVCHEN 101
+G GGFGSVY G + D VA+K + + E EV + V+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
+++L +L+ + + R + R + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 162 EEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
V+HRDIK NIL+D N K+ DFG L + T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 221 ISGRL-TRKSDVYSFGVLLLEIVSGRT 246
R R + V+S G+LL ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-44
Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 17/223 (7%)
Query: 48 NKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKE-----FMSEVASMANVNVCHEN 101
+ +GEG F +VYK R IVA+K + + + K+ + E+ + ++ H N
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPN 61
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
++ L LV+D+M + + + ++ +GL Y+H
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
+ ++HRD+K +N+LLD+N K++DFGL+K F + +V T Y APE
Sbjct: 118 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLF 173
Query: 222 SGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
R+ D+++ G +L E++ + D L + + +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-44
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 25/239 (10%)
Query: 39 IATNGFRWSNKIGEGGFGSVYKGR------LQDGTIVAVKVLSVESKQGE-KEFMSEVAS 91
+ + +G G FG V + VAVK+L + E + MSE+
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 92 MANVNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTL------------LGEEKRR 138
+ ++ H N+V L G C G +++ ++ +LS L E+ +
Sbjct: 70 LIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
+ + +G+ ++ +HRD+ NILL + KI DFGL++
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 199 ENTTHI-STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256
++ ++ L ++APE T +SDV+SFGVLL EI S + V++ E
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (378), Expect = 1e-44
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 41 TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE---KEFMSEVASMANVN 96
++ + +G GG V+ R L+ VAVKVL + + F E + A +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 97 VCHENLVKLHGGCID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
H +V ++ GP +V +Y+ +L + K E+I
Sbjct: 66 --HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIAD 119
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHI--STRVAG 210
+ L + H+ ++HRD+K +NI++ K+ DFG+++ ++ + + V G
Sbjct: 120 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176
Query: 211 TLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
T YL+PE A + +SDVYS G +L E+++G
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-44
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHE 100
F+ KIGEG +G VYK R G +VA+K + E++ + E++ + +N H
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HP 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
N+VKL LV++++ + + + + + +GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H V+HRD+K N+L++ K++DFGL++ F + V
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
+ D++S G + E+V+ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-44
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 40 ATNGFRWSNKIGEGGFGSVYKGR--LQDGTIVAVKVLSVESKQG--EKEFMSEVASMANV 95
A + +IGEG +G V+K R G VA+K + V++ + + EVA + ++
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 96 NVC-HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLG--EEKRRAKFGWKARREIIMG 152
H N+V+L C + + Q L ++ + ++++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTL 212
+ RGL ++H VVHRD+K NIL+ + K++DFGL++++ T V TL
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 213 GYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
Y APE + D++S G + E+ +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-43
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 11/210 (5%)
Query: 41 TNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE-KEFMSEVASMANVNVC 98
+ + IGEG +G V + VA+K +S Q + + E+ +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-- 64
Query: 99 HENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLA 158
HEN++ ++ + Y+ + + L K + + I RGL
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLK 123
Query: 159 YIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHIS--TRVAGTLGYLA 216
YIH +V+HRD+K SN+LL+ + KI DFGL+++ + H T T Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 217 PEYAISGRL-TRKSDVYSFGVLLLEIVSGR 245
PE ++ + T+ D++S G +L E++S R
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 2e-43
Identities = 46/218 (21%), Positives = 94/218 (43%), Gaps = 11/218 (5%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKL 105
KIGEG +G VYK + G A+K + +E + + E++ + + H N+VKL
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKL 65
Query: 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQ 165
+ +LV++++ + + ++ + G+AY H+
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD--- 118
Query: 166 PHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL 225
V+HRD+K N+L+++ KI+DFGL++ F + + S +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 226 TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
+ D++S G + E+V+G + + + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (365), Expect = 2e-42
Identities = 42/233 (18%), Positives = 86/233 (36%), Gaps = 22/233 (9%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
+IGEG FG +++G L + VA+K S + E + + C + ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCT-GIPNVYY 68
Query: 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH 167
+G +LV D + + + KF K + + IH +
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDL----LDLCGRKFSVKTVAMAAKQMLARVQSIH---EKS 121
Query: 168 VVHRDIKTSNILLDQNFNP-----KISDFGLSKLFPENTTHI------STRVAGTLGYLA 216
+V+RDIK N L+ + + + DFG+ K + + T ++GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 217 PEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 269
+ +R+ D+ + G + + + G +++
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-42
Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 14/213 (6%)
Query: 38 KIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS---VESKQGEKEFMSEVASMA 93
K+ N F + +G+G FG V R G A+K+L + +K ++E +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 94 NVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
N H L L V +Y L L R F + R I
Sbjct: 61 NTR--HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEI 114
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLG 213
L Y+H VV+RDIK N++LD++ + KI+DFGL K + + T GT
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPE 170
Query: 214 YLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT 246
YLAPE R D + GV++ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 7e-42
Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 23/245 (9%)
Query: 36 QLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMAN 94
+L++ N +R KIG G FG +Y G + G VA+K+ V++K + E
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 95 VNVCHENLVKLHGGCI-DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGI 153
+ + C +G ++V + + + KF K + +
Sbjct: 59 MQ--GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQM 112
Query: 154 GRGLAYIHEEIQPHVVHRDIKTSNIL---LDQNFNPKISDFGLSKLFPENTTHI------ 204
+ YIH + + +HRD+K N L + I DFGL+K + + TH
Sbjct: 113 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169
Query: 205 STRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVR 264
+ + GT Y + + +R+ D+ S G +L+ G + +++
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229
Query: 265 SINMK 269
M
Sbjct: 230 EKKMS 234
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-41
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 44 FRWSNKIGEGGFGSVYKGRL-QDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENL 102
+ + IG G FG VY+ +L G +VA+K + Q ++ E+ M ++ H N+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD--HCNI 75
Query: 103 VKLHGGCI------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRG 156
V+L D LV DY+P + + + + + + R
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 157 LAYIHEEIQPHVVHRDIKTSNILLDQN-FNPKISDFGLSKLFPENTTHISTRVAGTLGYL 215
LAYIH + HRDIK N+LLD + K+ DFG +K ++ + +
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRA 190
Query: 216 APEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
+ T DV+S G +L E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-41
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 22/208 (10%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGE------KEFMSEVASMANVNVCHEN 101
++G G F V K R G A K + + ++ EV+ + + H N
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPN 74
Query: 102 LVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIH 161
++ LH + IL+ + + L + + E + I G+ Y+H
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 162 EEIQPHVVHRDIKTSNILLDQNFNP----KISDFGLSKLFPENTTHISTRVAGTLGYLAP 217
+ H D+K NI+L P KI DFGL+ + GT ++AP
Sbjct: 131 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 185
Query: 218 EYAISGRLTRKSDVYSFGVLLLEIVSGR 245
E L ++D++S GV+ ++SG
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-39
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG--EKEFMSEVASMANVNVCHE 100
+ KIG+G FG V+K R + G VA+K + +E+++ + E+ + + HE
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HE 69
Query: 101 NLVKLHGGCIDGPCRI--------LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMG 152
N+V L C LV+D+ ++ KF + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQM 125
Query: 153 IGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTT---HISTRVA 209
+ GL YIH ++HRD+K +N+L+ ++ K++DFGL++ F + T
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 210 GTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
TL Y PE + R D++ G ++ E+ + + + + + L+ ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-39
Identities = 42/205 (20%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHE 100
+ KIGEG +G+V+K + + IVA+K + ++ + + E+ + + H+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HK 61
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
N+V+LH LV+++ + + + + + + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H +V+HRD+K N+L+++N K+++FGL++ F S V
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGR 245
+ + D++S G + E+ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG 199
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 1e-38
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 19/227 (8%)
Query: 23 EQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQG 81
E LK S N ++ + F +G G FG V + + G A+K+L +
Sbjct: 24 EDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK 81
Query: 82 EKE---FMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRR 138
K+ ++E + VN LVKL D +V +Y+ + L +R
Sbjct: 82 LKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRI 135
Query: 139 AKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198
+F R I Y+H +++RD+K N+L+DQ +++DFG +K
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR 245
T + GT LAPE +S + D ++ GVL+ E+ +G
Sbjct: 193 GRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-38
Identities = 42/205 (20%), Positives = 85/205 (41%), Gaps = 21/205 (10%)
Query: 50 IGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGG 108
+G G G V + + A+K+L Q + EV + ++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRAS-QCPHIVRIVDV 73
Query: 109 CID----GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI 164
+ C ++V + + L + +++ F + EI+ IG + Y+H
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 165 QPHVVHRDIKTSNILLDQNFNP---KISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAI 221
++ HRD+K N+L K++DFG +K + + + T Y+APE
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186
Query: 222 SGRLTRKSDVYSFGVLLLEIVSGRT 246
+ + D++S GV++ ++ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYP 211
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 11/206 (5%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVL--SVESKQGEKEFMSEVASMANVNVCHE 100
+R +G G +G+V + G VA+K L +S+ K E+ + ++ HE
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HE 77
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
N++ L D+ T LG+ + K G + ++ + +GL YI
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H ++HRD+K N+ ++++ KI DFGL++ T V
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVIL 191
Query: 221 ISGRLTRKSDVYSFGVLLLEIVSGRT 246
R T+ D++S G ++ E+++G+T
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-35
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 19/231 (8%)
Query: 26 LKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRL----QDGTIVAVKVLS----VE 77
L+ N + + K+ F +G G +G V+ R G + A+KVL V+
Sbjct: 9 LRTAN-LTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67
Query: 78 SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKR 137
+ + +E + ++ LV LH L+ DY+ L L +
Sbjct: 68 KAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQ 122
Query: 138 RAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197
R +F + + I L ++H+ +++RDIK NILLD N + ++DFGLSK F
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 198 PENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRT 246
+ T + GT+ Y+AP+ G + D +S GVL+ E+++G +
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 4e-35
Identities = 41/223 (18%), Positives = 90/223 (40%), Gaps = 24/223 (10%)
Query: 32 FSYNQLKIATNG---FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMS 87
+ Y + ++ K+G G + V++ + + V VK+L K K+
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKR 78
Query: 88 EVASMANVNVCHENLVKLHGGCIDGPCR--ILVYDYMPNNSLSQTLLGEEKRRAKFGWKA 145
E+ + N+ N++ L D R LV++++ N Q
Sbjct: 79 EIKILENLR-GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-------LYQTLTDYD 130
Query: 146 RREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD-QNFNPKISDFGLSKLFPENTTHI 204
R + I + L Y H ++HRD+K N+++D ++ ++ D+GL++ + +
Sbjct: 131 IRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 205 STRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRT 246
+ + PE + ++ D++S G +L ++ +
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-32
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHE 100
++ + +G G +GSV + G VAVK LS +S K E+ + ++ HE
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HE 77
Query: 101 NLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYI 160
N++ L D L L + K + +I I RGL YI
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 161 HEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYA 220
H ++HRD+K SN+ ++++ KI DFGL++ + T T Y APE
Sbjct: 138 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIM 190
Query: 221 ISGR-LTRKSDVYSFGVLLLEIVSGRT 246
++ + D++S G ++ E+++GRT
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-31
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 23/229 (10%)
Query: 44 FRWSNKIGEGGFGSVYKGR-LQDGTIVAVKVLS--VESKQGEKEFMSEVASMANVNVCHE 100
++ IG G G V VA+K LS +++ K E+ M VN H+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HK 76
Query: 101 NLVKLHGGCI------DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIG 154
N++ L + LV + M N + + + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQML 129
Query: 155 RGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPENTTHISTRVAGTLGY 214
G+ ++H ++HRD+K SNI++ + KI DFGL++ + T T Y
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYY 184
Query: 215 LAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKV 263
APE + D++S G ++ E+V + + +++ V +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 3e-30
Identities = 48/243 (19%), Positives = 97/243 (39%), Gaps = 28/243 (11%)
Query: 49 KIGEGGFGSVYKGR-LQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG 107
K+G G F +V+ + + + T VA+K++ K + E+ + VN + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVN--DADNTKEDS 76
Query: 108 GCIDGPCRIL-VYDYMPNNSLSQTLLGEE-----------KRRAKFGWKARREIIMGIGR 155
+ ++L +++ N + ++ E ++I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 156 GLAYIHEEIQPHVVHRDIKTSNILLDQNFNP------KISDFGLSKLFPENTTHISTRVA 209
GL Y+H + ++H DIK N+L++ +P KI+D G + + E+ T+
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SI 190
Query: 210 GTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDKVRSINMK 269
T Y +PE + +D++S L+ E+++G + D D + I
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 270 LYS 272
L
Sbjct: 251 LGE 253
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 5e-23
Identities = 31/158 (19%), Positives = 52/158 (32%), Gaps = 23/158 (14%)
Query: 48 NKIGEGGFGSVYKGRLQDGTIVAVKVLSVES----------KQGEKEFMSEVASMANVNV 97
+GEG +V+ + VK V G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA--IRSARN 63
Query: 98 CHENLVKLHGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGL 157
L KL G + VY + N L + L + K + + E++ I +
Sbjct: 64 EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116
Query: 158 AYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195
A + +VH D+ N+L+ I DF S
Sbjct: 117 AKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 272 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.74 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=330.11 Aligned_cols=210 Identities=30% Similarity=0.495 Sum_probs=185.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|++.+.||+|+||.||+|.++ +|+.||+|++... .......+.+|+..++.++ ||||+++++++.+++..+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC--CCCCCeEEEEEEECCEEE
Confidence 357999999999999999999986 7999999998633 2345567889999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++..
T Consensus 83 ivmEy~~~g~L~~~l----~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 83 LILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp EEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred EEEeecCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeee
Confidence 999999999999998 4556899999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehhhh
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLVDK 262 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 262 (272)
..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+.+..+..
T Consensus 156 ~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 218 (263)
T d2j4za1 156 APSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218 (263)
T ss_dssp CCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 54332 2346799999999999999999999999999999999999999988776655444433
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=328.78 Aligned_cols=206 Identities=28% Similarity=0.449 Sum_probs=179.1
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
..++|++.+.||+|+||+||+|.++ +|+.||+|++.... ......+.+|+..+++++ ||||+++++++.+++..++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC--CTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC--CCCEeeEeeeeccCceeEE
Confidence 3568999999999999999999986 79999999987543 233456889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||+++++.++|+|||++...
T Consensus 81 vmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 81 FLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheee
Confidence 99999999999998 4567899999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCC-ccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 198 PENT-THISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 198 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.... ........||+.|+|||++.+..+ +.++||||+||++|+|++|++||...+..
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 4322 223445679999999999988876 57899999999999999999999866543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=331.21 Aligned_cols=204 Identities=23% Similarity=0.404 Sum_probs=183.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||+|+||+||+|.+. +|+.||+|.+..........+.+|+..++.++ ||||+++++++..++..++||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC--CCCEeeEeEEEEECCEEEEEE
Confidence 357999999999999999999876 79999999998666566678999999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||++|++|.+++ ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|+++|+|||++.....
T Consensus 97 Ey~~gg~L~~~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCcHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999999887 335799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+...
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 322 2344679999999999999999999999999999999999999998665443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=329.33 Aligned_cols=208 Identities=24% Similarity=0.401 Sum_probs=181.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+..+++++ ||||+++++++.+++..++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--STTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC--CCCeeEEEEEEEECCEEEE
Confidence 67999999999999999999986 7999999998743 2334567889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||++|++|.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||++++++.++|+|||++...
T Consensus 86 vmEy~~gg~L~~~~----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 86 GLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EECCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEccCCCCHHHhh----hccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceec
Confidence 99999999999988 4567899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 198 PENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 198 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
.... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||...+....+.
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 220 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH
Confidence 5332 223344679999999999999999999999999999999999999998776554433
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=330.61 Aligned_cols=210 Identities=29% Similarity=0.378 Sum_probs=186.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
.++|++++.||+|+||.||+|+++ +|+.||+|++... .......+.+|+..++.+. ||||+++++++.+.+..+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEECSSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC--CCCEEEEEeeeccccccc
Confidence 467999999999999999999986 8999999999743 2345677889999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||++|++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.++|+|||++..
T Consensus 82 iv~ey~~gg~L~~~~----~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 82 FVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred cceeccCCCchhhhh----hcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccc
Confidence 999999999999998 5567899999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
...... .....+||+.|+|||++.+..++.++|+|||||++|+|++|++||...+..+.+..+
T Consensus 155 ~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i 217 (337)
T d1o6la_ 155 GISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp SCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 543222 234468999999999999999999999999999999999999999988766544443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=326.32 Aligned_cols=213 Identities=26% Similarity=0.391 Sum_probs=172.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEec--CCce
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCID--GPCR 115 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~--~~~~ 115 (272)
.++|++.+.||+|+||+||+|+++ +|+.||+|.+.... ......+.+|++.+++++ ||||+++++++.+ ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC--CTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC--CCCEeeEEEEEEeCCCCEE
Confidence 367999999999999999999876 79999999987543 233456888999999998 9999999999865 4568
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEI--QPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.++|+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 9999999999999999666556678999999999999999999999971 11399999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+..+.
T Consensus 161 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~ 222 (269)
T d2java1 161 ARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222 (269)
T ss_dssp HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH
Confidence 987643322 23346789999999999999999999999999999999999999987665543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=325.86 Aligned_cols=208 Identities=23% Similarity=0.384 Sum_probs=181.9
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
+.|++.+.||+|+||.||+|.+. +|+.||+|++..........+.+|++.+++++ ||||+++++++..++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC--CTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCCeEEEEEe
Confidence 46999999999999999999986 79999999998666666678899999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCCC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPEN 200 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~ 200 (272)
|+++++|.+++. ....++++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++......
T Consensus 90 y~~~g~L~~~~~---~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred cCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999999873 2346799999999999999999999999 9999999999999999999999999998754221
Q ss_pred CccccccccccccccCccccc-----cCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 201 TTHISTRVAGTLGYLAPEYAI-----SGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 201 ~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
. .......||+.|+|||++. +..++.++||||+||++|+|++|+.||...+..+.+.
T Consensus 164 ~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~ 225 (288)
T d2jfla1 164 I-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225 (288)
T ss_dssp H-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred c-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 1 1223467899999999984 4457899999999999999999999998776655433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=331.93 Aligned_cols=203 Identities=25% Similarity=0.427 Sum_probs=179.8
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCcee
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
+..++|++.+.||+|+||+||+|.+. +|+.||+|+++... ......+.+|+..+++++ ||||+++++++...+..+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC--CTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEE
Confidence 34678999999999999999999976 79999999997543 334467889999999998 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+||||++|++|.+++ .....+++..++.++.|++.||.|||+ + ||+||||||+|||++.+|.++|+|||++.
T Consensus 81 iVmEy~~gg~L~~~l----~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEECCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 999999999999998 445679999999999999999999996 6 89999999999999999999999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.
T Consensus 154 ~~~~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 154 QLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HHHH---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccCC---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 6532 223446899999999999999999999999999999999999999986553
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-48 Score=325.04 Aligned_cols=204 Identities=28% Similarity=0.468 Sum_probs=182.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++.+.||+|+||+||+|+++ +|+.||||++... .......+.+|+.+++.++ ||||+++++++..++..++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--BTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc--CcChhheeeeEeeCCeeee
Confidence 57999999999999999999986 7999999998743 2344567889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||++|++|...+ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.++|+|||++...
T Consensus 82 vmE~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 82 IMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeeecCCccccccc----cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEe
Confidence 99999999999988 5667788999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
.... ...+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+...
T Consensus 155 ~~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 155 PDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp SSCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 4332 34679999999999999999999999999999999999999998776554433
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6e-48 Score=327.29 Aligned_cols=207 Identities=22% Similarity=0.337 Sum_probs=183.7
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEe
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYD 120 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e 120 (272)
++|++.+.||+|+||.||+|.+. +|+.||+|++..........+.+|+..++++. ||||+++++++.++...++|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--STTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999976 79999999998665556677889999999998 9999999999999999999999
Q ss_pred ecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCCeEEeecCcccccC
Q 024118 121 YMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLFP 198 (272)
Q Consensus 121 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~--~~~~~~l~Dfg~~~~~~ 198 (272)
|++|++|.+.+. ....++++..++.++.||+.||.|||++ ||+||||||+|||++ .++.++|+|||++....
T Consensus 107 ~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998872 3445799999999999999999999999 999999999999997 67889999999998765
Q ss_pred CCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
.... .....+++.|+|||++.+..++.++|||||||++|+|++|++||...+..+.+.
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 238 (352)
T d1koba_ 181 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238 (352)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred CCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4332 344578999999999999999999999999999999999999998776555433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-48 Score=327.73 Aligned_cols=208 Identities=24% Similarity=0.391 Sum_probs=183.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..........+.+|+..+++++ ||||+++++++.+++..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC--CTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEEE
Confidence 358999999999999999999986 79999999997666566678889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCCeEEeecCccccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD--QNFNPKISDFGLSKLF 197 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~--~~~~~~l~Dfg~~~~~ 197 (272)
||++|++|.+++. .....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.++|+|||++...
T Consensus 103 E~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 103 EFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999999883 2345799999999999999999999999 999999999999995 4578999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+.
T Consensus 177 ~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 235 (350)
T d1koaa2 177 DPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235 (350)
T ss_dssp CTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 54332 334678999999999999999999999999999999999999998776554433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-48 Score=322.68 Aligned_cols=204 Identities=23% Similarity=0.400 Sum_probs=164.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.... ......+.+|+..++.++ ||||+++++++.+++..++|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK--HPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999986 79999999987442 233456778999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCCeEEeecCccc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLD---QNFNPKISDFGLSK 195 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~---~~~~~~l~Dfg~~~ 195 (272)
|||++|++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+||++. +++.++|+|||++.
T Consensus 86 mE~~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 86 MQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp ECCCCSCBHHHHH----HTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EeccCCCcHHHhh----hcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 9999999999998 4567899999999999999999999999 999999999999994 57889999999998
Q ss_pred ccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 196 LFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|++||...+..+
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 216 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 216 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 654322 2334679999999999999999999999999999999999999998665443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=316.17 Aligned_cols=216 Identities=29% Similarity=0.451 Sum_probs=184.7
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
+.-.+.|.+..++|++.+.||+|+||.||+|.++++..||||.+... ......+.+|+..+++++ ||||+++++++.
T Consensus 2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~ 78 (272)
T d1qpca_ 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQ--HQRLVRLYAVVT 78 (272)
T ss_dssp CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEEC
T ss_pred CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCC--CCCEeEEEeeec
Confidence 34456677788899999999999999999999998899999998643 345568999999999998 999999999875
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
+ +..++||||+++|+|.+++.. ....++++..++.++.|+++||.|||++ +|+||||||+||++++++.++|+|
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred c-CCeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecc
Confidence 5 567899999999999998733 2334689999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhC-CCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~ 255 (272)
||++...............+++.|+|||++.+..++.++||||+||++|+|+|| ++||...+..+
T Consensus 153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence 999987765444444456788999999999988999999999999999999995 55665554433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-47 Score=324.81 Aligned_cols=204 Identities=26% Similarity=0.386 Sum_probs=182.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
++|++++.||+|+||.||+|.++ +|+.||||++... .......+.+|+..++.+. ||||+++++++......++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC--CCcEeeccccccccccccc
Confidence 57999999999999999999986 7999999998633 2344567889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+.+++|...+ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.++|+|||++...
T Consensus 119 v~e~~~~g~l~~~l----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccchhhhH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 99999999999998 4556899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+....+.
T Consensus 192 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH
Confidence 432 234679999999999999999999999999999999999999998776554433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=315.57 Aligned_cols=208 Identities=29% Similarity=0.490 Sum_probs=172.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+.++|++.+.||+|+||+||+|.+.+++.||||.+.. .......+.+|++.+++++ ||||+++++++..++..++||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSSCEEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcC--CCCcccccceeccCCceEEEE
Confidence 4578999999999999999999998888999999874 3445568999999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++++|.+++. .....+++..++.++.|++.||.|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 80 E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 80 EFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp ECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred EecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccC
Confidence 9999999999873 3446688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCc
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGE 256 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~ 256 (272)
..........||+.|+|||++.+..++.++||||+|+++|+|+| |++||...+..+.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~ 211 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH
Confidence 44333444568899999999999999999999999999999999 5777766554443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=313.91 Aligned_cols=206 Identities=24% Similarity=0.347 Sum_probs=181.6
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC------cccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES------KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~------~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.++|++.+.||+|+||.||+|.++ +|+.||||++.... ......+.+|+..+++++ ||||+++++++.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITLHEVYENKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCEEEEEECSS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC--CCCCCcEEEEEEECC
Confidence 467999999999999999999986 79999999987432 223567899999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----CeEEe
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF----NPKIS 189 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~----~~~l~ 189 (272)
..++||||++|++|.+++ .....+++..++.++.|++.||.|||++ +|+||||||+||+++.++ .++++
T Consensus 87 ~~~iv~E~~~gg~L~~~i----~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 87 DVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEEcCCCccccchh----ccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEec
Confidence 999999999999999998 4456899999999999999999999999 999999999999998776 49999
Q ss_pred ecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 190 DFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
|||++........ .....+++.|+|||++.+..++.++||||+||++|+|++|+.||...+..+.+
T Consensus 160 DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 225 (293)
T d1jksa_ 160 DFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225 (293)
T ss_dssp CCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred chhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH
Confidence 9999987643322 33457899999999999999999999999999999999999999877655433
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=320.32 Aligned_cols=200 Identities=26% Similarity=0.423 Sum_probs=175.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc---ccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK---QGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+.|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+..+++++ ||||+++++++..++..++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC--CCCEeeEEEEEEECCEEEE
Confidence 45999999999999999999876 799999999875432 23356889999999998 9999999999999999999
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++++|..+. ..+.++++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++...
T Consensus 93 v~E~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 93 VMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEECCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 99999999998766 4557899999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCccccccccccccccCcccccc---CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAIS---GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.. .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+
T Consensus 166 ~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 166 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp SS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 32 233579999999999864 348899999999999999999999997665443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=318.59 Aligned_cols=209 Identities=25% Similarity=0.397 Sum_probs=180.8
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHHHHHhh-cccccccceeEeeeeEecCCcee
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSEVASMA-NVNVCHENLVKLHGGCIDGPCRI 116 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~~~-~~~~~~~~i~~l~~~~~~~~~~~ 116 (272)
++|++.+.||+|+||+||+|++. +|+.||||++... ..........|...+. .+. ||||+++++++.+++..+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~--hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE--HPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT--CTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC--CCcEEEEEEEEccCCcee
Confidence 68999999999999999999987 7999999999743 2233455666666654 456 999999999999999999
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++|+|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+++++|+|||++..
T Consensus 80 ivmEy~~~g~L~~~i----~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeecCCCcHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhh
Confidence 999999999999998 4567799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceehh
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~~ 260 (272)
...... ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+....+..+
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 215 (320)
T d1xjda_ 153 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215 (320)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 543322 233467899999999999999999999999999999999999999887765544443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-48 Score=319.08 Aligned_cols=213 Identities=28% Similarity=0.437 Sum_probs=185.4
Q ss_pred hhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 34 YNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 34 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
++.|.+..++|++.+.||+|+||+||+|.+. +|+.||||+++.. ......+.+|+..+++++ ||||+++++++.++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTRE 85 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCC--CCCEecCCccEeeC
Confidence 3456677889999999999999999999987 6899999998633 345567999999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
+..+++|||+++|+|.+++.. .....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence 999999999999999999843 2346789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcc-ccccCC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAV-DFDVQL 254 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~-~~~~~~ 254 (272)
++...............+++.|+|||++.+..++.++||||+||++|+|++|..|| ...+..
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~ 223 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence 99877655444444556788999999999999999999999999999999966654 444433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=307.93 Aligned_cols=198 Identities=29% Similarity=0.449 Sum_probs=170.5
Q ss_pred CCe-eeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec----CC
Q 024118 42 NGF-RWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GP 113 (272)
Q Consensus 42 ~~y-~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~ 113 (272)
.+| ++.+.||+|+||+||+|.+. ++..||+|.+... .......+.+|++.+++++ ||||+++++++.. ..
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEESSSCE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEeeccccCC
Confidence 344 78889999999999999986 7899999998754 2334457889999999999 9999999998864 34
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCCeEEee
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPH--VVHRDIKTSNILLD-QNFNPKISD 190 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--i~h~dl~p~nilv~-~~~~~~l~D 190 (272)
..++||||+++++|.+++ .....+++..++.++.||+.||.|||++ + |+||||||+|||++ +++.++|+|
T Consensus 86 ~~~ivmE~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp EEEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEEEeCCCCCcHHHHH----hccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEee
Confidence 578999999999999998 4556899999999999999999999998 7 99999999999996 578999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
||++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+
T Consensus 159 FGla~~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 159 LGLATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp TTGGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cCcceeccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 99998643322 344679999999998865 58999999999999999999999997544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=309.90 Aligned_cols=212 Identities=27% Similarity=0.447 Sum_probs=187.2
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
+.++|++.+.||+|+||+||+|++++++.||||.++.. ......+.+|+..+++++ ||||+++++++..+...++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~--HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLS--HEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCC--CTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcC--CCceeeEEEEEeeCCceEEEE
Confidence 45789999999999999999999998999999999744 345568999999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+++|+|.+++. .....+++..++.++.|+++||.|||++ ||+||||||+||++++++.++|+|||++.....
T Consensus 79 Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 79 EYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp ECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred EccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 9999999999973 3456788999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehh
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 260 (272)
..........++..|+|||.+.+..++.++||||+|+++|+|+| |+.||...+..+....+
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i 214 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence 44433444668899999999999999999999999999999998 89999887766544433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-46 Score=319.66 Aligned_cols=205 Identities=29% Similarity=0.402 Sum_probs=175.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec---CcccHHHHHHH---HHHhhcccccccceeEeeeeEecCC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE---SKQGEKEFMSE---VASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e---~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.++|++.+.||+|+||.||+|++. +|+.||+|++... .........+| +..++.+. ||||+++++++...+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~--hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD--CPFIVCMSYAFHTPD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC--CTTBCCEEEEEECSS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC--CCcEEEEEEEEEECC
Confidence 468999999999999999999986 7999999998632 12223334444 55566666 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||++|++|.+++ .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.++|+|||+
T Consensus 81 ~~~ivmE~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp EEEEEECCCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred EEEEEEEecCCCcHHHHH----HhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence 999999999999999998 4567789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 194 SKLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
+....... .....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.....
T Consensus 154 a~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 215 (364)
T d1omwa3 154 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215 (364)
T ss_dssp CEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH
T ss_pred eeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 98664332 334579999999999974 56899999999999999999999999876655433
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=313.24 Aligned_cols=208 Identities=29% Similarity=0.498 Sum_probs=172.7
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
.|.+..++|++.+.||+|+||+||+|+++ ..||||+++.. .......+.+|+..+++++ ||||+++++++.. +
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYSTA-P 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC--CTTBCCEEEEECS-S
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeeeeEEEec-c
Confidence 34566789999999999999999999865 35999998644 3344578889999999998 9999999998754 5
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||+++++|.+++. .....+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp SCEEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred EEEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccc
Confidence 6899999999999999983 2345699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-ccccccccccccccCccccccC---CCCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 194 SKLFPENT-THISTRVAGTLGYLAPEYAISG---RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 194 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
+....... ........||+.|+|||++.+. .++.++||||+||++|+|+||+.||...+..
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~ 215 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH
Confidence 97654322 2233446789999999998754 4788999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-46 Score=309.00 Aligned_cols=207 Identities=26% Similarity=0.394 Sum_probs=172.6
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC---cccHHHHHHHHHHhhcccccccceeEeeeeEecCC--
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES---KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP-- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~-- 113 (272)
..++|++.+.||+|+||.||+|.+. +|+.||+|+++... ......+.+|+..++.++ ||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~--hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETPA 82 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEEECSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC--CCCCCcccceeeeccCC
Confidence 3578999999999999999999876 79999999997542 233457889999999998 999999999987654
Q ss_pred --ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 114 --CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 114 --~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
..++||||++|++|.+.+ ....++++..++.++.|++.||.|||++ ||+||||||+||+++.++..+++||
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred CceEEEEEECCCCCEehhhh----cccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 378999999999999988 4566899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCC--ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 192 GLSKLFPENT--THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 192 g~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|.+....... ........||+.|+|||++.+..+++++||||+||++|+|+||++||...+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence 9987553322 223344678999999999999999999999999999999999999998766544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-46 Score=304.52 Aligned_cols=207 Identities=26% Similarity=0.374 Sum_probs=179.9
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc---------cHHHHHHHHHHhhcccccccceeEeeeeEe
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ---------GEKEFMSEVASMANVNVCHENLVKLHGGCI 110 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~---------~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~ 110 (272)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ....+.+|+..++++.. ||||+++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~~~~~~~ 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG-HPNIIQLKDTYE 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT-CTTBCCEEEEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcC-CCCeEEEEeecc
Confidence 478999999999999999999976 7999999998754221 22467889999999865 999999999999
Q ss_pred cCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 111 DGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 111 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
+++..++||||+++++|.+++ ..+.++++..++.++.||+.||.|||++ ||+||||||+||+++.++.++|+|
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCcceEEEEEcCCCchHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEcc
Confidence 999999999999999999999 4566899999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccC------CCCCCCceehHHHHHHHHHhCCCccccccCCCce
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISG------RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEY 257 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~ 257 (272)
||++........ .....||+.|.|||++.+. .++.++|+||+||++|+|++|+.||...+.....
T Consensus 154 FG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~ 224 (277)
T d1phka_ 154 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224 (277)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred chheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH
Confidence 999987654322 3446789999999998642 3678999999999999999999999877655433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=312.14 Aligned_cols=207 Identities=16% Similarity=0.281 Sum_probs=180.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
-++|++.+.||+|+||+||+|.+. +|+.||+|++.... .....+.+|+..++.++ ||||+++++++.+++..++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIAR--HRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSC--CTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCC--CCCCCeEEEEEEECCEEEEEE
Confidence 468999999999999999999986 79999999997543 33456789999999999 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--CCeEEeecCccccc
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN--FNPKISDFGLSKLF 197 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~--~~~~l~Dfg~~~~~ 197 (272)
||++|++|.+++. .....+++..++.++.||+.||.|||++ ||+||||||+||+++.+ +.++|+|||++...
T Consensus 81 E~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999982 2334799999999999999999999999 99999999999999854 47999999999865
Q ss_pred CCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 198 PENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
..... .....+++.|+|||.+.+..++.++|+||+||++|+|++|++||...+..+.+.
T Consensus 155 ~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~ 213 (321)
T d1tkia_ 155 KPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213 (321)
T ss_dssp CTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 43322 333568899999999999999999999999999999999999998877654433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-46 Score=311.78 Aligned_cols=213 Identities=28% Similarity=0.485 Sum_probs=169.7
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeC-CCc---EEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQ-DGT---IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~---~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+..++|++.+.||+|+||+||+|.++ +|+ .||||.+... .......+.+|+..+++++ ||||+++++++..++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC--CCCCccEEEEEeeCC
Confidence 34578999999999999999999875 333 5888887543 3334567899999999998 999999999999999
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||+++++|.+++. .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp SCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCccc
Confidence 9999999999999999873 3345799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc----ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceeh
Q 024118 194 SKLFPENTTH----ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL 259 (272)
Q Consensus 194 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~ 259 (272)
+......... ......+++.|+|||.+.+..++.++||||+||++|+|+| |++||...+..+....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~ 245 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9866433221 1122457889999999999999999999999999999998 8999987765544333
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=311.56 Aligned_cols=215 Identities=26% Similarity=0.408 Sum_probs=178.0
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeCC-C-----cEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD-G-----TIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~-----~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
|.+..++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+..++++.. ||||+++++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-HpnIv~l~~~~ 110 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS-HENIVNLLGAC 110 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcC-CCcEeEEEEEE
Confidence 45677899999999999999999998652 2 36899987533 33445678899999988832 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhccc-------------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEEK-------------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 170 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~~-------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h 170 (272)
...+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+|
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 999999999999999999999954321 124589999999999999999999999 9999
Q ss_pred cCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCcc
Q 024118 171 RDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAV 248 (272)
Q Consensus 171 ~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~ 248 (272)
|||||+||+++.++.++|+|||++........ .......+|+.|+|||.+.+..++.++||||+||++|+|+| |++||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999986543322 22334567999999999999999999999999999999998 89999
Q ss_pred ccccCCC
Q 024118 249 DFDVQLG 255 (272)
Q Consensus 249 ~~~~~~~ 255 (272)
...+...
T Consensus 268 ~~~~~~~ 274 (325)
T d1rjba_ 268 PGIPVDA 274 (325)
T ss_dssp TTCCCSH
T ss_pred CCCCHHH
Confidence 8766543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=306.47 Aligned_cols=217 Identities=31% Similarity=0.474 Sum_probs=176.6
Q ss_pred ChhHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 33 SYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 33 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..+.|.+..++|++.+.||+|+||.||+|.++++..||||++... ......+.+|+..+++++ ||||+++++++.+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcc--cCCEeEEEEEEec-
Confidence 344555667899999999999999999999988888999998633 345568999999999999 9999999999854
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
+..++||||+++|+|..++.. .....+++..++.++.||+.||.|||++ ||+||||||+||+++++++++|+|||
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCeEEEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccc
Confidence 567899999999999988843 2345699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhC-CCccccccCCCcee
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLGEYH 258 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~~~ 258 (272)
++...............+++.|+|||++.+..++.++||||+|+++|+|++| ++|+......+.+.
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~ 225 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 225 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9986654443334446689999999999999999999999999999999995 45555554444333
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=305.11 Aligned_cols=213 Identities=28% Similarity=0.435 Sum_probs=179.1
Q ss_pred HhhCCeeeeee-eeeccceEEEEEEeC---CCcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 39 IATNGFRWSNK-IGEGGFGSVYKGRLQ---DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 39 ~~~~~y~i~~~-lg~G~~~~v~~~~~~---~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+..++|.+... ||+|+||.||+|.++ ++..||||+++.. ......++.+|++.+++++ ||||+++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC--CCCEeeEeeeecc-C
Confidence 34567888885 999999999999764 3557999998744 3344568899999999998 9999999999865 4
Q ss_pred ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCc
Q 024118 114 CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGL 193 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~ 193 (272)
..++||||+++++|.+++. ..+..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+
T Consensus 82 ~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence 6889999999999999873 3456799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehh
Q 024118 194 SKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 194 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 260 (272)
+......... ......|++.|+|||++.+..++.++||||+||++|+|+| |+.||...+..+....+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i 225 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9876543222 2233467889999999998999999999999999999998 99999877655443333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=307.23 Aligned_cols=202 Identities=22% Similarity=0.326 Sum_probs=170.3
Q ss_pred hCCeeeee-eeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec----CCc
Q 024118 41 TNGFRWSN-KIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID----GPC 114 (272)
Q Consensus 41 ~~~y~i~~-~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~----~~~ 114 (272)
.++|++.+ .||+|+||.||+|.+. +|+.||||+++. .....+|+..+.++.. ||||+++++++.+ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~-hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQ-CPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTT-STTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcC-CCCCCeEEEEEeecccCCCE
Confidence 46899875 5999999999999875 799999999862 2456678877655532 9999999998865 456
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCeEEeec
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDF 191 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~---~~~~~l~Df 191 (272)
.++|||||+||+|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+||+++. .+.++|+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 89999999999999999431 235799999999999999999999999 9999999999999975 456999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
|++........ .....||+.|+|||++.+..++.++|+||+||++|+|++|++||...+...
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 99986654332 344679999999999999999999999999999999999999998766543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=302.64 Aligned_cols=206 Identities=30% Similarity=0.426 Sum_probs=171.0
Q ss_pred eeee-eeeeeccceEEEEEEeC---CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeE
Q 024118 44 FRWS-NKIGEGGFGSVYKGRLQ---DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 44 y~i~-~~lg~G~~~~v~~~~~~---~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~i 117 (272)
+.+. +.||+|+||+||+|.++ +++.||||+++.. .......+.+|+..+++++ ||||+++++++.. +..++
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC--CTTBCCEEEEEES-SSEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC--CCCCceEEEEecc-CCEEE
Confidence 3443 57999999999999754 3568999998643 2333467899999999998 9999999999865 45789
Q ss_pred EEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccccc
Q 024118 118 VYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLF 197 (272)
Q Consensus 118 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~ 197 (272)
||||+++|+|.+++ .....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.++|+|||++...
T Consensus 85 vmE~~~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 85 VMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp EEECCTTEEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 99999999999998 4556799999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceeh
Q 024118 198 PENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHL 259 (272)
Q Consensus 198 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~ 259 (272)
...... ......||+.|+|||.+.+..++.++||||+|+++|+|++ |++||...+..+....
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~ 222 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH
Confidence 543222 2233568899999999999999999999999999999998 8999987765544333
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=301.41 Aligned_cols=214 Identities=26% Similarity=0.351 Sum_probs=169.6
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCC----CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.+..++|++.+.||+|+||.||+|.+.. +..||||.++.. .......+.+|+..+++++ ||||+++++++. .
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEe-c
Confidence 4557889999999999999999998652 346888887533 3334467889999999998 999999999986 4
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
+..++||||+++++|.+++. ....++++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccch
Confidence 67899999999999998873 3456789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehh
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 260 (272)
++...............+|+.|+|||++.+..++.++||||+||++|+|++ |.+||...+..+....+
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i 222 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 998765444434445667899999999999999999999999999999998 89999987776544433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=302.59 Aligned_cols=200 Identities=26% Similarity=0.377 Sum_probs=169.9
Q ss_pred eeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcc-----cHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 46 WSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQ-----GEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 46 i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~-----~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
.++.||+|+||+||+|.++ +|+.||||+++..... ....+.+|+..+++++ ||||+++++++..++..++||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC--CTTBCCEEEEECCTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC--CCCEeEEEeeeccCCceeehh
Confidence 4689999999999999976 7999999998643221 2346889999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
||+.++++.... ..+..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.++|+|||++.....
T Consensus 80 E~~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 80 DFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp ECCSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred hhhcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence 999888777665 4567799999999999999999999999 999999999999999999999999999986544
Q ss_pred CCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
.... .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||...+..+
T Consensus 153 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 208 (299)
T d1ua2a_ 153 PNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208 (299)
T ss_dssp CCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred Cccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence 3222 2335689999999998754 57999999999999999999999998766544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=299.46 Aligned_cols=203 Identities=26% Similarity=0.376 Sum_probs=172.6
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCc------ccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESK------QGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..++|++.+.||+|+||.||+|.+. +|+.||||++..... ....++.+|+..++++...||||+++++++..+
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 3578999999999999999999976 799999999864311 112345678999988876699999999999999
Q ss_pred CceeEEEeecCC-CCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCCeEEee
Q 024118 113 PCRILVYDYMPN-NSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-NFNPKISD 190 (272)
Q Consensus 113 ~~~~iv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-~~~~~l~D 190 (272)
+..++||||+.+ +++.+++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++. ++.++|+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred CeEEEEEEeccCcchHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECc
Confidence 999999999976 5777777 4557899999999999999999999999 9999999999999984 57899999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCC-CCCCceehHHHHHHHHHhCCCcccccc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRL-TRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
||++....... .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+
T Consensus 155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred cccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 99998654322 344679999999999987765 577999999999999999999997643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=298.37 Aligned_cols=203 Identities=27% Similarity=0.439 Sum_probs=172.3
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++++.||+|+||+||+|.+. +|+.||+|+++... ......+.+|+++++++. ||||+++++++..++..++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC--CTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC--CCcEEEeccccccccceeEE
Confidence 58999999999999999999985 79999999986442 233567889999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+.++.+.... ......+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||.+....
T Consensus 80 ~e~~~~~~~~~~~---~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 80 FEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EECCSEEHHHHHH---HTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EeecCCchhhhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceecc
Confidence 9999765444332 23456799999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... ......|++.|.|||.+.... ++.++|+||+||++|+|++|+.||...+.
T Consensus 154 ~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 154 VPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp CCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 4332 233357899999999987766 57899999999999999999999976553
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=297.26 Aligned_cols=208 Identities=28% Similarity=0.459 Sum_probs=168.3
Q ss_pred HhhCCeeeeeeeeeccceEEEEEEeCC-C----cEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 39 IATNGFRWSNKIGEGGFGSVYKGRLQD-G----TIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 39 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~----~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
+..+.|++.+.||+|+||.||+|.+++ + ..||||.+.... ......+.+|+..+++++ ||||+++++++...
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC--CCCEeeeeEEEecC
Confidence 345679999999999999999998653 2 369999986442 334457889999999998 99999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...+++|||+.++++.+.+. .....+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence 99999999999999998873 3446799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCC-ccccccCC
Q 024118 193 LSKLFPENTT--HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRT-AVDFDVQL 254 (272)
Q Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~-p~~~~~~~ 254 (272)
++........ .......||+.|+|||++.+..++.++||||+||++|+|++|.. |+...+..
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~ 220 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH
Confidence 9986543322 12233567889999999999999999999999999999999655 45444433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.7e-44 Score=295.07 Aligned_cols=202 Identities=25% Similarity=0.403 Sum_probs=174.1
Q ss_pred CCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVY 119 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~ 119 (272)
++|++.+.||+|+||+||+|.+++|+.||||++.... .....++.+|+..+++++ ||||+++++.+...+..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC--CTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC--CCcEEeeeeecccCCceeEEE
Confidence 5899999999999999999999999999999997543 233578899999999998 999999999999999999999
Q ss_pred eecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccCC
Q 024118 120 DYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFPE 199 (272)
Q Consensus 120 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~ 199 (272)
|++.++.+..+. .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.++++|||.+.....
T Consensus 80 e~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 80 EHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp ECCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EeehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 999887777666 4567899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 200 NTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 200 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
.... .....+++.|.|||.+.+. .++.++|+||+||++|+|++|+.||...+.
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 153 PVRK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Cccc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 3221 2334578899999998765 468999999999999999999999976554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=296.36 Aligned_cols=221 Identities=24% Similarity=0.361 Sum_probs=173.9
Q ss_pred CCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEec-CcccHHHHHHHHHHhhccccccccee
Q 024118 31 AFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLV 103 (272)
Q Consensus 31 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~ 103 (272)
++..+.|.+..++|++.+.||+|+||.||+|.+. +++.||||.++.. .......+.+|...+.++.. |+||+
T Consensus 2 p~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~-h~~iv 80 (299)
T d1ywna1 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNVV 80 (299)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred CCCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcC-CCeEE
Confidence 3456677788899999999999999999999853 3568999998643 33345567778888877753 89999
Q ss_pred EeeeeEecC-CceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 024118 104 KLHGGCIDG-PCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVH 170 (272)
Q Consensus 104 ~l~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h 170 (272)
.+++++... ...+++|||+++++|.+++..... ....+++..+..++.|++.||.|||++ +|+|
T Consensus 81 ~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivH 157 (299)
T d1ywna1 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 157 (299)
T ss_dssp CEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcC
Confidence 999987654 468899999999999999965432 234589999999999999999999999 9999
Q ss_pred cCCCCCCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhC-CCcc
Q 024118 171 RDIKTSNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAV 248 (272)
Q Consensus 171 ~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~ 248 (272)
|||||+|||+++++.+||+|||++........ .......||+.|+|||.+.+..++.++||||+||++|+|++| .+||
T Consensus 158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986543322 223446789999999999999999999999999999999986 5688
Q ss_pred ccccCCC
Q 024118 249 DFDVQLG 255 (272)
Q Consensus 249 ~~~~~~~ 255 (272)
...+..+
T Consensus 238 ~~~~~~~ 244 (299)
T d1ywna1 238 PGVKIDE 244 (299)
T ss_dssp TTCCCSH
T ss_pred CCCCHHH
Confidence 7655433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=298.17 Aligned_cols=211 Identities=27% Similarity=0.455 Sum_probs=173.2
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCc----EEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGT----IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~----~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
.+|++.+.||+|+||+||+|.+. +|+ +||+|.+... .......+.+|+..+++++ ||||+++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC--CTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecC-Ce
Confidence 56999999999999999999875 454 5888877533 3445678999999999998 99999999999875 56
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
+++++++.+++|.+.+. .....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++.
T Consensus 86 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 78889999999998873 3456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc-ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehhh
Q 024118 196 LFPENTTH-ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLVD 261 (272)
Q Consensus 196 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~~ 261 (272)
........ ......||+.|+|||.+.+..++.++||||+||++|+|+| |.+||+..+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~ 227 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 76543322 2333467899999999999999999999999999999998 899998877665444443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=297.43 Aligned_cols=208 Identities=25% Similarity=0.421 Sum_probs=170.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-C-CcEEEEEEEEecC--cccHHHHHHHHHHhhcccc-cccceeEeeeeEec----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-D-GTIVAVKVLSVES--KQGEKEFMSEVASMANVNV-CHENLVKLHGGCID---- 111 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~-~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~-~~~~i~~l~~~~~~---- 111 (272)
.++|++++.||+|+||+||+|.+. + ++.||||++.... ........+|+..++.+.. .||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999874 4 6779999987542 2223345566666665531 29999999998853
Q ss_pred -CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 112 -GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 112 -~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
....++++|+++++.+.... ......+++..++.++.|++.||.|||++ +|+||||||+|||++..+.++|+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH---HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhh---hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34678999999887766444 24556789999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
||.+..... ........||+.|+|||++.+..++.++||||+||++|+|++|++||...+..+.
T Consensus 160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 223 (305)
T d1blxa_ 160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223 (305)
T ss_dssp CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence 999875432 2234456799999999999999999999999999999999999999987765443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=289.41 Aligned_cols=209 Identities=29% Similarity=0.455 Sum_probs=171.6
Q ss_pred HHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEec-CCcee
Q 024118 38 KIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRI 116 (272)
Q Consensus 38 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~-~~~~~ 116 (272)
.+.-++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+..+++++ ||||+++++++.+ ++..+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCC--CTTBCCEEEEECCC--CCE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCC--CCCEeeEEEEEEecCCcEE
Confidence 445678999999999999999999985 778999998633 34567899999999998 9999999998865 46689
Q ss_pred EEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 117 LVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 117 iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+||||+++|+|.+++.. .....+++..++.++.|++.|+.|||++ +|+||||+|+||+++.++.++++|||++..
T Consensus 78 lv~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp EEECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccccee
Confidence 99999999999999843 2334689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCceehh
Q 024118 197 FPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEYHLV 260 (272)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~~~~ 260 (272)
.... .....++..|+|||.+.+..+++++||||+|+++|+|+| |++||...+..+....+
T Consensus 153 ~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i 213 (262)
T d1byga_ 153 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred cCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 4332 222456888999999999999999999999999999998 79999877766544444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-42 Score=287.46 Aligned_cols=209 Identities=21% Similarity=0.285 Sum_probs=175.0
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
..++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+|++.++.+.. |++++.+++++..+...++|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~-~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAG-CTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTT-CTTCCCEEEEEEETTEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcC-CCCCCEEEEEeecCCccEEE
Confidence 4578999999999999999999976 799999998864432 2245667777777763 68999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----CCCeEEeecCc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ-----NFNPKISDFGL 193 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~-----~~~~~l~Dfg~ 193 (272)
|||+ +++|.+.+. .....+++..+..++.|++.+|.+||++ ||+||||||+||+++. .+.++|+|||+
T Consensus 80 me~~-~~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHH---hhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 9998 788988873 3445799999999999999999999999 9999999999999964 56799999999
Q ss_pred ccccCCCCc------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 194 SKLFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 194 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
+........ .......||+.|+|||++.+..+++++|+||||+++|+|++|+.||...+......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 986643221 12334579999999999999999999999999999999999999998766554433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=290.80 Aligned_cols=209 Identities=28% Similarity=0.471 Sum_probs=167.8
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC--CC--cEEEEEEEEec---CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ--DG--TIVAVKVLSVE---SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~--~~--~~v~vK~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
..++|++.+.||+|+||.||+|+.. ++ ..||||++... .......+.+|+..+++++ ||||+++++++.+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVLT- 82 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC--CTTBCCEEEEECS-
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEee-
Confidence 4578999999999999999999753 33 36899988643 2334467899999999998 9999999999965
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...++||||++++++.+.+. ....++++..++.++.|++.||.|||++ +|+||||||.||+++.++.++|+|||
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred cchheeeeeecCcchhhhhh---cccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence 46789999999999998873 3456799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccCCCce
Q 024118 193 LSKLFPENTTH--ISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQLGEY 257 (272)
Q Consensus 193 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~~~~~ 257 (272)
++......... ......++..|+|||.+.+..++.++||||+|+++|+|+| |+.||...+..+..
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~ 224 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH
Confidence 99976543322 2233456788999999999999999999999999999998 89999876655543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-43 Score=293.79 Aligned_cols=219 Identities=31% Similarity=0.445 Sum_probs=181.9
Q ss_pred HHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeeee
Q 024118 36 QLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHGG 108 (272)
Q Consensus 36 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~~ 108 (272)
.+....++|++.+.||+|+||+||+|+++ ++..||||.+..... ....++.+|+..+++++ ||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC--CCCcccceee
Confidence 45556788999999999999999999864 357899999864432 33567899999999998 9999999999
Q ss_pred EecCCceeEEEeecCCCCHhHHHhhcc--------------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCe
Q 024118 109 CIDGPCRILVYDYMPNNSLSQTLLGEE--------------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHV 168 (272)
Q Consensus 109 ~~~~~~~~iv~e~~~~~~L~~~~~~~~--------------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i 168 (272)
+......++++||+++++|.+++.... .....+++..+..++.|++.|+.|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999985422 1123588999999999999999999999 99
Q ss_pred EecCCCCCCEEEcCCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCC-C
Q 024118 169 VHRDIKTSNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-T 246 (272)
Q Consensus 169 ~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~-~ 246 (272)
+||||||+||+++.++.+||+|||++....... ........+++.|+|||.+.+..++.++||||+||++|+|++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999997654332 22233456888999999999999999999999999999999985 6
Q ss_pred ccccccCCCceeh
Q 024118 247 AVDFDVQLGEYHL 259 (272)
Q Consensus 247 p~~~~~~~~~~~~ 259 (272)
||...+..+....
T Consensus 242 p~~~~~~~e~~~~ 254 (301)
T d1lufa_ 242 PYYGMAHEEVIYY 254 (301)
T ss_dssp TTTTSCHHHHHHH
T ss_pred CCCCCCHHHHHHH
Confidence 7887766554333
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=292.76 Aligned_cols=203 Identities=26% Similarity=0.352 Sum_probs=168.8
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeEecCC----c
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP----C 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~----~ 114 (272)
.++|++++.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++ ||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC--CTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC--CCCCCcEEEEEeeccccccc
Confidence 467999999999999999999875 89999999986443 334567889999999998 999999999987653 2
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcc
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLS 194 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~ 194 (272)
.+++++++.+++|.+++. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|+|||++
T Consensus 85 ~~~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CEEEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 355666777999999983 34799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC--ccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 195 KLFPENT--THISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 195 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
....... ........|++.|.|||++.. ..++.++|+||+||++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 8654322 122344678999999999854 4578999999999999999999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=291.15 Aligned_cols=207 Identities=25% Similarity=0.393 Sum_probs=172.4
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec------
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------ 111 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~------ 111 (272)
.++|++++.||+|+||+||+|.+. +|+.||||++... ......++.+|+..++.++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC--CTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc--CCCccceEeeeeccccccc
Confidence 478999999999999999999976 8999999998644 3334567889999999998 9999999998765
Q ss_pred --CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 112 --GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 112 --~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
....+++|||+.++.+.... .....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++++
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred ccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 34578999999877666554 4566789999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCC---ccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCCc
Q 024118 190 DFGLSKLFPENT---THISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGE 256 (272)
Q Consensus 190 Dfg~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~ 256 (272)
|||++....... ........||+.|+|||++.+. .+++++|+||+||++|+|++|+.||...+....
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence 999997664322 1223335689999999998765 589999999999999999999999986655443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=292.51 Aligned_cols=210 Identities=28% Similarity=0.409 Sum_probs=180.3
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC----CCcEEEEEEEEec----CcccHHHHHHHHHHhhcccccccceeEeeeeEecC
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ----DGTIVAVKVLSVE----SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG 112 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~----~~~~v~vK~~~~~----~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~ 112 (272)
.++|++.+.||+|+||+||+|... +|+.||+|.+... .......+.+|++.+++++. ||||+++++.+...
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h-~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-SPFLVTLHYAFQTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-CTTBCCEEEEEEET
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC-CCeEEEeeeeeccC
Confidence 477999999999999999999752 5899999998532 22334567889999999982 38999999999999
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...+++|||+.+++|.+.+ .....+++..++.++.||+.|+.|||++ +|+||||||+||+++.++.++|+|||
T Consensus 102 ~~~~~v~e~~~~~~L~~~i----~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp TEEEEEECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred CceeeeeecccccHHHHHH----HhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeecc
Confidence 9999999999999999998 5566788999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCC--CCCCCceehHHHHHHHHHhCCCccccccCCCcee
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGR--LTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYH 258 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~ 258 (272)
++...............|++.|+|||.+.+.. ++.++||||+||++|+|++|+.||...+..+...
T Consensus 175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~ 242 (322)
T d1vzoa_ 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242 (322)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99876554444455567899999999997653 6789999999999999999999998776655433
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=291.18 Aligned_cols=219 Identities=26% Similarity=0.410 Sum_probs=178.7
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEeCC--------CcEEEEEEEEecCc-ccHHHHHHHHHHhhcccccccceeEeee
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESK-QGEKEFMSEVASMANVNVCHENLVKLHG 107 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~--------~~~v~vK~~~~~~~-~~~~~~~~e~~~~~~~~~~~~~i~~l~~ 107 (272)
|.+..++|++.+.||+|+||.||+|+..+ +..||||+++.... .....+.+|...+.++.. ||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~-HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcC-CCeEEeccc
Confidence 55777899999999999999999997532 24799999875433 344678888888888833 999999999
Q ss_pred eEecCCceeEEEeecCCCCHhHHHhhccc------------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 108 GCIDGPCRILVYDYMPNNSLSQTLLGEEK------------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 108 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
++.+++..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 99999999999999999999999954421 234689999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCC-ccccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENT-THISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+|||++.++.++|+|||.+....... ........+++.|+|||.+.+..+++++||||+|+++|+|++ |++||...+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999999998664332 222344668899999999999999999999999999999998 7999987766
Q ss_pred CCceeh
Q 024118 254 LGEYHL 259 (272)
Q Consensus 254 ~~~~~~ 259 (272)
...+..
T Consensus 244 ~~~~~~ 249 (299)
T d1fgka_ 244 EELFKL 249 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 554433
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=290.19 Aligned_cols=216 Identities=24% Similarity=0.408 Sum_probs=182.3
Q ss_pred HHHhhCCeeeeeeeeeccceEEEEEEe------CCCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeEeeeeE
Q 024118 37 LKIATNGFRWSNKIGEGGFGSVYKGRL------QDGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVKLHGGC 109 (272)
Q Consensus 37 ~~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~ 109 (272)
|.+..++|++.+.||+|+||.||+|++ .++..||||.++... ......+.+|+..++.+.. ||||+++++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~-HpnIv~~~g~~ 96 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN-HMNIVNLLGAC 96 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccC-CCCEEEEEEEE
Confidence 557778999999999999999999975 246789999987543 3344578889999998843 99999999999
Q ss_pred ecCCceeEEEeecCCCCHhHHHhhcc--------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 024118 110 IDGPCRILVYDYMPNNSLSQTLLGEE--------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKT 175 (272)
Q Consensus 110 ~~~~~~~iv~e~~~~~~L~~~~~~~~--------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p 175 (272)
......+++|||+++++|.+++.... .....+++..+..++.||+.|+.|||++ +++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 99999999999999999999985432 1234689999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHh-CCCccccccC
Q 024118 176 SNILLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVS-GRTAVDFDVQ 253 (272)
Q Consensus 176 ~nilv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~t-g~~p~~~~~~ 253 (272)
+||+++.++.++++|||.+........ .......+++.|+|||.+.+..++.++||||+||++|+|+| |.+||...+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654332 23344678999999999999999999999999999999998 6666766655
Q ss_pred CCc
Q 024118 254 LGE 256 (272)
Q Consensus 254 ~~~ 256 (272)
.+.
T Consensus 254 ~~~ 256 (311)
T d1t46a_ 254 DSK 256 (311)
T ss_dssp SHH
T ss_pred HHH
Confidence 443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-42 Score=287.59 Aligned_cols=225 Identities=18% Similarity=0.287 Sum_probs=180.0
Q ss_pred cCccCCCCCCcccccccccccCCChhHHHHhhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHH
Q 024118 10 FPSRVSAENTIGGEQILKNINAFSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSE 88 (272)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e 88 (272)
+++++.........+.+.+.+....... ..++|++++.||+|+||+||+|++. +|+.||||+++.. ....+.+|
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~E 79 (328)
T d3bqca1 5 SRARVYTDVNTHRPREYWDYESHVVEWG--NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKRE 79 (328)
T ss_dssp CCCSSSTTTTTTSCHHHHCGGGCCCCCC--CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHH
T ss_pred CcceeeccccccCCCccchhhhcccCCC--CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHH
Confidence 3334444444444444444433333322 3468999999999999999999986 7999999998632 34578889
Q ss_pred HHHhhcccccccceeEeeeeEec--CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCC
Q 024118 89 VASMANVNVCHENLVKLHGGCID--GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQP 166 (272)
Q Consensus 89 ~~~~~~~~~~~~~i~~l~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ 166 (272)
+..++.+.. ||||+++++++.. ....++||||+.+++|.... ..+++..++.++.||+.||.|||++
T Consensus 80 i~il~~l~~-hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~--- 148 (328)
T d3bqca1 80 IKILENLRG-GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM--- 148 (328)
T ss_dssp HHHHHHHTT-STTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHhccC-CCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---
Confidence 999998854 9999999999874 35688999999999987654 4689999999999999999999999
Q ss_pred CeEecCCCCCCEEEcCCC-CeEEeecCcccccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhC
Q 024118 167 HVVHRDIKTSNILLDQNF-NPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSG 244 (272)
Q Consensus 167 ~i~h~dl~p~nilv~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg 244 (272)
||+||||||+|||++.++ .++|+|||++........ .....+|+.|+|||.+.+.. ++.++|+||+||++|+|++|
T Consensus 149 gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g 226 (328)
T d3bqca1 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 226 (328)
T ss_dssp TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccceEEcCCCCeeeecccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccC
Confidence 999999999999998655 589999999986543322 34456899999999988654 79999999999999999999
Q ss_pred CCcccccc
Q 024118 245 RTAVDFDV 252 (272)
Q Consensus 245 ~~p~~~~~ 252 (272)
+.||....
T Consensus 227 ~~pf~~~~ 234 (328)
T d3bqca1 227 KEPFFHGH 234 (328)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCc
Confidence 99997544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=292.70 Aligned_cols=201 Identities=27% Similarity=0.405 Sum_probs=167.4
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEecCC---
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP--- 113 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~--- 113 (272)
..++|++++.||+|+||+||+|.+. +|+.||||+++.. .......+.+|+..++++. ||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFTPDETLD 93 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--BTTBCCCSEEECSCSSTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC--CCCeeEEEEEeccCcccc
Confidence 3578999999999999999999976 7999999998743 2233457889999999998 999999999987654
Q ss_pred ---ceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 024118 114 ---CRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISD 190 (272)
Q Consensus 114 ---~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~D 190 (272)
..++||||+ +.+|.... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++++|
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred ccceEEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence 468999999 66777766 346799999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCccccccccccccccCccccccC-CCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 191 FGLSKLFPENTTHISTRVAGTLGYLAPEYAISG-RLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
||++...... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|++||...+...
T Consensus 165 fg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~ 226 (346)
T d1cm8a_ 165 FGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226 (346)
T ss_dssp CTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH
Confidence 9999865432 2345789999999998765 46899999999999999999999998765443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=289.73 Aligned_cols=225 Identities=25% Similarity=0.390 Sum_probs=187.8
Q ss_pred CChhHHHHhhCCeeeeeeeeeccceEEEEEEeC------CCcEEEEEEEEecC-cccHHHHHHHHHHhhcccccccceeE
Q 024118 32 FSYNQLKIATNGFRWSNKIGEGGFGSVYKGRLQ------DGTIVAVKVLSVES-KQGEKEFMSEVASMANVNVCHENLVK 104 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~~~~~~~~~~~i~~ 104 (272)
+..+.|.+..++|++.+.||+|+||.||+|.+. ++..||||.++... ......+.+|+..++++. ||||++
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~ 87 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVR 87 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC--CTTBCC
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC--CCCEee
Confidence 344567788899999999999999999999763 36789999986432 233356889999999998 999999
Q ss_pred eeeeEecCCceeEEEeecCCCCHhHHHhhccc------ccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 024118 105 LHGGCIDGPCRILVYDYMPNNSLSQTLLGEEK------RRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNI 178 (272)
Q Consensus 105 l~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~ni 178 (272)
+++++...+..++||||+++|+|.+++..... ....++...+..++.|+++|+.|||++ +|+||||||+||
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 164 (308)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred eeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCce
Confidence 99999999999999999999999999854321 123468899999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeecCcccccCCCCc-cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhC-CCccccccCCCc
Q 024118 179 LLDQNFNPKISDFGLSKLFPENTT-HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSG-RTAVDFDVQLGE 256 (272)
Q Consensus 179 lv~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg-~~p~~~~~~~~~ 256 (272)
|++.++++||+|||++........ .......+++.|+|||.+.+..++.++|+||+|+++|+|+|| .+||...+..+.
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~ 244 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred eecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986543222 223335688999999999999999999999999999999998 588987776665
Q ss_pred eehhh
Q 024118 257 YHLVD 261 (272)
Q Consensus 257 ~~~~~ 261 (272)
+..+.
T Consensus 245 ~~~i~ 249 (308)
T d1p4oa_ 245 LRFVM 249 (308)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 54443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=288.27 Aligned_cols=213 Identities=30% Similarity=0.446 Sum_probs=174.3
Q ss_pred hhCCeeeeeeeeeccceEEEEEEeC-CCc--EEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEecCCce
Q 024118 40 ATNGFRWSNKIGEGGFGSVYKGRLQ-DGT--IVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCR 115 (272)
Q Consensus 40 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~--~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~ 115 (272)
..++|++.+.||+|+||.||+|.++ +|. .||||.+... .......+.+|++.+.++.. ||||+++++++...+..
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~-HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-HPNIINLLGACEHRGYL 86 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCC-CTTBCCEEEEEEETTEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccC-CCCEeeEEEEEecCCee
Confidence 4478999999999999999999876 555 4677776533 33345678999999999832 99999999999999999
Q ss_pred eEEEeecCCCCHhHHHhhcc------------cccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 024118 116 ILVYDYMPNNSLSQTLLGEE------------KRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQN 183 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~ 183 (272)
++||||+++|+|.+++.... .....+++..++.++.|++.|+.|||++ +|+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence 99999999999999985432 2346789999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCC-CccccccCCCcee
Q 024118 184 FNPKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGR-TAVDFDVQLGEYH 258 (272)
Q Consensus 184 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~-~p~~~~~~~~~~~ 258 (272)
+.++|+|||++........ .....+|..|+|||.+.+..++.++||||+|+++|+|++|. +||...+..+...
T Consensus 164 ~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999975432222 23346789999999999999999999999999999999965 5787766555433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-42 Score=289.62 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=166.2
Q ss_pred CeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecC------Cce
Q 024118 43 GFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG------PCR 115 (272)
Q Consensus 43 ~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~------~~~ 115 (272)
+|...+.||+|+||+||+|++. +|+.||||++..... ...+|+..+++++ ||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~--h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLD--HCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCC--CTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcC--CCCCCcEEEEEEecCccCCceEE
Confidence 6999999999999999999986 799999999874432 2236889999998 99999999988543 346
Q ss_pred eEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-CeEEeecCcc
Q 024118 116 ILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNF-NPKISDFGLS 194 (272)
Q Consensus 116 ~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~-~~~l~Dfg~~ 194 (272)
++||||++++ +...+.........+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .++|+|||++
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 8999999765 4444433334566899999999999999999999999 999999999999998765 7999999999
Q ss_pred cccCCCCccccccccccccccCcccccc-CCCCCCCceehHHHHHHHHHhCCCccccccCCC
Q 024118 195 KLFPENTTHISTRVAGTLGYLAPEYAIS-GRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLG 255 (272)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~ 255 (272)
........ .....|++.|.|||.+.+ ..++.++||||+||++|+|++|++||...+..+
T Consensus 171 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~ 230 (350)
T d1q5ka_ 171 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230 (350)
T ss_dssp EECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH
T ss_pred hhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH
Confidence 86643322 233578999999998875 468999999999999999999999998766443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-41 Score=281.76 Aligned_cols=208 Identities=24% Similarity=0.327 Sum_probs=166.7
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccc-eeEeeeeEecCCceeEE
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHEN-LVKLHGGCIDGPCRILV 118 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-i~~l~~~~~~~~~~~iv 118 (272)
.++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+..|++.++.+. |++ |+.+..+...++..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~--~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ--GGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHST--TSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHcc--CCCcccEEEEEEecCCEEEEE
Confidence 357999999999999999999876 7999999998754332 35678899998887 555 55566667788889999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCCeEEeecCccc
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQ---NFNPKISDFGLSK 195 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~---~~~~~l~Dfg~~~ 195 (272)
|||+ +++|...+. .....+++..+..++.|++.||+|||++ ||+||||||+||+++. +..++|+|||++.
T Consensus 82 me~~-~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 82 MELL-GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EECC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEc-CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 9999 556665552 3456799999999999999999999999 9999999999999864 4469999999998
Q ss_pred ccCCCCc------cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccCCCceeh
Q 024118 196 LFPENTT------HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQLGEYHL 259 (272)
Q Consensus 196 ~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~~~~~~~ 259 (272)
....... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 7643221 123345799999999999999999999999999999999999999987665544433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=279.52 Aligned_cols=198 Identities=22% Similarity=0.404 Sum_probs=173.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEE
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILV 118 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv 118 (272)
++|++++.||+|+||+||+|++. +|+.||||+++... .....++.+|+..++.++ ||||+++++++......+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC--cCCEEeeccccccccceeEE
Confidence 58999999999999999999986 79999999997543 234578889999999998 99999999999999999999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
++++.+++|..++ .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 80 FEFCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EECCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eeecccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhccc
Confidence 9999999888877 4567889999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccc
Q 024118 199 ENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVD 249 (272)
Q Consensus 199 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~ 249 (272)
..... .....++..|.|||.+.+.. ++.++||||+||++|+|++|+.||.
T Consensus 153 ~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 153 IPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp SCCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred CCCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 33222 22245677899999987665 6899999999999999999999863
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=283.94 Aligned_cols=201 Identities=28% Similarity=0.418 Sum_probs=162.1
Q ss_pred hCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHH--HHHHhhcccccccceeEeeeeEecCC----c
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMS--EVASMANVNVCHENLVKLHGGCIDGP----C 114 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~--e~~~~~~~~~~~~~i~~l~~~~~~~~----~ 114 (272)
.++|.+.+.||+|+||.||+|+. +|+.||||++... ....... |+..+.+++ ||||+++++++...+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~--HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLR--HENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCC--CCcCcceEEEEEeCCCcceE
Confidence 46789999999999999999987 5889999998633 2233334 444555666 999999999988654 5
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCCeEEe
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-----IQPHVVHRDIKTSNILLDQNFNPKIS 189 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-----~~~~i~h~dl~p~nilv~~~~~~~l~ 189 (272)
.++||||+++++|.+++. +.++++..++.++.|++.++.+||+. ...||+||||||+|||++.++.+||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 789999999999999993 34688999999999999999999962 12399999999999999999999999
Q ss_pred ecCcccccCCCCcc---ccccccccccccCccccccCC------CCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 190 DFGLSKLFPENTTH---ISTRVAGTLGYLAPEYAISGR------LTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 190 Dfg~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~------~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|||++......... ......||+.|+|||++.+.. ++.++||||+||++|+|+||.+||....
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 99999866433221 233467899999999987653 5678999999999999999998886433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=277.37 Aligned_cols=198 Identities=29% Similarity=0.461 Sum_probs=167.0
Q ss_pred eeeeeeeeccceEEEEEEeCC----CcEEEEEEEEec-CcccHHHHHHHHHHhhcccccccceeEeeeeEec-CCceeEE
Q 024118 45 RWSNKIGEGGFGSVYKGRLQD----GTIVAVKVLSVE-SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID-GPCRILV 118 (272)
Q Consensus 45 ~i~~~lg~G~~~~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~-~~~~~iv 118 (272)
.+.+.||+|+||+||+|.+.. ...||||.++.. ......++.+|++.+++++ ||||+++++++.. +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC--CCCEeEEeEEEEecCCceEEE
Confidence 346789999999999998653 235899998633 4445578999999999998 9999999999775 4578999
Q ss_pred EeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecCcccccC
Q 024118 119 YDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFGLSKLFP 198 (272)
Q Consensus 119 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~~~ 198 (272)
|||+++++|.+++. .....+++..+..++.|++.|+.|||+. +|+||||||+|||+++++.++|+|||++....
T Consensus 108 ~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 99999999999883 3445677888999999999999999999 99999999999999999999999999998664
Q ss_pred CCCc---cccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccc
Q 024118 199 ENTT---HISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDF 250 (272)
Q Consensus 199 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~ 250 (272)
.... .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||..
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 3321 223335688999999999999999999999999999999997777654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=284.61 Aligned_cols=200 Identities=27% Similarity=0.365 Sum_probs=168.0
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecC--cccHHHHHHHHHHhhcccccccceeEeeeeEecC-----
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVES--KQGEKEFMSEVASMANVNVCHENLVKLHGGCIDG----- 112 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~----- 112 (272)
.++|++.+.||+|+||+||+|++. +|+.||||++.... .....++.+|+..+++++ |||++++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC--CCCeeeEEEEEeecccccc
Confidence 578999999999999999999976 79999999987442 234457889999999998 99999999988633
Q ss_pred CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeecC
Q 024118 113 PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDFG 192 (272)
Q Consensus 113 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Dfg 192 (272)
...+++++++.+++|.+++ ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.++++|||
T Consensus 95 ~~~~~i~~~~~gg~L~~~~-----~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCCEEEEECCSEEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred CceEEEEEeecCCchhhhc-----ccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 3456777888899999998 335699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccccCC-CCCCCceehHHHHHHHHHhCCCccccccCC
Q 024118 193 LSKLFPENTTHISTRVAGTLGYLAPEYAISGR-LTRKSDVYSFGVLLLEIVSGRTAVDFDVQL 254 (272)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~il~~l~tg~~p~~~~~~~ 254 (272)
.+.... .......|++.|+|||.+.+.. ++.++|+||+||++|+|++|++||.+.+..
T Consensus 167 ~a~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~ 225 (348)
T d2gfsa1 167 LARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225 (348)
T ss_dssp ---CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hhcccC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence 997543 2233457889999999877765 688999999999999999999999766543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=284.24 Aligned_cols=198 Identities=24% Similarity=0.281 Sum_probs=161.2
Q ss_pred hCCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEec--CcccHHHHHHHHHHhhcccccccceeEeeeeEec------
Q 024118 41 TNGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE--SKQGEKEFMSEVASMANVNVCHENLVKLHGGCID------ 111 (272)
Q Consensus 41 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~------ 111 (272)
.++|++++.||+|+||+||+|.+. +|+.||||++... ......++.+|+..+++++ ||||+++++++..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC--CCCeeEEEEEEeccccccc
Confidence 368999999999999999999987 7999999999744 2334457889999999998 9999999999864
Q ss_pred CCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 024118 112 GPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFNPKISDF 191 (272)
Q Consensus 112 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~~~l~Df 191 (272)
....++||||+.++.+... ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++++||
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~-------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp CCEEEEEEECCSEEHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CceeEEEEeccchHHHHhh-------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence 3578999999976655433 24589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCcccccc
Q 024118 192 GLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDV 252 (272)
Q Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~ 252 (272)
|++....... ......+|+.|+|||++.+..+++++|+||+||++++|++|++||...+
T Consensus 164 ~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp CC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 9987654322 2344568999999999999999999999999999999999999997655
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-35 Score=250.50 Aligned_cols=203 Identities=21% Similarity=0.270 Sum_probs=158.2
Q ss_pred CCeeeeeeeeeccceEEEEEEeC-CCcEEEEEEEEecCcccHHHHHHHHHHhhcccc---------cccceeEeeeeEec
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVESKQGEKEFMSEVASMANVNV---------CHENLVKLHGGCID 111 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~---------~~~~i~~l~~~~~~ 111 (272)
.+|++++.||+|+||+||+|++. +|+.||||+++... .......+|+..++.+.. .|+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 56999999999999999999986 79999999987432 233456677777776641 26899999988764
Q ss_pred C--CceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCC---
Q 024118 112 G--PCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHE-EIQPHVVHRDIKTSNILLDQNFN--- 185 (272)
Q Consensus 112 ~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~i~h~dl~p~nilv~~~~~--- 185 (272)
. ....++++++.......... .......+++..++.++.|++.|+.+||+ . ||+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 3 45556666654443322221 22455678999999999999999999998 6 9999999999999976654
Q ss_pred ---eEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHHHHHHhCCCccccccC
Q 024118 186 ---PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLLLEIVSGRTAVDFDVQ 253 (272)
Q Consensus 186 ---~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il~~l~tg~~p~~~~~~ 253 (272)
++++|||.+...... .....|++.|+|||++.+..++.++|+||+||++++|++|+.||...+.
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 899999998754322 2345789999999999999999999999999999999999999986554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=4.4e-25 Score=170.75 Aligned_cols=170 Identities=15% Similarity=0.088 Sum_probs=119.4
Q ss_pred eeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCc------------------ccHHHHHHHHHHhhcccccccceeEe
Q 024118 44 FRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESK------------------QGEKEFMSEVASMANVNVCHENLVKL 105 (272)
Q Consensus 44 y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~------------------~~~~~~~~e~~~~~~~~~~~~~i~~l 105 (272)
+.+.+.||+|+||.||+|.+.+|+.||||+++.... ........|...+.++. |++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc--CCCcceE
Confidence 468899999999999999988999999998753210 01123345677777777 8888887
Q ss_pred eeeEecCCceeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCC
Q 024118 106 HGGCIDGPCRILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEEIQPHVVHRDIKTSNILLDQNFN 185 (272)
Q Consensus 106 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i~h~dl~p~nilv~~~~~ 185 (272)
++.. ..+++||++++..+. .+++..+..++.|++.++.+||++ ||+||||||+||+++++ .
T Consensus 80 ~~~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 80 YAWE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp EEEE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred EEec----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-C
Confidence 7552 347999999875432 244566778999999999999999 99999999999999866 5
Q ss_pred eEEeecCcccccCCCCccccccccccccccCccccccCCCCCCCceehHHHHH
Q 024118 186 PKISDFGLSKLFPENTTHISTRVAGTLGYLAPEYAISGRLTRKSDVYSFGVLL 238 (272)
Q Consensus 186 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~il 238 (272)
++|+|||.+............ ...... -.+ +....|+.++|+||+.--+
T Consensus 141 ~~liDFG~a~~~~~~~~~~~l--~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWREIL--ERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEECCCTTCEETTSTTHHHHH--HHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEEEECCCcccCCCCCcHHHH--HHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 899999998765422211100 000000 011 2245678899999976543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.05 E-value=7.2e-10 Score=88.16 Aligned_cols=150 Identities=16% Similarity=0.051 Sum_probs=101.2
Q ss_pred hHHHHhhCCeeeeeeeeeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCc
Q 024118 35 NQLKIATNGFRWSNKIGEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPC 114 (272)
Q Consensus 35 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~ 114 (272)
..+....+.|++++..+.++.+.||++.. +++.+++|............+.+|...+..+.. +--+++++.+...++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~-~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc-cCCCCcEEEEEecCCc
Confidence 34555667888888766666688998864 466678888764433334456677777666643 3346777777788888
Q ss_pred eeEEEeecCCCCHhHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc-------------------------------
Q 024118 115 RILVYDYMPNNSLSQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE------------------------------- 163 (272)
Q Consensus 115 ~~iv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~------------------------------- 163 (272)
.++||++++|.++.+.... ......++.++...+..||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999999887655411 111222344455555555532
Q ss_pred -------------------------CCCCeEecCCCCCCEEEcCCCCeEEeecCccc
Q 024118 164 -------------------------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSK 195 (272)
Q Consensus 164 -------------------------~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~ 195 (272)
....++|+|+.|.||++++++...|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12248999999999999876556799999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.67 E-value=6.6e-08 Score=76.07 Aligned_cols=133 Identities=15% Similarity=0.113 Sum_probs=85.6
Q ss_pred eeeecc-ceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCCceeEEEeecCCCCH
Q 024118 49 KIGEGG-FGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGPCRILVYDYMPNNSL 127 (272)
Q Consensus 49 ~lg~G~-~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~~~~iv~e~~~~~~L 127 (272)
.+..|. .+.||++...++..+++|........ .+..|...++.+....-.+++++....+++..+++|++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444454 46889998888888999986544322 34556666666553344467778877888889999999998765
Q ss_pred hHHHhhcccccccCChHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 024118 128 SQTLLGEEKRRAKFGWKARREIIMGIGRGLAYIHEE-------------------------------------------- 163 (272)
Q Consensus 128 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-------------------------------------------- 163 (272)
.+.. .+.. ..+.++...+..||+.
T Consensus 94 ~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 4321 0000 1112233333333321
Q ss_pred -----------CCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 164 -----------IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 164 -----------~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
....++|+|+.|.||+++++..+.++||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112489999999999998775567999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.32 E-value=2.5e-06 Score=71.31 Aligned_cols=78 Identities=12% Similarity=0.084 Sum_probs=49.0
Q ss_pred eeeeeeccceEEEEEEeC-CCcEEEEEEEEec-----C--cccHHHHHHHHHHhhcccccc-cceeEeeeeEecCCceeE
Q 024118 47 SNKIGEGGFGSVYKGRLQ-DGTIVAVKVLSVE-----S--KQGEKEFMSEVASMANVNVCH-ENLVKLHGGCIDGPCRIL 117 (272)
Q Consensus 47 ~~~lg~G~~~~v~~~~~~-~~~~v~vK~~~~~-----~--~~~~~~~~~e~~~~~~~~~~~-~~i~~l~~~~~~~~~~~i 117 (272)
.+.||.|....||++... +++.+++|..... . .....+...|.+.++.+.... ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999876 4778999965421 1 112234556777776654322 345555543 4556789
Q ss_pred EEeecCCCC
Q 024118 118 VYDYMPNNS 126 (272)
Q Consensus 118 v~e~~~~~~ 126 (272)
+||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.82 E-value=0.00012 Score=59.21 Aligned_cols=140 Identities=13% Similarity=0.017 Sum_probs=78.1
Q ss_pred cceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeee-----eEecCCceeEEEeecCCCCHh
Q 024118 54 GFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHG-----GCIDGPCRILVYDYMPNNSLS 128 (272)
Q Consensus 54 ~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~-----~~~~~~~~~iv~e~~~~~~L~ 128 (272)
--..||++...+|..||+|+.... ......+..|...+..+....-.++..+. ........+.++++++|..+.
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 347899999999999999997643 23445666777777666522111121111 223456678899998765321
Q ss_pred -----HHH-------------hhcc-cc-------------------cccCChH---HHHHHHHHHHHHHHHHh-hcCCC
Q 024118 129 -----QTL-------------LGEE-KR-------------------RAKFGWK---ARREIIMGIGRGLAYIH-EEIQP 166 (272)
Q Consensus 129 -----~~~-------------~~~~-~~-------------------~~~l~~~---~~~~i~~~i~~al~~LH-~~~~~ 166 (272)
.+. .... .. ...++.. .....+.++...+...- +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 100 0000 00 0111111 22223333333333221 11234
Q ss_pred CeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 167 HVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 167 ~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
+++|+|++|.||+++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 89999999999999743 46899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.75 E-value=0.00015 Score=60.21 Aligned_cols=79 Identities=20% Similarity=0.237 Sum_probs=52.6
Q ss_pred CCeeeeeeeeeccceEEEEEEeCC--------CcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEeeeeEecCC
Q 024118 42 NGFRWSNKIGEGGFGSVYKGRLQD--------GTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLHGGCIDGP 113 (272)
Q Consensus 42 ~~y~i~~~lg~G~~~~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~~~~~~~~ 113 (272)
+.+++ +.|+.|-...+|++...+ +..|++++.. . ........+|...++.+.. +.-.++++.++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~-~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSE-RHLGPKLYGIFSG-- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHH-TTSSSCEEEEETT--
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHh-CCCCCeEEEEcCC--
Confidence 34544 677778899999998643 3568888765 2 2334456678888777764 3335567766543
Q ss_pred ceeEEEeecCCCCHh
Q 024118 114 CRILVYDYMPNNSLS 128 (272)
Q Consensus 114 ~~~iv~e~~~~~~L~ 128 (272)
.+|+||++|.++.
T Consensus 117 --g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 --GRLEEYIPSRPLS 129 (395)
T ss_dssp --EEEECCCCEEECC
T ss_pred --ceEEEEeccccCC
Confidence 6899999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.74 E-value=0.0004 Score=55.55 Aligned_cols=162 Identities=12% Similarity=0.004 Sum_probs=81.8
Q ss_pred CChhHHHHhhCCeeeeeee-----eeccceEEEEEEeCCCcEEEEEEEEecCcccHHHHHHHHHHhhcccccccceeEee
Q 024118 32 FSYNQLKIATNGFRWSNKI-----GEGGFGSVYKGRLQDGTIVAVKVLSVESKQGEKEFMSEVASMANVNVCHENLVKLH 106 (272)
Q Consensus 32 ~~~~~~~~~~~~y~i~~~l-----g~G~~~~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~~~~~~~~~~~i~~l~ 106 (272)
.+.+++....++|.+.+.. ..|--.+.|.+...+|+ +++|+...... ...+..+...+..+......++..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4556666667778775333 34556788999877665 89998753321 2233444555555542222222222
Q ss_pred e------eEecCCceeEEEeecCCCCHhH-----HH---------hh-----------------------cccccccCCh
Q 024118 107 G------GCIDGPCRILVYDYMPNNSLSQ-----TL---------LG-----------------------EEKRRAKFGW 143 (272)
Q Consensus 107 ~------~~~~~~~~~iv~e~~~~~~L~~-----~~---------~~-----------------------~~~~~~~l~~ 143 (272)
. ..........++.+..+..... .. .. ..........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1222344556666666543210 00 00 0000001111
Q ss_pred HHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCEEEcCCCCeEEeecCcccc
Q 024118 144 KARREIIMGIGRGLAYIHEE-IQPHVVHRDIKTSNILLDQNFNPKISDFGLSKL 196 (272)
Q Consensus 144 ~~~~~i~~~i~~al~~LH~~-~~~~i~h~dl~p~nilv~~~~~~~l~Dfg~~~~ 196 (272)
......+......+...... -..|+||+|+.++|++++.+...-++||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 12222233333333333321 123899999999999999876668999999873
|